mirId	Cancer	Profile	PubMed Article
hsa-let-7a	acute myeloid leukemia	up	Inducing Apoptosis and Decreasing Cell Proliferation in Human Acute Promyelocytic Leukemia Through Regulation Expression of CASP3 by Let-7a-5p Blockage.
hsa-let-7a	acute myeloid leukemia	up	Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics.
hsa-let-7a	breast cancer	down	Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients.
hsa-let-7a	breast cancer	down	Tumor suppressor let-7a inhibits breast cancer cell proliferation, migration and invasion by targeting MAGE-A1.
hsa-let-7a	breast cancer	down	Arsenic trioxide inhibits cell growth and motility via up-regulation of let-7a in breast cancer cells.
hsa-let-7a	breast cancer	down	Let-7a mimic attenuates CCL18 induced breast cancer cell metastasis through Lin 28 pathway.
hsa-let-7a	breast cancer	down	Let-7a inhibits growth and migration of breast cancer cells by targeting HMGA1.
hsa-let-7a	breast cancer	down	MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7.
hsa-let-7a	breast cancer	down	The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer.
hsa-let-7a	breast cancer	down	Lin28 induces epithelial-to-mesenchymal transition and stemness via downregulation of let-7a in breast cancer cells.
hsa-let-7a	chondrosarcoma	down	Analysis of microRNAs expressions in chondrosarcoma.
hsa-let-7a	colon cancer	down	Let-7a inhibits tumor cell growth and metastasis by directly targeting RTKN in human colon cancer.
hsa-let-7a	colon cancer	down	[Periostin regulated by let-7/miR-98 family mediates the apoptosis and epithelial-mesenchymal transition of colon cancer].
hsa-let-7a	colorectal cancer	down	Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.
hsa-let-7a	colorectal cancer	down	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-let-7a	colorectal cancer	up	Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.
hsa-let-7a	colorectal cancer	down	IGF1/IGF1R and microRNA let-7e down-regulate each other and modulate proliferation and migration of colorectal cancer cells.
hsa-let-7a	esophageal squamous cell carcinoma	down	Lin28/microRNA-let-7a promotes metastasis under circumstances of hyperactive Wnt signaling in esophageal squamous cell carcinoma.
hsa-let-7a	esophageal squamous cell carcinoma	down	[Expressions and correlations of let-7a and IL-6 in esophageal squamous cell carcinoma].
hsa-let-7a	gastric cancer	down	Circulating microRNAs in plasma of patients with gastric cancers.
hsa-let-7a	gastric cancer	down	Lentiviral vector-mediated upregulation of let-7a inhibits gastric carcinoma cell growth in vitro and in vivo.
hsa-let-7a	gastric cancer	down	Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C.
hsa-let-7a	gastric cancer	down	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-let-7a	gastric cancer	down	Investigation and identification of let-7a related functional proteins in gastric carcinoma by proteomics.
hsa-let-7a	gastric cancer	down	Differentially expressed proteins identified in overexpressed let-7a gastric carcinoma cells by two-dimensional polyacrylamide gel electrophoresis.
hsa-let-7a	glioma	down	Overexpressed let-7a inhibits glioma cell malignancy by directly targeting K-ras, independently of PTEN.
hsa-let-7a	glioma	down	Let-7a suppresses glioma cell proliferation and invasion through TGF-?/Smad3 signaling pathway by targeting HMGA2.
hsa-let-7a	laryngeal cancer	down	[Diagnostic value of serum miRNA let-7a for laryngeal carcinoma and effects of let-7a on proliferation and apoptosis of laryngeal carcinoma cells].
hsa-let-7a	nasopharyngeal carcinoma	down	Let-7a inhibits proliferation and induces apoptosis by targeting EZH2 in nasopharyngeal carcinoma cells.
hsa-let-7a	nasopharyngeal carcinoma	down	Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma.
hsa-let-7a	nasopharyngeal carcinoma	down	Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
hsa-let-7a	non-small cell lung cancer	down	Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-let-7a	oral squamous cell carcinoma	down	Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
hsa-let-7a	osteosarcoma	down	Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells.
hsa-let-7a	osteosarcoma	down	CBX2 is a functional target of miRNA let-7a and acts as a tumor promoter in osteosarcoma.
hsa-let-7a	osteosarcoma	down	Let-7a inhibits osteosarcoma cell growth and lung metastasis by targeting Aurora-B.
hsa-let-7a	pancreatic ductal adenocarcinoma	down	XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.
hsa-let-7a	papillary thyroid carcinoma	down	Role of Lin28A/let-7a/c-Myc Pathway in Growth and Malignant Behavior of Papillary Thyroid Carcinoma.
hsa-let-7a	papillary thyroid carcinoma	down	Let-7a inhibits migration, invasion and tumor growth by targeting AKT2 in papillary thyroid carcinoma.
hsa-let-7a	prostate cancer	down	MiRNALet-7a mediates prostate cancer PC-3 cell invasion, migration by inducing epithelial-mesenchymal transition through CCR7/MAPK pathway.
hsa-let-7a	renal cell carcinoma	down	Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting c-myc.
hsa-let-7a-1	breast cancer	down	Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7a-1	breast cancer	down	Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.
hsa-let-7a-1	bronchioloalveolar carcinoma	down	let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7a-1	colon cancer	down	let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7a-1	esophageal squamous cell carcinoma	down	Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7a-1	esophageal squamous cell carcinoma	down	Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7a-1	gastric cancer	down	Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.
hsa-let-7a-1	hepatocellular carcinoma	down	MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7a-1	lung cancer	down	Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7a-1	lung cancer	down	Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7a-1	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7a-1	nasopharyngeal carcinoma	down	MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7a-1	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7a-1	pancreatic ductal adenocarcinoma	down	let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-let-7a-2	breast cancer	down	Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7a-2	breast cancer	down	Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.
hsa-let-7a-2	bronchioloalveolar carcinoma	down	let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7a-2	colon cancer	down	let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7a-2	esophageal squamous cell carcinoma	down	Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7a-2	esophageal squamous cell carcinoma	down	Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7a-2	gastric cancer	down	Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.
hsa-let-7a-2	hepatocellular carcinoma	down	MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7a-2	lung cancer	down	Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7a-2	lung cancer	down	Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7a-2	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7a-2	nasopharyngeal carcinoma	down	MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7a-2	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7a-2	pancreatic ductal adenocarcinoma	down	let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-let-7a-3	breast cancer	down	Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7a-3	breast cancer	down	Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.
hsa-let-7a-3	bronchioloalveolar carcinoma	down	let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7a-3	colon cancer	down	let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7a-3	esophageal squamous cell carcinoma	down	Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7a-3	esophageal squamous cell carcinoma	down	Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7a-3	gastric cancer	down	Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.
hsa-let-7a-3	hepatocellular carcinoma	down	MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7a-3	lung cancer	down	Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7a-3	lung cancer	down	Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7a-3	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7a-3	nasopharyngeal carcinoma	down	MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7a-3	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7a-3	pancreatic ductal adenocarcinoma	down	let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-let-7a-3p	prostate cancer	down	The miRNA let-7a1 inhibits the expression of insulin-like growth factor 1 receptor (IGF1R) in prostate cancer PC-3 cells.
hsa-let-7b	acute lymphoblastic leukemia	down	Suppression of the let-7b microRNA pathway by DNA hypermethylation in infant acute lymphoblastic leukemia with MLL gene rearrangements.
hsa-let-7b	breast cancer	down	The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer.
hsa-let-7b	breast cancer	down	Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-let-7b	breast cancer	down	Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7b	breast cancer	down	Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.
hsa-let-7b	bronchioloalveolar carcinoma	down	let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7b	colon cancer	down	let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7b	colorectal cancer	down	IGF1/IGF1R and microRNA let-7e down-regulate each other and modulate proliferation and migration of colorectal cancer cells.
hsa-let-7b	esophageal squamous cell carcinoma	down	Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7b	esophageal squamous cell carcinoma	down	Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7b	gastric cancer	down	let-7b/g silencing activates AKT signaling to promote gastric carcinogenesis.
hsa-let-7b	gastric cancer	down	Let-7b inhibits cell proliferation, migration, and invasion through targeting Cthrc1 in gastric cancer.
hsa-let-7b	gastric cancer	down	MicroRNA let-7b suppresses human gastric cancer malignancy by targeting ING1.
hsa-let-7b	gastric cancer	down	Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.
hsa-let-7b	glioma	down	Decreased let-7b is associated with poor prognosis in glioma.
hsa-let-7b	hepatocellular carcinoma	down	Let-7b contributes to hepatocellular cancer progression through Wnt/?-catenin signaling.
hsa-let-7b	hepatocellular carcinoma	down	MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7b	lung cancer	down	Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7b	lung cancer	down	Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7b	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7b	malignant melanoma	down	MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth.
hsa-let-7b	nasopharyngeal carcinoma	down	MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7b	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7b	pancreatic ductal adenocarcinoma	down	let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-let-7b	papillary thyroid carcinoma	down	Roles of microRNA let-7b in papillary thyroid carcinoma by regulating HMGA2.
hsa-let-7b	renal clear cell carcinoma	down	let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma.
hsa-let-7b-5p	chronic myelogenous leukemia	down	Differential expression profiles and functional analysis of plasma miRNAs associated with chronic myeloid leukemia phases.
hsa-let-7c	acute myeloid leukemia	down	miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia.
hsa-let-7c	acute promyelocytic leukemia	down	A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes.
hsa-let-7c	breast cancer	down	Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7c	breast cancer	down	Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.
hsa-let-7c	bronchioloalveolar carcinoma	down	let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7c	cholangiocarcinoma	down	Let-7c inhibits cholangiocarcinoma growth but promotes tumor cell invasion and growth at extrahepatic sites.
hsa-let-7c	colon cancer	down	let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7c	esophageal squamous cell carcinoma	down	Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7c	esophageal squamous cell carcinoma	down	Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7c	gastric cancer	down	Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.
hsa-let-7c	glioma	down	Let-7c Inhibits the Proliferation, Invasion, and Migration of Glioma Cells via Targeting E2F5.
hsa-let-7c	hepatocellular carcinoma	down	MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7c	hepatocellular carcinoma	down	MicroRNA let-7c Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma.
hsa-let-7c	hepatocellular carcinoma	down	MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma.
hsa-let-7c	lung cancer	down	Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7c	lung cancer	down	Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7c	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7c	nasopharyngeal carcinoma	down	MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7c	nasopharyngeal carcinoma	down	Knocking down CDK4 mediates the elevation of let-7c suppressing cell growth in nasopharyngeal carcinoma.
hsa-let-7c	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7c	non-small cell lung cancer	down	MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3.
hsa-let-7c	pancreatic ductal adenocarcinoma	down	let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-let-7c	prostate cancer	down	MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells.
hsa-let-7c	prostate cancer	down	MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth.
hsa-let-7c	renal clear cell carcinoma	down	let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma.
hsa-let-7d	breast cancer	down	Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7d	breast cancer	down	Let-7d Inhibits Growth and Metastasis in Breast Cancer by Targeting Jab1/Cops5.
hsa-let-7d	breast cancer	down	Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.
hsa-let-7d	bronchioloalveolar carcinoma	down	let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7d	chronic myelogenous leukemia	down	microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-let-7d	colon cancer	down	let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7d	esophageal squamous cell carcinoma	down	Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7d	esophageal squamous cell carcinoma	down	Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7d	gastric cancer	down	Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.
hsa-let-7d	head and neck squamous cell carcinoma	down	Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.
hsa-let-7d	head and neck squamous cell carcinoma	up	Low let-7d and high miR-205 expression levels positively influence HNSCC patient outcome.
hsa-let-7d	hepatocellular carcinoma	down	MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7d	lung cancer	down	Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7d	lung cancer	down	Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7d	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7d	nasopharyngeal carcinoma	down	MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7d	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7d	oral cancer	down	Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer.
hsa-let-7d	oral squamous cell carcinoma	down	Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
hsa-let-7d	pancreatic ductal adenocarcinoma	down	let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-let-7d	pancreatic ductal adenocarcinoma	down	MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors.
hsa-let-7d	renal cell carcinoma	down	Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7.
hsa-let-7e	breast cancer	down	Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7e	breast cancer	down	Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.
hsa-let-7e	bronchioloalveolar carcinoma	down	let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7e	colon cancer	down	let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7e	colorectal cancer	down	IGF1/IGF1R and microRNA let-7e down-regulate each other and modulate proliferation and migration of colorectal cancer cells.
hsa-let-7e	colorectal cancer	down	MicroRNA-33a and let-7e inhibit human colorectal cancer progression by targeting ST8SIA1.
hsa-let-7e	esophageal squamous cell carcinoma	down	Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7e	esophageal squamous cell carcinoma	down	Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7e	gastric cancer	down	Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.
hsa-let-7e	glioblastoma	down	Knockdown of NEAT1 restrained the malignant progression of glioma stem cells by activating microRNA let-7e.
hsa-let-7e	hepatocellular carcinoma	down	MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7e	lung cancer	down	Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7e	lung cancer	down	Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7e	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7e	nasopharyngeal carcinoma	down	MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7e	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7e	pancreatic ductal adenocarcinoma	down	let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-let-7e	papillary thyroid carcinoma	up	Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.
hsa-let-7f	glioma	down	Let-7f Inhibits Glioma Cell Proliferation, Migration, and Invasion by Targeting Periostin.
hsa-let-7f	hepatocellular carcinoma	down	Expression of serum miR-16, let-7f, and miR-21 in patients with hepatocellular carcinoma and their clinical significances.
hsa-let-7f	oral squamous cell carcinoma	down	Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
hsa-let-7f-1	breast cancer	down	Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7f-1	breast cancer	down	Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.
hsa-let-7f-1	bronchioloalveolar carcinoma	down	let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7f-1	colon cancer	down	let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7f-1	esophageal squamous cell carcinoma	down	Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7f-1	esophageal squamous cell carcinoma	down	Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7f-1	gastric cancer	down	Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.
hsa-let-7f-1	hepatocellular carcinoma	down	MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7f-1	lung cancer	down	Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7f-1	lung cancer	down	Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7f-1	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7f-1	nasopharyngeal carcinoma	down	MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7f-1	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7f-1	pancreatic ductal adenocarcinoma	down	let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-let-7f-2	breast cancer	down	Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7f-2	breast cancer	down	Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.
hsa-let-7f-2	bronchioloalveolar carcinoma	down	let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7f-2	colon cancer	down	let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7f-2	esophageal squamous cell carcinoma	down	Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7f-2	esophageal squamous cell carcinoma	down	Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7f-2	gastric cancer	down	Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.
hsa-let-7f-2	hepatocellular carcinoma	down	MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7f-2	lung cancer	down	Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7f-2	lung cancer	down	Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7f-2	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7f-2	nasopharyngeal carcinoma	down	MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7f-2	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7f-2	pancreatic ductal adenocarcinoma	down	let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-let-7g	breast cancer	down	The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer.
hsa-let-7g	breast cancer	down	Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7g	breast cancer	down	Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.
hsa-let-7g	breast cancer	down	MicroRNA Let-7g Directly Targets Forkhead Box C2 (FOXC2) to Modulate Bone Metastasis in Breast Cancer.
hsa-let-7g	bronchioloalveolar carcinoma	down	let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7g	colon cancer	down	let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7g	esophageal squamous cell carcinoma	down	Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7g	esophageal squamous cell carcinoma	down	Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7g	gastric cancer	down	let-7b/g silencing activates AKT signaling to promote gastric carcinogenesis.
hsa-let-7g	gastric cancer	down	Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.
hsa-let-7g	hepatocellular carcinoma	down	MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7g	hepatocellular carcinoma	down	MicroRNA let-7g and let-7i inhibit hepatoma cell growth concurrently via downregulation of the anti-apoptotic protein B-cell lymphoma-extra large.
hsa-let-7g	lung cancer	down	Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7g	lung cancer	down	Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7g	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7g	nasopharyngeal carcinoma	down	MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7g	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7g	osteosarcoma	up	Hsa-let-7g promotes osteosarcoma by reducing HOXB1 to activate NF-kB pathway.
hsa-let-7g	pancreatic ductal adenocarcinoma	down	let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-let-7g-5p	glioblastoma	down	miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.
hsa-let-7i	breast cancer	down	Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-let-7i	breast cancer	down	Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.
hsa-let-7i	bronchioloalveolar carcinoma	down	let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-let-7i	colon cancer	down	let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-let-7i	esophageal squamous cell carcinoma	down	Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-let-7i	esophageal squamous cell carcinoma	down	Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-let-7i	gastric cancer	down	Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.
hsa-let-7i	hepatocellular carcinoma	down	MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-let-7i	hepatocellular carcinoma	down	MicroRNA let-7g and let-7i inhibit hepatoma cell growth concurrently via downregulation of the anti-apoptotic protein B-cell lymphoma-extra large.
hsa-let-7i	hepatocellular carcinoma	down	Abrogating the interplay between IGF2BP1, 2 and 3 and IGF1R by let-7i arrests hepatocellular carcinoma growth.
hsa-let-7i	lung cancer	down	Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-let-7i	lung cancer	down	Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-let-7i	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-let-7i	nasopharyngeal carcinoma	down	MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-let-7i	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-let-7i	ovarian cancer	down	Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.
hsa-let-7i	pancreatic ductal adenocarcinoma	down	let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-mir-1	acute myeloid leukemia	up	Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics.
hsa-mir-1	bladder cancer	down	The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.
hsa-mir-1	bladder cancer	down	Hsa-miR-1 downregulates long non-coding RNA urothelial cancer associated 1 in bladder cancer.
hsa-mir-1	breast cancer	down	Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1.
hsa-mir-1	breast cancer	down	miR-1 inhibits the proliferation of breast cancer stem cells by targeting EVI-1.
hsa-mir-1	cervical cancer	down	Correlation the between the regulation of miRNA-1 in c-Met-induced EMT and cervical cancer progression.
hsa-mir-1	cervical cancer	down	miR-1 inhibits progression of high-risk papillomavirus-associated human cervical cancer by targeting G6PD.
hsa-mir-1	chordoma	down	Prognostic significance of miRNA-1 (miR-1) expression in patients with chordoma.
hsa-mir-1	chordoma	down	MicroRNA-1 (miR-1) inhibits chordoma cell migration and invasion by targeting slug.
hsa-mir-1	colorectal cancer	down	Tumor suppressor miR-1 restrains epithelial-mesenchymal transition and metastasis of colorectal carcinoma via the MAPK and PI3K/AKT pathway.
hsa-mir-1	colorectal cancer	down	MiR-1 suppresses tumor cell proliferation in colorectal cancer by inhibition of Smad3-mediated tumor glycolysis.
hsa-mir-1	esophageal cancer	down	miR-1 suppresses the proliferation and promotes the apoptosis of esophageal carcinoma cells by targeting Src.
hsa-mir-1	esophageal squamous cell carcinoma	down	MicroRNA-1 inhibits tumorigenicity of esophageal squamous cell carcinoma and enhances sensitivity to gefitinib.
hsa-mir-1	esophageal squamous cell carcinoma	down	Downregulation of microRNA-1 in esophageal squamous cell carcinoma correlates with an advanced clinical stage and its overexpression inhibits cell migration and invasion.
hsa-mir-1	esophageal squamous cell carcinoma	down	MicroRNA-1 suppresses proliferation, migration and invasion by targeting Notch2 in esophageal squamous cell carcinoma.
hsa-mir-1	gastric cancer	down	MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer.
hsa-mir-1	gastric cancer	down	MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET.
hsa-mir-1	gastric cancer	up	miRNA and mRNA expression profiles in gastric cancer patients and the relationship with circRNA.
hsa-mir-1	head and neck squamous cell carcinoma	down	Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
hsa-mir-1	head and neck squamous cell carcinoma	down	Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.
hsa-mir-1	head and neck squamous cell carcinoma	down	miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma.
hsa-mir-1	hepatocellular carcinoma	down	MicroRNA-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1.
hsa-mir-1	hepatocellular carcinoma	down	Downregulation of MicroRNA-1 is Associated with Poor Prognosis in Hepatocellular Carcinoma.
hsa-mir-1	kidney cancer	down	MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis.
hsa-mir-1	lung cancer	down	Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.
hsa-mir-1	lung cancer	down	Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.
hsa-mir-1	mucinous cystadenocarcinoma	down	Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.
hsa-mir-1	nasopharyngeal carcinoma	down	miR-1, regulated by LMP1, suppresses tumour growth and metastasis by targeting K-ras in nasopharyngeal carcinoma.
hsa-mir-1	nasopharyngeal carcinoma	down	EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma.
hsa-mir-1	non-small cell lung cancer	down	MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells.
hsa-mir-1	non-small cell lung cancer	down	Lung Endothelial MicroRNA-1 Regulates Tumor Growth and Angiogenesis.
hsa-mir-1	oral squamous cell carcinoma	down	Downregulation of miR-1 enhances tumorigenicity and invasiveness in oral squamous cell carcinomas.
hsa-mir-1	osteosarcoma	down	miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma Cells.
hsa-mir-1	osteosarcoma	down	MicroRNA-1 functions as a potential tumor suppressor in osteosarcoma by targeting Med1 and Med31.
hsa-mir-1	ovarian cancer	down	MicroRNA-1 inhibits ovarian cancer cell proliferation and migration through c-Met pathway.
hsa-mir-1	prostate cancer	down	Overexpression of MicroRNA-1 in Prostate Cancer Cells Modulates the Blood Vessel System of an In Vivo Hen's Egg Test-Chorioallantoic Membrane Model.
hsa-mir-1	prostate cancer	down	MiR-1 inhibits prostate cancer PC3 cells proliferation through the Akt/mTOR signaling pathway by binding to c-Met.
hsa-mir-1	prostate cancer	down	Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer.
hsa-mir-1	renal cell carcinoma	down	The functional significance of miR-1 and miR-133a in renal cell carcinoma.
hsa-mir-1-3p	bladder cancer	down	MiR-1-3p inhibits cell proliferation and invasion by regulating BDNF-TrkB signaling pathway in bladder cancer.
hsa-mir-1-3p	bladder cancer	down	miR-1-3p Contributes to Cell Proliferation and Invasion by Targeting Glutaminase in Bladder Cancer Cells.
hsa-mir-1-3p	breast cancer	down	Identification of microRNA expression in sentinel lymph nodes from patients with breast cancer via RNA sequencing for diagnostic accuracy.
hsa-mir-1-3p	hepatocellular carcinoma	down	miR-1-3p suppresses proliferation of hepatocellular carcinoma through targeting SOX9.
hsa-mir-1-3p	lung adenocarcinoma	down	MiR-1-3p Inhibits Lung Adenocarcinoma Cell Tumorigenesis via Targeting Protein Regulator of Cytokinesis 1.
hsa-mir-100	bladder cancer	down	Prognostic role of microRNA-100 in patients with bladder cancer.
hsa-mir-100	breast cancer	down	miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling.
hsa-mir-100	breast cancer	down	miR-100 Induces Epithelial-Mesenchymal Transition but Suppresses Tumorigenesis, Migration and Invasion.
hsa-mir-100	breast cancer	down	MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/?-catenin signaling pathway.
hsa-mir-100	cervical carcinoma	down	miR-99 inhibits cervical carcinoma cell proliferation by targeting TRIB2.
hsa-mir-100	chondrosarcoma	down	Analysis of microRNAs expressions in chondrosarcoma.
hsa-mir-100	chondrosarcoma	down	MicroRNA-100 Resensitizes Resistant Chondrosarcoma Cells to Cisplatin through Direct Targeting of mTOR.
hsa-mir-100	colon cancer	down	MicroRNA-100 functions as a tumor suppressor by inhibiting Lgr5 expression in colon cancer cells.
hsa-mir-100	colorectal cancer	down	MicroRNA-100 regulates SW620 colorectal cancer cell proliferation and invasion by targeting RAP1B.
hsa-mir-100	colorectal cancer	down	Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in colorectal cancer.
hsa-mir-100	colorectal cancer	down	Downregulation of miR-100/miR-125b is associated with lymph node metastasis in early colorectal cancer with submucosal invasion.
hsa-mir-100	esophageal cancer	down	miR-100 suppresses the proliferation and tumor growth of esophageal squamous cancer cells via targeting CXCR7.
hsa-mir-100	esophageal squamous cell carcinoma	down	MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma.
hsa-mir-100	esophageal squamous cell carcinoma	up	MicroRNA-100 promotes migration and invasion through mammalian target of rapamycin in esophageal squamous cell carcinoma.
hsa-mir-100	esophageal squamous cell carcinoma	down	Prognostic value of microRNA-100 in esophageal squamous cell carcinoma.
hsa-mir-100	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-100	gastric cancer	down	MicroRNA-100 suppresses human gastric cancer cell proliferation by targeting CXCR7.
hsa-mir-100	gastric cancer	down	C/EBP?-induced miR-100 expression suppresses tumor metastasis and growth by targeting ZBTB7A in gastric cancer.
hsa-mir-100	glioblastoma	down	Overexpression of miR-100 inhibits cell proliferation, migration, and chemosensitivity in human glioblastoma through FGFR3.
hsa-mir-100	glioblastoma	down	microRNA-100 Targets SMRT/NCOR2, Reduces Proliferation, and Improves Survival in Glioblastoma Animal Models.
hsa-mir-100	glioblastoma	down	Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.
hsa-mir-100	glioma	down	Roles of microRNA-99 family in human glioma.
hsa-mir-100	hepatocellular carcinoma	down	Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.
hsa-mir-100	hepatocellular carcinoma	down	Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.
hsa-mir-100	mesenchymal cancer	down	MicroRNA Expression Profiles in Kaposi's Sarcoma.
hsa-mir-100	non-small cell lung cancer	down	MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
hsa-mir-100	non-small cell lung cancer	down	Overexpression of miR-100 inhibits cancer growth, migration, and chemosensitivity in human NSCLC cells through fibroblast growth factor receptor 3.
hsa-mir-100	oral squamous cell carcinoma	down	Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy.
hsa-mir-100	osteosarcoma	down	MicroRNA-100 inhibits osteosarcoma cell proliferation by targeting Cyr61.
hsa-mir-100	osteosarcoma	down	MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR.
hsa-mir-100	osteosarcoma	down	MicroRNA-100 suppresses human osteosarcoma cell proliferation and chemo-resistance via ZNRF2.
hsa-mir-100	ovarian cancer	down	Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.
hsa-mir-100	ovarian carcinoma	down	Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.
hsa-mir-100	prostate cancer	down	Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2.
hsa-mir-100	renal cell carcinoma	up	Overexpression of microRNA-100 predicts an unfavorable prognosis in renal cell carcinoma.
hsa-mir-100-5p	esophageal adenocarcinoma	down	Circulating miRNA profile in esophageal adenocarcinoma.
hsa-mir-100-5p	gastric cancer	down	Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.
hsa-mir-101	adrenal cortical carcinoma	up	Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors.
hsa-mir-101	bladder cancer	down	MiR-101 acts as a novel bio-marker in the diagnosis of bladder carcinoma.
hsa-mir-101	bladder cancer	down	MicroRNA-101 inhibits cell migration and invasion in bladder cancer via targeting FZD4.
hsa-mir-101	bladder cancer	down	MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met.
hsa-mir-101	bladder cancer	down	miR-101 Suppresses Vascular Endothelial Growth Factor C That Inhibits Migration and Invasion and Enhances Cisplatin Chemosensitivity of Bladder Cancer Cells.
hsa-mir-101	breast cancer	down	MiRNA-101 inhibits breast cancer growth and metastasis by targeting CX chemokine receptor 7.
hsa-mir-101	breast cancer	down	MicroRNA-101 targets von Hippel-Lindau tumor suppressor (VHL) to induce HIF1? mediated apoptosis and cell cycle arrest in normoxia condition.
hsa-mir-101	breast cancer	up	Differential Expression of MicroRNAs in Breast Cancers from Four Different Ethnicities.
hsa-mir-101	breast cancer	down	MicroRNA-101 inhibits cell proliferation and induces apoptosis by targeting EYA1 in breast cancer.
hsa-mir-101	cervical cancer	down	MicroRNA-101 regulates the viability and invasion of cervical cancer cells.
hsa-mir-101	cervical cancer	down	MiR-101 affects proliferation and apoptosis of cervical cancer cells by inhibition of JAK2.
hsa-mir-101	cervical cancer	down	Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer.
hsa-mir-101	cervical carcinoma	down	MicroRNA-101 inhibits cell proliferation, invasion, and promotes apoptosis by regulating cyclooxygenase-2 in Hela cervical carcinoma cells.
hsa-mir-101	cholangiocarcinoma	down	miR-101 inhibits cholangiocarcinoma angiogenesis through targeting vascular endothelial growth factor (VEGF).
hsa-mir-101	colon cancer	down	Loss of miR-101 Expression Promotes Wnt/?-Catenin Signalling Pathway Activation and Malignancy in Colon Cancer Cells.
hsa-mir-101	colon cancer	down	MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase.
hsa-mir-101	colon cancer	down	Upregulation of miR-101 enhances the cytotoxic effect of anticancer drugs through inhibition of colon cancer cell proliferation.
hsa-mir-101	colorectal cancer	down	Interplay between long noncoding RNA ZEB1-AS1 and miR-101/ZEB1 axis regulates proliferation and migration of colorectal cancer cells.
hsa-mir-101	colorectal cancer	down	Gene module based regulator inference identifying miR-139 as a tumor suppressor in colorectal cancer.
hsa-mir-101	colorectal cancer	down	MicroRNA-101 down-regulates sphingosine kinase 1 in colorectal cancer cells.
hsa-mir-101	colorectal cancer	down	Low Serum Levels of miR-101 Are Associated with Poor Prognosis of Colorectal Cancer Patients After Curative Resection.
hsa-mir-101	endometrial cancer	down	MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.
hsa-mir-101	endometrial cancer	down	MicroRNA-101 inhibits angiogenesis via COX-2 in endometrial carcinoma.
hsa-mir-101	endometrial cancer	down	MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells.
hsa-mir-101	endometrial cancer	down	MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells.
hsa-mir-101	esophageal cancer	up	Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-101	esophageal squamous cell carcinoma	down	miR-101 suppresses tumor proliferation and migration, and induces apoptosis by targeting EZH2 in esophageal cancer cells.
hsa-mir-101	esophageal squamous cell carcinoma	down	Cyclooxygenase-2, a Potential Therapeutic Target, Is Regulated by miR-101 in Esophageal Squamous Cell Carcinoma.
hsa-mir-101	gastric cancer	down	MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.
hsa-mir-101	gastric cancer	down	MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion.
hsa-mir-101	gastric cancer	down	MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion.
hsa-mir-101	gastric cancer	down	Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer.
hsa-mir-101	gastric cancer	down	Down-regulation of miR-101 in gastric cancer correlates with COX-2 overexpression and tumor growth.
hsa-mir-101	gastric cancer	down	Expression and significance of miR-24 and miR-101 in patients with advanced gastric cancer.
hsa-mir-101	gastric cancer	down	miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
hsa-mir-101	gastric cancer	down	Low plasma levels of miR-101 are associated with tumor progression in gastric cancer.
hsa-mir-101	glioblastoma	down	Novel Therapy for Glioblastoma Multiforme by Restoring LRRC4 in Tumor Cells: LRRC4 Inhibits Tumor-Infitrating Regulatory T Cells by Cytokine and Programmed Cell Death 1-Containing Exosomes.
hsa-mir-101	glioblastoma	down	miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis.
hsa-mir-101	glioblastoma	down	Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
hsa-mir-101	glioma	down	MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
hsa-mir-101	glioma	down	miR-101 inhibits glioma cell invasion via the downregulation of COX-2.
hsa-mir-101	glioma	down	miR-101 reverses hypomethylation of the PRDM16 promoter to disrupt mitochondrial function in astrocytoma cells.
hsa-mir-101	glioma	down	Long non-coding RNA MALAT1 promotes proliferation and suppresses apoptosis of glioma cells through derepressing Rap1B by sponging miR-101.
hsa-mir-101	hepatocellular carcinoma	down	PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells.
hsa-mir-101	hepatocellular carcinoma	down	MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-mir-101	hepatocellular carcinoma	down	miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells.
hsa-mir-101	hepatocellular carcinoma	down	MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
hsa-mir-101	hepatocellular carcinoma	down	Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets.
hsa-mir-101	hepatocellular carcinoma	down	Diagnostic value of strand-specific miRNA-101-3p and miRNA-101-5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action.
hsa-mir-101	hepatocellular carcinoma	down	Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
hsa-mir-101	hepatocellular carcinoma	down	MicroRNA-101 suppresses migration and invasion via targeting vascular endothelial growth factor-C in hepatocellular carcinoma cells.
hsa-mir-101	hepatocellular carcinoma	down	miR-101 Inhibiting Cell Proliferation, Migration and Invasion in Hepatocellular Carcinoma through Downregulating Girdin.
hsa-mir-101	hepatocellular carcinoma	down	Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.
hsa-mir-101	hepatocellular carcinoma	up	Clinical effects of miR-101 on prognosis of hepatocellular carcinoma and carcinogenic mechanism of anti-miR-101.
hsa-mir-101	hepatocellular carcinoma	down	miR-101 suppresses HBV replication and expression by targeting FOXO1 in hepatoma carcinoma cell lines.
hsa-mir-101	laryngeal squamous cell carcinoma	down	MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8.
hsa-mir-101	laryngeal squamous cell carcinoma	down	MicroRNA-101 regulates autophagy, proliferation and apoptosis via targeting EZH2 in laryngeal squamous cell carcinoma.
hsa-mir-101	liver cancer	down	MiR-101 functions as a tumor suppressor by directly targeting nemo-like kinase in liver cancer.
hsa-mir-101	lung cancer	down	microRNA-101 inhibits lung cancer invasion through the regulation of enhancer of zeste homolog 2.
hsa-mir-101	lung cancer	down	The miR-101/RUNX1 feedback regulatory loop modulates chemo-sensitivity and invasion in human lung cancer.
hsa-mir-101	lung cancer	down	Micro ribonucleic acid (RNA)-101 inhibits cell proliferation and invasion of lung cancer by regulating cyclooxygenase-2.
hsa-mir-101	malignant melanoma	down	MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2.
hsa-mir-101	medulloblastoma	up	Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-101	nasopharyngeal carcinoma	down	miR-101 sensitizes human nasopharyngeal carcinoma cells to radiation by targeting stathmin 1.
hsa-mir-101	nasopharyngeal carcinoma	down	MicroRNA-101 inhibits invasion and angiogenesis through targeting ITGA3 and its systemic delivery inhibits lung metastasis in nasopharyngeal carcinoma.
hsa-mir-101	non-small cell lung cancer	down	MiR-101 inhibits the proliferation and metastasis of lung cancer by targeting zinc finger E-box binding homeobox 1.
hsa-mir-101	non-small cell lung cancer	down	MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
hsa-mir-101	non-small cell lung cancer	down	MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance.
hsa-mir-101	osteosarcoma	down	Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR.
hsa-mir-101	osteosarcoma	down	MicroRNA-101 inhibits proliferation, migration and invasion in osteosarcoma cells by targeting ROCK1.
hsa-mir-101	osteosarcoma	down	The proliferation and invasion of osteosarcoma are inhibited by miR-101 via targetting ZEB2.
hsa-mir-101	ovarian cancer	down	miRNA-101 inhibits ovarian cancer cells proliferation and invasion by down-regulating expression of SOCS-2.
hsa-mir-101	ovarian carcinoma	down	MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma.
hsa-mir-101	pancreatic cancer	down	miRNA-101 suppresses epithelial-to-mesenchymal transition by targeting HMGA2 in pancreatic cancer cells.
hsa-mir-101	pancreatic ductal adenocarcinoma	down	SNHG14 enhances gemcitabine resistance by sponging miR-101 to stimulate cell autophagy in pancreatic cancer.
hsa-mir-101	papillary thyroid carcinoma	down	MicroRNA-101 Targets CXCL12-Mediated Akt and Snail Signaling Pathways to Inhibit Cellular Proliferation and Invasion in Papillary Thyroid Carcinoma.
hsa-mir-101	papillary thyroid carcinoma	down	miR-101 inhibits cell proliferation by targeting Rac1 in papillary thyroid carcinoma.
hsa-mir-101	papillary thyroid carcinoma	down	Hsa-microRNA-101 suppresses migration and invasion by targeting Rac1 in thyroid cancer cells.
hsa-mir-101	papillary thyroid carcinoma	down	Overexpression of miR-101 promotes TRAIL-induced mitochondrial apoptosis in papillary thyroid carcinoma by targeting c-met and MCL-1.
hsa-mir-101	prostate cancer	down	miR-101 Enhances Cisplatin-Induced DNA Damage Through Decreasing Nicotinamide Adenine Dinucleotide Phosphate Levels by Directly Repressing Tp53-Induced Glycolysis and Apoptosis Regulator Expression in
hsa-mir-101	prostate cancer	down	Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo.
hsa-mir-101	renal cell carcinoma	down	Over-expression of DNA-PKcs in renal cell carcinoma regulates mTORC2 activation, HIF-2? expression and cell proliferation.
hsa-mir-101	renal clear cell carcinoma	up	Hypoxia-induced hsa-miR-101 promotes glycolysis by targeting TIGAR mRNA in clear cell renal cell carcinoma.
hsa-mir-101	retinoblastoma	down	miR-101, downregulated in retinoblastoma, functions as a tumor suppressor in human retinoblastoma cells by targeting EZH2.
hsa-mir-101	retinoblastoma	down	LncRNA XIST promotes the epithelial to mesenchymal transition of retinoblastoma via sponging miR-101.
hsa-mir-101-3p	acute myeloid leukemia	up	Micro-RNA Profiling of Exosomes from Marrow-Derived Mesenchymal Stromal Cells in Patients with Acute Myeloid Leukemia: Implications in Leukemogenesis.
hsa-mir-101-3p	esophageal cancer	down	miR-101-3p induces autophagy in endometrial carcinoma cells by targeting EZH2.
hsa-mir-101-3p	esophageal squamous cell carcinoma	down	Esophageal squamous cell carcinoma cell proliferation induced by exposure to low concentration of cigarette smoke extract is mediated via targeting miR-101-3p/COX-2 pathway.
hsa-mir-101-3p	gastric cancer	down	MiR-101-3p Suppresses HOX Transcript Antisense RNA (HOTAIR)-induced Proliferation and Invasion Through Directly Targeting SRF in Gastric Carcinoma Cells.
hsa-mir-101-3p	glioma	down	Long non-coding RNA SNHG6 promotes glioma tumorigenesis by sponging miR-101-3p.
hsa-mir-101-3p	hepatocellular carcinoma	down	LINC00052/miR-101-3p axis inhibits cell proliferation and metastasis by targeting SOX9 in hepatocellular carcinoma.
hsa-mir-101-3p	hepatocellular carcinoma	down	MicroRNA-101-3p suppresses proliferation and migration in hepatocellular carcinoma by targeting the HGF/c-Met pathway.
hsa-mir-101-3p	hepatocellular carcinoma	down	Identification of miR-101-3p targets and functional features based on bioinformatics, meta-analysis and experimental verification in hepatocellular carcinoma.
hsa-mir-101-3p	hepatocellular carcinoma	down	Downregulation of lncRNA NEAT1_2 radiosensitizes hepatocellular carcinoma cells through regulation of miR-101-3p/WEE1 axis.
hsa-mir-101-3p	oral cancer	down	Exosomes derived from microRNA-101-3p-overexpressing human bone marrow mesenchymal stem cells suppress oral cancer cell proliferation, invasion, and migration.
hsa-mir-101-3p	retinoblastoma	down	MicroRNA-101-3p inhibits proliferation in retinoblastoma cells by targeting EZH2 and HDAC9.
hsa-mir-101-5p	non-small cell lung cancer	down	miRNA-101-5p inhibits the growth and aggressiveness of NSCLC cells through targeting CXCL6.
hsa-mir-103	colorectal cancer	up	Upregulation of serum miR-103 predicts unfavorable prognosis in patients with colorectal cancer.
hsa-mir-103	colorectal cancer	up	PER3, a novel target of miR-103, plays a suppressive role in colorectal cancer in vitro.
hsa-mir-103	colorectal cancer	up	MicroRNA-103 Promotes Colorectal Cancer by Targeting Tumor Suppressor DICER and PTEN.
hsa-mir-103	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-103	gastric cancer	up	miR-103 Promotes Proliferation and Metastasis by Targeting KLF4 in Gastric Cancer.
hsa-mir-103	glioma	down	MicroRNA-103 suppresses glioma cell proliferation and invasion by targeting the brain-derived neurotrophic factor.
hsa-mir-103	hepatocellular carcinoma	up	MiR-103 regulates hepatocellular carcinoma growth by targeting AKAP12.
hsa-mir-103	nasopharyngeal carcinoma	up	MicroRNA-103 promotes nasopharyngeal carcinoma through targeting TIMP-3 and the Wnt/?-catenin pathway.
hsa-mir-103	non-small cell lung cancer	down	MiR-103 Functions as a Tumor Suppressor by Directly Targeting Programmed Cell Death 10 in NSCLC.
hsa-mir-103	prostate cancer	down	MicroRNA-103 suppresses tumor cell proliferation by targeting PDCD10 in prostate cancer.
hsa-mir-103a	colorectal cancer	up	Introduction of hsa-miR-103a and hsa-miR-1827 and hsa-miR-137 as new regulators of Wnt signaling pathway and their relation to colorectal carcinoma.
hsa-mir-103a	gastric cancer	down	MicroRNA-103a inhibits gastric cancer cell proliferation, migration and invasion by targeting c-Myb.
hsa-mir-103a	lung cancer	up	Hypoxic Lung-Cancer-Derived Extracellular Vesicle MicroRNA-103a Increases the Oncogenic Effects of Macrophages by Targeting PTEN.
hsa-mir-103a-3p	bladder cancer	up	Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-103a-3p	colorectal cancer	up	A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
hsa-mir-103a-3p	gastric cancer	up	miRNA-103a-3p Promotes Human Gastric Cancer Cell Proliferation by Targeting and Suppressing ATF7 in vitro.
hsa-mir-103a-3p	glioma	down	Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway.
hsa-mir-105	gastric cancer	down	DNMT3A-mediated down-regulation of microRNA-105 promotes gastric cancer cell proliferation.
hsa-mir-105	gastric cancer	down	MiR-105 inhibits gastric cancer cells metastasis, epithelial-mesenchymal transition by targeting SOX9.
hsa-mir-105	gastric cancer	down	Up-regulation of miRNA-105 inhibits the progression of gastric carcinoma by directly targeting SOX9.
hsa-mir-105	glioma	down	MicroRNA-105 inhibits human glioma cell malignancy by directly targeting SUZ12.
hsa-mir-105	glioma	down	MicroRNA-105 targets SOX9 and inhibits human glioma cell progression.
hsa-mir-105	hepatocellular carcinoma	down	MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma.
hsa-mir-105	prostate cancer	down	miR-105 Inhibits Prostate Tumour Growth by Suppressing CDK6 Levels.
hsa-mir-106a	breast cancer	up	MiRNA-106a promotes breast cancer progression by regulating DAX-1.
hsa-mir-106a	breast cancer	up	miRNA-106a Promotes Breast Cancer Cell Proliferation, Clonogenicity, Migration, and Invasion Through Inhibiting Apoptosis and Chemosensitivity.
hsa-mir-106a	cervical cancer	up	MicroRNA-106a promotes cell migration and invasion by targeting tissue inhibitor of matrix metalloproteinase 2 in cervical cancer.
hsa-mir-106a	cervical squamous cell carcinoma	down	MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma.
hsa-mir-106a	colorectal cancer	up	Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.
hsa-mir-106a	colorectal cancer	up	[Expression of plasma miR-106a in colorectal cancer and its clinical significance].
hsa-mir-106a	colorectal cancer	down	miR-106a suppresses tumor cells death in colorectal cancer through targeting ATG7.
hsa-mir-106a	colorectal cancer	down	MicroRNA-106a inhibits cell proliferation and induces apoptosis in colorectal cancer cells.
hsa-mir-106a	colorectal cancer	up	Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progression.
hsa-mir-106a	colorectal cancer	up	Biological effects and clinical characteristics of microRNA-106a in human colorectal cancer.
hsa-mir-106a	endometrial cancer	up	MiR-106a promotes tumor growth, migration, and invasion by targeting BCL2L11 in human endometrial adenocarcinoma.
hsa-mir-106a	endometrial cancer	up	TSA Suppresses miR-106b-93-25 Cluster Expression through Downregulation of MYC and Inhibits Proliferation and Induces Apoptosis in Human EMC.
hsa-mir-106a	esophageal squamous cell carcinoma	up	A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.
hsa-mir-106a	gastric cancer	up	Circulating microRNAs in plasma of patients with gastric cancers.
hsa-mir-106a	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-106a	gastric cancer	up	miR-106a Is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS.
hsa-mir-106a	gastric cancer	up	Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma.
hsa-mir-106a	gastric cancer	up	miR-106a confers cisplatin resistance by regulating PTEN/Akt pathway in gastric cancer cells.
hsa-mir-106a	gastric cancer	up	MicroRNA-106a targets TIMP2 to regulate invasion and metastasis of gastric cancer.
hsa-mir-106a	gastric cancer	up	Diagnostic significance of miR-106a in gastric cancer.
hsa-mir-106a	gastric cancer	up	MicroRNA-106a functions as an oncogene in human gastric cancer and contributes to proliferation and metastasis in vitro and in vivo.
hsa-mir-106a	glioblastoma	down	Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM.
hsa-mir-106a	glioma	down	MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.
hsa-mir-106a	glioma	up	microRNA-106a induces the proliferation and apoptosis of glioma cells through regulating JNK/MAPK pathway.
hsa-mir-106a	hepatocellular carcinoma	up	Overexpression of miR-21 Is Associated With Recurrence in Patients With Hepatitis B Virus-Mediated Hepatocellular Carcinoma Undergoing Liver Transplantation.
hsa-mir-106a	malignant melanoma	up	Suppression of connexin 43 expression by miR-106a promotes melanoma cell proliferation.
hsa-mir-106a	non-small cell lung cancer	up	miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.
hsa-mir-106a	non-small cell lung cancer	down	Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-106a	ovarian cancer	up	Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
hsa-mir-106a	ovarian cancer	up	MicroRNA-106a regulates phosphatase and tensin homologue expression and promotes the proliferation and invasion of ovarian cancer cells.
hsa-mir-106a	prostate cancer	up	miR-106a contributes to prostate carcinoma progression through PTEN.
hsa-mir-106a	renal cell carcinoma	up	Functional analysis of serum microRNAs miR-21 and miR-106a in renal cell carcinoma.
hsa-mir-106a*	follicular lymphoma	down	miR-106a* inhibits the proliferation of esophageal carcinoma cells by targeting CDK2-associated Cullin 1 (CACUL1).
hsa-mir-106a*	oral squamous cell carcinoma	down	MiR-106a* inhibits oral squamous cell carcinoma progression by directly targeting MeCP2 and suppressing the Wnt/?-Catenin signaling pathway.
hsa-mir-106a*	renal cell carcinoma	down	miR-106a* inhibits the proliferation of renal carcinoma cells by targeting IRS-2.
hsa-mir-106a-5p	clear cell renal cell cancer	down	Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles.
hsa-mir-106a-5p	renal cell carcinoma	down	MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5.
hsa-mir-106b	basal cell carcinoma	up	Expression of microRNAs in basal cell carcinoma.
hsa-mir-106b	breast cancer	up	MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
hsa-mir-106b	breast cancer	up	MicroRNA-106b targets FUT6 to promote cell migration, invasion, and proliferation in human breast cancer.
hsa-mir-106b	cervical carcinoma	up	MicroRNA-106b is involved in transforming growth factor ?1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma.
hsa-mir-106b	colorectal cancer	up	MicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1.
hsa-mir-106b	endometrial cancer	down	Supernatant versus exosomal urinary microRNAs. Two fractions with different outcomes in gynaecological cancers.
hsa-mir-106b	esophageal squamous cell carcinoma	up	[Expression of mir-106b in esophageal squamous cell carcinoma].
hsa-mir-106b	esophageal squamous cell carcinoma	up	miR-106b promotes cell invasion and metastasis via PTEN mediated EMT in ESCC.
hsa-mir-106b	esophageal squamous cell carcinoma	up	MiR-106b promotes migration and invasion through enhancing EMT via downregulation of Smad 7 in Kazakh's esophageal squamous cell carcinoma.
hsa-mir-106b	gastric cancer	up	Circulating microRNAs in plasma of patients with gastric cancers.
hsa-mir-106b	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-106b	gastric cancer	up	Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma.
hsa-mir-106b	gastric cancer	up	Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer
hsa-mir-106b	gastric cancer	up	miR-106b Promotes Metastasis of Early Gastric Cancer by Targeting ALEX1 in Vitro and in Vivo.
hsa-mir-106b	glioma	up	Down-regulation of miR-106b suppresses the growth of human glioma cells.
hsa-mir-106b	head and neck squamous cell carcinoma	up	Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas.
hsa-mir-106b	hepatocellular carcinoma	up	Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process.
hsa-mir-106b	hepatocellular carcinoma	up	Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma.
hsa-mir-106b	hepatocellular carcinoma	down	Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
hsa-mir-106b	hepatocellular carcinoma	up	miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
hsa-mir-106b	hepatocellular carcinoma	up	MiR-106b regulates the apoptosis and tumorigenesis of hepatocellular carcinoma via targeting Zinc finger and BTB domain-containing protein 7A (Zbtb7a).
hsa-mir-106b	laryngeal carcinoma	up	MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma.
hsa-mir-106b	laryngeal carcinoma	up	MicroRNA-106b regulates the tumor suppressor RUNX3 in laryngeal carcinoma cells.
hsa-mir-106b	medulloblastoma	up	miR-106b is overexpressed in medulloblastomas and interacts directly with PTEN.
hsa-mir-106b	non-small cell lung cancer	up	Expression of microRNAs-106b in nonsmall cell lung cancer.
hsa-mir-106b	osteosarcoma	up	The expression and function of miRNA-106 in pediatric osteosarcoma.
hsa-mir-106b	pituitary carcinoma	up	MicroRNA involvement in a metastatic non-functioning pituitary carcinoma.
hsa-mir-106b	renal cell carcinoma	up	miR-106b promotes proliferation and invasion by targeting Capicua through MAPK signaling in renal carcinoma cancer.
hsa-mir-106b	renal cell carcinoma	up	MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
hsa-mir-106b	retinoblastoma	up	MicroRNA-106b promotes the proliferation, migration and invasion of retinoblastoma cells by inhibiting the expression of ZBTB4 protein.
hsa-mir-106b	thyroid cancer	down	microRNA-106b-mediated down-regulation of C1orf24 expression induces apoptosis and suppresses invasion of thyroid cancer.
hsa-mir-106b-5p	cervical cancer	up	The role of miR-106p-5p in cervical cancer: from expression to molecular mechanism.
hsa-mir-106b-5p	colorectal cancer	down	miR-106b-5p inhibits the invasion and metastasis of colorectal cancer by targeting CTSA.
hsa-mir-106b-5p	glioma	up	MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes.
hsa-mir-106b-5p	hepatocellular carcinoma	up	miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathway.
hsa-mir-106b-5p	hepatocellular carcinoma	up	MicroRNA-106b-5p promotes hepatocellular carcinoma development via modulating FOG2.
hsa-mir-106b-5p	non-small cell lung cancer	up	MiR-106b-5p Promotes Proliferation and Inhibits Apoptosis by Regulating BTG3 in Non-Small Cell Lung Cancer.
hsa-mir-106b-5p	renal cell carcinoma	up	miR-106b-5p promotes renal cell carcinoma aggressiveness and stem-cell-like phenotype by activating Wnt/?-catenin signalling.
hsa-mir-107	acute promyelocytic leukemia	down	A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes.
hsa-mir-107	breast cancer	down	MiRNA-107 inhibits proliferation and migration by targeting CDK8 in breast cancer.
hsa-mir-107	breast cancer	down	MicroRNA-107 is downregulated and having tumor suppressive effect in breast cancer by negatively regulating BDNF.
hsa-mir-107	breast cancer	down	microRNAs-107 inhibited autophagy, proliferation, and migration of breast cancer cells by targeting HMGB1.
hsa-mir-107	breast cancer	down	miR-107 Enhances the Sensitivity of Breast Cancer Cells to Paclitaxel.
hsa-mir-107	colorectal cancer	down	MiR-107 function as a tumor suppressor gene in colorectal cancer by targeting transferrin receptor 1.
hsa-mir-107	esophageal squamous cell carcinoma	down	miR-107 functions as a tumor suppressor in human esophageal squamous cell carcinoma and targets Cdc42.
hsa-mir-107	gastric cancer	up	miR-107 regulates growth and metastasis of gastric cancer cells via activation of the PI3K-AKT signaling pathway by down-regulating FAT4.
hsa-mir-107	gastric cancer	up	miR-107 regulates tumor progression by targeting NF1 in gastric cancer.
hsa-mir-107	gastric cancer	up	MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer.
hsa-mir-107	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-107	gastric cancer	up	Upregulation of MicroRNA-107 induces proliferation in human gastric cancer cells by targeting the transcription factor FOXO1.
hsa-mir-107	gastric cancer	up	MicroRNA-107 promotes proliferation of gastric cancer cells by targeting cyclin dependent kinase 8.
hsa-mir-107	gastric cancer	up	Increased levels of serum and tissue miR-107 in human gastric cancer: Correlation with tumor hypoxia.
hsa-mir-107	gastric cancer	up	Tumor Expression of miR-10b, miR-21, miR-143 and miR-145 Is Related to Clinicopathological Features of Gastric Cancer in a Central European Population.
hsa-mir-107	gastric cancer	down	microRNA-107 inhibits gastric cancer cell proliferation and metastasis by targeting PI3K/AKT pathway.
hsa-mir-107	glioblastoma	down	LncRNA LINC00152 promoted glioblastoma progression through targeting the miR-107 expression.
hsa-mir-107	glioma	down	P53-induced microRNA-107 inhibits proliferation of glioma cells and down-regulates the expression of CDK6 and Notch-2.
hsa-mir-107	glioma	down	MicroRNA-107 inhibits glioma cell migration and invasion by modulating Notch2 expression.
hsa-mir-107	glioma	down	Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4.
hsa-mir-107	glioma	down	Upregulation of miR-107 Inhibits Glioma Angiogenesis and VEGF Expression.
hsa-mir-107	glioma	down	Knockdown of NEAT1 repressed the malignant progression of glioma through sponging miR-107 and inhibiting CDK14.
hsa-mir-107	head and neck squamous cell carcinoma	down	microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase C?
hsa-mir-107	head and neck squamous cell carcinoma	down	Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma.
hsa-mir-107	hepatocellular carcinoma	up	miR-107 promotes hepatocellular carcinoma cell proliferation by targeting Axin2.
hsa-mir-107	hepatocellular carcinoma	up	[Expression of microRNA-107 in hepatocellular carcinoma and its clinical significance].
hsa-mir-107	hepatocellular carcinoma	down	MiR-107 suppresses proliferation of hepatoma cells through targeting HMGA2 mRNA 3'UTR.
hsa-mir-107	non-small cell lung cancer	down	Clinicopathological and prognostic significance of microRNA-107 in human non small cell lung cancer.
hsa-mir-107	non-small cell lung cancer	down	MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer.
hsa-mir-107	osteosarcoma	down	Inhibitory Effect of MicroRNA-107 on Osteosarcoma Malignancy Through Regulation of Wnt/?-catenin Signaling in Vitro.
hsa-mir-107	osteosarcoma	up	MicroRNA-107 Promotes Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting Tropomyosin 1.
hsa-mir-107	ovarian cancer	down	MicroRNA-107 induces cell cycle arrests by directly targeting cyclin E1 in ovarian cancer.
hsa-mir-107	pancreatic ductal adenocarcinoma	up	Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and PTEN.
hsa-mir-107	prostate carcinoma	down	Dysregulation of the mitogen granulin in human cancer through the miR-15/107 microRNA gene group.
hsa-mir-10a	acute myeloid leukemia	up	MicroRNA-10a/b are regulators of myeloid differentiation and acute myeloid leukemia.
hsa-mir-10a	breast cancer	down	MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid.
hsa-mir-10a	breast cancer	down	MicroRNA-10a suppresses breast cancer progression via PI3K/Akt/mTOR pathway.
hsa-mir-10a	cervical cancer	up	MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells.
hsa-mir-10a	cervical cancer	up	Upregulation of miR-20a and miR-10a expression levels act as potential biomarkers of aggressive progression and poor prognosis in cervical cancer.
hsa-mir-10a	chronic myelogenous leukemia	down	Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.
hsa-mir-10a	colorectal cancer	down	miR-10a suppresses colorectal cancer metastasis by modulating the epithelial-to-mesenchymal transition and anoikis.
hsa-mir-10a	colorectal cancer	up	TUSC7 acts as a tumor suppressor in colorectal cancer.
hsa-mir-10a	diffuse large B-cell lymphoma	down	miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma.
hsa-mir-10a	ependymoma	down	Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-10a	esophageal squamous cell carcinoma	down	Tumor-suppressive microRNA-10a inhibits cell proliferation and metastasis by targeting Tiam1 in esophageal squamous cell carcinoma.
hsa-mir-10a	gastric cancer	up	miRNA expression profile in primary gastric cancers and paired lymph node metastases indicates that miR-10a plays a role in metastasis from primary gastric cancer to lymph nodes.
hsa-mir-10a	gastric cancer	down	MicroRNA-10a Is Down-Regulated by DNA Methylation and Functions as a Tumor Suppressor in Gastric Cancer Cells.
hsa-mir-10a	glioma	up	MicroRNA 10a induces glioma tumorigenesis by targeting myotubularin-related protein 3 and regulating the Wnt/?-catenin signaling pathway.
hsa-mir-10a	lung cancer	up	miRNA-10a promotes cancer cell proliferation in oral squamous cell carcinoma by upregulating GLUT1 and promoting glucose metabolism.
hsa-mir-10a	non-small cell lung cancer	up	MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN.
hsa-mir-10a	oral squamous cell carcinoma	up	miRNA-10a promotes cancer cell proliferation in oral squamous cell carcinoma by upregulating GLUT1 and promoting glucose metabolism.
hsa-mir-10a	pancreatic cancer	up	MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.
hsa-mir-10a	prostate cancer	down	MiR-10a functions as a tumor suppressor in prostate cancer via targeting KDM4A.
hsa-mir-10a-5p	breast cancer	down	S-equol inhibits proliferation and promotes apoptosis of human breast cancer MCF-7?cells via regulating miR-10a-5p and PI3K/AKT pathway.
hsa-mir-10a-5p	liver cancer	down	Hsa-miR-10a-5p downregulation in mutant UQCRB-expressing cells promotes the cholesterol biosynthesis pathway.
hsa-mir-10a-5p	papillary thyroid carcinoma	up	A three plasma microRNA signature for papillary thyroid carcinoma diagnosis in Chinese patients.
hsa-mir-10a-5p	renal cell carcinoma	down	Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.
hsa-mir-10b	acute myeloid leukemia	up	MiR-10b regulates the proliferation and apoptosis of pediatric acute myeloid leukemia through targeting HOXD10.
hsa-mir-10b	acute myeloid leukemia	up	MicroRNA-10a/b are regulators of myeloid differentiation and acute myeloid leukemia.
hsa-mir-10b	bladder cancer	up	MicroRNA-10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer.
hsa-mir-10b	breast cancer	down	Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-10b	breast cancer	up	Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer.
hsa-mir-10b	breast cancer	up	Critical role of miR-10b in transforming growth factor-?1-induced epithelial-mesenchymal transition in breast cancer.
hsa-mir-10b	breast cancer	up	Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways.
hsa-mir-10b	breast cancer	up	Enhanced motility and proliferation by miR-10b/FUT8/p-AKT axis in breast cancer cells.
hsa-mir-10b	breast cancer	up	Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients.
hsa-mir-10b	breast carcinoma	down	Different molecular subtypes of breast invasive ductal carcinoma.
hsa-mir-10b	cervical cancer	down	MicroRNA-10b inhibits proliferation, migration and invasion in cervical cancer cells via direct targeting of insulin-like growth factor-1 receptor.
hsa-mir-10b	colorectal cancer	up	MicroRNA-10b is upregulated and has an invasive role in colorectal cancer through enhanced Rhoc expression.
hsa-mir-10b	colorectal cancer	up	Overexpression of miR-10b in colorectal cancer patients: Correlation with TWIST-1 and E-cadherin expression.
hsa-mir-10b	colorectal cancer	up	miR-10b promotes invasion by targeting HOXD10 in colorectal cancer.
hsa-mir-10b	colorectal cancer	up	Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
hsa-mir-10b	endometrial cancer	up	miR-10b Inhibits Apoptosis and Promotes Proliferation and Invasion of Endometrial Cancer Cells via Targeting HOXB3.
hsa-mir-10b	ependymoma	up	Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-10b	esophageal cancer	up	MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines.
hsa-mir-10b	esophageal cancer	up	microRNA-10b confers cisplatin resistance by activating AKT/mTOR/P70S6K signaling via targeting PPAR? in esophageal cancer.
hsa-mir-10b	gastric cancer	up	Tumor Expression of miR-10b, miR-21, miR-143 and miR-145 Is Related to Clinicopathological Features of Gastric Cancer in a Central European Population.
hsa-mir-10b	gastric cancer	up	miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer.
hsa-mir-10b	gastric cancer	up	Clinicopathologic significance of miR-10b expression in gastric carcinoma.
hsa-mir-10b	gastric cancer	down	DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer.
hsa-mir-10b	gastric cancer	up	Augmented miR-10b expression associated with depressed expression of its target gene KLF4 involved in gastric carcinoma.
hsa-mir-10b	gastric cancer	up	MicroRNA-10b promotes migration and invasion through Hoxd10 in human gastric cancer.
hsa-mir-10b	glioblastoma	up	Oncogenic effects of miR-10b in glioblastoma stem cells.
hsa-mir-10b	glioblastoma	up	Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
hsa-mir-10b	glioblastoma	up	MicroRNA-10b mediates TGF-?1-regulated glioblastoma proliferation, migration and epithelial-mesenchymal transition.
hsa-mir-10b	glioma	up	MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10.
hsa-mir-10b	glioma	up	Neferine inhibits proliferation, migration and invasion of U251 glioma cells by down-regulation of miR-10b.
hsa-mir-10b	hepatocellular carcinoma	up	miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
hsa-mir-10b	hepatocellular carcinoma	up	MicroRNA-10b promotes migration and invasion through CADM1 in human hepatocellular carcinoma cells.
hsa-mir-10b	hepatocellular carcinoma	up	miR-10b is overexpressed in hepatocellular carcinoma and promotes cell proliferation, migration and invasion through RhoC, uPAR and MMPs.
hsa-mir-10b	hepatocellular carcinoma	up	MicroRNA-10b regulates epithelial-mesenchymal transition by modulating KLF4/KLF11/Smads in hepatocellular carcinoma.
hsa-mir-10b	lung cancer	up	microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.
hsa-mir-10b	malignant melanoma	up	miR-10b promoted melanoma progression through Wnt/?-catenin pathway by repressing ITCH expression.
hsa-mir-10b	malignant melanoma	up	Upregulation of Serum miR-10b Is Associated with Poor Prognosis in Patients with Melanoma.
hsa-mir-10b	malignant melanoma	down	The association between abnormal microRNA-10b expression and cancer risk: a meta-analysis.
hsa-mir-10b	medulloblastoma	up	microRNA-10b Is Overexpressed and Critical for Cell Survival and Proliferation in Medulloblastoma.
hsa-mir-10b	nasopharyngeal carcinoma	up	miR-10b Promotes Migration and Invasion in Nasopharyngeal Carcinoma Cells.
hsa-mir-10b	nasopharyngeal carcinoma	up	Over-expression of miR-10b in NPC patients: correlation with LMP1 and Twist1.
hsa-mir-10b	nasopharyngeal carcinoma	up	Study of miR-10b regulatory mechanism for epithelial-mesenchymal transition, invasion and migration in nasopharyngeal carcinoma cells.
hsa-mir-10b	non-small cell lung cancer	up	MicroRNA-10b indicates a poor prognosis of non-small cell lung cancer and targets E-cadherin.
hsa-mir-10b	non-small cell lung cancer	up	microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.
hsa-mir-10b	oral cancer	up	Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling.
hsa-mir-10b	osteosarcoma	up	miR-10b promotes invasion by targeting KLF4 in osteosarcoma cells.
hsa-mir-10b	pancreatic cancer	up	MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis.
hsa-mir-10b	pancreatic cancer	up	MicroRNA-10b is overexpressed in pancreatic cancer.
hsa-mir-10b	pancreatic ductal adenocarcinoma	up	microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinoma.
hsa-mir-10b	pancreatic ductal adenocarcinoma	up	microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-? actions.
hsa-mir-10b	pancreatic ductal adenocarcinoma	up	MiRNAs are Unlikely to be Involved in Retinoid Receptor Gene Regulation in Pancreatic Cancer Cells.
hsa-mir-10b	renal clear cell carcinoma	down	MicroRNA-10b Promotes Apoptosis via JNK Pathway in Clear Cell Renal Cell Carcinoma.
hsa-mir-10b*	osteosarcoma	down	Downregulation of miR-10B* is correlated with altered expression of mitotic kinases in osteosarcoma.
hsa-mir-10b-3p	esophageal squamous cell carcinoma	up	Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
hsa-mir-10b-3p	hepatocellular carcinoma	up	Up-regulation of miR-10b-3p promotes the progression of hepatocellular carcinoma cells via targeting CMTM5.
hsa-mir-10b-5p	gastric cancer	up	Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer.
hsa-mir-1178	pancreatic cancer	up	[Correlation between miR-1178 expression and clinicopathological significance in human pancreatic cancer].
hsa-mir-1178-3p	nasopharyngeal carcinoma	up	MiR-1178-3p promotes the proliferation, migration and invasion of nasopharyngeal carcinoma Sune-1 cells by targeting STK4.
hsa-mir-1179	breast cancer	down	Increased expression of miR-1179 inhibits breast cancer cell metastasis by modulating Notch signaling pathway and correlates with favorable prognosis.
hsa-mir-1179	colorectal cancer	up	MicroRNA expression profiles in human colorectal cancers with liver metastases.
hsa-mir-1179	esophageal squamous cell carcinoma	up	miR-1179 promotes cell invasion through SLIT2/ROBO1 axis in esophageal squamous cell carcinoma.
hsa-mir-1179	gastric cancer	down	Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer.
hsa-mir-1179	glioblastoma	down	MicroRNA-1179 inhibits glioblastoma cell proliferation and cell cycle progression via directly targeting E2F transcription factor 5.
hsa-mir-1179	hepatocellular carcinoma	down	MiRNA-1179 suppresses the metastasis of hepatocellular carcinoma by interacting with ZEB2.
hsa-mir-1179	non-small cell lung cancer	down	MicroRNA-1179 suppresses cell growth and invasion by targeting sperm-associated antigen 5-mediated Akt signaling in human non-small cell lung cancer.
hsa-mir-1180	bladder cancer	down	Up-regulation of p21(WAF1/CIP1) by miRNAs and its implications in bladder cancer cells.
hsa-mir-1180	hepatocellular carcinoma	up	MiR-1180 promoted the proliferation of hepatocellular carcinoma cells by repressing TNIP2 expression.
hsa-mir-1180	hepatocellular carcinoma	up	MiR-1180 promotes apoptotic resistance to human hepatocellular carcinoma via activation of NF-?B signaling pathway.
hsa-mir-1180	ovarian cancer	up	MiR-1180 from bone marrow MSCs promotes cell proliferation and glycolysis in ovarian cancer cells via SFRP1/Wnt pathway.
hsa-mir-1180	prostate cancer	down	MicroRNA-1180 is associated with growth and apoptosis in prostate cancer via TNF receptor associated factor 1 expression regulation and nuclear factor-?B signaling pathway activation.
hsa-mir-1181	ovarian cancer	up	Activation of ARK5/miR-1181/HOXA10 axis promotes epithelial-mesenchymal transition in ovarian cancer.
hsa-mir-1181	pancreatic cancer	down	MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
hsa-mir-1181	pancreatic cancer	down	miR-1181 inhibits invasion and proliferation via STAT3 in pancreatic cancer.
hsa-mir-1182	ovarian cancer	down	MiR-1182 inhibited metastasis and proliferation of ovarian cancer by targeting hTERT.
hsa-mir-1185	colorectal cancer	down	miR-496, miR-1185, miR-654, miR-3183 and miR-495 are downregulated in colorectal cancer cells and have putative roles in the mTOR pathway.
hsa-mir-1197	non-small cell lung cancer	up	MicroRNA-1197 downregulation inhibits proliferation and migration in human non- small cell lung cancer cells by upregulating HOXC11.
hsa-mir-1202	glioma	down	MiR-1202 functions as a tumor suppressor in glioma cells by targeting Rab1A.
hsa-mir-1202	hepatocellular carcinoma	down	MiR-1202 suppresses hepatocellular carcinoma cells migration and invasion by targeting cyclin dependent kinase 14.
hsa-mir-1204	hepatocellular carcinoma	up	miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418.
hsa-mir-1204	non-small cell lung cancer	down	The miR-1204 regulates apoptosis in NSCLC cells by targeting DEK.
hsa-mir-1204	non-small cell lung cancer	up	MicroRNA-1204 promotes cell proliferation by regulating PITX1 in non-small-cell lung cancer.
hsa-mir-1205	lung adenocarcinoma	up	microRNA-1205 promotes cell growth by targeting APC2 in lung adenocarcinoma.
hsa-mir-1205	non-small cell lung cancer	down	MiR-1205 functions as a tumor suppressor by disconnecting the synergy between KRAS and MDM4/E2F1 in non-small cell lung cancer.
hsa-mir-1207	nasopharyngeal carcinoma	down	Non-Coding RNA Pvt1 Promotes Cancer Stem Cell-Like Traits in Nasopharyngeal Cancer via Inhibiting miR-1207.
hsa-mir-1207	ovarian cancer	up	MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/?-catenin signaling pathway.
hsa-mir-1207-5p	breast cancer	up	PVT1-derived miR-1207-5p promotes breast cancer cell growth by targeting STAT6.
hsa-mir-1207-5p	colorectal cancer	down	The Role of MicroRNA-1207-5p in Colorectal Cancer.
hsa-mir-1207-5p	gastric cancer	down	miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase.
hsa-mir-1207-5p	hepatocellular carcinoma	down	MicroRNA-1207-5p inhibits hepatocellular carcinoma cell growth and invasion through the fatty acid synthase-mediated Akt/mTOR signalling pathway.
hsa-mir-1207-5p	lung cancer	down	miR-1207-5p suppresses lung cancer growth and metastasis by targeting CSF1.
hsa-mir-1208	renal cell carcinoma	down	MiR-1208 Increases the Sensitivity to Cisplatin by Targeting TBCK in Renal Cancer Cells.
hsa-mir-122	acute myeloid leukemia	down	Decreased expression of microRNA-122 is associated with an unfavorable prognosis in childhood acute myeloid leukemia and function analysis indicates a therapeutic potential.
hsa-mir-122	bladder cancer	down	MiR-122 targets VEGFC in bladder cancer to inhibit tumor growth and angiogenesis.
hsa-mir-122	breast cancer	down	MiR-122 Inhibits Cell Proliferation and Tumorigenesis of Breast Cancer by Targeting IGF1R.
hsa-mir-122	breast cancer	down	Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-mir-122	gallbladder carcinoma	down	miR-122 inhibits cancer cell malignancy by targeting PKM2 in gallbladder carcinoma.
hsa-mir-122	gastric cancer	down	Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer.
hsa-mir-122	gastric cancer	down	MicroRNA-122 inhibits proliferation and invasion in gastric cancer by targeting CREB1.
hsa-mir-122	glioma	down	miR-122/Wnt/?-catenin regulatory circuitry sustains glioma progression.
hsa-mir-122	glioma	down	MiR-122 inhibits cell proliferation and induces apoptosis by targeting runt-related transcription factors 2 in human glioma.
hsa-mir-122	glioma	down	Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122.
hsa-mir-122	hepatocellular carcinoma	down	Nuclear miR-122 directly regulates the biogenesis of cell survival oncomiR miR-21 at the posttranscriptional level.
hsa-mir-122	hepatocellular carcinoma	down	MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.
hsa-mir-122	hepatocellular carcinoma	down	miR-122 affects the viability and apoptosis of hepatocellular carcinoma cells.
hsa-mir-122	hepatocellular carcinoma	down	microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma.
hsa-mir-122	hepatocellular carcinoma	down	A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma.
hsa-mir-122	hepatocellular carcinoma	up	Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
hsa-mir-122	hepatocellular carcinoma	down	MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.
hsa-mir-122	hepatocellular carcinoma	up	Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-122	hepatocellular carcinoma	down	MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/?-catenin pathway.
hsa-mir-122	hepatocellular carcinoma	down	MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-mir-122	hepatocellular carcinoma	up	Epigenetic regulation of miR-122 by PPAR? and hepatitis B virus X protein in hepatocellular carcinoma cells.
hsa-mir-122	hepatocellular carcinoma	down	miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3.
hsa-mir-122	hepatocellular carcinoma	down	Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
hsa-mir-122	hepatocellular carcinoma	down	MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/?-cadherin signaling pathway.
hsa-mir-122	hepatocellular carcinoma	down	miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma.
hsa-mir-122	hepatocellular carcinoma	down	Crosstalk between microRNA-122 and FOX family genes in HepG2 cells.
hsa-mir-122	hepatocellular carcinoma	down	miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/?-catenin pathway.
hsa-mir-122	hepatocellular carcinoma	down	Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.
hsa-mir-122	hepatocellular carcinoma	down	Hepatitis B virus X protein mediated suppression of miRNA-122 expression enhances hepatoblastoma cell proliferation through cyclin G1-p53 axis.
hsa-mir-122	hepatocellular carcinoma	down	LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation.
hsa-mir-122	hepatocellular carcinoma	up	Expression Analysis of MicroRNA-21 and MicroRNA-122 in Hepatocellular Carcinoma.
hsa-mir-122	liver cancer	down	MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma.
hsa-mir-122	osteosarcoma	down	Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.
hsa-mir-122	pituitary carcinoma	up	MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas.
hsa-mir-122	renal cell carcinoma	up	MiR-122 promotes renal cancer cell proliferation by targeting Sprouty2.
hsa-mir-122	renal clear cell carcinoma	up	miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
hsa-mir-122*	hepatocellular carcinoma	down	The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitry.
hsa-mir-122-3p	lung cancer	down	MicroRNA-122-3p inhibits tumor cell proliferation and induces apoptosis by targeting Forkhead box O in A549 cells.
hsa-mir-122-5p	gastric cancer	down	MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4.
hsa-mir-122-5p	gastric cancer	down	miR-122-5p inhibits tumor cell proliferation and induces apoptosis by targeting MYC in gastric cancer cells.
hsa-mir-122-5p	hepatocellular carcinoma	down	Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
hsa-mir-122-5p	hepatocellular carcinoma	down	Potential clinical value and putative biological function of miR-122-5p in hepatocellular carcinoma: A comprehensive study using microarray and RNA sequencing data.
hsa-mir-122-5p	malignant melanoma	up	[miR-122-5p inhibits the proliferation of melanoma cells by targeting NOP14].
hsa-mir-122-5p	nasopharyngeal carcinoma	down	MiR-122-5p suppresses cell proliferation, migration and invasion by targeting SATB1 in nasopharyngeal carcinoma.
hsa-mir-122-5p	non-small cell lung cancer	up	MicroRNA-122-5p promotes the development of non-small cell lung cancer via downregulating p53 and activating PI3K-AKT pathway.
hsa-mir-122-5p	ovarian cancer	down	MicroRNA profiling of plasma exosomes from patients with ovarian cancer using high-throughput sequencing.
hsa-mir-1225-5p	gastric cancer	down	MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of ?-catenin signaling.
hsa-mir-1225-5p	thyroid cancer	down	MicroRNA-1225-5p inhibits the development and progression of thyroid cancer via targeting sirtuin 3.
hsa-mir-1228	breast cancer	up	MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein.
hsa-mir-1228	gastric cancer	down	microRNA-1228(?) impairs the pro-angiogenic activity of gastric cancer cells by targeting macrophage migration inhibitory factor.
hsa-mir-1228	hepatocellular carcinoma	up	miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop.
hsa-mir-1228*	gastric cancer	down	Restoration of miR-1228* expression suppresses epithelial-mesenchymal transition in gastric cancer.
hsa-mir-1229	breast cancer	up	MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/?-catenin signaling in breast cancer.
hsa-mir-1229	colorectal cancer	up	Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.
hsa-mir-122a	gastrointestinal cancer	down	MicroRNA-122a functions as a novel tumor suppressor downstream of adenomatous polyposis coli in gastrointestinal cancers.
hsa-mir-122a	hepatocellular carcinoma	down	Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
hsa-mir-122a	hepatocellular carcinoma	down	[MicroRNA profiling in patients with hepatocellular carcinoma].
hsa-mir-122a	hepatocellular carcinoma	down	Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma.
hsa-mir-1231	glioma	down	MicroRNA-1231 exerts a tumor suppressor role through regulating the EGFR/PI3K/AKT axis in glioma.
hsa-mir-1233	renal cell carcinoma	up	MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.
hsa-mir-1236	bladder cancer	down	Up-regulation of p21(WAF1/CIP1) by miRNAs and its implications in bladder cancer cells.
hsa-mir-1236	hepatocellular carcinoma	down	miR-1236 down-regulates alpha-fetoprotein, thus causing PTEN accumulation, which inhibits the PI3K/Akt pathway and malignant phenotype in hepatoma cells.
hsa-mir-1236	renal cell carcinoma	down	Targeted p21(WAF1/CIP1) activation by miR-1236 inhibits cell proliferation and correlates with favorable survival in renal cell carcinoma.
hsa-mir-1236-3p	gastric cancer	down	miR-1236-3p inhibits invasion and metastasis in gastric cancer by targeting MTA2.
hsa-mir-1236-3p	gastric cancer	down	Down-regulation of miR-1236-3p is correlated with clinical progression and unfavorable prognosis in gastric cancer.
hsa-mir-1236-3p	gastric cancer	down	MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
hsa-mir-1236-3p	lung adenocarcinoma	down	miR-1236-3p suppresses the migration and invasion by targeting KLF8 in lung adenocarcinoma A549 cells.
hsa-mir-1236-3p	lung cancer	down	microRNA-1236-3p Regulates DDP Resistance in Lung Cancer Cells.
hsa-mir-1238	non-small cell lung cancer	down	miR-1238 inhibits cell proliferation by targeting LHX2 in non-small cell lung cancer.
hsa-mir-124	anaplastic astrocytoma	down	miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
hsa-mir-124	bladder cancer	down	MiR-124 exerts tumor suppressive functions on the cell proliferation, motility and angiogenesis of bladder cancer by fine-tuning UHRF1.
hsa-mir-124	bladder cancer	down	MicroRNA-124 inhibits cell proliferation, invasion and migration by targeting CAV1 in bladder cancer.
hsa-mir-124	breast cancer	down	miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro.
hsa-mir-124	breast cancer	down	Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer.
hsa-mir-124	breast cancer	down	MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer.
hsa-mir-124	breast cancer	down	MicroRNA-124 suppresses breast cancer cell growth and motility by targeting CD151.
hsa-mir-124	breast cancer	down	Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer.
hsa-mir-124	breast cancer	down	MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer.
hsa-mir-124	breast cancer	down	miR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4.
hsa-mir-124	breast cancer	down	MicroRNA-124 inhibits cell proliferation and migration by regulating SNAI2 in breast cancer.
hsa-mir-124	breast cancer	down	Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients.
hsa-mir-124	cervical cancer	down	Methylation and expression of miRNAs in precancerous lesions and cervical cancer with HPV16 infection.
hsa-mir-124	cervical squamous cell carcinoma	down	Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK.
hsa-mir-124	colorectal cancer	down	Downregulation of microRNA-124 is an independent prognostic factor in patients with colorectal cancer.
hsa-mir-124	colorectal cancer	down	MicroRNA-124 Regulates the Proliferation of Colorectal Cancer Cells by Targeting iASPP.
hsa-mir-124	colorectal cancer	down	MiR-124 Suppresses Growth of Human Colorectal Cancer by Inhibiting STAT3.
hsa-mir-124	colorectal cancer	down	MiR-124 Radiosensitizes Human Colorectal Cancer Cells by Targeting PRRX1.
hsa-mir-124	colorectal cancer	down	KITENIN-targeting MicroRNA-124 Suppresses Colorectal Cancer Cell Motility and Tumorigenesis.
hsa-mir-124	colorectal cancer	down	Gene module based regulator inference identifying miR-139 as a tumor suppressor in colorectal cancer.
hsa-mir-124	colorectal cancer	down	MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer.
hsa-mir-124	colorectal cancer	down	Downregulation of rho-associated protein kinase 1 by miR-124 in colorectal cancer.
hsa-mir-124	colorectal cancer	down	MicroRNA-124 Reduces Pentose Phosphate Pathway and Proliferation by Targeting PRPS1 and RPIA mRNAs in Human Colorectal Cancer Cells.
hsa-mir-124	colorectal cancer	down	MicroRNA-124 (MiR-124) Inhibits Cell Proliferation, Metastasis and Invasion in Colorectal Cancer by Downregulating Rho-Associated Protein Kinase 1(ROCK1).
hsa-mir-124	colorectal cancer	down	[miR-124 regulates radiosensitivity of colorectal cancer cells by targeting PRRX1].
hsa-mir-124	colorectal cancer	down	MicroRNA-124 inhibits colorectal cancer cell proliferation and suppresses tumor growth by interacting with PLCB1 and regulating Wnt/?-catenin signaling pathway.
hsa-mir-124	colorectal cancer	down	miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1.
hsa-mir-124	esophageal cancer	down	Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.
hsa-mir-124	esophageal cancer	down	MicroRNA-124 inhibits proliferation and metastasis of esophageal cancer via negatively regulating NRP1.
hsa-mir-124	esophageal cancer	down	STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells.
hsa-mir-124	esophageal squamous cell carcinoma	down	Hypermethylation-mediated inactivation of miR-124 predicts poor prognosis and promotes tumor growth at least partially through targeting EZH2/H3K27me3 in ESCC.
hsa-mir-124	gastric adenocarcinoma	down	Expression of miR-124 in gastric adenocarcinoma and the effect on proliferation and invasion of gastric adenocarcinoma SCG-7901 cells.
hsa-mir-124	gastric cancer	down	miR-124 interacts with the Notch1 signalling pathway and has therapeutic potential against gastric cancer.
hsa-mir-124	gastric cancer	down	In vivo and in vitro effects of microRNA-124 on human gastric cancer by targeting JAG1 through the Notch signaling pathway.
hsa-mir-124	gastric cancer	down	MicroRNA-124 inhibits cell invasion and epithelial-mesenchymal transition by directly repressing Snail2 in gastric cancer.
hsa-mir-124	gastric cancer	down	miR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1.
hsa-mir-124	gastric cancer	down	[miR-124 suppresses cell proliferation and invasion in gastric carcinoma and its mechanism].
hsa-mir-124	gastric cancer	down	microRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer.
hsa-mir-124	gastric cancer	down	Lentivirus-mediated overexpression of miR-124 suppresses growth and invasion by targeting JAG1 and EZH2 in gastric cancer.
hsa-mir-124	gastric cancer	down	The clinical significance of miR-335, miR-124, miR-218 and miR-484 downregulation in gastric cancer.
hsa-mir-124	glioblastoma	down	miR-124 suppresses the migration and invasion of glioma cells in?vitro via Capn4.
hsa-mir-124	glioblastoma	down	miR-124 Acts as a Tumor Suppressor in Glioblastoma via the Inhibition of Signal Transducer and Activator of Transcription 3.
hsa-mir-124	glioblastoma	down	MiR-124 Functions as a Tumor Suppressor via Targeting hCLOCK1 in Glioblastoma.
hsa-mir-124	glioblastoma	down	miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
hsa-mir-124	glioblastoma	down	Downregulation of miR-124 promotes the growth and invasiveness of glioblastoma cells involving upregulation of PPP1R13L.
hsa-mir-124	glioblastoma	down	miR-124 suppresses glioblastoma growth and potentiates chemosensitivity by inhibiting AURKA.
hsa-mir-124	glioma	down	microRNA-124 Inhibits Migration and Invasion by Down-Regulating ROCK1 in Glioma.
hsa-mir-124	glioma	down	MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras.
hsa-mir-124	glioma	down	Downregulation of microRNA-124 predicts poor prognosis in glioma patients.
hsa-mir-124	glioma	down	Identification of microRNAs associated with glioma diagnosis and prognosis.
hsa-mir-124	glioma	down	Inhibition of the Hedgehog signaling pathway suppresses cell proliferation by regulating the Gli2/miR-124/AURKA axis in human glioma cells.
hsa-mir-124	hepatocellular carcinoma	down	MiRNA-124 inhibits the proliferation, migration and invasion of cancer cell in hepatocellular carcinoma by downregulating lncRNA-UCA1.
hsa-mir-124	hepatocellular carcinoma	down	PIK3C2A mRNA functions as a miR-124 sponge to facilitate CD151 expression and enhance malignancy of hepatocellular carcinoma cells.
hsa-mir-124	hepatocellular carcinoma	down	The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.
hsa-mir-124	hepatocellular carcinoma	down	MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA.
hsa-mir-124	hepatocellular carcinoma	down	MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3.
hsa-mir-124	hepatocellular carcinoma	down	circHIPK3 regulates cell proliferation and migration by sponging miR-124 and regulating AQP3 expression in hepatocellular carcinoma.
hsa-mir-124	lung adenocarcinoma	down	miR-124 inhibits cell proliferation, migration and invasion by directly targeting SOX9 in lung adenocarcinoma.
hsa-mir-124	lung cancer	down	Circular RNA HIPK3 exerts oncogenic properties through suppression of miR-124 in lung cancer.
hsa-mir-124	malignant melanoma	down	miR-124 inhibits proliferation, migration and invasion of malignant melanoma cells via targeting versican.
hsa-mir-124	malignant melanoma	down	Upregulation of miR-124 by physcion 8-O-?-glucopyranoside inhibits proliferation and invasion of malignant melanoma cells via repressing RLIP76.
hsa-mir-124	medulloblastoma	down	miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1.
hsa-mir-124	nasopharyngeal carcinoma	down	MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma.
hsa-mir-124	nasopharyngeal carcinoma	down	MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
hsa-mir-124	nasopharyngeal carcinoma	down	Long noncoding RNA NEAT1 promotes nasopharyngeal carcinoma progression through regulation of miR-124/NF-?B pathway.
hsa-mir-124	nasopharyngeal carcinoma	down	miR-124 suppresses proliferation and invasion of nasopharyngeal carcinoma cells through the Wnt/?-catenin signaling pathway by targeting Capn4.
hsa-mir-124	neuroblastoma	down	Silencing of miR-124 induces neuroblastoma SK-N-SH cell differentiation, cell cycle arrest and apoptosis through promoting AHR.
hsa-mir-124	non-small cell lung cancer	down	miRNA-124 down-regulates SOX8 expression and suppresses cell proliferation in non-small cell lung cancer.
hsa-mir-124	non-small cell lung cancer	down	miRNA-124 down-regulates SOX8 expression and suppresses cell proliferation in non-small cell lung cancer.
hsa-mir-124	non-small cell lung cancer	down	Down-regulation of microRNA-124 is correlated with tumor metastasis and poor prognosis in patients with lung cancer.
hsa-mir-124	non-small cell lung cancer	down	MiR-124 Inhibits Growth and Enhances Radiation-Induced Apoptosis in Non-Small Cell Lung Cancer by Inhibiting STAT3.
hsa-mir-124	non-small cell lung cancer	down	Overexpression of LIMD2 promotes the progression of non-small cell lung cancer.
hsa-mir-124	non-small cell lung cancer	down	MicroRNA-124 suppresses proliferation and glycolysis in non-small cell lung cancer cells by targeting AKT-GLUT1/HKII.
hsa-mir-124	non-small cell lung cancer	down	Inhibition of LHX2 by miR-124 suppresses cellular migration and invasion in non-small cell lung cancer.
hsa-mir-124	non-small cell lung cancer	down	miRNA-124 modulates lung carcinoma cell migration and invasion.
hsa-mir-124	non-small cell lung cancer	down	MicroRNA-124 suppresses tumor cell proliferation and invasion by targeting CD164 signaling pathway in non-small cell lung cancer.
hsa-mir-124	non-small cell lung cancer	down	MicroRNA-124 Functions as a Tumor Suppressor by Regulating CDH2 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
hsa-mir-124	non-small cell lung cancer	down	MicroRNA-124 suppresses Slug-mediated lung cancer metastasis.
hsa-mir-124	oral squamous cell carcinoma	down	MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1.
hsa-mir-124	osteosarcoma	down	The tumor suppressor role of miR-124 in osteosarcoma.
hsa-mir-124	osteosarcoma	down	MicroRNA-124 functions as a tumor suppressor and indicates prognosis in human osteosarcoma.
hsa-mir-124	osteosarcoma	down	The tumor suppressor miR-124 inhibits cell proliferation and invasion by targeting B7-H3 in osteosarcoma.
hsa-mir-124	ovarian cancer	down	MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1.
hsa-mir-124	ovarian cancer	down	Exosomal transfer of miR-124 inhibits normal fibroblasts to cancer-associated fibroblasts transition by targeting sphingosine kinase 1 in ovarian cancer.
hsa-mir-124	pancreatic cancer	down	Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1.
hsa-mir-124	pancreatic ductal adenocarcinoma	down	Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.
hsa-mir-124	pancreatic ductal adenocarcinoma	down	miR-124 Suppresses Pancreatic Ductal Adenocarcinoma Growth by Regulating Monocarboxylate Transporter 1-Mediated Cancer Lactate Metabolism.
hsa-mir-124	prostate cancer	down	MiR-124 suppresses cell motility and adhesion by targeting talin 1 in prostate cancer cells.
hsa-mir-124	renal cell carcinoma	down	Over-expression of mir-124 inhibits MMP-9 expression and decreases invasion of renal cell carcinoma cells.
hsa-mir-124	retinoblastoma	down	miR-124 inhibits proliferation and invasion of human retinoblastoma cells by targeting STAT3.
hsa-mir-124-3p	astrocytoma	down	Reductions in the expression of miR-124-3p, miR-128-1, and miR-221-3p in pediatric astrocytomas are related to high-grade supratentorial, and recurrent tumors in Mexican children.
hsa-mir-124-3p	bladder cancer	down	MicroRNA-124-3p inhibits cell migration and invasion in bladder cancer cells by targeting ROCK1.
hsa-mir-124-3p	bladder cancer	down	MiR-124-3p suppresses bladder cancer by targeting DNA methyltransferase 3B.
hsa-mir-124-3p	bladder cancer	down	MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
hsa-mir-124-3p	breast cancer	down	Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells.
hsa-mir-124-3p	breast cancer	down	Decreased miR-124-3p Expression Prompted Breast Cancer Cell Progression Mainly by Targeting Beclin-1.
hsa-mir-124-3p	breast cancer	down	miR-124-3p functions as a tumor suppressor in breast cancer by targeting CBL.
hsa-mir-124-3p	cervical cancer	down	MicroRNA-124-3p inhibits cell growth and metastasis in cervical cancer by targeting IGF2BP1.
hsa-mir-124-3p	esophageal squamous cell carcinoma	down	The role of DNMT1/hsa-miR-124-3p/BCAT1 pathway in regulating growth and invasion of esophageal squamous cell carcinoma.
hsa-mir-124-3p	gastric cancer	down	The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
hsa-mir-124-3p	gastric cancer	down	miR-124-3p acts as a potential marker and suppresses tumor growth in gastric cancer.
hsa-mir-124-3p	glioma	down	MicroRNA-124-3p represses cell growth and cell motility by targeting EphA2 in glioma.
hsa-mir-124-3p	glioma	down	MiR-124-3p suppresses glioma aggressiveness via targeting of Fra-2.
hsa-mir-124-3p	glioma	down	Amentoflavone induces apoptosis and suppresses glycolysis in glioma cells by targeting miR-124-3p.
hsa-mir-124-3p	hepatocellular carcinoma	down	MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study.
hsa-mir-124-3p	hepatocellular carcinoma	down	Reduced hsa-miR-124-3p levels are associated with the poor survival of patients with hepatocellular carcinoma.
hsa-mir-124-3p	papillary thyroid carcinoma	up	Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.
hsa-mir-124-5p	glioma	down	MiR-124-5p inhibits the growth of high-grade gliomas through posttranscriptional regulation of LAMB1.
hsa-mir-1244	lung carcinoma	down	miR-1244/Myocyte Enhancer Factor 2D Regulatory Loop Contributes to the Growth of Lung Carcinoma.
hsa-mir-1246	breast cancer	up	Exosomal MicroRNA MiR-1246 Promotes Cell Proliferation, Invasion and Drug Resistance by Targeting CCNG2 in Breast Cancer.
hsa-mir-1246	breast cancer	up	miRNA-1246 induces pro-inflammatory responses in mesenchymal stem/stromal cells by regulating PKA and PP2A.
hsa-mir-1246	cervical cancer	down	Down-regulation of miR-1246 in cervical cancer tissues and its clinical significance.
hsa-mir-1246	colorectal cancer	up	Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.
hsa-mir-1246	hepatocellular carcinoma	up	Circulating microRNA-1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma.
hsa-mir-1246	lung cancer	down	MicroRNA-1246 inhibits cell invasion and epithelial mesenchymal transition process by targeting CXCR4 in lung cancer cells.
hsa-mir-1246	lung cancer	up	Extracellular miR-1246 promotes lung cancer cell proliferation and enhances radioresistance by directly targeting DR5.
hsa-mir-1246	non-small cell lung cancer	up	Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer.
hsa-mir-1246	ovarian cancer	up	Clinical Impact of microRNAs Associated With Cancer Stem Cells as a Prognostic Factor in Ovarian Carcinoma.
hsa-mir-1246	prostate cancer	down	microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer.
hsa-mir-1247	bladder cancer	down	Inhibition of miR-1247 on cell proliferation and invasion in bladder cancer through its downstream target of RAB36.
hsa-mir-1247	non-small cell lung cancer	down	Silencing of miR-1247 by DNA methylation promoted non-small-cell lung cancer cell invasion and migration by effects of STMN1.
hsa-mir-1247	pancreatic cancer	down	Epigenetically altered miR-1247 functions as a tumor suppressor in pancreatic cancer.
hsa-mir-1247	pancreatic cancer	down	miR-1247 is Correlated with Prognosis of Pancreatic Cancer and Inhibits Cell Proliferation by Targeting Neuropilins.
hsa-mir-1247	renal cell carcinoma	down	Epigenetically altered miR-1247 functions as a tumor suppressor in pancreatic cancer.
hsa-mir-1247-5p	breast cancer	down	Downregulated miR-1247-5p associates with poor prognosis and facilitates tumor cell growth via DVL1/Wnt/?-catenin signaling in breast cancer.
hsa-mir-1247-5p	hepatocellular carcinoma	down	miR-1247-5p functions as a tumor suppressor in human hepatocellular carcinoma by targeting Wnt3.
hsa-mir-124a	acute lymphoblastic leukemia	down	Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.
hsa-mir-124a	epithelial ovarian cancer	down	Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.
hsa-mir-124a	glioblastoma	down	miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion.
hsa-mir-124a	glioma	down	miR-124a restoration inhibits glioma cell proliferation and invasion by suppressing IQGAP1 and ?-catenin.
hsa-mir-124a	glioma	down	microRNA-124a suppresses PHF19 over-expression, EZH2 hyper-activation, and aberrant cell proliferation in human glioma.
hsa-mir-124a	liver cancer	down	MicroRNA-124a inhibits cell proliferation and migration in liver cancer by regulating interleukin-11.
hsa-mir-124a	mantle cell lymphoma	up	microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-1250	oral squamous cell carcinoma	down	Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-1251-5p	ovarian cancer	up	MicroRNA-1251-5p Promotes Carcinogenesis and Autophagy via Targeting the Tumor Suppressor TBCC in Ovarian Cancer Cells.
hsa-mir-1253	non-small cell lung cancer	down	MicroRNA-1253 suppresses cell proliferation and invasion of non-small-cell lung carcinoma by targeting WNT5A.
hsa-mir-1254	cervical cancer	down	Decreased expression of miR-1254 is associated with cancer aggressiveness and predicts poor outcome in cervical cancer.
hsa-mir-1254	colorectal cancer	down	MicroRNA-1254 inhibits the migration of colon adenocarcinoma cells by targeting PSMD10.
hsa-mir-1254	lung cancer	up	miR-1254 promotes lung cancer cell proliferation by targeting SFRP1.
hsa-mir-1254	oral squamous cell carcinoma	down	MiR-1254 Functions as a Tumor Suppressor in Oral Squamous Cell Carcinoma by Targeting CD36.
hsa-mir-1256	non-small cell lung cancer	down	MiR-1256 suppresses proliferation and migration of non-small cell lung cancer via regulating TCTN1.
hsa-mir-1258	breast cancer	down	MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase.
hsa-mir-1258	breast cancer	down	The expression and clinical significance of microRNA-1258 and heparanase in human breast cancer.
hsa-mir-1258	colorectal cancer	down	Upregulated miR-1258 regulates cell cycle and inhibits cell proliferation by directly targeting E2F8 in CRC.
hsa-mir-1258	hepatocellular carcinoma	down	Loss of miR-1258 contributes to carcinogenesis and progression of liver cancer through targeting CDC28 protein kinase regulatory subunit 1B.
hsa-mir-1258	non-small cell lung cancer	down	MicroRNA-1258 suppresses tumour progression via GRB2/Ras/Erk pathway in non-small-cell lung cancer.
hsa-mir-1258	oral squamous cell carcinoma	down	MicroRNA-1258, regulated by c-Myb, inhibits growth and epithelial-to-mesenchymal transition phenotype via targeting SP1 in oral squamous cell carcinoma.
hsa-mir-1258	osteosarcoma	down	Overexpression of miR-1258 inhibits cell proliferation by targeting AKT3 in osteosarcoma.
hsa-mir-1259	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-125a	acute myeloid leukemia	up	miR-125b promotes MLL-AF9-driven murine acute myeloid leukemia involving a VEGFA-mediated non-cell-intrinsic mechanism.
hsa-mir-125a	breast cancer	up	MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the hippo signaling pathway.
hsa-mir-125a	cervical cancer	down	MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
hsa-mir-125a	colorectal cancer	down	Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.
hsa-mir-125a	colorectal cancer	down	Hypermethylation-Associated Silencing of miR-125a and miR-125b: A Potential Marker in Colorectal Cancer.
hsa-mir-125a	colorectal carcinoma	down	MicroRNA-125a inhibits tumorigenesis by targeting Smurf1 in colorectal carcinoma.
hsa-mir-125a	esophageal squamous cell carcinoma	up	ZEB1 induced miR-99b/let-7e/miR-125a cluster promotes invasion and metastasis in esophageal squamous cell carcinoma.
hsa-mir-125a	glioblastoma	down	miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma.
hsa-mir-125a	hepatocellular carcinoma	down	Mutual suppression of miR-125a and Lin28b in human hepatocellular carcinoma cells.
hsa-mir-125a	hepatocellular carcinoma	down	The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinoma.
hsa-mir-125a	hepatocellular carcinoma	down	Reduced miR-125a levels associated with poor survival of patients with hepatocellular cancer.
hsa-mir-125a	laryngeal carcinoma	down	Inhibition of HAX-1 by miR-125a reverses cisplatin resistance in laryngeal cancer stem cells.
hsa-mir-125a	laryngeal squamous cell carcinoma	down	miR-125a suppresses viability and glycolysis and induces apoptosis by targeting Hexokinase 2 in laryngeal squamous cell carcinoma.
hsa-mir-125a	osteosarcoma	down	MicroRNA-125a Regulates Cell Proliferation Via Directly Targeting E2F2 in Osteosarcoma.
hsa-mir-125a	ovarian cancer	down	MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1.
hsa-mir-125a	ovarian cancer	down	MiR-125a regulates ovarian cancer proliferation and invasion by repressing GALNT14 expression.
hsa-mir-125a	renal cell carcinoma	down	MicroRNA-125a suppresses cell migration, invasion, and regulates hyaluronic acid synthase 1 expression by targeting signal transducers and activators of transcription 3 in renal cell carcinoma cells.
hsa-mir-125a-3p	acute myeloid leukemia	down	The miR-125a-3p Inhibits TIM-3 Expression in AML Cell Line HL-60 In Vitro.
hsa-mir-125a-3p	gastric cancer	down	Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
hsa-mir-125a-3p	non-small cell lung cancer	down	Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
hsa-mir-125a-3p	non-small cell lung cancer	down	miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion.
hsa-mir-125a-3p	pancreatic ductal adenocarcinoma	down	miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn.
hsa-mir-125a-5p	basal cell carcinoma	up	Expression of microRNAs in basal cell carcinoma.
hsa-mir-125a-5p	bladder cancer	down	MiR-125a-5p suppresses bladder cancer progression through targeting FUT4.
hsa-mir-125a-5p	breast cancer	down	Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-125a-5p	colon cancer	down	miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1.
hsa-mir-125a-5p	colorectal cancer	down	miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA.
hsa-mir-125a-5p	colorectal cancer	down	miR-125a-5p inhibits colorectal cancer cell epithelial-mesenchymal transition, invasion and migration by targeting TAZ.
hsa-mir-125a-5p	gastric cancer	down	Low expression of miR-125a-5p is associated with poor prognosis in patients with gastric cancer.
hsa-mir-125a-5p	gastric cancer	down	MicroRNA-125a-5p inhibits invasion and metastasis of gastric cancer cells by targeting BRMS1 expression.
hsa-mir-125a-5p	glioblastoma	down	MiRNA-125a-5p inhibits glioblastoma cell proliferation and promotes cell differentiation by targeting TAZ.
hsa-mir-125a-5p	head and neck squamous cell carcinoma	up	Overexpression of hsa-miR-125a-5p enhances proliferation, migration and invasion of head and neck squamous cell carcinoma cell lines by upregulating C-C chemokine receptor type 7.
hsa-mir-125a-5p	hepatocellular carcinoma	down	miRNA-125a-5p inhibits hepatocellular carcinoma cell proliferation and induces apoptosis by targeting TP53 regulated inhibitor of apoptosis 1 and Bcl-2-like-2 protein.
hsa-mir-125a-5p	hepatocellular carcinoma	up	Serum microRNA-125a-5p as a potential biomarker of HCV-associated hepatocellular carcinoma.
hsa-mir-125a-5p	lung adenocarcinoma	down	miR-125a-5p upregulation suppresses the proliferation and induces the cell apoptosis of lung adenocarcinoma by targeting NEDD9.
hsa-mir-125a-5p	lung cancer	down	MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
hsa-mir-125a-5p	malignant melanoma	down	Lin28B promotes melanoma growth by mediating a microRNA regulatory circuit.
hsa-mir-125a-5p	non-small cell lung cancer	down	Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
hsa-mir-125a-5p	non-small cell lung cancer	up	Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.
hsa-mir-125a-5p	non-small cell lung cancer	down	PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathways.
hsa-mir-125a-5p	pancreatic ductal adenocarcinoma	up	Effects of miR-125a-5p on Cell Proliferation,Apoptosis and Cell Cycle of Pancreatic Cancer Cells.
hsa-mir-125a-5p	prostate carcinoma	up	MicroRNA-125a-5p regulates cancer cell proliferation and migration through NAIF1 in prostate carcinoma.
hsa-mir-125a-5p	retinoblastoma	down	Suppression of microRNA-125a-5p upregulates the TAZ-EGFR signaling pathway and promotes retinoblastoma proliferation.
hsa-mir-125a-5p	thyroid cancer	down	Down-Regulated miR-125a-5p Promotes the Reprogramming of Glucose Metabolism and Cell Malignancy by Increasing Levels of CD147 in Thyroid Cancer.
hsa-mir-125b	acute myeloid leukemia	up	[miR-125b promotes proliferation of human acute myeloid leukemia cells by targeting Bak1].
hsa-mir-125b	acute myeloid leukemia	up	miR-125b promotes MLL-AF9-driven murine acute myeloid leukemia involving a VEGFA-mediated non-cell-intrinsic mechanism.
hsa-mir-125b	acute myeloid leukemia	down	Overexpression of microRNA-125b inhibits human acute myeloid leukemia cells invasion, proliferation and promotes cells apoptosis by targeting NF-?B signaling pathway.
hsa-mir-125b	anaplastic thyroid carcinoma	down	MiR-125b inhibits anaplastic thyroid cancer cell migration and invasion by targeting PIK3CD.
hsa-mir-125b	bladder cancer	down	MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3.
hsa-mir-125b	bladder cancer	down	microRNA-125b inhibits cell migration and invasion by targeting matrix metallopeptidase 13 in bladder cancer.
hsa-mir-125b	bladder cancer	down	MiRNA-125b inhibits proliferation and migration by targeting SphK1 in bladder cancer.
hsa-mir-125b	breast cancer	up	Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.
hsa-mir-125b	breast cancer	up	Elevated microRNA-125b levels predict a worse prognosis in HER2-positive breast cancer patients.
hsa-mir-125b	breast cancer	down	MUCIN 1 ONCOPROTEIN EXPRESSION IS SUPPRESSED BY THE miR-125b ONCOMIR.
hsa-mir-125b	breast cancer	down	miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer.
hsa-mir-125b	breast cancer	down	MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells.
hsa-mir-125b	breast cancer	down	Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue.
hsa-mir-125b	breast cancer	down	The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer.
hsa-mir-125b	chronic lymphocytic leukemia	down	The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state.
hsa-mir-125b	chronic myelogenous leukemia	up	miR-125b regulates cell progression in chronic myeloid leukemia via targeting BAK1.
hsa-mir-125b	colorectal cancer	down	Hypermethylation-Associated Silencing of miR-125a and miR-125b: A Potential Marker in Colorectal Cancer.
hsa-mir-125b	colorectal cancer	up	MicroRNA miR-125b is a prognostic marker in human colorectal cancer.
hsa-mir-125b	colorectal cancer	down	Downregulation of miR-100/miR-125b is associated with lymph node metastasis in early colorectal cancer with submucosal invasion.
hsa-mir-125b	colorectal cancer	up	CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer.
hsa-mir-125b	esophageal squamous cell carcinoma	down	MicroRNA-125b inhibits cell proliferation and induces cell apoptosis in esophageal squamous cell carcinoma by targeting BMF.
hsa-mir-125b	follicular cancer	up	MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.
hsa-mir-125b	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-125b	gastric cancer	up	MiR-125b promotes cell migration and invasion by targeting PPP1CA-Rb signal pathways in gastric cancer, resulting in a poor prognosis.
hsa-mir-125b	gastric cancer	up	MicroRNA-125b promotes invasion and metastasis of gastric cancer by targeting STARD13 and NEU1.
hsa-mir-125b	gastric cancer	down	miR-125b Suppresses Proliferation and Invasion by Targeting MCL1 in Gastric Cancer.
hsa-mir-125b	gastric cancer	down	The functional mechanism of miR-125b in gastric cancer and its effect on the chemosensitivity of cisplatin.
hsa-mir-125b	glioblastoma	down	Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma.
hsa-mir-125b	glioblastoma	up	miR-125b promotes cell proliferation by directly targeting Lin28 in glioblastoma stem cells with low expression levels of miR-125b.
hsa-mir-125b	glioma	up	MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf.
hsa-mir-125b	glioma	up	miR-125b Inhibits Connexin43 and Promotes Glioma Growth.
hsa-mir-125b	glioma	down	Serum MicroRNA-125b as a Potential Biomarker for Glioma Diagnosis.
hsa-mir-125b	hepatocellular carcinoma	down	Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma.
hsa-mir-125b	hepatocellular carcinoma	down	Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer.
hsa-mir-125b	hepatocellular carcinoma	down	MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R.
hsa-mir-125b	hepatocellular carcinoma	down	MicroRNA-125b Functions as a Tumor Suppressor in Hepatocellular Carcinoma Cells.
hsa-mir-125b	hepatocellular carcinoma	down	Histone lysine methyltransferase, SUV39H1, promotes HCC progression and is negatively regulated by microRNA-125b.
hsa-mir-125b	hepatocellular carcinoma	down	Overexpression of microRNA-125b sensitizes human hepatocellular carcinoma cells to 5-fluorouracil through inhibition of glycolysis by targeting hexokinase II.
hsa-mir-125b	hepatocellular carcinoma	down	miR-125b suppresses the proliferation of hepatocellular carcinoma cells by targeting Sirtuin7.
hsa-mir-125b	lung cancer	up	Genetic variations in miR-125 family and the survival of non-small cell lung cancer in Chinese population.
hsa-mir-125b	lung cancer	down	Up-regulation of miR-125b reverses epithelial-mesenchymal transition in paclitaxel-resistant lung cancer cells.
hsa-mir-125b	malignant melanoma	down	MicroRNA-125b suppresses the epithelial-mesenchymal transition and cell invasion by targeting ITGA9 in melanoma.
hsa-mir-125b	malignant melanoma	down	MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression.
hsa-mir-125b	malignant melanoma	down	miR-125b induces cellular senescence in malignant melanoma.
hsa-mir-125b	nasopharyngeal carcinoma	up	MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-?B signaling pathway.
hsa-mir-125b	neuroblastoma	up	MicroRNA-125b is a novel negative regulator of p53.
hsa-mir-125b	non-small cell lung cancer	up	MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer.
hsa-mir-125b	oral squamous cell carcinoma	down	Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy.
hsa-mir-125b	oral squamous cell carcinoma	up	[Expression and clinical significance of plasma microRNA-125b level in patients with oral squamous cell carcinoma].
hsa-mir-125b	oral squamous cell carcinoma	down	miR-125b suppresses oral oncogenicity by targeting the anti-oxidative gene PRXL2A.
hsa-mir-125b	osteosarcoma	down	MiR-125b Functions as a Tumor Suppressor and Enhances Chemosensitivity to Cisplatin in Osteosarcoma.
hsa-mir-125b	osteosarcoma	down	miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3.
hsa-mir-125b	osteosarcoma	down	Upregulation of miR-300 and downregulation of miR-125b act as potential predictor biomarkers in progression, metastasis, and poor prognosis of osteosarcoma.
hsa-mir-125b	ovarian cancer	down	Roles and Mechanism of miR-199a and miR-125b in Tumor Angiogenesis.
hsa-mir-125b	ovarian cancer	down	Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.
hsa-mir-125b	ovarian cancer	down	PPAR? inhibits ovarian cancer cells proliferation through upregulation of miR-125b.
hsa-mir-125b	ovarian cancer	down	MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1.
hsa-mir-125b	ovarian cancer	down	MicroRNA-125b Suppresses Ovarian Cancer Progression via Suppression of the Epithelial-Mesenchymal Transition Pathway by Targeting the SET Protein.
hsa-mir-125b	ovarian cancer	up	A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer.
hsa-mir-125b	prostate cancer	down	Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis.
hsa-mir-125b	prostate cancer	up	Widespread deregulation of microRNA expression in human prostate cancer.
hsa-mir-125b	prostate cancer	up	Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer.
hsa-mir-125b	renal cell carcinoma	up	miR-125b is associated with renal cell carcinoma cell migration, invasion and apoptosis.
hsa-mir-125b	retinoblastoma	up	MicroRNA-125b promotes tumor growth and suppresses apoptosis by targeting DRAM2 in retinoblastoma.
hsa-mir-125b-1-3p	mesenchymal cancer	up	miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR.
hsa-mir-125b-2*	colorectal cancer	up	MicroRNA expression profiles in human colorectal cancers with liver metastases.
hsa-mir-125b-5p	breast cancer	down	miR-125b-5p inhibits breast cancer cell proliferation, migration and invasion by targeting KIAA1522.
hsa-mir-125b-5p	esophageal squamous cell carcinoma	down	miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma.
hsa-mir-125b-5p	hepatocellular carcinoma	down	miR-125b-5p inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma via targeting TXNRD1.
hsa-mir-125b-5p	laryngeal squamous cell carcinoma	down	MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2.
hsa-mir-126	bladder cancer	down	MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9.
hsa-mir-126	breast cancer	down	Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2.
hsa-mir-126	breast cancer	down	miR-126 regulated breast cancer cell invasion by targeting ADAM9.
hsa-mir-126	breast cancer	down	Clinical significance of blood-based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers.
hsa-mir-126	cervical cancer	down	The inhibition of miR-126 in cell migration and invasion of cervical cancer through regulating ZEB1.
hsa-mir-126	chronic myelogenous leukemia	up	Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia.
hsa-mir-126	colon cancer	down	MiR-126 suppresses colon cancer cell proliferation and invasion via inhibiting RhoA/ROCK signaling pathway.
hsa-mir-126	colon cancer	down	Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4.
hsa-mir-126	colon cancer	down	[miR-126 inhibits colon cancer proliferation and invasion through targeting IRS1, SLC7A5 and TOM1 gene].
hsa-mir-126	colon cancer	down	miR-126: A novel regulator in colon cancer.
hsa-mir-126	colon cancer	down	MicroRNA-126 inhibits colon cancer cell proliferation and invasion by targeting the chemokine (C-X-C motif) receptor 4 and Ras homolog gene family, member A, signaling pathway.
hsa-mir-126	colorectal cancer	down	Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer.
hsa-mir-126	colorectal cancer	down	Down-regulation of miR-126 expression in colorectal cancer and its clinical significance.
hsa-mir-126	colorectal cancer	down	Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer.
hsa-mir-126	colorectal cancer	down	MicroRNA-126 functions as a tumor suppressor in colorectal cancer cells by targeting CXCR4 via the AKT and ERK1/2 signaling pathways.
hsa-mir-126	colorectal cancer	down	Low expression of MicroRNA-126 is associated with poor prognosis in colorectal cancer.
hsa-mir-126	colorectal cancer	down	Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1?-VEGF signaling pathway.
hsa-mir-126	esophageal cancer	down	MicroRNA-126 inhibits the migration and invasion of endometrial cancer cells by targeting insulin receptor substrate 1.
hsa-mir-126	esophageal cancer	down	Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-126	esophageal squamous cell carcinoma	down	Insulin receptor substrate-1 and Golgi phosphoprotein 3 are downstream targets of miR?126 in esophageal squamous cell carcinoma.
hsa-mir-126	esophageal squamous cell carcinoma	down	MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway.
hsa-mir-126	gastric cancer	down	miR-126 functions as a tumour suppressor in human gastric cancer.
hsa-mir-126	gastric cancer	up	MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis.
hsa-mir-126	gastric cancer	down	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-126	gastric cancer	down	Mir-126 inhibits growth of SGC-7901 cells by synergistically targeting the oncogenes PI3KR2 and Crk, and the tumor suppressor PLK2.
hsa-mir-126	gastric cancer	down	Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A.
hsa-mir-126	gastric cancer	down	MicroRNA-126 inhibits cell proliferation in gastric cancer by targeting LAT-1.
hsa-mir-126	gastric cancer	down	miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer.
hsa-mir-126	gastric cancer	down	Dysregulation of miR-126/Crk protein axis predicts poor prognosis in gastric cancer patients.
hsa-mir-126	gastric cancer	down	MiR-126 functions as a tumor suppressor by targeting SRPK1 in human gastric cancer.
hsa-mir-126	gastric cancer	down	ADAM9 functions as a promoter of gastric cancer growth which is negatively and post-transcriptionally regulated by miR-126.
hsa-mir-126	gastric cancer	down	Down-regulated serum miR-126 is associated with aggressive progression and poor prognosis of gastric cancer.
hsa-mir-126	glioblastoma	down	Down-regulation of MicroRNA-126 in Glioblastoma and its Correlation with Patient Prognosis: A Pilot Study.
hsa-mir-126	glioblastoma	down	MiR-126 Regulates the ERK Pathway via Targeting KRAS to Inhibit the Glioma Cell Proliferation and Invasion.
hsa-mir-126	glioma	down	MicroRNA-126 acts as a tumor suppressor in glioma cells by targeting insulin receptor substrate 1 (IRS-1).
hsa-mir-126	hepatocellular carcinoma	down	MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway.
hsa-mir-126	hepatocellular carcinoma	down	Decreased expression of miR-126 correlates with metastatic recurrence of hepatocellular carcinoma.
hsa-mir-126	hepatocellular carcinoma	down	miR-126 inhibits cell proliferation and induces cell apoptosis of hepatocellular carcinoma cells partially by targeting Sox2.
hsa-mir-126	hepatocellular carcinoma	up	Effects of microRNA-126 on cell proliferation, apoptosis and tumor angiogenesis via the down-regulating ERK signaling pathway by targeting EGFL7 in hepatocellular carcinoma.
hsa-mir-126	liver cancer	down	Experimental study on the prevention of liver cancer angiogenesis via miR-126.
hsa-mir-126	malignant melanoma	up	Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
hsa-mir-126	malignant mesothelioma	down	MicroRNA-126 Suppresses Mesothelioma Malignancy by Targeting IRS1 and Interfering with Mitochondrial Function.
hsa-mir-126	malignant mesothelioma	down	Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: Role of miR-126 in cancer-stroma communication.
hsa-mir-126	non-small cell lung cancer	down	miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7.
hsa-mir-126	non-small cell lung cancer	down	miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A.
hsa-mir-126	non-small cell lung cancer	down	MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients.
hsa-mir-126	non-small cell lung cancer	down	Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application.
hsa-mir-126	non-small cell lung cancer	down	Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer.
hsa-mir-126	non-small cell lung cancer	down	Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
hsa-mir-126	non-small cell lung cancer	down	Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
hsa-mir-126	oral squamous cell carcinoma	up	Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer.
hsa-mir-126	oral squamous cell carcinoma	down	Suppressive effect of microRNA-126 on oral squamous cell carcinoma in vitro.
hsa-mir-126	osteosarcoma	down	MicroRNA-126 inhibits osteosarcoma cells proliferation by targeting Sirt1.
hsa-mir-126	osteosarcoma	down	miR-126 functions as a tumor suppressor in osteosarcoma by targeting Sox2.
hsa-mir-126	osteosarcoma	down	Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
hsa-mir-126	osteosarcoma	down	MicroRNA-126 Overexpression Inhibits Proliferation and Invasion in Osteosarcoma Cells.
hsa-mir-126	osteosarcoma	down	MicroRNA-126 Inhibits Proliferation, Migration, Invasion, and EMT in Osteosarcoma by Targeting ZEB1.
hsa-mir-126	osteosarcoma	down	Retraction: Yang, C., et al. miR-126 Functions as a Tumor Suppressor in Osteosarcoma by Targeting Sox2. Int. J. Mol. Sci. 2014, 15, 423-437, doi:10.3390/ijms15010423.
hsa-mir-126	ovarian cancer	down	microRNA-126 suppresses PAK4 expression in ovarian cancer SKOV3 cells.
hsa-mir-126	pancreatic adenocarcinoma	down	Simultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreatic adenocarcinoma.
hsa-mir-126	pancreatic ductal adenocarcinoma	down	MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors.
hsa-mir-126	papillary thyroid carcinoma	down	miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6.
hsa-mir-126	prostate cancer	down	MicroRNA-126 inhibits proliferation and metastasis in prostate cancer via regulation of ADAM9.
hsa-mir-126	renal cell carcinoma	down	Low Expression of miR-126 Is a Prognostic Marker for Metastatic Clear Cell Renal Cell Carcinoma.
hsa-mir-126	renal cell carcinoma	down	MicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma.
hsa-mir-126	small cell lung cancer	down	miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5.
hsa-mir-126	thyroid cancer	down	Interactive role of miR-126 on VEGF-A and progression of papillary and undifferentiated thyroid carcinoma.
hsa-mir-126*	non-small cell lung cancer	down	Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
hsa-mir-126-3p	non-small cell lung cancer	down	MiR-126-3p suppresses the growth, migration and invasion of NSCLC via targeting CCR1.
hsa-mir-126-3p	non-small cell lung cancer	down	miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study.
hsa-mir-126-3p	pancreatic cancer	down	Bone Marrow Mesenchymal Stem Cell-Derived Exosomal MicroRNA-126-3p Inhibits Pancreatic Cancer Development by Targeting ADAM9.
hsa-mir-126-3p	thyroid cancer	down	miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer.
hsa-mir-126-5p	acute myeloid leukemia	up	Upregulation of microRNA-126-5p is associated with drug resistance to cytarabine and poor prognosis in AML patients.
hsa-mir-126-5p	cervical cancer	down	miR-126-5p Restoration Promotes Cell Apoptosis in Cervical Cancer by Targeting Bcl2l2.
hsa-mir-126-5p	non-small cell lung cancer	down	miR-126-5p targets Malate Dehydrogenase 1 in non-small cell lung carcinomas.
hsa-mir-1260b	hepatocellular carcinoma	up	miR-1260b promotes cell migration and invasion of hepatocellular carcinoma by targeting the regulator of G-protein signaling 22.
hsa-mir-1260b	non-small cell lung cancer	up	Overexpression of miR-1260b in Non-small Cell Lung Cancer is Associated with Lymph Node Metastasis.
hsa-mir-1260b	non-small cell lung cancer	up	MiR-1260b promotes the migration and invasion in non-small cell lung cancer via targeting PTPRK.
hsa-mir-1260b	non-small cell lung cancer	up	miR-1260b, mediated by YY1, activates KIT signaling by targeting SOCS6 to regulate cell proliferation and apoptosis in NSCLC.
hsa-mir-1260b	renal cell carcinoma	up	Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells.
hsa-mir-1261	glioma	down	MiR-1261/circ-PTPRZ1/PAK1 pathway regulates glioma cell growth and invasion.
hsa-mir-1265	gastric cancer	down	MIR-1265 regulates cellular proliferation and apoptosis by targeting calcium binding protein 39 in gastric cancer and, thereby, impairing oncogenic autophagy.
hsa-mir-1266	cervical cancer	up	MiR-1266 promotes cell proliferation, migration and invasion in cervical cancer by targeting DAB2IP.
hsa-mir-1266	colorectal cancer	down	Low expression of microRNA-1266 promotes colorectal cancer progression via targeting FTO.
hsa-mir-1266	gastric cancer	down	miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase.
hsa-mir-1266	papillary thyroid carcinoma	down	MicroRNA-1266 suppresses papillary thyroid carcinoma cell metastasis and growth via targeting FGFR2.
hsa-mir-1266-5p	prostate cancer	down	Downregulation of miR-1266-5P, miR-185-5P and miR-30c-2 in prostatic cancer tissue and cell lines.
hsa-mir-1266-5p	prostate cancer	down	miR-1266-5p and miR-185-5p Promote Cell Apoptosis in Human Prostate Cancer Cell Lines
hsa-mir-1269	hepatocellular carcinoma	up	MicroRNA-1269 promotes proliferation in human hepatocellular carcinoma via downregulation of FOXO1.
hsa-mir-1269	hepatocellular carcinoma	up	Upregulated MiR-1269 in hepatocellular carcinoma and its clinical significance.
hsa-mir-1269	hepatocellular carcinoma	up	Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients.
hsa-mir-1269	lung cancer	up	miR-1269 promotes cell survival and proliferation by targeting tp53 and caspase-9 in lung cancer.
hsa-mir-1269a	colorectal cancer	up	miR-1269 promotes metastasis and forms a positive feedback loop with TGF-?.
hsa-mir-1269a	hepatocellular carcinoma	down	A single nucleotide variant in microRNA-1269a promotes the occurrence and process of hepatocellular carcinoma by targeting to oncogenes SPATS2L and LRP6.
hsa-mir-1269a	non-small cell lung cancer	up	MiR-1269a acts as an onco-miRNA in non-small cell lung cancer via down-regulating SOX6.
hsa-mir-1269b	hepatocellular carcinoma	up	HBx-induced MiR-1269b in NF-?B dependent manner upregulates cell division cycle 40 homolog (CDC40) to promote proliferation and migration in hepatoma cells.
hsa-mir-127	breast cancer	down	MicroRNA-127 is Downregulated by Tudor-SN Protein and Contributes to Metastasis and Proliferation in Breast Cancer Cell Line MDA-MB-231.
hsa-mir-127	breast cancer	down	miR-127 Regulates Cell Proliferation and Senescence by Targeting BCL6.
hsa-mir-127	esophageal squamous cell carcinoma	down	MicroRNA-127 is a tumor suppressor in human esophageal squamous cell carcinoma through the regulation of oncogene FMNL3.
hsa-mir-127	gastric cancer	down	miR-127 suppresses gastric cancer cell migration and invasion via targeting Wnt7a.
hsa-mir-127	gastric cancer	down	The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer.
hsa-mir-127	hepatocellular carcinoma	down	A Feedback Inhibition between miRNA-127 and TGF?/c-Jun Cascade in HCC Cell Migration via MMP13.
hsa-mir-127	hepatocellular carcinoma	down	MicroRNA-127 Post-Transcriptionally Downregulates Sept7 and Suppresses Cell Growth in Hepatocellular Carcinoma Cells.
hsa-mir-127	lung cancer	up	miR-127 promotes EMT and stem-like traits in lung cancer through a feed-forward regulatory loop.
hsa-mir-127	ovarian cancer	down	MiR-127 inhibits ovarian cancer migration and invasion by up-regulating ITGA6.
hsa-mir-127	pancreatic carcinoma	down	MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer.
hsa-mir-127-3p	colorectal cancer	up	A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
hsa-mir-127-3p	glioblastoma	down	Next Generation Sequencing Analysis of miRNAs: MiR-127-3p Inhibits Glioblastoma Proliferation and Activates TGF-? Signaling by Targeting SKI.
hsa-mir-127-3p	glioblastoma	up	MicroRNA-127-3p promotes glioblastoma cell migration and invasion by targeting the tumor-suppressor gene SEPT7.
hsa-mir-127-3p	osteosarcoma	down	MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.
hsa-mir-127-3p	osteosarcoma	down	MiR-127-3p inhibits cell growth and invasiveness by targeting ITGA6 in human osteosarcoma.
hsa-mir-127-3p	osteosarcoma	down	MicroRNA-127-3p inhibits proliferation and invasion by targeting SETD8 in human osteosarcoma cells.
hsa-mir-127-5p	hepatocellular carcinoma	down	MiR-127-5p targets the biliverdin reductase B/NF-?B pathway to suppress cell growth in hepatocellular carcinoma cells.
hsa-mir-1270	osteosarcoma	up	MicroRNA-1270 is associated with poor prognosis and its inhibition yielded anticancer mechanisms in human osteosarcoma.
hsa-mir-1271	breast cancer	down	miR-1271 inhibits ER? expression and confers letrozole resistance in breast cancer.
hsa-mir-1271	breast cancer	down	MiR-1271 as a tumor suppressor in breast cancer proliferation and progression via targeting SPIN1.
hsa-mir-1271	breast cancer	down	Estrogen receptor-?-miR-1271-SNAI2 feedback loop regulates transforming growth factor-?-induced breast cancer progression.
hsa-mir-1271	colorectal cancer	down	Suppression of Capn4 by microRNA-1271 impedes the proliferation and invasion of colorectal cancer cells.
hsa-mir-1271	colorectal cancer	down	MicroRNA-1271 suppresses the proliferation and invasion of colorectal cancer cells by regulating metadherin/Wnt signaling.
hsa-mir-1271	colorectal cancer	down	miR-1271 enhances the sensitivity of colorectal cancer cells to cisplatin.
hsa-mir-1271	endometrial cancer	down	MiR-1271 inhibits cell proliferation and metastasis by targeting LDHA in endometrial cancer.
hsa-mir-1271	endometrial cancer	down	Over-expression of miR-1271 inhibits endometrial cancer cells proliferation and induces cell apoptosis by targeting CDK1.
hsa-mir-1271	gastric cancer	down	miR-1271 Regulates Cisplatin Resistance of Human Gastric Cancer Cell Lines by Targeting IGF1R, IRS1, mTOR, and BCL2.
hsa-mir-1271	gastric cancer	down	MiR-1271 Inhibits Cell Proliferation, Invasion and EMT in Gastric Cancer by Targeting FOXQ1.
hsa-mir-1271	hepatocellular carcinoma	down	A functional screening identifies five miRNAs controlling glypican-3: Role of miR-1271 down-regulation in hepatocellular carcinoma.
hsa-mir-1271	hepatocellular carcinoma	down	MicroRNA-1271 functions as a metastasis and epithelial-mesenchymal transition inhibitor in human HCC by targeting the PTP4A1/c-Src axis.
hsa-mir-1271	non-small cell lung cancer	down	Inhibition of the growth of non-small cell lung cancer by miRNA-1271.
hsa-mir-1271	oral squamous cell carcinoma	down	miR-1271 inhibits OSCC cell growth and metastasis by targeting ALK.
hsa-mir-1271	osteosarcoma	up	Expression and role of microRNA-1271 in the pathogenesis of osteosarcoma.
hsa-mir-1271	ovarian cancer	down	MiR-1271 Inhibits Ovarian Cancer Growth by Targeting Cyclin G1.
hsa-mir-1271	pancreatic cancer	down	MiR-1271 negatively regulates AKT/MTOR signaling and promotes apoptosis via targeting PDK1 in pancreatic cancer.
hsa-mir-1271	pancreatic cancer	down	miR-1271 inhibits migration, invasion and epithelial-mesenchymal transition by targeting ZEB1 and TWIST1 in pancreatic cancer cells.
hsa-mir-1271	prostate cancer	down	MiR-1271 Inhibits Cell Growth in Prostate Cancer by Targeting ERG.
hsa-mir-1273e	gastric cancer	down	Long Intergenic Non-Protein-Coding RNA 01138 Accelerates Tumor Growth and Invasion in Gastric Cancer by Regulating miR-1273e.
hsa-mir-1274a	gastric cancer	up	The role of microRNA-1274a in the tumorigenesis of gastric cancer: accelerating cancer cell proliferation and migration via directly targeting FOXO4.
hsa-mir-1274a	renal clear cell carcinoma	up	Downregulation of microRNA-1274a induces cell apoptosis through regulation of BMPR1B in clear cell renal cell carcinoma.
hsa-mir-1275	chronic myelogenous leukemia	up	LncRNA HAND2-AS1 inhibits proliferation and promotes apoptosis of chronic myeloid leukemia cells by sponging with micRNA-1275.
hsa-mir-1275	gastric cancer	down	MicroRNA-1275 inhibits cell migration and invasion in gastric cancer by regulating vimentin and E-cadherin via JAZF1.
hsa-mir-1275	nasopharyngeal carcinoma	down	MicroRNA-1275 suppresses cell growth, and retards G1/S transition in human nasopharyngeal carcinoma by down-regulation of HOXB5.
hsa-mir-1275	non-small cell lung cancer	up	MiR-1275 promotes non-small cell lung cancer cell proliferation and metastasis by regulating LZTS3 expression.
hsa-mir-1275	squamous carcinoma	up	MiR-1275 promotes cell migration, invasion and proliferation in squamous cell carcinoma of head and neck via up-regulating IGF-1R and CCR7.
hsa-mir-1277	hepatocellular carcinoma	down	MicroRNA-1277 inhibits proliferation and migration of hepatocellular carcinoma HepG2 cells by targeting and suppressing BMP4 expression and reflects the significant indicative role in hepatocellular c
hsa-mir-128	acute lymphoblastic leukemia	up	Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia.
hsa-mir-128	acute myeloid leukemia	up	Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia.
hsa-mir-128	colorectal cancer	down	MicroRNA-128 suppresses cell growth and metastasis in colorectal carcinoma by targeting IRS1.
hsa-mir-128	colorectal cancer	down	Posttranscriptional regulation of Galectin-3 by miR-128 contributes to colorectal cancer progression.
hsa-mir-128	gastric cancer	down	The SNAIL/miR-128 axis regulated growth, invasion, metastasis, and epithelial-to-mesenchymal transition of gastric cancer.
hsa-mir-128	gastric cancer	down	MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.
hsa-mir-128	gastric cancer	down	Long noncoding RNA PVT1-214 enhances gastric cancer progression by upregulating TrkC expression in competitively sponging way.
hsa-mir-128	glioblastoma	down	Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation.
hsa-mir-128	glioblastoma	down	PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma.
hsa-mir-128	glioblastoma	down	miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma.
hsa-mir-128	glioblastoma	down	Dysregulation of microRNA-128 expression in WHO grades 2 glioma is associated with glioma-associated epilepsy: Down-regulation of miR-128 induces glioma-associated seizure.
hsa-mir-128	glioblastoma	down	MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors.
hsa-mir-128	glioma	down	MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a.
hsa-mir-128	glioma	down	Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal.
hsa-mir-128	glioma	down	MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells.
hsa-mir-128	glioma	down	MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1.
hsa-mir-128	glioma	down	Proteomic screening and identification of microRNA-128 targets in glioma cells.
hsa-mir-128	glioma	down	Serum microRNA-128 as a biomarker for diagnosis of glioma.
hsa-mir-128	head and neck squamous cell carcinoma	down	Functions of MiRNA-128 on the regulation of head and neck squamous cell carcinoma growth and apoptosis.
hsa-mir-128	hepatocellular carcinoma	down	miR-128 modulates hepatocellular carcinoma by inhibition of ITGA2 and ITGA5 expression.
hsa-mir-128	lung cancer	down	MicroRNA-128 promotes apoptosis in lung cancer by directly targeting NIMA-related kinase 2.
hsa-mir-128	meningioma	down	Serum microRNA-128 as a biomarker for diagnosis of glioma.
hsa-mir-128	osteosarcoma	up	MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN.
hsa-mir-128	osteosarcoma	down	MicroRNA-128 inhibits EMT of human osteosarcoma cells by directly targeting integrin ?2.
hsa-mir-128	pancreatic cancer	down	miR-128 induces pancreas cancer cell apoptosis by targeting MDM4.
hsa-mir-128	prostate cancer	down	MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells.
hsa-mir-128	prostate cancer	down	miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells.
hsa-mir-128-3p	anaplastic thyroid carcinoma	down	Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer.
hsa-mir-128-3p	glioma	down	miR-128-3p inhibits glioma cell proliferation and differentiation by targeting NPTX1 through IRS-1/PI3K/AKT signaling pathway.
hsa-mir-128-3p	glioma	down	LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway.
hsa-mir-128-3p	hepatocellular carcinoma	down	MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1.
hsa-mir-128-3p	hepatocellular carcinoma	down	miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients.
hsa-mir-128-3p	lung cancer	down	A two-miRNA signature (miR-33a-5p and miR-128-3p) in whole blood as potential biomarker for early diagnosis of lung cancer.
hsa-mir-1280	bladder cancer	down	MicroRNA-1280 Inhibits Invasion and Metastasis by Targeting ROCK1 in Bladder Cancer.
hsa-mir-1280	colorectal cancer	down	tRF/miR-1280 Suppresses Stem Cell-like Cells and Metastasis in Colorectal Cancer.
hsa-mir-1280	malignant melanoma	down	Anti-tumor activity of miR-1280 in melanoma by regulation of Src.
hsa-mir-1280	non-small cell lung cancer	up	Upregulation of MiR-1280 Expression in Non-small Cell Lung Cancer Tissues.
hsa-mir-1283	glioma	down	Overexpression of miR-1283 inhibits cell proliferation and invasion of glioma cells by targeting ATF4.
hsa-mir-1284	breast cancer	down	MiR-1284 inhibits the growth and invasion of breast cancer cells by targeting ZIC2.
hsa-mir-1284	gastric cancer	down	miR-1284 modulates multidrug resistance of gastric cancer cells by targeting EIF4A1.
hsa-mir-1284	gastric cancer	down	MiR-1284 suppresses gastric cancer progression by targeting EIF4A1.
hsa-mir-1285	renal cell carcinoma	down	Tumor suppressive microRNA-1285 regulates novel molecular targets: Aberrant expression and functional significance in renal cell carcinoma.
hsa-mir-1285-3p	osteosarcoma	down	miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1.
hsa-mir-1287	hepatocellular carcinoma	down	Mir-1287 suppresses the proliferation, invasion, and migration in hepatocellular carcinoma by targeting PIK3R3.
hsa-mir-1288	esophageal squamous cell carcinoma	up	Overexpression of microRNA-1288 in oesophageal squamous cell carcinoma.
hsa-mir-128a	hepatocellular carcinoma	up	[miR-128a is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation by targeting RND3].
hsa-mir-128a	medulloblastoma	down	MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence.
hsa-mir-128b	gastric cancer	down	PGC-1?/SNAI1 axis regulates tumor growth and metastasis by targeting miR-128b in gastric cancer.
hsa-mir-128b	gastric cancer	down	MicroRNA-128b suppresses tumor growth and promotes apoptosis by targeting A2bR in gastric cancer.
hsa-mir-128b	gastric cancer	down	MiR-128b is down-regulated in gastric cancer and negatively regulates tumour cell viability by targeting PDK1/Akt/NF-?B axis.
hsa-mir-129	breast cancer	down	[The down-regulation of miR-129 in breast cancer and its effect on breast cancer migration and motility].
hsa-mir-129	breast cancer	down	MiR-129 blocks estrogen induction of NOTCH signaling activity in breast cancer stem-like cells.
hsa-mir-129	colorectal cancer	down	miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer.
hsa-mir-129	esophageal squamous cell carcinoma	down	LncRNA NEAT1 Regulates Cell Viability and Invasion in Esophageal Squamous Cell Carcinoma through the miR-129/CTBP2 Axis.
hsa-mir-129	gastric cancer	down	MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3.
hsa-mir-129	glioblastoma	down	Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.
hsa-mir-129	glioma	down	MiR-129 triggers autophagic flux by regulating a novel Notch-1/ E2F7/Beclin-1 axis to impair the viability of human malignant glioma cells.
hsa-mir-129	glioma	down	LncRNA MALAT1/miR-129 axis promotes glioma tumorigenesis by targeting SOX2.
hsa-mir-129	hepatocellular carcinoma	down	miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma.
hsa-mir-129	non-small cell lung cancer	down	MiR-129 regulates MMP9 to control metastasis of non-small cell lung cancer.
hsa-mir-129	prostate cancer	down	Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
hsa-mir-129	prostate cancer	down	MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer.
hsa-mir-129-1-3p	gastric cancer	down	Growth inhibitory effects of three miR-129 family members on gastric cancer.
hsa-mir-129-2-3p	gastric cancer	down	Growth inhibitory effects of three miR-129 family members on gastric cancer.
hsa-mir-129-3p	gastric cancer	down	Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer.
hsa-mir-129-3p	glioblastoma	down	MicroRNA-129-3p suppresses tumor growth by targeting E2F5 in glioblastoma.
hsa-mir-129-3p	renal cell carcinoma	down	miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.
hsa-mir-129-5p	breast cancer	down	microRNA-129-5p suppresses Adriamycin resistance in breast cancer by targeting SOX2.
hsa-mir-129-5p	breast cancer	down	MiR-129-5p is downregulated in breast cancer cells partly due to promoter H3K27m3 modification and regulates epithelial-mesenchymal transition and multi-drug resistance.
hsa-mir-129-5p	breast cancer	down	miR-129-5p suppresses breast cancer proliferation by targeting CBX4.
hsa-mir-129-5p	breast cancer	down	Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer.
hsa-mir-129-5p	cervical cancer	down	Upregulation of microRNA-129-5p inhibits cell invasion, migration and tumor angiogenesis by inhibiting ZIC2 via downregulation of the Hedgehog signaling pathway in cervical cancer.
hsa-mir-129-5p	chondrosarcoma	down	MiR-129-5p Inhibits Proliferation and Invasion of Chondrosarcoma Cells by Regulating SOX4/Wnt/?-Catenin Signaling Pathway.
hsa-mir-129-5p	colon cancer	down	LncRNA MALAT1 induces colon cancer development by regulating miR-129-5p/HMGB1 axis.
hsa-mir-129-5p	gastric cancer	down	MiR-129-5p influences the progression of gastric cancer cells through interacting with SPOCK1.
hsa-mir-129-5p	gastric cancer	down	Growth inhibitory effects of three miR-129 family members on gastric cancer.
hsa-mir-129-5p	gastric cancer	down	lncRNA-AC130710 targeting by miR-129-5p is upregulated in gastric cancer and associates with poor prognosis.
hsa-mir-129-5p	gastric cancer	down	MiR-129-5p suppresses gastric cancer cell invasion and proliferation by inhibiting COL1A1.
hsa-mir-129-5p	gastric cancer	down	MiR-129-5p functions as a tumor suppressor in gastric cancer progression through targeting ADAM9.
hsa-mir-129-5p	glioblastoma	down	Potential mechanisms of microRNA-129-5p in inhibiting cell processes including viability, proliferation, migration and invasiveness of glioblastoma cells U87 through targeting FNDC3B.
hsa-mir-129-5p	glioma	down	MiR-129-5p inhibits glioma cell progression in vitro and in vivo by targeting TGIF2.
hsa-mir-129-5p	glioma	down	MicroRNA-129-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting DNMT3A.
hsa-mir-129-5p	hepatocellular carcinoma	down	MicroRNA-129-5p inhibits hepatocellular carcinoma cell metastasis and invasion via targeting ETS1.
hsa-mir-129-5p	laryngeal squamous cell carcinoma	down	Down-Regulation of miR-129-5p Inhibits Growth and Induces Apoptosis in Laryngeal Squamous Cell Carcinoma by Targeting APC.
hsa-mir-129-5p	lung cancer	down	Tumor suppressor function of miR-129-5p in lung cancer.
hsa-mir-129-5p	lung cancer	down	miRNA-129-5p suppresses cell proliferation and invasion in lung cancer by targeting microspherule protein 1, E-cadherin and vimentin.
hsa-mir-129-5p	malignant melanoma	down	Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) Promotes Tumor Growth and Metastasis Through TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) Axis in Malignant Melanoma.
hsa-mir-129-5p	medullary thyroid carcinoma	down	MiR-129-5p is down-regulated and involved in the growth, apoptosis and migration of medullary thyroid carcinoma cells through targeting RET.
hsa-mir-129-5p	non-small cell lung cancer	down	MiR-129-5p inhibits non-small cell lung cancer cell stemness and chemoresistance through targeting DLK1.
hsa-mir-129-5p	osteosarcoma	down	MicroRNA-129-5p suppresses cell proliferation, migration and invasion via targeting ROCK1 in osteosarcoma.
hsa-mir-129-5p	ovarian cancer	down	A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.
hsa-mir-129-5p	prostate cancer	down	miR-129-5p inhibits prostate cancer proliferation via targeting ETV1.
hsa-mir-1290	colon cancer	up	Up-regulation of microRNA-1290 impairs cytokinesis and affects the reprogramming of colon cancer cells.
hsa-mir-1290	esophageal squamous cell carcinoma	up	MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis.
hsa-mir-1290	esophageal squamous cell carcinoma	up	Prognostic value of combined and individual expression of microRNA-1290 and its target gene nuclear factor I/X in human esophageal squamous cell carcinoma.
hsa-mir-1290	esophageal squamous cell carcinoma	up	MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC).
hsa-mir-1290	gastric cancer	up	sMicroRNA-1290 inhibits cells proliferation and migration by targeting FOXA1 in gastric cancer cells.
hsa-mir-1290	gastric cancer	up	Exosome-mediated transfer of miR-1290 promotes cell proliferation and invasion in gastric cancer via NKD1.
hsa-mir-1290	lung adenocarcinoma	up	miR-1290 promotes lung adenocarcinoma cell proliferation and invasion by targeting SOCS4.
hsa-mir-1290	non-small cell lung cancer	down	Overexpression of miR-1290 contributes to cell proliferation and invasion of non small cell lung cancer by targeting interferon regulatory factor 2.
hsa-mir-1290	non-small cell lung cancer	up	Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer.
hsa-mir-1290	non-small cell lung cancer	up	miR-1290 is a potential prognostic biomarker in non-small cell lung cancer.
hsa-mir-1290	pancreatic ductal adenocarcinoma	up	miRNA-1290 Promotes Aggressiveness in Pancreatic Ductal Adenocarcinoma by Targeting IKK1.
hsa-mir-1290	renal clear cell carcinoma	up	microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.
hsa-mir-1291	hepatocellular carcinoma	up	Clinical Impact of Circulated miR-1291 in Plasma of Patients with Liver Cirrhosis (LC) and Hepatocellular Carcinoma (HCC): Implication on Glypican-3 Expression.
hsa-mir-1291	pancreatic cancer	down	Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models.
hsa-mir-1291	renal cell carcinoma	down	Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 (GLUT1) in renal cell carcinoma.
hsa-mir-1292-5p	gastric cancer	down	MicroRNA-1292-5p inhibits cell growth, migration and invasion of gastric carcinoma by targeting DEK.
hsa-mir-1294	esophageal squamous cell carcinoma	down	Down-Regulation of MiR-1294 is Related to Dismal Prognosis of Patients with Esophageal Squamous Cell Carcinoma through Elevating C-MYC Expression.
hsa-mir-1294	gastric cancer	down	Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer.
hsa-mir-1294	glioma	down	MicroRNA-1294 inhibits the proliferation and enhances the chemosensitivity of glioma to temozolomide via the direct targeting of TPX2.
hsa-mir-1294	oral squamous cell carcinoma	down	MicroRNA-1294 inhibited oral squamous cell carcinoma growth by targeting c-Myc.
hsa-mir-1295b-3p	colorectal cancer	down	Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer.
hsa-mir-1296	colorectal cancer	up	MicroRNA-1296 Facilitates Proliferation, Migration And Invasion Of Colorectal Cancer Cells By Targeting SFPQ.
hsa-mir-1296	hepatocellular carcinoma	down	MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
hsa-mir-1296	prostate cancer	down	Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.
hsa-mir-1296-5p	breast cancer	down	miR-1296-5p decreases ERBB2 expression to inhibit the cell proliferation in ERBB2-positive breast cancer.
hsa-mir-1296-5p	gastric cancer	down	The tumor-suppressive function of miR-1296-5p by targeting EGFR and CDK6 in gastric cancer.
hsa-mir-1296-5p	gastric cancer	down	miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression.
hsa-mir-1297	cervical cancer	down	MicroRNA-1297 inhibits metastasis and epithelial-mesenchymal transition by targeting AEG-1 in cervical cancer.
hsa-mir-1297	cervical cancer	down	MicroRNA-1297 contributes to the progression of human cervical carcinoma through PTEN.
hsa-mir-1297	gastric cancer	down	Downregulation of MiR-1297 predicts poor prognosis and enhances gastric cancer cell growth by targeting CREB1.
hsa-mir-1297	glioma	down	Involvement of microRNA-1297, a new regulator of HMGA1, in the regulation of glioma cell growth in vivo and in vitro.
hsa-mir-1297	liver cancer	up	miR-1297 promotes cell proliferation by inhibiting RB1 in liver cancer.
hsa-mir-1297	lung adenocarcinoma	down	miR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2.
hsa-mir-1297	oral squamous cell carcinoma	down	microRNA-1297 involves in the progression of oral squamous cell carcinoma through PTEN.
hsa-mir-1297	pancreatic adenocarcinoma	down	MiR-1297 suppresses pancreatic cancer cell proliferation and metastasis by targeting MTDH.
hsa-mir-1297	pancreatic cancer	down	MiR-1297 suppresses pancreatic cancer cell proliferation and metastasis by targeting MTDH.
hsa-mir-1297	prostate cancer	down	MicroRNA-1297 inhibits prostate cancer cell proliferation and invasion by targeting the AEG-1/Wnt signaling pathway.
hsa-mir-1298	gastric cancer	down	MiR-1298 expression correlates with prognosis and inhibits cell proliferation and invasion of gastric cancer.
hsa-mir-1299	hepatocellular carcinoma	down	miR-1299 suppresses cell proliferation of hepatocellular carcinoma (HCC) by targeting CDK6.
hsa-mir-1301	glioma	down	Association between downexpression of miR-1301 and poor prognosis in patients with glioma.
hsa-mir-1301	hepatocellular carcinoma	down	miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/?-catenin signaling through targeting BCL9.
hsa-mir-1301	liver cancer	up	Identification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform.
hsa-mir-1301	osteosarcoma	down	MicroRNA-1301 inhibits migration and invasion of osteosarcoma cells by targeting BCL9.
hsa-mir-1301	prostate cancer	up	miR-1301 promotes prostate cancer proliferation through directly targeting PPP2R2C.
hsa-mir-1301-3p	breast cancer	down	MiR-1301-3p inhibits human breast cancer cell proliferation by regulating cell cycle progression and apoptosis through directly targeting ICT1.
hsa-mir-1301-3p	prostate cancer	up	miR-1301-3p promotes prostate cancer stem cell expansion by targeting SFRP1 and GSK3?.
hsa-mir-1303	gastric cancer	up	miR-1303 Targets Claudin-18 Gene to Modulate Proliferation and Invasion of Gastric Cancer Cells.
hsa-mir-1303	neuroblastoma	up	miR-1303 promotes the proliferation of neuroblastoma cell SH-SY5Y by targeting GSK3? and SFRP1.
hsa-mir-1304	non-small cell lung cancer	down	MicroRNA-1304 suppresses human non-small cell lung cancer cell growth in vitro by targeting heme oxygenase-1.
hsa-mir-1306-3p	gastric cancer	down	Circular RNA circNHSL1 promotes gastric cancer progression through the miR-1306-3p/SIX1/vimentin axis.
hsa-mir-1307	colorectal cancer	down	The polymorphic terminal-loop of pre-miR-1307 binding with MBNL1 contributes to colorectal carcinogenesis via interference with Dicer1 recruitment.
hsa-mir-1307	prostate cancer	up	miR-1307 promotes the proliferation of prostate cancer by targeting FOXO3A.
hsa-mir-1307-3p	breast cancer	up	miR-1307-3p Stimulates Breast Cancer Development and Progression by Targeting SMYD4.
hsa-mir-1307-3p	lung cancer	up	MicroRNA-1307-3p promotes lung cancer cell proliferation by targeting EGFR.
hsa-mir-130a	acute myeloid leukemia	up	Physiological expression of miR-130a during differentiation of CD34+ human hematopoietic stem cells results in the inhibition of monocyte differentiation.
hsa-mir-130a	basal cell carcinoma	up	Expression of microRNAs in basal cell carcinoma.
hsa-mir-130a	breast cancer	down	MicroRNA-130a inhibits cell proliferation, invasion and migration in human breast cancer by targeting the RAB5A.
hsa-mir-130a	breast cancer	down	microRNA-130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO-1.
hsa-mir-130a	cervical cancer	up	MicroRNA-130a regulated by HPV18 E6 promotes proliferation and invasion of cervical cancer cells by targeting TIMP2.
hsa-mir-130a	chronic myelogenous leukemia	down	Functional studies of miR-130a on the inhibitory pathways of apoptosis in patients with chronic myeloid leukemia.
hsa-mir-130a	colorectal cancer	up	MicroRNA-130a is upregulated in colorectal cancer and promotes cell growth and motility by directly targeting forkhead box F2.
hsa-mir-130a	endometrial cancer	down	Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.
hsa-mir-130a	esophageal cancer	up	Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-130a	gastric cancer	up	Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells.
hsa-mir-130a	gastric cancer	up	Onco-miR-130 promotes cell proliferation and migration by targeting TGF?R2 in gastric cancer.
hsa-mir-130a	glioma	down	Downregulation of miR-130a promotes cell growth and epithelial to mesenchymal transition by activating HMGB2 in glioma.
hsa-mir-130a	hepatocellular carcinoma	up	Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell.
hsa-mir-130a	hepatocellular carcinoma	down	MicroRNA-130a is down-regulated in hepatocellular carcinoma and associates with poor prognosis.
hsa-mir-130a	hepatocellular carcinoma	down	Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.
hsa-mir-130a	hepatocellular carcinoma	down	Identifying microRNA panels specifically associated with hepatocellular carcinoma and its different etiologies.
hsa-mir-130a	non-small cell lung cancer	down	MiR-130 exerts tumor suppressive function on the tumorigenesis of human non-small cell lung cancer by targeting PTEN.
hsa-mir-130a	osteosarcoma	up	MicroRNA-130a promotes the metastasis and epithelial-mesenchymal transition of osteosarcoma by targeting PTEN.
hsa-mir-130a	prostate cancer	down	Epigenetic Disruption of miR-130a Promotes Prostate Cancer By Targeting SEC23B and DEPDC1.
hsa-mir-130a	serous ovarian cancer	up	miR-130a upregulates mTOR pathway by targeting TSC1 and is transactivated by NF-?B in high-grade serous ovarian carcinoma.
hsa-mir-130a-3p	breast cancer	down	MiR-130a-3p inhibits migration and invasion by regulating RAB5B in human breast cancer stem cell-like cells.
hsa-mir-130a-3p	gastric cancer	down	MicroRNA-130a-3p suppresses cell migration and invasion by inhibition of TBL1XR1-mediated EMT in human gastric carcinoma.
hsa-mir-130a-3p	nasopharyngeal carcinoma	down	MicroRNA-130a-3p suppresses cell viability, proliferation and invasion in nasopharyngeal carcinoma by inhibiting CXCL12.
hsa-mir-130a-5p	gastric cancer	down	miR-23b-3p and miR-130a-5p affect cell growth, migration and invasion by targeting CB1R via the Wnt/?-catenin signaling pathway in gastric carcinoma.
hsa-mir-130b	bladder cancer	up	miR-130b promotes bladder cancer cell proliferation, migration and invasion by targeting VGLL4.
hsa-mir-130b	colorectal cancer	up	MicroRNA-130b Promotes Tumor Development and Is Associated with Poor Prognosis in Colorectal Cancer.
hsa-mir-130b	colorectal cancer	up	MicroRNA-130b Promotes Tumor Development and Is Associated with Poor Prognosis in Colorectal Cancer.
hsa-mir-130b	colorectal cancer	down	Microrna 130b Suppresses Migration and Invasion of Colorectal Cancer Cells through Downregulation of Integrin ?1.
hsa-mir-130b	endometrial cancer	down	Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.
hsa-mir-130b	esophageal squamous cell carcinoma	up	MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
hsa-mir-130b	gastric cancer	up	Onco-miR-130 promotes cell proliferation and migration by targeting TGF?R2 in gastric cancer.
hsa-mir-130b	glioblastoma	up	Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway.
hsa-mir-130b	glioma	up	MicroRNA-130b promotes cell proliferation and invasion by inhibiting peroxisome proliferator-activated receptor-? in human glioma cells.
hsa-mir-130b	glioma	up	Suppression of microRNA-130b inhibits glioma cell proliferation and invasion, and induces apoptosis by PTEN/AKT signaling.
hsa-mir-130b	glioma	up	miR-130b regulates the proliferation, invasion and apoptosis of glioma cells via targeting of CYLD.
hsa-mir-130b	glioma	up	MicroRNA-130b promotes cell migration and invasion by inhibiting peroxisome proliferator-activated receptor-? in human glioma.
hsa-mir-130b	glioma	up	MicroRNA-130b promotes cell migration and invasion by targeting peroxisome proliferator-activated receptor gamma in human glioma.
hsa-mir-130b	hepatocellular carcinoma	up	MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1? signaling.
hsa-mir-130b	hepatocellular carcinoma	up	Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.
hsa-mir-130b	hepatocellular carcinoma	up	High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma.
hsa-mir-130b	hepatocellular carcinoma	down	Repression of microRNA-130b by thyroid hormone enhances cell motility.
hsa-mir-130b	lung cancer	up	MicroRNA-130b promotes lung cancer progression via PPAR?/VEGF-A/BCL-2-mediated suppression of apoptosis.
hsa-mir-130b	neuroblastoma	up	MicroRNA-130b promotes cell migration and invasion by targeting peroxisome proliferator-activated receptor gamma in human glioma.
hsa-mir-130b	non-small cell lung cancer	down	MiR-130 exerts tumor suppressive function on the tumorigenesis of human non-small cell lung cancer by targeting PTEN.
hsa-mir-130b	non-small cell lung cancer	up	An alternative microRNA-mediated post-transcriptional regulation of GADD45A by p53 in human non-small-cell lung cancer cells.
hsa-mir-130b	non-small cell lung cancer	up	MicroRNA-130b functions as an oncomiRNA in non-small cell lung cancer by targeting tissue inhibitor of metalloproteinase-2.
hsa-mir-130b	osteosarcoma	down	Restoration of microRNA-130b expression suppresses osteosarcoma cell malignant behavior in vitro.
hsa-mir-130b	osteosarcoma	up	miR-130b targets NKD2 and regulates the Wnt signaling to promote proliferation and inhibit apoptosis in osteosarcoma cells.
hsa-mir-130b	ovarian cancer	down	Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1.
hsa-mir-130b	papillary thyroid carcinoma	down	MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.
hsa-mir-130b	prostate cancer	down	MiR-130b suppresses prostate cancer metastasis through down-regulation of MMP2.
hsa-mir-130b	prostate cancer	down	Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer.
hsa-mir-130b	renal cell carcinoma	up	miR-130b Promotes Sunitinib Resistance through Regulation of PTEN in Renal Cell Carcinoma.
hsa-mir-130b*	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-130b-3p	bladder cancer	up	Genome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin ?1 Signaling Pathways in Bladder Carcinoma.
hsa-mir-130b-3p	breast carcinoma	down	miR-130b-3p inhibits cell invasion and migration by targeting the Notch ligand Delta-like 1 in breast carcinoma.
hsa-mir-130b-3p	nephroblastoma	up	Aberrant expression and mechanism of miR-130b-3p/phosphatase and tensin homolog in nephroblastoma in children.
hsa-mir-132	bladder cancer	down	MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition via TGF?1/Smad2 signaling pathway in human bladder cancer.
hsa-mir-132	breast cancer	down	Aberrant Expression of Breast Development-Related MicroRNAs, miR-22, miR-132, and miR-212, in Breast Tumor Tissues.
hsa-mir-132	breast cancer	down	MicroRNA-132 suppresses cell proliferation in human breast cancer by directly targeting FOXA1.
hsa-mir-132	breast cancer	down	MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1.
hsa-mir-132	colorectal cancer	down	miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2.
hsa-mir-132	colorectal cancer	down	miR-132 Regulates Adriamycin Resistance in Colorectal Cancer Cells Through Targeting Extracellular Signal-Regulated Kinase 1.
hsa-mir-132	colorectal cancer	down	Down-Regulation of microRNA-132 is Associated with Poor Prognosis of Colorectal Cancer.
hsa-mir-132	colorectal cancer	down	Downregulation of microRNA-132 by DNA hypermethylation is associated with cell invasion in colorectal cancer.
hsa-mir-132	gastric cancer	up	miR-132 upregulation promotes gastric cancer cell growth through suppression of FoxO1 translation.
hsa-mir-132	gastric cancer	up	Upregulation of microRNA-132 in gastric cancer promotes cell proliferation via retinoblastoma 1 targeting.
hsa-mir-132	glioma	up	Upregulation of miR-132 expression in glioma and its clinical significance.
hsa-mir-132	glioma	down	miR-132 weakens proliferation and invasion of glioma cells via the inhibition of Gli1.
hsa-mir-132	glioma	down	Knockdown of long non-coding RNA NEAT1 inhibits glioma cell migration and invasion via modulation of SOX2 targeted by miR-132.
hsa-mir-132	hepatocellular carcinoma	down	Diagnostic and prognostic potential of serum miR-132/212 cluster in patients with hepatocellular carcinoma.
hsa-mir-132	hepatocellular carcinoma	down	Downregulation of microRNA-132 indicates progression in hepatocellular carcinoma.
hsa-mir-132	liver cancer	down	Effects of MicroRNA-132 Transfection on the Proliferation and Apoptosis of Human Liver Cancer Cells in vitro and in vivo.
hsa-mir-132	lung cancer	down	miR-132 inhibits lung cancer cell migration and invasion by targeting SOX4.
hsa-mir-132	non-small cell lung cancer	down	MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition by regulating TGF?1/Smad2 in human non-small cell lung cancer.
hsa-mir-132	osteosarcoma	down	MicroRNA-132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox4.
hsa-mir-132	osteosarcoma	down	Loss of microRNA-132 predicts poor prognosis in patients with primary osteosarcoma.
hsa-mir-132	osteosarcoma	down	miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells.
hsa-mir-132	ovarian cancer	down	miR-132 targeting E2F5 suppresses cell proliferation, invasion, migration in ovarian cancer cells.
hsa-mir-132	pancreatic cancer	up	miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor.
hsa-mir-132	pancreatic carcinoma	down	Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.
hsa-mir-132	prostate cancer	down	Identification of tumor suppressive role of microRNA-132 and its target gene in tumorigenesis of prostate cancer.
hsa-mir-132	thyroid cancer	down	miR-132 targets FOXA1 and exerts tumor-suppressing functions in thyroid cancer.
hsa-mir-132-3p	breast cancer	down	MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer.
hsa-mir-132-3p	gastric cancer	up	Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer.
hsa-mir-132-3p	glioma	up	miR-132-3p boosts caveolae-mediated transcellular transport in glioma endothelial cells by targeting PTEN/PI3K/PKB/Src/Cav-1 signaling pathway.
hsa-mir-1323	hepatocellular carcinoma	up	LncRNA GAS5-mediated miR-1323 promotes tumor progression by targeting TP53INP1 in hepatocellular carcinoma.
hsa-mir-133a	bladder cancer	down	The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.
hsa-mir-133a	bladder cancer	down	MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer.
hsa-mir-133a	breast cancer	down	microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
hsa-mir-133a	breast cancer	down	MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1.
hsa-mir-133a	breast cancer	down	Evaluation of in vivo antitumor effects of low-frequency ultrasound-mediated miRNA-133a microbubble delivery in breast cancer.
hsa-mir-133a	cervical cancer	down	miR-133a inhibits cervical cancer growth by targeting EGFR.
hsa-mir-133a	cervical cancer	down	Involvement of NEAT1/miR-133a axis in promoting cervical cancer progression via targeting SOX4.
hsa-mir-133a	colorectal cancer	down	Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.
hsa-mir-133a	colorectal cancer	down	Tumor suppressor functions of miR-133a in colorectal cancer.
hsa-mir-133a	colorectal cancer	down	The clinicopathological significance of miR-133a in colorectal cancer.
hsa-mir-133a	colorectal cancer	down	Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.
hsa-mir-133a	colorectal cancer	down	MicroRNA-133a suppresses colorectal cancer cell invasion by targeting Fascin1.
hsa-mir-133a	esophageal squamous cell carcinoma	down	miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
hsa-mir-133a	esophageal squamous cell carcinoma	down	CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma.
hsa-mir-133a	gastric cancer	down	MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer.
hsa-mir-133a	gastric cancer	down	MicroRNA-133a functions as a tumor suppressor in gastric cancer.
hsa-mir-133a	gastric cancer	down	Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R.
hsa-mir-133a	gastric cancer	down	MicroRNA-133a inhibits proliferation and invasion, and induces apoptosis in gastric carcinoma cells via targeting fascin actin-bundling protein 1.
hsa-mir-133a	gastric cancer	up	miRNA and mRNA expression profiles in gastric cancer patients and the relationship with circRNA.
hsa-mir-133a	gastric cancer	down	MicroRNA-133a inhibits gastric cancer cells growth, migration, and epithelial-mesenchymal transition process by targeting presenilin 1.
hsa-mir-133a	glioma	down	miR-150-5p and miR-133a suppress glioma cell proliferation and migration through targeting membrane-type-1 matrix metalloproteinase.
hsa-mir-133a	glioma	down	Upregulation of microRNA-133a and downregulation of connective tissue growth factor suppress cell proliferation, migration, and invasion in human glioma through the JAK/STAT signaling pathway.
hsa-mir-133a	head and neck squamous cell carcinoma	down	Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.
hsa-mir-133a	head and neck squamous cell carcinoma	down	Tumor suppressive microRNA-133a regulates novel targets: Moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma.
hsa-mir-133a	hepatocellular carcinoma	down	MicroRNA-133a inhibits cell proliferation, colony formation ability, migration and invasion by targeting matrix metallopeptidase 9 in hepatocellular carcinoma.
hsa-mir-133a	hepatocellular carcinoma	down	MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma.
hsa-mir-133a	hepatocellular carcinoma	down	MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1.
hsa-mir-133a	hepatocellular carcinoma	down	MiR-133a acts as an anti-oncogene in Hepatocellular carcinoma by inhibiting FOSL2 through TGF-?/Smad3 signaling pathway.
hsa-mir-133a	lung squamous cell carcinoma	down	Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma.
hsa-mir-133a	non-small cell lung cancer	down	MiR-133a is downregulated in non-small cell lung cancer: a study of clinical significance.
hsa-mir-133a	non-small cell lung cancer	down	MicroRNA-133a downregulated EGFR expression in human non-small cell lung cancer cells via AKT/ERK signaling.
hsa-mir-133a	non-small cell lung cancer	down	MiR-133a suppressed cell migration and invasion by targeting SOX4 in non-small cell lung cancer.
hsa-mir-133a	non-small cell lung cancer	down	Down-regulation of miR-133a as a poor prognosticator in non-small cell lung cancer.
hsa-mir-133a	osteosarcoma	down	MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion via Targeting IGF-1R.
hsa-mir-133a	osteosarcoma	down	MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1.
hsa-mir-133a	ovarian cancer	down	miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor.
hsa-mir-133a	pancreatic cancer	down	miR-133a Functions as a Tumor Suppressor and Directly Targets FSCN1 in Pancreatic Cancer.
hsa-mir-133a	renal cell carcinoma	down	The functional significance of miR-1 and miR-133a in renal cell carcinoma.
hsa-mir-133a-1	breast cancer	down	Expression of circulating miR-17, miR-25, and miR-133 in breast cancer patients.
hsa-mir-133a-1	glioma	down	Down-regulation of MicroRNA-133 predicts poor overall survival and regulates the growth and invasive abilities in glioma.
hsa-mir-133a-1	hepatocellular carcinoma	down	Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.
hsa-mir-133a-1	lung adenocarcinoma	down	miR-133 involves in lung adenocarcinoma cell metastasis by targeting FLOT2.
hsa-mir-133a-1	lung cancer	down	Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.
hsa-mir-133a-1	prostate cancer	down	microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor.
hsa-mir-133a-2	breast cancer	down	Expression of circulating miR-17, miR-25, and miR-133 in breast cancer patients.
hsa-mir-133a-2	glioma	down	Down-regulation of MicroRNA-133 predicts poor overall survival and regulates the growth and invasive abilities in glioma.
hsa-mir-133a-2	hepatocellular carcinoma	down	Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.
hsa-mir-133a-2	lung adenocarcinoma	down	miR-133 involves in lung adenocarcinoma cell metastasis by targeting FLOT2.
hsa-mir-133a-2	lung cancer	down	Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.
hsa-mir-133a-2	prostate cancer	down	microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor.
hsa-mir-133a-3p	colorectal cancer	down	MiR-133a-3p Targets SUMO-Specific Protease 1 to Inhibit Cell Proliferation and Cell Cycle Progress in Colorectal Cancer.
hsa-mir-133a-3p	esophageal adenocarcinoma	down	Profiling of circulating microRNAs in patients with Barrett's esophagus and esophageal adenocarcinoma.
hsa-mir-133a-3p	esophageal squamous cell carcinoma	down	miR-133a-3p suppresses cell proliferation, migration, and invasion and promotes apoptosis in esophageal squamous cell carcinoma.
hsa-mir-133a-3p	oral squamous cell carcinoma	down	MiR-133a-3p Inhibits Oral Squamous Cell Carcinoma (OSCC) Proliferation and Invasion by Suppressing COL1A1.
hsa-mir-133a-3p	prostate cancer	down	Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
hsa-mir-133b	bladder cancer	down	MicroRNA-133b suppresses bladder cancer malignancy by targeting TAGLN2-mediated cell cycle.
hsa-mir-133b	bladder cancer	down	MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer.
hsa-mir-133b	breast cancer	down	MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer.
hsa-mir-133b	breast cancer	down	Expression of circulating miR-17, miR-25, and miR-133 in breast cancer patients.
hsa-mir-133b	breast cancer	down	LncRNA NEAT1 Silenced miR-133b Promotes Migration and Invasion of Breast Cancer Cells.
hsa-mir-133b	cervical carcinoma	up	MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways.
hsa-mir-133b	colorectal cancer	up	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-133b	colorectal cancer	down	miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression.
hsa-mir-133b	colorectal cancer	down	miR-133b suppresses metastasis by targeting HOXA9 in human colorectal cancer.
hsa-mir-133b	colorectal cancer	down	DNA methylation is involved in the aberrant expression of miR-133b in colorectal cancer cells.
hsa-mir-133b	esophageal squamous cell carcinoma	down	MicroRNA-133b inhibits cell proliferation and promotes apoptosis by targeting cullin 4B in esophageal squamous cell carcinoma.
hsa-mir-133b	esophageal squamous cell carcinoma	down	MicroRNA-133b/EGFR axis regulates esophageal squamous cell carcinoma metastases by suppressing anoikis resistance and anchorage-independent growth.
hsa-mir-133b	esophageal squamous cell carcinoma	down	miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
hsa-mir-133b	gastric cancer	down	miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer.
hsa-mir-133b	gastric cancer	down	MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells.
hsa-mir-133b	gastric cancer	down	MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer.
hsa-mir-133b	gastric cancer	down	The role of microRNA-133b and its target gene FSCN1 in gastric cancer.
hsa-mir-133b	gastric cancer	down	Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.
hsa-mir-133b	gastric cancer	down	MiR-133b inhibits proliferation and invasion of gastric cancer cells by up-regulating FBN1 expression.
hsa-mir-133b	gastric cancer	down	miR-133b acts as a tumor suppressor and negatively regulates ATP citrate lyase via PPAR? in gastric cancer.
hsa-mir-133b	gastric cancer	down	MiR-133b inhibits growth of human gastric cancer cells by silencing PKM-splicer PTBP1.
hsa-mir-133b	glioblastoma	down	MicroRNA-133b inhibits cell migration and invasion by targeting matrix metalloproteinase 14 in glioblastoma.
hsa-mir-133b	glioma	down	miR-133b inhibits glioma cell proliferation and invasion by targeting Sirt1.
hsa-mir-133b	glioma	down	Down-regulation of MicroRNA-133 predicts poor overall survival and regulates the growth and invasive abilities in glioma.
hsa-mir-133b	glioma	down	miR-133b acts as a tumor suppressor and negatively regulates EMP2 in glioma.
hsa-mir-133b	glioma	down	MicroRNA-133b expression associates with clinicopathological features and prognosis in glioma.
hsa-mir-133b	hepatocellular carcinoma	down	Overexpression of microRNA-133b is associated with the increased survival of patients with hepatocellular carcinoma after curative hepatectomy: Involvement of the EGFR/PI3K/Akt/mTOR signaling pathway.
hsa-mir-133b	hepatocellular carcinoma	down	MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.
hsa-mir-133b	hepatocellular carcinoma	down	MicroRNA-133b Inhibits Proliferation, Cellular Migration, and Invasion Via Targeting LASP1 in Hepatocarcinoma Cells.
hsa-mir-133b	hepatocellular carcinoma	down	Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.
hsa-mir-133b	lung adenocarcinoma	down	miR-133 involves in lung adenocarcinoma cell metastasis by targeting FLOT2.
hsa-mir-133b	lung cancer	down	MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer.
hsa-mir-133b	lung cancer	down	Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.
hsa-mir-133b	nasopharyngeal carcinoma	down	miR-133b, a microRNA targeting S1PR1, suppresses nasopharyngeal carcinoma cell proliferation.
hsa-mir-133b	non-small cell lung cancer	down	MicroRNA-133b inhibits the migration and invasion of non small cell lung cancer cells via targeting FSCN1.
hsa-mir-133b	non-small cell lung cancer	down	miR-133b inhibits cell growth, migration, and invasion by targeting MMP9 in non-small cell lung cancer.
hsa-mir-133b	osteosarcoma	down	MicroRNA-133b inhibits cell proliferation and invasion in osteosarcoma by targeting to Sirt1.
hsa-mir-133b	osteosarcoma	down	Downregulation of miR-133b/miR-503 acts as efficient prognostic and diagnostic factors in patients with osteosarcoma and these predictor biomarkers are correlated with overall survival.
hsa-mir-133b	prostate cancer	down	microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor.
hsa-mir-133b	prostate cancer	down	Posttranscriptional Regulation of Human Antigen R by miR-133b Enhances Docetaxel Cytotoxicity Through the Inhibition of ATP-Binding Cassette Subfamily G Member 2 in Prostate Cancer Cells.
hsa-mir-133b	renal cell carcinoma	down cell lines;	microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.
hsa-mir-133b	renal cell carcinoma	down cell line;	microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.
hsa-mir-134	breast cancer	down	MicroRNA-134 targets KRAS to suppress breast cancer cell proliferation, migration and invasion.
hsa-mir-134	cervical cancer	down	Silencing of long non-coding RNA NCK1-AS1 inhibits cell proliferation and migration via inhibition of microRNA-134 in cervical cancer.
hsa-mir-134	colorectal cancer	down	Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.
hsa-mir-134	endometrial cancer	down	MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins.
hsa-mir-134	esophageal squamous cell carcinoma	down	MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway.
hsa-mir-134	gastric cancer	down	MicroRNA-134 functions as a tumor suppressor gene in gastric cancer.
hsa-mir-134	gastric cancer	down	MicroRNA-134 suppresses cell proliferation in gastric cancer cells via targeting of GOLPH3.
hsa-mir-134	glioblastoma	down	Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma.
hsa-mir-134	glioma	down	MicroRNA-134 modulates glioma cell U251 proliferation and invasion by targeting KRAS and suppressing the ERK pathway.
hsa-mir-134	head and neck squamous cell carcinoma	up	miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene.
hsa-mir-134	hepatocellular carcinoma	down	Genome-Wide Screening Identified That miR-134 Acts as a Metastasis Suppressor by Targeting Integrin ?1 in Hepatocellular Carcinoma.
hsa-mir-134	non-small cell lung cancer	down	miR-134 inhibits non-small cell lung cancer growth by targeting the epidermal growth factor receptor.
hsa-mir-134	non-small cell lung cancer	down	Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1.
hsa-mir-134	non-small cell lung cancer	down	miR-134 suppresses the migration and invasion of non?small cell lung cancer by targeting ITGB1.
hsa-mir-134	osteosarcoma	down	miR-134 inhibits osteosarcoma cell invasion and metastasis through targeting MMP1 and MMP3 in vitro and in vivo.
hsa-mir-134	osteosarcoma	down	MicroRNA-134 inhibits osteosarcoma angiogenesis and proliferation by targeting the VEGFA/VEGFR1 pathway.
hsa-mir-134	osteosarcoma	down	Decreased miR-134 expression and its tumor-suppressive function in human osteosarcoma.
hsa-mir-134	renal cell carcinoma	down	miR-134 Functions as a Tumor Suppressor in Cell Proliferation and Epithelial-to-Mesenchymal Transition by Targeting KRAS in Renal Cell Carcinoma Cells.
hsa-mir-134-5p	nasopharyngeal carcinoma	down	Long non-coding RNA PCAT7 regulates ELF2 signaling through inhibition of miR-134-5p in nasopharyngeal carcinoma.
hsa-mir-135a	bladder cancer	up	Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer.
hsa-mir-135a	breast cancer	up	miRNA-135a promotes breast cancer cell migration and invasion by targeting HOXA10.
hsa-mir-135a	breast cancer	down	Loss of Estrogen-Regulated MIR135A1 at 3p21.1 Promotes Tamoxifen Resistance in Breast Cancer.
hsa-mir-135a	breast cancer	down	Tumor-suppressive miRNA-135a inhibits breast cancer cell proliferation by targeting ELK1 and ELK3 oncogenes.
hsa-mir-135a	colorectal cancer	up	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-135a	colorectal cancer	up	MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro.
hsa-mir-135a	gastric cancer	down	miR-135a suppresses migration of gastric cancer cells by targeting TRAF5-mediated NF-?B activation.
hsa-mir-135a	gastric cancer	down	miR-135a acts as a tumor suppressor in gastric cancer in part by targeting KIFC1.
hsa-mir-135a	gastric cancer	up	miR-135a promotes gastric cancer progression and resistance to oxaliplatin.
hsa-mir-135a	glioblastoma	down	MicroRNA-135a regulates NHE9 to inhibit proliferation and migration of glioblastoma cells.
hsa-mir-135a	glioma	down	miR-135a inhibits glioma cell proliferation and invasion by directly targeting FOXO1.
hsa-mir-135a	hepatocellular carcinoma	up	Factor VII-Induced MicroRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
hsa-mir-135a	hepatocellular carcinoma	up	miRNA-135a promotes hepatocellular carcinoma cell migration and invasion by targeting forkhead box O1.
hsa-mir-135a	lung cancer	down	MiR-135a inhibits migration and invasion and regulates EMT-related marker genes by targeting KLF8 in lung cancer cells.
hsa-mir-135a	malignant melanoma	up	MiR-135 post-transcriptionally regulates FOXO1 expression and promotes cell proliferation in human malignant melanoma cells.
hsa-mir-135a	nasopharyngeal carcinoma	down	Knockdown of lncRNA ZFAS1 inhibits progression of nasopharyngeal carcinoma by sponging miR-135a.
hsa-mir-135a	nasopharyngeal carcinoma	down	MicroRNA-135a Inhibits Nasopharyngeal Carcinoma Cell Proliferation Through Targeting Interleukin-17.
hsa-mir-135a	non-small cell lung cancer	down	Serum microRNA-135a downregulation as a prognostic marker of non-small cell lung cancer.
hsa-mir-135a	pancreatic ductal adenocarcinoma	down	MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma.
hsa-mir-135a	prostate cancer	down	Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2.
hsa-mir-135a	prostate cancer	down	MicroRNA-135a induces prostate cancer cell apoptosis via inhibition of STAT6.
hsa-mir-135a	renal cell carcinoma	down	Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma.
hsa-mir-135a-1	colorectal cancer	up	MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-135a-1	esophageal squamous cell carcinoma	up	miR-135 promotes proliferation and stemness of oesophageal squamous cell carcinoma by targeting RERG.
hsa-mir-135a-1	non-small cell lung cancer	up	Downregulation of MicroRNA-135 Promotes Sensitivity of Non-Small Cell Lung Cancer to Gefitinib by Targeting TRIM16.
hsa-mir-135a-1	pancreatic ductal adenocarcinoma	up	MiR-135 suppresses glycolysis and promotes pancreatic cancer cell adaptation to metabolic stress by targeting phosphofructokinase-1.
hsa-mir-135a-2	colorectal cancer	up	MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-135a-2	esophageal squamous cell carcinoma	up	miR-135 promotes proliferation and stemness of oesophageal squamous cell carcinoma by targeting RERG.
hsa-mir-135a-2	non-small cell lung cancer	up	Downregulation of MicroRNA-135 Promotes Sensitivity of Non-Small Cell Lung Cancer to Gefitinib by Targeting TRIM16.
hsa-mir-135a-2	pancreatic ductal adenocarcinoma	up	MiR-135 suppresses glycolysis and promotes pancreatic cancer cell adaptation to metabolic stress by targeting phosphofructokinase-1.
hsa-mir-135a-3p	ovarian cancer	down	MicroRNA-135a-3p is downregulated and serves as a tumour suppressor in ovarian cancer by targeting CCR2.
hsa-mir-135a-3p	ovarian cancer	down	miR-135a-3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer.
hsa-mir-135a-5p	clear cell renal cell cancer	down	Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles.
hsa-mir-135a-5p	gastric cancer	up	Regulation of BGC-823 cell sensitivity to adriamycin via miRNA-135a-5p.
hsa-mir-135a-5p	hepatocellular carcinoma	up	Down-reguation of Krüppel-like factor-4 by microRNA-135a-5p promotes proliferation and metastasis in hepatocellular carcinoma by transforming growth factor-?1.
hsa-mir-135a-5p	lung cancer	up	Downregulation of lysyl oxidase-like 4 LOXL4 by miR-135a-5p promotes lung cancer progression in vitro and in vivo.
hsa-mir-135a-5p	thyroid carcinoma	down	MiR-135a-5p modulates biological functions of thyroid carcinoma cells via targeting VCAN 3'-UTR.
hsa-mir-135b	cervical cancer	up	Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1.
hsa-mir-135b	colonic adenocarcinoma	down	Down-regulation of miR-135b in colon adenocarcinoma induced by a TGF-? receptor I kinase inhibitor (SD-208).
hsa-mir-135b	colorectal cancer	up	Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
hsa-mir-135b	colorectal cancer	up	Correction: miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.
hsa-mir-135b	colorectal cancer	up	Identification and functional screening of microRNAs highly deregulated in colorectal cancer.
hsa-mir-135b	colorectal cancer	up	Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer.
hsa-mir-135b	colorectal cancer	up	MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer.
hsa-mir-135b	colorectal cancer	up	Identification of microRNA-135b in Stool as a Potential Noninvasive Biomarker for Colorectal Cancer and Adenoma.
hsa-mir-135b	colorectal cancer	up	MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer.
hsa-mir-135b	colorectal cancer	up	miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.
hsa-mir-135b	colorectal cancer	up	MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-135b	colorectal cancer	up	Knockdown of Mir-135b Sensitizes Colorectal Cancer Cells to Oxaliplatin-Induced Apoptosis Through Increase of FOXO1.
hsa-mir-135b	esophageal squamous cell carcinoma	up	miR-135 promotes proliferation and stemness of oesophageal squamous cell carcinoma by targeting RERG.
hsa-mir-135b	gastric cancer	up	[Clinicopathological significance and function of miR-135b in the occurrence and development of gastric cancer].
hsa-mir-135b	glioblastoma	up	MicroRNA-135b exerts oncogenic activity in glioblastoma via the inhibition of glycerol kinase 5 expression.
hsa-mir-135b	glioblastoma	down	miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
hsa-mir-135b	hepatocellular carcinoma	up	GAS5 Regulates RECK Expression and Inhibits Invasion Potential of HCC Cells by Sponging miR-135b.
hsa-mir-135b	lung adenocarcinoma	up	Peripheral lung adenocarcinomas harboring epithelial growth factor receptor mutations with microRNA-135b overexpression are more likely to invade visceral pleura.
hsa-mir-135b	lung cancer	up	MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1.
hsa-mir-135b	malignant melanoma	up	MiR-135b is a novel oncogenic factor in cutaneous melanoma by targeting LATS2.
hsa-mir-135b	non-small cell lung cancer	up	LncRNA GAS5 Inhibits Tumorigenesis and Enhances Radiosensitivity By Suppressing miR-135b Expression in Non-Small Cell Lung Cancer.
hsa-mir-135b	non-small cell lung cancer	up	Downregulation of MicroRNA-135 Promotes Sensitivity of Non-Small Cell Lung Cancer to Gefitinib by Targeting TRIM16.
hsa-mir-135b	pancreatic ductal adenocarcinoma	up	MiR-135 suppresses glycolysis and promotes pancreatic cancer cell adaptation to metabolic stress by targeting phosphofructokinase-1.
hsa-mir-135b	prostate cancer	down	miR-135b inhibits tumour metastasis in prostate cancer by targeting STAT6.
hsa-mir-135b-5p	gastric cancer	up	Differential MicroRNA Expression Between Gastric Cancer Tissue and Non-cancerous Gastric Mucosa According to Helicobacter pylori Status.
hsa-mir-135b-5p	gastric cancer	up	miR-135b-5p promotes gastric cancer progression by targeting CMTM3.
hsa-mir-135b-5p	gastric cancer	up	Helicobacter pylori-induced miR-135b-5p promotes cisplatin resistance in gastric cancer.
hsa-mir-135b-5p	pancreatic cancer	up	Overexpression of miR-135b-5p promotes unfavorable clinical characteristics and poor prognosis via the repression of SFRP4 in pancreatic cancer.
hsa-mir-136	cervical carcinoma	down	microRNA-136 inhibits proliferation and promotes apoptosis and radiosensitivity of cervical carcinoma through the NF-?B pathway by targeting E2F1.
hsa-mir-136	chondrosarcoma	down	Analysis of microRNAs expressions in chondrosarcoma.
hsa-mir-136	colon cancer	down	MicroRNA-136 inhibits colon cancer cell proliferation and invasion through targeting liver receptor homolog-1/Wnt signaling.
hsa-mir-136	colon cancer	down	miR-136 targets MIEN1 and involves the metastasis of colon cancer by suppressing epithelial-to-mesenchymal transition.
hsa-mir-136	gallbladder carcinoma	down	Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4.
hsa-mir-136	gastric cancer	down	MiR-136 inhibits gastric cancer-specific peritoneal metastasis by targeting HOXC10.
hsa-mir-136	gastric cancer	down	MiR-136 triggers apoptosis in human gastric cancer cells by targeting AEG-1 and BCL2.
hsa-mir-136	glioblastoma	down	Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.
hsa-mir-136	glioma	down	MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2.
hsa-mir-136	malignant melanoma	down	Effects of microRNA-136 on melanoma cell proliferation, apoptosis, and epithelial-mesenchymal transition by targetting PMEL through the Wnt signaling pathway.
hsa-mir-136	non-small cell lung cancer	up	Upregulation of miR-136 in human non-small cell lung cancer cells promotes Erk1/2 activation by targeting PPP2R2A.
hsa-mir-136	oral squamous cell carcinoma	down	Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-136	osteosarcoma	down	MicroRNA-136 functions as a tumor suppressor in osteosarcoma via regulating metadherin.
hsa-mir-136	osteosarcoma	down	Downregulation of miR-136 promotes the progression of osteosarcoma and is associated with the prognosis of patients with osteosarcoma.
hsa-mir-136	renal cell carcinoma	down	Tumor suppressor microRNA-136-5p regulates the cellular function of renal cell carcinoma.
hsa-mir-136-5p	lung adenocarcinoma	up	Role of upregulated miR-136-5p in lung adenocarcinoma: A study of 1242 samples utilizing bioinformatics analysis.
hsa-mir-137	acute lymphoblastic leukemia	down	MiR-137 inhibits cell proliferation in acute lymphoblastic leukemia by targeting JARID1B.
hsa-mir-137	anaplastic astrocytoma	down	miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
hsa-mir-137	astrocytoma	down	miR-137 acts as a tumor suppressor in astrocytoma by targeting RASGRF1.
hsa-mir-137	bladder cancer	up	MicroRNA-137 Upregulation Increases Bladder Cancer Cell Proliferation and Invasion by Targeting PAQR3.
hsa-mir-137	colon cancer	down	miR-137 suppresses proliferation, migration and invasion of colon cancer cell lines by targeting TCF4.
hsa-mir-137	colorectal cancer	down	Introduction of hsa-miR-103a and hsa-miR-1827 and hsa-miR-137 as new regulators of Wnt signaling pathway and their relation to colorectal carcinoma.
hsa-mir-137	colorectal cancer	down	MicroRNA-137, an HMGA1 Target, Suppresses Colorectal Cancer Cell Invasion and Metastasis in Mice by Directly Targeting FMNL2.
hsa-mir-137	colorectal cancer	down	Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer.
hsa-mir-137	colorectal cancer	down	Epigenetic silencing of miR-137 contributes to early colorectal carcinogenesis by impaired Aurora-A inhibition.
hsa-mir-137	endometrial cancer	down	miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation.
hsa-mir-137	gastric cancer	down	miR-137 plays tumor suppressor roles in gastric cancer cell lines by targeting KLF12 and MYO1C.
hsa-mir-137	gastric cancer	down	miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42.
hsa-mir-137	gastric cancer	down	Clinical Significance of MiR-137 Expression in Patients with Gastric Cancer After Radical Gastrectomy.
hsa-mir-137	glioblastoma	down	PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137.
hsa-mir-137	glioblastoma	down	Circulating microRNA-137 is a potential biomarker for human glioblastoma.
hsa-mir-137	glioblastoma	down	miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
hsa-mir-137	glioblastoma	down	miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2.
hsa-mir-137	glioblastoma	down	MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
hsa-mir-137	glioblastoma	down	Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
hsa-mir-137	glioblastoma	down	MiR-137 inhibits proliferation and angiogenesis of human glioblastoma cells by targeting EZH2.
hsa-mir-137	glioblastoma	down	Direct transfection of miR-137 mimics is more effective than DNA demethylation of miR-137 promoter to augment anti-tumor mechanisms of delphinidin in human glioblastoma U87MG and LN18 cells.
hsa-mir-137	glioma	down	Overexpressed miRNA-137 inhibits human glioma cells growth by targeting Rac1.
hsa-mir-137	glioma	down	Long non-coding RNA XIST exerts oncogenic functions in human glioma by targeting miR-137.
hsa-mir-137	hepatocellular carcinoma	up	Upregulation of miR-137 reverses sorafenib resistance and cancer-initiating cell phenotypes by degrading ANT2 in hepatocellular carcinoma.
hsa-mir-137	hepatocellular carcinoma	down	MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
hsa-mir-137	hepatocellular carcinoma	down	FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2.
hsa-mir-137	hepatocellular carcinoma	down	EDIL3 is a novel regulator of epithelial mesenchymal transition controlling early recurrence of hepatocellular carcinoma.
hsa-mir-137	lung cancer	down	Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer.
hsa-mir-137	lung cancer	down	MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer.
hsa-mir-137	lung cancer	up	Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
hsa-mir-137	malignant melanoma	down	miR-137 inhibits glutamine catabolism and growth of malignant melanoma by targeting glutaminase.
hsa-mir-137	malignant melanoma	down	Long non-coding RNA GAS5 inhibits tumorigenesis via miR-137 in melanoma.
hsa-mir-137	malignant melanoma	up	miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma.
hsa-mir-137	malignant melanoma	down	miR-137 inhibits melanoma cell proliferation through downregulation of GLO1.
hsa-mir-137	malignant melanoma	down	Mechanism of miR-137 regulating migration and invasion of melanoma cells by targeting PIK3R3 gene.
hsa-mir-137	malignant melanoma	down	miR-137 suppresses tumor growth of malignant melanoma by targeting aurora kinase A.
hsa-mir-137	multiple myeloma	down	miR-137 suppresses the phosphorylation of AKT and improves the dexamethasone sensitivity in multiple myeloma cells via targeting MITF.
hsa-mir-137	multiple myeloma	down	miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma.
hsa-mir-137	neuroblastoma	down	MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A.
hsa-mir-137	non-small cell lung cancer	down	microRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18.
hsa-mir-137	non-small cell lung cancer	down	miR-137 inhibits the proliferation of human non-small cell lung cancer cells by targeting SRC3.
hsa-mir-137	non-small cell lung cancer	down	MicroRNA-137 inhibits cell migration and invasion by targeting bone morphogenetic protein-7 (BMP7) in non-small cell lung cancer cells.
hsa-mir-137	non-small cell lung cancer	down	Aberrant microRNA-137 promoter methylation is associated with lymph node metastasis and poor clinical outcomes in non-small cell lung cancer.
hsa-mir-137	oral squamous cell carcinoma	down	Expression of MiRNA-137 in oral squamous cell carcinoma and its clinical significance.
hsa-mir-137	osteosarcoma	down	MicroRNA-137 is downregulated in human osteosarcoma and regulates cell proliferation and migration through targeting FXYD6.
hsa-mir-137	ovarian cancer	down	miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1.
hsa-mir-137	ovarian cancer	down	MicroRNA-137 suppresses tumor growth in epithelial ovarian cancer in vitro and in vivo.
hsa-mir-137	ovarian cancer	down	MicroRNA-29a inhibits cell migration and invasion by targeting Roundabout 1 in breast cancer cells.
hsa-mir-137	ovarian cancer	down	microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP.
hsa-mir-137	pancreatic cancer	down	MiR-137 functions as a tumor suppressor in pancreatic cancer by targeting MRGBP.
hsa-mir-137	pancreatic cancer	down	MicroRNA-137 reduces stemness features of pancreatic cancer cells by targeting KLF12.
hsa-mir-137	papillary thyroid carcinoma	up	BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases.
hsa-mir-137	papillary thyroid carcinoma	down	miR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12.
hsa-mir-137	prostate cancer	down	Downregulated NOX4 underlies a novel inhibitory role of microRNA-137 in prostate cancer.
hsa-mir-137	renal cell carcinoma	down	miR-137 inhibits renal cell carcinoma growth in vitro and in vivo.
hsa-mir-137	renal clear cell carcinoma	down	MiR-137 suppresses tumor growth and metastasis in clear cell renal cell carcinoma.
hsa-mir-137	squamous carcinoma	up	MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck.
hsa-mir-137	thyroid cancer	down	microRNA-137 is downregulated in thyroid cancer and inhibits proliferation and invasion by targeting EGFR.
hsa-mir-137	uveal melanoma	down	Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.
hsa-mir-138	anaplastic thyroid carcinoma	down	Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
hsa-mir-138	breast cancer	down	Long non-coding RNA H19 regulates cell growth and metastasis via miR-138 in breast cancer.
hsa-mir-138	breast cancer	down	CREPT regulated by miR-138 promotes breast cancer progression.
hsa-mir-138	cervical cancer	down	MicroRNA-138 inhibits proliferation of cervical cancer cells by targeting c-Met.
hsa-mir-138	cervical cancer	down	MicroRNA-138 inhibits proliferation, migration and invasion through targeting hTERT in cervical cancer.
hsa-mir-138	chronic lymphocytic leukemia	down	miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in chronic lymphocytic leukemia.
hsa-mir-138	chronic myelogenous leukemia	down	BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia.
hsa-mir-138	colorectal cancer	down	Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2.
hsa-mir-138	esophageal cancer	up	?-solanine enhances the chemosensitivity of esophageal cancer cells by inducing microRNA?138 expression.
hsa-mir-138	esophageal squamous cell carcinoma	down	Downregulation of miR-138 predicts poor prognosis in patients with esophageal squamous cell carcinoma.
hsa-mir-138	esophageal squamous cell carcinoma	down	Downregulation of miR-138 Sustains NF-?B Activation and Promotes Lipid Raft Formation in Esophageal Squamous Cell Carcinoma.
hsa-mir-138	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-138	gastric cancer	down	miR-138 inhibits gastric cancer growth by suppressing SOX4.
hsa-mir-138	glioblastoma	up	MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM.
hsa-mir-138	head and neck squamous cell carcinoma	down	MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines.
hsa-mir-138	head and neck squamous cell carcinoma	down	Role of microRNA-138 as a potential tumor suppressor in head and neck squamous cell carcinoma.
hsa-mir-138	head and neck squamous cell carcinoma	down	Down regulation of RhoC by microRNA-138 results in de-activation of FAK, Src and Erk(1/2) signaling pathway in head and neck squamous cell carcinoma.
hsa-mir-138	hepatocellular carcinoma	down	MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma.
hsa-mir-138	hepatocellular carcinoma	down	MicroRNA-138 inhibits cell proliferation in hepatocellular carcinoma by targeting Sirt1.
hsa-mir-138	hepatocellular carcinoma	down	LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
hsa-mir-138	hepatocellular carcinoma	down	miR-138 suppresses cell proliferation and invasion by inhibiting SOX9 in hepatocellular carcinoma.
hsa-mir-138	hepatocellular carcinoma	down	HCV core inhibits hepatocellular carcinoma cell replicative senescence through downregulating microRNA-138 expression.
hsa-mir-138	laryngeal carcinoma	down	MicroRNA-138 inhibits proliferation and induces apoptosis of laryngeal carcinoma via targeting MAPK6.
hsa-mir-138	laryngeal squamous cell carcinoma	down	MicroRNA-138 suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting EZH2 and PI3K/AKT signaling.
hsa-mir-138	lung cancer	down	miR-138 suppresses the proliferation, metastasis and autophagy of non-small cell lung cancer by targeting Sirt1.
hsa-mir-138	lung cancer	down	Up-regulation of microRNA-138 induce radiosensitization in lung cancer cells.
hsa-mir-138	lung cancer	down	TGF?1-induced down-regulation of microRNA-138 contributes to epithelial-mesenchymal transition in primary lung cancer cells.
hsa-mir-138	malignant melanoma	down	MicroRNA-138 suppresses proliferation, invasion and glycolysis in malignant melanoma cells by targeting HIF-1?.
hsa-mir-138	multiple myeloma	up	Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche.
hsa-mir-138	nasopharyngeal carcinoma	down	MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene.
hsa-mir-138	non-small cell lung cancer	down	MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung Cancer.
hsa-mir-138	non-small cell lung cancer	down	miR-138 inhibits proliferation by targeting 3-phosphoinositide-dependent protein kinase-1 in non-small cell lung cancer cells.
hsa-mir-138	non-small cell lung cancer	down	Prognostic potential of microRNA-138 and its target mRNA PDK1 in sera for patients with non-small cell lung cancer.
hsa-mir-138	non-small cell lung cancer	up	MicroRNA-138 negatively regulates non-small cell lung cancer cells through the interaction with cyclin D3.
hsa-mir-138	non-small cell lung cancer	down	MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.
hsa-mir-138	non-small cell lung cancer	down	MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.
hsa-mir-138	non-small cell lung cancer	down	HOXA4-regulated miR-138 suppresses proliferation and gefitinib resistance in non-small cell lung cancer.
hsa-mir-138	non-small cell lung cancer	down	MicroRNA-138 Inhibits Cell Growth, Invasion, and EMT of Non-Small Cell Lung Cancer Via SOX4/p53 Feedback Loop.
hsa-mir-138	non-small cell lung cancer	down	MicroRNA-138 inhibits migration and invasion of non-small cell lung cancer cells by targeting LIMK1.
hsa-mir-138	oral squamous cell carcinoma	down	Altered levels of miR-21, miR-125b-2*, miR-134, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
hsa-mir-138	oral squamous cell carcinoma	down	miR-138 suppresses the proliferation of oral squamous cell carcinoma cells by targeting Yes-associated protein 1.
hsa-mir-138	oral squamous cell carcinoma	down	In situ measurement of miR-138 expression in oral squamous cell carcinoma tissue supports the role of this microRNA as a tumor suppressor.
hsa-mir-138	osteosarcoma	down	MicroRNA-138 functions as a tumor suppressor in osteosarcoma by targeting differentiated embryonic chondrocyte gene 2.
hsa-mir-138	osteosarcoma	down	MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells.
hsa-mir-138	ovarian cancer	down	MicroRNA-138 inhibits SOX12 expression and the proliferation, invasion and migration of ovarian cancer cells.
hsa-mir-138	ovarian cancer	down	MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1?
hsa-mir-138	papillary thyroid carcinoma	down	Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
hsa-mir-138	papillary thyroid carcinoma	down	Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.
hsa-mir-138	prostate cancer	down	MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells.
hsa-mir-138	renal cell carcinoma	down	The network of DAB2IP-miR-138 in regulating drug resistance of renal cell carcinoma associated with stem-like phenotypes.
hsa-mir-138	renal cell carcinoma	down	MiR-138 induces renal carcinoma cell senescence by targeting EZH2 and is downregulated in human clear cell renal cell carcinoma.
hsa-mir-138	renal cell carcinoma	down	MicroRNA-138 suppresses cell proliferation and invasion of renal cell carcinoma by directly targeting SOX9.
hsa-mir-138	renal clear cell carcinoma	down	MiR-138 suppresses expression of hypoxia-inducible factor 1? (HIF-1?) in clear cell renal cell carcinoma 786-O cells.
hsa-mir-138	small cell lung cancer	down	MicroRNA-138 Regulates DNA Damage Response in Small Cell Lung Cancer Cells by Directly Targeting H2AX.
hsa-mir-138-5p	bladder cancer	down	miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells.
hsa-mir-138-5p	breast cancer	down	MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1.
hsa-mir-138-5p	cervical cancer	down	Decreased Expression of MiR-138-5p by LncRNA H19 in Cervical Cancer Promotes Tumor Proliferation.
hsa-mir-138-5p	colorectal cancer	down	The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer.
hsa-mir-138-5p	glioma	down	MiR-218-5p targets LHFPL3 to regulate proliferation, migration, and epithelial-mesenchymal transitions of human glioma cells.
hsa-mir-138-5p	lung adenocarcinoma	down	MiR-138-5p suppresses lung adenocarcinoma cell epithelial-mesenchymal transition, proliferation and metastasis by targeting ZEB2.
hsa-mir-138-5p	nasopharyngeal carcinoma	down	MicroRNA-138-5p controls sensitivity of nasopharyngeal carcinoma to radiation by targeting EIF4EBP1.
hsa-mir-138-5p	oral squamous cell carcinoma	down	Interplay between ?Np63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
hsa-mir-138-5p	pancreatic cancer	down	miR-138-5p suppresses autophagy in pancreatic cancer by targeting SIRT1.
hsa-mir-138-5p	retinoblastoma	down	Mir-138-5p acts as a tumor suppressor by targeting pyruvate dehydrogenase kinase 1 in human retinoblastoma.
hsa-mir-139	breast cancer	down	Role of miR-139 as a surrogate marker for tumor aggression in breast cancer.
hsa-mir-139	colorectal cancer	down	Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation.
hsa-mir-139	colorectal cancer	down	Gene module based regulator inference identifying miR-139 as a tumor suppressor in colorectal cancer.
hsa-mir-139	colorectal carcinoma	down	Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation.
hsa-mir-139	glioma	down	MiR-139 Inhibits Mcl-1 Expression and Potentiates TMZ-Induced Apoptosis in Glioma.
hsa-mir-139	hepatocellular carcinoma	down	The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2.
hsa-mir-139	hepatocellular carcinoma	down	Derepression of c-Fos caused by MicroRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma.
hsa-mir-139	hepatocellular carcinoma	down	miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway.
hsa-mir-139	hepatocellular carcinoma	down	MicroRNA-139 inhibits hepatocellular carcinoma cell growth through down-regulating karyopherin alpha 2.
hsa-mir-139	hepatocellular carcinoma	down	MicroRNA-139 suppresses hepatocellular carcinoma cell proliferation and migration by directly targeting Topoisomerase I.
hsa-mir-139	medulloblastoma	up	Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-139	non-small cell lung cancer	down	Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer.
hsa-mir-139	osteosarcoma	down	miR-139 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1.
hsa-mir-139	papillary thyroid carcinoma	down	MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression.
hsa-mir-139	prostate cancer	down	MicroRNA-139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL.
hsa-mir-139-3p	colorectal cancer	up	MicroRNA expression profiles in human colorectal cancers with liver metastases.
hsa-mir-139-3p	colorectal cancer	down	Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.
hsa-mir-139-3p	glioma	down	MiRNA-139-3p inhibits the proliferation, invasion, and migration of human glioma cells by targeting MDA-9/syntenin.
hsa-mir-139-3p	head and neck cancer	down	Role of host-microRNA Hsa-miR-139-3p in HPV-16 induced carcinomas.
hsa-mir-139-3p	hepatocellular carcinoma	down	MicroRNA-139-3p suppresses tumor growth and metastasis in hepatocellular carcinoma by repressing ANXA2R.
hsa-mir-139-3p	laryngeal cancer	down	New miRNA expression abnormalities in laryngeal squamous cell carcinoma.
hsa-mir-139-5p	adrenal cortical carcinoma	up	MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer.
hsa-mir-139-5p	basal cell carcinoma	down	Expression of microRNAs in basal cell carcinoma.
hsa-mir-139-5p	bladder cancer	down	MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogene.
hsa-mir-139-5p	breast cancer	down	MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.
hsa-mir-139-5p	colorectal cancer	down	MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1.
hsa-mir-139-5p	colorectal cancer	down	Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
hsa-mir-139-5p	colorectal cancer	down	MiR-139-5p reverses CD44+/CD133+-associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells.
hsa-mir-139-5p	colorectal cancer	down	miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1.
hsa-mir-139-5p	endometrial cancer	down	Tumor-suppressor role of miR-139-5p in endometrial cancer.
hsa-mir-139-5p	gallbladder carcinoma	down	MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma.
hsa-mir-139-5p	gastric cancer	down	LINC00152/miR-139-5p regulates gastric cancer cell aerobic glycolysis by targeting PRKAA1.
hsa-mir-139-5p	glioblastoma	down	miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM.
hsa-mir-139-5p	glioma	down	Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT).
hsa-mir-139-5p	glioma	down	MicroRNA-139-5p acts as a tumor suppressor by targeting ELTD1 and regulating cell cycle in glioblastoma multiforme.
hsa-mir-139-5p	hepatocellular carcinoma	down	Up-regulation of SNHG6 activates SERPINH1 expression by competitive binding to miR-139-5p to promote hepatocellular carcinoma progression.
hsa-mir-139-5p	hepatocellular carcinoma	down	miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
hsa-mir-139-5p	hepatocellular carcinoma	down	Reanalysis of microRNA expression profiles identifies novel biomarkers for hepatocellular carcinoma prognosis.
hsa-mir-139-5p	hepatocellular carcinoma	down	miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
hsa-mir-139-5p	nasopharyngeal carcinoma	down	MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition.
hsa-mir-139-5p	non-small cell lung cancer	down	MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.
hsa-mir-139-5p	non-small cell lung cancer	down	Expression and clinical significance of miR-139-5p in non-small cell lung cancer.
hsa-mir-139-5p	oral squamous cell carcinoma	down	MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.
hsa-mir-139-5p	osteosarcoma	down	MiR-139-5p suppresses osteosarcoma cell growth and invasion through regulating DNMT1.
hsa-mir-139-5p	ovarian cancer	down	MicroRNA-139-5p Inhibit Cell Proliferation and Invasion by Targeting RHO-Associated Coiled-Coil Containing Protein Kinase 2 in Ovarian Cancer.
hsa-mir-139-5p	prostate cancer	down	MicroRNA-139-5P inhibits human prostate cancer cell proliferation by targeting Notch1.
hsa-mir-139-5p	prostate cancer	down	Downregulation of miR-139-5p promotes prostate cancer progression through regulation of SOX5.
hsa-mir-140	breast cancer	up	Examining estrogen regulation of cancer stem cells through multicolor lineage tracing.
hsa-mir-140	colorectal cancer	down	MicroRNA-140 Inhibits the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
hsa-mir-140	colorectal cancer	down	microRNA -140-5p inhibits colorectal cancer invasion and metastasis by targeting ADAMTS5 and IGFBP5.
hsa-mir-140	esophageal cancer	down	Down-Regulation of miR-140 Induces EMT and Promotes Invasion by Targeting Slug in Esophageal Cancer.
hsa-mir-140	gastric cancer	down	MicroRNA-140 Inhibits Cell Proliferation in Gastric Cancer Cell Line HGC-27 by Suppressing SOX4.
hsa-mir-140	non-small cell lung cancer	up	Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC.
hsa-mir-140	non-small cell lung cancer	down	miR-140 Suppresses Tumor Growth and Metastasis of Non-Small Cell Lung Cancer by Targeting Insulin-Like Growth Factor 1 Receptor.
hsa-mir-140	osteosarcoma	down	MicroRNA-140 suppresses osteosarcoma tumor growth by enhancing anti-tumor immune response and blocking mTOR signaling.
hsa-mir-140	prostate cancer	down	MicroRNA-140 inhibit prostate cancer cell invasion and migration by targeting YES proto-oncogene 1.
hsa-mir-140	uveal melanoma	down	Long noncoding RNA MALAT1 promotes uveal melanoma cell growth and invasion by silencing of miR-140.
hsa-mir-140-3p	basal cell carcinoma	down	Expression of microRNAs in basal cell carcinoma.
hsa-mir-140-3p	breast cancer	down	miR-140-3p inhibits breast cancer proliferation and migration by directly regulating the expression of tripartite motif 28.
hsa-mir-140-3p	chordoma	up	MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.
hsa-mir-140-3p	chordoma	up	Identification of miR-140-3p as a marker associated with poor prognosis in spinal chordoma.
hsa-mir-140-3p	lung cancer	down	MicroRNA-140-3p inhibits proliferation, migration and invasion of lung cancer cells by targeting ATP6AP2.
hsa-mir-140-3p	non-small cell lung cancer	down	MiR-140-3p suppressed cell growth and invasion by downregulating the expression of ATP8A1 in non-small cell lung cancer.
hsa-mir-140-5p	breast cancer	down	miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1.
hsa-mir-140-5p	breast cancer	down	Analysis of miRNA-mRNA network reveals miR-140-5p as a suppressor of breast cancer glycolysis via targeting GLUT1.
hsa-mir-140-5p	breast cancer	down	MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer.
hsa-mir-140-5p	cervical cancer	down	Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC1.
hsa-mir-140-5p	chronic myelogenous leukemia	down	miR-140-5p induces cell apoptosis and decreases Warburg effect in chronic myeloid leukemia by targeting SIX1.
hsa-mir-140-5p	colorectal cancer	down	Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
hsa-mir-140-5p	colorectal carcinoma	down	miR-140-5p inhibits cell proliferation and invasion in colorectal carcinoma by targeting SOX4.
hsa-mir-140-5p	gastric cancer	down	MicroRNA-140-5p inhibits cell proliferation, migration and promotes cell apoptosis in gastric cancer through the negative regulation of THY1-mediated Notch signaling.
hsa-mir-140-5p	gastric cancer	down	miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1.
hsa-mir-140-5p	gastric cancer	down	MicroRNA-140-5p suppresses cell proliferation and invasion in gastric cancer by targeting WNT1 in the WNT/?-catenin signaling pathway.
hsa-mir-140-5p	glioma	down	MicroRNA-140-5p inhibits cell proliferation and invasion by regulating VEGFA/MMP2 signaling in glioma.
hsa-mir-140-5p	hepatocellular carcinoma	down	MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways.
hsa-mir-140-5p	hepatocellular carcinoma	down	MicroRNA-140-5p suppresses tumor growth and metastasis by targeting TGFBR1 and FGF9 in hepatocellular carcinoma.
hsa-mir-140-5p	hepatocellular carcinoma	down	miR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRA.
hsa-mir-140-5p	hypopharyngeal carcinoma	down	[miR-140-5p affects the migration and invasion of hypopharyngeal carcinoma cells by downregulating ADAM10 expression].
hsa-mir-140-5p	hypopharyngeal squamous cell carcinoma	down	MicroR-140-5p suppresses tumor cell migration and invasion by targeting ADAM10-mediated Notch1 signaling pathway in hypopharyngeal squamous cell carcinoma.
hsa-mir-140-5p	liver cancer	down	MicroRNA-140-5p suppresses tumor growth and metastasis by targeting TGFBR1 and FGF9 in hepatocellular carcinoma.
hsa-mir-140-5p	non-small cell lung cancer	down	Effect of miR-140-5p on the regulation of proliferation and apoptosis in NSCLC and its underlying mechanism.
hsa-mir-140-5p	oral squamous cell carcinoma	down	MicroRNA-140-5p inhibits the tumorigenesis of oral squamous cell carcinoma by targeting p21-activated kinase 4.
hsa-mir-140-5p	ovarian cancer	down	miR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRA.
hsa-mir-140-5p	retinoblastoma	down	miR-140-5p suppresses retinoblastoma cell proliferation, migration, and invasion by targeting CEMIP and CADM3.
hsa-mir-140-5p	retinoblastoma	down	MiR-140-5p suppresses retinoblastoma cell growth via inhibiting c-Met/AKT/mTOR pathway.
hsa-mir-141	bladder cancer	down	Expression of microRNAs in the Urine of Patients With Bladder Cancer.
hsa-mir-141	bladder cancer	up	Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?
hsa-mir-141	breast cancer	up	Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.
hsa-mir-141	breast cancer	down	Downregulation of miRNA-141 in breast cancer cells is associated with cell migration and invasion: involvement of ANP32E targeting.
hsa-mir-141	cervical cancer	up	Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer.
hsa-mir-141	colon cancer	up	miR-141 promotes colon cancer cell proliferation by inhibiting MAP2K4.
hsa-mir-141	colorectal cancer	down	miR-141 Inhibits Proliferation and Migration of Colorectal Cancer SW480 Cells.
hsa-mir-141	colorectal cancer	down	Role of microRNA-141 in colorectal cancer with lymph node metastasis.
hsa-mir-141	colorectal cancer	down	MicroRNA-141 inhibits tumor growth and minimizes therapy resistance in colorectal cancer.
hsa-mir-141	colorectal cancer	down	MiR-200 suppresses metastases of colorectal cancer through ZEB1.
hsa-mir-141	colorectal cancer	up	MicroRNA-141 regulates the tumour suppressor DLC-1 in colorectal cancer.
hsa-mir-141	colorectal cancer	up	MicroRNA-200 as potential diagnostic markers for colorectal cancer: meta-analysis and experimental validation.
hsa-mir-141	esophageal cancer	up	miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas.
hsa-mir-141	esophageal squamous cell carcinoma	up	Lentiviral-Mediated Overexpression of MicroRNA-141 Promotes Cell Proliferation and Inhibits Apoptosis in Human Esophageal Squamous Cell Carcinoma.
hsa-mir-141	gastric cancer	down	Down-regulation of miR-141 in gastric cancer and its involvement in cell growth.
hsa-mir-141	gastric cancer	down	miR-141 suppresses proliferation and motility of gastric cancer cells by targeting HDGF.
hsa-mir-141	gastric cancer	down	The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression.
hsa-mir-141	gastric cancer	down	MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif, TAZ.
hsa-mir-141	gastric cancer	down	MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression.
hsa-mir-141	gastric cancer	down	Anti-proliferative role and prognostic implication of miR-141 in gastric cancer.
hsa-mir-141	glioma	down	Epigenetic modification of miR-141 regulates SKA2 by an endogenous 'sponge' HOTAIR in glioma.
hsa-mir-141	glioma	down	MicroRNA-141 inhibits glioma cells growth and metastasis by targeting TGF-?2.
hsa-mir-141	glioma	down	MiR-200c and miR-141 inhibit ZEB1 synergistically and suppress glioma cell growth and migration.
hsa-mir-141	head and neck squamous cell carcinoma	down	MicroRNA-141 suppresses growth and metastatic potential of head and neck squamous cell carcinoma.
hsa-mir-141	hepatocellular carcinoma	down	[Over-expression of miR-141 inhibits the proliferation, invasion and migration of hepatocellular carcinoma MHCC-97H cells].
hsa-mir-141	hepatocellular carcinoma	down	Expression Profile of MicroRNA-200 Family in Hepatocellular Carcinoma With Bile Duct Tumor Thrombus.
hsa-mir-141	hepatocellular carcinoma	down	miR-141 suppresses the growth and metastasis of HCC cells by targeting E2F3.
hsa-mir-141	hepatocellular carcinoma	down	microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3beta in hepatocellular carcinoma cells.
hsa-mir-141	lung adenocarcinoma	down	miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.
hsa-mir-141	lung adenocarcinoma	down	HOXC13 promotes proliferation of lung adenocarcinoma via modulation of CCND1 and CCNE1.
hsa-mir-141	lung cancer	up	MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.
hsa-mir-141	malignant melanoma	up	MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion.
hsa-mir-141	mesenchymal cancer	down	MicroRNA Expression Profiles in Kaposi's Sarcoma.
hsa-mir-141	nasopharyngeal carcinoma	up	BRD7 expression and c-Myc activation forms a double-negative feedback loop that controls the cell proliferation and tumor growth of nasopharyngeal carcinoma by targeting oncogenic miR-141.
hsa-mir-141	non-small cell lung cancer	down	Inhibition of miR-141 reverses cisplatin resistance in non-small cell lung cancer cells via upregulation of programmed cell death protein 4.
hsa-mir-141	non-small cell lung cancer	up	High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.
hsa-mir-141	non-small cell lung cancer	up	MicroRNA-141 promotes the proliferation of non-small cell lung cancer cells by regulating expression of PHLPP1 and PHLPP2.
hsa-mir-141	non-small cell lung cancer	up	MicroRNA-141 is a biomarker for progression of squamous cell carcinoma and adenocarcinoma of the lung: clinical analysis of 125 patients.
hsa-mir-141	oral cancer	down	Grainyhead-like 2 regulates epithelial plasticity and stemness in oral cancer cells.
hsa-mir-141	osteosarcoma	down	Tumor-Suppressing Effects of miR-141 in Human Osteosarcoma.
hsa-mir-141	ovarian cancer	down	A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
hsa-mir-141	ovarian cancer	up	Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
hsa-mir-141	ovarian cancer	up	The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition.
hsa-mir-141	pancreatic cancer	down	MicroRNA-141, downregulated in pancreatic cancer, inhibited the cell proliferation and invasion by directly targeting MAP4K4.
hsa-mir-141	prostate cancer	up	A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.
hsa-mir-141	prostate cancer	down	miR-141 inhibits prostatic cancer cell proliferation and migration, and induces cell apoptosis via targeting of RUNX1.
hsa-mir-141	prostate cancer	up	Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer.
hsa-mir-141	prostate cancer	down	Re: MicroRNA-141 Suppresses Prostate Cancer Stem Cells and Metastasis by Targeting a Cohort of Pro-Metastasis Genes.
hsa-mir-141	prostate cancer	up	Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients.
hsa-mir-141	prostate cancer	down	MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes.
hsa-mir-141	renal cell carcinoma	down	MicroRNA-141 is downregulated in human renal cell carcinoma and regulates cell survival by targeting CDC25B.
hsa-mir-141	renal clear cell carcinoma	down	Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
hsa-mir-141	thyroid cancer	down	microRNA-141 inhibits thyroid cancer cell growth and metastasis by targeting insulin receptor substrate 2.
hsa-mir-141-3p	cervical cancer	up	microRNA-141-3p fosters the growth, invasion, and tumorigenesis of cervical cancer cells by targeting FOXA2.
hsa-mir-141-3p	colorectal cancer	down	MiR-141-3p inhibits cell proliferation, migration and invasion by targeting TRAF5 in colorectal cancer.
hsa-mir-141-3p	esophageal squamous cell carcinoma	up	Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN.
hsa-mir-141-3p	gastric cancer	down	MiR-141-3p suppresses gastric cancer induced transition of normal fibroblast and BMSC to cancer-associated fibroblasts via targeting STAT4.
hsa-mir-141-3p	gastric cancer	down	Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients.
hsa-mir-141-3p	glioblastoma	up	MicroRNA-141-3p promotes glioma cell growth and temozolomide resistance by directly targeting p53.
hsa-mir-141-3p	glioma	down	miR-141-3p functions as a tumor suppressor modulating activating transcription factor 5 in glioma.
hsa-mir-141-3p	hepatocellular carcinoma	down	Role of microRNA-141-3p in the progression and metastasis of hepatocellular carcinoma cell.
hsa-mir-141-3p	hepatocellular carcinoma	down	A qRT-PCR and Gene Functional Enrichment Study Focused on Downregulation of miR-141-3p in Hepatocellular Carcinoma and Its Clinicopathological Significance.
hsa-mir-141-3p	non-small cell lung cancer	down	MiR-141-3p functions as a tumor suppressor through directly targeting ZFR in non-small cell lung cancer.
hsa-mir-141-3p	osteosarcoma	down	miR-141-3p suppresses proliferation and promotes apoptosis by targeting GLI2 in osteosarcoma cells.
hsa-mir-141-3p	prostate cancer	down	Downregulation of miR-141-3p promotes bone metastasis via activating NF-?B signaling in prostate cancer.
hsa-mir-141-3p	prostate cancer	up	MiR-141-3p promotes prostate cancer cell proliferation through inhibiting kruppel-like factor-9 expression.
hsa-mir-142	breast cancer	up	miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway.
hsa-mir-142	endometrial cancer	down	miR-142 Suppresses Endometrial Cancer Proliferation In Vitro and In Vivo by Targeting Cyclin D1.
hsa-mir-142	hepatocellular carcinoma	down	Identifying microRNA panels specifically associated with hepatocellular carcinoma and its different etiologies.
hsa-mir-142	hepatocellular carcinoma	down	Over-expression of Thrombospondin 4 correlates with loss of miR-142 and contributes to migration and vascular invasion of advanced hepatocellular carcinoma.
hsa-mir-142	nasopharyngeal carcinoma	up	MicroRNA-142 promotes the development of nasopharyngeal carcinoma through targeting PTEN.
hsa-mir-142-3p	acute lymphoblastic leukemia	down	MicroRNA-142-3p inhibits cell proliferation in human acute lymphoblastic leukemia by targeting the MLL-AF4 oncogene.
hsa-mir-142-3p	acute myeloid leukemia	down	Upregulation of miR-142-3p Improves Drug Sensitivity of Acute Myelogenous Leukemia through Reducing P-Glycoprotein and Repressing Autophagy by Targeting HMGB1.
hsa-mir-142-3p	breast cancer	down	Aberrant Expression of miR-142-3p and its Target Gene HMGA1 and FZD7 in Breast Cancer and its Clinical Significance.
hsa-mir-142-3p	breast cancer	down	microRNA miR-142-3p Inhibits Breast Cancer Cell Invasiveness by Synchronous Targeting of WASL, Integrin Alpha V, and Additional Cytoskeletal Elements.
hsa-mir-142-3p	colon cancer	down	MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells.
hsa-mir-142-3p	colorectal cancer	down	Downregulation of Plasma MiR-142-3p and MiR-26a-5p in Patients With Colorectal Carcinoma.
hsa-mir-142-3p	colorectal cancer	up	MicroRNA-142-3p Promotes Cellular Invasion of Colorectal Cancer Cells by Activation of RAC1.
hsa-mir-142-3p	colorectal cancer	down	miR-142-3p Suppresses Cell Growth by Targeting CDK4 in Colorectal Cancer.
hsa-mir-142-3p	colorectal cancer	down	Serum level of miR-142-3p predicts prognostic outcome for colorectal cancer following curative resection.
hsa-mir-142-3p	gastric cancer	up	miRNA and mRNA expression profiles in gastric cancer patients and the relationship with circRNA.
hsa-mir-142-3p	gastric cancer	down	Downregulation of microRNA-142-3p and its tumor suppressor role in gastric cancer.
hsa-mir-142-3p	glioblastoma	down	Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma.
hsa-mir-142-3p	hepatocellular carcinoma	down	MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells.
hsa-mir-142-3p	hepatocellular carcinoma	down	MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility.
hsa-mir-142-3p	hepatocellular carcinoma	down	miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA.
hsa-mir-142-3p	hepatocellular carcinoma	down	miR-142-3p Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Regulating HMGB1 Gene Expression.
hsa-mir-142-3p	hepatocellular carcinoma	down	lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
hsa-mir-142-3p	hepatocellular carcinoma	down	MALAT1 functions as a competing endogenous RNA to regulate SMAD5 expression by acting as a sponge for miR-142-3p in hepatocellular carcinoma.
hsa-mir-142-3p	lung adenocarcinoma	down	MiR-142-3p suppresses the proliferation, migration and invasion through inhibition of NR2F6 in lung adenocarcinoma.
hsa-mir-142-3p	mantle cell lymphoma	down	microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-142-3p	nasopharyngeal carcinoma	down	EZH2-DNMT1-mediated epigenetic silencing of miR-142-3p promotes metastasis through targeting ZEB2 in nasopharyngeal carcinoma.
hsa-mir-142-3p	nasopharyngeal carcinoma	up	MiR-142-3p Suppresses SOCS6 Expression and Promotes Cell Proliferation in Nasopharyngeal Carcinoma.
hsa-mir-142-3p	non-small cell lung cancer	up	MiR-142-3p represses TGF-?-induced growth inhibition through repression of TGF?R1 in non-small cell lung cancer.
hsa-mir-142-3p	non-small cell lung cancer	down	MicroRNA-142-3p/MALAT1 inhibits lung cancer progression through repressing ?-catenin expression.
hsa-mir-142-3p	non-small cell lung cancer	down	MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
hsa-mir-142-3p	oral squamous cell carcinoma	up	Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
hsa-mir-142-3p	osteosarcoma	down	MiR-142-3p Functions as a Potential Tumor Suppressor in Human Osteosarcoma by Targeting HMGA1.
hsa-mir-142-3p	ovarian cancer	down	MicroRNA-142-3p inhibits cell proliferation and chemoresistance in ovarian cancer via targeting sirtuin 1.
hsa-mir-142-3p	renal cell carcinoma	up	Oncogenic microRNA-142-3p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
hsa-mir-142-3p	uveal melanoma	down	miR-142-3p suppresses uveal melanoma by targeting CDC25C, TGF?R1, GNAQ, WASL, and RAC1.
hsa-mir-142-5p	clear cell renal cell cancer	up	Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles.
hsa-mir-142-5p	colorectal cancer	up	MiR-142-5p act as an oncogenic microRNA in colorectal cancer: Clinicopathological and functional insights.
hsa-mir-142-5p	colorectal cancer	down	Transcatheter arterial infusion chemotherapy increases expression level of miR-142-5p in stage III colorectal cancer.
hsa-mir-142-5p	colorectal cancer	up	miR-142-5p promotes development of colorectal cancer through targeting SDHB and facilitating generation of aerobic glycolysis.
hsa-mir-142-5p	hepatocellular carcinoma	down	MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility.
hsa-mir-142-5p	intrahepatic cholangiocarcinoma	up	Enhanced plasma miR-142-5p promotes the progression of intrahepatic cholangiocarcinoma via targeting PTEN.
hsa-mir-142-5p	lung cancer	down	Uncovering growth-suppressive MicroRNAs in lung cancer.
hsa-mir-142-5p	malt lymphoma	up	Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication.
hsa-mir-142-5p	mantle cell lymphoma	down	microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-142-5p	non-small cell lung cancer	down	MiR-142-5p Suppresses Tumorigenesis by Targeting PIK3CA in Non-Small Cell Lung Cancer.
hsa-mir-142-5p	non-small cell lung cancer	up	miR-142-5p regulates CD4+ T cells in human non-small cell lung cancer through PD-L1 expression via the PTEN pathway.
hsa-mir-142-5p	osteosarcoma	down	MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.
hsa-mir-142-5p	pancreatic cancer	down	miR-142-5p regulates pancreatic cancer cell proliferation and apoptosis by regulation of RAP1A.
hsa-mir-142-5p	renal cell carcinoma	up	MicroRNA-142-5p promotes cell growth and migration in renal cell carcinoma by targeting BTG3.
hsa-mir-143	acute myeloid leukemia	down	Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia.
hsa-mir-143	acute myeloid leukemia	down	MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia.
hsa-mir-143	bladder cancer	down	LncRNA UCA1 promotes the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway.
hsa-mir-143	bladder cancer	down	miR-143 inhibits bladder cancer cell proliferation and enhances their sensitivity to gemcitabine by repressing IGF-1R signaling.
hsa-mir-143	bladder cancer	down	MicroRNA-143 as a tumor suppressor for bladder cancer.
hsa-mir-143	bladder cancer	down	MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells.
hsa-mir-143	bladder cancer	down	Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways.
hsa-mir-143	bladder cancer	down	MicroRNA-143/Musashi-2/KRAS cascade contributes positively to carcinogenesis in human bladder cancer.
hsa-mir-143	breast cancer	down	MicroRNA?143 targets CD44 to inhibit breast cancer progression and stem cell-like properties.
hsa-mir-143	breast cancer	down	MicroRNA-143 is downregulated in breast cancer and regulates DNA methyltransferases 3A in breast cancer cells.
hsa-mir-143	breast cancer	down	miR-143 suppresses epithelial-mesenchymal transition and inhibits tumor growth of breast cancer through down-regulation of ERK5.
hsa-mir-143	breast cancer	down	MicroRNA-143 inhibits cell growth by targeting ERK5 and MAP3K7 in breast cancer.
hsa-mir-143	cervical cancer	down	MicroRNA-143 regulates cell migration and invasion by targeting GOLM1 in cervical cancer.
hsa-mir-143	cervical cancer	down	miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2.
hsa-mir-143	cervical cancer	down	A Functional Polymorphism in the Promoter of MiR-143/145 Is Associated With the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case-Control Study.
hsa-mir-143	colon cancer	down	MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells.
hsa-mir-143	colon cancer	down	The Evi1, microRNA-143, K-Ras axis in colon cancer.
hsa-mir-143	colon cancer	down	miR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation.
hsa-mir-143	colon cancer	down	Forced expression of miR-143 represses ERK5/c-Myc and p68/p72 signaling in concert with miR-145 in gut tumors of Apc(Min) mice.
hsa-mir-143	colon cancer	down	Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon.
hsa-mir-143	colon cancer	down	Overexpression of miRNA-143 Inhibits Colon Cancer Cell Proliferation by Inhibiting Glucose Uptake.
hsa-mir-143	colon cancer	down	miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells.
hsa-mir-143	colorectal cancer	down	miRNA-143 replacement therapy harnesses the proliferation and migration of colorectal cancer cells in vitro.
hsa-mir-143	colorectal cancer	down	Down-regulation of microRNA-143 is associated with colorectal cancer progression.
hsa-mir-143	colorectal cancer	down	MicroRNA-143 inhibits colorectal cancer cell proliferation through targeting MMP7.
hsa-mir-143	colorectal cancer	down	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-143	colorectal cancer	down	MicroRNA signatures: novel biomarker for colorectal cancer?
hsa-mir-143	colorectal cancer	down	Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer.
hsa-mir-143	colorectal cancer	down	RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets.
hsa-mir-143	colorectal cancer	down	MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers.
hsa-mir-143	colorectal cancer	down	The regulation of Toll-like receptor 2 by miR-143 suppresses the invasion and migration of a subset of human colorectal carcinoma cells.
hsa-mir-143	colorectal carcinoma	down	[Effect of microRNA143 expression on cell proliferation in colonic carcinoma].
hsa-mir-143	colorectal carcinoma	down	MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer.
hsa-mir-143	colorectal carcinoma	down	Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
hsa-mir-143	endometrial cancer	down	Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.
hsa-mir-143	endometrial cancer	down	MiR-143 inhibits endometrial cancer cell proliferation and metastasis by targeting MAPK1.
hsa-mir-143	esophageal cancer	up	Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-143	esophageal cancer	up	Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma.
hsa-mir-143	esophageal squamous cell carcinoma	down	MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma.
hsa-mir-143	esophageal squamous cell carcinoma	down	MiR-143 inhibits tumor cell proliferation and invasion by targeting STAT3 in esophageal squamous cell carcinoma.
hsa-mir-143	esophageal squamous cell carcinoma	down	miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.
hsa-mir-143	esophageal squamous cell carcinoma	down	Erratum to: miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.
hsa-mir-143	gastric cancer	up	Evaluation of MicroRNA Expression Pattern of Gastric Adenocarcinoma Associated with Socioeconomic, Environmental and Lifestyle Factors in Northwestern Hungary.
hsa-mir-143	gastric cancer	down	MicroRNA-143 suppresses gastric cancer cell growth and induces apoptosis by targeting COX-2.
hsa-mir-143	gastric cancer	down	Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2.
hsa-mir-143	gastric cancer	down	[Expression of miR-143 and miR-145 and their functional study in gastric carcinoma].
hsa-mir-143	gastric cancer	down	miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6.
hsa-mir-143	gastric cancer	down	MiR-143 inhibits cell proliferation and invasion by targeting DNMT3A in gastric cancer.
hsa-mir-143	gastric cancer	down	miR-143 Inhibits Cell Proliferation of Gastric Cancer Cells Through Targeting GATA6.
hsa-mir-143	gastric cancer	down	Study of miR-143 expression in stomach cancer.
hsa-mir-143	gastric cancer	down	Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase.
hsa-mir-143	glioblastoma	down	miR-143 inhibits oncogenic traits by degrading NUAK2 in glioblastoma.
hsa-mir-143	glioblastoma	down	miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells.
hsa-mir-143	glioblastoma	up	Targeting MicroRNA-143 Leads to Inhibition of Glioblastoma Tumor Progression.
hsa-mir-143	glioma	down	miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells.
hsa-mir-143	hepatocellular carcinoma	down	[miR-143 inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of TLR2 expression].
hsa-mir-143	hepatocellular carcinoma	down	MicroRNA-143 inhibits tumorigenesis in hepatocellular carcinoma by downregulating GATA6.
hsa-mir-143	hepatocellular carcinoma	down	Overexpression of miR-21 Is Associated With Recurrence in Patients With Hepatitis B Virus-Mediated Hepatocellular Carcinoma Undergoing Liver Transplantation.
hsa-mir-143	lung cancer	up	Stromal expression of miR-143/145 promotes neoangiogenesis in lung cancer development.
hsa-mir-143	lung cancer	down	Multipronged activity of combinatorial miR-143 and miR-506 inhibits Lung Cancer cell cycle progression and angiogenesis in vitro.
hsa-mir-143	lung cancer	down	Effects of miR-143 overexpression on proliferation, apoptosis, EGFR and downstream signaling pathways in PC9/GR cell line.
hsa-mir-143	malignant melanoma	down	MicroRNA-143 targets Syndecan-1 to repress cell growth in melanoma.
hsa-mir-143	nasopharyngeal carcinoma	down	MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma.
hsa-mir-143	nasopharyngeal carcinoma	down	Identification of miR-143 as a tumour suppressor in nasopharyngeal carcinoma based on microRNA expression profiling.
hsa-mir-143	nasopharyngeal carcinoma	down	Upregulated microRNA-143 inhibits cell proliferation in human nasopharyngeal carcinoma.
hsa-mir-143	nasopharyngeal carcinoma	down	miR-143 inhibits proliferation and metastasis of nasopharyngeal carcinoma cells via targeting FMNL1 based on clinical and radiologic findings.
hsa-mir-143	non-small cell lung cancer	down	miR-143 suppresses the proliferation of NSCLC cells by inhibiting the epidermal growth factor receptor.
hsa-mir-143	non-small cell lung cancer	down	miR-143 inhibits NSCLC cell growth and metastasis by targeting Limk1.
hsa-mir-143	non-small cell lung cancer	down	miR-143 inhibits cell proliferation by targeting autophagy-related 2B in non-small cell lung cancer H1299 cells.
hsa-mir-143	oral cancer	down	MicroRNA-143 suppresses oral squamous cell carcinoma (OSCC) cell growth, invasion and glucose metabolism through targeting Hexokinase2.
hsa-mir-143	oral squamous cell carcinoma	down	Decreased microRNA-143 expression and its tumor suppressive function in human oral squamous cell carcinoma.
hsa-mir-143	oral squamous cell carcinoma	down	Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis.
hsa-mir-143	oral squamous cell carcinoma	down	Down Regulation of miR-34a and miR-143 May Indirectly Inhibit p53 in Oral Squamous Cell Carcinoma: a Pilot Study.
hsa-mir-143	osteosarcoma	down	microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2.
hsa-mir-143	osteosarcoma	down	A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma.
hsa-mir-143	pancreatic ductal adenocarcinoma	down	XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.
hsa-mir-143	prostate cancer	down	miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice.
hsa-mir-143	prostate cancer	down	miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS.
hsa-mir-143	prostate cancer	down	MicroRNA-143 inhibits cell migration and invasion by targeting matrix metalloproteinase 13 in prostate cancer.
hsa-mir-143	prostate cancer	down	The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer.
hsa-mir-143	prostate cancer	down	Insulin-like growth factor-I induces chemoresistence to docetaxel by inhibiting miR-143 in human prostate cancer.
hsa-mir-143	prostate cancer	down	Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer.
hsa-mir-143	renal cell carcinoma	down	The tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma.
hsa-mir-143	retinoblastoma	down	Suppressive effect of microRNA-143 in retinoblastoma.
hsa-mir-143	thyroid carcinoma	down	lncRNA CCAT1 promotes cell proliferation, migration, and invasion by down-regulation of miR-143 in FTC-133 thyroid carcinoma cell line.
hsa-mir-143-3p	breast cancer	down	MiR-143-3p inhibits the proliferation, cell migration and invasion of human breast cancer cells by modulating the expression of MAPK7.
hsa-mir-143-3p	breast cancer	down	miR-143-3p targeting LIM domain kinase 1 suppresses the progression of triple-negative breast cancer cells.
hsa-mir-143-3p	cervical cancer	down	Long non-coding RNA HOTAIR promotes cervical cancer progression through regulating BCL2 via targeting miR-143-3p.
hsa-mir-143-3p	colorectal cancer	down	MicroRNA-143-3p suppresses tumorigenesis by targeting catenin-?1 in colorectal cancer.
hsa-mir-143-3p	colorectal cancer	down	MicroRNA-143-3p inhibits colorectal cancer metastases by targeting ITGA6 and ASAP3.
hsa-mir-143-3p	esophageal squamous cell carcinoma	down	MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial-mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma.
hsa-mir-143-3p	gallbladder carcinoma	down	miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K/AKT pathway in gallbladder carcinoma.
hsa-mir-143-3p	gastric cancer	down	MicroRNA-143-3p, up-regulated in H. pylori-positive gastric cancer, suppresses tumor growth, migration and invasion by directly targeting AKT2.
hsa-mir-143-3p	laryngeal squamous cell carcinoma	down	MiR-143-3p suppresses cell proliferation, migration, and invasion by targeting Melanoma-Associated Antigen A9 in laryngeal squamous cell carcinoma.
hsa-mir-143-3p	malignant melanoma	down	MicroRNA-143-3p inhibits growth and invasiveness of melanoma cells by targeting cyclooxygenase-2 and inversely correlates with malignant melanoma progression.
hsa-mir-143-3p	osteosarcoma	down	miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2.
hsa-mir-143-3p	ovarian cancer	down	MiR-143-3p suppresses the progression of ovarian cancer.
hsa-mir-144	acute lymphoblastic leukemia	down	MicroRNA-144 regulates cancer cell proliferation and cell-cycle transition in acute lymphoblastic leukemia through the interaction of FMN2.
hsa-mir-144	bladder cancer	down	miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling.
hsa-mir-144	breast cancer	down	miR-144 functions as a tumor suppressor in breast cancer through inhibiting ZEB1/2-mediated epithelial mesenchymal transition process.
hsa-mir-144	breast cancer	down	MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55.
hsa-mir-144	cervical cancer	down	miR-144 inhibits growth and metastasis of cervical cancer cells by targeting VEGFA and VEGFC.
hsa-mir-144	cholangiocarcinoma	down	MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
hsa-mir-144	esophageal squamous cell carcinoma	down	MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2.
hsa-mir-144	gastric cancer	down	MicroRNA-144 functions as a tumor suppressor in gastric cancer by targeting cyclooxygenase-2.
hsa-mir-144	gastric cancer	down	The role of miR-144/GSPT1 axis in gastric cancer.
hsa-mir-144	gastric cancer	down	MicroRNA-144 inhibits the metastasis of gastric cancer by targeting MET expression.
hsa-mir-144	gastric cancer	down	miR-144 suppresses cell proliferation and invasion in gastric cancer through downregulation of activating enhancer-binding protein 4.
hsa-mir-144	hepatocellular carcinoma	down	Intravenous miR-144 inhibits tumor growth in diethylnitrosamine-induced hepatocellular carcinoma in mice.
hsa-mir-144	hepatocellular carcinoma	down	MiR-144 suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SMAD4.
hsa-mir-144	hepatocellular carcinoma	down	miR-144 reverses chemoresistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway.
hsa-mir-144	hepatocellular carcinoma	down	MicroRNA-144 inhibits hepatocellular carcinoma cell proliferation, invasion and migration by targeting ZFX.
hsa-mir-144	hepatocellular carcinoma	down	miR-144 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting E2F3.
hsa-mir-144	hepatocellular carcinoma	down	MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1.
hsa-mir-144	laryngeal squamous cell carcinoma	down	miR-144 suppresses the growth and metastasis of laryngeal squamous cell carcinoma by targeting IRS1.
hsa-mir-144	lung cancer	down	Downregulating microRNA-144 mediates a metabolic shift in lung cancer cells by regulating GLUT1 expression.
hsa-mir-144	lung cancer	down	MiR-144 Inhibits Proliferation and Induces Apoptosis and Autophagy in Lung Cancer Cells by Targeting TIGAR.
hsa-mir-144	medullary thyroid carcinoma	up	Evaluation of miRNAs expression in medullary thyroid carcinoma tissue samples: miR-34a and miR-144 as promising overexpressed markers in MTC.
hsa-mir-144	nasopharyngeal carcinoma	up	MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.
hsa-mir-144	non-small cell lung cancer	down	A novel circular RNA hsa_circ_0020123 exerts oncogenic properties through suppression of miR-144 in non-small cell lung cancer.
hsa-mir-144	oral squamous cell carcinoma	up	Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
hsa-mir-144	osteosarcoma	down	The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression.
hsa-mir-144	osteosarcoma	down	MicroRNA-144 suppresses osteosarcoma growth and metastasis by targeting ROCK1 and ROCK2.
hsa-mir-144	osteosarcoma	down	MiR-144 Inhibits Tumor Growth and Metastasis in Osteosarcoma via Dual-suppressing RhoA/ROCK1 Signaling Pathway.
hsa-mir-144	ovarian cancer	down	MicroRNA-144 mediates metabolic shift in ovarian cancer cells by directly targeting Glut1.
hsa-mir-144	pancreatic ductal adenocarcinoma	down	XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.
hsa-mir-144	papillary thyroid carcinoma	down	MicroRNA-144 inhibits proliferation by targeting WW domain-containing transcription regulator protein 1 in papillary thyroid cancer.
hsa-mir-144	renal cell carcinoma	down	MiR-144 inhibits cell proliferation of renal cell carcinoma by targeting MTOR.
hsa-mir-144	thyroid cancer	down	Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2.
hsa-mir-144	uveal melanoma	down	MiR-144 Inhibits Uveal Melanoma Cell Proliferation and Invasion by Regulating c-Met Expression.
hsa-mir-144-3p	gastric cancer	down	MicroRNA-144-3p suppresses gastric cancer progression by inhibiting epithelial-to-mesenchymal transition through targeting PBX3.
hsa-mir-144-3p	glioma	down	miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met.
hsa-mir-144-3p	glioma	down	The Inhibition of miR-144-3p on Cell Proliferation and Metastasis by Targeting TOP2A in HCMV-Positive Glioblastoma Cells.
hsa-mir-144-3p	hepatocellular carcinoma	down	MicroRNA-144-3p suppresses tumor growth and angiogenesis by targeting SGK3 in hepatocellular carcinoma.
hsa-mir-144-3p	hepatocellular carcinoma	down	A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma.
hsa-mir-144-3p	multiple myeloma	down	MiR-144-3p inhibits cell proliferation and induces apoptosis in multiple myeloma by targeting c-Met.
hsa-mir-144-3p	neuroblastoma	down	microRNA-144-3p suppresses human neuroblastoma cell proliferation by targeting HOXA7.
hsa-mir-144-3p	non-small cell lung cancer	down	Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data.
hsa-mir-144-3p	osteosarcoma	down	TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
hsa-mir-144-3p	papillary thyroid carcinoma	up	MiR-144-3p promotes the tumor growth and metastasis of papillary thyroid carcinoma by targeting paired box gene 8.
hsa-mir-144-3p	prostate cancer	down	MicroRNA-144-3p inhibits cell proliferation and induces cell apoptosis in prostate cancer by targeting CEP55.
hsa-mir-144-3p	renal cell carcinoma	down	miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8.
hsa-mir-144-3p	renal clear cell carcinoma	up	Mir-144-3p Promotes Cell Proliferation, Metastasis, Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Downregulating ARID1A.
hsa-mir-145	basal cell carcinoma	down	Expression of microRNAs in basal cell carcinoma.
hsa-mir-145	bladder cancer	down	Role of STAT3 and FOXO1 in the divergent therapeutic responses of non-metastatic and metastatic bladder cancer cells to miR-145.
hsa-mir-145	bladder cancer	down	miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors.
hsa-mir-145	bladder cancer	down	MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells.
hsa-mir-145	bladder cancer	down	Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways.
hsa-mir-145	bladder cancer	down	socs7, a target gene of microRNA-145, regulates interferon-? induction through STAT3 nuclear translocation in bladder cancer cells.
hsa-mir-145	bladder cancer	down	Aberrant expression of microRNAs in bladder cancer.
hsa-mir-145	bladder cancer	down	miR-145 inhibits invasion of bladder cancer cells by targeting PAK1.
hsa-mir-145	bladder cancer	down	Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells.
hsa-mir-145	breast cancer	down	miR-145 inhibits breast cancer cell growth through RTKN.
hsa-mir-145	breast cancer	down	miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells.
hsa-mir-145	breast cancer	down	MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF.
hsa-mir-145	breast cancer	down	Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-145	breast cancer	down	miR-145 inhibits proliferation and migration of breast cancer cells by directly or indirectly regulating TGF-?1 expression.
hsa-mir-145	breast cancer	down	Expression of miRNA-206 and miRNA-145 in breast cancer and correlation with prognosis.
hsa-mir-145	breast cancer	down	MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1.
hsa-mir-145	breast cancer	down	miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1.
hsa-mir-145	cervical cancer	down	Glucocorticoid regulation of a novel HPV E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells.
hsa-mir-145	cervical cancer	down	Downregulation of microRNA-145 is associated with aggressive progression and poor prognosis in human cervical cancer.
hsa-mir-145	cervical cancer	down	A Functional Polymorphism in the Promoter of MiR-143/145 Is Associated With the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case-Control Study.
hsa-mir-145	cervical cancer	down	Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection.
hsa-mir-145	cervical carcinoma	down	miR-145 Contributes to the Progression of Cervical Carcinoma by Directly Regulating FSCN1.
hsa-mir-145	chondrosarcoma	down	The Epigenetic Regulation of SOX9 by miR-145 in Human Chondrosarcoma.
hsa-mir-145	colon cancer	down	Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene.
hsa-mir-145	colon cancer	down	MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis.
hsa-mir-145	colon cancer	down	Forced expression of miR-143 represses ERK5/c-Myc and p68/p72 signaling in concert with miR-145 in gut tumors of Apc(Min) mice.
hsa-mir-145	colon cancer	down	Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon.
hsa-mir-145	colon cancer	up	miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.
hsa-mir-145	colon cancer	down	Epigenetically regulated miR-145 suppresses colon cancer invasion and metastasis by targeting LASP1.
hsa-mir-145	colon cancer	down	miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells.
hsa-mir-145	colon cancer	down	Inhibition of SW620 human colon cancer cells by upregulating miRNA-145.
hsa-mir-145	colorectal cancer	down	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-145	colorectal cancer	down	MicroRNA signatures: novel biomarker for colorectal cancer?
hsa-mir-145	colorectal cancer	down	Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.
hsa-mir-145	colorectal cancer	down	RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets.
hsa-mir-145	colorectal cancer	down	MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1.
hsa-mir-145	colorectal cancer	up	Up-regulation of microRNA-145 associates with lymph node metastasis in colorectal cancer.
hsa-mir-145	colorectal cancer	down	Evaluation of microRNAs-29a, 92a and 145 in colorectal carcinoma as candidate diagnostic markers: An Egyptian pilot study.
hsa-mir-145	colorectal cancer	down	MicroRNA-145 suppresses cell migration and invasion by targeting paxillin in human colorectal cancer cells.
hsa-mir-145	colorectal cancer	down	MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway.
hsa-mir-145	colorectal cancer	down	Expression profiling of selected microRNA signatures in plasma and tissues of Saudi colorectal cancer patients by qPCR.
hsa-mir-145	colorectal cancer	down	miR-145 suppresses colorectal cancer cell migration and invasion by targeting an ETS-related gene.
hsa-mir-145	colorectal cancer	down	microRNA-145 regulates tumor suppressor candidate 3 and mitogen-activated protein kinase pathway to inhibit the progression of colorectal cancer.
hsa-mir-145	colorectal cancer	down	Circular RNA PVT1 promotes metastasis via miR-145 sponging in CRC.
hsa-mir-145	colorectal carcinoma	down	Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
hsa-mir-145	endometrial cancer	up	Up-regulation of microRNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells.
hsa-mir-145	endometrial cancer	down	Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.
hsa-mir-145	esophageal cancer	down	miR-145 targets the SOX11 3'UTR to suppress endometrial cancer growth.
hsa-mir-145	esophageal cancer	up	MicroRNA-145 promotes esophageal cancer cells proliferation and metastasis by targeting SMAD5.
hsa-mir-145	esophageal cancer	down	Episomal lentiviral vector-mediated miR-145 overexpression inhibits proliferation and induces apoptosis of human esophageal carcinoma cells.
hsa-mir-145	esophageal squamous cell carcinoma	down	miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
hsa-mir-145	esophageal squamous cell carcinoma	up	Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma.
hsa-mir-145	esophageal squamous cell carcinoma	down	MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma.
hsa-mir-145	esophageal squamous cell carcinoma	down	miR-145 inhibits proliferation and invasion of esophageal squamous cell carcinoma in part by targeting c-Myc.
hsa-mir-145	esophageal squamous cell carcinoma	down	Evaluating the miR-302b and miR-145 expression in formalin-fixed paraffin-embedded samples of esophageal squamous cell carcinoma.
hsa-mir-145	esophageal squamous cell carcinoma	down	MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.
hsa-mir-145	esophageal squamous cell carcinoma	down	MicroRNA-145 performs as a tumor suppressor in human esophageal squamous cell carcinoma by targeting phospholipase C epsilon 1.
hsa-mir-145	gallbladder carcinoma	up	miR-145 sensitizes gallbladder cancer to cisplatin by regulating multidrug resistance associated protein 1.
hsa-mir-145	gastric cancer	down	MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer.
hsa-mir-145	gastric cancer	down	[Expression of miR-143 and miR-145 and their functional study in gastric carcinoma].
hsa-mir-145	gastric cancer	down	MicroRNA-145 exerts tumor-suppressive and chemo-resistance lowering effects by targeting CD44 in gastric cancer.
hsa-mir-145	gastric cancer	down	miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6.
hsa-mir-145	glioblastoma	down	MiR-145 inhibits the epithelial-to-mesenchymal transition via targeting ADAM19 in human glioblastoma.
hsa-mir-145	glioblastoma	down	MiR-145 inhibits EGF-induced epithelial-to-mesenchymal transition via targeting Smad2 in human glioblastoma.
hsa-mir-145	glioblastoma	down	NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma.
hsa-mir-145	glioblastoma	down	Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.
hsa-mir-145	glioblastoma	down	miR-145 is a potential biomarker for predicting clinical outcome in glioblastomas.
hsa-mir-145	glioma	down	miR-145 is a potential biomarker for predicting clinical outcome in glioblastomas.
hsa-mir-145	glioma	down	NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma.
hsa-mir-145	glioma	down	MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells.
hsa-mir-145	glioma	down	ROCK1, a novel target of miR-145, promotes glioma cell invasion.
hsa-mir-145	glioma	down	miR-145 Inhibits Migration and Invasion of Glioma Stem Cells by Targeting ABCG2.
hsa-mir-145	hepatocellular carcinoma	down	Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-145	hepatocellular carcinoma	down	MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.
hsa-mir-145	hepatocellular carcinoma	down	miR-145 suppresses cell invasion in hepatocellular carcinoma cells: miR-145 targets ADAM17.
hsa-mir-145	hepatocellular carcinoma	down	MicroRNA-145: a promising biomarker for hepatocellular carcinoma (HCC).
hsa-mir-145	hepatocellular carcinoma	down	MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling.
hsa-mir-145	hepatocellular carcinoma	down	MicroRNA-145 inhibits cell proliferation by directly targeting ADAM17 in hepatocellular carcinoma.
hsa-mir-145	hepatocellular carcinoma	down	MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1.
hsa-mir-145	hepatocellular carcinoma	down	Interaction of microRNA-21/145 and Smad3 domain-specific phosphorylation in hepatocellular carcinoma.
hsa-mir-145	hepatocellular carcinoma	down	MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma.
hsa-mir-145	hepatocellular carcinoma	down	Investigation of the clinical significance and prognostic value of microRNA-145 in human hepatocellular carcinoma.
hsa-mir-145	hepatocellular carcinoma	down	MicroRNA-145 inhibits proliferation and promotes apoptosis of HepG2 cells by targeting ROCK1 through the ROCK1/NF-?B signaling pathway.
hsa-mir-145	intrahepatic cholangiocarcinoma	down	MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma.
hsa-mir-145	kidney cancer	down	MicroRNA-145 Targets the Metalloprotease ADAM17 and Is Suppressed in Renal Cell Carcinoma Patients.
hsa-mir-145	laryngeal squamous cell carcinoma	down	MYO5A inhibition by miR-145 acts as a predictive marker of occult neck lymph node metastasis in human laryngeal squamous cell carcinoma.
hsa-mir-145	laryngeal squamous cell carcinoma	down	Curcumin suppresses the progression of laryngeal squamous cell carcinoma through the upregulation of miR-145 and inhibition of the PI3K/Akt/mTOR pathway.
hsa-mir-145	laryngeal squamous cell carcinoma	down	Long noncoding RNA LINC00339 promotes laryngeal squamous cell carcinoma cell proliferation and invasion via sponging miR-145.
hsa-mir-145	liver cancer	down	MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer.
hsa-mir-145	lung adenocarcinoma	down	Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
hsa-mir-145	lung adenocarcinoma	down	MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1.
hsa-mir-145	lung adenocarcinoma	down	microRNA-145 suppresses lung adenocarcinoma-initiating cell proliferation by targeting OCT4.
hsa-mir-145	lung adenocarcinoma	down	[miR-145 inhibits lung adenocarcinoma stem cells proliferation by targeting OCT4 gene].
hsa-mir-145	lung adenocarcinoma	down	MiR-145 regulates cancer stem-like properties and epithelial-to-mesenchymal transition in lung adenocarcinoma-initiating cells.
hsa-mir-145	lung adenocarcinoma	down	MiRNA-145 suppresses lung adenocarcinoma cell invasion and migration by targeting N-cadherin.
hsa-mir-145	lung cancer	down	Interaction of lincRNA ROR and p53/miR-145 correlates with lung cancer stem cell signatures.
hsa-mir-145	lung cancer	down	Uncovering growth-suppressive MicroRNAs in lung cancer.
hsa-mir-145	lung cancer	down	MicroRNA-145 inhibits lung cancer cell metastasis.
hsa-mir-145	lung cancer	down	MicroRNA-145 inhibits migration and invasion by down-regulating FSCN1 in lung cancer.
hsa-mir-145	lung cancer	up	Stromal expression of miR-143/145 promotes neoangiogenesis in lung cancer development.
hsa-mir-145	nasopharyngeal carcinoma	down	MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma.
hsa-mir-145	nasopharyngeal carcinoma	down	miR-145 inhibits invasion and metastasis by directly targeting Smad3 in nasopharyngeal cancer.
hsa-mir-145	nasopharyngeal carcinoma	down	MiR-145 inhibits metastasis by targeting fascin actin-bundling protein 1 in nasopharyngeal carcinoma.
hsa-mir-145	neuroblastoma	down	NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma.
hsa-mir-145	non-small cell lung cancer	down	miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc.
hsa-mir-145	non-small cell lung cancer	down	Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application.
hsa-mir-145	non-small cell lung cancer	down	MiR-145 acts as a metastasis suppressor by targeting metadherin in lung cancer.
hsa-mir-145	non-small cell lung cancer	down	Low miR-145 expression level is associated with poor pathological differentiation and poor prognosis in non-small cell lung cancer.
hsa-mir-145	non-small cell lung cancer	up	Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.
hsa-mir-145	non-small cell lung cancer	down	Low miR-145 silenced by DNA methylation promotes NSCLC cell proliferation, migration and invasion by targeting mucin 1.
hsa-mir-145	non-small cell lung cancer	down	MicroRNA-145 inhibits migration and invasion via inhibition of fascin 1 protein expression in non-small-cell lung cancer cells.
hsa-mir-145	non-small cell lung cancer	down	MiR-145 and miR-203 represses TGF-?-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
hsa-mir-145	non-small cell lung cancer	down	miR-145 and miR-497 suppress TGF-?-induced epithelial-mesenchymal transition of non-small cell lung cancer by targeting MTDH.
hsa-mir-145	non-small cell lung cancer	down	Serum levels of candidate microRNA diagnostic markers differ among the stages of non-small-cell lung cancer.
hsa-mir-145	oral squamous cell carcinoma	down	Downregulation of miR-145 expression in oral squamous cell carcinomas and its clinical significance.
hsa-mir-145	oral squamous cell carcinoma	down	MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6.
hsa-mir-145	oral squamous cell carcinoma	down	Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis.
hsa-mir-145	osteosarcoma	down	MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells.
hsa-mir-145	osteosarcoma	down	microRNA-145 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1.
hsa-mir-145	osteosarcoma	down	miR-145 inhibits osteosarcoma cells proliferation and invasion by targeting ROCK1.
hsa-mir-145	osteosarcoma	up	miR-145 promotes osteosarcoma growth by reducing expression of the transcription factor friend leukemia virus integration 1.
hsa-mir-145	osteosarcoma	down	MicroRNA-145 Suppresses Osteosarcoma Metastasis via Targeting MMP16.
hsa-mir-145	osteosarcoma	down	MicroRNA-145 inhibits tumour growth and metastasis in osteosarcoma by targeting cyclin-dependent kinase, CDK6.
hsa-mir-145	ovarian cancer	down	MicroRNA-145 Function as a Cell Growth Repressor by Directly Targeting c-Myc in Human Ovarian Cancer.
hsa-mir-145	ovarian cancer	down	MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1.
hsa-mir-145	ovarian cancer	down	Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.
hsa-mir-145	ovarian cancer	down	miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma.
hsa-mir-145	ovarian cancer	down	miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
hsa-mir-145	ovarian cancer	down	Quercetin induces the apoptosis of human ovarian carcinoma cells by upregulating the expression of microRNA-145.
hsa-mir-145	ovarian cancer	down	miR-145 inhibits glutamine metabolism through c-myc/GLS1 pathways in ovarian cancer cells.
hsa-mir-145	pancreatic adenocarcinoma	down	MiRNA-145 increases therapeutic sensibility to gemcitabine treatment of pancreatic adenocarcinoma cells.
hsa-mir-145	pancreatic cancer	down	MicroRNA-145 suppresses cell proliferation, invasion and migration in pancreatic cancer cells by targeting NEDD9.
hsa-mir-145	pancreatic cancer	down	MiR-145 functions as a tumor suppressor via regulating angiopoietin-2 in pancreatic cancer cells.
hsa-mir-145	pancreatic ductal adenocarcinoma	down	XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.
hsa-mir-145	primary cns lymphomas	down	Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.
hsa-mir-145	prostate cancer	down	The functional significance of microRNA-145 in prostate cancer.
hsa-mir-145	prostate cancer	down	Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.
hsa-mir-145	prostate cancer	down	MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer.
hsa-mir-145	prostate cancer	down	The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer.
hsa-mir-145	prostate cancer	down	miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.
hsa-mir-145	renal cell carcinoma	down	The tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma.
hsa-mir-145	renal cell carcinoma	down	miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma.
hsa-mir-145	retinoblastoma	down	miR-145 suppressed human retinoblastoma cell proliferation and invasion by targeting ADAM19.
hsa-mir-145	uveal melanoma	down	MicroRNA 145 may play an important role in uveal melanoma cell growth by potentially targeting insulin receptor substrate-1.
hsa-mir-145-3p	non-small cell lung cancer	down	microRNA-145-3p inhibits non-small cell lung cancer cell migration and invasion by targeting PDK1 via the mTOR signaling pathway.
hsa-mir-145-5p	breast cancer	down	miR-145-5p Suppresses Breast Cancer Progression by Inhibiting SOX2.
hsa-mir-145-5p	colorectal cancer	down	Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
hsa-mir-145-5p	esophageal squamous cell carcinoma	down	miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-?B Signaling Pathway in Esophageal Squamous Cell Carcinoma.
hsa-mir-145-5p	gastric cancer	down	Differential MicroRNA Expression Between Gastric Cancer Tissue and Non-cancerous Gastric Mucosa According to Helicobacter pylori Status.
hsa-mir-145-5p	gastric cancer	down	MicroRNA-145-5p inhibits gastric cancer invasiveness through targeting N-cadherin and ZEB2 to suppress epithelial-mesenchymal transition.
hsa-mir-145-5p	gastric cancer	down	Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer.
hsa-mir-145-5p	hepatocellular carcinoma	down	Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
hsa-mir-145-5p	hepatocellular carcinoma	down	miR-145-5p Acts as a Novel Tumor Suppressor in Hepatocellular Carcinoma Through Targeting RAB18.
hsa-mir-145-5p	laryngeal squamous cell carcinoma	down	Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
hsa-mir-145-5p	malignant melanoma	down	miR-145-5p inhibits tumor occurrence and metastasis through the NF-?B signaling pathway by targeting TLR4 in malignant melanoma.
hsa-mir-145-5p	non-small cell lung cancer	down	miR-145-5p inhibits epithelial-mesenchymal transition via the JNK signaling pathway by targeting MAP3K1 in non-small cell lung cancer cells.
hsa-mir-1468	hepatocellular carcinoma	up	MicroRNA-1468 promotes tumor progression by activating PPAR-?-mediated AKT signaling in human hepatocellular carcinoma.
hsa-mir-1468-5p	glioma	down	MicroRNA-1468-5p inhibits glioma cell proliferation and induces cell cycle arrest by targeting RRM1.
hsa-mir-1469	lung cancer	down	MiRNA-1469 promotes lung cancer cells apoptosis through targeting STAT5a.
hsa-mir-146a	breast cancer	down	Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells.
hsa-mir-146a	breast cancer	down	Clinical significance of miR-146a in gastric cancer cases.
hsa-mir-146a	breast cancer	down	MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer.
hsa-mir-146a	cervical cancer	up	miR-146a promotes cervical cancer cell viability via targeting IRAK1 and TRAF6.
hsa-mir-146a	chronic myelogenous leukemia	down	ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
hsa-mir-146a	colon cancer	up	MicroRNA-146a induces immune suppression and drug-resistant colorectal cancer cells.
hsa-mir-146a	colorectal cancer	up	MicroRNA-146a promote cell migration and invasion in human colorectal cancer via carboxypeptidase M/src-FAK pathway.
hsa-mir-146a	esophageal squamous cell carcinoma	down	Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma.
hsa-mir-146a	follicular thyroid carcinoma	up	miR-146a and miR-146b promote proliferation, migration and invasion of follicular thyroid carcinoma via inhibition of ST8SIA4.
hsa-mir-146a	gastric cancer	down	Clinicopathological significance of the microRNA-146a/WASP-family verprolin-homologous protein-2 axis in gastric cancer.
hsa-mir-146a	gastric cancer	down	MiR-146a functions as a small silent player in gastric cancer.
hsa-mir-146a	gastric cancer	down	Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.
hsa-mir-146a	gastric cancer	down	MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis.
hsa-mir-146a	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-146a	gastric cancer	down	Clinical significance of miR-146a in gastric cancer cases.
hsa-mir-146a	gastric cancer	down	microRNA-146a targets the L1 cell adhesion molecule and suppresses the metastatic potential of gastric cancer.
hsa-mir-146a	gastric cancer	up	microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-kappaB by targeting CARD10 and COPS8 in gastric cancer.
hsa-mir-146a	gastric cancer	up	MicroRNA-146a promotes gastric cancer cell apoptosis by targeting transforming growth factor ?-activated kinase 1.
hsa-mir-146a	glioma	down	MicroRNA-146a inhibits glioma development by targeting Notch1.
hsa-mir-146a	glioma	down	Microglial SMAD4 regulated by microRNA-146a promotes migration of microglia which support tumor progression in a glioma environment.
hsa-mir-146a	hepatocellular carcinoma	down	MiR-146a suppresses hepatocellular carcinoma by downregulating TRAF6.
hsa-mir-146a	hepatocellular carcinoma	up	Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.
hsa-mir-146a	hepatocellular carcinoma	down	Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-146a	hepatocellular carcinoma	down	Synergistic effect of MiR-146a mimic and cetuximab on hepatocellular carcinoma cells.
hsa-mir-146a	hepatocellular carcinoma	down	microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
hsa-mir-146a	lung cancer	down	Regulation of COX-2 expression by miR-146a in lung cancer cells.
hsa-mir-146a	lung cancer	down	miR-146a and miR-196a-2 genes polymorphisms and its circulating levels in lung cancer patients.
hsa-mir-146a	malignant melanoma	down	Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
hsa-mir-146a	malignant melanoma	up	miR-146a promotes cell migration and invasion in melanoma by directly targeting SMAD4.
hsa-mir-146a	neuroblastoma	down	miR-146a induces apoptosis in neuroblastoma cells by targeting BCL11A.
hsa-mir-146a	non-small cell lung cancer	down	miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells.
hsa-mir-146a	non-small cell lung cancer	down	MicroRNA-146a rs2910164 polymorphism is associated with susceptibility to non-small cell lung cancer in the Chinese population.
hsa-mir-146a	non-small cell lung cancer	up	Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.
hsa-mir-146a	non-small cell lung cancer	down	MicroRNA-146a inhibits epithelial mesenchymal transition in non-small cell lung cancer by targeting insulin receptor substrate 2.
hsa-mir-146a	oral squamous cell carcinoma	up	miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes.
hsa-mir-146a	pancreatic cancer	down	miR-146a suppresses invasion of pancreatic cancer cells.
hsa-mir-146a	pancreatic cancer	down	Clinical significance of miR-146a in gastric cancer cases.
hsa-mir-146a	papillary thyroid carcinoma	down	MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
hsa-mir-146a	prostate cancer	down	Clinical significance of miR-146a in gastric cancer cases.
hsa-mir-146a	prostate cancer	down	miR-146a functions as a tumor suppressor in prostate cancer by targeting Rac1.
hsa-mir-146a	prostate cancer	down	LncRNA PVT1 regulates prostate cancer cell growth by inducing the methylation of miR-146a.
hsa-mir-146a	renal cell carcinoma	up	Carbamylated albumin stimulates microRNA-146, which is increased in human renal cell carcinoma.
hsa-mir-146a-5p	bladder cancer	up	Expression Level of Urinary MicroRNA-146a-5p Is Increased in Patients With Bladder Cancer and Decreased in Those After Transurethral Resection.
hsa-mir-146a-5p	gastric cancer	down	The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
hsa-mir-146a-5p	hepatocellular carcinoma	down	Down-regulation of miR-146a-5p and its potential targets in hepatocellular carcinoma validated by a TCGA- and GEO-based study.
hsa-mir-146a-5p	non-small cell lung cancer	down	MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2.
hsa-mir-146a-5p	non-small cell lung cancer	down	Transcriptomic studies provide insights into the tumor suppressive role of miR-146a-5p in non-small cell lung cancer (NSCLC) cells.
hsa-mir-146b	anaplastic thyroid carcinoma	up	A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.
hsa-mir-146b	anaplastic thyroid carcinoma	up	p21 participates in the regulation of anaplastic thyroid cancer cell proliferation by miR-146b.
hsa-mir-146b	bladder cancer	up	MicroRNA-146b Overexpression Promotes Human Bladder Cancer Invasion via Enhancing ETS2-Mediated mmp2 mRNA Transcription.
hsa-mir-146b	breast cancer	down	Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells.
hsa-mir-146b	breast cancer	down	STAT3 Induction of miR-146b Forms a Feedback Loop to Inhibit the NF-?B to IL-6 Signaling Axis and STAT3-Driven Cancer Phenotypes.
hsa-mir-146b	esophageal cancer	up	Transcriptional regulation of miR-146b by C/EBP? LAP2 in esophageal cancer cells.
hsa-mir-146b	follicular thyroid carcinoma	up	Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.
hsa-mir-146b	follicular thyroid carcinoma	up	miR-146a and miR-146b promote proliferation, migration and invasion of follicular thyroid carcinoma via inhibition of ST8SIA4.
hsa-mir-146b	gastric cancer	down	Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.
hsa-mir-146b	glioblastoma	up	The immune-related microRNA miR-146b is upregulated in glioblastoma recurrence.
hsa-mir-146b	glioma	down	microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs.
hsa-mir-146b	malignant melanoma	down	Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
hsa-mir-146b	non-small cell lung cancer	down	Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-146b	non-small cell lung cancer	up	Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
hsa-mir-146b	oral squamous cell carcinoma	up	miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes.
hsa-mir-146b	ovarian cancer	up	miR-146b promotes cell proliferation and increases chemosensitivity, but attenuates cell migration and invasion via FBXL10 in ovarian cancer.
hsa-mir-146b	papillary thyroid carcinoma	up	Loss of DNA methylation is related to increased expression of miR-21 and miR-146b in papillary thyroid carcinoma.
hsa-mir-146b	papillary thyroid carcinoma	up	IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma.
hsa-mir-146b	papillary thyroid carcinoma	up	Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.
hsa-mir-146b	papillary thyroid carcinoma	up	MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
hsa-mir-146b	papillary thyroid carcinoma	up	MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.
hsa-mir-146b	papillary thyroid carcinoma	up	Prognostic Implications of miR-146b Expression and Its Functional Role in Papillary Thyroid Carcinoma.
hsa-mir-146b	papillary thyroid carcinoma	up	Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.
hsa-mir-146b	primary thyroid lymphoma	up	A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.
hsa-mir-146b	prostate cancer	down	MicroRNA-146b acts as a potential tumor suppressor in human prostate cancer.
hsa-mir-146b	prostate cancer	up	MiR-146b inhibits autophagy in prostate cancer by targeting the PTEN/Akt/mTOR signaling pathway.
hsa-mir-146b	renal cell carcinoma	up	Carbamylated albumin stimulates microRNA-146, which is increased in human renal cell carcinoma.
hsa-mir-146b	thyroid cancer	up	MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
hsa-mir-146b-3p	cervical cancer	up	Down-regulation of HPGD by miR-146b-3p promotes cervical cancer cell proliferation, migration and anchorage-independent growth through activation of STAT3 and AKT pathways.
hsa-mir-146b-3p	thyroid cancer	up	MicroRNA-146b-3p promotes cell metastasis by directly targeting NF2 in human papillary thyroid cancer.
hsa-mir-146b-5p	colorectal cancer	up	miR-146b-5p regulates cell growth, invasion, and metabolism by targeting PDHB in colorectal cancer.
hsa-mir-146b-5p	gallbladder carcinoma	down	Identification of miR-146b-5p in tissues as a novel biomarker for prognosis of gallbladder carcinoma.
hsa-mir-146b-5p	gallbladder carcinoma	down	MicroRNA-146b-5p inhibits the growth of gallbladder carcinoma by targeting epidermal growth factor receptor.
hsa-mir-146b-5p	glioblastoma	down	MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma.
hsa-mir-146b-5p	glioma	down	miR-146b-5p inhibits glioma migration and invasion by targeting MMP16.
hsa-mir-146b-5p	hepatocellular carcinoma	down	Down-regulation of miR-146b-5p by long noncoding RNA MALAT1 in hepatocellular carcinoma promotes cancer growth and metastasis.
hsa-mir-146b-5p	non-small cell lung cancer	down	MiR-146b-5p functions as a suppressor miRNA and prognosis predictor in non-small cell lung cancer.
hsa-mir-146b-5p	osteosarcoma	up	miR-146b-5p promotes invasion and metastasis contributing to chemoresistance in osteosarcoma by targeting zinc and ring finger 3.
hsa-mir-146b-5p	papillary thyroid carcinoma	up	MicroRNA miR-146b-5p regulates signal transduction of TGF-? by repressing SMAD4 in thyroid cancer.
hsa-mir-146b-5p	papillary thyroid carcinoma	up	Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
hsa-mir-146b-5p	papillary thyroid carcinoma	up	MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3.
hsa-mir-146b-5p	papillary thyroid carcinoma	up	In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
hsa-mir-146b-5p	papillary thyroid carcinoma	up	MicroRNA-146b-5p as an oncomiR promotes papillary thyroid carcinoma development by targeting CCDC6.
hsa-mir-146b-5p	thyroid cancer	up	MicroRNA-146b-3p promotes cell metastasis by directly targeting NF2 in human papillary thyroid cancer.
hsa-mir-147	breast cancer	down	Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer.
hsa-mir-147	breast cancer	down	MicroRNA-147 suppresses proliferation, invasion and migration through the AKT/mTOR signaling pathway in breast cancer.
hsa-mir-147	colon cancer	down	Ectopic expression of miR-147 inhibits stem cell marker and epithelial-mesenchymal transition (EMT)-related protein expression in colon cancer cells.
hsa-mir-147	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-147	gastric cancer	up	Downregulation of MicroRNA-147 Inhibits Cell Proliferation and Increases the Chemosensitivity of Gastric Cancer Cells to 5-Fluorouracil by Directly Targeting PTEN.
hsa-mir-147	hepatocellular carcinoma	down	MicroRNA-147 suppresses human hepatocellular carcinoma proliferation migration and chemosensitivity by inhibiting HOXC6.
hsa-mir-147	non-small cell lung cancer	down	Serum level of microRNA-147 as diagnostic biomarker in human non-small cell lung caner.
hsa-mir-147	oral squamous cell carcinoma	down	Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-1470	esophageal squamous cell carcinoma	up	Overexpression of microRNA-1470 promotes proliferation and migration, and inhibits senescence of esophageal squamous carcinoma cells.
hsa-mir-147b	colorectal cancer	down	LncRNA MAFG-AS1 promotes the progression of colorectal cancer by sponging miR-147b and activation of NDUFA4.
hsa-mir-147b	colorectal cancer	down	MicroRNA-147b Promotes Proliferation and Invasion of Human Colorectal Cancer by Targeting RAS Oncogene Family (RAP2B).
hsa-mir-147b	hepatocellular carcinoma	up	MicroRNA miR-147b promotes tumor growth via targeting UBE2N in hepatocellular carcinoma.
hsa-mir-148a	anaplastic thyroid carcinoma	down	miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.
hsa-mir-148a	bladder cancer	down	MicroRNA-148a represents an independent prognostic marker in bladder cancer.
hsa-mir-148a	breast cancer	down	MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1.
hsa-mir-148a	breast cancer	down	A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.
hsa-mir-148a	cervical cancer	down	Up-regulation of miRNA-148a inhibits proliferation, invasion, and migration while promoting apoptosis of cervical cancer cells by down-regulating RRS1.
hsa-mir-148a	cervical squamous cell carcinoma	down	MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma.
hsa-mir-148a	chordoma	up	MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.
hsa-mir-148a	colorectal cancer	down	MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer.
hsa-mir-148a	colorectal cancer	down	Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding.
hsa-mir-148a	colorectal cancer	down	Altered miR-21, miRNA-148a Expression in Relation to KRAS Mutation Status as Indicator of Adenoma-Carcinoma Transitional Pattern in Colorectal Adenoma and Carcinoma Lesions.
hsa-mir-148a	colorectal cancer	down	miR-148a inhibits cell proliferation and migration through targeting ErbB3 in colorectal cancer.
hsa-mir-148a	colorectal cancer	down	Significance of miR-148a in Colorectal Neoplasia: Downregulation of miR-148a Contributes to the Carcinogenesis and Cell Invasion of Colorectal Cancer.
hsa-mir-148a	esophageal squamous cell carcinoma	down	MicroRNA-148a regulates the MAPK/ERK signaling pathway and suppresses the development of esophagus squamous cell carcinoma via targeting MAP3K9.
hsa-mir-148a	esophageal squamous cell carcinoma	down	MiR-148a modulates HLA-G expression and influences tumor apoptosis in esophageal squamous cell carcinoma.
hsa-mir-148a	gastric cancer	up	miR-148a promoted cell proliferation by targeting p27 in gastric cancer cells.
hsa-mir-148a	gastric cancer	down	MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.
hsa-mir-148a	gastric cancer	down	MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer.
hsa-mir-148a	gastric cancer	down	microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition.
hsa-mir-148a	gastric cancer	down	MiR-148a is down-regulated in gastric cancer, targets MMP7 and indicates tumor invasiveness and poor prognosis.
hsa-mir-148a	gastric cancer	down	The role of miR-148a in gastric cancer.
hsa-mir-148a	gastric cancer	down	[Impact of miR-148a on the proliferation of gastric carcinoma MKN45 cells and its mechanism].
hsa-mir-148a	gastric cancer	down	MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer.
hsa-mir-148a	gastric cancer	down	miR-148a suppresses cell invasion and migration in gastric cancer by targeting DNA methyltransferase 1.
hsa-mir-148a	gastric cancer	down	miR-148a downregulates the expression of transforming growth factor-?2 and SMAD2 in gastric cancer.
hsa-mir-148a	gastrointestinal cancer	down	MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation.
hsa-mir-148a	glioblastoma	up	microRNA-148a Is a Prognostic oncomiR That Targets MIG6 and BIM to Regulate EGFR and Apoptosis in Glioblastoma.
hsa-mir-148a	glioma	up	MiR-148a increases glioma cell migration and invasion by downregulating GADD45A in human gliomas with IDH1 R132H mutations.
hsa-mir-148a	hepatocellular carcinoma	down	Identification of plasma miR-148a as a noninvasive biomarker for hepatocellular carcinoma.
hsa-mir-148a	hepatocellular carcinoma	down	MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.
hsa-mir-148a	hepatocellular carcinoma	down	microRNA-148a inhibits hepatocellular carcinoma cell invasion by targeting sphingosine-1-phosphate receptor 1.
hsa-mir-148a	kidney cancer	down	miR-148a increases the sensitivity to cisplatin by targeting Rab14 in renal cancer cells.
hsa-mir-148a	laryngeal squamous cell carcinoma	up	miR-148a and miR-375 may serve as predictive biomarkers for early diagnosis of laryngeal carcinoma.
hsa-mir-148a	lung adenocarcinoma	down	MicroRNA-148a inhibits cell proliferation and cell cycle progression in lung adenocarcinoma via directly targeting transcription factor E2F3.
hsa-mir-148a	nasopharyngeal carcinoma	down	Silencing of miRNA-148a by hypermethylation activates the integrin-mediated signaling pathway in nasopharyngeal carcinoma.
hsa-mir-148a	non-small cell lung cancer	down	MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells.
hsa-mir-148a	non-small cell lung cancer	down	Decreased miRNA-148a is associated with lymph node metastasis and poor clinical outcomes and functions as a suppressor of tumor metastasis in non-small cell lung cancer.
hsa-mir-148a	non-small cell lung cancer	down	Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening.
hsa-mir-148a	non-small cell lung cancer	down	MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC.
hsa-mir-148a	non-small cell lung cancer	down	MicroRNA-148a Suppresses Invasion and Metastasis of Human Non-Small-Cell Lung Cancer.
hsa-mir-148a	non-small cell lung cancer	down	MicroRNA-148a suppresses proliferation and invasion potential of non-small cell lung carcinomas via regulation of STAT3.
hsa-mir-148a	oral squamous cell carcinoma	down	Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-148a	osteosarcoma	up	Increased expression of microRNA-148a in osteosarcoma promotes cancer cell growth by targeting PTEN.
hsa-mir-148a	ovarian cancer	down	Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation.
hsa-mir-148a	ovarian cancer	down	MicroRNA-148a inhibits migration and invasion of ovarian cancer cells via targeting sphingosine-1-phosphate receptor 1.
hsa-mir-148a	ovarian cancer	down	Overexpression of miR-148a inhibits viability and invasion of ovarian cancer OVCAR3 cells by targeting FOXO3.
hsa-mir-148a	pancreatic cancer	down	MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2.
hsa-mir-148a	pancreatic ductal adenocarcinoma	down	Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma.
hsa-mir-148a	pancreatic ductal adenocarcinoma	down	MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B.
hsa-mir-148a	pancreatic ductal adenocarcinoma	down	MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
hsa-mir-148a	papillary thyroid carcinoma	down	Downregulation of cyclin-dependent kinase 8 by microRNA-148a suppresses proliferation and invasiveness of papillary thyroid carcinomas.
hsa-mir-148a	renal cell carcinoma	down	miR-148a suppresses human renal cell carcinoma malignancy by targeting AKT2.
hsa-mir-148a-3p	bladder cancer	down	miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer.
hsa-mir-148a-3p	esophageal cancer	down	miR-148a-3p Suppresses the Proliferation and Invasion of Esophageal Cancer by Targeting DNMT1.
hsa-mir-148a-3p	gastric cancer	down	Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer.
hsa-mir-148a-3p	non-small cell lung cancer	down	microRNA-148a-3p inhibited the proliferation and epithelial-mesenchymal transition progression of non-small-cell lung cancer via modulating Ras/MAPK/Erk signaling.
hsa-mir-148b	colorectal cancer	down	MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer.
hsa-mir-148b	endometrial cancer	down	MiR-148b functions as a tumor suppressor by targeting endoplasmic reticulum metallo protease 1 in human endometrial cancer cells.
hsa-mir-148b	gastric cancer	down	MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation.
hsa-mir-148b	hepatocellular carcinoma	down	MicroRNA-148b expression is decreased in hepatocellular carcinoma and associated with prognosis.
hsa-mir-148b	hepatocellular carcinoma	down	MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/?-catenin pathway.
hsa-mir-148b	hepatocellular carcinoma	down	Downregulation of miR-148b as biomarker for early detection of hepatocellular carcinoma and may serve as a prognostic marker.
hsa-mir-148b	hepatocellular carcinoma	down	Profiles of tissue microRNAs; miR-148b and miR-25 serve as potential prognostic biomarkers for hepatocellular carcinoma.
hsa-mir-148b	liver cancer	down	microRNA-148b suppresses hepatic cancer stem cell by targeting neuropilin-1.
hsa-mir-148b	lung cancer	down	Restoration of BRG1 inhibits proliferation and metastasis of lung cancer by regulating tumor suppressor miR-148b.
hsa-mir-148b	nasopharyngeal carcinoma	down	MicroRNA-148b suppresses proliferation, migration, and invasion of nasopharyngeal carcinoma cells by targeting metastasis-associated gene 2.
hsa-mir-148b	non-small cell lung cancer	down	miR-148b functions as a tumor suppressor in non-small cell lung cancer by targeting carcinoembryonic antigen (CEA).
hsa-mir-148b	non-small cell lung cancer	down	Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening.
hsa-mir-148b	non-small cell lung cancer	down	MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival.
hsa-mir-148b	non-small cell lung cancer	down	MicroRNA-148b is a potential prognostic biomarker and predictor of response to radiotherapy in non-small-cell lung cancer.
hsa-mir-148b	non-small cell lung cancer	down	MicroRNA-148b inhibits proliferation and the epithelial-mesenchymal transition and increases radiosensitivity in non-small cell lung carcinomas by regulating ROCK1.
hsa-mir-148b	non-small cell lung cancer	down	Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
hsa-mir-148b	ovarian cancer	up	Increased expression of miR-148b in ovarian carcinoma and its clinical significance.
hsa-mir-148b	ovarian carcinoma	up	Increased expression of miR-148b in ovarian carcinoma and its clinical significance.
hsa-mir-148b	pancreatic cancer	down	miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPK?1.
hsa-mir-148b	pancreatic cancer	down	MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines.
hsa-mir-148b-3p	breast cancer	down	Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR.
hsa-mir-148b-3p	gastric cancer	down	miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis.
hsa-mir-148b-3p	gastrointestinal stromal tumor	down	miR-148b-3p functions as a tumor suppressor in GISTs by directly targeting KIT.
hsa-mir-148b-3p	glioma	down	The Role of HOTAIR/miR-148b-3p/USF1 on Regulating the Permeability of BTB.
hsa-mir-148b-3p	renal cell carcinoma	down	MiR-148b-3p inhibits renal carcinoma cell growth and pro-angiogenic phenotype of endothelial cell potentially by modulating FGF2.
hsa-mir-149	breast cancer	down	MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis.
hsa-mir-149	colorectal cancer	down	MicroRNA-149 Suppresses Colorectal Cancer Cell Migration and Invasion by Directly Targeting Forkhead Box Transcription Factor FOXM1.
hsa-mir-149	colorectal cancer	down	EphB3-targeted regulation of miR-149 in the migration and invasion of human colonic carcinoma HCT116 and SW620 cells.
hsa-mir-149	gastric cancer	down	MicroRNA-149 inhibits proliferation and cell cycle progression through the targeting of ZBTB2 in human gastric cancer.
hsa-mir-149	glioblastoma	down	miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma.
hsa-mir-149	glioblastoma	down	MicroRNA-149 is epigenetically silenced tumor-suppressive microRNA, involved in cell proliferation and downregulation of AKT1 and cyclin?D1 in human glioblastoma multiforme.
hsa-mir-149	head and neck squamous cell carcinoma	down	The association between genetic polymorphism and the processing efficiency of miR-149 affects the prognosis of patients with head and neck squamous cell carcinoma.
hsa-mir-149	hepatocellular carcinoma	down	miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
hsa-mir-149	nasopharyngeal carcinoma	up	miR-149 promotes epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma cells.
hsa-mir-149	neuroblastoma	down	MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
hsa-mir-149	non-small cell lung cancer	down	miR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by Targeting FOXM1.
hsa-mir-149	non-small cell lung cancer	down	miR-149 suppresses human non-small cell lung cancer growth and metastasis by inhibiting the FOXM1/cyclin D1/MMP2 axis.
hsa-mir-149	ovarian cancer	down	MicroRNA-149 suppresses the proliferation and increases the sensitivity of ovarian cancer cells to cisplatin by targeting X-linked inhibitor of apoptosis.
hsa-mir-149	renal cell carcinoma	down	Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.
hsa-mir-149*	colorectal cancer	down	miR-6883 Family miRNAs Target CDK4/6 to Induce G1 Phase Cell-Cycle Arrest in Colon Cancer Cells.
hsa-mir-149-3p	gastric cancer	down	ZEB1-AS1 initiates a miRNA-mediated ceRNA network to facilitate gastric cancer progression.
hsa-mir-149-3p	gastric cancer	down	18?-glycyrrhetinic acid suppresses gastric cancer by activation of miR-149-3p-Wnt-1 signaling.
hsa-mir-149-3p	non-small cell lung cancer	up	LINC00472 Acts as a Tumor Suppressor in NSCLC through KLLN-Mediated p53-Signaling Pathway via MicroRNA-149-3p and MicroRNA-4270.
hsa-mir-149-5p	osteosarcoma	down	miR-149-5p inhibits cell growth by regulating TWEAK/Fn14/PI3K/AKT pathway and predicts favorable survival in human osteosarcoma.
hsa-mir-149-5p	renal cell carcinoma	down	Tumor suppressor miR-149-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
hsa-mir-150	adult t-cell leukemia	up	STAT1: A Novel Target of miR-150 and miR-223 Is Involved in the Proliferation of HTLV-I-Transformed and ATL Cells.
hsa-mir-150	breast cancer	up	miR-150 promotes human breast cancer growth and malignant behavior by targeting the pro-apoptotic purinergic P2X7 receptor.
hsa-mir-150	breast cancer	up	miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway.
hsa-mir-150	Burkitt lymphoma	down	miR-150 might inhibit cell proliferation and promote cell apoptosis by targeting LMO4 in Burkitt lymphoma.
hsa-mir-150	cervical cancer	up	MicroRNA-150 promotes cell proliferation, migration, and invasion of cervical cancer through targeting PDCD4.
hsa-mir-150	cervical cancer	up	microRNA-150 promotes cervical cancer cell growth and survival by targeting FOXO4.
hsa-mir-150	chronic lymphocytic leukemia	up	Opposite prognostic significance of cellular and serum circulating microRNA-150 in Chronic Lymphocytic Leukemia patients.
hsa-mir-150	chronic myelogenous leukemia	down	Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.
hsa-mir-150	colorectal cancer	up	Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.
hsa-mir-150	colorectal cancer	down	MiR-150 alleviates EMT and cell invasion of colorectal cancer through targeting Gli1.
hsa-mir-150	colorectal cancer	down	Circ-ZNF609 promotes migration of colorectal cancer by inhibiting Gli1 expression via microRNA-150.
hsa-mir-150	colorectal cancer	down	Increasing miR-150 and lowering HMGA2 inhibit proliferation and cycle progression of colon cancer in SW480 cells.
hsa-mir-150	cutaneous t-cell lymphoma	down	Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.
hsa-mir-150	esophageal cancer	down	Targeting of miR-150 on Gli1 gene to inhibit proliferation and cell cycle of esophageal carcinoma EC9706.
hsa-mir-150	esophageal squamous cell carcinoma	down	MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducers ZEB1.
hsa-mir-150	gastric cancer	up	MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2.
hsa-mir-150	hepatocellular carcinoma	down	microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
hsa-mir-150	hepatocellular carcinoma	down	Long Non-Coding RNA PVT1/miR-150/ HIG2 Axis Regulates the Proliferation, Invasion and the Balance of Iron Metabolism of Hepatocellular Carcinoma.
hsa-mir-150	hepatocellular carcinoma	down	MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis.
hsa-mir-150	intrahepatic cholangiocarcinoma	down	Upregulated circulating miR-150 is associated with the risk of intrahepatic cholangiocarcinoma.
hsa-mir-150	lung adenocarcinoma	up	Altered miR-143 and miR-150 expressions in peripheral blood mononuclear cells for diagnosis of non-small cell lung cancer.
hsa-mir-150	lung cancer	up	miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1.
hsa-mir-150	malignant melanoma	up	MicroRNA-150 inhibitors enhance cell apoptosis of melanoma by targeting PDCD4.
hsa-mir-150	malignant melanoma	down	MiR-150 suppresses tumor growth in melanoma through downregulation of MYB.
hsa-mir-150	mantle cell lymphoma	down	microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-150	non-small cell lung cancer	up	Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer.
hsa-mir-150	non-small cell lung cancer	up	MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4.
hsa-mir-150	non-small cell lung cancer	up	C-myc/miR-150/EPG5 axis mediated dysfunction of autophagy promotes development of non-small cell lung cancer.
hsa-mir-150	non-small cell lung cancer	up	Jumonji domain containing 2A predicts prognosis and regulates cell growth in lung cancer depending on miR-150.
hsa-mir-150	osteosarcoma	down	MicroRNA-150 functions as a tumor suppressor in osteosarcoma by targeting IGF2BP1.
hsa-mir-150	osteosarcoma	down	MicroRNA-150 Inhibits Cell Invasion and Migration and Is Downregulated in Human Osteosarcoma.
hsa-mir-150	osteosarcoma	down	[MicroRNA-150 inhibits osteosarcoma cell proliferation by targeting RUNX2 gene].
hsa-mir-150	osteosarcoma	down	miR-150 is downregulated in osteosarcoma and suppresses cell proliferation, migration and invasion by targeting ROCK1.
hsa-mir-150	osteosarcoma	down	Expression of microRNA-150 and its Target Gene IGF2BP1 in Human Osteosarcoma and their Clinical Implications.
hsa-mir-150	ovarian cancer	down	miR-150 enhances apoptotic and anti-tumor effects of paclitaxel in paclitaxel-resistant ovarian cancer cells by targeting Notch3.
hsa-mir-150	pancreatic cancer	down	Hypoxia promotes C-X-C chemokine receptor type 4 expression through microRNA-150 in pancreatic cancer cells.
hsa-mir-150	pancreatic ductal adenocarcinoma	down	The Clinical Significance of miR-34a in Pancreatic Ductal Carcinoma and Associated Molecular and Cellular Mechanisms.
hsa-mir-150	pancreatic ductal adenocarcinoma	down	A Decrease in miR-150 Regulates the Malignancy of Pancreatic Cancer by Targeting c-Myb and MUC4.
hsa-mir-150	prostate cancer	up	MIR-150 promotes prostate cancer stem cell development via suppressing p27Kip1.
hsa-mir-150	prostate cancer	down	MicroRNA-150 suppresses epithelial-mesenchymal transition, invasion, and metastasis in prostate cancer through the TRPM4-mediated ?-catenin signaling pathway.
hsa-mir-150*	colorectal cancer	up	MicroRNA expression profiles in human colorectal cancers with liver metastases.
hsa-mir-150*	pancreatic cancer	down	Upregulation of miR-150* and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R.
hsa-mir-150-3p	esophageal squamous cell carcinoma	down	Regulation of SPOCK1 by dual strands of pre-miR-150 inhibit cancer cell migration and invasion in esophageal squamous cell carcinoma.
hsa-mir-150-3p	head and neck squamous cell carcinoma	down	Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
hsa-mir-150-5p	acute myeloid leukemia	up	MicroRNA expression profiling in adrenal myelolipoma.
hsa-mir-150-5p	breast cancer	up	Role of microRNA-150-5p/SRCIN1 axis in the progression of breast cancer.
hsa-mir-150-5p	colonic adenocarcinoma	up	miR-150-5p represses TP53 tumor suppressor gene to promote proliferation of colon adenocarcinoma.
hsa-mir-150-5p	colorectal cancer	down	miR-150-5p suppresses tumor progression by targeting VEGFA in colorectal cancer.
hsa-mir-150-5p	colorectal cancer	down	MiR-150-5p Suppresses Colorectal Cancer Cell Migration and Invasion through Targeting MUC4.
hsa-mir-150-5p	colorectal cancer	down	Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
hsa-mir-150-5p	esophageal squamous cell carcinoma	down	Regulation of SPOCK1 by dual strands of pre-miR-150 inhibit cancer cell migration and invasion in esophageal squamous cell carcinoma.
hsa-mir-150-5p	glioma	down	miR-150-5p and miR-133a suppress glioma cell proliferation and migration through targeting membrane-type-1 matrix metalloproteinase.
hsa-mir-150-5p	head and neck squamous cell carcinoma	down	Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
hsa-mir-150-5p	hepatocellular carcinoma	down	miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14.
hsa-mir-150-5p	hepatocellular carcinoma	down	Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
hsa-mir-150-5p	malignant melanoma	down	MiR-150-5p regulates melanoma proliferation, invasion and metastasis via SIX1-mediated Warburg Effect.
hsa-mir-150-5p	nasopharyngeal carcinoma	down	CircRNA ZNF609 promotes growth and metastasis of nasopharyngeal carcinoma by competing with microRNA-150-5p.
hsa-mir-150-5p	non-small cell lung cancer	down	miR-150-5p Inhibits Non-Small-Cell Lung Cancer Metastasis and Recurrence by Targeting HMGA2 and ?-Catenin Signaling.
hsa-mir-150-5p	non-small cell lung cancer	down	Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
hsa-mir-150-5p	pancreatic cancer	down	[MiR-150-5p inhibits the proliferation and promoted apoptosis of pancreatic cancer cells].
hsa-mir-151	chronic myelogenous leukemia	down	Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.
hsa-mir-151-3p	osteosarcoma	up	MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.
hsa-mir-151-5p	gastric cancer	up	Notch1 pathway-mediated microRNA-151-5p promotes gastric cancer progression.
hsa-mir-151-5p	papillary thyroid carcinoma	up	Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.
hsa-mir-151a-3p	esophageal adenocarcinoma	up	Circulating miRNA profile in esophageal adenocarcinoma.
hsa-mir-151a-5p	colorectal cancer	up	A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
hsa-mir-152	breast cancer	down	Downregulation of MicroRNA-152 and Inhibition of Cell Proliferation, Migration, and Invasion in Breast Cancer.
hsa-mir-152	breast cancer	down	A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.
hsa-mir-152	breast cancer	down	microRNA-152 inhibits cell proliferation, migration and invasion in breast cancer.
hsa-mir-152	cervical cancer	up	miR-152 may function as an early diagnostic and prognostic biomarker in patients with cervical intraepithelial neoplasia and patients with cervical cancer.
hsa-mir-152	colorectal cancer	down	[Expression of microRNA-152 in colorectal cancer and its relationship with prognosis].
hsa-mir-152	colorectal cancer	down	Restoration of miR-152 expression suppresses cell proliferation, survival, and migration through inhibition of AKT-ERK pathway in colorectal cancer.
hsa-mir-152	colorectal cancer	down	miR-152 functions as a tumor suppressor in colorectal cancer by targeting PIK3R3.
hsa-mir-152	endometrial cancer	down	Role of MicroRNAs in carcinogenesis that potential for biomarker of endometrial cancer.
hsa-mir-152	endometrial cancer	down	miR-152 inhibits proliferation of human endometrial cancer cells via inducing G2/M phase arrest by suppressing CDC25B expression.
hsa-mir-152	endometrial cancer	down	miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer.
hsa-mir-152	gastric cancer	down	miR-152 suppresses gastric cancer cell proliferation and motility by targeting CD151.
hsa-mir-152	gastrointestinal cancer	down	MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation.
hsa-mir-152	gastrointestinal stromal tumor	down	MicroRNA-152 inhibits tumor cell growth while inducing apoptosis via the transcriptional repression of cathepsin L in gastrointestinal stromal tumor.
hsa-mir-152	glioblastoma	down	MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Kr?ppel-like factor 4.
hsa-mir-152	glioma	down	MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3.
hsa-mir-152	hepatocellular carcinoma	down	MicroRNA-152 inhibits tumor cell growth by directly targeting RTKN in hepatocellular carcinoma.
hsa-mir-152	multiple myeloma	down	Downregulation of MicroRNA-152 Contributes to High Expression of DKK1 in Multiple Myeloma.
hsa-mir-152	nasopharyngeal carcinoma	down	MiR-152 functioning as a tumor suppressor that interacts with DNMT1 in nasopharyngeal carcinoma.
hsa-mir-152	non-small cell lung cancer	down	MiR-152 regulates metastases of non-small cell lung cancer cells by targeting neuropilin-1.
hsa-mir-152	non-small cell lung cancer	down	MicroRNA-152 targets ADAM17 to suppress NSCLC progression.
hsa-mir-152	non-small cell lung cancer	down	Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening.
hsa-mir-152	osteosarcoma	down	MicroRNA-152 Suppresses Human Osteosarcoma Cell Proliferation and Invasion by Targeting E2F Transcription Factor 3.
hsa-mir-152	osteosarcoma	down	Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma.
hsa-mir-152	ovarian cancer	down	Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation.
hsa-mir-152	ovarian cancer	down	MicroRNA-152 inhibits ovarian cancer cell proliferation and migration and may infer improved outcomes in ovarian cancer through targeting FOXP1.
hsa-mir-152	pancreatic cancer	down	MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines.
hsa-mir-152	prostate cancer	down	[Circulating miR-152 helps early prediction of postoperative biochemical recurrence of prostate cancer].
hsa-mir-152-3p	glioblastoma	down	Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2 : MiR-152-3p regulate glioma cell apoptosis and invasion.
hsa-mir-152-3p	hepatocellular carcinoma	down	Function of MiR-152 As a Tumor Suppressor in Human Breast Cancer By Targeting PIK3CA.
hsa-mir-152-3p	hepatocellular carcinoma	down	miR-152-3p Modulates hepatic carcinogenesis by targeting cyclin-dependent kinase 8.
hsa-mir-152-3p	malignant melanoma	down	Long non-coding RNA HOTAIR acts as a competing endogenous RNA to promote malignant melanoma progression by sponging miR-152-3p.
hsa-mir-152-3p	prostate cancer	up	A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate Cancer.
hsa-mir-153	bladder cancer	down	MicroRNA-153 Decreases Tryptophan Catabolism and Inhibits Angiogenesis in Bladder Cancer by Targeting Indoleamine 2,3-Dioxygenase 1.
hsa-mir-153	breast cancer	down	MicroRNA-153 inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition in breast cancer via direct targeting of RUNX2.
hsa-mir-153	breast cancer	down	MiR-153 inhibits epithelial-mesenchymal transition by targeting metadherin in human breast cancer.
hsa-mir-153	breast cancer	down	miR-153 inhibits the migration and the tube formation of endothelial cells by blocking the paracrine of angiopoietin 1 in breast cancer cells.
hsa-mir-153	breast cancer	down	Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-?) signaling pathway.
hsa-mir-153	breast cancer	up	MiR-153 promotes breast cancer cell apoptosis by targeting HECTD3.
hsa-mir-153	colon cancer	down	miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy.
hsa-mir-153	esophageal squamous cell carcinoma	down	MicroRNA-153 inhibits tumor progression in esophageal squamous cell carcinoma by targeting SNAI1.
hsa-mir-153	gastric cancer	down	MicroRNA-153 functions as a tumor suppressor in gastric cancer via targeting Kruppel-like factor 5.
hsa-mir-153	gastric cancer	down	MiR-153 regulates metastases of gastric cancer through Snail.
hsa-mir-153	glioblastoma	down	MicroRNA-153 is tumor suppressive in glioblastoma stem cells.
hsa-mir-153	glioblastoma	down	MicroRNA-153 regulates glutamine metabolism in glioblastoma through targeting glutaminase.
hsa-mir-153	glioblastoma	down	MiR-153 as a Tumor Suppressor in Glioblastoma Multiforme is Downregulated by DNA Methylation.
hsa-mir-153	glioma	down	MicroRNA-153 suppresses cell invasion by targeting SNAI1 and predicts patient prognosis in glioma.
hsa-mir-153	hepatocellular carcinoma	up	MicroRNA-153 promotes Wnt/?-catenin activation in hepatocellular carcinoma through suppression of WWOX.
hsa-mir-153	hepatocellular carcinoma	up	MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells.
hsa-mir-153	laryngeal squamous cell carcinoma	down	MicroRNA-153 inhibits the proliferation and invasion of human laryngeal squamous cell carcinoma by targeting KLF5.
hsa-mir-153	laryngeal squamous cell carcinoma	down	MicroRNA-153 suppresses human laryngeal squamous cell carcinoma migration and invasion by targeting the SNAI1 gene.
hsa-mir-153	lung cancer	down	Suppression of AKT expression by miR-153 produced anti-tumor activity in lung cancer.
hsa-mir-153	non-small cell lung cancer	down	MiR-153 inhibits migration and invasion of human non-small-cell lung cancer by targeting ADAM19.
hsa-mir-153	osteosarcoma	down	MicroRNA-153 inhibits osteosarcoma cells proliferation and invasion by targeting TGF-?2.
hsa-mir-153	osteosarcoma	down	Knockdown of Long Noncoding RNA TUG1 Inhibits the Proliferation and Cellular Invasion of Osteosarcoma Cells By Sponging MiR-153.
hsa-mir-153	ovarian cancer	down	MicroRNA-153 functions as a tumor suppressor by targeting SET7 and ZEB2 in ovarian cancer cells.
hsa-mir-153	prostate cancer	up	Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
hsa-mir-153-3p	acute lymphoblastic leukemia	down	miR-153-3p Suppresses Inhibitor of Growth Protein 2 Expression to Function as Tumor Suppressor in Acute Lymphoblastic Leukemia.
hsa-mir-153-3p	glioma	down	MicroRNA-153-3p enhances cell radiosensitivity by targeting BCL2 in human glioma.
hsa-mir-153-3p	malignant melanoma	down	MicroRNA-153-3p suppress cell proliferation and invasion by targeting SNAI1 in melanoma.
hsa-mir-154	breast cancer	down	MicroRNA-154 inhibits growth and invasion of breast cancer cells through targeting E2F5.
hsa-mir-154	breast cancer	down	MicroRNA-154/ADAM9 axis inhibits the proliferation, migration and invasion of breast cancer cells.
hsa-mir-154	colorectal cancer	down	miR-154 suppresses colorectal cancer cell growth and motility by targeting TLR2.
hsa-mir-154	gastric cancer	down	MicroRNA-154 inhibits the growth and metastasis of gastric cancer cells by directly targeting MTDH.
hsa-mir-154	gastric cancer	down	MicroRNA-154 Inhibits the Growth and Invasion of Gastric Cancer Cells by Targeting DIXDC1/WNT Signaling.
hsa-mir-154	glioma	down	Downregulation of miR-154 in human glioma and its clinicopathological and prognostic significance.
hsa-mir-154	hepatocellular carcinoma	down	miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor.
hsa-mir-154	malignant melanoma	down	MiR-154 inhibits cells proliferation and metastasis in melanoma by targeting AURKA and serves as a novel prognostic indicator.
hsa-mir-154	non-small cell lung cancer	down	miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2.
hsa-mir-154	non-small cell lung cancer	down	RETRACTION of articles with plagiarism in common with other publications.
hsa-mir-154	non-small cell lung cancer	down	miR-154 suppresses non-small cell lung cancer growth in vitro and in vivo.
hsa-mir-154	non-small cell lung cancer	down	MicroRNA-154 functions as a tumor suppressor in non-small cell lung cancer through directly targeting B-cell-specific Moloney murine leukemia virus insertion site 1.
hsa-mir-154	non-small cell lung cancer	down	MicroRNA-154 functions as a tumor suppressor and directly targets HMGA2 in human non-small cell lung cancer.
hsa-mir-154	osteosarcoma	down	MicroRNA-154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a.
hsa-mir-154	prostate cancer	down	miR-154 inhibits prostate cancer cell proliferation by targeting CCND2.
hsa-mir-154-5p	breast cancer	down	SNHG5 Promotes Breast Cancer Proliferation by Sponging the miR-154-5p/PCNA Axis.
hsa-mir-154-5p	glioblastoma	down	MiRNA-154-5p inhibits cell proliferation and metastasis by targeting PIWIL1 in glioblastoma.
hsa-mir-154-5p	prostate cancer	down	miRNA-154-5p Inhibits Proliferation, Migration and Invasion by Targeting E2F5 in Prostate Cancer Cell Lines.
hsa-mir-155	acute myeloid leukemia	up	MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report.
hsa-mir-155	acute myeloid leukemia	up	Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia.
hsa-mir-155	acute myeloid leukemia	up	Overexpressed miR-155 is associated with initial presentation and poor outcome in Chinese pediatric acute myeloid leukemia.
hsa-mir-155	acute myeloid leukemia	up	Alleviating the progression of acute myeloid leukemia (AML) by sulforaphane through controlling miR-155 levels.
hsa-mir-155	anaplastic large-cell lymphoma	up	Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation.
hsa-mir-155	bladder cancer	down	Expression of microRNAs in the Urine of Patients With Bladder Cancer.
hsa-mir-155	bladder cancer	up	Correlation of Increased Expression of MicroRNA-155 in Bladder Cancer and Prognosis.
hsa-mir-155	bladder cancer	up	MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1.
hsa-mir-155	bladder cancer	up	MiR-155 affects proliferation and apoptosis of bladder cancer cells by regulating GSK-3?/?-catenin pathway.
hsa-mir-155	breast cancer	up	Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients.
hsa-mir-155	breast cancer	up	A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer.
hsa-mir-155	breast cancer	up	Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.
hsa-mir-155	breast cancer	up	MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer.
hsa-mir-155	breast cancer	up	Clinical significance of blood-based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers.
hsa-mir-155	breast cancer	up	MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene.
hsa-mir-155	breast cancer	up	MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer.
hsa-mir-155	breast cancer	up	[Expression and its clinical significance of miR-155 in human primary breast cancer].
hsa-mir-155	breast cancer	up	Clinical significance of MicoRNA-155 expression in human breast cancer.
hsa-mir-155	breast cancer	up	Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-155	breast cancer	up	17?-Estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells.
hsa-mir-155	breast cancer	up	miR-155 drives telomere fragility in human breast cancer by targeting TRF1.
hsa-mir-155	breast cancer	up	Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females.
hsa-mir-155	breast cancer	up	MiRNA-155 mediates TAM resistance by modulating SOCS6-STAT3 signalling pathway in breast cancer.
hsa-mir-155	breast cancer	up	Matrix Gla protein repression by miR-155 promotes oncogenic signals in breast cancer MCF-7 cells.
hsa-mir-155	cervical cancer	up	MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer.
hsa-mir-155	cervical cancer	up	Mir-155 promotes cervical cancer cell proliferation through suppression of its target gene LKB1.
hsa-mir-155	chronic lymphocytic leukemia	up	Signal Transducer and Activator of Transcription-3 Induces MicroRNA-155 Expression in Chronic Lymphocytic Leukemia.
hsa-mir-155	chronic lymphocytic leukemia	up	MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report.
hsa-mir-155	chronic lymphocytic leukemia	up	LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas.
hsa-mir-155	chronic myelogenous leukemia	down	Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.
hsa-mir-155	chronic myelogenous leukemia	up	microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-mir-155	clear cell renal cell cancer	up	microRNA-155 silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in renal cancer cells.
hsa-mir-155	colon cancer	up	Correlation between expression of miR-155 in colon cancer and serum carcinoembryonic antigen level and its contribution to recurrence and metastasis forecast.
hsa-mir-155	colorectal cancer	up	Upregulation of microRNA-155 promotes the migration and invasion of colorectal cancer cells through the regulation of claudin-1 expression.
hsa-mir-155	colorectal cancer	down	MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1 in vitro.
hsa-mir-155	colorectal cancer	up	Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy.
hsa-mir-155	cutaneous t-cell lymphoma	up	Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma.
hsa-mir-155	cutaneous t-cell lymphoma	up	STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.
hsa-mir-155	diffuse large B-cell lymphoma	up	Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma.
hsa-mir-155	endometrial cancer	up	Angiotensin II type I receptor and miR-155 in endometrial cancers: synergistic antiproliferative effects of anti-miR-155 and losartan on endometrial cancer cells.
hsa-mir-155	esophageal cancer	down	MicroRNA-155 inversely correlates with esophageal cancer progression through regulating tumor-associated macrophage FGF2 expression.
hsa-mir-155	gallbladder carcinoma	up	High expression of microRNA-155 is associated with the aggressive malignant behavior of gallbladder carcinoma.
hsa-mir-155	gastric cancer	down	microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis.
hsa-mir-155	gastric cancer	down	Downregulation of microRNA-155 accelerates cell growth and invasion by targeting c-myc in human gastric carcinoma cells.
hsa-mir-155	gastric cancer	up	MiR-155 promotes gastric cancer growth and invasion by negatively regulating Transforming Growth Factor Beta Receptor 2.
hsa-mir-155	glioma	up	MicroRNA-155 Promotes Glioma Cell Proliferation via the Regulation of MXI1.
hsa-mir-155	glioma	up	Overexpression of microRNA-155 predicts poor prognosis in glioma patients.
hsa-mir-155	glioma	up	MiRNA-155 promotes proliferation by targeting caudal-type homeobox 1 (CDX1) in glioma cells.
hsa-mir-155	hepatocellular carcinoma	up	Crosstalk between liver-related microRNAs and Wnt/?-catenin pathway in hepatocellular carcinoma patients.
hsa-mir-155	hepatocellular carcinoma	up	Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice.
hsa-mir-155	hepatocellular carcinoma	up	[Expression and survival prediction of microRNA-155 in hepatocellular carcinoma after liver transplantation].
hsa-mir-155	hepatocellular carcinoma	up	Clinical significance of microRNA-155 expression in hepatocellular carcinoma.
hsa-mir-155	hepatocellular carcinoma	up	MiR-155 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells through the activation of PI3K/SGK3/?-catenin signaling pathways.
hsa-mir-155	laryngeal squamous cell carcinoma	up	YB-1 promotes laryngeal squamous cell carcinoma progression by inducing miR-155 expression via c-Myb.
hsa-mir-155	laryngeal squamous cell carcinoma	up	The Expression of MicroRNA-155 in Plasma and Tissue Is Matched in Human Laryngeal Squamous Cell Carcinoma.
hsa-mir-155	liver cancer	up	TGF-?1 acts through miR-155 to down-regulate TP53INP1 in promoting epithelial-mesenchymal transition and cancer stem cell phenotypes.
hsa-mir-155	lung adenocarcinoma	up	Potential diagnostic value of miR-155 in serum from lung adenocarcinoma patients.
hsa-mir-155	lung cancer	up	Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells.
hsa-mir-155	lung cancer	up	MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression.
hsa-mir-155	lung cancer	up	Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia.
hsa-mir-155	malignant melanoma	down	Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
hsa-mir-155	malignant melanoma	down	MicroRNA-155 targets the SKI gene in human melanoma cell lines.
hsa-mir-155	malt lymphoma	up	Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication.
hsa-mir-155	mantle cell lymphoma	up	microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-155	nasopharyngeal carcinoma	up	Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A.
hsa-mir-155	nasopharyngeal carcinoma	up	MiR-155 up-regulation by LMP1 DNA contributes to increased nasopharyngeal carcinoma cell proliferation and migration.
hsa-mir-155	nasopharyngeal carcinoma	up	Inhibition of MiR-155 suppresses cell migration in nasopharyngeal carcinoma through targeting ZDHHC2.
hsa-mir-155	non-small cell lung cancer	down	Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-155	non-small cell lung cancer	up	MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN.
hsa-mir-155	non-small cell lung cancer	up	Critical role of miR-155/FoxO1/ROS axis in the regulation of non-small cell lung carcinomas.
hsa-mir-155	oral squamous cell carcinoma	up	Upregulation of a potential prognostic biomarker, miR-155, enhances cell proliferation in patients with oral squamous cell carcinoma.
hsa-mir-155	oral squamous cell carcinoma	up	MicroRNA-155 in oral squamous cell carcinoma: Overexpression, localization, and prognostic potential.
hsa-mir-155	oral squamous cell carcinoma	up	MiR-155 regulates oral squamous cell carcinoma Tca8113 cell proliferation, cycle, and apoptosis via regulating p27Kip1.
hsa-mir-155	ovarian cancer	down	MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.
hsa-mir-155	papillary thyroid carcinoma	up	Upregulated miR-155 in Papillary Thyroid Carcinoma Promotes Tumor Growth by Targeting APC and Activating Wnt/?-Catenin Signaling.
hsa-mir-155	papillary thyroid carcinoma	up	Sevoflurane inhibits the progression of PTC by downregulating miR-155.
hsa-mir-155	prostate cancer	up	A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.
hsa-mir-155	rectal cancer	up	The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer.
hsa-mir-155	rectal cancer	up	Expression of Circulating miR-155, miR-21, miR-221, miR-30a, miR-34a and miR-29a: Comparison of Colonic and Rectal Cancer.
hsa-mir-155	rectal carcinoma	up	The comparison of miR-155 with computed tomography and computed tomography plus serum amyloid A protein in staging rectal cancer.
hsa-mir-155	renal clear cell carcinoma	up	miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
hsa-mir-155	squamous carcinoma	up	Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-155	uveal melanoma	up	MiR-155 Promotes Uveal Melanoma Cell Proliferation and Invasion by Regulating NDFIP1 Expression.
hsa-mir-155	waldenstrom's macroglobulinemia	up	LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas.
hsa-mir-155	waldenstrom's macroglobulinemia	up	MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report.
hsa-mir-155-3p	breast cancer	down	MiR-155-3p acts as a tumor suppressor and reverses paclitaxel resistance via negative regulation of MYD88 in human breast cancer.
hsa-mir-155-3p	hepatocellular carcinoma	up	MicroRNA-155-3p promotes hepatocellular carcinoma formation by suppressing FBXW7 expression.
hsa-mir-155-5p	cervical cancer	up	MiR-155-5p accelerates the metastasis of cervical cancer cell via targeting TP53INP1.
hsa-mir-155-5p	cervical cancer	down	MiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer.
hsa-mir-155-5p	colorectal carcinoma	up	Up-regulated miR-155-5p promotes cell proliferation, invasion and metastasis in colorectal carcinoma.
hsa-mir-155-5p	gastric cancer	down	The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
hsa-mir-155-5p	gastric cancer	down	Decreased miR-155-5p, miR-15a, and miR-186 Expression in Gastric Cancer Is Associated with Advanced Tumor Grade and Metastasis
hsa-mir-155-5p	gastric cancer	down	The tumor suppressor role of miR-155-5p in gastric cancer.
hsa-mir-155-5p	hepatocellular carcinoma	up	MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
hsa-mir-15a	breast cancer	down	MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
hsa-mir-15a	cervical carcinoma	down	MiR-15a and miR-16 induce autophagy and enhance chemosensitivity of Camptothecin.
hsa-mir-15a	chronic lymphocytic leukemia	down	Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.
hsa-mir-15a	chronic lymphocytic leukemia	down	miR-15 and miR-16 induce apoptosis by targeting BCL2.
hsa-mir-15a	chronic lymphocytic leukemia	down	Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
hsa-mir-15a	chronic lymphocytic leukemia	down	Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.
hsa-mir-15a	chronic lymphocytic leukemia	down	Downregulation of miR-15a and miR-16-1 at 13q14 in Chronic Lymphocytic Leukemia.
hsa-mir-15a	colon cancer	down	Overexpression of microRNA-15 increases the chemosensitivity of colon cancer cells to 5-fluorouracil and oxaliplatin by inhibiting the nuclear factor-?B signalling pathway and inducing apoptosis.
hsa-mir-15a	colorectal cancer	down	Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
hsa-mir-15a	colorectal cancer	down	LINC00473 promotes the Taxol resistance via miR-15a in colorectal cancer.
hsa-mir-15a	esophageal cancer	up	Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-15a	gastric cancer	down	Reduction of gastric cancer proliferation and invasion by miR-15a mediated suppression of Bmi-1 translation.
hsa-mir-15a	glioma	up	Identification of microRNAs associated with glioma diagnosis and prognosis.
hsa-mir-15a	hepatocellular carcinoma	down	MiR-15a suppresses hepatocarcinoma cell migration and invasion by directly targeting cMyb.
hsa-mir-15a	lung cancer	down	Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.
hsa-mir-15a	neuroblastoma	up	miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid.
hsa-mir-15a	neuroblastoma	up	MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression.
hsa-mir-15a	non-small cell lung cancer	down	MicroRNA-15a induces cell apoptosis and inhibits metastasis by targeting BCL2L2 in non-small cell lung cancer.
hsa-mir-15a	osteosarcoma	down	MiRNA-15a inhibits proliferation, migration and invasion by targeting TNFAIP1 in human osteosarcoma cells.
hsa-mir-15a	pancreatic cancer	down	Dysregulation of miR-15a and miR-214 in human pancreatic cancer.
hsa-mir-15a	pancreatic cancer	up	Dysregulation of miR-15a and miR-214 in human pancreatic cancer.
hsa-mir-15a	pancreatic ductal adenocarcinoma	down	miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression.
hsa-mir-15a	prostate cancer	down	Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1.
hsa-mir-15a	prostate cancer	down	A microRNA code for prostate cancer metastasis.
hsa-mir-15a	renal cell carcinoma	down	Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
hsa-mir-15a	squamous carcinoma	down	miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.
hsa-mir-15a-3p	cervical cancer	down	Over-expression of miR-15a-3p enhances the radiosensitivity of cervical cancer by targeting tumor protein D52.
hsa-mir-15a-3p	colorectal cancer	up	Oncogenic Role of miR-15a-3p in 13q Amplicon-Driven Colorectal Adenoma-to-Carcinoma Progression.
hsa-mir-15a-3p	gastric cancer	down	miR-15a-3p and miR-16-1-3p Negatively Regulate Twist1 to Repress Gastric Cancer Cell Invasion and Metastasis.
hsa-mir-15a-3p	osteosarcoma	down	Downregulation of microRNA-15a-3p is correlated with clinical outcome and negatively regulates cancer proliferation and migration in human osteosarcoma.
hsa-mir-15a-3p	ovarian cancer	down	MiR-15a-3p suppresses the growth and metastasis of ovarian cancer cell by targeting Twist1.
hsa-mir-15a-3p	prostate cancer	down	miR-15a-3p Suppresses Prostate Cancer Cell Proliferation and Invasion by Targeting SLC39A7 Via Downregulating Wnt/?-Catenin Signaling Pathway.
hsa-mir-15a-5p	chronic myelogenous leukemia	down	MiR-15a-5p negatively regulates cell survival and metastasis by targeting CXCL10 in chronic myeloid leukemia.
hsa-mir-15a-5p	endometrial cancer	down	miR-15a-5p suppresses endometrial cancer cell growth via Wnt/?-catenin signaling pathway by inhibiting WNT3A.
hsa-mir-15a-5p	hepatocellular carcinoma	down	MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.
hsa-mir-15b	cervical carcinoma	up	Increased expression of miR-15b is associated with clinicopathological features and poor prognosis in cervical carcinoma.
hsa-mir-15b	chronic lymphocytic leukemia	down	miR-15 and miR-16 induce apoptosis by targeting BCL2.
hsa-mir-15b	chronic lymphocytic leukemia	down	Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.
hsa-mir-15b	colon cancer	down	Overexpression of microRNA-15 increases the chemosensitivity of colon cancer cells to 5-fluorouracil and oxaliplatin by inhibiting the nuclear factor-?B signalling pathway and inducing apoptosis.
hsa-mir-15b	colorectal cancer	down	Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
hsa-mir-15b	colorectal cancer	up	Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.
hsa-mir-15b	glioblastoma	down	miR-15b Inhibits the Progression of Glioblastoma Cells Through Targeting Insulin-like Growth Factor Receptor 1.
hsa-mir-15b	glioma	down	MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3.
hsa-mir-15b	hepatocellular carcinoma	down	Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression.
hsa-mir-15b	hepatocellular carcinoma	down	LncRNA-H19 activates CDC42/PAK1 pathway to promote cell proliferation, migration and invasion by targeting miR-15b in hepatocellular carcinoma.
hsa-mir-15b	lung cancer	down	Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.
hsa-mir-15b	malignant melanoma	up	MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
hsa-mir-15b	neuroblastoma	up	miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid.
hsa-mir-15b	non-small cell lung cancer	up	MicroRNA-15b promotes proliferation and invasion of non?small cell lung carcinoma cells by directly targeting TIMP2.
hsa-mir-15b	pancreatic cancer	up	miR-15b promotes epithelial-mesenchymal transition by inhibiting SMURF2 in pancreatic cancer.
hsa-mir-15b	prostate cancer	down	A microRNA code for prostate cancer metastasis.
hsa-mir-15b	tongue cancer	down	MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.
hsa-mir-15b-5p	colorectal cancer	down	miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-?B/XIAP axis.
hsa-mir-15b-5p	gastric cancer	up	Overexpression of miR-15b-5p promotes gastric cancer metastasis by regulating PAQR3.
hsa-mir-15b-5p	hepatocellular carcinoma	down	OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and ?-catenin signaling pathways.
hsa-mir-15b-5p	non-small cell lung cancer	up	Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
hsa-mir-15b-5p	osteosarcoma	down	The miR-15b-5p/PDK4 axis regulates osteosarcoma proliferation through modulation of the Warburg effect.
hsa-mir-16	bladder cancer	down	MicroRNA-16 Inhibits Bladder Cancer Proliferation by Targeting Cyclin D1.
hsa-mir-16	brain cancer	up	MicroRNA-target cross-talks: Key players in glioblastoma multiforme.
hsa-mir-16	breast cancer	down	MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression.
hsa-mir-16	breast cancer	down	Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
hsa-mir-16	breast cancer	down	Overexpression of microRNA-16 declines cellular growth, proliferation and induces apoptosis in human breast cancer cells.
hsa-mir-16	cervical carcinoma	down	MiR-15a and miR-16 induce autophagy and enhance chemosensitivity of Camptothecin.
hsa-mir-16	chronic lymphocytic leukemia	down	Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.
hsa-mir-16	chronic myelogenous leukemia	down	ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
hsa-mir-16	colorectal adenocarcinoma	up	Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients.
hsa-mir-16	colorectal cancer	down	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-16	colorectal cancer	down	Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
hsa-mir-16	colorectal cancer	down	microRNA-16 represses colorectal cancer cell growth in vitro by regulating the p53/survivin signaling pathway.
hsa-mir-16	colorectal cancer	down	Prognostic Significance of MicroRNA-16 Expression in Human Colorectal Cancer.
hsa-mir-16	colorectal cancer	down	Deregulation of the miR-16-KRAS axis promotes colorectal cancer.
hsa-mir-16	esophageal squamous cell carcinoma	up	Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
hsa-mir-16	gastric cancer	down	Oncogenic role of long non-coding RNA SNHG12 in gastric cancer cells by targeting miR-16.
hsa-mir-16	glioblastoma	down	Tumor suppressors microRNA-302d and microRNA-16 inhibit human glioblastoma multiforme by targeting NF-?B and FGF2.
hsa-mir-16	glioma	up	Identification of microRNAs associated with glioma diagnosis and prognosis.
hsa-mir-16	glioma	down	MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-?B1/MMP9 signaling pathway.
hsa-mir-16	glioma	down	Up-regulation of microRNA-16 in glioblastoma inhibits the function of endothelial cells and tumor angiogenesis by targeting Bmi-1.
hsa-mir-16	head and neck squamous cell carcinoma	up	Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
hsa-mir-16	hepatocellular carcinoma	down	Circulating microRNAs as biomarkers for hepatocellular carcinoma.
hsa-mir-16	hepatocellular carcinoma	down	Expression of serum miR-16, let-7f, and miR-21 in patients with hepatocellular carcinoma and their clinical significances.
hsa-mir-16	hepatocellular carcinoma	down	Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
hsa-mir-16	hepatocellular carcinoma	down	Inhibition of microRNA-16 facilitates the paclitaxel resistance by targeting IKBKB via NF-?B signaling pathway in hepatocellular carcinoma.
hsa-mir-16	laryngeal carcinoma	up	MicroRNA-16 targets zyxin and promotes cell motility in human laryngeal carcinoma cell line HEp-2.
hsa-mir-16	lung adenocarcinoma	down	Quercetin Decreases Claudin-2 Expression Mediated by Up-Regulation of microRNA miR-16 in Lung Adenocarcinoma A549 Cells.
hsa-mir-16	nasopharyngeal carcinoma	down	miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways.
hsa-mir-16	non-small cell lung cancer	down	miR-16 mimics inhibit TGF-?1-induced epithelial-to-mesenchymal transition via activation of autophagy in non-small cell lung carcinoma cells.
hsa-mir-16	non-small cell lung cancer	down	Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells.
hsa-mir-16	oral cancer	down	Quercetin inhibits cell viability, migration and invasion by regulating miR-16/HOXA10 axis in oral cancer.
hsa-mir-16	oral squamous cell carcinoma	down	Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
hsa-mir-16	oral squamous cell carcinoma	down	Loss of miR-16 contributes to tumor progression by activation of tousled-like kinase 1 in oral squamous cell carcinoma.
hsa-mir-16	oral squamous cell carcinoma	down	MiRNA-16 inhibited oral squamous carcinoma tumor growth in vitro and in vivo via suppressing Wnt/?-catenin signaling pathway.
hsa-mir-16	oral squamous cell carcinoma	down	MicroRNA-16 functions as a tumor-suppressor gene in oral squamous cell carcinoma by targeting AKT3 and BCL2L2.
hsa-mir-16	osteosarcoma	down	MicroRNA-16 suppressed the invasion and migration of osteosarcoma by directly inhibiting RAB23.
hsa-mir-16	osteosarcoma	down	MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.
hsa-mir-16	osteosarcoma	down	miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma.
hsa-mir-16	ovarian cancer	down	MicroRNA-16 inhibits migration and invasion via regulation of the Wnt/?-catenin signaling pathway in ovarian cancer.
hsa-mir-16	pancreatic ductal adenocarcinoma	down	MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors.
hsa-mir-16	papillary thyroid carcinoma	down	Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
hsa-mir-16	prostate cancer	down	A microRNA code for prostate cancer metastasis.
hsa-mir-16	renal cell carcinoma	up	Upregulated microRNA-16 as an oncogene in renal cell carcinoma.
hsa-mir-16	squamous carcinoma	down	miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.
hsa-mir-16-1	chronic lymphocytic leukemia	down	miR-15 and miR-16 induce apoptosis by targeting BCL2.
hsa-mir-16-1	chronic lymphocytic leukemia	down	Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.
hsa-mir-16-1	colon cancer	down	Overexpression of microRNA-15 increases the chemosensitivity of colon cancer cells to 5-fluorouracil and oxaliplatin by inhibiting the nuclear factor-?B signalling pathway and inducing apoptosis.
hsa-mir-16-1	lung cancer	down	Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.
hsa-mir-16-1	neuroblastoma	up	miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid.
hsa-mir-16-1	prostate cancer	down	A microRNA code for prostate cancer metastasis.
hsa-mir-16-1-3p	chronic lymphocytic leukemia	down	Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
hsa-mir-16-1-3p	gastric cancer	down	miR-15a-3p and miR-16-1-3p Negatively Regulate Twist1 to Repress Gastric Cancer Cell Invasion and Metastasis.
hsa-mir-16-2	chronic lymphocytic leukemia	down	miR-15 and miR-16 induce apoptosis by targeting BCL2.
hsa-mir-16-2	chronic lymphocytic leukemia	down	Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.
hsa-mir-16-2	colon cancer	down	Overexpression of microRNA-15 increases the chemosensitivity of colon cancer cells to 5-fluorouracil and oxaliplatin by inhibiting the nuclear factor-?B signalling pathway and inducing apoptosis.
hsa-mir-16-2	lung cancer	down	Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.
hsa-mir-16-2	neuroblastoma	up	miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid.
hsa-mir-16-2	prostate cancer	down	A microRNA code for prostate cancer metastasis.
hsa-mir-16-5p	breast cancer	down	MiR-16-5p inhibits breast cancer by reducing AKT3 to restrain NF-?B pathway.
hsa-mir-16-5p	breast carcinoma	down	MicroRNA-16-5p overexpression suppresses proliferation and invasion as well as triggers apoptosis by targeting VEGFA expression in breast carcinoma.
hsa-mir-16-5p	chordoma	down	miR-16-5p inhibits chordoma cell proliferation, invasion and metastasis by targeting Smad3.
hsa-mir-16-5p	glioma	down	MiR-16-5p is frequently down-regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy.
hsa-mir-16-5p	non-small cell lung cancer	down	Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
hsa-mir-17	acute myeloid leukemia	down	HIF-1? downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation.
hsa-mir-17	b-cell lymphoma	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-17	basal cell carcinoma	up	Expression of microRNAs in basal cell carcinoma.
hsa-mir-17	bladder cancer	up	[Role of lncRNA PTENP1 in tumorigenesis and progression of bladder cancer and the molecular mechanism].
hsa-mir-17	brain cancer	up	MicroRNA-target cross-talks: Key players in glioblastoma multiforme.
hsa-mir-17	breast cancer	up	MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.
hsa-mir-17	breast cancer	up	Expression of circulating miR-17, miR-25, and miR-133 in breast cancer patients.
hsa-mir-17	breast carcinoma	up	MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
hsa-mir-17	cholangiocarcinoma	up	miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
hsa-mir-17	chronic myelogenous leukemia	up	microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-mir-17	chronic myelogenous leukemia	up	miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.
hsa-mir-17	colorectal cancer	up	Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.
hsa-mir-17	colorectal cancer	up	MicroRNA-17 promotes cell proliferation and migration in human colorectal cancer by downregulating SIK1.
hsa-mir-17	colorectal cancer	up	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-17	colorectal cancer	up	MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-17	colorectal carcinoma	up	Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma.
hsa-mir-17	esophageal adenocarcinoma	down	MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotype.
hsa-mir-17	esophageal squamous cell carcinoma	up	TNF-? is a novel target of miR-19a.
hsa-mir-17	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-17	gastric cancer	up	Overexpression of miR-17 in gastric cancer is correlated with proliferation-associated oncogene amplification.
hsa-mir-17	gastric cancer	up	Inhibition of microRNA-17/20a suppresses cell proliferation in gastric cancer by modulating UBE2C expression.
hsa-mir-17	gastric cancer	up	MicroRNA-17 as a promising diagnostic biomarker of gastric cancer: An investigation combining TCGA, GEO, meta-analysis, and bioinformatics.
hsa-mir-17	glioma	down	Decreased MiR-17 in glioma cells increased cell viability and migration by increasing the expression of Cyclin D1, p-Akt and Akt.
hsa-mir-17	glioma	up	Identification and functional characterization of microRNAs involved in the malignant progression of gliomas.
hsa-mir-17	glioma	up	Increased expression of microRNA-17 predicts poor prognosis in human glioma.
hsa-mir-17	hepatocellular carcinoma	up	MiR-17-92 cluster promotes hepatocarcinogenesis.
hsa-mir-17	lung cancer	up	A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
hsa-mir-17	lung cancer	up	Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
hsa-mir-17	lung cancer	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-17	malignant melanoma	up	Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
hsa-mir-17	malignant melanoma	down	MicroRNA-17 inhibits tumor growth by stimulating T-cell mediated host immune response.
hsa-mir-17	mantle cell lymphoma	up	The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
hsa-mir-17	medulloblastoma	up	The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
hsa-mir-17	nasopharyngeal cancer	up	Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma.
hsa-mir-17	nasopharyngeal carcinoma	up	MicroRNA-19a promotes nasopharyngeal carcinoma by targeting transforming growth factor ? receptor 2.
hsa-mir-17	non-small cell lung cancer	down	H19 promotes non-small-cell lung cancer (NSCLC) development through STAT3 signaling via sponging miR-17.
hsa-mir-17	osteosarcoma	up	Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
hsa-mir-17	osteosarcoma	up	The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.
hsa-mir-17	osteosarcoma	up	MicroRNA-17 promotes osteosarcoma cells proliferation and migration and inhibits apoptosis by regulating SASH1 expression.
hsa-mir-17	osteosarcoma	up	Serum microRNA-17 functions as a prognostic biomarker in osteosarcoma.
hsa-mir-17	ovarian cancer	down	miR-17 inhibits ovarian cancer cell peritoneal metastasis by targeting ITGA5 and ITGB1.
hsa-mir-17	prostate cancer	down	MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway.
hsa-mir-17	t-cell lymphoblastic lymphoma	up	Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma.
hsa-mir-17-5p	bladder cancer	up	Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-17-5p	breast cancer	down	Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA.
hsa-mir-17-5p	breast cancer	up	miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1.
hsa-mir-17-5p	breast cancer	down	STAT3 is required for MiR-17-5p-mediated sensitization to chemotherapy-induced apoptosis in breast cancer cells.
hsa-mir-17-5p	cervical cancer	up	MiR-17-5p promotes cervical cancer cell proliferation and metastasis by targeting transforming growth factor-? receptor 2.
hsa-mir-17-5p	cervical cancer	down	MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells.
hsa-mir-17-5p	cervical cancer	down	Long Noncoding RNA HOTAIR: An Oncogene in Human Cervical Cancer Interacting with MicroRNA-17-5p.
hsa-mir-17-5p	colorectal cancer	up	A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
hsa-mir-17-5p	colorectal cancer	up	Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
hsa-mir-17-5p	gastric cancer	up	MicroRNA-17-5p promotes gastric cancer proliferation, migration and invasion by directly targeting early growth response 2.
hsa-mir-17-5p	gastric cancer	up	Circulating microRNAs in plasma of patients with gastric cancers.
hsa-mir-17-5p	gastric cancer	up	Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma.
hsa-mir-17-5p	gastric cancer	up	miR-17-5p promotes proliferation by targeting SOCS6 in gastric cancer cells.
hsa-mir-17-5p	hepatocellular carcinoma	up	miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway.
hsa-mir-17-5p	hepatocellular carcinoma	up	miR-17-5p as a novel prognostic marker for hepatocellular carcinoma.
hsa-mir-17-5p	hepatocellular carcinoma	up	DEAD Box Protein 5 Inhibits Liver Tumorigenesis by Stimulating Autophagy via Interaction with p62/SQSTM1.
hsa-mir-17-5p	malignant melanoma	up	Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
hsa-mir-17-5p	malignant melanoma	up	Regulation of cancer aggressive features in melanoma cells by microRNAs.
hsa-mir-17-5p	nasopharyngeal carcinoma	up	MiR-17-5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21.
hsa-mir-17-5p	non-small cell lung cancer	down	MicroRNA-17-5p inhibits proliferation and triggers apoptosis in non-small cell lung cancer by targeting transforming growth factor ? receptor 2.
hsa-mir-17-5p	non-small cell lung cancer	down	Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-17-5p	non-small cell lung cancer	up	Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients.
hsa-mir-17-5p	osteosarcoma	up	miR-17-5p promotes proliferation and epithelial-mesenchymal transition in human osteosarcoma cells by targeting SRC kinase signaling inhibitor 1.
hsa-mir-17-5p	ovarian cancer	up	MicroRNA-17-5p induces drug resistance and invasion of ovarian carcinoma cells by targeting PTEN signaling.
hsa-mir-17-5p	pancreatic adenocarcinoma	up	MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes.
hsa-mir-17-5p	pancreatic cancer	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-17-5p	pancreatic cancer	up	MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.
hsa-mir-17-5p	pancreatic cancer	up	miR-17-5p Inhibitor Enhances Chemosensitivity to Gemcitabine Via Upregulating Bim Expression in Pancreatic Cancer Cells.
hsa-mir-17-5p	pituitary carcinoma	up	MicroRNA involvement in a metastatic non-functioning pituitary carcinoma.
hsa-mir-181a	acute myeloid leukemia	down	MicroRNA 181a Influences the Expression of HMGB1 and CD4 in Acute Leukemias.
hsa-mir-181a	acute myeloid leukemia	up	[MiR-181a Promotes Proliferation of Human Acute Myeloid Leukemia Cells by Targeting ATM].
hsa-mir-181a	acute promyelocytic leukemia	up	PML/RAR? -regulated miR-181a/b cluster targets the tumor suppressor RASSF1A in Acute Promyelocytic Leukemia.
hsa-mir-181a	breast cancer	up	Transforming growth factor-? regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM.
hsa-mir-181a	breast cancer	down	Decreased serum miR-181a is a potential new tool for breast cancer screening.
hsa-mir-181a	cervical cancer	up	MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
hsa-mir-181a	cervical cancer	down	MiR-181a Inhibits Cervical Cancer Development Via Downregulating GRP78.
hsa-mir-181a	cervical cancer	down	MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells.
hsa-mir-181a	chondrosarcoma	up	The expression of miR-181a-5p and miR-371b-5p in chondrosarcoma.
hsa-mir-181a	chronic lymphocytic leukemia	down	Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
hsa-mir-181a	chronic lymphocytic leukemia	down	miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
hsa-mir-181a	colon cancer	up	miR-181a mediates metabolic shift in colon cancer cells via the PTEN/AKT pathway.
hsa-mir-181a	colon cancer	up	IL-1?/NF-kb signaling promotes colorectal cancer cell growth through miR-181a/PTEN axis.
hsa-mir-181a	colorectal cancer	up	MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1.
hsa-mir-181a	colorectal cancer	up	MicroRNA-181a promotes angiogenesis in colorectal cancer by targeting SRCIN1 to promote the SRC/VEGF signaling pathway.
hsa-mir-181a	gastric cancer	up	MicroRNA-181a Functions as an Oncogene in Gastric Cancer by Targeting Caprin-1.
hsa-mir-181a	gastric cancer	up	MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6.
hsa-mir-181a	gastric cancer	up	Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility.
hsa-mir-181a	gastric cancer	down	MicroRNA-181a Inhibits Tumor Proliferation, Invasiveness, and Metastasis and Is Downregulated in Gastric Cancer.
hsa-mir-181a	glioblastoma	down	The correlation of microRNA-181a and target genes with poor prognosis of glioblastoma patients.
hsa-mir-181a	glioblastoma	down	Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme.
hsa-mir-181a	glioma	down	hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells.
hsa-mir-181a	glioma	up	MiR-181a regulates blood-tumor barrier permeability by targeting Kr?ppel-like factor 6.
hsa-mir-181a	glioma	down	Kaiso (ZBTB33) Downregulation by Mirna-181a Inhibits Cell Proliferation, Invasion, and the Epithelial-Mesenchymal Transition in Glioma Cells.
hsa-mir-181a	glioma	down	Circular RNA hsa_circ_0076248 promotes oncogenesis of glioma by sponging miR-181a to modulate SIRT1 expression.
hsa-mir-181a	hepatocellular carcinoma	up	Polycyclic aromatic hydrocarbon (PAH)-mediated upregulation of hepatic microRNA-181 family promotes cancer cell migration by targeting MAPK phosphatase-5, regulating the activation of p38 MAPK.
hsa-mir-181a	hepatocellular carcinoma	up	Up-regulated MicroRNA-181a induces carcinogenesis in Hepatitis B virus-related hepatocellular carcinoma by targeting E2F5.
hsa-mir-181a	hepatocellular carcinoma	up	Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression.
hsa-mir-181a	laryngeal cancer	down	MYCT1 represses apoptosis of laryngeal cancerous cells through the MAX/miR-181a/NPM1 pathway.
hsa-mir-181a	laryngeal squamous cell carcinoma	down	miR-181a targets GATA6 to inhibit the progression of human laryngeal squamous cell carcinoma.
hsa-mir-181a	malignant melanoma	down	Piceatannol induced apoptosis through up-regulation of microRNA-181a in melanoma cells.
hsa-mir-181a	neuroblastoma	up	MiR-181a/b induce the growth, invasion, and metastasis of neuroblastoma cells through targeting ABI1.
hsa-mir-181a	non-small cell lung cancer	down	MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1.
hsa-mir-181a	oral squamous cell carcinoma	down	miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras.
hsa-mir-181a	osteosarcoma	up	MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.
hsa-mir-181a	osteosarcoma	up	MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell.
hsa-mir-181a	osteosarcoma	up	MicroRNA-181a promotes proliferation and inhibits apoptosis by suppressing CFIm25 in osteosarcoma.
hsa-mir-181a	pancreatic cancer	up	LPS Induced miR-181a Promotes Pancreatic Cancer Cell Migration via Targeting PTEN and MAP2K4.
hsa-mir-181a	prostate cancer	up	MiR-181a promotes epithelial to mesenchymal transition of prostate cancer cells by targeting TGIF2.
hsa-mir-181a	renal clear cell carcinoma	up	Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
hsa-mir-181a	thyroid cancer	up	MiR-181a promotes growth of thyroid cancer cells by targeting tumor suppressor RB1.
hsa-mir-181a-1	glioblastoma	down	MicroRNA-181 inhibits glioblastoma cell growth by directly targeting CCL8.
hsa-mir-181a-1	glioma	down	MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1.
hsa-mir-181a-1	hepatocellular carcinoma	up	Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.
hsa-mir-181a-1	non-small cell lung cancer	down	MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2.
hsa-mir-181a-1	ovarian cancer	down	MicroRNA-181 Functions as an Antioncogene and Mediates NF-?B Pathway by Targeting RTKN2 in Ovarian Cancers.
hsa-mir-181a-1	papillary thyroid carcinoma	up	Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.
hsa-mir-181a-1	prostate cancer	up	microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression.
hsa-mir-181a-2	glioblastoma	down	MicroRNA-181 inhibits glioblastoma cell growth by directly targeting CCL8.
hsa-mir-181a-2	glioma	down	MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1.
hsa-mir-181a-2	hepatocellular carcinoma	up	Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.
hsa-mir-181a-2	non-small cell lung cancer	down	MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2.
hsa-mir-181a-2	ovarian cancer	down	MicroRNA-181 Functions as an Antioncogene and Mediates NF-?B Pathway by Targeting RTKN2 in Ovarian Cancers.
hsa-mir-181a-2	papillary thyroid carcinoma	up	Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.
hsa-mir-181a-2	prostate cancer	up	microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression.
hsa-mir-181a-2*	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-181a-5p	cervical cancer	up	MiR-181a-5p Promotes Proliferation and Invasion, and Inhibits Apoptosis of Cervical Cancer Cells via Regulating Inositol Polyphosphate-5-Phosphatase A (INPP5A).
hsa-mir-181a-5p	cervical cancer	down	Interference of the long noncoding RNA CDKN2B-AS1 upregulates miR-181a-5p/TGF?I axis to restrain the metastasis and promote apoptosis and senescence of cervical cancer cells.
hsa-mir-181a-5p	colorectal cancer	up	A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
hsa-mir-181a-5p	endometrial cancer	down	LncRNA CCAT1 negatively regulates miR-181a-5p to promote endometrial carcinoma cell proliferation and migration.
hsa-mir-181a-5p	gastric cancer	up	Hsa-miR-181a-5p Expression and Effects on Cell Proliferation in Gastric Cancer.
hsa-mir-181a-5p	hepatocellular carcinoma	down	miR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met.
hsa-mir-181a-5p	hepatocellular carcinoma	down	MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-?/Smad pathway in hepatocellular carcinoma.
hsa-mir-181a-5p	non-small cell lung cancer	down	MiR-181a-5p inhibits cell proliferation and migration by targeting Kras in non-small cell lung cancer A549 cells.
hsa-mir-181a-5p	non-small cell lung cancer	down	MicroRNA-181a-5p Impedes IL-17-Induced Nonsmall Cell Lung Cancer Proliferation and Migration through Targeting VCAM-1.
hsa-mir-181b	acute myeloid leukemia	up	Aberrant Expression of the miR-181b/miR-222 after Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia.
hsa-mir-181b	acute promyelocytic leukemia	up	PML/RAR? -regulated miR-181a/b cluster targets the tumor suppressor RASSF1A in Acute Promyelocytic Leukemia.
hsa-mir-181b	breast cancer	up	Transforming growth factor-? regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM.
hsa-mir-181b	breast cancer	up	miR-181b promotes chemoresistance in breast cancer by regulating Bim expression.
hsa-mir-181b	cervical cancer	up	miR-181b promotes cell proliferation and reduces apoptosis by repressing the expression of adenylyl cyclase 9 (AC9) in cervical cancer cells.
hsa-mir-181b	chronic lymphocytic leukemia	down	Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
hsa-mir-181b	chronic lymphocytic leukemia	down	miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
hsa-mir-181b	gastric adenocarcinoma	down	MicroRNA-181b targets cAMP responsive element binding protein 1 in gastric adenocarcinomas.
hsa-mir-181b	gastric cancer	down	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-181b	glioblastoma	down	Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma.
hsa-mir-181b	glioma	down	hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells.
hsa-mir-181b	glioma	down	MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas.
hsa-mir-181b	glioma	down	MiR-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells.
hsa-mir-181b	glioma	down	MicroRNA-181b inhibits cellular proliferation and invasion of glioma cells via targeting Sal-like protein 4.
hsa-mir-181b	glioma	down	lncRNA CCAT1 Promotes Glioma Tumorigenesis by Sponging miR-181b.
hsa-mir-181b	hepatocellular carcinoma	up	Polycyclic aromatic hydrocarbon (PAH)-mediated upregulation of hepatic microRNA-181 family promotes cancer cell migration by targeting MAPK phosphatase-5, regulating the activation of p38 MAPK.
hsa-mir-181b	hepatocellular carcinoma	up	Hepatitis B virus X protein promotes proliferation of hepatocellular carcinoma cells by upregulating miR-181b by targeting ING5.
hsa-mir-181b	lung cancer	down	microRNA-181b suppresses the metastasis of lung cancer cells by targeting sex determining region Y-related high mobility group-box 6 (Sox6).
hsa-mir-181b	neuroblastoma	up	MiR-181a/b induce the growth, invasion, and metastasis of neuroblastoma cells through targeting ABI1.
hsa-mir-181b	non-small cell lung cancer	down	Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
hsa-mir-181b	non-small cell lung cancer	down	MicroRNA-181b is downregulated in non-small cell lung cancer and inhibits cell motility by directly targeting HMGB1.
hsa-mir-181b	oral squamous cell carcinoma	up	Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia.
hsa-mir-181b	osteosarcoma	up	MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.
hsa-mir-181b	osteosarcoma	up	[microRNA-181b promotes migration and invasion of osteosarcoma cells by targeting N-myc downstream regulated gene 2].
hsa-mir-181b	ovarian cancer	up	MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2.
hsa-mir-181b	papillary thyroid carcinoma	up	BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases.
hsa-mir-181b	prostate cancer	up	MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3.
hsa-mir-181b	retinoblastoma	up	Hypoxia-induced miR-181b enhances angiogenesis of retinoblastoma cells by targeting PDCD10 and GATA6.
hsa-mir-181b-1	glioblastoma	down	MicroRNA-181 inhibits glioblastoma cell growth by directly targeting CCL8.
hsa-mir-181b-1	glioma	down	MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1.
hsa-mir-181b-1	hepatocellular carcinoma	up	Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.
hsa-mir-181b-1	non-small cell lung cancer	down	MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2.
hsa-mir-181b-1	ovarian cancer	down	MicroRNA-181 Functions as an Antioncogene and Mediates NF-?B Pathway by Targeting RTKN2 in Ovarian Cancers.
hsa-mir-181b-1	papillary thyroid carcinoma	up	Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.
hsa-mir-181b-1	prostate cancer	up	microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression.
hsa-mir-181b-2	glioblastoma	down	MicroRNA-181 inhibits glioblastoma cell growth by directly targeting CCL8.
hsa-mir-181b-2	glioma	down	MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1.
hsa-mir-181b-2	hepatocellular carcinoma	up	Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.
hsa-mir-181b-2	non-small cell lung cancer	down	MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2.
hsa-mir-181b-2	ovarian cancer	down	MicroRNA-181 Functions as an Antioncogene and Mediates NF-?B Pathway by Targeting RTKN2 in Ovarian Cancers.
hsa-mir-181b-2	papillary thyroid carcinoma	up	Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.
hsa-mir-181b-2	prostate cancer	up	microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression.
hsa-mir-181b-3p	breast cancer	up	miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.
hsa-mir-181b-5p	astrocytoma	down	MiR-181b-5p downregulates NOVA1 to suppress proliferation, migration and invasion and promote apoptosis in astrocytoma.
hsa-mir-181b-5p	squamous carcinoma	up	Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
hsa-mir-181c	basal cell carcinoma	up	Expression of microRNAs in basal cell carcinoma.
hsa-mir-181c	gastric cancer	up	Upregulation of MicroRNA 181c Expression in Gastric Cancer Tissues and Plasma.
hsa-mir-181c	glioblastoma	down	MicroRNA-181 inhibits glioblastoma cell growth by directly targeting CCL8.
hsa-mir-181c	glioblastoma	down	Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines.
hsa-mir-181c	glioblastoma	down	MicroRNA-181c inhibits glioblastoma cell invasion, migration and mesenchymal transition by targeting TGF-? pathway.
hsa-mir-181c	glioma	down	MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1.
hsa-mir-181c	hepatocellular carcinoma	up	Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.
hsa-mir-181c	medulloblastoma	down	Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-181c	neuroblastoma	down	miR-181c expression in neuroblastoma children and proliferation of neuroblastoma M17 cells.
hsa-mir-181c	neuroblastoma	down	MiR-181c modulates the proliferation, migration, and invasion of neuroblastoma cells by targeting Smad7.
hsa-mir-181c	non-small cell lung cancer	down	MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2.
hsa-mir-181c	non-small cell lung cancer	up	miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1.
hsa-mir-181c	osteosarcoma	up	MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.
hsa-mir-181c	ovarian cancer	down	MicroRNA-181 Functions as an Antioncogene and Mediates NF-?B Pathway by Targeting RTKN2 in Ovarian Cancers.
hsa-mir-181c	ovarian cancer	down	MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression.
hsa-mir-181c	pancreatic cancer	up	Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
hsa-mir-181c	papillary thyroid carcinoma	up	Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.
hsa-mir-181c	prostate cancer	up	microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression.
hsa-mir-181c*	basal cell carcinoma	up	Expression of microRNAs in basal cell carcinoma.
hsa-mir-181c-5p	pancreatic cancer	up	Long non-coding RNA GAS5 antagonizes the chemoresistance of pancreatic cancer cells through down-regulation of miR-181c-5p.
hsa-mir-181d	basal cell carcinoma	up	Expression of microRNAs in basal cell carcinoma.
hsa-mir-181d	colorectal cancer	down	PEAK1, acting as a tumor promoter in colorectal cancer, is regulated by the EGFR/KRas signaling axis and miR-181d.
hsa-mir-181d	esophageal squamous cell carcinoma	down	MicroRNA-181d is a tumor suppressor in human esophageal squamous cell carcinoma inversely regulating Derlin-1.
hsa-mir-181d	gastric cancer	up	miRNA and mRNA expression profiles in gastric cancer patients and the relationship with circRNA.
hsa-mir-181d	glioblastoma	down	MicroRNA-181 inhibits glioblastoma cell growth by directly targeting CCL8.
hsa-mir-181d	glioma	down	MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2.
hsa-mir-181d	glioma	down	MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1.
hsa-mir-181d	hepatocellular carcinoma	up	Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.
hsa-mir-181d	hepatocellular carcinoma	up	Polycyclic aromatic hydrocarbon (PAH)-mediated upregulation of hepatic microRNA-181 family promotes cancer cell migration by targeting MAPK phosphatase-5, regulating the activation of p38 MAPK.
hsa-mir-181d	medulloblastoma	down	Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-181d	non-small cell lung cancer	down	MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2.
hsa-mir-181d	ovarian cancer	down	MicroRNA-181 Functions as an Antioncogene and Mediates NF-?B Pathway by Targeting RTKN2 in Ovarian Cancers.
hsa-mir-181d	papillary thyroid carcinoma	up	Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.
hsa-mir-181d	prostate cancer	up	microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression.
hsa-mir-181d-5p	non-small cell lung cancer	down	Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
hsa-mir-182	basal cell carcinoma	up	Expression of microRNAs in basal cell carcinoma.
hsa-mir-182	bladder cancer	up	Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.
hsa-mir-182	breast cancer	up	Up-regulation of miR-182 by ?-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK.
hsa-mir-182	breast cancer	up	Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
hsa-mir-182	breast cancer	up	Higher expression of circulating miR-182 as a novel biomarker for breast cancer.
hsa-mir-182	breast cancer	up	MiR-182 promotes proliferation and invasion and elevates the HIF-1?-VEGF-A axis in breast cancer cells by targeting FBXW7.
hsa-mir-182	breast cancer	up	High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer.
hsa-mir-182	cervical cancer	up	[miR-182 promotes cell proliferation of cervical cancer cells by targeting adenomatous polyposis coli (APC) gene].
hsa-mir-182	colorectal adenocarcinoma	up	Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients.
hsa-mir-182	colorectal cancer	up	Up-regulation of miR-182 expression in colorectal cancer tissues and its prognostic value.
hsa-mir-182	colorectal cancer	up	microRNA-182 targets special AT-rich sequence-binding protein 2 to promote colorectal cancer proliferation and metastasis.
hsa-mir-182	colorectal cancer	up	Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression.
hsa-mir-182	colorectal cancer	up	SATB1 and 2 in colorectal cancer.
hsa-mir-182	colorectal cancer	up	miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer.
hsa-mir-182	colorectal cancer	up	Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancer.
hsa-mir-182	colorectal cancer	up	Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
hsa-mir-182	colorectal cancer	up	miR-182 contributes to cell proliferation, invasion and tumor growth in colorectal cancer by targeting DAB2IP.
hsa-mir-182	colorectal carcinoma	up	Increased expression of miRNA-182 in colorectal carcinoma: an independent and tissue-specific prognostic factor.
hsa-mir-182	endometrial cancer	up	MicroRNA-182 Promotes Tumor Cell Growth by Targeting Transcription Elongation Factor A-like 7 in Endometrial Carcinoma.
hsa-mir-182	gallbladder carcinoma	up	TGF-? upregulates miR-182 expression to promote gallbladder cancer metastasis by targeting CADM1.
hsa-mir-182	gastric adenocarcinoma	down	MicroRNA-182 targets cAMP-responsive element-binding protein?1 and suppresses cell growth in human gastric adenocarcinoma.
hsa-mir-182	gastric cancer	down	MicroRNA-182 inhibits proliferation through targeting oncogenic ANUBL1 in gastric cancer.
hsa-mir-182	glioma	up	The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas.
hsa-mir-182	glioma	up	miR-182 as a prognostic marker for glioma progression and patient survival.
hsa-mir-182	head and neck squamous cell carcinoma	up	Overexpression of TP53 mutation-associated microRNA-182 promotes tumor cell proliferation and migration in head and neck squamous cell carcinoma.
hsa-mir-182	hepatocellular carcinoma	up	MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma.
hsa-mir-182	hepatocellular carcinoma	up	MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma.
hsa-mir-182	hepatocellular carcinoma	up	OncomiR miR-96 and miR-182 promote cell proliferation and invasion through targeting ephrinA5 in hepatocellular carcinoma.
hsa-mir-182	hepatocellular carcinoma	up	Wnt/?-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion.
hsa-mir-182	hepatocellular carcinoma	up	Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
hsa-mir-182	hepatocellular carcinoma	up	Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma.
hsa-mir-182	lung cancer	up	Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia.
hsa-mir-182	lung cancer	up	Downregulation of microRNA-182 inhibits cell growth and invasion by targeting programmed cell death 4 in human lung adenocarcinoma cells.
hsa-mir-182	lung cancer	down	[Methylation Status of miR-182 Promoter in Lung Cancer Cell Lines].
hsa-mir-182	lung cancer	up	MiR-182 enhances radioresistance in non-small cell lung cancer cells by regulating FOXO3.
hsa-mir-182	malignant melanoma	up	Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
hsa-mir-182	malignant melanoma	up	Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor.
hsa-mir-182	malignant mesothelioma	up	miR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in Mesothelioma.
hsa-mir-182	medullary thyroid carcinoma	up	MiR-182 promotes cancer invasion by linking RET oncogene activated NF-?B to loss of the HES1/Notch1 regulatory circuit.
hsa-mir-182	mesenchymal cancer	up	MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes.
hsa-mir-182	non-small cell lung cancer	up	MiR-182 promotes cell proliferation by suppressing FBXW7 and FBXW11 in non-small cell lung cancer.
hsa-mir-182	non-small cell lung cancer	up	Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
hsa-mir-182	non-small cell lung cancer	down	miR-182 suppresses invadopodia formation and metastasis in non-small cell lung cancer by targeting cortactin gene.
hsa-mir-182	osteosarcoma	down	The Downregulation of MiR-182 Is Associated with the Growth and Invasion of Osteosarcoma Cells through the Regulation of TIAM1 Expression.
hsa-mir-182	osteosarcoma	down	MicroRNA-182 downregulates Wnt/?-catenin signaling, inhibits proliferation, and promotes apoptosis in human osteosarcoma cells by targeting HOXA9.
hsa-mir-182	ovarian cancer	up	The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimul
hsa-mir-182	ovarian cancer	up	Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.
hsa-mir-182	ovarian cancer	up	Anti-MiR-182 reduces ovarian cancer burden, invasion and metastasis: An in vivo study in orthotopic xenografts of nude mice.
hsa-mir-182	ovarian carcinoma	up	MicroRNA-182 promotes cell growth, invasion and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas.
hsa-mir-182	pancreatic cancer	up	MicroRNA-182 promotes pancreatic cancer cell proliferation and migration by targeting ?-TrCP2.
hsa-mir-182	papillary thyroid carcinoma	up	miR-182 targets CHL1 and controls tumor growth and invasion in papillary thyroid carcinoma.
hsa-mir-182	prostate cancer	up	Overexpressed microRNA-182 promotes proliferation and invasion in prostate cancer PC-3 cells by down-regulating N-myc downstream regulated gene 1 (NDRG1).
hsa-mir-182	prostate cancer	up	Hypoxia-inducible miR-182 enhances HIF1? signaling via targeting PHD2 and FIH1 in prostate cancer.
hsa-mir-182	prostate cancer	up	MiR-182 promotes prostate cancer progression through activating Wnt/?-catenin signal pathway.
hsa-mir-182	prostate cancer	up	miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells.
hsa-mir-182	renal cell carcinoma	down	MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway.
hsa-mir-182	renal clear cell carcinoma	down	MicroRNA-182 suppresses clear cell renal cell carcinoma migration and invasion by targeting IGF1R.
hsa-mir-182	uveal melanoma	down	Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2.
hsa-mir-182-5p	acute myeloid leukemia	up	MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target.
hsa-mir-182-5p	bladder cancer	up	Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer.
hsa-mir-182-5p	breast cancer	up	Apoptosis-inducing and antiproliferative effect by inhibition of miR-182-5p through the regulation of CASP9 expression in human breast cancer.
hsa-mir-182-5p	hepatocellular carcinoma	up	miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a.
hsa-mir-182-5p	hepatocellular carcinoma	up	LINC01018 confers a novel tumor suppressor role in hepatocellular carcinoma through sponging microRNA-182-5p.
hsa-mir-182-5p	oral squamous cell carcinoma	up	MicroRNA-182-5p Modulates Oral Squamous Cell Carcinoma Migration and Invasion Via Targeting MTSS1 Gene.
hsa-mir-182-5p	oral squamous cell carcinoma	up	miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.
hsa-mir-182-5p	prostate cancer	up	MicroRNA-182-5p Promotes Cell Invasion and Proliferation by Down Regulating FOXF2, RECK and MTSS1 Genes in Human Prostate Cancer.
hsa-mir-182-5p	prostate cancer	up	Androgen receptor regulated microRNA miR-182-5p promotes prostate cancer progression by targeting the ARRDC3/ITGB4 pathway.
hsa-mir-182-5p	renal cell carcinoma	down	Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway.
hsa-mir-1826	breast cancer	down	MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer.
hsa-mir-1826	colorectal cancer	up	Circulating miR-1826 in plasma correlates with circulating tumor cells and is a prognostic marker in colorectal cancer.
hsa-mir-1826	kidney cancer	down	MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.
hsa-mir-1827	colorectal cancer	up	Introduction of hsa-miR-103a and hsa-miR-1827 and hsa-miR-137 as new regulators of Wnt signaling pathway and their relation to colorectal carcinoma.
hsa-mir-1827	colorectal cancer	down	microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
hsa-mir-1827	medulloblastoma	up	Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-183	astrocytoma	up	Up-Regulation of microRNA-183 Promotes Cell Proliferation and Invasion in Glioma By Directly Targeting NEFL.
hsa-mir-183	bladder cancer	up	MicroRNA expression signatures of bladder cancer revealed by deep sequencing.
hsa-mir-183	bladder cancer	up	Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.
hsa-mir-183	bladder cancer	up	MiR-183 maintains canonical Wnt signaling activity and regulates growth and apoptosis in bladder cancer via targeting AXIN2.
hsa-mir-183	breast cancer	down	Dysregulated miR-183 inhibits migration in breast cancer cells.
hsa-mir-183	breast cancer	up	Overexpression of mir-183 and mir-494 promotes proliferation and migration in human breast cancer cell lines.
hsa-mir-183	breast cancer	up	High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer.
hsa-mir-183	cervical cancer	down	MicroRNA-183 functions as the tumor suppressor via inhibiting cellular invasion and metastasis by targeting MMP-9 in cervical cancer.
hsa-mir-183	colon cancer	up	miR-183 functions as an oncogene by targeting ABCA1 in colon cancer.
hsa-mir-183	colorectal cancer	up	miR-183 regulates autophagy and apoptosis in colorectal cancer through targeting of UVRAG.
hsa-mir-183	colorectal cancer	up	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-183	colorectal cancer	up	Overexpression of microRNA-183 in human colorectal cancer and its clinical significance.
hsa-mir-183	colorectal cancer	up	Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
hsa-mir-183	endometrial cancer	up	The effects of microRNA-183 promots cell proliferation and invasion by targeting MMP-9 in endometrial cancer.
hsa-mir-183	esophageal cancer	up	MicroRNA-183 induces epithelial-mesenchymal transition and promotes endometrial cancer cell migration and invasion in by targeting CPEB1.
hsa-mir-183	esophageal cancer	up	miRNA-183 suppresses apoptosis and promotes proliferation in esophageal cancer by targeting PDCD4.
hsa-mir-183	esophageal squamous cell carcinoma	up	MicroRNA-183 promotes proliferation and invasion in oesophageal squamous cell carcinoma by targeting programmed cell death 4.
hsa-mir-183	follicular thyroid carcinoma	up	Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.
hsa-mir-183	gastric cancer	down	MicroRNA-183 inhibits gastric cancer proliferation and invasion via directly targeting Bmi-1.
hsa-mir-183	gastric cancer	down	miR-183 inhibits invasion of gastric cancer by targeting Ezrin.
hsa-mir-183	gastric cancer	up	MicroRNA-183 inhibits apoptosis and promotes proliferation and invasion of gastric cancer cells by targeting PDCD4.
hsa-mir-183	gastric cancer	up	MicroRNA-183 Functions As an Oncogene by Regulating PDCD4 in Gastric Cancer.
hsa-mir-183	gastric cancer	up	miR-183 inhibits autophagy and apoptosis in gastric cancer cells by targeting ultraviolet radiation resistance-associated gene.
hsa-mir-183	glioblastoma	up	Up-Regulation of microRNA-183 Promotes Cell Proliferation and Invasion in Glioma By Directly Targeting NEFL.
hsa-mir-183	glioma	up	Upregulation of miR-183 expression and its clinical significance in human brain glioma.
hsa-mir-183	glioma	up	The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas.
hsa-mir-183	hepatocellular carcinoma	up	miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells.
hsa-mir-183	hepatocellular carcinoma	up	Expression and Significance of MicroRNA-183 in Hepatocellular Carcinoma.
hsa-mir-183	hepatocellular carcinoma	up	Wnt/?-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion.
hsa-mir-183	hepatocellular carcinoma	up	Crosstalk between liver-related microRNAs and Wnt/?-catenin pathway in hepatocellular carcinoma patients.
hsa-mir-183	hepatocellular carcinoma	down	Potential Role of microRNA-183 as a Tumor Suppressor in Hepatocellular Carcinoma.
hsa-mir-183	hepatocellular carcinoma	up	Expression Analysis of Serum microRNA-34a and microRNA-183 in Hepatocellular Carcinoma
hsa-mir-183	hepatocellular carcinoma	up	MiR-21 and miR-183 can simultaneously target SOCS6 and modulate growth and invasion of hepatocellular carcinoma (HCC) cells.
hsa-mir-183	kidney cancer	up	microRNA-183 plays as oncogenes by increasing cell proliferation, migration and invasion via targeting protein phosphatase 2A in renal cancer cells.
hsa-mir-183	malignant mesothelioma	up	miR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in Mesothelioma.
hsa-mir-183	medullary thyroid carcinoma	up	MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets.
hsa-mir-183	nasopharyngeal carcinoma	down	MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma.
hsa-mir-183	nasopharyngeal carcinoma	down	MiR-183 overexpression inhibits tumorigenesis and enhances DDP-induced cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma.
hsa-mir-183	non-small cell lung cancer	up	Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
hsa-mir-183	osteosarcoma	down	MiR-183 inhibits osteosarcoma cell growth and invasion by regulating LRP6-Wnt/?-catenin signaling pathway.
hsa-mir-183	osteosarcoma	down	Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
hsa-mir-183	papillary thyroid carcinoma	up	miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
hsa-mir-183	prostate cancer	up	miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells.
hsa-mir-183	prostate cancer	up	microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer.
hsa-mir-183	renal cell carcinoma	up	High serum miR-183 level is associated with poor responsiveness of renal cancer to natural killer cells.
hsa-mir-183	retinoblastoma	down	MicroRNA-183 suppresses retinoblastoma cell growth, invasion and migration by targeting LRP6.
hsa-mir-183*	cervical cancer	up	Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer.
hsa-mir-183-3p	lung cancer	up	Up-regulation of microRNA-183-3p is a potent prognostic marker for lung adenocarcinoma of female non-smokers.
hsa-mir-183-3p	prostate cancer	down	microRNA-183-3p Inhibits Progression of Human Prostate Cancer by Downregulating High-Mobility Group Nucleosome Binding Domain 5.
hsa-mir-183-5p	adrenal cortical carcinoma	up	MicroRNA expression profiling in adrenal myelolipoma.
hsa-mir-183-5p	breast cancer	up	MiRNA-183-5p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting the PDCD4.
hsa-mir-183-5p	cervical cancer	down	MicroRNA-183-5p Inhibits Aggressiveness of Cervical Cancer Cells by Targeting Integrin Subunit Beta 1 (ITGB1).
hsa-mir-183-5p	colorectal cancer	up	Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
hsa-mir-183-5p	lung cancer	down	miR-183-5p functions as a tumor suppressor in lung cancer through PIK3CA inhibition.
hsa-mir-183-5p	non-small cell lung cancer	up	MiR-183-5p is required for non-small cell lung cancer progression by repressing PTEN.
hsa-mir-184	adrenal cortical carcinoma	up	MicroRNA expression profiling in adrenal myelolipoma.
hsa-mir-184	colorectal cancer	down	MicroRNA-184 inhibits cell proliferation and metastasis in human colorectal cancer by directly targeting IGF-1R.
hsa-mir-184	endometrial cancer	down	Decreased expression of miR-184 restrains the growth and invasion of endometrial carcinoma cells through CDC25A-dependent Notch signaling pathway.
hsa-mir-184	glioblastoma	down	MiR-184 Retarded the Proliferation, Invasiveness and Migration of Glioblastoma Cells by Repressing Stanniocalcin-2.
hsa-mir-184	glioma	down	Identification and functional characterization of microRNAs involved in the malignant progression of gliomas.
hsa-mir-184	glioma	down	MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma.
hsa-mir-184	glioma	up	Expression of microRNA-184 in glioma.
hsa-mir-184	head and neck squamous cell carcinoma	up	Co-targeting of multiple microRNAs on factor-inhibiting hypoxia-inducible factor (FIH) gene for the pathogenesis of head and neck carcinomas.
hsa-mir-184	hepatocellular carcinoma	up	Mir-184 Post-Transcriptionally Regulates SOX7 Expression and Promotes Cell Proliferation in Human Hepatocellular Carcinoma.
hsa-mir-184	hepatocellular carcinoma	up	MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma.
hsa-mir-184	malignant melanoma	down	Regulation of cancer aggressive features in melanoma cells by microRNAs.
hsa-mir-184	nasopharyngeal carcinoma	down	miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2.
hsa-mir-184	neuroblastoma	down	MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2.
hsa-mir-184	neuroblastoma	down	MicroRNA-184-mediated inhibition of tumour growth in an orthotopic murine model of neuroblastoma.
hsa-mir-184	non-small cell lung cancer	down	MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
hsa-mir-184	non-small cell lung cancer	up	Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2.
hsa-mir-184	squamous carcinoma	up	MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma.
hsa-mir-185	bladder cancer	up	Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-185	breast cancer	down	MicroRNA-185 inhibits proliferation by targeting c-Met in human breast cancer cells.
hsa-mir-185	breast cancer	down	MiR-185 is involved in human breast carcinogenesis by targeting Vegfa.
hsa-mir-185	chondrosarcoma	down	Downregulation of miR-185 and upregulation of miR-218 expression may be potential diagnostic and prognostic biomarkers of human chondrosarcoma.
hsa-mir-185	colon cancer	down	miRNA-185 serves as a prognostic factor and suppresses migration and invasion through Wnt1 in colon cancer.
hsa-mir-185	colorectal cancer	down	MicroRNA-185 is a novel tumor suppressor by negatively modulating the Wnt/?-catenin pathway in human colorectal cancer.
hsa-mir-185	esophageal squamous cell carcinoma	down	[Molecular mechanism and effect of microRNA185 on proliferation, migration and invasion of esophageal squamous cell carcinoma].
hsa-mir-185	esophageal squamous cell carcinoma	down	Plasma miR-185 is decreased in esophageal squamous cell carcinoma patients and might suppress tumor migration and invasion by targeting RAGE.
hsa-mir-185	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-185	gastric cancer	down	miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer.
hsa-mir-185	gastric cancer	down	XIST promotes gastric cancer (GC) progression through TGF-?1 via targeting miR-185.
hsa-mir-185	glioma	down	LRRC4 inhibits glioma cell growth and invasion through a miR-185-dependent pathway.
hsa-mir-185	hepatocellular carcinoma	down	miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway.
hsa-mir-185	hepatocellular carcinoma	down	MicroRNA-185 inhibits cell proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Six2.
hsa-mir-185	hepatocellular carcinoma	down	Integrin-?5, a miR-185-targeted gene, promotes hepatocellular carcinoma tumorigenesis by regulating ?-catenin stability.
hsa-mir-185	malignant melanoma	down	Regulation of cancer aggressive features in melanoma cells by microRNAs.
hsa-mir-185	nasopharyngeal carcinoma	down	MicroRNA-185 inhibits cell proliferation while promoting apoptosis and autophagy through negative regulation of TGF-?1/mTOR axis and HOXC6 in nasopharyngeal carcinoma.
hsa-mir-185	non-small cell lung cancer	down	MiR-185 inhibits cell proliferation and invasion of non-small cell lung cancer by targeting KLF7.
hsa-mir-185	non-small cell lung cancer	down	miR-185 acts as a tumor suppressor by targeting AKT1 in non-small cell lung cancer cells.
hsa-mir-185	osteosarcoma	down	MicroRNA-185 inhibits proliferation, migration and invasion in human osteosarcoma MG63 cells by targeting vesicle-associated membrane protein 2.
hsa-mir-185	pancreatic cancer	down	MicroRNA-185 suppresses pancreatic cell proliferation by targeting transcriptional coactivator with PDZ-binding motif in pancreatic cancer.
hsa-mir-185-5p	cutaneous t-cell lymphoma	down	Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.
hsa-mir-185-5p	gastric cancer	up	Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer.
hsa-mir-185-5p	glioma	down	Long noncoding RNA FOXD2-AS1 promotes glioma malignancy and tumorigenesis via targeting miR-185-5p/CCND2 axis.
hsa-mir-185-5p	glioma	down	FoxD2-AS1 promotes glioma progression by regulating miR-185-5P/HMGA2 axis and PI3K/AKT signaling pathway.
hsa-mir-185-5p	hepatocellular carcinoma	down	miR-185-5p targets ROCK2 and inhibits cell migration and invasion of hepatocellular carcinoma.
hsa-mir-185-5p	malignant melanoma	down	Long non-coding RNA UCA1 targets miR-185-5p and regulates cell mobility by affecting epithelial-mesenchymal transition in melanoma via Wnt/?-catenin signaling pathway.
hsa-mir-185-5p	prostate cancer	down	Downregulation of miR-1266-5P, miR-185-5P and miR-30c-2 in prostatic cancer tissue and cell lines.
hsa-mir-185-5p	prostate cancer	down	miR-1266-5p and miR-185-5p Promote Cell Apoptosis in Human Prostate Cancer Cell Lines
hsa-mir-186	bladder cancer	down	MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1.
hsa-mir-186	breast cancer	down	miR-186 inhibits proliferation, migration, and epithelial-mesenchymal transition in breast cancer cells by targeting Twist1.
hsa-mir-186	cervical cancer	down	Long Noncoding RNA ANRIL Promotes Cervical Cancer Development By Acting as a Sponge of miR-186.
hsa-mir-186	cervical cancer	down	Upregulation of kazrin F by miR-186 suppresses apoptosis but promotes epithelial-mesenchymal transition to contribute to malignancy in human cervical cancer cells.
hsa-mir-186	colon carcinoma	down	[Expression of hsa-miR-186 and its role in human colon carcinoma cells].
hsa-mir-186	esophageal squamous cell carcinoma	down	microRNA-186 inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma by targeting SKP2.
hsa-mir-186	gastric cancer	down	MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1? regulation.
hsa-mir-186	gastrointestinal stromal tumor	down	Downregulation of miR-186 is associated with metastatic recurrence of gastrointestinal stromal tumors.
hsa-mir-186	hepatocellular carcinoma	down	miR-186 modulates hepatocellular carcinoma cell proliferation and mobility via targeting MCRS1-mediated Wnt/?-catenin signaling.
hsa-mir-186	lung cancer	down	MicroRNA-186 suppresses lung cancer progression by targeting SIRT6.
hsa-mir-186	lung cancer	down	MicroRNA-186 suppresses cell proliferation and metastasis through targeting MAP3K2 in non-small cell lung cancer.
hsa-mir-186	malignant melanoma	up	miR-186 suppressed CYLD expression and promoted cell proliferation in human melanoma.
hsa-mir-186	multiple myeloma	down	miR-186 inhibits cell proliferation in multiple myeloma by repressing Jagged1.
hsa-mir-186	neuroblastoma	down	Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms.
hsa-mir-186	non-small cell lung cancer	down	MiR-186 inhibits proliferation, migration, and invasion of non-small cell lung cancer cells by downregulating Yin Yang 1.
hsa-mir-186	non-small cell lung cancer	down	miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation.
hsa-mir-186	non-small cell lung cancer	down	MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells.
hsa-mir-186	oral squamous cell carcinoma	down	MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
hsa-mir-186	pancreatic ductal adenocarcinoma	up	miR-186 and 326 Predict the Prognosis of Pancreatic Ductal Adenocarcinoma and Affect the Proliferation and Migration of Cancer Cells.
hsa-mir-186	prostate cancer	down	miR-186 inhibits cell proliferation of prostate cancer by targeting GOLPH3.
hsa-mir-186	prostate cancer	down	miRNA-186 inhibits prostate cancer cell proliferation and tumor growth by targeting YY1 and CDK6.
hsa-mir-186	retinoblastoma	down	Suppression of Disheveled-Axin Domain Containing 1 (DIXDC1) by MicroRNA-186 Inhibits the Proliferation and Invasion of Retinoblastoma Cells.
hsa-mir-186-5p	colon cancer	up	MicroRNA-186-5p overexpression modulates colon cancer growth by repressing the expression of the FAM134B tumour inhibitor.
hsa-mir-186-5p	osteosarcoma	down	miR-186-5p Functions as a Tumor Suppressor in Human Osteosarcoma by Targeting FOXK1.
hsa-mir-187	cervical cancer	down	miR-187 inhibits the growth of cervical cancer cells by targeting FGF9.
hsa-mir-187	colorectal cancer	down	MicroRNA-187, a downstream effector of TGF? pathway, suppresses Smad-mediated epithelial-mesenchymal transition in colorectal cancer.
hsa-mir-187	colorectal cancer	down	MicroRNA-187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer.
hsa-mir-187	gastric cancer	up	MicroRNA-187 regulates gastric cancer progression by targeting the tumor suppressor CRMP1.
hsa-mir-187	gastric cancer	up	MicroRNA-187 promotes growth and metastasis of gastric cancer by inhibiting FOXA2.
hsa-mir-187	gastric cancer	down	Effects of downregulated expression of microRNA-187 in gastric cancer.
hsa-mir-187	hepatocellular carcinoma	down	MicroRNA-187 inhibits tumor growth and metastasis via targeting of IGF-1R in hepatocellular carcinoma.
hsa-mir-187	non-small cell lung cancer	up	MicroRNA-187 modulates epithelial-mesenchymal transition by targeting PTRF in non-small cell lung cancer.
hsa-mir-187	oral squamous cell carcinoma	up	Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.
hsa-mir-187	osteosarcoma	down	miR-187 inhibits tumor growth and invasion by directly targeting MAPK12 in osteosarcoma.
hsa-mir-187	prostate cancer	down	MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer.
hsa-mir-187*	oral squamous cell carcinoma	up	Plasma miR-187* is a potential biomarker for oral carcinoma.
hsa-mir-187-3p	hepatocellular carcinoma	down	MiR-187-3p Enhances Propranolol Sensitivity of Hemangioma Stem Cells.
hsa-mir-187-3p	hepatocellular carcinoma	down	miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4.
hsa-mir-187-5p	non-small cell lung cancer	down	MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
hsa-mir-188	glioma	down	miR-188 Inhibits Glioma Cell Proliferation and Cell Cycle Progression Through Targeting ?-Catenin.
hsa-mir-188	nasopharyngeal carcinoma	down	MicroRNA-188 suppresses G 1 /S transition by targeting multiple cyclin/CDK complexes.
hsa-mir-188	oral squamous cell carcinoma	down	microRNA-188 is downregulated in oral squamous cell carcinoma and inhibits proliferation and invasion by targeting SIX1.
hsa-mir-188-5p	gastric cancer	down	MiR-188-5p suppresses gastric cancer cell proliferation and invasion via targeting ZFP91.
hsa-mir-188-5p	gastric cancer	up	miR-188-5p emerges as an oncomiRNA to promote gastric cancer cell proliferation and migration via upregulation of SALL4.
hsa-mir-188-5p	gastric cancer	up	Aberrantly expressed miR-188-5p promotes gastric cancer metastasis by activating Wnt/?-catenin signaling.
hsa-mir-188-5p	hepatocellular carcinoma	down	MicroRNA-188-5p Suppresses Tumor Cell Proliferation and Metastasis by Directly Targeting FGF5 in Hepatocellular Carcinoma.
hsa-mir-188-5p	prostate cancer	down	miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression.
hsa-mir-18a	b-cell lymphoma	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-18a	basal cell carcinoma	up	Expression of microRNAs in basal cell carcinoma.
hsa-mir-18a	bladder cancer	down	microRNA-18a, a member of the oncogenic miR-17-92 cluster, targets Dicer and suppresses cell proliferation in bladder cancer T24 cells.
hsa-mir-18a	breast cancer	up	MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.
hsa-mir-18a	breast carcinoma	up	MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
hsa-mir-18a	cholangiocarcinoma	up	miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
hsa-mir-18a	chronic myelogenous leukemia	up	microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-mir-18a	chronic myelogenous leukemia	up	miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.
hsa-mir-18a	colon cancer	up	MicroRNA-18a Attenuates DNA Damage Repair through Suppressing the Expression of Ataxia Telangiectasia Mutated in Colorectal Cancer.
hsa-mir-18a	colorectal cancer	up	MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-18a	colorectal cancer	up	microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers.
hsa-mir-18a	colorectal cancer	up	Plasma miR-200c and miR-18a as potential biomarkers for the detection of colorectal carcinoma.
hsa-mir-18a	colorectal cancer	down	miR-18a Inhibits CDC42 and Plays a Tumour Suppressor Role in Colorectal Cancer Cells.
hsa-mir-18a	colorectal cancer	down	[Study on the Effect of Overexpression of miR-18a on Cellular Proliferation and Migration by Targeting ATM in Human Colorectal Cancer Cells].
hsa-mir-18a	esophageal squamous cell carcinoma	up	TNF-? is a novel target of miR-19a.
hsa-mir-18a	esophageal squamous cell carcinoma	up	Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma.
hsa-mir-18a	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-18a	gastric cancer	up	Diagnostic and prognostic value of circulating miR-18a in the plasma of patients with gastric cancer.
hsa-mir-18a	gastric cancer	up	MicroRNA-18a modulates P53 expression by targeting IRF2 in gastric cancer patients.
hsa-mir-18a	glioblastoma	up	MiR-18a regulates the proliferation, migration and invasion of human glioblastoma cell by targeting neogenin.
hsa-mir-18a	glioblastoma	up	The malignancy of miR-18a in human glioblastoma via directly targeting CBX7.
hsa-mir-18a	hepatocellular carcinoma	up	MiR-17-92 cluster promotes hepatocarcinogenesis.
hsa-mir-18a	hepatocellular carcinoma	up	MicroRNA-18a promotes hepatocellular carcinoma proliferation, migration, and invasion by targeting Bcl2L10.
hsa-mir-18a	hepatocellular carcinoma	up	microRNA-18a Promotes Cell Migration and Invasion Through Inhibiting Dicer l Expression in Hepatocellular Carcinoma In Vitro.
hsa-mir-18a	hepatocellular carcinoma	up	MicroRNA-18a promotes proliferation and metastasis in hepatocellular carcinoma via targeting KLF4.
hsa-mir-18a	hepatocellular carcinoma	up	Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
hsa-mir-18a	hepatocellular carcinoma	up	A novel SOCS5/miR-18/miR-25 axis promotes tumorigenesis in liver cancer.
hsa-mir-18a	lung cancer	up	A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
hsa-mir-18a	lung cancer	up	Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
hsa-mir-18a	lung cancer	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-18a	malignant melanoma	up	Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
hsa-mir-18a	malignant melanoma	up	Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
hsa-mir-18a	mantle cell lymphoma	up	The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
hsa-mir-18a	medulloblastoma	up	The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
hsa-mir-18a	nasopharyngeal carcinoma	up	miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
hsa-mir-18a	nasopharyngeal carcinoma	up	MicroRNA-19a promotes nasopharyngeal carcinoma by targeting transforming growth factor ? receptor 2.
hsa-mir-18a	neuroblastoma	up	MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma.
hsa-mir-18a	non-small cell lung cancer	up	Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC.
hsa-mir-18a	osteosarcoma	up	Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
hsa-mir-18a	osteosarcoma	down	MicroRNA-18a inhibits cell growth and induces apoptosis in osteosarcoma by targeting MED27.
hsa-mir-18a	osteosarcoma	up	The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.
hsa-mir-18a	ovarian cancer	down	MicroRNA-18a inhibits ovarian cancer growth via directly targeting TRIAP1 and IPMK.
hsa-mir-18a	pancreatic cancer	up	Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer.
hsa-mir-18a	pancreatic ductal adenocarcinoma	up	Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-18a	prostate cancer	up	MicroRNA-18a is elevated in prostate cancer and promotes tumorigenesis through suppressing STK4 in vitro and in vivo.
hsa-mir-18a-5p	colorectal cancer	up	A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
hsa-mir-18a-5p	glioma	up	Long noncoding RNA GAS5 regulates the proliferation, migration, and invasion of glioma cells by negatively regulating miR-18a-5p.
hsa-mir-18a-5p	lung cancer	up	MicroRNA-18a-5p functions as an oncogene by directly targeting IRF2 in lung cancer.
hsa-mir-18a-5p	nasopharyngeal carcinoma	up	Tumor-educated platelet miR-34c-3p and miR-18a-5p as potential liquid biopsy biomarkers for nasopharyngeal carcinoma diagnosis.
hsa-mir-18a-5p	non-small cell lung cancer	up	MicroRNA-18a-5p functions as an oncogene by directly targeting IRF2 in lung cancer.
hsa-mir-18a-5p	renal cell carcinoma	up	Identification of miR-18a-5p as an oncogene and prognostic biomarker in RCC.
hsa-mir-18b	basal cell carcinoma	up	Expression of microRNAs in basal cell carcinoma.
hsa-mir-18b	breast cancer	up	microRNA-18b is upregulated in breast cancer and modulates genes involved in cell migration.
hsa-mir-18b	colorectal cancer	up	Upregulation of microRNA-18b contributes to the development of colorectal cancer through inhibiting CDKN2B.
hsa-mir-18b	malignant melanoma	down	The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma Progression.
hsa-mir-18b-5p	colorectal cancer	up	A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
hsa-mir-190	breast cancer	down	miR-190 suppresses breast cancer metastasis by regulation of TGF-?-induced epithelial-mesenchymal transition.
hsa-mir-190	gastric cancer	up	MicroRNA-190 regulates FOXP2 genes in human gastric cancer.
hsa-mir-190	hepatocellular carcinoma	up	miR-190 promotes HCC proliferation and metastasis by targeting PHLPP1.
hsa-mir-1908	glioblastoma	up	MicroRNA-1908 functions as a glioblastoma oncogene by suppressing PTEN tumor suppressor pathway.
hsa-mir-1908	glioma	up	miR-1908 as a novel prognosis marker of glioma via promoting malignant phenotype and modulating SPRY4/RAF1 axis.
hsa-mir-1908	non-small cell lung cancer	down	miR-1908 Overexpression Inhibits Proliferation, Changing Akt Activity and p53 Expression in Hypoxic NSCLC Cells.
hsa-mir-1908	osteosarcoma	up	MicroRNA-1908 is upregulated in human osteosarcoma and regulates cell proliferation and migration by repressing PTEN expression.
hsa-mir-190b	hepatocellular carcinoma	up	Up-Regulation of MicroRNA-190b Plays a Role for Decreased IGF-1 That Induces Insulin Resistance in Human Hepatocellular Carcinoma.
hsa-mir-191	breast cancer	up	Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue.
hsa-mir-191	breast cancer	down	Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status.
hsa-mir-191	breast cancer	up	HIF-inducible miR-191 promotes migration in breast cancer through complex regulation of TGF?-signaling in hypoxic microenvironment.
hsa-mir-191	breast cancer	up	P53-miR-191-SOX4 regulatory loop affects apoptosis in breast cancer.
hsa-mir-191	colorectal cancer	down	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-191	colorectal cancer	up	miR-191 promotes tumorigenesis of human colorectal cancer through targeting C/EBP?.
hsa-mir-191	colorectal carcinoma	up	MicroRNA-191 correlates with poor prognosis of colorectal carcinoma and plays multiple roles by targeting tissue inhibitor of metalloprotease 3.
hsa-mir-191	colorectal carcinoma	up	MicroRNA-191 correlates with poor prognosis of colorectal carcinoma and plays multiple roles by targeting tissue inhibitor of metalloprotease 3.
hsa-mir-191	esophageal squamous cell carcinoma	up	Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
hsa-mir-191	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-191	glioblastoma	up	MiRNA-191 functions as an oncogene in primary glioblastoma by directly targeting NDST1.
hsa-mir-191	hepatocellular carcinoma	up	MicroRNA-191 promotes hepatocellular carcinoma cell proliferation by has_circ_0000204/miR-191/KLF6 axis.
hsa-mir-191	hepatocellular carcinoma	up	Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinoma.
hsa-mir-191	intrahepatic cholangiocarcinoma	up	MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma.
hsa-mir-191	non-small cell lung cancer	up	MicroRNA-191 targets CCAAT/enhanced binding protein ? and functions as an oncogenic molecule in human non-small cell lung carcinoma cells.
hsa-mir-191	osteosarcoma	up	MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.
hsa-mir-191	osteosarcoma	up	MicroRNA-191 promotes osteosarcoma cells proliferation by targeting checkpoint kinase 2.
hsa-mir-191	osteosarcoma	up	Increased expression of microRNA-191 as a potential serum biomarker for diagnosis and prognosis in human osteosarcoma.
hsa-mir-191	pancreatic cancer	up	An elevated expression of serum exosomal microRNA-191, -?21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker.
hsa-mir-191	pancreatic cancer	up	MicroRNA-191 promotes pancreatic cancer progression by targeting USP10.
hsa-mir-191	prostate cancer	up	Upregulation of microRNA-191 can serve as an independent prognostic marker for poor survival in prostate cancer.
hsa-mir-191	prostate cancer	up	Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer.
hsa-mir-191-5p	renal cell carcinoma	down	MicroRNA-191-5p exerts a tumor suppressive role in renal cell carcinoma.
hsa-mir-1915-3p	breast cancer	up	Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer.
hsa-mir-192	acute lymphoblastic leukemia	down	Tumor suppressive function of microRNA-192 in acute lymphoblastic leukemia.
hsa-mir-192	acute myeloid leukemia	down	MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2.
hsa-mir-192	bladder cancer	down	Expression of microRNAs in the Urine of Patients With Bladder Cancer.
hsa-mir-192	bladder cancer	down	Regulation of growth of human bladder cancer by miR-192.
hsa-mir-192	chronic lymphocytic leukemia	down	Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia.
hsa-mir-192	colon cancer	down	SRPX2 regulates colon cancer cell metabolism by miR-192/215 via PI3K-Akt.
hsa-mir-192	colon cancer	down	Prognostic significance of miR-215 in colon cancer.
hsa-mir-192	colorectal cancer	down	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-192	colorectal cancer	down	microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer.
hsa-mir-192	epithelial ovarian cancer	down	Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.
hsa-mir-192	esophageal squamous cell carcinoma	up	Mir-192 suppresses apoptosis and promotes proliferation in esophageal aquamous cell caicinoma by targeting Bim.
hsa-mir-192	gastric cancer	up	MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro.
hsa-mir-192	gastric cancer	up	Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer.
hsa-mir-192	gastric cancer	up	MiR-215/192 participates in gastric cancer progression.
hsa-mir-192	hepatocellular carcinoma	down	miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.
hsa-mir-192	hepatocellular carcinoma	down	miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features.
hsa-mir-192	hypopharyngeal cancer	up	NF-?B inhibition reverses acidic bile-induced miR-21, miR-155, miR-192, miR-34a, miR-375 and miR-451a deregulations in human hypopharyngeal cells.
hsa-mir-192	lung cancer	down	MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells.
hsa-mir-192	ovarian carcinoma	up	The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas.
hsa-mir-192	pancreatic ductal adenocarcinoma	up	Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma.
hsa-mir-192	prostate cancer	up	miR-192 Is Overexpressed and Promotes Cell Proliferation in Prostate Cancer.
hsa-mir-192-3p	colon cancer	down	MicroRNA-192-5p is a predictive biomarker of survival for Stage IIIB colon cancer patients.
hsa-mir-192-5p	bladder cancer	down	MiR-192-5p suppresses the growth of bladder cancer cells via targeting Yin Yang 1.
hsa-mir-192-5p	colon cancer	down	MicroRNA-192-5p is a predictive biomarker of survival for Stage IIIB colon cancer patients.
hsa-mir-192-5p	esophageal squamous cell carcinoma	up	A novel serum microRNA signature to screen esophageal squamous cell carcinoma.
hsa-mir-192-5p	osteosarcoma	down	MicroRNA-192-5p suppresses the initiation and progression of osteosarcoma by targeting USP1.
hsa-mir-193a	acute myeloid leukemia	down	A regulatory circuitry between miR-193a/miR-600 and WT1 enhances leukemogenesis in acute myeloid leukemia.
hsa-mir-193a	breast cancer	down	MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1.
hsa-mir-193a	colon cancer	down	MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression.
hsa-mir-193a	colon cancer	down	Clinical and biological significance of miR-193a-3p targeted KRAS in colorectal cancer pathogenesis.
hsa-mir-193a	epithelial ovarian cancer	down	Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.
hsa-mir-193a	non-small cell lung cancer	down	Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.
hsa-mir-193a-3p	breast cancer	down	Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer.
hsa-mir-193a-3p	esophageal squamous cell carcinoma	up	Upregulated miR-193a-3p as an oncogene in esophageal squamous cell carcinoma regulating cellular proliferation, migration and apoptosis.
hsa-mir-193a-3p	lung cancer	down	miR-193a-3p functions as a tumor suppressor in lung cancer by downregulating ERBB4.
hsa-mir-193a-3p	non-small cell lung cancer	down	Expression and clinicopathological significance of miR-193a-3p and its potential target astrocyte elevated gene-1 in non-small lung cancer tissues.
hsa-mir-193a-3p	non-small cell lung cancer	down	miR-193a-3p inhibition of the Slug activator PAK4 suppresses non-small cell lung cancer aggressiveness via the p53/Slug/L1CAM pathway.
hsa-mir-193a-3p	pancreatic ductal adenocarcinoma	down	MiR-193a-3p inhibits pancreatic ductal adenocarcinoma cell proliferation by targeting CCND1.
hsa-mir-193a-3p	prostate cancer	down	MicroRNA-193a-3p inhibits cell proliferation in prostate cancer by targeting cyclin D1.
hsa-mir-193a-3p	renal cell carcinoma	up	Downregulation of miR-193a-3p inhibits cell growth and migration in renal cell carcinoma by targeting PTEN.
hsa-mir-193a-3p	renal cell carcinoma	up	MiR-193a-3p and miR-224 mediate renal cell carcinoma progression by targeting alpha-2,3-sialyltransferase IV and the phosphatidylinositol 3 kinase/Akt pathway.
hsa-mir-193a-3p	renal cell carcinoma	up	A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma.
hsa-mir-193a-5p	colorectal cancer	down	Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
hsa-mir-193a-5p	gastric cancer	down	MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
hsa-mir-193a-5p	glioblastoma	down	MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.
hsa-mir-193a-5p	glioma	down	MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.
hsa-mir-193a-5p	hepatocellular carcinoma	up	Role of miR-193a-5p in the proliferation and apoptosis of hepatocellular carcinoma.
hsa-mir-193b	breast cancer	down	Regulation of RAB22A by mir-193b inhibits breast cancer growth and metastasis mediated by exosomes.
hsa-mir-193b	breast cancer	down	Downregulation of tumor suppressive microRNAs in vivo in dense breast tissue of postmenopausal women.
hsa-mir-193b	breast cancer	down	Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
hsa-mir-193b	breast cancer	cell lines:MDA-MB-231,MCF-7;	Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A.
hsa-mir-193b	breast cancer	cell line:MDA-MB-231,MCF-7;	Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A.
hsa-mir-193b	cervical cancer	up	Methylation and expression of miRNAs in precancerous lesions and cervical cancer with HPV16 infection.
hsa-mir-193b	colon cancer	down	MicroRNA-193b acts as a tumor suppressor in colon cancer progression via targeting RAB22A.
hsa-mir-193b	colorectal cancer	down	miR-193b directly targets STMN1 and inhibits the malignant phenotype in colorectal cancer.
hsa-mir-193b	esophageal cancer	down	MicroRNA-193b acts as a tumor suppressor gene in human esophageal squamous cell carcinoma via target regulation of KRAS.
hsa-mir-193b	gastric cancer	down	MicroRNA-193b inhibits the proliferation, migration and invasion of gastric cancer cells via targeting cyclin D1.
hsa-mir-193b	glioma	up	miR-193b promotes cell proliferation by targeting Smad3 in human glioma.
hsa-mir-193b	hepatocellular carcinoma	down	miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy.
hsa-mir-193b	liver cancer	down	Deregulation of microRNA-193b affects the proliferation of liver cancer via myeloid cell leukemia-1.
hsa-mir-193b	malignant melanoma	up	miR-193b Regulates Mcl-1 in Melanoma.
hsa-mir-193b	malignant melanoma	down	Stathmin 1 is a potential novel oncogene in melanoma.
hsa-mir-193b	non-small cell lung cancer	down	MicroRNA-193b modulates proliferation, migration, and invasion of non-small cell lung cancer cells.
hsa-mir-193b	ovarian cancer	down	Tissue miR-193b as a Novel Biomarker for Patients with Ovarian Cancer.
hsa-mir-193b	primary cns lymphomas	down	Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.
hsa-mir-193b	prostate cancer	down	Methylation-associated miR-193b silencing activates master drivers of aggressive prostate cancer.
hsa-mir-193b-3p	gastric cancer	down	Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer.
hsa-mir-194	bladder cancer	down	MiR-194 inhibits cell proliferation and invasion via repression of RAP2B in bladder cancer.
hsa-mir-194	colorectal cancer	down	Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGF?.
hsa-mir-194	colorectal cancer	down	microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer.
hsa-mir-194	colorectal cancer	down	MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway.
hsa-mir-194	colorectal cancer	down	Overexpression of miR-194 Reverses HMGA2-driven Signatures in Colorectal Cancer.
hsa-mir-194	colorectal cancer	up	MicroRNA-194 modulates epithelial-mesenchymal transition in human colorectal cancer metastasis.
hsa-mir-194	esophageal squamous cell carcinoma	down	miR-194 inhibits proliferation and invasion and promotes apoptosis by targeting KDM5B in esophageal squamous cell carcinoma cells.
hsa-mir-194	gastric cancer	down	miR-194 inhibits gastric cancer cell proliferation and tumorigenesis by targeting KDM5B.
hsa-mir-194	gastric cancer	up	MiRNA-194 activates the Wnt/?-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFU.
hsa-mir-194	gastric cancer	down	Application values of miR-194 and miR-29 in the diagnosis and prognosis of gastric cancer.
hsa-mir-194	gastric cancer	down	MicroRNA-194 Inhibits the Epithelial-Mesenchymal Transition in Gastric Cancer Cells by Targeting FoxM1.
hsa-mir-194	gastric cancer	down	miR-194 targets RBX1 gene to modulate proliferation and migration of gastric cancer cells.
hsa-mir-194	glioma	down	MicroRNA-194 represses glioma cell epithelial?to?mesenchymal transition by targeting Bmi1.
hsa-mir-194	hepatocellular carcinoma	down	NF-?B signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1?.
hsa-mir-194	hepatocellular carcinoma	down	MicroRNA-194 inhibits cell invasion and migration in hepatocellular carcinoma through PRC1-mediated inhibition of Wnt/?-catenin signaling pathway.
hsa-mir-194	hepatocellular carcinoma	down	MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
hsa-mir-194	laryngeal squamous cell carcinoma	down	MiR-194 functions as a tumor suppressor in laryngeal squamous cell carcinoma by targeting Wee1.
hsa-mir-194	liver cancer	down	miR-194 inhibits liver cancer stem cell expansion by regulating RAC1 pathway.
hsa-mir-194	lung cancer	down	miR-194 suppresses metastasis of non-small cell lung cancer through regulating expression of BMP1 and p27(kip1.)
hsa-mir-194	nasopharyngeal carcinoma	down	MiR-194 regulates nasopharyngeal carcinoma progression by modulating MAP3K3 expression.
hsa-mir-194	non-small cell lung cancer	down	miR-194 suppresses high glucose-induced non-small cell lung cancer cell progression by targeting NFAT5.
hsa-mir-194	non-small cell lung cancer	down	MiR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 protein.
hsa-mir-194	osteosarcoma	down	microRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R.
hsa-mir-194	osteosarcoma	down	Knockdown of Long Non-Coding RNA NEAT1 Inhibits Proliferation and Invasion and Induces Apoptosis of Osteosarcoma by Inhibiting miR-194 Expression.
hsa-mir-194	osteosarcoma	down	miR-194 Suppresses Proliferation and Migration and Promotes Apoptosis of Osteosarcoma Cells by Targeting CDH2.
hsa-mir-194	ovarian cancer	up	MicroRNA-194 promotes the growth, migration, and invasion of ovarian carcinoma cells by targeting protein tyrosine phosphatase nonreceptor type 12.
hsa-mir-194	ovarian carcinoma	up	The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas.
hsa-mir-194	pancreatic ductal adenocarcinoma	up	Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma.
hsa-mir-194	prostate cancer	up	MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2.
hsa-mir-194	prostate cancer	down	MicroRNA-194 suppresses prostate cancer migration and invasion by downregulating human nuclear distribution protein.
hsa-mir-194-5p	bladder cancer	down	MiR-194-5p inhibits cell migration and invasion in bladder cancer by targeting E2F3.
hsa-mir-194-5p	bladder cancer	down	Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
hsa-mir-194-5p	breast cancer	down	Knockdown of miR-194-5p inhibits cell proliferation, migration and invasion in breast cancer by regulating the Wnt/?-catenin signaling pathway.
hsa-mir-194-5p	gastric cancer	down	The SOX2OT/miR-194-5p axis regulates cell proliferation and mobility of gastric cancer through suppressing epithelial-mesenchymal transition.
hsa-mir-194-5p	glioma	down	Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122.
hsa-mir-195	adrenal cortical carcinoma	down	miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer.
hsa-mir-195	adrenal cortical carcinoma	down	The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
hsa-mir-195	bladder cancer	down	Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells.
hsa-mir-195	bladder cancer	down	microRNA-195 inhibits cell proliferation in bladder cancer via inhibition of cell division control protein 42 homolog/signal transducer and activator of transcription-3 signaling.
hsa-mir-195	breast cancer	down	MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1.
hsa-mir-195	breast cancer	down	Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer.
hsa-mir-195	breast cancer	down	Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.
hsa-mir-195	breast cancer	down	Serum microRNA-195 is down-regulated in breast cancer: a potential marker for the diagnosis of breast cancer.
hsa-mir-195	breast cancer	down	miR-195 inhibits tumor growth and angiogenesis through modulating IRS1 in breast cancer.
hsa-mir-195	cervical cancer	down	MicroRNA-195 inhibits the behavior of cervical cancer tumors by directly targeting HDGF.
hsa-mir-195	cervical cancer	down	microRNA-195 inhibits the proliferation, migration and invasion of cervical cancer cells via the inhibition of CCND2 and MYB expression.
hsa-mir-195	cervical cancer	down	MiR-195 Suppresses Cervical Cancer Migration and Invasion Through Targeting Smad3.
hsa-mir-195	chronic lymphocytic leukemia	down	miR-15 and miR-16 induce apoptosis by targeting BCL2.
hsa-mir-195	chronic lymphocytic leukemia	down	Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.
hsa-mir-195	colon cancer	down	Overexpression of microRNA-15 increases the chemosensitivity of colon cancer cells to 5-fluorouracil and oxaliplatin by inhibiting the nuclear factor-?B signalling pathway and inducing apoptosis.
hsa-mir-195	colon carcinoma	down	MiR-195 suppresses colon cancer proliferation and metastasis by targeting WNT3A.
hsa-mir-195	colorectal cancer	down	MicroRNA-195 suppresses colorectal cancer cells proliferation via targeting FGF2 and regulating Wnt/?-catenin pathway.
hsa-mir-195	colorectal cancer	down	Tumor suppressive effects of the pleiotropically acting miR-195 in colorectal cancer cells.
hsa-mir-195	colorectal cancer	down	microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells.
hsa-mir-195	colorectal cancer	down	Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
hsa-mir-195	colorectal cancer	down	MicroRNA-195 inhibits colorectal cancer cell proliferation, colony-formation and invasion through targeting CARMA3.
hsa-mir-195	colorectal cancer	down	Expression profiling of selected microRNA signatures in plasma and tissues of Saudi colorectal cancer patients by qPCR.
hsa-mir-195	colorectal cancer	down	Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.
hsa-mir-195	esophageal cancer	down	miR-195 Regulates Proliferation and Apoptosis through Inhibiting the mTOR/p70s6k Signaling Pathway by Targeting HMGA2 in Esophageal Carcinoma Cells.
hsa-mir-195	esophageal squamous cell carcinoma	down	Differential expression of miR-195 in esophageal squamous cell carcinoma and miR-195 expression inhibits tumor cell proliferation and invasion by targeting of Cdc42.
hsa-mir-195	gastric cancer	down	MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer.
hsa-mir-195	gastric cancer	down	MicroRNA-195 inhibits human gastric cancer by directly targeting basic fibroblast growth factor.
hsa-mir-195	glioblastoma	down	MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion.
hsa-mir-195	glioma	down	MicroRNA-195 Inhibits the Proliferation of Human Glioma Cells by Directly Targeting Cyclin D1 and Cyclin E1.
hsa-mir-195	glioma	down	Effects of microRNA-195 on the Prognosis of Glioma Patients and the Proliferation and Apoptosis of Human Glioma Cells.
hsa-mir-195	hepatocellular carcinoma	down	Clinical significance of miR-195 in hepatocellular carcinoma and its biological function in tumor progression.
hsa-mir-195	hepatocellular carcinoma	down	MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2 and CDC42.
hsa-mir-195	hepatocellular carcinoma	down	MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells.
hsa-mir-195	hepatocellular carcinoma	down	microRNA-195 functions as a tumor suppressor by inhibiting CBX4 in hepatocellular carcinoma.
hsa-mir-195	hepatocellular carcinoma	down	MiR-195 suppresses the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by inhibiting YAP.
hsa-mir-195	hepatocellular carcinoma	down	Identification of a TGF-?-miR-195 positive feedback loop in hepatocytes and its deregulation in hepatoma cells.
hsa-mir-195	hepatocellular carcinoma	down	Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
hsa-mir-195	hepatocellular carcinoma	down	miR-195 inhibits cell proliferation via targeting AEG-1 in hepatocellular carcinoma.
hsa-mir-195	hepatocellular carcinoma	down	miR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.
hsa-mir-195	hepatocellular carcinoma	down	Expression of microRNA-195 is transactivated by Sp1 but inhibited by histone deacetylase 3 in hepatocellular carcinoma cells.
hsa-mir-195	hepatocellular carcinoma	down	Long intergenic noncoding RNA SNHG16 interacts with miR-195 to promote proliferation, invasion and tumorigenesis in hepatocellular carcinoma.
hsa-mir-195	laryngeal carcinoma	down	Expression of miR-195 in laryngeal squamous cell carcinoma and its effect on proliferation and apoptosis of Hep-2.
hsa-mir-195	laryngeal squamous cell carcinoma	down	MicroRNA-195 inhibits growth and invasion of laryngeal carcinoma cells by directly targeting DCUN1D1.
hsa-mir-195	lung adenocarcinoma	down	MicroRNA-195 suppresses the progression of lung adenocarcinoma by directly targeting apelin.
hsa-mir-195	lung cancer	down	Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.
hsa-mir-195	lung cancer	down	MiR-195 suppresses non-small cell lung cancer by targeting CHEK1.
hsa-mir-195	neuroblastoma	up	miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid.
hsa-mir-195	non-small cell lung cancer	down	MicroRNA-195 inhibits non-small cell lung cancer cell proliferation, migration and invasion by targeting MYB.
hsa-mir-195	non-small cell lung cancer	down	miR-195 inhibits the growth and metastasis of NSCLC cells by targeting IGF1R.
hsa-mir-195	non-small cell lung cancer	down	MiR-195 suppresses non-small cell lung cancer by targeting CHEK1.
hsa-mir-195	non-small cell lung cancer	down	miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer.
hsa-mir-195	non-small cell lung cancer	down	Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.
hsa-mir-195	osteosarcoma	down	microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN.
hsa-mir-195	osteosarcoma	down	MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1.
hsa-mir-195	pancreatic cancer	down	MicroRNA-195 inhibits the proliferation and invasion of pancreatic cancer cells by targeting the fatty acid synthase/Wnt signaling pathway.
hsa-mir-195	papillary thyroid carcinoma	down	microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.
hsa-mir-195	papillary thyroid carcinoma	down	MiR-195 Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting CCND1 and FGF2.
hsa-mir-195	prostate cancer	down	A microRNA code for prostate cancer metastasis.
hsa-mir-195	prostate cancer	down	miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
hsa-mir-195	prostate cancer	down	miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells.
hsa-mir-195	prostate cancer	down	miR-195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression.
hsa-mir-195	prostate carcinoma	down	MicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma.
hsa-mir-195	renal clear cell carcinoma	down	MicroRNA-195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways.
hsa-mir-195-5p	colorectal cancer	down	miR-195-5p/NOTCH2-mediated EMT modulates IL-4 secretion in colorectal cancer to affect M2-like TAM polarization.
hsa-mir-195-5p	gastric cancer	up	Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer.
hsa-mir-195-5p	hepatocellular carcinoma	down	MicroRNA-195-5p acts as an anti-oncogene by targeting PHF19 in hepatocellular carcinoma.
hsa-mir-195-5p	hepatocellular carcinoma	down	Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
hsa-mir-195-5p	malignant melanoma	down	MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells.
hsa-mir-195-5p	non-small cell lung cancer	down	MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
hsa-mir-195-5p	oral squamous cell carcinoma	down	miR-195-5p Suppresses the Proliferation, Migration, and Invasion of Oral Squamous Cell Carcinoma by Targeting TRIM14.
hsa-mir-195-5p	osteosarcoma	up	Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
hsa-mir-195-5p	osteosarcoma	down	MicroRNA-195-5p suppresses osteosarcoma cell proliferation and invasion by suppressing naked cuticle homolog 1.
hsa-mir-195-5p	ovarian cancer	down	Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3?/?-catenin signaling pathway.
hsa-mir-195-5p	renal cell carcinoma	down	miR-195-5p is critical in REG?-mediated regulation of wnt/?-catenin pathway in renal cell carcinoma.
hsa-mir-196a	breast cancer	up	MicroRNA-196a post-transcriptionally upregulates the UBE2C proto-oncogene and promotes cell proliferation in breast cancer.
hsa-mir-196a	cervical cancer	up	MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27(Kip1.).
hsa-mir-196a	cervical cancer	up	Clinical significance of serum miR-196a in cervical intraepithelial neoplasia and cervical cancer.
hsa-mir-196a	colorectal cancer	down	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-196a	colorectal cancer	up	Upregulation of microRNA-196a and microRNA-196b cooperatively correlate with aggressive progression and unfavorable prognosis in patients with colorectal cancer.
hsa-mir-196a	esophageal adenocarcinoma	up	MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.
hsa-mir-196a	esophageal squamous cell carcinoma	up	Negative regulation of lncRNA GAS5 by miR-196a inhibits esophageal squamous cell carcinoma growth.
hsa-mir-196a	esophageal squamous cell carcinoma	up	MicroRNA-196a as a Potential Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma.
hsa-mir-196a	gastric cancer	up	Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer.
hsa-mir-196a	gastric cancer	up	MiR-196a Is Up-regulated in Gastric cancer and Promotes Cell proliferation by Down-regulating p27kip1.
hsa-mir-196a	gastrointestinal stromal tumor	up	Upregulation of miR-196a and HOTAIR Drive Malignant Character in Gastrointestinal Stromal Tumors.
hsa-mir-196a	glioblastoma	up	MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of I?B? both in vitro and in vivo.
hsa-mir-196a	head and neck squamous cell carcinoma	up	MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance.
hsa-mir-196a	hepatocellular carcinoma	up	HCV core protein-induced upregulation of microRNA-196a promotes aberrant proliferation in hepatocellular carcinoma by targeting FOXO1.
hsa-mir-196a	laryngeal cancer	up	Upregulation of MiR-196a promotes cell proliferation by downregulating p27(kip1) in laryngeal cancer.
hsa-mir-196a	liver cancer	up	Downregulation of microRNA-196a inhibits human liver cancer cell proliferation and invasion by targeting FOXO1.
hsa-mir-196a	lung cancer	up	Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells.
hsa-mir-196a	non-small cell lung cancer	up	Downregulation of microRNA-196a inhibits stem cell self-renewal ability and stemness in non-small-cell lung cancer through upregulating GPX3 expression.
hsa-mir-196a	non-small cell lung cancer	up	MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5.
hsa-mir-196a	ovarian carcinoma	up	Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma.
hsa-mir-196a	pancreatic cancer	up	MiR-196a Promotes Pancreatic Cancer Progression by Targeting Nuclear Factor Kappa-B-Inhibitor Alpha.
hsa-mir-196a	pancreatic ductal adenocarcinoma	up	MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
hsa-mir-196a	squamous carcinoma	up	Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-196a*	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-196a-1	glioblastoma	up	MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.
hsa-mir-196a-1	oral cancer	up	OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway.
hsa-mir-196a-1	oral squamous cell carcinoma	up	miR-196a Overexpression and miR-196a2 Gene Polymorphism Are Prognostic Predictors of Oral Carcinomas.
hsa-mir-196a-2	glioblastoma	up	MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.
hsa-mir-196a-2	oral cancer	up	OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway.
hsa-mir-196a-2	oral squamous cell carcinoma	up	miR-196a Overexpression and miR-196a2 Gene Polymorphism Are Prognostic Predictors of Oral Carcinomas.
hsa-mir-196a-5p	gastric cancer	up	Clinical significance of upregulation of mir-196a-5p in gastric cancer and enriched KEGG pathway analysis of target genes.
hsa-mir-196a-5p	gastric cancer	up	MicroRNA expression profiling provides novel insights into immune-related pathways involved in gastric cancer.
hsa-mir-196a-5p	gastric cancer	up	Differential MicroRNA Expression Between Gastric Cancer Tissue and Non-cancerous Gastric Mucosa According to Helicobacter pylori Status.
hsa-mir-196a-5p	prostate cancer	down	Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes.
hsa-mir-196b	colorectal cancer	up	The diagnostic effect of serum miR-196b as biomarker in colorectal cancer.
hsa-mir-196b	colorectal cancer	up	Upregulation of microRNA-196a and microRNA-196b cooperatively correlate with aggressive progression and unfavorable prognosis in patients with colorectal cancer.
hsa-mir-196b	esophageal cancer	up	Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-196b	gastric cancer	up	Epigenetic regulation of miR-196b expression in gastric cancer.
hsa-mir-196b	gastric cancer	up	Transcriptional regulation of miR-196b by ETS2 in gastric cancer cells.
hsa-mir-196b	gastric cancer	up	Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer.
hsa-mir-196b	glioblastoma	up	Downregulation of miR-196b Promotes Glioma Cell Sensitivity to Temozolomide Chemotherapy and Radiotherapy.
hsa-mir-196b	glioblastoma	up	MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.
hsa-mir-196b	glioblastoma	up	Upregulation of miR-196b confers a poor prognosis in glioblastoma patients via inducing a proliferative phenotype.
hsa-mir-196b	lung cancer	up	miR-196b promotes lung cancer cell migration and invasion through the targeting of GATA6.
hsa-mir-196b	oral cancer	up	OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway.
hsa-mir-196b	oral squamous cell carcinoma	up	miR-196a Overexpression and miR-196a2 Gene Polymorphism Are Prognostic Predictors of Oral Carcinomas.
hsa-mir-196b	oral squamous cell carcinoma	up	Aberrant DNA hypomethylation of miR-196b contributes to migration and invasion of oral cancer.
hsa-mir-196b	pancreatic cancer	up	MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer.
hsa-mir-196b-5p	breast cancer	down	Downregulation of MiR-196b-5p impedes cell proliferation and metastasis in breast cancer through regulating COL1A1.
hsa-mir-196b-5p	colorectal cancer	up	Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway.
hsa-mir-196b-5p	gastric cancer	up	Methylation of the HOXA10 Promoter Directs miR-196b-5p-Dependent Cell Proliferation and Invasion of Gastric Cancer Cells.
hsa-mir-196b-5p	papillary thyroid carcinoma	down	Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.
hsa-mir-197	breast cancer	up	Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females.
hsa-mir-197	cervical cancer	down	miR-197 is downregulated in cervical carcinogenesis and suppresses cell proliferation and invasion through targeting forkhead box M1.
hsa-mir-197	esophageal cancer	down	Implications of microRNA-197 downregulated expression in esophageal cancer with poor prognosis.
hsa-mir-197	follicular thyroid carcinoma	up	A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.
hsa-mir-197	gastric cancer	down	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-197	gastric cancer	down	MicroRNA-197 inhibits gastric cancer progression by directly targeting metadherin.
hsa-mir-197	glioblastoma	down	MicroRNA-197 inhibits cell proliferation by targeting GAB2 in glioblastoma.
hsa-mir-197	hepatocellular carcinoma	down	Anti-miR-197 inhibits migration in HCC cells by targeting KAI 1/CD82.
hsa-mir-197	hepatocellular carcinoma	up	MicroRNA-197 Promotes Metastasis of Hepatocellular Carcinoma by Activating Wnt/?-Catenin Signaling.
hsa-mir-197	hepatocellular carcinoma	down	Reciprocal control of miR-197 and IL-6/STAT3 pathway reveals miR-197 as potential therapeutic target for hepatocellular carcinoma.
hsa-mir-197	lung cancer	up	Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia.
hsa-mir-197	multiple myeloma	down	miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma.
hsa-mir-197	uterine leiomyoma	down	Upregulation of miR-197 inhibits cell proliferation by directly targeting IGFBP5 in human uterine leiomyoma cells.
hsa-mir-197-3p	hepatocellular carcinoma	down	MicroRNA-197-3p acts as a prognostic marker and inhibits cell invasion in hepatocellular carcinoma.
hsa-mir-197-5p	mesenchymal cancer	down	miR-197-5p inhibits sarcomagenesis and induces cellular senescence via repression of KIAA0101.
hsa-mir-1974	adrenal cortical carcinoma	down	The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
hsa-mir-1976	non-small cell lung cancer	down	MicroRNA-1976 functions as a tumor suppressor and serves as a prognostic indicator in non-small cell lung cancer by directly targeting PLCE1.
hsa-mir-198	breast cancer	down	miR-198 functions as a tumor suppressor in breast cancer by targeting CUB domain-containing protein 1.
hsa-mir-198	colorectal cancer	down	MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8.
hsa-mir-198	colorectal cancer	down	MiR-198 affects the proliferation and apoptosis of colorectal cancer through regulation of ADAM28/JAK-STAT signaling pathway.
hsa-mir-198	gastric cancer	down	MicroRNA-198 inhibits proliferation and induces apoptosis by directly suppressing FGFR1 in gastric cancer.
hsa-mir-198	glioblastoma	down	MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT.
hsa-mir-198	glioma	down	Decreased microRNA-198 expression and its prognostic significance in human glioma.
hsa-mir-198	hepatocellular carcinoma	down	Lower expressed miR-198 and its potential targets in hepatocellular carcinoma: a clinicopathological and in silico study.
hsa-mir-198	hepatocellular carcinoma	down	miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway.
hsa-mir-198	lung cancer	down	MicroRNA-198 Inhibits Proliferation and Induces Apoptosis of Lung Cancer Cells Via Targeting FGFR1.
hsa-mir-198	osteosarcoma	down	MicroRNA-198 inhibited tumorous behaviors of human osteosarcoma through directly targeting ROCK1.
hsa-mir-198	pancreatic cancer	down	A Tumorigenic Factor Interactome Connected Through Tumor Suppressor MicroRNA-198 in Human Pancreatic Cancer.
hsa-mir-198	pancreatic ductal adenocarcinoma	up	MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.
hsa-mir-199a	chondrosarcoma	down	CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells.
hsa-mir-199a	colon cancer	down	Downregulation of miR-199a/b-5p is associated with GCNT2 induction upon epithelial-mesenchymal transition in colon cancer.
hsa-mir-199a	colorectal cancer	down	Serum miR-199a as a potential diagnostic biomarker for detection of colorectal cancer.
hsa-mir-199a	gastric cancer	up	miR-199a regulates the tumor suppressor mitogen-activated protein kinase kinase kinase 11 in gastric cancer.
hsa-mir-199a	hepatocellular carcinoma	down	[MicroRNA profiling in patients with hepatocellular carcinoma].
hsa-mir-199a	hepatocellular carcinoma	down	Circulating microRNAs as biomarkers for hepatocellular carcinoma.
hsa-mir-199a	hepatocellular carcinoma	down	Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma.
hsa-mir-199a	hepatocellular carcinoma	down	MiR-199a regulates cell proliferation and survival by targeting FZD7.
hsa-mir-199a	hepatocellular carcinoma	down	Suppression of miR-199a maturation by HuR is?crucial for hypoxia-induced glycolytic switch in?hepatocellular carcinoma.
hsa-mir-199a	kidney cancer	down	Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3?.
hsa-mir-199a	mantle cell lymphoma	down	MiR-199a mediated the dissemination of human mantle cell lymphoma by interacting with the CCR7/CCL21 pair.
hsa-mir-199a	non-small cell lung cancer	down	MiR-199a suppresses the hypoxia-induced proliferation of non-small cell lung cancer cells through targeting HIF1?
hsa-mir-199a	ovarian cancer	down	Roles and Mechanism of miR-199a and miR-125b in Tumor Angiogenesis.
hsa-mir-199a	ovarian cancer	down	Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.
hsa-mir-199a	ovarian cancer	down	Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression.
hsa-mir-199a	primary cns lymphomas	down	Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.
hsa-mir-199a	prostate cancer	down	MiR-199a suppresses prostate cancer paclitaxel resistance by targeting YES1.
hsa-mir-199a	renal cell carcinoma	down	MiR-199a targeting ROCK1 to affect kidney cell proliferation, invasion and apoptosis.
hsa-mir-199a	renal cell carcinoma	down	The putative tumor suppressor, miR-199a, regulated by Snail, modulates clear cell renal cell carcinoma aggressiveness by repressing ROCK1.
hsa-mir-199a-1	acute myeloid leukemia	down	MicroRNA-199 inhibits proliferation and promotes apoptosis in children with acute myeloid leukemia by mediating caspase-3.
hsa-mir-199a-1	hepatocellular carcinoma	down	MicroRNA-199 suppresses cell proliferation, migration and invasion by downregulating RGS17 in hepatocellular carcinoma.
hsa-mir-199a-2	acute myeloid leukemia	down	MicroRNA-199 inhibits proliferation and promotes apoptosis in children with acute myeloid leukemia by mediating caspase-3.
hsa-mir-199a-2	hepatocellular carcinoma	down	MicroRNA-199 suppresses cell proliferation, migration and invasion by downregulating RGS17 in hepatocellular carcinoma.
hsa-mir-199a-3p	clear cell renal cell cancer	up	MiR-199a-3p acts as a tumor suppressor in clear cell renal cell carcinoma.
hsa-mir-199a-3p	esophageal adenocarcinoma	up	MicroRNA 223 is Up-regulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1.
hsa-mir-199a-3p	esophageal cancer	down	MiR-199a-3p decreases esophageal cancer cell proliferation by targeting p21 activated kinase 4.
hsa-mir-199a-3p	gastric cancer	down	MicroRNA-199a-3p is downregulated in gastric carcinomas and modulates cell proliferation.
hsa-mir-199a-3p	gastric cancer	up	MiR-199a-3p promotes gastric cancer progression by targeting ZHX1.
hsa-mir-199a-3p	gastric cancer	up	miR-199a-3p targets ETNK1 to promote invasion and migration in gastric cancer cells and is associated with poor prognosis.
hsa-mir-199a-3p	glioma	down	MicroRNA-199a-3p suppresses glioma cell proliferation by regulating the AKT/mTOR signaling pathway.
hsa-mir-199a-3p	glioma	down	Circulating miR-199a-3p in plasma and its potential diagnostic and prognostic value in glioma.
hsa-mir-199a-3p	hepatocellular carcinoma	down	miR-199a-3p inhibits cell proliferation and induces apoptosis by targeting YAP1, suppressing Jagged1-Notch signaling in human hepatocellular carcinoma.
hsa-mir-199a-3p	hepatocellular carcinoma	down	Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
hsa-mir-199a-3p	kidney cancer	down	miR-199a-3p inhibits hepatocyte growth factor/c-Met signaling in renal cancer carcinoma.
hsa-mir-199a-3p	malignant melanoma	down	Gambogic Acid Inhibits Melanoma through Regulation of miR-199a-3p/ZEB1 Signalling.
hsa-mir-199a-3p	osteosarcoma	down	MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.
hsa-mir-199a-3p	osteosarcoma	down	A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma.
hsa-mir-199a-3p	osteosarcoma	up	Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
hsa-mir-199a-3p	osteosarcoma	down	Polymeric nanoparticle-based delivery of microRNA-199a-3p inhibits proliferation and growth of osteosarcoma cells.
hsa-mir-199a-3p	osteosarcoma	down	CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma.
hsa-mir-199a-3p	papillary thyroid carcinoma	down	miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma.
hsa-mir-199a-3p	renal cell carcinoma	down	miR-199a-3p inhibits hepatocyte growth factor/c-Met signaling in renal cancer carcinoma.
hsa-mir-199a-5p	bladder cancer	down	miR-199a-5p suppresses human bladder cancer cell metastasis by targeting CCR7.
hsa-mir-199a-5p	cervical carcinoma	up	miR-199a-5p promotes proliferation and metastasis and epithelial-mesenchymal transition through targeting PIAS3 in cervical carcinoma.
hsa-mir-199a-5p	colorectal cancer	down	MiR-199a-5p Inhibits the Growth and Metastasis of Colorectal Cancer Cells by Targeting ROCK1.
hsa-mir-199a-5p	colorectal cancer	down	The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
hsa-mir-199a-5p	esophageal adenocarcinoma	up	MicroRNA 223 is Up-regulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1.
hsa-mir-199a-5p	esophageal cancer	down	Overexpression of miR-199a-5p decreases esophageal cancer cell proliferation through repression of mitogen-activated protein kinase kinase kinase-11 (MAP3K11).
hsa-mir-199a-5p	gastric cancer	up	Up-regulated miR-199a-5p in gastric cancer functions as an oncogene and targets klotho.
hsa-mir-199a-5p	glioma	down	microRNA-199a-5p suppresses glioma progression by inhibiting MAGT1.
hsa-mir-199a-5p	hepatocellular carcinoma	down	Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion.
hsa-mir-199a-5p	hepatocellular carcinoma	down	Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.
hsa-mir-199a-5p	hepatocellular carcinoma	down	Increase of miR-199a-5p by protoporphyrin IX, a photocatalyzer, directly inhibits E2F3, sensitizing mesenchymal tumor cells to anti-cancer agents.
hsa-mir-199a-5p	hepatocellular carcinoma	down	Mutual Regulation of MiR-199a-5p and HIF-1? Modulates the Warburg Effect in Hepatocellular Carcinoma.
hsa-mir-199a-5p	hepatocellular carcinoma	down	MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.
hsa-mir-199a-5p	hepatocellular carcinoma	down	MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma.
hsa-mir-199a-5p	malignant melanoma	down	MicroRNA-199a-5p inhibits tumor proliferation in melanoma by mediating HIF-1?.
hsa-mir-199a-5p	non-small cell lung cancer	down	miR-199a-5p and miR-495 target GRP78 within UPR pathway of lung cancer.
hsa-mir-199a-5p	non-small cell lung cancer	down	MiR-199a-5p suppresses non-small cell lung cancer via targeting MAP3K11.
hsa-mir-199a-5p	osteosarcoma	up	MicroRNA-199a-5p promotes tumour growth by dual-targeting PIAS3 and p27 in human osteosarcoma.
hsa-mir-199a-5p	ovarian cancer	down	miRNA-199a-5p suppresses proliferation and invasion by directly targeting NF-?B1 in human ovarian cancer cells.
hsa-mir-199a-5p	papillary thyroid carcinoma	down	miR-199a-5p inhibits the progression of papillary thyroid carcinoma by targeting SNAI1.
hsa-mir-199a-5p	prostate adenocarcinoma	down	Downregulation of miR-199a-5p promotes prostate adeno-carcinoma progression through loss of its inhibition of HIF-1?.
hsa-mir-199b	acute myeloid leukemia	down	MicroRNA-199 inhibits proliferation and promotes apoptosis in children with acute myeloid leukemia by mediating caspase-3.
hsa-mir-199b	acute myeloid leukemia	down	miR-199b, a novel tumor suppressor miRNA in acute myeloid leukemia with prognostic implications.
hsa-mir-199b	choriocarcinoma	down	Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma.
hsa-mir-199b	colorectal cancer	down	Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling.
hsa-mir-199b	follicular thyroid carcinoma	down	Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.
hsa-mir-199b	hepatocellular carcinoma	down	[MicroRNA profiling in patients with hepatocellular carcinoma].
hsa-mir-199b	hepatocellular carcinoma	down	Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1? in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
hsa-mir-199b	hepatocellular carcinoma	down	MicroRNA-199 suppresses cell proliferation, migration and invasion by downregulating RGS17 in hepatocellular carcinoma.
hsa-mir-199b	prostate cancer	down	MiR199b Suppresses Expression of Hypoxia-Inducible Factor 1? (HIF-1?) in Prostate Cancer Cells.
hsa-mir-199b-3p	esophageal adenocarcinoma	up	MicroRNA 223 is Up-regulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1.
hsa-mir-199b-5p	breast cancer	down	MiR-199b-5p targets HER2 in breast cancer cells.
hsa-mir-199b-5p	breast cancer	down	Down-regulation of miR-199b-5p is correlated with poor prognosis for breast cancer patients.
hsa-mir-199b-5p	cervical cancer	up	MiR-199b-5p promotes tumor growth and metastasis in cervical cancer by down-regulating KLK10.
hsa-mir-199b-5p	colon cancer	down	Downregulation of miR-199a/b-5p is associated with GCNT2 induction upon epithelial-mesenchymal transition in colon cancer.
hsa-mir-199b-5p	hepatocellular carcinoma	down	Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.
hsa-mir-199b-5p	hepatocellular carcinoma	down	MicroRNA-199b-5p attenuates TGF-?1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
hsa-mir-199b-5p	medulloblastoma	down	The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma.
hsa-mir-199b-5p	mesenchymal cancer	down	MicroRNA Expression Profiles in Kaposi's Sarcoma.
hsa-mir-199b-5p	osteosarcoma	up	Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma.
hsa-mir-199b-5p	papillary thyroid carcinoma	up	Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma.
hsa-mir-199b-5p	renal cell carcinoma	down	miR-199b-5p serves as a tumor suppressor in renal cell carcinoma.
hsa-mir-19a	acute myeloid leukemia	up	High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
hsa-mir-19a	b-cell lymphoma	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-19a	bladder cancer	up	miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer.
hsa-mir-19a	breast cancer	up	MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.
hsa-mir-19a	breast cancer	up	Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.
hsa-mir-19a	breast carcinoma	up	MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
hsa-mir-19a	cervical cancer	up	MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5.
hsa-mir-19a	cholangiocarcinoma	up	miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
hsa-mir-19a	chronic myelogenous leukemia	up	miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.
hsa-mir-19a	colorectal cancer	up	MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-19a	colorectal cancer	up	Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-? induced epithelial-to-mesenchymal transition in colorectal cancer.
hsa-mir-19a	colorectal cancer	up	Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.
hsa-mir-19a	colorectal cancer	down	Overexpression of miR-19a inhibits colorectal cancer angiogenesis by suppressing KRAS expression.
hsa-mir-19a	colorectal cancer	up	miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1.
hsa-mir-19a	colorectal cancer	up	MiR-19a enhances cell proliferation, migration and invasion through improving lymphangiogenesis via targeting thrombospondin-1 in colorectal cancer.
hsa-mir-19a	esophageal squamous cell carcinoma	up	TNF-? is a novel target of miR-19a.
hsa-mir-19a	esophageal squamous cell carcinoma	up	Plasma microRNA-19a as a potential biomarker for esophageal squamous cell carcinoma diagnosis and prognosis.
hsa-mir-19a	gastric cancer	up	MicroRNA-19a regulates the proliferation, migration and invasion of human gastric cancer cells by targeting CUL5.
hsa-mir-19a	gastric cancer	up	Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.
hsa-mir-19a	gastric cancer	up	MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN.
hsa-mir-19a	gastric cancer	up	miR-19a Promotes Cell Growth and Tumorigenesis through Targeting SOCS1 in Gastric Cancer.
hsa-mir-19a	gastric cancer	up	MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1.
hsa-mir-19a	gastric cancer	up	MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
hsa-mir-19a	gastric cancer	up	MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
hsa-mir-19a	glioma	up	miR-19a and miR-19b Overexpression in Gliomas.
hsa-mir-19a	glioma	up	MicroRNA-19a promotes glioma cell growth by repressing LRIG1.
hsa-mir-19a	glioma	up	Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-19a	hepatocellular carcinoma	up	Pterostilbene increases PTEN expression through the targeted downregulation of microRNA-19a in hepatocellular carcinoma.
hsa-mir-19a	hepatocellular carcinoma	up	MiR-17-92 cluster promotes hepatocarcinogenesis.
hsa-mir-19a	laryngeal squamous cell carcinoma	up	MiR-19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP-2 expression.
hsa-mir-19a	lung cancer	up	A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
hsa-mir-19a	lung cancer	up	Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
hsa-mir-19a	lung cancer	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-19a	mantle cell lymphoma	up	The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
hsa-mir-19a	medulloblastoma	up	The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
hsa-mir-19a	multiple myeloma	up	MicroRNA-19a functions as an oncogene by regulating PTEN/AKT/pAKT pathway in myeloma.
hsa-mir-19a	nasopharyngeal carcinoma	up	MicroRNA-19a promotes nasopharyngeal carcinoma by targeting transforming growth factor ? receptor 2.
hsa-mir-19a	neuroblastoma	up	MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma.
hsa-mir-19a	non-small cell lung cancer	up	Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer.
hsa-mir-19a	non-small cell lung cancer	up	MicroRNA-19a promotes proliferative and migratory abilities of NSCLC cells by inhibiting PTEN expression.
hsa-mir-19a	non-small cell lung cancer	up	miRNA-19 promotes non-small-cell lung cancer cell proliferation via inhibiting CBX7 expression.
hsa-mir-19a	osteosarcoma	up	The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.
hsa-mir-19a	osteosarcoma	up	Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
hsa-mir-19a	osteosarcoma	up	MiR-19a regulates the cell growth and apoptosis of osteosarcoma stem cells by targeting PTEN.
hsa-mir-19a	osteosarcoma	up	miR-19 promotes osteosarcoma progression by targeting SOCS6.
hsa-mir-19a	osteosarcoma	up	MicroRNA-19 contributes to the malignant phenotypes of osteosarcoma in vitro by targeting Pax6.
hsa-mir-19a	ovarian cancer	up	MiR-19a negatively regulated the expression of PTEN and promoted the growth of ovarian cancer cells.
hsa-mir-19a	t-cell lymphoblastic lymphoma	up	Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma.
hsa-mir-19a-3p	breast cancer	down	MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene.
hsa-mir-19a-3p	colorectal cancer	up	A panel of microRNA signature in serum for colorectal cancer diagnosis.
hsa-mir-19a-3p	hepatocellular carcinoma	up	microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma.
hsa-mir-19a-3p	multiple myeloma	up	MicroRNA-19a functions as an oncogene by regulating PTEN/AKT/pAKT pathway in myeloma.
hsa-mir-19b	acute myeloid leukemia	up	High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
hsa-mir-19b	b-cell lymphoma	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-19b	basal cell carcinoma	up	Expression of microRNAs in basal cell carcinoma.
hsa-mir-19b	breast cancer	up	Over-expression of long non-coding RNA PTENP1 inhibits cell proliferation and migration via suppression of miR-19b in breast cancer cells.
hsa-mir-19b	breast cancer	up	MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.
hsa-mir-19b	breast cancer	up	MiR-19b suppresses PTPRG to promote breast tumorigenesis.
hsa-mir-19b	breast cancer	up	miR-19b promotes breast cancer metastasis through targeting MYLIP and its related cell adhesion molecules.
hsa-mir-19b	breast carcinoma	up	MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
hsa-mir-19b	cervical cancer	up	MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5.
hsa-mir-19b	cholangiocarcinoma	up	miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
hsa-mir-19b	chronic myelogenous leukemia	up	miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.
hsa-mir-19b	colorectal cancer	up	MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-19b	esophageal squamous cell carcinoma	up	TNF-? is a novel target of miR-19a.
hsa-mir-19b	gastric cancer	up	MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN.
hsa-mir-19b	gastric cancer	up	MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1.
hsa-mir-19b	glioma	up	miR-19a and miR-19b Overexpression in Gliomas.
hsa-mir-19b	glioma	up	Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-19b	hepatocellular carcinoma	up	MiR-17-92 cluster promotes hepatocarcinogenesis.
hsa-mir-19b	hepatocellular carcinoma	up	Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease.
hsa-mir-19b	lung cancer	up	A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
hsa-mir-19b	lung cancer	up	Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
hsa-mir-19b	lung cancer	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-19b	mantle cell lymphoma	up	The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
hsa-mir-19b	medulloblastoma	up	The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
hsa-mir-19b	multiple myeloma	up	Differential Expression of MicroRNA-19b Promotes Proliferation of Cancer Stem Cells by Regulating the TSC1/mTOR Signaling Pathway in Multiple Myeloma.
hsa-mir-19b	nasopharyngeal carcinoma	down	MicroRNA-19b Promotes Nasopharyngeal Carcinoma More Sensitive to Cisplatin by Suppressing KRAS.
hsa-mir-19b	osteosarcoma	up	The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.
hsa-mir-19b	osteosarcoma	up	Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
hsa-mir-19b-1	gastric cancer	up	Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.
hsa-mir-19b-1	non-small cell lung cancer	up	miRNA-19 promotes non-small-cell lung cancer cell proliferation via inhibiting CBX7 expression.
hsa-mir-19b-1	osteosarcoma	up	MicroRNA-19 contributes to the malignant phenotypes of osteosarcoma in vitro by targeting Pax6.
hsa-mir-19b-1	osteosarcoma	up	miR-19 promotes osteosarcoma progression by targeting SOCS6.
hsa-mir-19b-1	t-cell lymphoblastic lymphoma	up	Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma.
hsa-mir-19b-1*	basal cell carcinoma	up	Expression of microRNAs in basal cell carcinoma.
hsa-mir-19b-2	gastric cancer	up	Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.
hsa-mir-19b-2	non-small cell lung cancer	up	miRNA-19 promotes non-small-cell lung cancer cell proliferation via inhibiting CBX7 expression.
hsa-mir-19b-2	osteosarcoma	up	MicroRNA-19 contributes to the malignant phenotypes of osteosarcoma in vitro by targeting Pax6.
hsa-mir-19b-2	osteosarcoma	up	miR-19 promotes osteosarcoma progression by targeting SOCS6.
hsa-mir-19b-2	t-cell lymphoblastic lymphoma	up	Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma.
hsa-mir-19b-3p	breast cancer	down	miR-19b-3p inhibits breast cancer cell proliferation and reverses saracatinib-resistance by regulating PI3K/Akt pathway.
hsa-mir-19b-3p	colon cancer	up	miR-19b-3p promotes colon cancer proliferation and oxaliplatin-based chemoresistance by targeting SMAD4: validation by bioinformatics and experimental analyses.
hsa-mir-19b-3p	lung cancer	up	miR-19 in blood plasma reflects lung cancer occurrence but is not specifically associated with radon exposure.
hsa-mir-19b-3p	malignant melanoma	up	Matrine exerts inhibitory effects in melanoma through the regulation of miR-19b-3p/PTEN.
hsa-mir-19b-3p	nasopharyngeal carcinoma	up	MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-?B axis.
hsa-mir-19b-3p	pancreatic cancer	up	miR-19b-3p promotes human pancreatic cancer Capan-2 cells proliferation by targeting phosphatase and tension homolog.
hsa-mir-200a	bladder cancer	down	Expression of microRNAs in the Urine of Patients With Bladder Cancer.
hsa-mir-200a	breast cancer	up	Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.
hsa-mir-200a	breast cancer	up	MicroRNA-200a Promotes Anoikis Resistance and Metastasis by Targeting YAP1 in Human Breast Cancer.
hsa-mir-200a	breast cancer	down	microRNA-200a Inhibits Cell Proliferation by Targeting Mitochondrial Transcription Factor A in Breast Cancer.
hsa-mir-200a	breast cancer	down	A TP73-AS1/miR-200a/ZEB1 regulating loop promotes breast cancer cell invasion and migration.
hsa-mir-200a	breast cancer	up	MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer.
hsa-mir-200a	colorectal cancer	down	MiR-200 suppresses metastases of colorectal cancer through ZEB1.
hsa-mir-200a	endometrial cancer	up	MiR-200a promotes epithelial-mesenchymal transition of endometrial cancer cells by negatively regulating FOXA2 expression.
hsa-mir-200a	esophageal adenocarcinoma	up	Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.
hsa-mir-200a	esophageal cancer	up	Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-200a	esophageal cancer	up	miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas.
hsa-mir-200a	gastric adenocarcinoma	down	Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/?-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
hsa-mir-200a	gastric adenocarcinoma	down	Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.
hsa-mir-200a	glioma	down	MiR-200a impairs glioma cell growth, migration, and invasion by targeting SIM2-s.
hsa-mir-200a	glioma	down	microRNA-200a functions as a tumor suppressor by targeting FOXA1 in glioma.
hsa-mir-200a	hepatocellular carcinoma	down	MiR-200a inhibits cell proliferation and EMT by down-regulating the ASPH expression levels and affecting ERK and PI3K/Akt pathways in human hepatoma cells.
hsa-mir-200a	hepatocellular carcinoma	down	MicroRNA-200a Suppresses Cell Invasion and Migration by Directly Targeting GAB1 in Hepatocellular Carcinoma.
hsa-mir-200a	hepatocellular carcinoma	down	MicroRNA-200a inhibits cell growth and metastasis by targeting Foxa2 in hepatocellular carcinoma.
hsa-mir-200a	hepatocellular carcinoma	down	The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma.
hsa-mir-200a	hepatocellular carcinoma	down	The microRNA-200 family-A potential diagnostic marker in hepatocellular carcinoma?
hsa-mir-200a	hepatocellular carcinoma	down	miR-200a suppresses cell growth and migration by targeting MACC1 and predicts prognosis in hepatocellular carcinoma.
hsa-mir-200a	hepatocellular carcinoma	down	MicroRNA-200a suppresses metastatic potential of side population cells in human hepatocellular carcinoma by decreasing ZEB2.
hsa-mir-200a	hepatocellular carcinoma	down	MicroRNA-200a inhibits epithelial-mesenchymal transition in human hepatocellular carcinoma cell line.
hsa-mir-200a	lung adenocarcinoma	down	miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.
hsa-mir-200a	lung cancer	up	MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.
hsa-mir-200a	malignant melanoma	up	MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion.
hsa-mir-200a	malignant melanoma	down	MiR-200a Regulates CDK4/6 Inhibitor Effect by Targeting CDK6 in Metastatic Melanoma.
hsa-mir-200a	meningioma	down	Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway.
hsa-mir-200a	mesenchymal cancer	down	MicroRNA Expression Profiles in Kaposi's Sarcoma.
hsa-mir-200a	nasopharyngeal carcinoma	up	MicroRNA-200a mediates nasopharyngeal carcinoma cell proliferation through the activation of nuclear factor-?B.
hsa-mir-200a	neuroblastoma	down	miR-200a inhibits tumor proliferation by targeting AP-2? in neuroblastoma cells.
hsa-mir-200a	non-small cell lung cancer	up	MiR-200a enhances the migrations of A549 and SK-MES-1 cells by regulating the expression of TSPAN1.
hsa-mir-200a	non-small cell lung cancer	down	MicroRNA-200a Targets EGFR and c-Met to Inhibit Migration, Invasion, and Gefitinib Resistance in Non-Small Cell Lung Cancer.
hsa-mir-200a	oral cancer	down	Grainyhead-like 2 regulates epithelial plasticity and stemness in oral cancer cells.
hsa-mir-200a	oral squamous cell carcinoma	down	QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.
hsa-mir-200a	ovarian cancer	up	MicroRNA-200a promotes proliferation and invasion of ovarian cancer cells by targeting PTEN.
hsa-mir-200a	ovarian cancer	up	The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition.
hsa-mir-200a	ovarian cancer	down	A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
hsa-mir-200a	ovarian cancer	up	Upregulation of microRNA-200a associates with tumor proliferation, CSCs phenotype and chemosensitivity in ovarian cancer.
hsa-mir-200a	ovarian cancer	up	The circulating microRNA-200 family in whole blood are potential biomarkers for high-grade serous epithelial ovarian cancer.
hsa-mir-200a	pancreatic cancer	down	Interleukin-9 Promotes Pancreatic Cancer Cells Proliferation and Migration via the miR-200a/Beta-Catenin Axis.
hsa-mir-200a	pancreatic ductal adenocarcinoma	down	XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.
hsa-mir-200a	pancreatic ductal adenocarcinoma	down	MiR-200a Suppresses the Proliferation and Metastasis in Pancreatic Ductal Adenocarcinoma through Downregulation of DEK Gene.
hsa-mir-200a	prostate cancer	down	MicroRNA-200a suppresses prostate cancer progression through BRD4/AR signaling pathway.
hsa-mir-200a	renal cell carcinoma	down	Tumor suppressive microRNA-200a inhibits renal cell carcinoma development by directly targeting TGFB2.
hsa-mir-200a	renal cell carcinoma	down	MiRNA-200a induce cell apoptosis in renal cell carcinoma by directly targeting SIRT1.
hsa-mir-200a-3p	breast cancer	up	Identification of microRNA expression in sentinel lymph nodes from patients with breast cancer via RNA sequencing for diagnostic accuracy.
hsa-mir-200a-3p	gastric cancer	up	Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.
hsa-mir-200a-3p	hepatocellular carcinoma	down	Circ-ZEB1.33 promotes the proliferation of human HCC by sponging miR-200a-3p and upregulating CDK6.
hsa-mir-200a-3p	renal cell carcinoma	down	MicroRNA-200a-3p suppresses tumor proliferation and induces apoptosis by targeting SPAG9 in renal cell carcinoma.
hsa-mir-200b	astrocytoma	down	Prognostic value of coexistence of abnormal expression of micro-RNA-200b and cyclic adenosine monophosphate-responsive element-binding protein 1 in human astrocytoma.
hsa-mir-200b	bladder cancer	down	Expression of microRNAs in the Urine of Patients With Bladder Cancer.
hsa-mir-200b	breast cancer	up	Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.
hsa-mir-200b	breast cancer	down	Regulation of the MicroRNA 200b (miRNA-200b) by Transcriptional Regulators PEA3 and ELK-1 Protein Affects Expression of Pin1 Protein to Control Anoikis.
hsa-mir-200b	breast cancer	down	miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family.
hsa-mir-200b	cervical carcinoma	down	MicroRNA-200b suppresses cell invasion and metastasis by inhibiting the epithelial-mesenchymal transition in cervical carcinoma.
hsa-mir-200b	cholangiocarcinoma	down	Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.
hsa-mir-200b	colon cancer	down	MicroRNA-200b is downregulated in colon cancer budding cells.
hsa-mir-200b	colorectal cancer	up	Exosome-mediated miR-200b promotes colorectal cancer proliferation upon TGF-?1 exposure.
hsa-mir-200b	colorectal cancer	up	microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs.
hsa-mir-200b	colorectal cancer	down	MiR-200 suppresses metastases of colorectal cancer through ZEB1.
hsa-mir-200b	endometrial cancer	up	MicroRNA-200b is overexpressed in endometrial adenocarcinomas and enhances MMP2 activity by downregulating TIMP2 in human endometrial cancer cell line HEC-1A cells.
hsa-mir-200b	esophageal squamous cell carcinoma	down	miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2.
hsa-mir-200b	esophageal squamous cell carcinoma	down	Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin ?1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism.
hsa-mir-200b	gastric cancer	up	MicroRNA-200b Regulates Cell Proliferation, Invasion, and Migration by Directly Targeting ZEB2 in Gastric Carcinoma.
hsa-mir-200b	gastric cancer	down	miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.
hsa-mir-200b	glioma	down	miR-200b as a prognostic factor targets multiple members of RAB family in glioma.
hsa-mir-200b	glioma	down	Decreased expression of microRNA-200b is an independent unfavorable prognostic factor for glioma patients.
hsa-mir-200b	glioma	down	[miR-200b suppresses glioma cell invasion by targeting PROM1].
hsa-mir-200b	glioma	down	MicroRNA-200b expression level is negatively associated with pathological grading in human gliomas.
hsa-mir-200b	glioma	down	miR-200b is a key regulator of tumor progression and metabolism targeting lactate dehydrogenase A in human malignant glioma.
hsa-mir-200b	hepatocellular carcinoma	down	Methylation-associated silencing of miR-200b facilitates human hepatocellular carcinoma progression by directly targeting BMI1.
hsa-mir-200b	hepatocellular carcinoma	down	Upregulation of miR-200b Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration by Targeting HMGB3 Protein.
hsa-mir-200b	hepatocellular carcinoma	down	The microRNA-200 family-A potential diagnostic marker in hepatocellular carcinoma?
hsa-mir-200b	lung adenocarcinoma	down	miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.
hsa-mir-200b	lung cancer	up	MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.
hsa-mir-200b	malignant melanoma	up	MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion.
hsa-mir-200b	mesenchymal cancer	down	MicroRNA Expression Profiles in Kaposi's Sarcoma.
hsa-mir-200b	mucinous cystadenocarcinoma	up	Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.
hsa-mir-200b	nasopharyngeal carcinoma	down	miR-200b Suppresses Cell Growth, Migration and Invasion by Targeting Notch1 in Nasopharyngeal Carcinoma.
hsa-mir-200b	non-small cell lung cancer	down	miR-200b inhibits migration and invasion in non-small cell lung cancer cells via targeting FSCN1.
hsa-mir-200b	non-small cell lung cancer	down	Overexpression of lncRNA HOXA11-AS promotes cell epithelial-mesenchymal transition by repressing miR-200b in non-small cell lung cancer.
hsa-mir-200b	oral cancer	down	Grainyhead-like 2 regulates epithelial plasticity and stemness in oral cancer cells.
hsa-mir-200b	oral squamous cell carcinoma	down	QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.
hsa-mir-200b	osteosarcoma	down	MicroRNA-200b acts as a tumor suppressor in osteosarcoma via targeting ZEB1.
hsa-mir-200b	ovarian cancer	up	The circulating microRNA-200 family in whole blood are potential biomarkers for high-grade serous epithelial ovarian cancer.
hsa-mir-200b	ovarian cancer	up	The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition.
hsa-mir-200b	ovarian cancer	down	A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
hsa-mir-200b	pancreatic ductal adenocarcinoma	down	XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.
hsa-mir-200b	prostate cancer	down	miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1.
hsa-mir-200b	prostate cancer	down	miR-200b inhibits prostate cancer EMT, growth and metastasis.
hsa-mir-200b	renal cell carcinoma	down	MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
hsa-mir-200b	tongue cancer	down	MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.
hsa-mir-200b-3p	glioma	down	MicroRNA-200b-3p suppresses epithelial-mesenchymal transition and inhibits tumor growth of glioma through down-regulation of ERK5.
hsa-mir-200b-3p	oral squamous cell carcinoma	up	miR-200b-3p in plasma is a potential diagnostic biomarker in oral squamous cell carcinoma.
hsa-mir-200b-3p	ovarian cancer	up	Plasma miR-200b in ovarian carcinoma patients: distinct pattern of pre/post-treatment variation compared to CA-125 and potential for prediction of progression-free survival.
hsa-mir-200c	bladder cancer	down	MiR-200c inhibits bladder cancer progression by targeting lactate dehydrogenase A.
hsa-mir-200c	bladder cancer	down	miR-200c Inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3.
hsa-mir-200c	bladder cancer	up	MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK.
hsa-mir-200c	bladder cancer	down	Expression of microRNAs in the Urine of Patients With Bladder Cancer.
hsa-mir-200c	breast cancer	up	Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.
hsa-mir-200c	breast cancer	down	MiR-200c suppresses TGF-? signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
hsa-mir-200c	breast cancer	down	HDAC inhibitor suppresses proliferation and invasion of breast cancer cells through regulation of miR-200c targeting CRKL.
hsa-mir-200c	breast cancer	down	miR-200c inhibits breast cancer proliferation by targeting KRAS.
hsa-mir-200c	cervical cancer	down	MicroRNA-200c suppressed cervical cancer cell metastasis and growth via targeting MAP4K4.
hsa-mir-200c	cholangiocarcinoma	down	Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.
hsa-mir-200c	colon cancer	down	miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1.
hsa-mir-200c	colon cancer	up	The roles of miR-200c in colon cancer and associated molecular mechanisms.
hsa-mir-200c	colorectal cancer	down	miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1.
hsa-mir-200c	colorectal cancer	up	MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
hsa-mir-200c	colorectal cancer	up	Plasma miR-200c and miR-18a as potential biomarkers for the detection of colorectal carcinoma.
hsa-mir-200c	colorectal cancer	up	microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs.
hsa-mir-200c	colorectal cancer	down	MiR-200 suppresses metastases of colorectal cancer through ZEB1.
hsa-mir-200c	colorectal cancer	up	Expression of miR-200c and its clinicopathological significance in patients with colorectal cancer.
hsa-mir-200c	colorectal cancer	down	Resveratrol Inhibits Proliferation, Invasion, and Epithelial-Mesenchymal Transition by Increasing miR-200c Expression in HCT-116 Colorectal Cancer Cells.
hsa-mir-200c	colorectal cancer	down	Nicotine downregulates microRNA-200c to promote metastasis and the epithelial-mesenchymal transition in human colorectal cancer cells.
hsa-mir-200c	colorectal cancer	down	miR-200c, a tumor suppressor that modulate the expression of cancer stem cells markers and epithelial-mesenchymal transition in colorectal cancer.
hsa-mir-200c	endometrial cancer	down	MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro.
hsa-mir-200c	endometrial cancer	up	The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma.
hsa-mir-200c	gastric cancer	down	miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.
hsa-mir-200c	gastric cancer	down	The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression.
hsa-mir-200c	gastric cancer	down	miR-200c inhibits TGF-?-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer.
hsa-mir-200c	gastric cancer	down	MicroRNA-200c as a prognostic and sensitivity marker for platinum chemotherapy in advanced gastric cancer.
hsa-mir-200c	glioma	down	MiR-200c Inhibits the Tumor Progression of Glioma via Targeting Moesin.
hsa-mir-200c	glioma	down	MiR-200c and miR-141 inhibit ZEB1 synergistically and suppress glioma cell growth and migration.
hsa-mir-200c	head and neck squamous cell carcinoma	down	MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
hsa-mir-200c	hepatocellular carcinoma	down	Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-200c	hepatocellular carcinoma	down	Expression Profile of MicroRNA-200 Family in Hepatocellular Carcinoma With Bile Duct Tumor Thrombus.
hsa-mir-200c	hepatocellular carcinoma	down	MicroRNA-200c expression is decreased in hepatocellular carcinoma and associated with poor prognosis.
hsa-mir-200c	kidney cancer	down	MicroRNA-200c suppresses cell growth and metastasis by targeting Bmi-1 and E2F3 in renal cancer cells.
hsa-mir-200c	laryngeal cancer	up	MicroRNA profile in site-specific head and neck squamous cell cancer.
hsa-mir-200c	lung adenocarcinoma	down	miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.
hsa-mir-200c	lung cancer	up	MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.
hsa-mir-200c	malignant melanoma	up	MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion.
hsa-mir-200c	malignant melanoma	down	Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.
hsa-mir-200c	malignant melanoma	down	miR-200c Inhibits Melanoma Progression and Drug Resistance through Down-Regulation of Bmi-1.
hsa-mir-200c	malignant melanoma	down	miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment.
hsa-mir-200c	mesenchymal cancer	down	MicroRNA Expression Profiles in Kaposi's Sarcoma.
hsa-mir-200c	mucinous cystadenocarcinoma	up	Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.
hsa-mir-200c	nasopharyngeal carcinoma	up	MicroRNA-200c plays an oncogenic role in nasopharyngeal carcinoma by targeting PTEN.
hsa-mir-200c	non-small cell lung cancer	up	High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.
hsa-mir-200c	non-small cell lung cancer	up	Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer.
hsa-mir-200c	non-small cell lung cancer	down	MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1.
hsa-mir-200c	non-small cell lung cancer	down	The Downregulation of miR-200c Promotes Lactate Dehydrogenase A Expression and Non-Small Cell Lung Cancer Progression.
hsa-mir-200c	oral cancer	down	Grainyhead-like 2 regulates epithelial plasticity and stemness in oral cancer cells.
hsa-mir-200c	oral squamous cell carcinoma	down	MiR-200c inhibited the proliferation of oral squamous cell carcinoma cells by targeting Akt pathway and its downstream Glut1.
hsa-mir-200c	oropharyngeal cancer	up	MicroRNA profile in site-specific head and neck squamous cell cancer.
hsa-mir-200c	ovarian cancer	down	A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
hsa-mir-200c	ovarian cancer	down	Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel.
hsa-mir-200c	ovarian cancer	up	Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
hsa-mir-200c	ovarian cancer	up	miR-200c modulates ovarian cancer cell metastasis potential by targeting zinc finger E-box-binding homeobox 2 (ZEB2) expression.
hsa-mir-200c	ovarian cancer	up	The circulating microRNA-200 family in whole blood are potential biomarkers for high-grade serous epithelial ovarian cancer.
hsa-mir-200c	ovarian cancer	down	Long Noncoding RNA MALAT1 Functions as a Sponge of MiR-200c in Ovarian Cancer.
hsa-mir-200c	ovarian cancer	up	The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition.
hsa-mir-200c	pancreatic ductal adenocarcinoma	down	XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.
hsa-mir-200c	rectal cancer	up	The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer.
hsa-mir-200c	renal clear cell carcinoma	down	Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
hsa-mir-200c	renal clear cell carcinoma	down	miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
hsa-mir-200c-3p	gastric cancer	down	A proposed method for the relative quantification of levels of circulating microRNAs in the plasma of gastric cancer patients.
hsa-mir-200c-3p	nephroblastoma	down	miR-200c-3p Suppresses the Proliferative, Migratory, and Invasive Capacities of Nephroblastoma Cells via Targeting FRS2.
hsa-mir-200c-3p	pancreatic ductal adenocarcinoma	down	A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis.
hsa-mir-202	bladder cancer	down	miR-202 inhibits cell proliferation, migration, and invasion by targeting EGFR in human bladder cancer.
hsa-mir-202	breast cancer	down	MiR-202 inhibits cell proliferation, invasion, and migration in breast cancer by targeting ROCK1 gene.
hsa-mir-202	colorectal cancer	down	MiR-202 inhibits the proliferation and invasion of colorectal cancer by targeting UHRF1.
hsa-mir-202	esophageal adenocarcinoma	down	miR-202 Suppresses Cell Proliferation by Targeting FOXR2 in Endometrial Adenocarcinoma.
hsa-mir-202	esophageal squamous cell carcinoma	down	MicroRNA-202 inhibits tumor progression by targeting LAMA1 in esophageal squamous cell carcinoma.
hsa-mir-202	follicular lymphoma	down	Targetome profiling, pathway analysis and genetic association study implicate miR-202 in lymphomagenesis.
hsa-mir-202	glioma	down	MicroRNA-202 inhibits cell proliferation, migration and invasion of glioma by directly targeting metadherin.
hsa-mir-202	hepatocellular carcinoma	down	miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally.
hsa-mir-202	lung cancer	down	MicroRNA-202 induces cell cycle arrest and apoptosis in lung cancer cells through targeting cyclin D1.
hsa-mir-202	non-small cell lung cancer	down	miR-202 functions as a tumor suppressor in non-small cell lung cancer by targeting STAT3.
hsa-mir-202	osteosarcoma	up	TGF-?1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma.
hsa-mir-202	prostate cancer	down	miR-202 suppresses prostate cancer growth and metastasis by targeting PIK3CA.
hsa-mir-202	retinoblastoma	down	Shikonin-mediated up-regulation of miR-34a and miR-202 inhibits retinoblastoma proliferation.
hsa-mir-202-3p	colorectal carcinoma	down	MicroRNA-202-3p Inhibits Cell Proliferation by Targeting ADP-Ribosylation Factor-like 5A in Human Colorectal Carcinoma.
hsa-mir-202-3p	gastric cancer	down	Decrease of miR-202-3p Expression, a Novel Tumor Suppressor, in Gastric Cancer.
hsa-mir-202-3p	papillary thyroid carcinoma	down	MiR-202-3p functions as a tumor suppressor and reduces cell migration and invasion in papillary thyroid carcinoma.
hsa-mir-202-5p	colorectal carcinoma	down	MicroRNA-202-5p functions as a tumor suppressor in colorectal carcinoma by directly targeting SMARCC1.
hsa-mir-202-5p	papillary thyroid carcinoma	down	LncRNA NORAD promotes thyroid carcinoma progression through targeting miR-202-5p.
hsa-mir-203	basal cell carcinoma	down	MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma.
hsa-mir-203	bladder cancer	up	Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-203	bladder cancer	down	microRNA-203 suppresses bladder cancer development by repressing bcl-w expression.
hsa-mir-203	bladder cancer	down	Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer.
hsa-mir-203	bladder cancer	down	MiR-203 Suppresses Bladder Cancer Cell Growth and Targets the Twist1.
hsa-mir-203	breast cancer	up	Anti-miR-203 Upregulates SOCS3 Expression in Breast Cancer Cells and Enhances Cisplatin Chemosensitivity.
hsa-mir-203	breast cancer	up	miR-203 facilitates tumor growth and metastasis by targeting fibroblast growth factor 2 in breast cancer.
hsa-mir-203	breast cancer	up	Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3.
hsa-mir-203	cervical cancer	down	Effect of miRNA-203 on cervical cancer cells and its underlying mechanism.
hsa-mir-203	cervical cancer	down	miR-203 Suppresses Tumor Growth and Angiogenesis by Targeting VEGFA in Cervical Cancer.
hsa-mir-203	cervical cancer	down	BANF1 Is Downregulated by IRF1-Regulated MicroRNA-203 in Cervical Cancer.
hsa-mir-203	cervical cancer	down	Identification of microRNAs (miR-203/miR-7) as potential markers for the early detection of lymph node metastases in patients with cervical cancer.
hsa-mir-203	colon cancer	up	Long noncoding RNA B3GALT5-AS1 suppresses colon cancer liver metastasis via repressing microRNA-203.
hsa-mir-203	colorectal cancer	up	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-203	colorectal cancer	down	MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity.
hsa-mir-203	colorectal cancer	down	MiRNA-203 suppresses cell proliferation, migration and invasion in colorectal cancer via targeting of EIF5A2.
hsa-mir-203	colorectal cancer	down	miR-203 is a predictive biomarker for colorectal cancer and its expression is associated with BIRC5.
hsa-mir-203	esophageal adenocarcinoma	down	Deciphering the Unique MicroRNA Signature in Human Esophageal Adenocarcinoma.
hsa-mir-203	esophageal cancer	down	MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer.
hsa-mir-203	esophageal cancer	down	miR-203 inhibits the proliferation and self-renewal of esophageal cancer stem-like cells by suppressing stem renewal factor Bmi-1.
hsa-mir-203	esophageal cancer	up	Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma.
hsa-mir-203	esophageal cancer	up	Evaluation of mir-203 Expression Levels and DNA Promoter Methylation Status in Serum of Patients with Endometrial Cancer.
hsa-mir-203	esophageal squamous cell carcinoma	down	Epigenetic silencing of miR-203 in Kazakh patients with esophageal squamous cell carcinoma by MassARRAY spectrometry.
hsa-mir-203	esophageal squamous cell carcinoma	down	MicroRNA-203 inhibits cell proliferation by repressing ?Np63 expression in human esophageal squamous cell carcinoma.
hsa-mir-203	esophageal squamous cell carcinoma	down	miR-203 is a Direct Transcriptional Target of E2F1 and Causes G1 Arrest in Esophageal Cancer Cells.
hsa-mir-203	gastric cancer	down	Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
hsa-mir-203	gastric cancer	down	MiRNA-203 suppresses tumor cell proliferation, migration and invasion by targeting Slug in gastric cancer.
hsa-mir-203	gastric cancer	down	MiR-203 inhibits tumor invasion and metastasis in gastric cancer by ATM.
hsa-mir-203	gastric cancer	down	Retraction Note: MicroRNA-203 suppresses gastric cancer growth by targeting PIBF1/Akt signaling.
hsa-mir-203	gastric cancer	down	MiR-203 acts as a radiosensitizer of gastric cancer cells by directly targeting ZEB1.
hsa-mir-203	gastric cancer	down	The expression level of miR-203 in patients with gastric cancer and its clinical significance.
hsa-mir-203	gastric cancer	down	miR-203 Inhibits the Invasion and EMT of Gastric Cancer Cells by Directly Targeting Annexin A4.
hsa-mir-203	gastric cancer	down	MicroRNA-203 suppresses gastric cancer growth by targeting PIBF1/Akt signaling.
hsa-mir-203	glioblastoma	down	Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma.
hsa-mir-203	glioblastoma	down	Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive RNA-sequencing transcriptome profiling.
hsa-mir-203	glioma	down	MicroRNA 203 Modulates Glioma Cell Migration via Robo1/ERK/MMP-9 Signaling.
hsa-mir-203	glioma	down	Silencing of lncRNA-CCDC26 Restrains the Growth and Migration of Glioma Cells In Vitro and In Vivo Via Targeting miR-203.
hsa-mir-203	glioma	down	Bufalin Inhibits Cellular Proliferation and Cancer Stem Cell-Like Phenotypes via Upregulation of MiR-203 in Glioma.
hsa-mir-203	head and neck squamous cell carcinoma	down	microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
hsa-mir-203	hepatocellular carcinoma	down	Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B.
hsa-mir-203	hepatocellular carcinoma	down	Upregulation of RASAL2 promotes proliferation and metastasis, and is targeted by miR-203 in hepatocellular carcinoma.
hsa-mir-203	hepatocellular carcinoma	down	LncRNA CRNDE promotes hepatocellular carcinoma cell proliferation, invasion, and migration through regulating miR-203/ BCAT1 axis.
hsa-mir-203	hepatocellular carcinoma	down	miR-203 inhibits proliferation of HCC cells by targeting survivin.
hsa-mir-203	hepatocellular carcinoma	down	Association between underexpression of microrna-203 and clinicopathological significance in hepatocellular carcinoma tissues.
hsa-mir-203	hepatocellular carcinoma	down	miR-203 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting oncogene ADAM9 and oncogenic long non-coding RNA HULC.
hsa-mir-203	hypopharyngeal cancer	up	Effect of microRNA-203 on tumor growth in human hypopharyngeal squamous cell carcinoma.
hsa-mir-203	kidney cancer	down	miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
hsa-mir-203	laryngeal squamous cell carcinoma	down	MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours.
hsa-mir-203	laryngeal squamous cell carcinoma	down	miR-203 is involved in the laryngeal carcinoma pathogenesis via targeting VEGFA and Cox-2.
hsa-mir-203	liver cancer	down	MicroRNA-203 suppresses proliferation in liver cancer associated with PIK3CA, p38 MAPK, c-Jun, and GSK3 signaling.
hsa-mir-203	lung adenocarcinoma	down	Direct interaction between miR-203 and ZEB2 suppresses epithelial-mesenchymal transition signaling and reduces lung adenocarcinoma chemoresistance.
hsa-mir-203	lung cancer	down	The expression and function of microRNA-203 in lung cancer.
hsa-mir-203	lung cancer	down	miR-203 Suppresses the Proliferation and Migration and Promotes the Apoptosis of Lung Cancer Cells by Targeting SRC.
hsa-mir-203	lung cancer	down	[miR-203 inhibits lung cancer cell metastasis by targeting fatty acid binding protein 4].
hsa-mir-203	lung carcinoma	down	miR-203 Inhibits Frizzled-2 Expression via CD82/KAI1 Expression in Human Lung Carcinoma Cells.
hsa-mir-203	malignant melanoma	down	Anti-oncogenic MicroRNA-203 Induces Senescence by Targeting E2F3 in Human Melanoma Cells.
hsa-mir-203	malignant melanoma	down	MicroRNA-203 inhibits malignant melanoma cell migration by targeting versican.
hsa-mir-203	malignant melanoma	down	Analysis of microRNA-203 function in CREB/MITF/RAB27a pathway: comparison between canine and human melanoma cells.
hsa-mir-203	malignant melanoma	down	MiR-203 inhibits melanoma invasive and proliferative abilities by targeting the polycomb group gene BMI1.
hsa-mir-203	malignant melanoma	down	DNA methylation contributes toward silencing of antioncogenic microRNA-203 in human and canine melanoma cells.
hsa-mir-203	malignant melanoma	down	RAB22A overexpression promotes the tumor growth of melanoma.
hsa-mir-203	malignant melanoma	down	Expression of miR-203 is decreased and associated with the prognosis of melanoma patients.
hsa-mir-203	malignant melanoma	up	MicroRNA-203 reinforces stemness properties in melanoma and augments tumorigenesis in vivo.
hsa-mir-203	multiple myeloma	down	miR-203 inhibits cell growth and regulates G1/S transition by targeting Bmi-1 in myeloma cells.
hsa-mir-203	non-small cell lung cancer	up	MicroRNA-203 promotes the progression of non-small cell lung cancer via surviving.
hsa-mir-203	non-small cell lung cancer	down	MicroRNA-203 inhibits cellular proliferation and invasion by targeting Bmi1 in non-small cell lung cancer.
hsa-mir-203	non-small cell lung cancer	down	MiR-145 and miR-203 represses TGF-?-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
hsa-mir-203	non-small cell lung cancer	down	MicroRNA-mediated epigenetic targeting of Survivin significantly enhances the antitumor activity of paclitaxel against non-small cell lung cancer.
hsa-mir-203	oral squamous cell carcinoma	up	Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
hsa-mir-203	osteosarcoma	down	MiR-34a and miR-203 Inhibit Survivin Expression to Control Cell Proliferation and Survival in Human Osteosarcoma Cells.
hsa-mir-203	osteosarcoma	down	Development and validation of nomogram based on miR-203 and clinicopathological characteristics predicting survival after neoadjuvant chemotherapy and surgery for patients with non-metastatic osteosar
hsa-mir-203	osteosarcoma	down	MiR-203 Determines Poor Outcome and Suppresses Tumor Growth by Targeting TBK1 in Osteosarcoma.
hsa-mir-203	osteosarcoma	down	miR-203 Acts as a Tumor Suppressor Gene in Osteosarcoma by Regulating RAB22A.
hsa-mir-203	ovarian cancer	down	miR-203 Functions as a Tumor Suppressor by Inhibiting Epithelial to Mesenchymal Transition in Ovarian Cancer.
hsa-mir-203	ovarian cancer	up	MiR-203 promotes the growth and migration of ovarian cancer cells by enhancing glycolytic pathway.
hsa-mir-203	ovarian cancer	down	miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGF? pathway.
hsa-mir-203	pancreatic adenocarcinoma	up	MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma.
hsa-mir-203	pancreatic cancer	down	miR-203 inhibits tumor cell migration and invasion via caveolin-1 in pancreatic cancer cells.
hsa-mir-203	pancreatic cancer	up	miR-203 promotes proliferation, migration and invasion by degrading SIK1 in pancreatic cancer.
hsa-mir-203	pancreatic ductal adenocarcinoma	up	Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-203	prostate cancer	down	Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance.
hsa-mir-203	prostate cancer	down	MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.
hsa-mir-203	prostate cancer	down	The miR-203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK-3?/?-CATENIN signal pathway.
hsa-mir-203	renal cell carcinoma	down	MicroRNA-203 Inhibits Long Noncoding RNA HOTAIR and Regulates Tumorigenesis through Epithelial-to-mesenchymal Transition Pathway in Renal Cell Carcinoma.
hsa-mir-203	rhabdomyosarcoma	down	miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in Rhabdomyosarcoma.
hsa-mir-203	squamous carcinoma	down	MicroRNA expression profiles of esophageal cancer.
hsa-mir-203	squamous carcinoma	up	Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-203a	bladder cancer	down	MiR-203a functions as a tumor suppressor in bladder cancer by targeting SIX4.
hsa-mir-203a	esophageal cancer	down	Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
hsa-mir-203a	gastric cancer	down	miR-203a suppresses cell proliferation by targeting E2F transcription factor 3 in human gastric cancer.
hsa-mir-203a	hepatocellular carcinoma	down	EGR1 mediates miR-203a suppress the hepatocellular carcinoma cells progression by targeting HOXD3 through EGFR signaling pathway.
hsa-mir-203a	hepatocellular carcinoma	down	HOXD3 targeted by miR-203a suppresses cell metastasis and angiogenesis through VEGFR in human hepatocellular carcinoma cells.
hsa-mir-203a	multiple myeloma	down	Down-regulation of miR-203a by lncRNA PVT1 in multiple myeloma promotes cell proliferation.
hsa-mir-203a	renal cell carcinoma	up	miR-203a regulates proliferation, migration, and apoptosis by targeting glycogen synthase kinase-3? in human renal cell carcinoma.
hsa-mir-203a-3p	colorectal cancer	up	miR-203a-3p promotes colorectal cancer proliferation and migration by targeting PDE4D.
hsa-mir-203a-3p	nasopharyngeal carcinoma	down	MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
hsa-mir-204	breast cancer	down	miR-204 regulates the biological behavior of breast cancer MCF-7 cells by directly targeting FOXA1.
hsa-mir-204	breast cancer	down	Angiogenesis Analysis by In Vitro Coculture Assays in Transwell Chambers in Ovarian Cancer.
hsa-mir-204	breast cancer	down	MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway.
hsa-mir-204	breast cancer	down	Cooperative multi-targeting of signaling networks by angiomiR-204 inhibits vasculogenic mimicry in breast cancer cells.
hsa-mir-204	cervical cancer	down	MicroRNA-204 inhibits cell migration and invasion in human cervical cancer by regulating transcription factor 12.
hsa-mir-204	colon cancer	down	[Expression and proliferative regulation of miR-204 related to mitochondrial transcription factor A in colon cancer].
hsa-mir-204	endometrial cancer	down	The dual regulatory role of miR-204 in cancer.
hsa-mir-204	esophageal cancer	down	miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer.
hsa-mir-204	gastric cancer	down	miR-204 regulates the EMT by targeting snai1 to suppress the invasion and migration of gastric cancer.
hsa-mir-204	gastric cancer	down	Reduced expression of serum miR-204 predicts poor prognosis of gastric cancer.
hsa-mir-204	gastric cancer	down	Integrated MicroRNA-mRNA Analysis Reveals miR-204 Inhibits Cell Proliferation in Gastric Cancer by Targeting CKS1B, CXCL1 and GPRC5A.
hsa-mir-204	gastric cancer	down	SNP rs3202538 in 3'UTR region of ErbB3 regulated by miR-204 and miR-211 promote gastric cancer development in Chinese population.
hsa-mir-204	gastric cancer	down	MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells.
hsa-mir-204	glioblastoma	down	miR-204 functions as a tumor suppressor gene, at least partly by suppressing CYP27A1 in glioblastoma.
hsa-mir-204	glioma	down	Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype.
hsa-mir-204	glioma	down	Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204.
hsa-mir-204	glioma	down	Downregulation of miR-204 expression correlates with poor clinical outcome of glioma patients.
hsa-mir-204	head and neck squamous cell carcinoma	down	miR-204 inhibits angiogenesis and promotes sensitivity to cetuximab in head and neck squamous cell carcinoma cells by blocking JAK2-STAT3 signaling.
hsa-mir-204	head and neck squamous cell carcinoma	down	miR-204 enhances p27 mRNA stability by targeting Brd4 in head and neck squamous cell carcinoma.
hsa-mir-204	hepatocellular carcinoma	down	MiR-204 inhibits hepatocellular cancer drug resistance and metastasis through targeting NUAK1.
hsa-mir-204	intrahepatic cholangiocarcinoma	down	miR-204 inhibits epithelial to mesenchymal transition by targeting slug in intrahepatic cholangiocarcinoma cells.
hsa-mir-204	lung adenocarcinoma	down	MicroRNA-204 targets SOX4 to inhibit metastasis of lung adenocarcinoma.
hsa-mir-204	lung adenocarcinoma	down	MicroRNA-204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2-signal transducer and activator of transcription 3 path
hsa-mir-204	lung carcinoma	down	miR-204 suppresses non-small-cell lung carcinoma (NSCLC) invasion and migration by targeting JAK2.
hsa-mir-204	malignant melanoma	down	Regulation of cancer aggressive features in melanoma cells by microRNAs.
hsa-mir-204	malignant melanoma	down	BANCR contributes to the growth and invasion of melanoma by functioning as a competing endogenous RNA to upregulate Notch2 expression by sponging miR?204.
hsa-mir-204	medulloblastoma	down	Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas.
hsa-mir-204	nasopharyngeal carcinoma	down	Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells.
hsa-mir-204	neuroblastoma	down	Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN.
hsa-mir-204	non-small cell lung cancer	down	miR-204 functions as a tumor suppressor by regulating SIX1 in NSCLC.
hsa-mir-204	non-small cell lung cancer	down	MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1.
hsa-mir-204	non-small cell lung cancer	down	miRNA-204 suppresses human non-small cell lung cancer by targeting ATF2.
hsa-mir-204	non-small cell lung cancer	down	Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.
hsa-mir-204	osteosarcoma	down	MicroRNA-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting Sirtuin 1.
hsa-mir-204	ovarian cancer	down	Regulation of miRNAs on c-met protein expression in ovarian cancer and its implication.
hsa-mir-204	papillary thyroid carcinoma	down	DNA methylation-mediated silencing of miR-204 is a potential prognostic marker for papillary thyroid carcinoma.
hsa-mir-204	prostate cancer	down	MiR-204 enhances mitochondrial apoptosis in doxorubicin-treated prostate cancer cells by targeting SIRT1/p53 pathway.
hsa-mir-204	prostate cancer	down	The dual regulatory role of miR-204 in cancer.
hsa-mir-204	prostate cancer	up	Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.
hsa-mir-204	renal cell carcinoma	down	Upregulation of microRNA-204 inhibits cell proliferation, migration and invasion in human renal cell carcinoma cells by downregulating SOX4.
hsa-mir-204	renal cell carcinoma	down	miR-204 inhibits the proliferation and invasion of renal cell carcinoma by inhibiting RAB22A expression.
hsa-mir-204	renal clear cell carcinoma	down	VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma.
hsa-mir-204	retinoblastoma	down	MiR-204, down-regulated in retinoblastoma, regulates proliferation and invasion of human retinoblastoma cells by targeting CyclinD2 and MMP-9.
hsa-mir-204	retinoblastoma	down	Long noncoding RNA NEAT1 promotes the growth of human retinoblastoma cells via regulation of miR-204/CXCR4 axis.
hsa-mir-204	thyroid cancer	down	MiR-204 regulates HMGA2 expression and inhibits cell proliferation in human thyroid cancer.
hsa-mir-204-3p	glioma	down	The miR-204-3p-targeted IGFBP2 pathway is involved in xanthohumol-induced glioma cell apoptotic death.
hsa-mir-204-3p	hepatocellular carcinoma	down	Growth inhibition of hepatocellular carcinoma tumor endothelial cells by miR-204-3p and underlying mechanism.
hsa-mir-204-5p	breast cancer	down	Tumor Suppressor miRNA-204-5p Regulates Growth, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer.
hsa-mir-204-5p	breast cancer	down	MiR-204-5p/Six1 feedback loop promotes epithelial-mesenchymal transition in breast cancer.
hsa-mir-204-5p	colorectal cancer	up	miR-204-5p expression in colorectal cancer: an autophagy-associated gene.
hsa-mir-204-5p	colorectal cancer	down	miR-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A.
hsa-mir-204-5p	endometrial cancer	down	Clinical value screening, prognostic significance and key pathway identification of miR-204-5p in endometrial carcinoma: A study based on the Cancer Genome Atlas (TCGA), and bioinformatics analysis.
hsa-mir-204-5p	gastric cancer	down	MicroRNA-204-5p inhibits gastric cancer cell proliferation by downregulating USP47 and RAB22A.
hsa-mir-204-5p	hepatocellular carcinoma	down	miR-204-5p suppresses hepatocellular cancer proliferation by regulating homeoprotein SIX1 expression.
hsa-mir-204-5p	hepatocellular carcinoma	down	miR-204-5p targeting SIRT1 regulates hepatocellular carcinoma progression.
hsa-mir-204-5p	malignant melanoma	down	miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma.
hsa-mir-204-5p	papillary thyroid carcinoma	down	miR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma.
hsa-mir-204-5p	prostate cancer	down	Tumor suppressor miRNA-204-5p promotes apoptosis by targeting BCL2 in prostate cancer cells.
hsa-mir-205	adrenal cortical carcinoma	down	MicroRNA-205 suppresses the growth of adrenocortical carcinoma SW-13?cells via targeting Bcl-2.
hsa-mir-205	bladder cancer	down	Long non-coding RNA HOTAIR regulates cyclin J via inhibition of microRNA-205 expression in bladder cancer.
hsa-mir-205	bladder cancer	up	Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer.
hsa-mir-205	bladder cancer	up	Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-205	bladder cancer	down	Expression of microRNAs in the Urine of Patients With Bladder Cancer.
hsa-mir-205	breast cancer	down	Suppression of cell growth and invasion by miR-205 in breast cancer.
hsa-mir-205	breast cancer	down	Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-205	breast cancer	down	miRNA-205 affects infiltration and metastasis of breast cancer.
hsa-mir-205	breast cancer	up	Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females.
hsa-mir-205	breast cancer	down	MicroRNA-205 inhibits the proliferation and invasion of breast cancer by regulating AMOT expression.
hsa-mir-205	breast cancer	up	Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.
hsa-mir-205	breast cancer	down	MicroRNA-205 increases the sensitivity of docetaxel in breast cancer.
hsa-mir-205	breast cancer	down	The association between differentially expressed micro RNAs in breast cancer cell lines and the micro RNA-205 gene polymorphism in breast cancer tissue.
hsa-mir-205	cervical cancer	down	MiR-205 serves as a prognostic factor and suppresses proliferation and invasion by targeting insulin-like growth factor receptor 1 in human cervical cancer.
hsa-mir-205	cervical cancer	up	miR-205 Expression Promotes Cell Proliferation and Migration of Human Cervical Cancer Cells.
hsa-mir-205	cervical cancer	up	Serum microRNA-205 as a novel biomarker for cervical cancer patients.
hsa-mir-205	cervical squamous cell carcinoma	up	miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes.
hsa-mir-205	chronic myelogenous leukemia	down	microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-mir-205	colon cancer	up	Expression levels of miR-205 and miR-506 in colon cancer tissues and their relationships with clinicopathological features.
hsa-mir-205	colorectal cancer	down	MicroRNA-205 functions as a tumor suppressor in colorectal cancer by targeting cAMP responsive element binding protein 1 (CREB1).
hsa-mir-205	colorectal cancer	down	Estrogen receptor beta reduces colon cancer metastasis through a novel miR-205 - PROX1 mechanism.
hsa-mir-205	endometrial cancer	up	miR-205 promotes epithelial-mesenchymal transition by targeting AKT signaling in endometrial cancer cells.
hsa-mir-205	endometrial cancer	up	miR-205 promotes tumor proliferation and invasion through targeting ESRRG in endometrial carcinoma.
hsa-mir-205	endometrial cancer	down	MiR-205 inhibits cell apoptosis by targeting phosphatase and tensin homolog deleted on chromosome ten in endometrial cancer Ishikawa cells.
hsa-mir-205	endometrial cancer	up	Overexpression of microRNA-205 predicts lymph node metastasis and indicates an unfavorable prognosis in endometrial cancer.
hsa-mir-205	endometrial cancer	up	miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells.
hsa-mir-205	esophageal cancer	up	Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma.
hsa-mir-205	esophageal cancer	up	miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas.
hsa-mir-205	esophageal squamous cell carcinoma	down	Predictive Value of Serum miR-10b, miR-29c, and miR-205 as Promising Biomarkers in Esophageal Squamous Cell Carcinoma Screening.
hsa-mir-205	gastric cancer	down	Down-regulation of MicroRNA-205 promotes gastric cancer cell proliferation.
hsa-mir-205	gastric cancer	down	miR-205 regulation of ICT1 has an oncogenic potential via promoting the migration and invasion of gastric cancer cells.
hsa-mir-205	glioblastoma	down	Epigenetic Modification of MicroRNA-205 and its Association with Glioblastoma Multiform.
hsa-mir-205	glioma	down	MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A.
hsa-mir-205	glioma	down	Identification of microRNA-205 as a potential prognostic indicator for human glioma.
hsa-mir-205	glioma	down	Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
hsa-mir-205	glioma	down	TGF-?1 regulating miR-205/miR-195 expression affects the TGF-? signal pathway by respectively targeting SMAD2/SMAD7.
hsa-mir-205	glioma	down	MiR-205 suppresses epithelial-mesenchymal transition and inhibits tumor growth of human glioma through down-regulation of HOXD9.
hsa-mir-205	head and neck squamous cell carcinoma	down	Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.
hsa-mir-205	head and neck squamous cell carcinoma	up	Low let-7d and high miR-205 expression levels positively influence HNSCC patient outcome.
hsa-mir-205	hepatocellular carcinoma	down	MiR-205 suppresses tumor growth, invasion, and epithelial-mesenchymal transition by targeting SEMA4C in hepatocellular carcinoma.
hsa-mir-205	hepatocellular carcinoma	down	Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis.
hsa-mir-205	hepatocellular carcinoma	down	MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
hsa-mir-205	hepatocellular carcinoma	down	MicroRNA-205 is downregulated in hepatocellular carcinoma and inhibits cell growth and metastasis via directly targeting vascular endothelial growth factor A.
hsa-mir-205	kidney cancer	down	MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer.
hsa-mir-205	laryngeal carcinoma	up	[Effect of microRNA-205 on proliferation of laryngeal carcinoma cell line Hep-2].
hsa-mir-205	laryngeal squamous cell carcinoma	down	MicroRNA-205 suppresses proliferation and promotes apoptosis in laryngeal squamous cell carcinoma.
hsa-mir-205	laryngeal squamous cell carcinoma	up	miR-205 promotes proliferation and invasion of laryngeal squamous cell carcinoma by suppressing CDK2AP1 expression.
hsa-mir-205	lung cancer	up	Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients.
hsa-mir-205	lung cancer	up	miR-205 regulates A549 cells proliferation by targeting PTEN.
hsa-mir-205	malignant melanoma	down	miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein.
hsa-mir-205	malignant melanoma	down	Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.
hsa-mir-205	malignant melanoma	down	Chemically Modified Synthetic microRNA-205 Inhibits the Growth of Melanoma Cells In Vitro and In Vivo.
hsa-mir-205	neuroblastoma	down	MiR-205 Inhibits Growth and Invasion of Neuroblastoma by Targeting cAMP Responsive Element Binding Protein 1.
hsa-mir-205	non-small cell lung cancer	up	Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.
hsa-mir-205	non-small cell lung cancer	up	miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN.
hsa-mir-205	non-small cell lung cancer	up	Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
hsa-mir-205	osteosarcoma	down	MiR-205 functions as a tumor suppressor via targeting TGF-? in osteosarcoma.
hsa-mir-205	osteosarcoma	down	Long noncoding RNA MALAT1 promotes cell proliferation through suppressing miR-205 and promoting SMAD4 expression in osteosarcoma.
hsa-mir-205	ovarian cancer	up	miR-205 regulates the proliferation and invasion of ovarian cancer cells via suppressing PTEN/SMAD4 expression.
hsa-mir-205	ovarian cancer	up	The role of miR-205 in the VEGF-mediated promotion of human ovarian cancer cell invasion.
hsa-mir-205	ovarian cancer	up	MicroRNA-205 promotes cell invasion by repressing TCF21 in human ovarian cancer.
hsa-mir-205	pancreatic cancer	down	Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
hsa-mir-205	prostate cancer	down	Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells.
hsa-mir-205	prostate cancer	down	Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer.
hsa-mir-205	prostate cancer	down	MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer.
hsa-mir-205	prostate cancer	down	miR-205 is frequently downregulated in prostate cancer and acts as a tumor suppressor by inhibiting tumor growth.
hsa-mir-205	prostate cancer	down	Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31.
hsa-mir-205	prostate cancer	down	MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer.
hsa-mir-205	prostate cancer	down	Editorial Comment to MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer.
hsa-mir-205	prostate carcinoma	down	microRNA-205 and microRNA-338-3p Reduces Cell Apoptosis in Prostate Carcinoma Tissue and LNCaP Prostate Carcinoma Cells by Directly Targeting the B-Cell Lymphoma 2 (Bcl-2) Gene.
hsa-mir-205	renal cell carcinoma	down	miRNA-205 Is a Candidate Tumor Suppressor that Targets ZEB2 in Renal Cell Carcinoma.
hsa-mir-205	squamous carcinoma	down	MicroRNA expression profiles of esophageal cancer.
hsa-mir-205	thyroid cancer	down	Modulatory role of miR-205 in angiogenesis and progression of thyroid cancer.
hsa-mir-205-3p	non-small cell lung cancer	up	Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients.
hsa-mir-205-5p	bladder cancer	down	Circ0001429 regulates progression of bladder cancer through binding miR-205-5p and promoting VEGFA expression.
hsa-mir-205-5p	breast cancer	up	MiR-205-5p inhibition by locked nucleic acids impairs metastatic potential of breast cancer cells.
hsa-mir-205-5p	esophageal cancer	up	miR-205-5p contributes to paclitaxel resistance and progression of endometrial cancer by downregulating FOXO1.
hsa-mir-205-5p	gastric cancer	up	Micro-RNA 205-5p is Involved in the Progression of Gastric Cancer and Targets Phosphatase and Tensin Homolog (PTEN) in SGC-7901 Human Gastric Cancer Cells.
hsa-mir-205-5p	non-small cell lung cancer	up	miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study.
hsa-mir-205-5p	non-small cell lung cancer	up	Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients.
hsa-mir-205-5p	prostate cancer	down	Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell aggressiveness and is involved in prostate cancer pathogenesis.
hsa-mir-205-5p	prostate cancer	down	miR-205-5p inhibits cell migration and invasion in prostatic carcinoma by targeting ZEB1.
hsa-mir-2053	hepatocellular carcinoma	down	MicroRNA-2053 overexpression inhibits the development and progression of hepatocellular carcinoma.
hsa-mir-206	bladder cancer	down	MicroRNA-206 acts as a tumor suppressor in bladder cancer via targeting YRDC.
hsa-mir-206	breast cancer	up	Expression of miRNA-206 and miRNA-145 in breast cancer and correlation with prognosis.
hsa-mir-206	breast cancer	down	miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2.
hsa-mir-206	breast cancer	down	Overexpression of miR-206 suppresses glycolysis, proliferation and migration in breast cancer cells via PFKFB3 targeting.
hsa-mir-206	cervical cancer	down	miR-206 inhibits cell proliferation, migration, and invasion by targeting BAG3 in human cervical cancer.
hsa-mir-206	cervical cancer	down	Decreased microRNA-206 and its function in cervical cancer.
hsa-mir-206	clear cell renal cell cancer	down	Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles.
hsa-mir-206	colorectal cancer	down	microRNA-206 attenuates tumor proliferation and migration involving the downregulation of NOTCH3 in colorectal cancer.
hsa-mir-206	colorectal cancer	down	MicroRNA-206 functions as a tumor suppressor in colorectal cancer by targeting FMNL2.
hsa-mir-206	colorectal cancer	down	miR-206 is an independent prognostic factor and inhibits tumor invasion and migration in colorectal cancer.
hsa-mir-206	colorectal cancer	down	MicroRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targeting TM4SF1.
hsa-mir-206	gastric cancer	down	MiR-206 inhibits gastric cancer proliferation in part by repressing CyclinD2.
hsa-mir-206	gastric cancer	down	Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.
hsa-mir-206	gastric cancer	down	MicroRNA-206 suppresses gastric cancer cell growth and metastasis.
hsa-mir-206	gastric cancer	down	Activation of PAX3-MET pathways due to miR-206 loss promotes gastric cancer metastasis.
hsa-mir-206	gastric cancer	down	MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met Pathway.
hsa-mir-206	gastric cancer	down	Diagnostic and Prognostic Value of Serum MicroRNA-206 in Patients with Gastric Cancer.
hsa-mir-206	gastric cancer	down	MiR-206 inhibits proliferation, migration, and invasion of gastric cancer cells by targeting the MUC1 gene.
hsa-mir-206	glioblastoma	down	MicroRNA-206 Inhibited the Progression of Glioblastoma Through BCL-2.
hsa-mir-206	glioma	down	MicroRNA-206 attenuates glioma cell proliferation, migration, and invasion by blocking the WNT/?-catenin pathway via direct targeting of Frizzled 7 mRNA.
hsa-mir-206	head and neck squamous cell carcinoma	down	MiR-206 inhibits Head and neck squamous cell carcinoma cell progression by targeting HDAC6 via PTEN/AKT/mTOR pathway.
hsa-mir-206	head and neck squamous cell carcinoma	down	Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
hsa-mir-206	hepatocellular carcinoma	down	MiRNA-206 inhibits hepatocellular carcinoma cell proliferation and migration but promotes apoptosis by modulating cMET expression.
hsa-mir-206	hepatocellular carcinoma	down	MicroRNA-206, down-regulated in hepatocellular carcinoma, suppresses cell proliferation and promotes apoptosis.
hsa-mir-206	hepatocellular carcinoma	down	MicroRNA-206, down-regulated in hepatocellular carcinoma, suppresses cell proliferation and promotes apoptosis.
hsa-mir-206	hepatocellular carcinoma	down	miR-206 inhibits the growth of hepatocellular carcinoma cells via targeting CDK9.
hsa-mir-206	hepatocellular carcinoma	down	LINC00707 contributes to hepatocellular carcinoma progression via sponging miR-206 to increase CDK14.
hsa-mir-206	hepatocellular carcinoma	down	miR-206 inhibits cell proliferation, invasion, and migration by down-regulating PTP1B in hepatocellular carcinoma.
hsa-mir-206	laryngeal squamous cell carcinoma	down	Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.
hsa-mir-206	laryngeal squamous cell carcinoma	down	miR-206 inhibits human laryngeal squamous cell carcinoma cell growth by regulation of cyclinD2.
hsa-mir-206	lung adenocarcinoma	down	MicroRNA-206 inhibits the viability and migration of human lung adenocarcinoma cells partly by targeting MET.
hsa-mir-206	lung adenocarcinoma	down	MicroRNA-206 suppresses TGF-? signalling to limit tumor growth and metastasis in lung adenocarcinoma.
hsa-mir-206	lung cancer	down	Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
hsa-mir-206	lung cancer	down	Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.
hsa-mir-206	lung cancer	down	MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/ Akt/mTOR pathway.
hsa-mir-206	malignant melanoma	down	MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D.
hsa-mir-206	medulloblastoma	down	MiR-206, a Cerebellum Enriched miRNA Is Downregulated in All Medulloblastoma Subgroups and Its Overexpression Is Necessary for Growth Inhibition of Medulloblastoma Cells.
hsa-mir-206	medulloblastoma	down	MicroRNA-206 inhibits the viability and migration of medulloblastoma cells by targeting LIM and SH3 protein 1.
hsa-mir-206	non-small cell lung cancer	down	miR-206 inhibits non small cell lung cancer cell proliferation and invasion by targeting SOX9.
hsa-mir-206	non-small cell lung cancer	down	MicroRNA-206 attenuates the growth and angiogenesis in non-small cell lung cancer cells by blocking the 14-3-3?/STAT3/HIF-1?/VEGF signaling.
hsa-mir-206	oral squamous cell carcinoma	down	MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma [Retraction].
hsa-mir-206	oral squamous cell carcinoma	down	MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma.
hsa-mir-206	osteosarcoma	down	MicroRNA-206 Reduces Osteosarcoma Cell Malignancy In Vitro by Targeting the PAX3-MET Axis.
hsa-mir-206	osteosarcoma	down	MALAT1 induces osteosarcoma progression by targeting miR-206/CDK9 axis.
hsa-mir-206	ovarian cancer	down	[Role of miR-206/CDK4 in modulating the growth and chemotlerapy sensitivity of ovarian cancer cells].
hsa-mir-206	papillary thyroid carcinoma	down	Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma.
hsa-mir-206	prostate cancer	up	MicroRNA-206 regulates the epithelial-mesenchymal transition and inhibits the invasion and metastasis of prostate cancer cells by targeting Annexin A2.
hsa-mir-206	prostate cancer	down	MiR-206 inhibits proliferation and migration of prostate cancer cells by targeting CXCL11.
hsa-mir-206	rhabdomyosarcoma	down	Heme oxygenase-1 controls an HDAC4-miR-206 pathway of oxidative stress in rhabdomyosarcoma.
hsa-mir-206	thyroid cancer	down	miR-206 inhibits thyroid cancer proliferation and invasion by targeting RAP1B.
hsa-mir-208	esophageal squamous cell carcinoma	up	Mir-208 promotes cell proliferation by repressing SOX6 expression in human esophageal squamous cell carcinoma.
hsa-mir-208a	gastric cancer	up	MiR-208a enhances cell proliferation and invasion of gastric cancer by targeting SFRP1 and negatively regulating MEG3.
hsa-mir-208a	lung cancer	up	Radiation-induced miR-208a increases the proliferation and radioresistance by targeting p21 in human lung cancer cells.
hsa-mir-208a	osteosarcoma	up	LncRNA-SRA1 Suppresses Osteosarcoma Cell Proliferation While Promoting Cell Apoptosis.
hsa-mir-208a-3p	colorectal cancer	up	MiR-208a-3p functions as an oncogene in colorectal cancer by targeting PDCD4.
hsa-mir-208a-3p	gastric cancer	down	miR-208a-3p suppresses cell apoptosis by targeting PDCD4 in gastric cancer.
hsa-mir-208b	osteosarcoma	down	MicroRNA-208b inhibits human osteosarcoma progression by targeting ROR2.
hsa-mir-20a	acute myeloid leukemia	down	HIF-1? downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation.
hsa-mir-20a	b-cell lymphoma	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-20a	breast cancer	up	Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.
hsa-mir-20a	breast cancer	up	MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.
hsa-mir-20a	breast cancer	up	MiR-20a and miR-20b negatively regulate autophagy by targeting RB1CC1/FIP200 in breast cancer cells.
hsa-mir-20a	breast cancer	up	MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability.
hsa-mir-20a	breast cancer	down	A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance.
hsa-mir-20a	breast carcinoma	up	MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
hsa-mir-20a	cervical cancer	up	miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells.
hsa-mir-20a	cervical cancer	up	Circulating miRNA-20a and miRNA-203 for Screening Lymph Node Metastasis in Early Stage Cervical Cancer.
hsa-mir-20a	cervical cancer	up	MiR-20a promotes cervical cancer proliferation and metastasis in vitro and in vivo.
hsa-mir-20a	cervical cancer	up	Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer.
hsa-mir-20a	cervical cancer	up	Upregulation of miR-20a and miR-10a expression levels act as potential biomarkers of aggressive progression and poor prognosis in cervical cancer.
hsa-mir-20a	cervical carcinoma	up	Up-regulation of miR-20a by HPV16 E6 exerts growth-promoting effects by targeting PDCD6 in cervical carcinoma cells.
hsa-mir-20a	cholangiocarcinoma	up	miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
hsa-mir-20a	chronic myelogenous leukemia	up	microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-mir-20a	chronic myelogenous leukemia	up	miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.
hsa-mir-20a	colorectal cancer	up	miR-20a-directed regulation of BID is associated with the TRAIL sensitivity in colorectal cancer.
hsa-mir-20a	colorectal cancer	up	MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-20a	colorectal cancer	up	MicroRNA signatures: novel biomarker for colorectal cancer?
hsa-mir-20a	colorectal cancer	up	Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancer.
hsa-mir-20a	colorectal cancer	up	Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progression.
hsa-mir-20a	colorectal cancer	up	Knockdown of MiR-20a Enhances Sensitivity of Colorectal Cancer Cells to Cisplatin by Increasing ASK1 Expression.
hsa-mir-20a	colorectal cancer	up	microRNA-20a enhances the epithelial-to-mesenchymal transition of colorectal cancer cells by modulating matrix metalloproteinases.
hsa-mir-20a	colorectal cancer	up	Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.
hsa-mir-20a	colorectal cancer	up	miR-20a regulates sensitivity of colorectal cancer cells to NK cells by targeting MICA.
hsa-mir-20a	colorectal cancer	up	MicroRNA-related transcription factor regulatory networks in human colorectal cancer.
hsa-mir-20a	colorectal cancer	up	The Efficacy of miR-20a as a Diagnostic and Prognostic Biomarker for Colorectal Cancer: A Systematic Review and Meta-Analysis.
hsa-mir-20a	esophageal squamous cell carcinoma	up	TNF-? is a novel target of miR-19a.
hsa-mir-20a	esophageal squamous cell carcinoma	up	Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-mir-20a	gastric cancer	up	Involvement of miR-20a in Promoting Gastric Cancer Progression by Targeting Early Growth Response 2 (EGR2).
hsa-mir-20a	gastric cancer	up	miR-20a enhances cisplatin resistance of human gastric cancer cell line by targeting NFKBIB.
hsa-mir-20a	glioma	up	[Expression of hsa-miR-20a in human glioma tissues and its effect on the proliferation of human glioma cells in vitro].
hsa-mir-20a	glioma	up	DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.
hsa-mir-20a	glioma	up	MicroRNA-20a Regulates Glioma Cell Proliferation, Invasion, and Apoptosis by Targeting CUGBP Elav-Like Family Member 2.
hsa-mir-20a	hepatocellular carcinoma	down	Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma.
hsa-mir-20a	hepatocellular carcinoma	up	MiR-20a Induces Cell Radioresistance by Activating the PTEN/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma.
hsa-mir-20a	hepatocellular carcinoma	up	MiR-17-92 cluster promotes hepatocarcinogenesis.
hsa-mir-20a	lung cancer	up	A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
hsa-mir-20a	lung cancer	up	Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
hsa-mir-20a	lung cancer	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-20a	malignant melanoma	up	Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
hsa-mir-20a	malignant melanoma	down	Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex.
hsa-mir-20a	mantle cell lymphoma	up	The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
hsa-mir-20a	medulloblastoma	up	The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
hsa-mir-20a	nasopharyngeal cancer	up	Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma.
hsa-mir-20a	nasopharyngeal carcinoma	up	MicroRNA-19a promotes nasopharyngeal carcinoma by targeting transforming growth factor ? receptor 2.
hsa-mir-20a	non-small cell lung cancer	up	MicroRNA-20a promotes proliferation and invasion by directly targeting early growth response 2 in non-small cell lung carcinoma.
hsa-mir-20a	oral squamous cell carcinoma	up	HPV 16 E7 inhibits OSCC cell proliferation, invasion, and metastasis by upregulating the expression of miR-20a.
hsa-mir-20a	osteosarcoma	up	Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
hsa-mir-20a	osteosarcoma	down	miRNA-20a upregulates TAK1 and increases proliferation in osteosarcoma cells.
hsa-mir-20a	osteosarcoma	up	The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.
hsa-mir-20a	ovarian cancer	up	miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells.
hsa-mir-20a	ovarian cancer	up	Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression.
hsa-mir-20a	pituitary carcinoma	up	MicroRNA involvement in a metastatic non-functioning pituitary carcinoma.
hsa-mir-20a	prostate cancer	up	miR-20a promotes Prostate cancer invasion and migration through targeting ABL2.
hsa-mir-20a-3p	gastric cancer	up	Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer.
hsa-mir-20a-5p	colorectal cancer	up	MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4.
hsa-mir-20a-5p	colorectal cancer	up	Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
hsa-mir-20a-5p	colorectal cancer	up	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-20a-5p	glioma	down	Long non-coding RNA SNHG16 contributes to glioma malignancy by competitively binding miR-20a-5p with E2F1.
hsa-mir-20a-5p	neuroblastoma	down	MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma.
hsa-mir-20a-5p	non-small cell lung cancer	down	Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
hsa-mir-20b	bladder cancer	down	MicroRNA-20b inhibits the proliferation, migration and invasion of bladder cancer EJ cells via the targeting of cell cycle regulation and Sp-1-mediated MMP-2 expression.
hsa-mir-20b	breast cancer	up	MicroRNA-20b promotes cell growth of breast cancer cells partly via targeting phosphatase and tensin homologue (PTEN).
hsa-mir-20b	breast cancer	down	A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance.
hsa-mir-20b	breast cancer	up	MiR-20a and miR-20b negatively regulate autophagy by targeting RB1CC1/FIP200 in breast cancer cells.
hsa-mir-20b	cervical cancer	up	Human papillomavirus E6-regulated microRNA-20b promotes invasion in cervical cancer by targeting tissue inhibitor of metalloproteinase 2.
hsa-mir-20b	esophageal cancer	up	MicroRNA-20b (miR-20b) Promotes the Proliferation, Migration, Invasion, and Tumorigenicity in Esophageal Cancer Cells via the Regulation of Phosphatase and Tensin Homologue Expression.
hsa-mir-20b	gastric cancer	up	miR-20b overexpression is predictive of poor prognosis in gastric cancer.
hsa-mir-20b	hepatocellular carcinoma	up	Crucial Role for Early Growth Response-1 in the Transcriptional Regulation of miR-20b in Breast Cancer.
hsa-mir-20b	hepatocellular carcinoma	up	MicroRNA-20b promotes proliferation of H22 hepatocellular carcinoma cells by targeting PTEN.
hsa-mir-20b	prostate cancer	up	miR-20b promotes cellular proliferation and migration by directly regulating phosphatase and tensin homolog in prostate cancer.
hsa-mir-20b-5p	esophageal squamous cell carcinoma	up	A novel serum microRNA signature to screen esophageal squamous cell carcinoma.
hsa-mir-20b-5p	non-small cell lung cancer	up	Regulation of BTG3 by microRNA-20b-5p in non-small cell lung cancer.
hsa-mir-20b-5p	renal cell carcinoma	down	MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
hsa-mir-21	adrenal cortical carcinoma	up	The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
hsa-mir-21	ampullary adenocarcinoma	up	MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions.
hsa-mir-21	b-cell lymphoma	up	Effects of microRNA-21 on apoptosis by regulating the expression of PTEN in diffuse large B-cell lymphoma.
hsa-mir-21	b-cell lymphoma	up	Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies.
hsa-mir-21	b-cell lymphoma	up	miR-21 expression predicts prognosis in diffuse large B-cell lymphoma.
hsa-mir-21	brain cancer	up	MicroRNA-target cross-talks: Key players in glioblastoma multiforme.
hsa-mir-21	breast cancer	up	Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor.
hsa-mir-21	breast cancer	up	Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
hsa-mir-21	breast cancer	up	Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.
hsa-mir-21	breast cancer	up	BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1.
hsa-mir-21	breast cancer	up	Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion.
hsa-mir-21	breast cancer	up	MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression.
hsa-mir-21	breast cancer	up	Next-generation sequencing of microRNAs for breast cancer detection.
hsa-mir-21	breast cancer	up	Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.
hsa-mir-21	breast cancer	up	Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue.
hsa-mir-21	breast cancer	up	Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer.
hsa-mir-21	breast cancer	up	
hsa-mir-21	breast cancer	up	Overexpression of MicroRNA-21 in the Serum of Breast Cancer Patients.
hsa-mir-21	breast cancer	up	A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer.
hsa-mir-21	breast cancer	up	The Regulation and Function of miR-21-FOXO3a-miR-34b/c Signaling in Breast Cancer.
hsa-mir-21	breast cancer	up	Combination of miR-21 with Circulating Tumor Cells Markers Improve Diagnostic Specificity of Metastatic Breast Cancer.
hsa-mir-21	breast cancer	up	Quantitative Measurement of Serum MicroRNA-21 Expression in Relation to Breast Cancer Metastasis in Chinese Females.
hsa-mir-21	breast cancer	up	Tissue specific expression of extracellular microRNA in human breast cancers and normal human breast tissue in vivo.
hsa-mir-21	breast cancer	up	Clinical significance of blood-based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers.
hsa-mir-21	breast cancer	up	Interrelation of the Circulating and Tissue MicroRNA-21 with Tissue PDCD4 Expression and the Invasiveness of Iraqi Female Breast Tumors.
hsa-mir-21	breast cancer	up	miR-21: A gene of dual regulation in breast cancer.
hsa-mir-21	breast cancer	up	MicroRNA-21 induces breast cancer cell invasion and migration by suppressing smad7 via EGF and TGF-? pathways.
hsa-mir-21	breast cancer	up	Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients.
hsa-mir-21	breast cancer	up	MEG3 overexpression inhibits the tumorigenesis of breast cancer by downregulating miR-21 through the PI3K/Akt pathway.
hsa-mir-21	cervical cancer	up	Transregulation of microRNA miR-21 promoter by AP-1 transcription factor in cervical cancer cells.
hsa-mir-21	cervical cancer	up	MicroRNA-21 promotes proliferation, migration, and invasion of cervical cancer through targeting TIMP3.
hsa-mir-21	cervical cancer	up	MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer.
hsa-mir-21	cervical cancer	up	Overexpression of miR-21 promotes the proliferation and migration of cervical cancer cells via the inhibition of PTEN.
hsa-mir-21	cervical cancer	up	Circulating MicroRNA-21 Is Involved in Lymph Node Metastasis in Cervical Cancer by Targeting RASA1.
hsa-mir-21	cervical carcinoma	up	MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells.
hsa-mir-21	cholangiocarcinoma	up	MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3.
hsa-mir-21	cholangiocarcinoma	up	PTEN and PDCD4 are bona fide targets of microRNA-21 in human cholangiocarcinoma.
hsa-mir-21	cholangiocarcinoma	up	miR-21 Targets 15-PGDH and Promotes Cholangiocarcinoma Growth.
hsa-mir-21	cholangiocarcinoma	up	miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells.
hsa-mir-21	chronic lymphocytic leukemia	up	Microenvironment regulates the expression of miR-21 and tumor suppressor genes PTEN, PIAS3 and PDCD4 through ZAP-70 in chronic lymphocytic leukemia.
hsa-mir-21	chronic myelogenous leukemia	up	microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-mir-21	colon cancer	up	Folate status, folate-related genes and serum miR-21 expression: Implications for miR-21 as a biomarker.
hsa-mir-21	colon cancer	down	miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.
hsa-mir-21	colon cancer	up	Expression of miR-21 and miR-138 in colon cancer and its effect on cell proliferation and prognosis.
hsa-mir-21	colorectal cancer	up	[Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer].
hsa-mir-21	colorectal cancer	up	Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1?-VEGF signaling pathway.
hsa-mir-21	colorectal cancer	up	Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.
hsa-mir-21	colorectal cancer	up	Correlation of over-expressions of miR-21 and Notch-1 in human colorectal cancer with clinical stages.
hsa-mir-21	colorectal cancer	up	MicroRNA-21 controls hTERT via PTEN in human colorectal cancer cell proliferation.
hsa-mir-21	colorectal cancer	up	MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
hsa-mir-21	colorectal cancer	up	MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-21	colorectal cancer	up	Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps.
hsa-mir-21	colorectal cancer	up	Increased expression of microRNA-21and its association with chemotherapeutic response in human colorectal cancer.
hsa-mir-21	colorectal cancer	up	Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells.
hsa-mir-21	colorectal cancer	up	Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer.
hsa-mir-21	colorectal cancer	up	MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.
hsa-mir-21	colorectal cancer	up	Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
hsa-mir-21	colorectal cancer	down	Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer.
hsa-mir-21	colorectal carcinoma	up	MiRNA-21 Expression Decreases from Primary Tumors to Liver Metastases in Colorectal Carcinoma.
hsa-mir-21	colorectal carcinoma	up	Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
hsa-mir-21	diffuse large B-cell lymphoma	up	Inhibition of miR-21 Induces Biological and Behavioral Alterations in Diffuse Large B-Cell Lymphoma.
hsa-mir-21	endometrial cancer	up	Highly increased maspin expression corresponds with up-regulation of miR-21 in endometrial cancer: a preliminary report.
hsa-mir-21	esophageal cancer	up	Exosome-shuttling microRNA-21 promotes cell migration and invasion-targeting PDCD4 in esophageal cancer.
hsa-mir-21	esophageal cancer	up	MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer.
hsa-mir-21	esophageal cancer	up	The expression of miR-21 and miR-375 predict prognosis of esophageal cancer.
hsa-mir-21	esophageal cancer	up	[Diagnostic values of salivary versus and plasma microRNA-21 for early esophageal cancer].
hsa-mir-21	esophageal cancer	up	Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma.
hsa-mir-21	esophageal squamous cell carcinoma	up	Expression, Tissue Distribution and Function of miR-21 in Esophageal Squamous Cell Carcinoma.
hsa-mir-21	esophageal squamous cell carcinoma	up	Down-Regulation of PTEN Expression Modulated by Dysregulated miR-21 Contributes to the Progression of Esophageal Cancer.
hsa-mir-21	esophageal squamous cell carcinoma	up	Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
hsa-mir-21	esophageal squamous cell carcinoma	up	Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma.
hsa-mir-21	esophageal squamous cell carcinoma	up	Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma.
hsa-mir-21	esophageal squamous cell carcinoma	down	Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma.
hsa-mir-21	esophageal squamous cell carcinoma	up	Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma.
hsa-mir-21	esophageal squamous cell carcinoma	up	miR-21 Down-Regulation Suppresses Cell Growth, Invasion and Induces Cell Apoptosis by Targeting FASL, TIMP3, and RECK Genes in Esophageal Carcinoma.
hsa-mir-21	esophageal squamous cell carcinoma	up	MicroRNA-21 promotes the proliferation and inhibits apoptosis in Eca109 via activating ERK1/2/MAPK pathway.
hsa-mir-21	esophageal squamous cell carcinoma	up	Downregulation of microRNA-21 inhibited radiation-resistance of esophageal squamous cell carcinoma.
hsa-mir-21	esophageal squamous cell carcinoma	up	Circulating plasma microRNAs in the detection of esophageal squamous cell carcinoma.
hsa-mir-21	esophageal squamous cell carcinoma	up	Circulating miR-21 as an independent predictive biomarker for chemoresistance in esophageal squamous cell carcinoma.
hsa-mir-21	gastric cancer	up	Mel-18 negatively regulates stem cell-like properties through downregulation of miR-21 in gastric cancer.
hsa-mir-21	gastric cancer	up	miR-21 plays a pivotal role in gastric cancer pathogenesis and progression.
hsa-mir-21	gastric cancer	up	Circulating microRNAs in plasma of patients with gastric cancers.
hsa-mir-21	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-21	gastric cancer	up	microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN.
hsa-mir-21	gastric cancer	up	MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer.
hsa-mir-21	gastric cancer	up	miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer.
hsa-mir-21	gastric cancer	up	Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.
hsa-mir-21	gastric cancer	up	Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma.
hsa-mir-21	gastric cancer	up	Oxidative Stress Upregulates PDCD4 Expression in Patients with Gastric Cancer via miR-21.
hsa-mir-21	gastric cancer	up	Evaluation of MicroRNA Expression Pattern of Gastric Adenocarcinoma Associated with Socioeconomic, Environmental and Lifestyle Factors in Northwestern Hungary.
hsa-mir-21	gastric cancer	up	MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog.
hsa-mir-21	gastric cancer	up	Stromal miR-21 is more important than miR-21 of tumour cells for the progression of gastric cancer.
hsa-mir-21	gastric cancer	up	miR-21 inhibits the effects of cyclooxygenase-2 inhibitor NS398 on apoptosis and invasion in gastric cancer cells.
hsa-mir-21	gastric cancer	up	Targeting MicroRNA-21 Suppresses Gastric Cancer Cell Proliferation and Migration via PTEN/Akt Signaling Axis.
hsa-mir-21	gastric cancer	up	miR-21 modulates prostaglandin signaling and promotes gastric tumorigenesis by targeting 15-PGDH.
hsa-mir-21	gastric cancer	up	Evaluation of circulating miR-21 and miR-222 as diagnostic biomarkers for gastric cancer.
hsa-mir-21	gastric cancer	up	Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer.
hsa-mir-21	gastric cancer	up	Tumor Expression of miR-10b, miR-21, miR-143 and miR-145 Is Related to Clinicopathological Features of Gastric Cancer in a Central European Population.
hsa-mir-21	gastric cancer	up	Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.
hsa-mir-21	gastric cancer	up	miRNA-21 promotes gastric cancer growth by adjusting prostaglandin E2.
hsa-mir-21	gastric cancer	up	MicroRNA-21 promotes TGF-?1-induced epithelial-mesenchymal transition in gastric cancer through up-regulating PTEN expression.
hsa-mir-21	gastric cancer	up	[Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer].
hsa-mir-21	gastric cancer	up	Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer
hsa-mir-21	gastrointestinal stromal tumor	down	miRNA-21 sensitizes gastrointestinal stromal tumors (GISTs) cells to Imatinib via targeting B-cell lymphoma 2 (Bcl-2).
hsa-mir-21	glioblastoma	up	Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
hsa-mir-21	glioblastoma	up	MicroRNA-21 Promotes Glioblastoma Tumorigenesis by Down-regulating Insulin-like Growth Factor-binding Protein-3 (IGFBP3).
hsa-mir-21	glioblastoma	up	MiR-21 up-regulation mediates glioblastoma cancer stem cells apoptosis and proliferation by targeting FASLG.
hsa-mir-21	glioblastoma	up	Delivery of anti-microRNA-21 antisense-oligodeoxynucleotide using amphiphilic peptides for glioblastoma gene therapy.
hsa-mir-21	glioblastoma	up	Sulforaphane enhances temozolomide-induced apoptosis due to downregulation of miR-21 via Wnt/?-catenin signaling in glioblastoma.
hsa-mir-21	glioblastoma	up	Targeting strategies on miRNA-21 and PDCD4 for glioblastoma.
hsa-mir-21	glioblastoma	up	Prognostic role of microRNA-21 expression in gliomas: a meta-analysis.
hsa-mir-21	glioblastoma	up	MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators.
hsa-mir-21	glioblastoma	up	MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells.
hsa-mir-21	glioblastoma	up	MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme.
hsa-mir-21	glioblastoma	up	Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status.
hsa-mir-21	glioblastoma	up	Co-delivery of as-miR-21 and 5-FU by poly(amidoamine) dendrimer attenuates human glioma cell growth in vitro.
hsa-mir-21	glioblastoma	up	Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo.
hsa-mir-21	glioblastoma	down	MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide.
hsa-mir-21	glioblastoma	up	Heterogeneous Nuclear Ribonucleoprotein C1/C2 Controls the Metastatic Potential of Glioblastoma by Regulating PDCD4.
hsa-mir-21	glioblastoma	up	PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma.
hsa-mir-21	glioblastoma	up	Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma.
hsa-mir-21	glioblastoma	up	The influence of distinct regulatory miRNAs of the p15/p16/RB1/E2F pathway on the clinical progression of glioblastoma.
hsa-mir-21	glioma	up	miR-21 Is Linked to Glioma Angiogenesis: A Co-Localization Study.
hsa-mir-21	glioma	up	MicroRNA-21 promotes glioma cell proliferation and inhibits senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT signaling pathway.
hsa-mir-21	glioma	up	Identification of microRNAs associated with glioma diagnosis and prognosis.
hsa-mir-21	head and neck cancer	up	MicroRNA alterations in head and neck squamous cell carcinoma.
hsa-mir-21	head and neck cancer	up	[Expression of mir-21 and mir-375 in laryngeal squamous cell carcinoma].
hsa-mir-21	head and neck squamous cell carcinoma	up	Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.
hsa-mir-21	head and neck squamous cell carcinoma	up	Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
hsa-mir-21	head and neck squamous cell carcinoma	up	Clusterin Is a Gene-Specific Target of microRNA-21 in Head and Neck Squamous Cell Carcinoma.
hsa-mir-21	head and neck squamous cell carcinoma	up	Co-targeting of multiple microRNAs on factor-inhibiting hypoxia-inducible factor (FIH) gene for the pathogenesis of head and neck carcinomas.
hsa-mir-21	hepatoblastoma	up	Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study.
hsa-mir-21	hepatocellular carcinoma	up	Overexpression of microRNA-21 strengthens stem cell-like characteristics in a hepatocellular carcinoma cell line.
hsa-mir-21	hepatocellular carcinoma	up	MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3.
hsa-mir-21	hepatocellular carcinoma	down	Expression of serum miR-16, let-7f, and miR-21 in patients with hepatocellular carcinoma and their clinical significances.
hsa-mir-21	hepatocellular carcinoma	up	Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor ? and androgen receptor.
hsa-mir-21	hepatocellular carcinoma	up	Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma.
hsa-mir-21	hepatocellular carcinoma	up	miR-21 expression predicts prognosis in hepatocellular carcinoma.
hsa-mir-21	hepatocellular carcinoma	up	Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog.
hsa-mir-21	hepatocellular carcinoma	up	MicroRNA-21 promotes cell proliferation in human hepatocellular carcinoma partly by targeting HEPN1.
hsa-mir-21	hepatocellular carcinoma	up	Anti-miR-21 Suppresses Hepatocellular Carcinoma Growth via Broad Transcriptional Network Deregulation.
hsa-mir-21	hepatocellular carcinoma	up	miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells.
hsa-mir-21	hepatocellular carcinoma	up	MiR-21 promoted proliferation and migration in hepatocellular carcinoma through negative regulation of Navigator-3.
hsa-mir-21	hepatocellular carcinoma	up	Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
hsa-mir-21	hepatocellular carcinoma	up	Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies.
hsa-mir-21	hepatocellular carcinoma	up	Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice.
hsa-mir-21	hepatocellular carcinoma	up	Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
hsa-mir-21	hepatocellular carcinoma	up	Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-21	hepatocellular carcinoma	up	miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma.
hsa-mir-21	hepatocellular carcinoma	up	Thyroid hormone regulation of miR-21 enhances migration and invasion of hepatoma.
hsa-mir-21	hepatocellular carcinoma	up	MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.
hsa-mir-21	hepatocellular carcinoma	up	Interaction of microRNA-21/145 and Smad3 domain-specific phosphorylation in hepatocellular carcinoma.
hsa-mir-21	hepatocellular carcinoma	up	Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis.
hsa-mir-21	hepatocellular carcinoma	up	Expression Analysis of MicroRNA-21 and MicroRNA-122 in Hepatocellular Carcinoma.
hsa-mir-21	hepatocellular carcinoma	up	Overexpression of miR-21 Is Associated With Recurrence in Patients With Hepatitis B Virus-Mediated Hepatocellular Carcinoma Undergoing Liver Transplantation.
hsa-mir-21	hepatocellular carcinoma	up	MiR-21 and miR-183 can simultaneously target SOCS6 and modulate growth and invasion of hepatocellular carcinoma (HCC) cells.
hsa-mir-21	hepatocellular carcinoma	up	Clinical significance of microRNA-21 expression in disease progression of patients with hepatocellular carcinoma.
hsa-mir-21	hepatocellular carcinoma	up	Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.
hsa-mir-21	hepatocellular carcinoma	up	Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.
hsa-mir-21	hepatocellular carcinoma	up	HBx-induced miR-21 suppresses cell apoptosis in hepatocellular carcinoma by targeting interleukin-12.
hsa-mir-21	hypopharyngeal squamous cell carcinoma	up	Altered Expression of miR-21 and PTEN in Human Laryngeal and Hypopharyngeal Squamous Cell Carcinomas.
hsa-mir-21	kidney cancer	up	miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer.
hsa-mir-21	laryngeal cancer	up	MicroRNA profile in site-specific head and neck squamous cell cancer.
hsa-mir-21	laryngeal carcinoma	up	Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
hsa-mir-21	laryngeal squamous cell carcinoma	up	Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma.
hsa-mir-21	laryngeal squamous cell carcinoma	up	Altered Expression of miR-21 and PTEN in Human Laryngeal and Hypopharyngeal Squamous Cell Carcinomas.
hsa-mir-21	laryngeal squamous cell carcinoma	up	MicroRNA-21 in laryngeal squamous cell carcinoma: Diagnostic and prognostic features.
hsa-mir-21	liver cancer	up	microRNA 21-mediated suppression of Sprouty1 by Pokemon affects liver cancer cell growth and proliferation.
hsa-mir-21	liver cancer	up	Suppression of miR-21 Expression Inhibits Cell Proliferation and Migration of Liver Cancer Cells by Targeting Phosphatase and Tensin Homolog (PTEN).
hsa-mir-21	lung cancer	up	Expression and significance of miRNA-21 and BTG2 in lung cancer.
hsa-mir-21	lung cancer	up	Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients.
hsa-mir-21	lung cancer	up	Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia.
hsa-mir-21	malignant melanoma	up	microRNA-21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells.
hsa-mir-21	malignant melanoma	up	MicroRNA-21 regulates the ERK/NF-?B signaling pathway to affect the proliferation, migration and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4 and PTEN.
hsa-mir-21	malignant melanoma	up	Quantification of microRNA-21 and microRNA-125b in melanoma tissue.
hsa-mir-21	malignant melanoma	up	MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of MiR-21 inhibitor.
hsa-mir-21	malignant melanoma	up	Expression and clinicopathological significance of microRNA-21 and programmed cell death 4 in malignant melanoma.
hsa-mir-21	medullary thyroid carcinoma	up	MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma.
hsa-mir-21	mucinous cystadenocarcinoma	up	Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.
hsa-mir-21	multiple myeloma	up	Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine.
hsa-mir-21	multiple myeloma	up	Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts.
hsa-mir-21	nasopharyngeal carcinoma	up	Activation of miR-21 by STAT3 Induces Proliferation and Suppresses Apoptosis in Nasopharyngeal Carcinoma by Targeting PTEN Gene.
hsa-mir-21	nasopharyngeal carcinoma	up	Downregulation of microRNA-21 enhances radiosensitivity in nasopharyngeal carcinoma.
hsa-mir-21	neuroblastoma	up	MicroRNA-21 promotes the proliferation and invasion of neuroblastoma cells through targeting CHL1.
hsa-mir-21	non-small cell lung cancer	up	MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN.
hsa-mir-21	non-small cell lung cancer	up	The role of microRNA-21 in predicting brain metastases from non-small cell lung cancer.
hsa-mir-21	non-small cell lung cancer	up	MiR-21 suppresses the anticancer activities of curcumin by targeting PTEN gene in human non-small cell lung cancer A549 cells.
hsa-mir-21	non-small cell lung cancer	up	Alteration in Mir-21/PTEN expression modulates gefitinib resistance in non-small cell lung cancer.
hsa-mir-21	non-small cell lung cancer	up	MicroRNA-21 (miR-21) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China.
hsa-mir-21	non-small cell lung cancer	up	Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4.
hsa-mir-21	non-small cell lung cancer	up	Effect of miR-21 on Apoptosis in Lung Cancer Cell Through Inhibiting the PI3K/ Akt/NF-?B Signaling Pathway in Vitro and in Vivo.
hsa-mir-21	non-small cell lung cancer	up	miR-21 regulates growth and EMT in lung cancer cells via PTEN/Akt/GSK3? signaling.
hsa-mir-21	non-small cell lung cancer	up	Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.
hsa-mir-21	non-small cell lung cancer	up	High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.
hsa-mir-21	non-small cell lung cancer	up	Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer.
hsa-mir-21	non-small cell lung cancer	up	Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.
hsa-mir-21	non-small cell lung cancer	up	[Overexpression of miR-21 promotes proliferation and reduces apoptosis in non-small cell lung cancer].
hsa-mir-21	non-small cell lung cancer	up	Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application.
hsa-mir-21	non-small cell lung cancer	up	Reduction of Plasma MicroRNA-21 is Associated with Chemotherapeutic Response in Patients with Non-small Cell Lung Cancer.
hsa-mir-21	non-small cell lung cancer	up	Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
hsa-mir-21	non-small cell lung cancer	up	Overexpression of miRNA-21 promotes radiation-resistance of non-small cell lung cancer.
hsa-mir-21	non-small cell lung cancer	up	Let-7g and miR-21 expression in non-small cell lung cancer: Correlation with clinicopathological and molecular features.
hsa-mir-21	non-small cell lung cancer	up	Role of microRNA-21 in radiosensitivity in non-small cell lung cancer cells by targeting PDCD4 gene.
hsa-mir-21	non-small cell lung cancer	up	Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
hsa-mir-21	non-small cell lung cancer	up	MicroRNA-21 regulates non-small cell lung cancer cell proliferation by affecting cell apoptosis via COX-19.
hsa-mir-21	oral cancer	up	MicroRNA-21 Promotes Oral Cancer Invasion via the Wnt/?-Catenin Pathway by Targeting DKK2.
hsa-mir-21	oral carcinoma	up	MicroRNA-21 promotes perineural invasion and impacts survival in patients with oral carcinoma.
hsa-mir-21	oral squamous cell carcinoma	up	Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia.
hsa-mir-21	oral squamous cell carcinoma	up	Altered levels of miR-21, miR-125b-2*, miR-134, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
hsa-mir-21	oral squamous cell carcinoma	up	Berberine-targeted miR-21 chemosensitizes oral carcinomas stem cells.
hsa-mir-21	oral squamous cell carcinoma	up	Low expression of lncRNA MEG3 promotes the progression of oral squamous cell carcinoma by targeting miR-21.
hsa-mir-21	oropharyngeal cancer	up	MicroRNA profile in site-specific head and neck squamous cell cancer.
hsa-mir-21	osteosarcoma	up	MicroRNA-21 Inhibits the Apoptosis of Osteosarcoma Cell Line SAOS-2 Via Targeting Caspase-8.
hsa-mir-21	osteosarcoma	up	MicroRNA-21 is involved in osteosarcoma cell invasion and migration.
hsa-mir-21	osteosarcoma	up	A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma.
hsa-mir-21	osteosarcoma	up	Identification of Serum MicroRNA-21 as a Biomarker for Chemosensitivity and Prognosis in Human Osteosarcoma.
hsa-mir-21	osteosarcoma	up	lncRNA-NEF is downregulated in osteosarcoma and inhibits cancer cell migration and invasion by downregulating miRNA-21.
hsa-mir-21	osteosarcoma	up	MicroRNA-21 promotes proliferation, invasion and suppresses apoptosis in human osteosarcoma line MG63 through PTEN/Akt pathway.
hsa-mir-21	osteosarcoma	up	MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells.
hsa-mir-21	ovarian cancer	up	The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer.
hsa-mir-21	ovarian cancer	up	Long non-coding RNA GAS5 inhibits ovarian cancer cell proliferation via the control of microRNA-21 and SPRY2 expression.
hsa-mir-21	pancreatic adenocarcinoma	up	Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma.
hsa-mir-21	pancreatic cancer	up	MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival.
hsa-mir-21	pancreatic cancer	up	MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance.
hsa-mir-21	pancreatic cancer	up	An elevated expression of serum exosomal microRNA-191, -?21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker.
hsa-mir-21	pancreatic ductal adenocarcinoma	up	MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.
hsa-mir-21	pancreatic ductal adenocarcinoma	up	Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma.
hsa-mir-21	pancreatic ductal adenocarcinoma	up	Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.
hsa-mir-21	pancreatic ductal adenocarcinoma	up	MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
hsa-mir-21	pancreatic ductal adenocarcinoma	up	MicroRNA-21 in Pancreatic Ductal Adenocarcinoma Tumor-Associated Fibroblasts Promotes Metastasis.
hsa-mir-21	pancreatic ductal adenocarcinoma	up	MiR-21 upregulation induced by promoter zone histone acetylation is associated with chemoresistance to gemcitabine and enhanced malignancy of pancreatic cancer cells.
hsa-mir-21	pancreatic ductal adenocarcinoma	up	Modulation of FoxO1 expression by miR-21 to promote growth of pancreatic ductal adenocarcinoma.
hsa-mir-21	pancreatic ductal adenocarcinoma	up	Interplay of miR-21 and FoxO1 modulates growth of pancreatic ductal adenocarcinoma.
hsa-mir-21	pancreatic ductal adenocarcinoma	up	MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.
hsa-mir-21	pancreatic ductal adenocarcinoma	up	Circulating microRNA-99 family as liquid biopsy marker in pancreatic adenocarcinoma.
hsa-mir-21	pancreatic ductal adenocarcinoma	up	[MicroRNA-21 correlates TGF-?1 pathway of pancreatic ductal adenocarcinoma].
hsa-mir-21	papillary thyroid carcinoma	up	miRNA-21 promotes cell proliferation and invasion via VHL/PI3K/AKT in papillary thyroid carcinoma.
hsa-mir-21	papillary thyroid carcinoma	up	MicroRNA-21 regulates biological behaviors in papillary thyroid carcinoma by targeting programmed cell death 4.
hsa-mir-21	papillary thyroid carcinoma	up	In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
hsa-mir-21	papillary thyroid carcinoma	up	Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.
hsa-mir-21	papillary thyroid carcinoma	up	MicroRNA Expression Profiles in Papillary Thyroid Carcinoma, Benign Thyroid Nodules and Healthy Controls.
hsa-mir-21	papillary thyroid carcinoma	up	Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.
hsa-mir-21	papillary thyroid carcinoma	up	Loss of DNA methylation is related to increased expression of miR-21 and miR-146b in papillary thyroid carcinoma.
hsa-mir-21	prostate cancer	up	MicroRNA-21 inhibits p57Kip2 expression in prostate cancer.
hsa-mir-21	prostate cancer	up	A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.
hsa-mir-21	prostate cancer	up	A microRNA code for prostate cancer metastasis.
hsa-mir-21	prostate cancer	up	Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer.
hsa-mir-21	rectal cancer	up	Expression of Circulating miR-155, miR-21, miR-221, miR-30a, miR-34a and miR-29a: Comparison of Colonic and Rectal Cancer.
hsa-mir-21	renal cell carcinoma	up	MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
hsa-mir-21	renal cell carcinoma	up	MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.
hsa-mir-21	renal cell carcinoma	up	Functional analysis of serum microRNAs miR-21 and miR-106a in renal cell carcinoma.
hsa-mir-21	renal cell carcinoma	up	Upregulation of miR-21 expression is a valuable predicator of advanced clinicopathological features and poor prognosis in patients with renal cell carcinoma through the p53/p21?cyclin E2?Bax/caspase-3
hsa-mir-21	renal cell carcinoma	up	The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma.
hsa-mir-21	renal cell carcinoma	up	miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer.
hsa-mir-21	renal cell carcinoma	up	MicroRNA-21 is overexpressed in renal cell carcinoma.
hsa-mir-21	renal cell carcinoma	up	The IGF-I/JAK2-STAT3/miR-21 signaling pathway may be associated with human renal cell carcinoma cell growth.
hsa-mir-21	renal cell carcinoma	up	Targeting miR-21 decreases expression of multi-drug resistant genes and promotes chemosensitivity of renal carcinoma.
hsa-mir-21	renal cell carcinoma	up	MicroRNA-21 functions as an oncogene and promotes cell proliferation and invasion via TIMP3 in renal cancer.
hsa-mir-21	retinoblastoma	up	Seed-targeting anti-miR-21 inhibiting malignant progression of retinoblastoma and analysis of their phosphorylation signaling pathways.
hsa-mir-21	squamous carcinoma	up	Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-21	uveal melanoma	up	Role of microRNA-21 in uveal melanoma cell invasion and metastasis by regulating p53 and its downstream protein.
hsa-mir-21-3p	colorectal cancer	up	Inhibition of microRNA-21-3p suppresses proliferation as well as invasion and induces apoptosis by targeting RNA-binding protein with multiple splicing through Smad4/extra cellular signal-regulated pr
hsa-mir-21-3p	hepatocellular carcinoma	down	MicroRNA-21-3p, a berberine-induced miRNA, directly down-regulates human methionine adenosyltransferases 2A and 2B and inhibits hepatoma cell growth.
hsa-mir-21-3p	laryngeal cancer	up	New miRNA expression abnormalities in laryngeal squamous cell carcinoma.
hsa-mir-21-3p	liver cancer	up	Suppression of miR-21-3p enhances TRAIL-mediated apoptosis in liver cancer stem cells by suppressing the PI3K/Akt/Bad cascade via regulating PTEN.
hsa-mir-21-3p	oral cancer	up	Next-generation Sequencing for microRNA Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.
hsa-mir-21-3p	oral squamous cell carcinoma	up	Next-generation Sequencing for microRNA Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.
hsa-mir-21-5p	clear cell renal cell cancer	up	Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles.
hsa-mir-21-5p	colorectal cancer	up	A panel of microRNA signature in serum for colorectal cancer diagnosis.
hsa-mir-21-5p	colorectal cancer	up	Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
hsa-mir-21-5p	esophageal cancer	up	Increased miR-203-3p and reduced miR-21-5p synergistically inhibit proliferation, migration, and invasion in esophageal cancer cells.
hsa-mir-21-5p	hepatocellular carcinoma	up	Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
hsa-mir-21-5p	laryngeal squamous cell carcinoma	up	Expression Levels and Clinical Significance of miR-21-5p, miR-let-7a, and miR-34c-5p in Laryngeal Squamous Cell Carcinoma.
hsa-mir-21-5p	lung adenocarcinoma	up	miR-21-5p promotes lung adenocarcinoma progression partially through targeting SET/TAF-I?.
hsa-mir-21-5p	non-small cell lung cancer	up	MiR-21-5p promotes the progression of non-small-cell lung cancer by regulating the expression of SMAD7.
hsa-mir-21-5p	rectal cancer	up	Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
hsa-mir-21-5p	squamous carcinoma	up	Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
hsa-mir-210	adrenal cortical carcinoma	up	The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
hsa-mir-210	bladder cancer	up	Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.
hsa-mir-210	breast cancer	down	MicroRNA-210 interacts with FBXO31 to regulate cancer proliferation cell cycle and migration in human breast cancer.
hsa-mir-210	cervical cancer	up	Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer.
hsa-mir-210	colorectal cancer	up	Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1?-VEGF signaling pathway.
hsa-mir-210	colorectal cancer	up	Exosomes secreted from human colon cancer cells influence the adhesion of neighboring metastatic cells: Role of microRNA-210.
hsa-mir-210	colorectal cancer	up	Hypoxia-inducible MiR-210 is an independent prognostic factor and contributes to metastasis in colorectal cancer.
hsa-mir-210	colorectal cancer	up	Circulating miR-210 as a diagnostic and prognostic biomarker for colorectal cancer.
hsa-mir-210	esophageal cancer	up	Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-210	esophageal squamous cell carcinoma	down	MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1).
hsa-mir-210	esophageal squamous cell carcinoma	down	The Role of MicroRNA-210 in Esophageal Squamous Cell Carcinoma.
hsa-mir-210	esophageal squamous cell carcinoma	down	MiR-210 expression reverses radioresistance of stem-like cells of oesophageal squamous cell carcinoma.
hsa-mir-210	gastric cancer	down	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-210	glioblastoma	up	Acute hypoxia induces upregulation of microRNA-210 expression in glioblastoma spheroids.
hsa-mir-210	glioblastoma	down	miR-210 inhibits cell migration and invasion by targeting the brain-derived neurotrophic factor in glioblastoma.
hsa-mir-210	glioblastoma	up	MicroRNA-210 regulates cell proliferation and apoptosis by targeting regulator of differentiation 1 in glioblastoma cells.
hsa-mir-210	glioma	up	MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
hsa-mir-210	glioma	up	MiR-210 up-regulation inhibits proliferation and induces apoptosis in glioma cells by targeting SIN3A.
hsa-mir-210	hepatocellular carcinoma	up	Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma.
hsa-mir-210	hepatocellular carcinoma	up	Effects of knockdown of miR-210 in combination with ionizing radiation on human hepatoma xenograft in nude mice.
hsa-mir-210	hepatocellular carcinoma	up	MicroRNA-210 promotes cancer angiogenesis by targeting fibroblast growth factor receptor-like 1 in hepatocellular carcinoma.
hsa-mir-210	hepatocellular carcinoma	up	Up-Regulation of hsa-miR-210 Promotes Venous Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma.
hsa-mir-210	kidney cancer	up	miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis.
hsa-mir-210	lung adenocarcinoma	up	miR-210 promotes lung adenocarcinoma proliferation, migration, and invasion by targeting lysyl oxidase-like 4.
hsa-mir-210	lung cancer	up	miR-210 promotes lung adenocarcinoma proliferation, migration, and invasion by targeting lysyl oxidase-like 4.
hsa-mir-210	lung cancer	up	MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines.
hsa-mir-210	malignant melanoma	up	MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
hsa-mir-210	malignant melanoma	up	Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
hsa-mir-210	malignant melanoma	up	A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients.
hsa-mir-210	medulloblastoma	up	Expression levels of vascular endothelial cell growth factor and microRNA-210 are increased in medulloblastoma and metastatic medulloblastoma.
hsa-mir-210	multiple myeloma	up	New role of hypoxia in pathophysiology of multiple myeloma through miR-210.
hsa-mir-210	non-small cell lung cancer	up	Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
hsa-mir-210	osteosarcoma	up	miR-210 promotes human osteosarcoma cell migration and invasion by targeting FGFRL1.
hsa-mir-210	osteosarcoma	up	Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma.
hsa-mir-210	osteosarcoma	up	Downregulation of microRNA-210 inhibits osteosarcoma growth in vitro and in vivo.
hsa-mir-210	ovarian cancer	up	miR-210, a modulator of hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cell.
hsa-mir-210	renal cell carcinoma	up	MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.
hsa-mir-210	renal cell carcinoma	up	Expression of microRNA-210 in tissue and serum of renal carcinoma patients and its effect on renal carcinoma cell proliferation, apoptosis, and invasion.
hsa-mir-210	renal clear cell carcinoma	up	Overexpression of miR-210, a downstream target of HIF1?, causes centrosome amplification in renal carcinoma cells.
hsa-mir-210	renal clear cell carcinoma	up	miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
hsa-mir-210	renal clear cell carcinoma	up	Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma.
hsa-mir-210-3p	glioblastoma	up	Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing.
hsa-mir-210-3p	non-small cell lung cancer	up	miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study.
hsa-mir-210-3p	prostate cancer	up	Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-?B signaling pathway.
hsa-mir-210-3p	renal clear cell carcinoma	up	microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.
hsa-mir-211	breast cancer	down	MicroRNA-211, a direct negative regulator of CDC25B expression, inhibits triple-negative breast cancer cells' growth and migration.
hsa-mir-211	breast cancer	down	Targeting PDK4 inhibits breast cancer metabolism.
hsa-mir-211	cervical cancer	down	miR-211 inhibits proliferation, invasion and migration of cervical cancer via targeting SPARC.
hsa-mir-211	colon cancer	down	[Expression and proliferative regulation of miR-204 related to mitochondrial transcription factor A in colon cancer].
hsa-mir-211	colorectal cancer	up	MicroRNA-211 expression promotes colorectal cancer cell growth in vitro and in vivo by targeting tumor suppressor CHD5.
hsa-mir-211	gastric cancer	down	SNP rs3202538 in 3'UTR region of ErbB3 regulated by miR-204 and miR-211 promote gastric cancer development in Chinese population.
hsa-mir-211	gastric cancer	down	MiR-211 inhibits cell proliferation and invasion of gastric cancer by down-regulating SOX4.
hsa-mir-211	glioblastoma	down	Methylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT/?-catenin pathway in GBM.
hsa-mir-211	glioma	down	MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma.
hsa-mir-211	glioma	down	The Effect of MCM3AP-AS1/miR-211/KLF5/AGGF1 Axis Regulating Glioblastoma Angiogenesis.
hsa-mir-211	hepatocellular carcinoma	down	MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinoma.
hsa-mir-211	hepatocellular carcinoma	down	miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.
hsa-mir-211	hepatocellular carcinoma	up	[MiR-211 promotes invasion of hepatoma cells by targeting estrogen receptor alpha].
hsa-mir-211	malignant melanoma	down	microRNA in situ hybridization for miR-211 detection as an ancillary test in melanoma diagnosis.
hsa-mir-211	malignant melanoma	down	The regulation of miRNA-211 expression and its role in melanoma cell invasiveness.
hsa-mir-211	malignant melanoma	down	Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma.
hsa-mir-211	malignant melanoma	down	Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor.
hsa-mir-211	malignant melanoma	down	Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.
hsa-mir-211	non-small cell lung cancer	up	miR-211 promotes non-small cell lung cancer proliferation by targeting SRCIN1.
hsa-mir-211	non-small cell lung cancer	up	MicroRNA-211 promotes non-small-cell lung cancer proliferation and invasion by targeting MxA.
hsa-mir-211	oral squamous cell carcinoma	up	Establishing of mouse oral carcinoma cell lines derived from transgenic mice and their use as syngeneic tumorigenesis models.
hsa-mir-211	oral squamous cell carcinoma	up	microRNA-211 promotes proliferation, migration, and invasion ability of oral squamous cell carcinoma cells via targeting the bridging integrator 1 protein.
hsa-mir-211	prostate cancer	down	MicroRNA-211 suppresses prostate cancer proliferation by targeting SPARC.
hsa-mir-211-5p	hepatocellular carcinoma	down	Regulatory role of miR-211-5p in hepatocellular carcinoma metastasis by targeting ZEB2.
hsa-mir-211-5p	kidney cancer	down	miR-211-5p Suppresses Metastatic Behavior by Targeting SNAI1 in Renal Cancer.
hsa-mir-211-5p	osteosarcoma	down	MicroRNA-211-5p promotes the apoptosis and inhibits the migration of osteosarcoma cells by targeting proline-rich protein PRR11.
hsa-mir-212	breast cancer	down	Aberrant Expression of Breast Development-Related MicroRNAs, miR-22, miR-132, and miR-212, in Breast Tumor Tissues.
hsa-mir-212	cervical cancer	down	Effect of miR-212 targeting TCF7L2 on the proliferation and metastasis of cervical cancer.
hsa-mir-212	colorectal cancer	down	Genetic and Epigenetic Down-regulation of MicroRNA-212 Promotes Colorectal Tumor Metastasis via Dysregulation of MnSOD.
hsa-mir-212	gastric cancer	down	miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer.
hsa-mir-212	gastric cancer	down	Down-regulation of miR-212 expression by DNA hypermethylation in human gastric cancer cells.
hsa-mir-212	hepatocellular carcinoma	down	Histone Demethylase Retinoblastoma Binding Protein 2 is Overexpressed in Hepatocellular Carcinoma and Negatively Regulated by hsa-miR-212.
hsa-mir-212	hepatocellular carcinoma	down	Diagnostic and prognostic potential of serum miR-132/212 cluster in patients with hepatocellular carcinoma.
hsa-mir-212	hepatocellular carcinoma	down	MicroRNA-212 inhibits hepatocellular carcinoma cell proliferation and induces apoptosis by targeting FOXA1.
hsa-mir-212	nasopharyngeal carcinoma	down	MicroRNA-212 inhibits the metastasis of nasopharyngeal carcinoma by targeting SOX4.
hsa-mir-212	non-small cell lung cancer	down	MicroRNA-212 functions as a tumor-suppressor in human non-small cell lung cancer by targeting SOX4.
hsa-mir-212	non-small cell lung cancer	down	miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED.
hsa-mir-212	non-small cell lung cancer	up	MiR-212 displays Tumor Promoting properties in NSCLC Cells and targets the Hedgehog Pathway Receptor PTCH1.
hsa-mir-212	non-small cell lung cancer	up	Synaptic acetylcholinesterase targeted by microRNA-212 functions as a tumor suppressor in non-small cell lung cancer.
hsa-mir-212	osteosarcoma	down	MicroRNA-212 inhibits osteosarcoma cells proliferation and invasion by down-regulation of Sox4.
hsa-mir-212	osteosarcoma	down	MicroRNA-212 suppresses the proliferation and migration of osteosarcoma cells by targeting forkhead box protein A1.
hsa-mir-212	ovarian cancer	down	MiR-212 exerts suppressive effect on SKOV3 ovarian cancer cells through targeting HBEGF.
hsa-mir-212	pancreatic cancer	up	miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor.
hsa-mir-212	pancreatic ductal adenocarcinoma	up	miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1.
hsa-mir-212	pancreatic ductal adenocarcinoma	up	miR-212 regulated by HIF-1? promotes the progression of pancreatic cancer.
hsa-mir-212	prostate cancer	down	A potential regulatory loop between Lin28B:miR?212 in androgen-independent prostate cancer.
hsa-mir-212	prostate cancer	down	MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence.
hsa-mir-212	renal cell carcinoma	down	MicroRNA-212 inhibits the proliferation, migration and invasion of renal cell carcinoma by targeting X-linked inhibitor of apoptosis protein (XIAP).
hsa-mir-212	thyroid cancer	down	Function of miR-212 as a tumor suppressor in thyroid cancer by targeting SIRT1.
hsa-mir-212-3p	glioblastoma	down	MiR-212-3p inhibits glioblastoma cell proliferation by targeting SGK3.
hsa-mir-212-3p	hepatocellular carcinoma	down	MicroRNA-212-3p inhibits the Proliferation and Invasion of Human Hepatocellular Carcinoma Cells by Suppressing CTGF expression.
hsa-mir-212-5p	acute myeloid leukemia	down	MiR-212-5p regulates the proliferation and apoptosis of AML cells through targeting FZD5.
hsa-mir-214	bladder cancer	down	MicroRNA-214 Suppresses Oncogenesis and Exerts Impact on Prognosis by Targeting PDRG1 in Bladder Cancer.
hsa-mir-214	breast cancer	down	miR-214 promotes apoptosis and sensitizes breast cancer cells to doxorubicin by targeting the RFWD2-p53 cascade.
hsa-mir-214	breast cancer	down	Tumor-suppressing roles of miR-214 and miR-218 in breast cancer.
hsa-mir-214	breast cancer	down	MiR-214 negatively regulates proliferation and WNT/?-catenin signaling in breast cancer.
hsa-mir-214	cervical cancer	down	MiR-214 inhibits cell migration, invasion and promotes the drug sensitivity in human cervical cancer by targeting FOXM1.
hsa-mir-214	cervical cancer	down	MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-?-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7.
hsa-mir-214	cervical cancer	down	MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells.
hsa-mir-214	cervical cancer	down	Effects of miR-214 on cervical cancer cell proliferation, apoptosis and invasion via modulating PI3K/AKT/mTOR signal pathway.
hsa-mir-214	cervical squamous cell carcinoma	down	Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK.
hsa-mir-214	colon cancer	down	microRNA-214 functions as a tumor suppressor in human colon cancer via the suppression of ADP-ribosylation factor-like protein 2.
hsa-mir-214	colon cancer	down	[Expression and proliferative regulation of miR-204 related to mitochondrial transcription factor A in colon cancer].
hsa-mir-214	colorectal cancer	down	The FOXD3/miR-214/MED19 axis suppresses tumour growth and metastasis in human colorectal cancer.
hsa-mir-214	esophageal cancer	up	LncRNA BDNF-AS inhibits proliferation, migration, invasion and EMT in oesophageal cancer cells by targeting miR-214.
hsa-mir-214	esophageal cancer	down	Regulation of ?-catenin-mediated esophageal cancer growth and invasion by miR-214.
hsa-mir-214	esophageal squamous cell carcinoma	down	miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer.
hsa-mir-214	esophageal squamous cell carcinoma	down	MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma.
hsa-mir-214	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-214	gastric cancer	up	Down-regulated miRNA-214 induces a cell cycle G1 arrest in gastric cancer cells by up-regulating the PTEN protein.
hsa-mir-214	gastric cancer	up	Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer.
hsa-mir-214	gastric cancer	up	Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasis.
hsa-mir-214	gastric cancer	up	MicroRNA-214 promotes peritoneal metastasis through regulating PTEN negatively in gastric cancer.
hsa-mir-214	gastric cancer	up	MicroRNA-214 promotes the proliferation, migration and invasion of gastric cancer MKN28 cells by suppressing the expression of Dact2.
hsa-mir-214	gastric cancer	up	Potential diagnostic and prognostic value of plasma long noncoding RNA LINC00086 and miR-214 expression in gastric cancer.
hsa-mir-214	glioma	up	Associations between the Expression of micro-RNA 214 and clinicopathologic parameters of glioma.
hsa-mir-214	glioma	down	miRNA-214 inhibits cellular proliferation and migration in glioma cells targeting caspase-1 involved in pyroptosis.
hsa-mir-214	hepatocellular carcinoma	down	MicroRNA-214 suppresses the proliferation of human hepatocellular carcinoma cells by targeting E2F3.
hsa-mir-214	hepatocellular carcinoma	down	Dynamic regulation of uncoupling protein 2 expression by microRNA-214 in hepatocellular carcinoma.
hsa-mir-214	hepatocellular carcinoma	down	MicroRNA-214 suppresses cell proliferation and migration and cell metabolism by targeting PDK2 and PHF6 in hepatocellular carcinoma.
hsa-mir-214	hepatocellular carcinoma	down	miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators.
hsa-mir-214	hepatocellular carcinoma	up	MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines.
hsa-mir-214	hepatocellular carcinoma	down	MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of ?-catenin.
hsa-mir-214	hepatocellular carcinoma	down	Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis.
hsa-mir-214	hepatocellular carcinoma	down	Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.
hsa-mir-214	hepatocellular carcinoma	down	Downreguation of FoxM1 by miR-214 inhibits proliferation and migration in hepatocellular carcinoma.
hsa-mir-214	lung adenocarcinoma	up	TWIST1 upregulates miR-214 to promote epithelial-to-mesenchymal transition and metastasis in lung adenocarcinoma.
hsa-mir-214	lung adenocarcinoma	up	microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein (Sufu).
hsa-mir-214	lung cancer	down	microRNA-214 Governs Lung Cancer Growth and Metastasis by Targeting Carboxypeptidase-D.
hsa-mir-214	malignant melanoma	up	Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models.
hsa-mir-214	malignant melanoma	up	Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
hsa-mir-214	multiple myeloma	down	Restoration of miR-214 expression reduces growth of myeloma cells through a positive regulation of P53 and inhibition of DNA replication.
hsa-mir-214	nasopharyngeal carcinoma	up	miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma.
hsa-mir-214	nasopharyngeal carcinoma	up	Knockdown of miR-214 Promotes Apoptosis and Inhibits Cell Proliferation in Nasopharyngeal Carcinoma.
hsa-mir-214	non-small cell lung cancer	up	Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2.
hsa-mir-214	oral cancer	up	MiR-214 regulates oral cancer KB cell apoptosis through targeting RASSF5.
hsa-mir-214	osteosarcoma	up	Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
hsa-mir-214	osteosarcoma	up	MicroRNA-214 functions as an oncogene in human osteosarcoma by targeting TRAF3.
hsa-mir-214	ovarian cancer	down	MiR-214 suppressed ovarian cancer and negatively regulated semaphorin 4D.
hsa-mir-214	ovarian cancer	up	Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.
hsa-mir-214	ovarian cancer	down	MicroRNA-214 Suppresses Ovarian Cancer by Targeting ?-Catenin.
hsa-mir-214	pancreatic cancer	down	Dysregulation of miR-15a and miR-214 in human pancreatic cancer.
hsa-mir-214	pancreatic cancer	up	Dysregulation of miR-15a and miR-214 in human pancreatic cancer.
hsa-mir-214	papillary thyroid carcinoma	up	BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases.
hsa-mir-214	primary cns lymphomas	down	Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.
hsa-mir-214	renal cell carcinoma	down	microRNA-214 Reduces IGF-1 Receptor Expression and Downstream mTORC1 Signaling in Renal Carcinoma Cells.
hsa-mir-214-3p	bladder cancer	up	LncRNA MT1JP functions as a tumor suppressor via regulating miR-214-3p expression in bladder cancer.
hsa-mir-214-3p	breast cancer	up	Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer.
hsa-mir-214-3p	esophageal cancer	down	Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1.
hsa-mir-214-3p	gastric cancer	up	The FENDRR/miR-214-3P/TET2 axis affects cell malignant activity via RASSF1A methylation in gastric cancer.
hsa-mir-214-3p	hepatocellular carcinoma	down	Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
hsa-mir-214-3p	hepatocellular carcinoma	down	LncRNA HOXA11-AS promotes hepatocellular carcinoma progression by repressing miR-214-3p.
hsa-mir-214-3p	hepatocellular carcinoma	down	MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis.
hsa-mir-214-3p	multiple myeloma	up	Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.
hsa-mir-214-3p	oral squamous cell carcinoma	down	LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
hsa-mir-214-5p	glioblastoma	up	Exosomal miR-214-5p Released from Glioblastoma Cells Modulates Inflammatory Response of Microglia after Lipopolysaccharide Stimulation through Targeting CXCR5.
hsa-mir-214-5p	hepatocellular carcinoma	down	MicroRNA-214-5p Inhibits the Invasion and Migration of Hepatocellular Carcinoma Cells by Targeting Wiskott-Aldrich Syndrome Like.
hsa-mir-214-5p	hepatocellular carcinoma	down	miR-214-5p targets KLF5 and suppresses proliferation of human hepatocellular carcinoma cells.
hsa-mir-214-5p	prostate cancer	down	miR-214-5p inhibits human prostate cancer proliferation and migration through regulating CRMP5.
hsa-mir-215	breast cancer	down	MicroRNA-215 acts as a tumor suppressor in breast cancer by targeting AKT serine/threonine kinase 1.
hsa-mir-215	cervical cancer	up	MicroRNA-215 is a potential prognostic marker for cervical cancer.
hsa-mir-215	colon cancer	down	Prognostic significance of miR-215 in colon cancer.
hsa-mir-215	colon cancer	down	SRPX2 regulates colon cancer cell metabolism by miR-192/215 via PI3K-Akt.
hsa-mir-215	colon cancer	down	MicroRNA-215 suppresses cell proliferation, migration and invasion of colon cancer by repressing Yin-Yang 1.
hsa-mir-215	colorectal cancer	down	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-215	colorectal cancer	down	Identification and functional screening of microRNAs highly deregulated in colorectal cancer.
hsa-mir-215	colorectal cancer	down	microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer.
hsa-mir-215	gastric cancer	up	MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro.
hsa-mir-215	gastric cancer	up	MiR-215 modulates gastric cancer cell proliferation by targeting RB1.
hsa-mir-215	gastric cancer	up	MiR-215/192 participates in gastric cancer progression.
hsa-mir-215	gastric cancer	up	Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.
hsa-mir-215	gastric cancer	up	miR-215 promotes cell migration and invasion of gastric cancer by targeting Retinoblastoma tumor suppressor gene 1.
hsa-mir-215	gastric cancer	up	miR-215 promotes cell migration and invasion of gastric cancer cell lines by targeting FOXO1.
hsa-mir-215	glioma	up	MicroRNA-215 enhances invasion and migration by targeting retinoblastoma tumor suppressor gene 1 in high-grade glioma.
hsa-mir-215	glioma	up	MiR-215, an activator of the CTNNBIP1/?-catenin pathway, is a marker of poor prognosis in human glioma.
hsa-mir-215	hepatocellular carcinoma	up	Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.
hsa-mir-215	hepatocellular carcinoma	down	Insight into the molecular mechanism of LINC00152/miR-215/CDK13 axis in hepatocellular carcinoma progression.
hsa-mir-215	hepatocellular carcinoma	up	Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carc
hsa-mir-215	non-small cell lung cancer	down	miR-215 suppresses proliferation and migration of non-small cell lung cancer cells.
hsa-mir-215	non-small cell lung cancer	down	miR-215 functions as a tumor suppressor and directly targets ZEB2 in human non-small cell lung cancer.
hsa-mir-215	ovarian carcinoma	up	The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas.
hsa-mir-215	pancreatic cancer	down	MicroRNA-215 functions as a tumor suppressor and directly targets ZEB2 in human pancreatic cancer.
hsa-mir-215	papillary thyroid carcinoma	down	miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3?/Snail signaling by targeting ARFGEF1.
hsa-mir-215-3p	cervical cancer	down	MicroRNA-215-3p suppresses the growth and metastasis of cervical cancer cell via targeting SOX9.
hsa-mir-215-5p	colorectal cancer	down	MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9.
hsa-mir-216a	breast cancer	down	MicroRNA-216a suppresses the proliferation and migration of human breast cancer cells via the Wnt/?-catenin signaling pathway.
hsa-mir-216a	colorectal cancer	down	Overexpression of microRNA-216a inhibits autophagy by targeting regulated MAP1S in colorectal cancer.
hsa-mir-216a	colorectal cancer	down	Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer.
hsa-mir-216a	esophageal squamous cell carcinoma	down	Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma.
hsa-mir-216a	gastric cancer	down	MicroRNA-216a inhibits the metastasis of gastric cancer cells by targeting JAK2/STAT3-mediated EMT process.
hsa-mir-216a	gastric cancer	up	Disregulation of miR-216a and miR-217 in Gastric Cancer and Their Clinical Significance.
hsa-mir-216a	glioma	down	Overexpression of MicroRNA-216a Suppresses Proliferation, Migration, and Invasion of Glioma Cells By Targeting Leucine-rich Repeat-containing G Protein-coupled Receptor 5.
hsa-mir-216a	glioma	down	Differentiation antagonizing non-protein coding RNA modulates the proliferation, migration, and angiogenesis of glioma cells by targeting the miR-216a/LGR5 axis and the PI3K/AKT signaling pathway.
hsa-mir-216a	hepatocellular carcinoma	up	Androgen pathway stimulates microRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis.
hsa-mir-216a	hepatocellular carcinoma	up	MiR-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
hsa-mir-216a	oral squamous cell carcinoma	down	MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
hsa-mir-216a	osteosarcoma	down	miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14.
hsa-mir-216a	pancreatic cancer	down	MiR-216a decreases MALAT1 expression, induces G2/M arrest and apoptosis in pancreatic cancer cells.
hsa-mir-216a	pancreatic cancer	down	[Expression of miR-216a in pancreatic cancer and its clinical significance].
hsa-mir-216a	pancreatic cancer	down	MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2.
hsa-mir-216a	pancreatic cancer	down	miR-216a may inhibit pancreatic tumor growth by targeting JAK2.
hsa-mir-216a	renal cell carcinoma	down	MiR-216a exerts tumor-suppressing functions in renal cell carcinoma by targeting TLR4.
hsa-mir-216a-3p	colorectal cancer	down	MiR-216a-3p inhibits colorectal cancer cell proliferation through direct targeting COX-2 and ALOX5.
hsa-mir-216a-3p	pancreatic ductal adenocarcinoma	down	The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster.
hsa-mir-216a-5p	colorectal cancer	down	Downregulation of miR-216a-5p by long noncoding RNA PVT1 suppresses colorectal cancer progression via modulation of YBX1 expression.
hsa-mir-216a-5p	pancreatic ductal adenocarcinoma	down	The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster.
hsa-mir-216a-5p	renal cell carcinoma	up	miR-216a-5p acts as an oncogene in renal cell carcinoma.
hsa-mir-216a-5p	small cell lung cancer	down	miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins.
hsa-mir-216a-5p	uveal melanoma	down	MiR-216a-5p/Hexokinase 2 axis regulates uveal melanoma growth through modulation of Warburg effect.
hsa-mir-216b	acute myeloid leukemia	up	Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia.
hsa-mir-216b	breast cancer	down	Regulation of the P2X7R by microRNA-216b in human breast cancer.
hsa-mir-216b	breast cancer	down	miR-216b suppresses breast cancer growth and metastasis by targeting SDCBP.
hsa-mir-216b	cervical cancer	down	MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.
hsa-mir-216b	colorectal cancer	down	MiR-216b suppresses colorectal cancer proliferation, migration, and invasion by targeting SRPK1.
hsa-mir-216b	colorectal cancer	down	MiR-216b functions as a tumor suppressor by targeting HMGB1-mediated JAK2/STAT3 signaling way in colorectal cancer.
hsa-mir-216b	esophageal squamous cell carcinoma	down	Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma.
hsa-mir-216b	gastric adenocarcinoma	down	MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8.
hsa-mir-216b	gastric adenocarcinoma	down	Retraction Note to: MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8.
hsa-mir-216b	gastric cancer	down	MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8.
hsa-mir-216b	glioma	down	miR-216b inhibits glioma cell migration and invasion through suppression of FoxM1.
hsa-mir-216b	glioma	down	Downregulation of microRNA-216b contributes to glioma cell growth and migration by promoting AEG-1-mediated signaling.
hsa-mir-216b	hepatocellular carcinoma	down	MicroRNA-216b is downregulated in hepatocellular carcinoma and inhibits HepG2 cell growth by targeting Forkhead box protein M1.
hsa-mir-216b	malignant melanoma	down	microRNA-216b inhibits cell proliferation and migration in human melanoma by targeting FOXM1 in vitro and in vivo.
hsa-mir-216b	nasopharyngeal carcinoma	down	miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma.
hsa-mir-216b	nasopharyngeal carcinoma	down	[miR-216b suppresses cell proliferation and invasion by targeting PKC? in nasopharyngeal carcinoma cells].
hsa-mir-216b	non-small cell lung cancer	down	MiR-216b suppresses cell proliferation, migration, invasion, and epithelial-mesenchymal transition by regulating FOXM1 expression in human non-small cell lung cancer.
hsa-mir-216b	osteosarcoma	down	MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1.
hsa-mir-216b	ovarian cancer	down	MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1.
hsa-mir-216b	pancreatic cancer	down	MiR-216b inhibits pancreatic cancer cell progression and promotes apoptosis by down-regulating KRAS.
hsa-mir-216b	pancreatic ductal adenocarcinoma	down	MicroRNA-216b reduces growth, migration and invasion of pancreatic ductal adenocarcinoma cells by directly targeting ?-associated coiled-coil containing protein kinase 1.
hsa-mir-216b	renal clear cell carcinoma	down	miR-216b Post-Transcriptionally Downregulates Oncogene KRAS and Inhibits Cell Proliferation and Invasion in Clear Cell Renal Cell Carcinoma.
hsa-mir-216b-3p	lung adenocarcinoma	down	MicroRNA-216b-3p inhibits lung adenocarcinoma cell growth via regulating PDZ binding kinase/T-LAK-cell-originated protein kinase.
hsa-mir-216b-3p	pancreatic ductal adenocarcinoma	down	The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster.
hsa-mir-216b-5p	pancreatic cancer	down	MicroRNA-216b-5p Functions as a Tumor-suppressive RNA by Targeting TPT1 in Pancreatic Cancer Cells.
hsa-mir-216b-5p	pancreatic ductal adenocarcinoma	down	The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster.
hsa-mir-217	acute myeloid leukemia	down	MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS.
hsa-mir-217	breast cancer	up	MiR-217 Promotes Tumor Proliferation in Breast Cancer via Targeting DACH1.
hsa-mir-217	cervical cancer	down	MicroRNA-217 functions as a tumor suppressor in cervical cancer cells through targeting Rho-associated protein kinase 1.
hsa-mir-217	colorectal cancer	down	miR-217 regulates tumor growth and apoptosis by targeting the MAPK signaling pathway in colorectal cancer.
hsa-mir-217	gastric cancer	down	microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer.
hsa-mir-217	gastric cancer	down	The MicroRNA-217 Functions as a Potential Tumor Suppressor in Gastric Cancer by Targeting GPC5.
hsa-mir-217	gastric cancer	down	MicroRNA-217 suppressed epithelial-to-mesenchymal transition in gastric cancer metastasis through targeting PTPN14.
hsa-mir-217	gastric cancer	down	Long non-coding RNA Hotair promotes gastric cancer progression via miR-217-GPC5 axis.
hsa-mir-217	gastric cancer	down	HOTAIR enhanced paclitaxel and doxorubicin resistance in gastric cancer cells partly through inhibiting miR-217 expression.
hsa-mir-217	glioblastoma	up	MiR-217 promoted the proliferation and invasion of glioblastoma by repressing YWHAG.
hsa-mir-217	glioma	down	TTBK2 circular RNA promotes glioma malignancy by regulating miR-217/HNF1?/Derlin-1 pathway.
hsa-mir-217	glioma	down	MicroRNA-217 inhibits cell proliferation and invasion by targeting Runx2 in human glioma.
hsa-mir-217	hepatocellular carcinoma	down	Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma.
hsa-mir-217	hepatocellular carcinoma	down	miR-217 suppresses proliferation, migration, and invasion promoting apoptosis via targeting MTDH in hepatocellular carcinoma.
hsa-mir-217	hepatocellular carcinoma	up	MiR-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
hsa-mir-217	hepatocellular carcinoma	down	miR-217 inhibits invasion of hepatocellular carcinoma cells through direct suppression of E2F3.
hsa-mir-217	hepatocellular carcinoma	up	miR-217 targeting DKK1 promotes cancer stem cell properties via activation of the Wnt signaling pathway in hepatocellular carcinoma.
hsa-mir-217	laryngeal cancer	down	miR-217 inhibits laryngeal cancer metastasis by repressing AEG-1 and PD-L1 expression.
hsa-mir-217	liver cancer	down	HOTAIR contributes to the growth of liver cancer via targeting miR-217.
hsa-mir-217	lung cancer	down	MicroRNA-217 functions as a tumour suppressor gene and correlates with cell resistance to cisplatin in lung cancer.
hsa-mir-217	malignant melanoma	down	Long noncoding RNA OIP5-AS1 acts as a competing endogenous RNA to promote glutamine catabolism and malignant melanoma growth by sponging miR-217.
hsa-mir-217	non-small cell lung cancer	down	Long non-coding RNA HOTAIR regulates the development of non-small cell lung cancer through miR-217/DACH1 signaling pathway.
hsa-mir-217	non-small cell lung cancer	down	MicroRNA-217 alleviates development of non-small cell lung cancer by inhibiting AKT3 via PI3K pathway.
hsa-mir-217	osteosarcoma	down	Loss of miR-217 promotes osteosarcoma cell proliferation through targeting SETD8.
hsa-mir-217	osteosarcoma	down	MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in osteosarcoma.
hsa-mir-217	osteosarcoma	down	The microRNA-217 functions as a tumor suppressor and is frequently downregulated in human osteosarcoma.
hsa-mir-217	osteosarcoma	down	MiR-217 Inhibits Proliferation, Migration, and Invasion by Targeting SIRT1 in Osteosarcoma.
hsa-mir-217	ovarian cancer	down	MiR-217 Inhibits M2-Like Macrophage Polarization by Suppressing Secretion of Interleukin-6 in Ovarian Cancer.
hsa-mir-217	pancreatic adenocarcinoma	down	MicroRNA-217 inhibits cell proliferation, invasion and migration by targeting Tpd52l2 in human pancreatic adenocarcinoma.
hsa-mir-217	pancreatic ductal adenocarcinoma	down	Regulation of actin-binding protein ANLN by antitumor miR-217 inhibits cancer cell aggressiveness in pancreatic ductal adenocarcinoma.
hsa-mir-217	pancreatic ductal adenocarcinoma	down	The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.
hsa-mir-217	pancreatic ductal adenocarcinoma	down	MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
hsa-mir-217	pancreatic ductal adenocarcinoma	down	MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.
hsa-mir-217	renal cell carcinoma	down	LncRNA HOTAIR regulates HIF-1?/AXL signaling through inhibition of miR-217 in renal cell carcinoma.
hsa-mir-217	thyroid cancer	down	miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer.
hsa-mir-218	bladder cancer	down	MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1.
hsa-mir-218	breast cancer	down	Silencing of miRNA-218 promotes migration and invasion of breast cancer via Slit2-Robo1 pathway.
hsa-mir-218	breast cancer	down	Tumor-suppressing roles of miR-214 and miR-218 in breast cancer.
hsa-mir-218	breast cancer	down	CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.
hsa-mir-218	cervical cancer	down	Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion.
hsa-mir-218	cervical cancer	down	MicroRNA-218 increases cellular sensitivity to Rapamycin via targeting Rictor in cervical cancer.
hsa-mir-218	cervical cancer	down	MiR-218 produces anti-tumor effects on cervical cancer cells in vitro.
hsa-mir-218	cervical cancer	down	Methylation and expression of miRNAs in precancerous lesions and cervical cancer with HPV16 infection.
hsa-mir-218	cervical cancer	down	MicroRNA-218 inhibits EMT, migration and invasion by targeting SFMBT1 and DCUN1D1 in cervical cancer.
hsa-mir-218	cervical squamous cell carcinoma	down	Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma.
hsa-mir-218	chondrosarcoma	up	Downregulation of miR-185 and upregulation of miR-218 expression may be potential diagnostic and prognostic biomarkers of human chondrosarcoma.
hsa-mir-218	choriocarcinoma	down	MicroRNA-218 inhibits the proliferation of human choriocarcinoma JEG-3 cell line by targeting Fbxw8.
hsa-mir-218	colorectal cancer	down	MicroRNA-218 Inhibits Cell Cycle Progression and Promotes Apoptosis in Colon Cancer by Downregulating BMI1 Polycomb Ring Finger Oncogene.
hsa-mir-218	colorectal cancer	down	Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer.
hsa-mir-218	colorectal cancer	down	MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
hsa-mir-218	colorectal cancer	down	Downregulation of YEATS4 by miR-218 sensitizes colorectal cancer cells to L-OHP-induced cell apoptosis by inhibiting cytoprotective autophagy.
hsa-mir-218	colorectal cancer	down	MACC1 is post-transcriptionally regulated by miR-218 in colorectal cancer.
hsa-mir-218	colorectal cancer	down	MiR-218 regulates epithelial-mesenchymal transition and angiogenesis in colorectal cancer via targeting CTGF.
hsa-mir-218	esophageal cancer	down	Serum microRNA-218 is a potential biomarker for esophageal cancer.
hsa-mir-218	esophageal cancer	down	MiR-218 suppresses metastasis and invasion of endometrial cancer via negatively regulating ADD2.
hsa-mir-218	esophageal squamous cell carcinoma	up	miR-218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin.
hsa-mir-218	esophageal squamous cell carcinoma	down	MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1.
hsa-mir-218	gastric cancer	down	Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer.
hsa-mir-218	gastric cancer	down	[Reduced expression of miR-218 and its significance in gastric cancer].
hsa-mir-218	gastric cancer	down	Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.
hsa-mir-218	gastric cancer	down	Reduced expression of circulating microRNA-218 in gastric cancer and correlation with tumor invasion and prognosis.
hsa-mir-218	gastric cancer	down	MicroRNA-218 is upregulated in gastric cancer after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and increases chemosensitivity to cisplatin.
hsa-mir-218	gastric cancer	down	Thermo-chemotherapy Induced miR-218 upregulation inhibits the invasion of gastric cancer via targeting Gli2 and E-cadherin.
hsa-mir-218	gastric cancer	down	miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
hsa-mir-218	gastric cancer	down	miR-218 tissue expression level is associated with aggressive progression of gastric cancer.
hsa-mir-218	gastric cancer	down	miR-218 inhibits proliferation, migration, and EMT of gastric cancer cells by targeting WASF3.
hsa-mir-218	gastric cancer	down	miR-218 suppresses gastric cancer cell proliferation and invasion via regulation of angiopoietin-2.
hsa-mir-218	gastric cancer	down	The clinical significance of miR-335, miR-124, miR-218 and miR-484 downregulation in gastric cancer.
hsa-mir-218	gastric cancer	down	miR-218 inhibited tumor angiogenesis by targeting ROBO1 in gastric cancer.
hsa-mir-218	gastrointestinal stromal tumor	down	MicroRNA-218 inhibits gastrointestinal stromal tumor cell and invasion by targeting KIT.
hsa-mir-218	glioma	down	MicroRNA-218 Inhibits Glioma Invasion, Migration, Proliferation and Cancer Stem-like Cell Self-renewal by Targeting the Polycomb Group Gene Bmi1.
hsa-mir-218	glioma	down	Expression of microRNA-218 and its clinicopathological and prognostic significance in human glioma cases.
hsa-mir-218	glioma	down	miR-218 inhibits the proliferation of glioma U87 cells through the inactivation of the CDK6/cyclin D1/p21(Cip1/Waf1) pathway.
hsa-mir-218	glioma	down	miR-218 inhibits the tumorgenesis and proliferation of glioma cells by targeting Robo1.
hsa-mir-218	head and neck squamous cell carcinoma	down	Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma.
hsa-mir-218	hepatocellular carcinoma	down	miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10.
hsa-mir-218	hepatocellular carcinoma	down	Overexpression of miR-218 inhibits hepatocellular carcinoma cell growth through RET
hsa-mir-218	hepatocellular carcinoma	down	MicroRNA-218 and microRNA-520a inhibit cell proliferation by downregulating E2F2 in hepatocellular carcinoma.
hsa-mir-218	laryngeal squamous cell carcinoma	down	Long non-coding RNA CCAT1/miR-218/ZFX axis modulates the progression of laryngeal squamous cell cancer.
hsa-mir-218	lung adenocarcinoma	down	miR-218 suppresses epithelial-to-mesenchymal transition by targeting Robo1 and Ecop in lung adenocarcinoma cells.
hsa-mir-218	lung cancer	down	Inhibition of pulmonary carcinoma proliferation or metastasis of miR-218 via down-regulating CDCP1 expression.
hsa-mir-218	lung cancer	down	MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis.
hsa-mir-218	lung cancer	down	MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma.
hsa-mir-218	lung cancer	down	MiRNA-218, a new regulator of HMGB1, suppresses cell migration and invasion in non-small cell lung cancer.
hsa-mir-218	lung cancer	down	ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis.
hsa-mir-218	lung cancer	down	Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling.
hsa-mir-218	lung squamous cell carcinoma	down	Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.
hsa-mir-218	lung squamous cell carcinoma	down	MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma.
hsa-mir-218	malignant melanoma	down	Expression patterns of microRNA-218 and its potential functions by targeting CIP2A and BMI1 genes in melanoma.
hsa-mir-218	nasopharyngeal cancer	down	MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway.
hsa-mir-218	non-small cell lung cancer	down	Downregulation of miR-218 by nicotine promotes cell proliferation through targeting CDK6 in non-small cell lung cancer.
hsa-mir-218	oral cancer	down	The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer.
hsa-mir-218	oral cancer	down	MicroRNA-218 promotes cisplatin resistance in oral cancer via the PPP2R5A/Wnt signaling pathway.
hsa-mir-218	osteosarcoma	down	miRNA-218 Inhibits Osteosarcoma Cell Migration and Invasion by Down-regulating of TIAM1, MMP2 and MMP9.
hsa-mir-218	osteosarcoma	up	[MicroRNA-218 promotes osteosarcoma cell apoptosis by down-regulating oncogene B lymphoma mouse Moloney leukemia virus insertion region 1].
hsa-mir-218	osteosarcoma	down	MiR-218 promotes apoptosis of U2OS osteosarcoma cells through targeting BIRC5.
hsa-mir-218	osteosarcoma	down	miR-218 suppresses the proliferation of osteosarcoma through downregulation of E2F2.
hsa-mir-218	ovarian cancer	down	MicroRNA-218 inhibits proliferation and invasion in ovarian cancer by targeting Runx2.
hsa-mir-218	pancreatic ductal adenocarcinoma	down	Enhancer of Zeste Homolog 2 Silences miR-218 in Human Pancreatic Ductal Adenocarcinoma Cells by Inducing Formation of Heterochromatin.
hsa-mir-218	prostate cancer	down	Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.
hsa-mir-218	prostate cancer	down	microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression.
hsa-mir-218	prostate cancer	down	MicroRNA-218 inhibits tumor growth and increases chemosensitivity to CDDP treatment by targeting BCAT1 in prostate cancer.
hsa-mir-218	prostate cancer	down	Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer.
hsa-mir-218	renal cell carcinoma	down	MicroRNA-218 Inhibits Cell Migration and Invasion in Renal Cell Carcinoma Through Targeting Caveolin-2 Involved in Focal Adhesion Pathway.
hsa-mir-218	renal cell carcinoma	down	miR-218 suppresses the proliferation of osteosarcoma through downregulation of E2F2.
hsa-mir-218	renal cell carcinoma	down	Effect of MicroRNA-218 on the viability, apoptosis and invasion of renal cell carcinoma cells under hypoxia by targeted downregulation of CXCR7 expression.
hsa-mir-218	renal clear cell carcinoma	down	miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
hsa-mir-218	renal clear cell carcinoma	down	MicroRNA-218 inhibits the cell proliferation and migration in clear cell renal cell carcinoma through targeting cancerous inhibitor of protein phosphatase 2A.
hsa-mir-218-5p	cervical cancer	down	MicroRNA-218-5p inhibits cell growth and metastasis in cervical cancer via LYN/NF-?B signaling pathway.
hsa-mir-218-5p	gallbladder carcinoma	down	miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer.
hsa-mir-218-5p	glioma	down	MiR-218-5p targets LHFPL3 to regulate proliferation, migration, and epithelial-mesenchymal transitions of human glioma cells.
hsa-mir-218-5p	glioma	down	miR-218-5p inhibits the stem cell properties and invasive ability of the A2B5+CD133- subgroup of human glioma stem cells.
hsa-mir-218-5p	non-small cell lung cancer	down	Tumor-suppressive miR-218-5p inhibits cancer cell proliferation and migration via EGFR in non-small cell lung cancer.
hsa-mir-219	glioma	down	MicroRNA-219 exerts a tumor suppressive role in glioma via targeting Sal-like protein 4.
hsa-mir-219	non-small cell lung cancer	down	MicroRNA-219 is downregulated in non-small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2.
hsa-mir-219-5p	chordoma	down	miR-219-5p inhibits proliferation and clonogenicity in chordoma cells and is associated with tumor recurrence.
hsa-mir-219-5p	colorectal cancer	down	MicroRNA-219-5p functions as a?tumor suppressor partially by targeting platelet-derived growth factor receptor alpha in colorectal cancer.
hsa-mir-219-5p	colorectal cancer	down	miR-219-5p suppresses the proliferation and invasion of colorectal cancer cells by targeting calcyphosin.
hsa-mir-219-5p	colorectal cancer	down	microRNA-219-5p inhibits epithelial-mesenchymal transition and metastasis of colorectal cancer by targeting lymphoid enhancer-binding factor 1.
hsa-mir-219-5p	esophageal squamous cell carcinoma	down	MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2.
hsa-mir-219-5p	glioblastoma	down	miR-219-5p Inhibits Receptor Tyrosine Kinase Pathway by Targeting EGFR in Glioblastoma.
hsa-mir-219-5p	glioma	down	miR-219-5p Inhibits Receptor Tyrosine Kinase Pathway by Targeting EGFR in Glioblastoma.
hsa-mir-219-5p	hepatocellular carcinoma	down	MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3.
hsa-mir-219-5p	hepatocellular carcinoma	down	Propofol-induced miR-219-5p inhibits growth and invasion of hepatocellular carcinoma through suppression of GPC3-mediated Wnt/?-catenin signalling activation.
hsa-mir-219-5p	papillary thyroid carcinoma	down	miR-219-5p Modulates Cell Growth of Papillary Thyroid Carcinoma by Targeting Estrogen Receptor ?
hsa-mir-219a-5p	breast cancer	down	miR-219a-5p inhibits breast cancer cell migration and epithelial-mesenchymal transition by targeting myocardin-related transcription factor A.
hsa-mir-22	bladder cancer	down	MiR-22 suppresses epithelial-mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop.
hsa-mir-22	breast cancer	down	miR-22 suppresses tumorigenesis and improves radiosensitivity of breast cancer cells by targeting Sirt1.
hsa-mir-22	breast cancer	down	MicroRNA-22 inhibits cell growth and metastasis in breast cancer via targeting of SIRT1.
hsa-mir-22	breast cancer	down	A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.
hsa-mir-22	breast cancer	down	miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer.
hsa-mir-22	breast cancer	down	Serum miR-22 Could be a Potential Biomarker for the Prognosis of Breast Cancer.
hsa-mir-22	breast cancer	down	MicroRNA-22 inhibits proliferation, invasion and metastasis of breast cancer cells through targeting truncated neurokinin-1 receptor and ER?.
hsa-mir-22	breast cancer	down	MicroRNA-22 Suppresses Breast Cancer Cell Growth and Increases Paclitaxel Sensitivity by Targeting NRAS.
hsa-mir-22	cervical cancer	down	Suppression of miR-22, a tumor suppressor in cervical cancer, by human papillomavirus 16 E6 via a p53/miR-22/HDAC6 pathway.
hsa-mir-22	cervical cancer	down	miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer.
hsa-mir-22	colon cancer	down	MicroRNA-22 regulates hypoxia signaling in colon cancer cells.
hsa-mir-22	colon cancer	down	MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells.
hsa-mir-22	colon cancer	down	miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9.
hsa-mir-22	colorectal cancer	down	Clinical significance of miR-22 expression in patients with colorectal cancer.
hsa-mir-22	colorectal cancer	down	The Jun/miR-22/HuR regulatory axis contributes to tumourigenesis in colorectal cancer.
hsa-mir-22	esophageal squamous cell carcinoma	down	Increased miRNA-22 expression sensitizes esophageal squamous cell carcinoma to irradiation.
hsa-mir-22	esophageal squamous cell carcinoma	down	miR-22 is down-regulated in esophageal squamous cell carcinoma and inhibits cell migration and invasion.
hsa-mir-22	gastric cancer	down	miR-22 is down-regulated in gastric cancer, and its overexpression inhibits cell migration and invasion via targeting transcription factor Sp1.
hsa-mir-22	gastric cancer	down	Reduced expression of miR-22 in gastric cancer is related to clinicopathologic characteristics or patient prognosis.
hsa-mir-22	gastric cancer	down	miR-22 suppresses the proliferation and invasion of gastric cancer cells by inhibiting CD151.
hsa-mir-22	gastric cancer	down	microRNA-22 acts as a metastasis suppressor by targeting metadherin in gastric cancer.
hsa-mir-22	gastric cancer	down	MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail.
hsa-mir-22	glioblastoma	down	miR-22 inhibits the proliferation, motility, and invasion of human glioblastoma cells by directly targeting SIRT1.
hsa-mir-22	hepatocellular carcinoma	down	MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma.
hsa-mir-22	hepatocellular carcinoma	down	microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity.
hsa-mir-22	hepatocellular carcinoma	down	MicroRNA-22 expression in hepatocellular carcinoma and its correlation with ezrin protein.
hsa-mir-22	hepatocellular carcinoma	down	miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.
hsa-mir-22	kidney cancer	down	MicroRNA-22 functions as a tumor suppressor by targeting SIRT1 in renal cell carcinoma.
hsa-mir-22	liver cancer	down	microRNA-22 downregulation of galectin-9 influences lymphocyte apoptosis and tumor cell proliferation in liver cancer.
hsa-mir-22	lung cancer	down	Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3.
hsa-mir-22	lung cancer	down	miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer.
hsa-mir-22	lung cancer	down	MiR-22 inhibits lung cancer cell EMT and invasion through targeting Snail.
hsa-mir-22	malignant melanoma	down	Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22.
hsa-mir-22	medulloblastoma	down	MiR-22 is Frequently Down-regulated in Medulloblastomas, and Inhibits Cell Proliferation via the Novel Target PAPST1.
hsa-mir-22	multiple myeloma	down	miR-22 suppresses DNA ligase III addiction in multiple myeloma.
hsa-mir-22	non-small cell lung cancer	up	Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer.
hsa-mir-22	oral squamous cell carcinoma	down	MicroRNA-22 suppresses cell proliferation, migration and invasion in oral squamous cell carcinoma by targeting NLRP3.
hsa-mir-22	osteosarcoma	down	miR-22 inhibits osteosarcoma cell proliferation and migration by targeting HMGB1 and inhibiting HMGB1-mediated autophagy.
hsa-mir-22	osteosarcoma	down	Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma.
hsa-mir-22	osteosarcoma	down	miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer.
hsa-mir-22	osteosarcoma	down	Roles of microRNA-22 in Suppressing Proliferation and Promoting Sensitivity of Osteosarcoma Cells via Metadherin-mediated Autophagy.
hsa-mir-22	prostate cancer	down	miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer.
hsa-mir-22	prostate cancer	up	MTA1-activated Epi-microRNA-22 regulates E-cadherin and prostate cancer invasiveness.
hsa-mir-22	prostate cancer	up	Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis.
hsa-mir-22	renal clear cell carcinoma	down	MicroRNA-22 is downregulated in clear cell renal cell carcinoma, and inhibits cell growth, migration and invasion by targeting PTEN.
hsa-mir-22	retinoblastoma	down	Effects of miR-22 on viability, migration, invasion and apoptosis in retinoblastoma Y79 cells by targeting high-mobility group box 1.
hsa-mir-22	t-cell lymphoma	down	miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9.
hsa-mir-22-3p	hepatocellular carcinoma	down	Berberine upregulates miR-22-3p to suppress hepatocellular carcinoma cell proliferation by targeting Sp1.
hsa-mir-22-3p	hepatocellular carcinoma	down	Catalpol inhibits cell proliferation, invasion and migration through regulating miR-22-3p/MTA3 signalling in hepatocellular carcinoma.
hsa-mir-220a	oral squamous cell carcinoma	down	Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-221	anaplastic thyroid carcinoma	up	A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.
hsa-mir-221	bladder cancer	up	Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-221	bladder cancer	up	MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL.
hsa-mir-221	brain cancer	up	MicroRNA-target cross-talks: Key players in glioblastoma multiforme.
hsa-mir-221	breast cancer	up	TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer.
hsa-mir-221	breast cancer	up	From microRNA functions to microRNA therapeutics: Novel targets and novel drugs in breast cancer research and treatment (Review).
hsa-mir-221	breast cancer	up	miR-221/222 promotes S-phase entry and cellular migration in control of basal-like breast cancer.
hsa-mir-221	breast cancer	up	MiR-221/222 promote epithelial-mesenchymal transition by targeting Notch3 in breast cancer cell lines.
hsa-mir-221	breast cancer	up	Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
hsa-mir-221	breast cancer	up	Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression.
hsa-mir-221	breast cancer	up	miR-221/222 promote tumor growth and suppress apoptosis by targeting lncRNA GAS5 in breast cancer.
hsa-mir-221	breast cancer	down	Knockdown of miR-221 promotes the cisplatin-inducing apoptosis by targeting the BIM-Bax/Bak axis in breast cancer.
hsa-mir-221	cervical cancer	up	MicroRNA-221 targets PTEN to reduce the sensitivity of cervical cancer cells to gefitinib through the PI3K/Akt signaling pathway.
hsa-mir-221	cervical cancer	up	Upregulated exosomal miR-221/222 promotes cervical cancer via repressing methyl-CpG-binding domain protein 2.
hsa-mir-221	colon carcinoma	up	[MicroRNA-221 promotes colon carcinoma cell proliferation in vitro by inhibiting CDKN1C/p57 expression].
hsa-mir-221	colorectal cancer	up	MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma.
hsa-mir-221	colorectal cancer	up	[MicroRNA-221 controls CDKN1C/P57 expression in human colorectal carcinoma].
hsa-mir-221	colorectal cancer	up	MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK.
hsa-mir-221	colorectal cancer	up	miR-221 targets QKI to enhance the tumorigenic capacity of human colorectal cancer stem cells.
hsa-mir-221	colorectal cancer	up	miR-221 inhibits autophagy and targets TP53INP1 in colorectal cancer cells.
hsa-mir-221	esophageal cancer	up	Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma.
hsa-mir-221	extrahepatic cholangiocarcinoma	up	miR-221 Promotes Epithelial-Mesenchymal Transition through Targeting PTEN and Forms a Positive Feedback Loop with ?-catenin/c-Jun Signaling Pathway in Extra-Hepatic Cholangiocarcinoma.
hsa-mir-221	follicular thyroid carcinoma	up	Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.
hsa-mir-221	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-221	gastric cancer	up	Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance.
hsa-mir-221	gastric cancer	up	Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer.
hsa-mir-221	gastric cancer	up	miR-221 and miR-222 synergistically regulate hepatocyte growth factor activator inhibitor type 1 to promote cell proliferation and migration in gastric cancer.
hsa-mir-221	gastrointestinal stromal tumor	down	Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors.
hsa-mir-221	gastrointestinal stromal tumor	down	Multiple sporadic gastrointestinal stromal tumors concomitant with ampullary adenocarcinoma: a case report with KIT and PDGFRA mutational analysis and miR-221/222 expression profile.
hsa-mir-221	glioblastoma	up	Serum expression level of miR-504 can differentiate between glioblastoma multiforme and solitary brain metastasis of non-small cell lung carcinoma.
hsa-mir-221	glioma	up	Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo.
hsa-mir-221	glioma	up	MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma.
hsa-mir-221	glioma	up	Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221.
hsa-mir-221	glioma	up	MicroRNA-221 targeting PI3-K/Akt signaling axis induces cell proliferation and BCNU resistance in human glioblastoma.
hsa-mir-221	glioma	up	MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2.
hsa-mir-221	glioma	down	Suppression of miR-221 inhibits glioma cells proliferation and invasion via targeting SEMA3B.
hsa-mir-221	hepatocellular carcinoma	up	Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
hsa-mir-221	hepatocellular carcinoma	up	MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.
hsa-mir-221	hepatocellular carcinoma	up	Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice.
hsa-mir-221	hepatocellular carcinoma	up	miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.
hsa-mir-221	hepatocellular carcinoma	up	Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-221	hepatocellular carcinoma	up	MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-mir-221	hepatocellular carcinoma	up	Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro.
hsa-mir-221	hepatocellular carcinoma	up	Clinical potential of miRNA-221 as a novel prognostic biomarker for hepatocellular carcinoma.
hsa-mir-221	hepatocellular carcinoma	up	MiR-221 mediates the epithelial-mesenchymal transition of hepatocellular carcinoma by targeting AdipoR1.
hsa-mir-221	hepatocellular carcinoma	up	miR-221 regulates CD44 in hepatocellular carcinoma through the PI3K-AKT-mTOR pathway.
hsa-mir-221	hepatocellular carcinoma	up	MiR-221 Promotes Hepatocellular Carcinoma Cells Migration via Targeting PHF2.
hsa-mir-221	hepatocellular carcinoma	up	miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker.
hsa-mir-221	hepatocellular carcinoma	up	In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
hsa-mir-221	hepatocellular carcinoma	up	Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.
hsa-mir-221	laryngeal squamous cell carcinoma	up	Up-regulated miR-221 expression as a molecular diagnostic marker in laryngeal squamous cell carcinoma and its correlation with Apaf-1 expression.
hsa-mir-221	liver cancer	up	Expression and prognostic significance of miR-375 and miR-221 in liver cancer.
hsa-mir-221	liver cancer	up	Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses tumor properties.
hsa-mir-221	malignant melanoma	up	The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway.
hsa-mir-221	medulloblastoma	down	Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-221	neuroblastoma	up	microRNA-221 enhances MYCN via targeting nemo-like kinase, and functions as an oncogene related to poor prognosis in neuroblastoma.
hsa-mir-221	non-small cell lung cancer	up	Serum expression level of miR-504 can differentiate between glioblastoma multiforme and solitary brain metastasis of non-small cell lung carcinoma.
hsa-mir-221	non-small cell lung cancer	up	miRNA-221 acts as an oncogenic role by directly targeting TIMP2 in non-small-cell lung carcinoma.
hsa-mir-221	non-small cell lung cancer	up	Overexpression of MicroRNA-221 is associated with poor prognosis in non-small cell lung cancer patients.
hsa-mir-221	non-small cell lung cancer	up	miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.
hsa-mir-221	non-small cell lung cancer	down	Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-221	non-small cell lung cancer	up	MicroRNA-221 promotes human non-small cell lung cancer cell H460 growth.
hsa-mir-221	oral squamous cell carcinoma	up	miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells.
hsa-mir-221	oral squamous cell carcinoma	up	Ginsenoside Rg3 inhibits growth and epithelial-mesenchymal transition of human oral squamous carcinoma cells by down-regulating miR-221.
hsa-mir-221	oral squamous cell carcinoma	up	Downregulation of miR-221 Inhibits Cell Migration and Invasion through Targeting Methyl-CpG Binding Domain Protein 2 in Human Oral Squamous Cell Carcinoma Cells.
hsa-mir-221	oral squamous cell carcinoma	up	Downregulation of miR-221/222 by a microRNA sponge promotes apoptosis in oral squamous cell carcinoma cells through upregulation of PTEN.
hsa-mir-221	osteosarcoma	up	MicroRNA-221 Induces Cell Survival and Cisplatin Resistance through PI3K/Akt Pathway in Human Osteosarcoma.
hsa-mir-221	osteosarcoma	up	miR-221 increases osteosarcoma?cell?proliferation, invasion and migration partly through?the downregulation of PTEN.
hsa-mir-221	osteosarcoma	up	Long Noncoding RNA GAS5 Suppresses Cell Growth and Epithelial-Mesenchymal Transition in Osteosarcoma by Regulating the miR-221/ARHI Pathway.
hsa-mir-221	osteosarcoma	up	MicroRNA-221 promotes cisplatin resistance in osteosarcoma cells by targeting PPP2R2A.
hsa-mir-221	ovarian cancer	up	Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.
hsa-mir-221	ovarian cancer	up	Overexpression of miRNA-221 promotes cell proliferation by targeting the apoptotic protease activating factor-1 and indicates a poor prognosis in ovarian cancer.
hsa-mir-221	ovarian cancer	up	miR-221 regulates proliferation and apoptosis of ovarian cancer cells by targeting BMF.
hsa-mir-221	pancreatic adenocarcinoma	up	Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma.
hsa-mir-221	pancreatic cancer	up	Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA.
hsa-mir-221	pancreatic cancer	up	miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases.
hsa-mir-221	pancreatic cancer	up	Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells.
hsa-mir-221	papillary thyroid carcinoma	up	MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
hsa-mir-221	papillary thyroid carcinoma	up	In vivo imaging of functional targeting of miR-221 in papillary thyroid carcinoma.
hsa-mir-221	papillary thyroid carcinoma	up	In vivo imaging of miR-221 biogenesis in papillary thyroid carcinoma.
hsa-mir-221	papillary thyroid carcinoma	up	Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.
hsa-mir-221	papillary thyroid carcinoma	up	Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
hsa-mir-221	papillary thyroid carcinoma	up	MicroRNA-221 promotes papillary thyroid carcinoma cell migration and invasion via targeting RECK and regulating epithelial-mesenchymal transition.
hsa-mir-221	papillary thyroid carcinoma	up	[Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
hsa-mir-221	papillary thyroid carcinoma	up	Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.
hsa-mir-221	prostate cancer	up	MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A.
hsa-mir-221	prostate cancer	down	Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1.
hsa-mir-221	prostate cancer	up	Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells.
hsa-mir-221	prostate cancer	down	MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.
hsa-mir-221	prostate cancer	up	The correlation between microRNA-221/222 cluster overexpression and malignancy: an updated meta-analysis including 2693 patients.
hsa-mir-221	rectal cancer	up	Expression of Circulating miR-155, miR-21, miR-221, miR-30a, miR-34a and miR-29a: Comparison of Colonic and Rectal Cancer.
hsa-mir-221	renal cell carcinoma	up	miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma.
hsa-mir-221	retinoblastoma	up	Upregulated miR-221/222 promotes cell proliferation and invasion and is associated with invasive features in retinoblastoma.
hsa-mir-221	squamous carcinoma	up	Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-221	thyroid carcinoma	up	MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle.
hsa-mir-221*	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-221-3p	cervical cancer	up	MicroRNA-221-3p, a TWIST2 target, promotes cervical cancer metastasis by directly targeting THBS2.
hsa-mir-221-3p	cervical squamous cell carcinoma	up	Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma.
hsa-mir-221-3p	hepatocellular carcinoma	up	Potential of C1QTNF1-AS1 regulation in human hepatocellular carcinoma.
hsa-mir-221-3p	hepatocellular carcinoma	up	C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3.
hsa-mir-221-3p	hepatocellular carcinoma	up	MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis.
hsa-mir-221-3p	hepatocellular carcinoma	up	Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
hsa-mir-221-3p	medulloblastoma	down	Downregulation of EIF5A2 by miR-221-3p inhibits cell proliferation, promotes cell cycle arrest and apoptosis in medulloblastoma cells.
hsa-mir-221-3p	pancreatic cancer	up	MicroRNA-221-3p is up-regulated and serves as a potential biomarker in pancreatic cancer.
hsa-mir-222	acute myeloid leukemia	down	Aberrant Expression of the miR-181b/miR-222 after Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia.
hsa-mir-222	adenoid cystic carcinoma	up	Downregulation of miR-222 Induces Apoptosis and Cellular Migration in Adenoid Cystic Carcinoma Cells.
hsa-mir-222	anaplastic thyroid carcinoma	up	A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.
hsa-mir-222	bladder cancer	up	Increased expression of miR-222 is associated with poor prognosis in bladder cancer.
hsa-mir-222	bladder cancer	up	miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cells.
hsa-mir-222	breast cancer	up	MiR-221/222 promote epithelial-mesenchymal transition by targeting Notch3 in breast cancer cell lines.
hsa-mir-222	breast cancer	up	TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer.
hsa-mir-222	breast cancer	up	Analysis of serum genome-wide microRNAs for breast cancer detection.
hsa-mir-222	breast cancer	up	miR-221/222 promotes S-phase entry and cellular migration in control of basal-like breast cancer.
hsa-mir-222	breast cancer	up	miR-221/222 promote tumor growth and suppress apoptosis by targeting lncRNA GAS5 in breast cancer.
hsa-mir-222	cervical cancer	up	Upregulated exosomal miR-221/222 promotes cervical cancer via repressing methyl-CpG-binding domain protein 2.
hsa-mir-222	chondrosarcoma	down	Analysis of microRNAs expressions in chondrosarcoma.
hsa-mir-222	chordoma	down	MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.
hsa-mir-222	colorectal cancer	up	microRNA-222 promotes colorectal cancer cell migration and invasion by targeting MST3.
hsa-mir-222	gastric cancer	up	Evaluation of circulating miR-21 and miR-222 as diagnostic biomarkers for gastric cancer.
hsa-mir-222	gastric cancer	up	miR-221 and miR-222 synergistically regulate hepatocyte growth factor activator inhibitor type 1 to promote cell proliferation and migration in gastric cancer.
hsa-mir-222	gastric cancer	up	The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway.
hsa-mir-222	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-222	gastric cancer	up	Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK.
hsa-mir-222	gastric cancer	up	Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer.
hsa-mir-222	gastric cancer	up	Circulating miR-222 in plasma and its potential diagnostic and prognostic value in gastric cancer.
hsa-mir-222	gastric cancer	up	miR-222/VGLL4/YAP-TEAD1 regulatory loop promotes proliferation and invasion of gastric cancer cells.
hsa-mir-222	gastrointestinal stromal tumor	down	Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors.
hsa-mir-222	gastrointestinal stromal tumor	down	Multiple sporadic gastrointestinal stromal tumors concomitant with ampullary adenocarcinoma: a case report with KIT and PDGFRA mutational analysis and miR-221/222 expression profile.
hsa-mir-222	glioblastoma	down	Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
hsa-mir-222	glioma	up	Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo.
hsa-mir-222	glioma	up	MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma.
hsa-mir-222	glioma	up	MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2.
hsa-mir-222	hepatocellular carcinoma	up	Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice.
hsa-mir-222	hepatocellular carcinoma	up	miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.
hsa-mir-222	hepatocellular carcinoma	up	Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-222	hepatocellular carcinoma	up	MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-mir-222	hepatocellular carcinoma	up	[Expression of serum microRNAs (miR-222, miR-181, miR-216) in human hepatocellular carcinoma and its clinical significance].
hsa-mir-222	hepatocellular carcinoma	up	GNAI3 inhibits tumor cell migration and invasion and is post-transcriptionally regulated by miR-222 in hepatocellular carcinoma.
hsa-mir-222	hepatocellular carcinoma	up	Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
hsa-mir-222	malignant melanoma	up	The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway.
hsa-mir-222	medulloblastoma	up	Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-222	nasopharyngeal carcinoma	up	microRNA-222 promotes tumor growth and confers radioresistance in nasopharyngeal carcinoma by targeting PTEN.
hsa-mir-222	non-small cell lung cancer	up	miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.
hsa-mir-222	non-small cell lung cancer	up	Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application.
hsa-mir-222	non-small cell lung cancer	up	MicroRNA-222 promotes human non-small cell lung cancer H460 growth by targeting p27.
hsa-mir-222	oral squamous cell carcinoma	up	miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells.
hsa-mir-222	oral squamous cell carcinoma	up	Downregulation of miR-221/222 by a microRNA sponge promotes apoptosis in oral squamous cell carcinoma cells through upregulation of PTEN.
hsa-mir-222	ovarian carcinoma	up	miR-222 promotes invasion and migration of ovarian carcinoma by targeting PTEN.
hsa-mir-222	pancreatic cancer	up	Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancreatic Cancer.
hsa-mir-222	pancreatic cancer	up	miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases.
hsa-mir-222	papillary thyroid carcinoma	up	MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
hsa-mir-222	papillary thyroid carcinoma	up	MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.
hsa-mir-222	papillary thyroid carcinoma	up	Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.
hsa-mir-222	papillary thyroid carcinoma	up	Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.
hsa-mir-222	papillary thyroid carcinoma	up	Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
hsa-mir-222	papillary thyroid carcinoma	up	miR-222 expression is correlated with the ATA risk stratifications in papillary thyroid carcinomas.
hsa-mir-222	papillary thyroid carcinoma	up	BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases.
hsa-mir-222	papillary thyroid carcinoma	up	Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.
hsa-mir-222	papillary thyroid carcinoma	up	MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
hsa-mir-222	prostate cancer	up	The correlation between microRNA-221/222 cluster overexpression and malignancy: an updated meta-analysis including 2693 patients.
hsa-mir-222	prostate cancer	up	Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells.
hsa-mir-222	prostate cancer	down	MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.
hsa-mir-222	retinoblastoma	up	Upregulated miR-221/222 promotes cell proliferation and invasion and is associated with invasive features in retinoblastoma.
hsa-mir-222	thyroid carcinoma	up	MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle.
hsa-mir-222-3p	endometrial cancer	up	Elevated MiR-222-3p Promotes Proliferation and Invasion of Endometrial Carcinoma via Targeting ER?.
hsa-mir-222-3p	hepatocellular carcinoma	up	MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis.
hsa-mir-222-3p	oral cancer	up	A Three-MicroRNA Signature as a Potential Biomarker for the Early Detection of Oral Cancer.
hsa-mir-222-3p	osteosarcoma	up	miR-222-3p promotes osteosarcoma cell migration and invasion through targeting TIMP3.
hsa-mir-223	acute myeloid leukemia	down	miR-223 decreases cell proliferation and enhances cell apoptosis in acute myeloid leukemia via targeting FBXW7.
hsa-mir-223	acute myeloid leukemia	down	Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia.
hsa-mir-223	bladder cancer	up	Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-223	breast cancer	up	miRNA-223 suppresses FOXO1 and functions as a potential tumor marker in breast cancer.
hsa-mir-223	breast cancer	down	Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrol.
hsa-mir-223	cervical cancer	down	MiR-223 inhibited cell metastasis of human cervical cancer by modulating epithelial-mesenchymal transition.
hsa-mir-223	chronic lymphocytic leukemia	down	MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia.
hsa-mir-223	chronic lymphocytic leukemia	down	[Expression of microRNA-223 and its clinical value in B lymphoproliferative disorders].
hsa-mir-223	chronic myelogenous leukemia	down	MEF2C and CEBPA: Possible co-regulators in chronic myeloid leukemia disease progression.
hsa-mir-223	colon cancer	up	miR-223 promotes colon cancer by directly targeting p120 catenin.
hsa-mir-223	colonic adenocarcinoma	up	miR-223-RhoB signaling pathway regulates the proliferation and apoptosis of colon adenocarcinoma.
hsa-mir-223	colorectal cancer	up	Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.
hsa-mir-223	colorectal cancer	up	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-223	colorectal cancer	up	Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.
hsa-mir-223	colorectal cancer	up	MicroRNA-223 functions as an oncogene in human colorectal cancer cells.
hsa-mir-223	colorectal cancer	up	Overexpression of miR-223 correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.
hsa-mir-223	colorectal cancer	up	C/EBP-?-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer.
hsa-mir-223	endometrial cancer	down	MiR-223 suppresses endometrial carcinoma cells proliferation by targeting IGF-1R.
hsa-mir-223	esophageal adenocarcinoma	up	MicroRNA 223 is Up-regulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1.
hsa-mir-223	esophageal cancer	down	Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-223	esophageal squamous cell carcinoma	up	Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma.
hsa-mir-223	esophageal squamous cell carcinoma	up	Circulating plasma microRNAs in the detection of esophageal squamous cell carcinoma.
hsa-mir-223	gallbladder carcinoma	down	miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1.
hsa-mir-223	gastric cancer	down	miRNA-223 inhibits epithelial-mesenchymal transition in gastric carcinoma cells via Sp1.
hsa-mir-223	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-223	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-223	gastric cancer	up	MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4.
hsa-mir-223	gastric cancer	up	Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.
hsa-mir-223	glioblastoma	up	microRNA-223 promotes the growth and invasion of glioblastoma cells by targeting tumor suppressor PAX6.
hsa-mir-223	glioblastoma	up	Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells.
hsa-mir-223	hepatocellular carcinoma	down	Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma.
hsa-mir-223	hepatocellular carcinoma	up	Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
hsa-mir-223	hepatocellular carcinoma	down	[Role of microRNA-223 and its target gene oncogene c-myc in hepatocellular carcinoma pathogenesis.]
hsa-mir-223	hepatocellular carcinoma	down	Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-223	hepatocellular carcinoma	down	Sulfatide Epigenetically Regulates miR-223 and Promotes the Migration of Human Hepatocellular Carcinoma Cells.
hsa-mir-223	hepatocellular carcinoma	down	Decreased expression of microRNA-223 promotes cell proliferation in hepatocellular carcinoma cells via the insulin-like growth factor-1 signaling pathway.
hsa-mir-223	hepatocellular carcinoma	down	miRNA-223-3p regulates NLRP3 to promote apoptosis and inhibit proliferation of hep3B cells.
hsa-mir-223	kidney cancer	up	[Expression of miR-223 in clear cell renal cell carcinoma and its significance].
hsa-mir-223	lung cancer	down	miR-223 functions as a potent tumor suppressor of the Lewis lung carcinoma cell line by targeting insulin-like growth factor-1 receptor and cyclin-dependent kinase 2.
hsa-mir-223	lung cancer	up	MicroRNA-223 Promotes Tumor Progression in Lung Cancer A549 Cells via Activation of the NF-?B Signaling Pathway.
hsa-mir-223	mantle cell lymphoma	down	MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia.
hsa-mir-223	mantle cell lymphoma	down	[Expression of microRNA-223 and its clinical value in B lymphoproliferative disorders].
hsa-mir-223	mantle cell lymphoma	down	miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11.
hsa-mir-223	mantle cell lymphoma	down	[Prognostic significance of miRNA-223 targeting SOX11 in mantle cell lymphoma].
hsa-mir-223	mucinous cystadenocarcinoma	up	Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.
hsa-mir-223	nasopharyngeal cancer	down	Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma.
hsa-mir-223	nasopharyngeal carcinoma	down	MiR-223 targeting MAFB suppresses proliferation and migration of nasopharyngeal carcinoma cells.
hsa-mir-223	non-small cell lung cancer	down	miRNA-223 is an anticancer gene in human non-small cell lung cancer through the PI3K/AKT pathway by targeting EGFR.
hsa-mir-223	oral cancer	up	Circulating miR-223 in Oral Cancer: Its Potential as a Novel Diagnostic Biomarker and Therapeutic Target.
hsa-mir-223	oral squamous cell carcinoma	up	MiR-223 promotes oral squamous cell carcinoma proliferation and migration by regulating FBXW7.
hsa-mir-223	oral squamous cell carcinoma	up	Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
hsa-mir-223	osteosarcoma	down	miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma.
hsa-mir-223	pancreatic ductal adenocarcinoma	up	HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion.
hsa-mir-223	prostate cancer	down	Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrol.
hsa-mir-223	prostate cancer	down	Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.
hsa-mir-223	splenic marginal zone lymphoma	down	MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia.
hsa-mir-223	splenic marginal zone lymphoma	down	[Expression of microRNA-223 and its clinical value in B lymphoproliferative disorders].
hsa-mir-223-3p	bladder cancer	down	Ginkgolide B Inhibits Human Bladder Cancer Cell Migration and Invasion Through MicroRNA-223-3p.
hsa-mir-223-3p	bladder cancer	down	MicroRNA-223-3p inhibits human bladder cancer cell migration and invasion.
hsa-mir-223-3p	clear cell renal cell cancer	up	MiR-223-3p promotes cell proliferation and metastasis by downregulating SLC4A4 in clear cell renal cell carcinoma.
hsa-mir-223-3p	esophageal squamous cell carcinoma	up	A novel serum microRNA signature to screen esophageal squamous cell carcinoma.
hsa-mir-223-3p	gastric cancer	up	NF-?B/miR-223-3p/ARID1A axis is involved in Helicobacter pylori CagA-induced gastric carcinogenesis and progression.
hsa-mir-223-3p	glioblastoma	down	MiR-223-3p overexpression inhibits cell proliferation and migration by regulating inflammation-associated cytokines in glioblastomas.
hsa-mir-223-3p	head and neck squamous cell carcinoma	up	MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma.
hsa-mir-223-3p	lung squamous cell carcinoma	down	MiR-223-3p functions as a tumor suppressor in lung squamous cell carcinoma by miR-223-3p-mutant p53 regulatory feedback loop.
hsa-mir-223-3p	osteosarcoma	down	miR-223-3p Inhibits Human Osteosarcoma Metastasis and Progression by Directly Targeting CDH6.
hsa-mir-223-3p	ovarian cancer	up	MicroRNA-223-3p Regulates Ovarian Cancer Cell Proliferation and Invasion by Targeting SOX11 Expression.
hsa-mir-223-3p	prostate cancer	up	MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer.
hsa-mir-223-5p	non-small cell lung cancer	down	MiR-223-5p suppresses tumor growth and metastasis in non-small cell lung cancer by targeting E2F8.
hsa-mir-224	bladder cancer	up	Down-regulation of microRNA-224 -inhibites growth and epithelial-to-mesenchymal transition phenotype -via modulating SUFU expression in bladder cancer cells.
hsa-mir-224	breast cancer	up	MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells.
hsa-mir-224	breast cancer	up	MicroRNA-224 Promotes Tumorigenesis through Downregulation of Caspase-9 in Triple-Negative Breast Cancer.
hsa-mir-224	cervical cancer	up	Over-Expressed miR-224 Promotes the Progression of Cervical Cancer via Targeting RASSF8.
hsa-mir-224	cervical cancer	up	Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer.
hsa-mir-224	colorectal cancer	up	microRNA-224 Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer by Repressing PHLPP1 and PHLPP2.
hsa-mir-224	colorectal cancer	up	Up-regulation of miR-224 promotes cancer cell proliferation and invasion and predicts relapse of colorectal cancer.
hsa-mir-224	colorectal cancer	up	Molecular biomarkers and classification models in the evaluation of the prognosis of colorectal cancer.
hsa-mir-224	colorectal cancer	down	MicroRNA-224 suppresses colorectal cancer cell migration by targeting Cdc42.
hsa-mir-224	colorectal cancer	up	The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.
hsa-mir-224	colorectal cancer	up	Integrated Analysis of miRNA and mRNA Endorses a Twenty miRNAs Signature for Colorectal Carcinoma.
hsa-mir-224	colorectal cancer	up	miR-224 Controls Human Colorectal Cancer Cell Line HCT116 Proliferation by Targeting Smad4.
hsa-mir-224	esophageal squamous cell carcinoma	tissue;	Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma.
hsa-mir-224	esophageal squamous cell carcinoma	up	LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
hsa-mir-224	gastric cancer	up	[Effect of antisense miR-224 on gastric cancer cell proliferation and apoptosis].
hsa-mir-224	gastric cancer	up	Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
hsa-mir-224	glioma	up	Upregulation of microRNA-224 confers a poor prognosis in glioma patients.
hsa-mir-224	hepatocellular carcinoma	up	Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.
hsa-mir-224	hepatocellular carcinoma	up	Transcriptional regulation of miR-224 upregulated in human HCCs by NF?B inflammatory pathways.
hsa-mir-224	hepatocellular carcinoma	up	Androgen pathway stimulates microRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis.
hsa-mir-224	hepatocellular carcinoma	up	MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms.
hsa-mir-224	hepatocellular carcinoma	up	miR-224 promotes cell migration and invasion by modulating p-PAK4 and MMP-9 via targeting HOXD10 in human hepatocellular carcinoma.
hsa-mir-224	hepatocellular carcinoma	up	MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma.
hsa-mir-224	hepatocellular carcinoma	up	Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
hsa-mir-224	hepatocellular carcinoma	up	Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function.
hsa-mir-224	meningioma	up	MicroRNA-224 targets ERG2 and contributes to malignant progressions of meningioma.
hsa-mir-224	non-small cell lung cancer	down	Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.
hsa-mir-224	non-small cell lung cancer	up	MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7.
hsa-mir-224	non-small cell lung cancer	up	miR-224 enhances invasion and metastasis by targeting HOXD10 in non-small cell lung cancer cells.
hsa-mir-224	non-small cell lung cancer	up	The miR-224 promotes non-small cell lung cancer cell proliferation by directly targeting RASSF8.
hsa-mir-224	oral squamous cell carcinoma	down	MicroRNA-224, negatively regulated by c-jun, inhibits growth and epithelial-to-mesenchymal transition phenotype via targeting ADAM17 in oral squamous cell carcinoma.
hsa-mir-224	osteosarcoma	down	MicroRNA-224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1.
hsa-mir-224	ovarian cancer	up	Upregulated microRNA-224 promotes ovarian cancer cell proliferation by targeting KLLN.
hsa-mir-224	pancreatic cancer	up	MicroRNA-224 Promotes Pancreatic Cancer Cell Proliferation and Migration by Targeting the TXNIP-Mediated HIF1? Pathway.
hsa-mir-224	prostate cancer	down	MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
hsa-mir-224	prostate cancer	down	Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer.
hsa-mir-224	prostate cancer	down	MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer.
hsa-mir-224	renal cell carcinoma	up	MiR-193a-3p and miR-224 mediate renal cell carcinoma progression by targeting alpha-2,3-sialyltransferase IV and the phosphatidylinositol 3 kinase/Akt pathway.
hsa-mir-224	renal clear cell carcinoma	up	Extracellular miR-224 as a prognostic marker for clear cell renal cell carcinoma.
hsa-mir-224	renal clear cell carcinoma	up	microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.
hsa-mir-224-3p	cervical cancer	up	miR-224-3p inhibits autophagy in cervical cancer cells by targeting FIP200.
hsa-mir-224-5p	breast cancer	up	MiRNA-224-5p inhibits autophagy in breast cancer cells via targeting Smad4.
hsa-mir-224-5p	hepatocellular carcinoma	up	Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
hsa-mir-224-5p	ovarian cancer	up	Expression of miR-224-5p is associated with the original cisplatin resistance of ovarian papillary serous carcinoma.
hsa-mir-224-5p	uveal melanoma	down	Long non-coding RNA FTH1P3 facilitates uveal melanoma cell growth and invasion through miR-224-5p.
hsa-mir-224-5p	uveal melanoma	down	miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3/AKT3 in uveal melanoma.
hsa-mir-2278	chronic myelogenous leukemia	down	Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeti
hsa-mir-2392	gastric cancer	down	MiR-2392 suppresses metastasis and epithelial-mesenchymal transition by targeting MAML3 and WHSC1 in gastric cancer.
hsa-mir-23a	bladder cancer	up	Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-23a	breast cancer	up	c-MYC regulated miR-23a~24-2~27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2.
hsa-mir-23a	breast cancer	up	MiR-23a promotes TGF-?1-induced EMT and tumor metastasis in breast cancer cells by directly targeting CDH1 and activating Wnt/?-catenin signaling.
hsa-mir-23a	colon carcinoma	up	[Expression and clinical significance of miR-23a and metastasis suppressor 1 in colon carcinoma].
hsa-mir-23a	colorectal cancer	up	Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.
hsa-mir-23a	colorectal cancer	up	MicroRNA-23a promotes colorectal cancer cell survival by targeting PDK4.
hsa-mir-23a	colorectal cancer	up	Serum overexpression of miR-301a and miR-23a in patients with colorectal cancer.
hsa-mir-23a	colorectal cancer	up	MicroRNA-23a promotes colorectal cancer cell migration and proliferation by targeting at MARK1.
hsa-mir-23a	gastric adenocarcinoma	up	MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor.
hsa-mir-23a	gastric adenocarcinoma	up	miR-23a targets interferon regulatory factor 1 and modulates cellular proliferation and paclitaxel-induced apoptosis in gastric adenocarcinoma cells.
hsa-mir-23a	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-23a	gastric cancer	up	MiR-23a in Amplified 19p13.13 Loci Targets Metallothionein 2A and Promotes Growth in Gastric Cancer Cells.
hsa-mir-23a	gastric cancer	up	Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer.
hsa-mir-23a	gastric cancer	up	microRNA-23a promotes cell growth and metastasis in gastric cancer via targeting SPRY2-mediated ERK signaling.
hsa-mir-23a	gastric cancer	up	miR-23a/b promote tumor growth and suppress apoptosis by targeting PDCD4 in gastric cancer.
hsa-mir-23a	glioma	up	Identification of microRNAs associated with glioma diagnosis and prognosis.
hsa-mir-23a	glioma	up	Targeting microRNA-23a to inhibit glioma cell invasion via HOXD10.
hsa-mir-23a	hepatocellular carcinoma	up	Stat3-mediated activation of miR-23a suppresses gluconeogenesis in hepatocellular carcinoma by downregulating G6PC and PGC-1?
hsa-mir-23a	hepatocellular carcinoma	up	MicroRNAs and clinical implications in hepatocellular carcinoma.
hsa-mir-23a	hepatocellular carcinoma	up	MicroRNA-23a downregulates the expression of interferon regulatory factor-1 in hepatocellular carcinoma cells.
hsa-mir-23a	laryngeal cancer	up	High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis.
hsa-mir-23a	laryngeal carcinoma	up	Upregulation of microRNA-23a regulates proliferation and apoptosis by targeting APAF-1 in laryngeal carcinoma.
hsa-mir-23a	malignant melanoma	down	MicroRNA-23a inhibits melanoma cell proliferation, migration, and invasion in mice through a negative feedback regulation of sdcbp and the MAPK/ERK signaling pathway.
hsa-mir-23a	neuroblastoma	up	MicroRNA-23a promotes neuroblastoma cell metastasis by targeting CDH1.
hsa-mir-23a	non-small cell lung cancer	up	Clinical value of microRNA-23a upregulation in non-small cell lung cancer.
hsa-mir-23a	osteosarcoma	down	MiR-23a Functions as a Tumor Suppressor in Osteosarcoma.
hsa-mir-23a	osteosarcoma	down	miR-23a suppresses proliferation of osteosarcoma cells by targeting SATB1.
hsa-mir-23a	pancreatic cancer	up	MicroRNA-23a promotes pancreatic cancer metastasis by targeting epithelial splicing regulator protein 1.
hsa-mir-23a	papillary thyroid carcinoma	down	MicroRNA-23a inhibits the growth of papillary thyroid carcinoma via regulating cyclin G1.
hsa-mir-23a	prostate cancer	down	Downregulation of microRNA-23a suppresses prostate cancer metastasis by targeting the PAK6-LIMK1 signaling pathway.
hsa-mir-23a-3p	acute myeloid leukemia	up	Long noncoding RNA NEAT1 modulates cell proliferation and apoptosis by regulating miR-23a-3p/SMC1A in acute myeloid leukemia.
hsa-mir-23a-3p	oral squamous cell carcinoma	down	miR-23a-3p suppresses cell proliferation in oral squamous cell carcinomas by targeting FGF2 and correlates with a better prognosis: miR-23a-3p inhibits OSCC growth by targeting FGF2.
hsa-mir-23a-3p	renal cell carcinoma	up	MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC.
hsa-mir-23a-5p	pancreatic ductal adenocarcinoma	down	miR-23a-5p inhibits cell proliferation and invasion in pancreatic ductal adenocarcinoma by suppressing ECM1 expression.
hsa-mir-23b	bladder cancer	up	Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-23b	bladder cancer	down	MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer.
hsa-mir-23b	breast cancer	up	miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study.
hsa-mir-23b	cervical cancer	down	MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
hsa-mir-23b	cervical cancer	down	miR-23b as a potential tumor suppressor and its regulation by DNA methylation in cervical cancer.
hsa-mir-23b	cervical cancer	down	MiR-23b controls ALDH1A1 expression in cervical cancer stem cells.
hsa-mir-23b	chondrosarcoma	down	Inhibition of Src by microRNA-23b increases the cisplatin sensitivity of chondrosarcoma cells.
hsa-mir-23b	colorectal cancer	down	Downregulation of mir-23b in plasma is associated with poor prognosis in patients with colorectal cancer.
hsa-mir-23b	endometrial cancer	up	Long non-coding RNA tumor suppressor candidate 7 advances chemotherapy sensitivity of endometrial carcinoma through targeted silencing of miR-23b.
hsa-mir-23b	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-23b	gastric cancer	up	Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer.
hsa-mir-23b	gastric cancer	down	The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis.
hsa-mir-23b	gastric cancer	up	miR-23a/b promote tumor growth and suppress apoptosis by targeting PDCD4 in gastric cancer.
hsa-mir-23b	gastric cancer	up	Up-Regulation of Plasma miR-23b is Associated with Poor Prognosis of Gastric Cancer.
hsa-mir-23b	glioma	up	Long Non-coding RNA TUSC7, a Target of miR-23b, Plays Tumor-Suppressing Roles in Human Gliomas.
hsa-mir-23b	glioma	down	miRNA expression profiling in migrating glioblastoma cells: regulation of cell migration and invasion by miR-23b via targeting of Pyk2.
hsa-mir-23b	hepatocellular carcinoma	down	microRNA-23b suppresses epithelial-mesenchymal transition (EMT) and metastasis in hepatocellular carcinoma via targeting Pyk2.
hsa-mir-23b	hepatocellular carcinoma	up	MicroRNA-23b functions as an oncogene and activates AKT/GSK3?/?-catenin signaling by targeting ST7L in hepatocellular carcinoma.
hsa-mir-23b	lung carcinoma	down	miR-23b suppresses lung carcinoma cell proliferation through CCNG1.
hsa-mir-23b	nasopharyngeal carcinoma	up	MicroRNA-23b regulates nasopharyngeal carcinoma cell proliferation and metastasis by targeting E-cadherin.
hsa-mir-23b	non-small cell lung cancer	down	PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathways.
hsa-mir-23b	oral squamous cell carcinoma	down	The tumor-suppressive microRNA-23b/27b cluster regulates the MET oncogene in oral squamous cell carcinoma.
hsa-mir-23b	ovarian cancer	up	MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.
hsa-mir-23b	prostate cancer	down	miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer.
hsa-mir-23b	renal cell carcinoma	down	MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.
hsa-mir-23b-3p	gastric cancer	down	miR-23b-3p and miR-130a-5p affect cell growth, migration and invasion by targeting CB1R via the Wnt/?-catenin signaling pathway in gastric carcinoma.
hsa-mir-23b-3p	osteosarcoma	up	miR-23b-3p suppressing PGC1? promotes proliferation through reprogramming metabolism in osteosarcoma.
hsa-mir-23b-5p	acute myeloid leukemia	down	Micro-RNA Profiling of Exosomes from Marrow-Derived Mesenchymal Stromal Cells in Patients with Acute Myeloid Leukemia: Implications in Leukemogenesis.
hsa-mir-23c	hepatocellular carcinoma	down	miR-23c suppresses tumor growth of human hepatocellular carcinoma by attenuating ERBB2IP.
hsa-mir-24	bladder cancer	down	MicroRNA-24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3.
hsa-mir-24	breast cancer	up	Association between mir-24 and mir-378 in formalin-fixed paraffin-embedded tissues of breast cancer.
hsa-mir-24	breast carcinoma	up	MicroRNA miR-24 Enhances Tumor Invasion and Metastasis by Targeting PTPN9 and PTPRF to Promote EGF Signaling.
hsa-mir-24	colorectal cancer	down	Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
hsa-mir-24	gastric cancer	down	Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV.
hsa-mir-24	gastric cancer	up	Expression and significance of miR-24 and miR-101 in patients with advanced gastric cancer.
hsa-mir-24	glioma	up	MiR-24 regulates the proliferation and invasion of glioma by ST7L via ?-catenin/Tcf-4 signaling.
hsa-mir-24	glioma	up	Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-24	hepatocellular carcinoma	up	MicroRNA-24 Modulates Aflatoxin B1-Related Hepatocellular Carcinoma Prognosis and Tumorigenesis.
hsa-mir-24	hepatocellular carcinoma	up	miR-24 promotes the proliferation and invasion of HCC cells by targeting SOX7.
hsa-mir-24	hepatocellular carcinoma	up	MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53.
hsa-mir-24	laryngeal squamous cell carcinoma	down	miR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein.
hsa-mir-24	lung cancer	up	Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients.
hsa-mir-24	lung carcinoma	up	MiR-24 promotes the proliferation and apoptosis of lung carcinoma via targeting MAPK7.
hsa-mir-24	nasopharyngeal carcinoma	up	[Clinical significance of plasma miR-24 dysregulation in nasopharyngeal carcinoma].
hsa-mir-24	nasopharyngeal carcinoma	down	MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1.
hsa-mir-24	nasopharyngeal carcinoma	down	MiR-24 enhances radiosensitivity in nasopharyngeal carcinoma by targeting SP1.
hsa-mir-24	nasopharyngeal carcinoma	down	Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5.
hsa-mir-24	non-small cell lung cancer	up	Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer.
hsa-mir-24	non-small cell lung cancer	up	Upregulation of miR-24 promotes cell proliferation by targeting NAIF1 in non-small cell lung cancer.
hsa-mir-24	non-small cell lung cancer	up	MiR-24 promotes migration and invasion of non-small cell lung cancer by targeting ZNF367.
hsa-mir-24	oral squamous cell carcinoma	up	miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis.
hsa-mir-24	oral squamous cell carcinoma	up	Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-24	osteosarcoma	down	MicroRNA-24 inhibits osteosarcoma cell proliferation both in vitro and in vivo by targeting LPAAT?.
hsa-mir-24	prostate cancer	down	miR-24 regulates CDKN1B/p27 expression in prostate cancer.
hsa-mir-24-2-5p	breast cancer	up	c-MYC regulated miR-23a~24-2~27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2.
hsa-mir-24-3p	bladder cancer	up	miR-24-3p regulates bladder cancer cell proliferation, migration, invasion and autophagy by targeting DEDD.
hsa-mir-24-3p	breast cancer	up	miRNA-24-3p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting p27Kip1.
hsa-mir-24-3p	colorectal cancer	down	Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.
hsa-mir-24-3p	glioma	up	miR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1.
hsa-mir-24-3p	hepatocellular carcinoma	up	MiR-24-3p enhances cell growth in hepatocellular carcinoma by targeting metallothionein 1M.
hsa-mir-24-3p	Hodgkin's lymphoma	up	miR-24-3p Is Overexpressed in Hodgkin Lymphoma and Protects Hodgkin and Reed-Sternberg Cells from Apoptosis.
hsa-mir-24-3p	lung adenocarcinoma	up	Long Noncoding RNA LINC00472 Inhibits Proliferation and Promotes Apoptosis of Lung Adenocarcinoma Cells via Regulating miR-24-3p/ DEDD.
hsa-mir-24-3p	lung cancer	up	miR-24-3p promotes cell migration and proliferation in lung cancer by targeting SOX7.
hsa-mir-24-3p	papillary thyroid carcinoma	down	MIR22HG inhibits cell growth, migration and invasion through regulating the miR-24-3p/p27kip1 axis in thyroid papillary carcinomas.
hsa-mir-25	astrocytoma	up	miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL.
hsa-mir-25	breast cancer	down	Expression of circulating miR-17, miR-25, and miR-133 in breast cancer patients.
hsa-mir-25	cervical carcinoma	up	[miR-25 promotes cell proliferation by targeting RECK in human cervical carcinoma HeLa cells].
hsa-mir-25	colon cancer	down	MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7.
hsa-mir-25	colorectal cancer	up	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-25	colorectal cancer	up	The expression of miR-25 is increased in colorectal cancer and is associated with patient prognosis.
hsa-mir-25	endometrial cancer	up	TSA Suppresses miR-106b-93-25 Cluster Expression through Downregulation of MYC and Inhibits Proliferation and Induces Apoptosis in Human EMC.
hsa-mir-25	esophageal squamous cell carcinoma	up	MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma.
hsa-mir-25	esophageal squamous cell carcinoma	up	Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma.
hsa-mir-25	esophageal squamous cell carcinoma	up	miR-25 promotes metastasis via targeting FBXW7 in esophageal squamous cell carcinoma.
hsa-mir-25	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-25	gastric cancer	up	miR-25 promotes gastric cancer cells growth and motility by targeting RECK.
hsa-mir-25	gastric cancer	up	MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival.
hsa-mir-25	gastric cancer	up	Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer
hsa-mir-25	gastric cancer	up	Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
hsa-mir-25	gastric cancer	up	MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.
hsa-mir-25	glioblastoma	up	miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL.
hsa-mir-25	glioma	up	miR-25 promotes glioma cell proliferation by targeting CDKN1C.
hsa-mir-25	head and neck squamous cell carcinoma	up	Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas.
hsa-mir-25	hepatocellular carcinoma	up	Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma.
hsa-mir-25	hepatocellular carcinoma	up	Profiles of tissue microRNAs; miR-148b and miR-25 serve as potential prognostic biomarkers for hepatocellular carcinoma.
hsa-mir-25	hepatocellular carcinoma	up	miR-25 promotes hepatocellular carcinoma cell growth, migration and invasion by inhibiting RhoGDI1.
hsa-mir-25	hepatocellular carcinoma	up	A novel SOCS5/miR-18/miR-25 axis promotes tumorigenesis in liver cancer.
hsa-mir-25	hepatocellular carcinoma	up	miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
hsa-mir-25	malignant melanoma	up	Upregulated MicroRNA-25 Mediates the Migration of Melanoma Cells by Targeting DKK3 through the WNT/?-Catenin Pathway.
hsa-mir-25	malignant melanoma	up	miR-25 Promotes Melanoma Progression by regulating RNA binding motif protein 47.
hsa-mir-25	non-small cell lung cancer	up	miR-25 is up-regulated in non-small cell lung cancer and promotes cell proliferation and motility by targeting FBXW7.
hsa-mir-25	non-small cell lung cancer	up	Elevated microRNA-25 inhibits cell apoptosis in lung cancer by targeting RGS3.
hsa-mir-25	non-small cell lung cancer	up	Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42.
hsa-mir-25	non-small cell lung cancer	up	miR-25 targets the modulator of apoptosis 1 gene in lung cancer.
hsa-mir-25	non-small cell lung cancer	up	Clinical significance of serum miR-25 in non-small-cell lung cancer.
hsa-mir-25	non-small cell lung cancer	up	Low plasma miR-25 expression is a favorite prognosis factor in non-small cell lung cancer.
hsa-mir-25	osteosarcoma	down	MicroRNA-25 suppresses proliferation, migration, and invasion of osteosarcoma by targeting SOX4.
hsa-mir-25	ovarian cancer	up	Ginsenoside Rb1 inhibits hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cells by regulating microRNA-25.
hsa-mir-25	ovarian cancer	up	MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer.
hsa-mir-25	ovarian cancer	up	MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2.
hsa-mir-25	prostate cancer	down	miR-25 Modulates Invasiveness and Dissemination of Human Prostate Cancer Cells via Regulation of ?v- and ?6-Integrin Expression.
hsa-mir-25	small cell lung cancer	up	MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2.
hsa-mir-25-3p	glioma	up	miR-25-3p promotes glioma cell proliferation and migration by targeting FBXW7 and DKK3.
hsa-mir-25-3p	osteosarcoma	up	Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
hsa-mir-25-3p	retinoblastoma	up	MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN/Akt pathway.
hsa-mir-26a	acute myeloid leukemia	down	Critical Role of c-Myc in Acute Myeloid Leukemia Involving Direct Regulation of miR-26a and Histone Methyltransferase EZH2.
hsa-mir-26a	bladder cancer	down	miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1.
hsa-mir-26a	breast cancer	down	Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer.
hsa-mir-26a	breast cancer	down	MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1.
hsa-mir-26a	breast cancer	down	MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer.
hsa-mir-26a	breast cancer	down	miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer.
hsa-mir-26a	cholangiocarcinoma	up	MicroRNA-26a promotes cholangiocarcinoma growth by activating ?-catenin.
hsa-mir-26a	chronic myelogenous leukemia	down	ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
hsa-mir-26a	colon cancer	up	MiR-26a downregulates retinoblastoma in colorectal cancer.
hsa-mir-26a	colorectal cancer	down	Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer.
hsa-mir-26a	colorectal cancer	down	LncRNA SNHG6 promotes the migration, invasion, and epithelial-mesenchymal transition of colorectal cancer cells by miR-26a/EZH2 axis.
hsa-mir-26a	esophageal squamous cell carcinoma	down	MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2.
hsa-mir-26a	esophageal squamous cell carcinoma	down	miR-26a and miR-26b inhibit esophageal squamous cancer cell proliferation through suppression of c-MYC pathway.
hsa-mir-26a	esophageal squamous cell carcinoma	down	Down-regulated miR-26a promotes proliferation, migration, and invasion via negative regulation of MTDH in esophageal squamous cell carcinoma.
hsa-mir-26a	gastric cancer	down	miR-26a/b Inhibit Tumor Growth and Angiogenesis by Targeting the HGF-VEGF Axis in Gastric Carcinoma.
hsa-mir-26a	gastric cancer	down	miR-26a Suppresses Tumor Growth and Metastasis by Targeting FGF9 in Gastric Cancer.
hsa-mir-26a	glioblastoma	up	The influence of distinct regulatory miRNAs of the p15/p16/RB1/E2F pathway on the clinical progression of glioblastoma.
hsa-mir-26a	glioma	up	Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma.
hsa-mir-26a	glioma	up	MicroRNA-26a Promotes Tumor Growth and Angiogenesis in Glioma by Directly Targeting Prohibitin.
hsa-mir-26a	glioma	down	Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-26a	hepatocellular carcinoma	down	microRNA-26a induces a mitochondrial apoptosis mediated by p53 through targeting to inhibit Mcl1 in human hepatocellular carcinoma.
hsa-mir-26a	hepatocellular carcinoma	up	miR-26a promotes hepatocellular carcinoma invasion and metastasis by inhibiting PTEN and inhibits cell growth by repressing EZH2.
hsa-mir-26a	hepatocellular carcinoma	down	Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.
hsa-mir-26a	hepatocellular carcinoma	down	MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
hsa-mir-26a	hepatocellular carcinoma	down	Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.
hsa-mir-26a	hepatocellular carcinoma	down	Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways.
hsa-mir-26a	hepatocellular carcinoma	down	IL-6 upregulation contributes to the reduction of miR-26a expression in hepatocellular carcinoma cells.
hsa-mir-26a	hepatocellular carcinoma	down	MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting IL-6-Stat3 pathway.
hsa-mir-26a	hepatocellular carcinoma	down	MicroRNA-26a Inhibits Angiogenesis by Down-Regulating VEGFA through the PIK3C2?/Akt/HIF-1? Pathway in Hepatocellular Carcinoma.
hsa-mir-26a	hepatocellular carcinoma	down	MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting HGF-cmet pathway.
hsa-mir-26a	hepatocellular carcinoma	down	MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin.
hsa-mir-26a	hepatocellular carcinoma	down	microRNA-26a suppresses recruitment of macrophages by down-regulating macrophage colony-stimulating factor expression through the PI3K/Akt pathway in hepatocellular carcinoma.
hsa-mir-26a	laryngeal squamous cell carcinoma	down	MicroRNA-26a inhibits proliferation and tumorigenesis via targeting CKS2 in laryngeal squamous cell carcinoma.
hsa-mir-26a	lung cancer	down	MicroRNA-26a/b Regulate DNA Replication Licensing, Tumorigenesis and Prognosis by Targeting CDC6 in Lung Cancer.
hsa-mir-26a	malignant melanoma	down	MicroRNA-26a Is Strongly Downregulated in Melanoma and Induces Cell Death through Repression of Silencer of Death Domains (SODD).
hsa-mir-26a	multiple myeloma	down	MicroRNA-26a inhibits multiple myeloma cell growth by suppressing cyclin-dependent kinase 6 expression.
hsa-mir-26a	oral squamous cell carcinoma	down	MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.
hsa-mir-26a	osteosarcoma	down	Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients.
hsa-mir-26a	osteosarcoma	down	miR-26a suppresses osteosarcoma migration and invasion by directly targeting HMGA1.
hsa-mir-26a	osteosarcoma	down	MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1.
hsa-mir-26a	osteosarcoma	down	MicroRNA-26a inhibits osteosarcoma cell proliferation by targeting IGF-1.
hsa-mir-26a	ovarian cancer	up	MiR-26a promotes ovarian cancer proliferation and tumorigenesis.
hsa-mir-26a	papillary thyroid carcinoma	down	miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma.
hsa-mir-26a	primary thyroid lymphoma	down	A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.
hsa-mir-26a	prostate cancer	down	Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms.
hsa-mir-26a	prostate cancer	down	MiR-26a inhibits prostate cancer progression by repression of Wnt5a.
hsa-mir-26a	prostate cancer	down	Downregulated microRNA-26a modulates prostate cancer cell proliferation and apoptosis by targeting COX-2.
hsa-mir-26a	prostate cancer	down	MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells.
hsa-mir-26a	renal cell carcinoma	down	Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.
hsa-mir-26a	thyroid cancer	down	MiR-26a inhibits thyroid cancer cell proliferation by targeting ARPP19.
hsa-mir-26a-5p	acute myeloid leukemia	up	Micro-RNA Profiling of Exosomes from Marrow-Derived Mesenchymal Stromal Cells in Patients with Acute Myeloid Leukemia: Implications in Leukemogenesis.
hsa-mir-26a-5p	bladder cancer	down	Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer.
hsa-mir-26a-5p	breast cancer	down	MicroRNA-26a-5p inhibits breast cancer cell growth by suppressing RNF6 expression.
hsa-mir-26a-5p	colorectal cancer	down	Downregulation of Plasma MiR-142-3p and MiR-26a-5p in Patients With Colorectal Carcinoma.
hsa-mir-26a-5p	hepatocellular carcinoma	down	miR-26a-5p suppresses tumor metastasis by regulating EMT and is associated with prognosis in HCC.
hsa-mir-26a-5p	hepatocellular carcinoma	down	Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study.
hsa-mir-26a-5p	prostate cancer	down	Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1.
hsa-mir-26b	b-cell lymphoma	down	Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies.
hsa-mir-26b	bladder cancer	up	Micro-RNA profiling in kidney and bladder cancers.
hsa-mir-26b	breast cancer	down	MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11.
hsa-mir-26b	breast cancer	down	MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer.
hsa-mir-26b	breast cancer	down	MiRNA-26b inhibits cellular proliferation by targeting CDK8 in breast cancer.
hsa-mir-26b	breast cancer	down	MicroRNA-26b suppresses autophagy in breast cancer cells by targeting DRAM1 mRNA, and is downregulated by irradiation.
hsa-mir-26b	cervical cancer	down	MicroRNA-26b acts as an antioncogene and prognostic factor in cervical cancer.
hsa-mir-26b	colorectal cancer	down	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-26b	colorectal cancer	down	Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer.
hsa-mir-26b	colorectal cancer	up	MicroRNA 26b promotes colorectal cancer metastasis by down-regulating PTEN and WNT5A.
hsa-mir-26b	esophageal squamous cell carcinoma	down	miR-26a and miR-26b inhibit esophageal squamous cancer cell proliferation through suppression of c-MYC pathway.
hsa-mir-26b	gastric cancer	down	miR-26a/b Inhibit Tumor Growth and Angiogenesis by Targeting the HGF-VEGF Axis in Gastric Carcinoma.
hsa-mir-26b	gastric cancer	down	Mir-26b inhibits growth and resistance to paclitaxel chemotherapy by silencing the CDC6 gene in gastric cancer.
hsa-mir-26b	gastric cancer	down	MicroRNA-26b inhibits tumor metastasis by targeting the KPNA2/c-jun pathway in human gastric cancer.
hsa-mir-26b	glioblastoma	down	MiR-26b suppresses cell proliferation and invasion by targeting cyclooxygenase 2 in human glioblastoma.
hsa-mir-26b	glioma	down	Role of microRNA-26b in glioma development and its mediated regulation on EphA2.
hsa-mir-26b	hepatocellular carcinoma	down	MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X.
hsa-mir-26b	hepatocellular carcinoma	down	MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2.
hsa-mir-26b	hepatocellular carcinoma	down	Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies.
hsa-mir-26b	hepatocellular carcinoma	down	MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.
hsa-mir-26b	laryngeal carcinoma	up	Downregulation of miRNA-26b inhibits cancer proliferation of laryngeal carcinoma through autophagy by targeting ULK2 and inactivation of the PTEN/AKT pathway.
hsa-mir-26b	lung cancer	down	MicroRNA-26a/b Regulate DNA Replication Licensing, Tumorigenesis and Prognosis by Targeting CDC6 in Lung Cancer.
hsa-mir-26b	lung cancer	down	MiR-26b suppresses tumor cell proliferation, migration and invasion by directly targeting COX-2 in lung cancer.
hsa-mir-26b	lung cancer	down	[MiR-26b regulates invasion and migration of lung cancer cells through targeting hENT1 depending on RhoA/ROCK-1 pathway].
hsa-mir-26b	malignant melanoma	down	MiR-26b inhibits melanoma cell proliferation and enhances apoptosis by suppressing TRAF5-mediated MAPK activation.
hsa-mir-26b	nasopharyngeal carcinoma	down	Down-regulation of miR-26b induces cisplatin resistance in nasopharyngeal carcinoma by repressing JAG1.
hsa-mir-26b	non-small cell lung cancer	down	Expression of miRNA-26b in the diagnosis and prognosis of patients with non-small-cell lung cancer.
hsa-mir-26b	non-small cell lung cancer	down	Down-regulation of microRNA-26b modulates non-small cell lung cancer cells chemoresistance and migration through the association of PTEN.
hsa-mir-26b	non-small cell lung cancer	down	MicroRNA-26b suppresses the metastasis of non-small cell lung cancer by targeting MIEN1 via NF-?B/MMP-9/VEGF pathways.
hsa-mir-26b	oral squamous cell carcinoma	down	MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.
hsa-mir-26b	osteosarcoma	down	miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells.
hsa-mir-26b	osteosarcoma	down	MicroRNA-26b inhibits metastasis of osteosarcoma via targeting CTGF and Smad1.
hsa-mir-26b	osteosarcoma	down	MicroRNA-26b inhibits osteosarcoma cell migration and invasion by down-regulating PFKFB3 expression.
hsa-mir-26b	prostate cancer	down	miR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells.
hsa-mir-26b	prostate cancer	down	Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms.
hsa-mir-26b	renal cell carcinoma	down	Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.
hsa-mir-26b	small cell lung cancer	down	MicroRNA-26b suppresses tumorigenicity and promotes apoptosis in small cell lung cancer cells by targeting myeloid cell leukemia 1 protein.
hsa-mir-26b-5p	bladder cancer	down	Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer.
hsa-mir-26b-5p	gastric cancer	down	A proposed method for the relative quantification of levels of circulating microRNAs in the plasma of gastric cancer patients.
hsa-mir-26b-5p	hepatocellular carcinoma	down	MicroRNA-26b-5p enhances T cell responses by targeting PIM-2 in hepatocellular carcinoma.
hsa-mir-26b-5p	hepatocellular carcinoma	down	Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma.
hsa-mir-26b-5p	hepatocellular carcinoma	down	Regulation of proliferation, angiogenesis and apoptosis in hepatocellular carcinoma by miR-26b-5p.
hsa-mir-26b-5p	intrahepatic cholangiocarcinoma	down	MicroRNA-26b-5p regulates cell proliferation, invasion and metastasis in human intrahepatic cholangiocarcinoma by targeting S100A7.
hsa-mir-26b-5p	multiple myeloma	down	miR-26b-5p suppresses proliferation and promotes apoptosis in multiple myeloma cells by targeting JAG1.
hsa-mir-27a	acute leukemia	down	MiR-27a functions as a tumor suppressor in acute leukemia by regulating 14-3-3?.
hsa-mir-27a	acute myeloid leukemia	down	MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1.
hsa-mir-27a	breast cancer	up	miR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis.
hsa-mir-27a	breast cancer	up	c-MYC regulated miR-23a~24-2~27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2.
hsa-mir-27a	breast cancer	up	Arsenic trioxide suppresses cell growth and migration via inhibition of miR-27a in breast cancer cells.
hsa-mir-27a	cervical adenocarcinoma	down	miR-27a inhibits cervical adenocarcinoma progression by downregulating the TGF-?RI signaling pathway.
hsa-mir-27a	cervical cancer	up	B4GALT3 up-regulation by miR-27a contributes to the oncogenic activity in human cervical cancer cells.
hsa-mir-27a	chronic myelogenous leukemia	up	microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-mir-27a	colorectal cancer	up	Knockdown of miR-27a sensitizes colorectal cancer stem cells to TRAIL by promoting the formation of Apaf-1-caspase-9 complex.
hsa-mir-27a	colorectal cancer	down	Tumor Suppressor MicroRNA-27a in Colorectal Carcinogenesis and Progression by Targeting SGPP1 and Smad2.
hsa-mir-27a	colorectal cancer	up	Novel evidence for curcumin and boswellic acid induced chemoprevention through regulation of miR-34a and miR-27a in colorectal cancer.
hsa-mir-27a	esophageal cancer	up	Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-27a	esophageal squamous cell carcinoma	down	microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS.
hsa-mir-27a	esophageal squamous cell carcinoma	down	MicroRNA-27a directly targets KRAS to inhibit cell proliferation in esophageal squamous cell carcinoma.
hsa-mir-27a	esophageal squamous cell carcinoma	up	Increased Expression of MiR-27a and MiR-24-2 in Esophageal Squamous Cell Carcinoma.
hsa-mir-27a	esophageal squamous cell carcinoma	down	MicroRNA-27a downregulates the expression of Hsp90 and enhances the radiosensitivity in esophageal squamous cell carcinoma.
hsa-mir-27a	gastric adenocarcinoma	up	MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin.
hsa-mir-27a	gastric cancer	up	Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells.
hsa-mir-27a	gastric cancer	up	miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition.
hsa-mir-27a	gastric cancer	up	Cell-Free miR-27a, a Potential Diagnostic and Prognostic Biomarker for Gastric Cancer.
hsa-mir-27a	gastric cancer	up	MiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting SFRP1 via Wnt/?-catenin signaling pathway.
hsa-mir-27a	glioma	down	Emerging role of microRNA-27a in human malignant glioma cell survival via targeting of prohibitin.
hsa-mir-27a	glioma	up	MiR-27a regulates Wnt/beta-catenin signaling through targeting SFRP1 in glioma.
hsa-mir-27a	glioma	up	Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-27a	hepatocellular carcinoma	up	MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor ?.
hsa-mir-27a	hepatocellular carcinoma	up	Obesity-associated miR-27a upregulation promotes hepatocellular carcinoma metastasis through suppressing SFRP1.
hsa-mir-27a	laryngeal carcinoma	up	MicroRNA-27a promotes proliferation and suppresses apoptosis by targeting PLK2 in laryngeal carcinoma.
hsa-mir-27a	liver cancer	up	Adipose tissue-secreted miR-27a promotes liver cancer by targeting FOXO1 in obese individuals.
hsa-mir-27a	lung cancer	up	MIR-27a regulates the TGF-? signaling pathway by targeting SMAD2 and SMAD4 in lung cancer.
hsa-mir-27a	malignant melanoma	up	Silencing of microRNA-27a facilitates autophagy and apoptosis of melanoma cells through the activation of the SYK-dependent mTOR signaling pathway.
hsa-mir-27a	multiple myeloma	up	Increased expression of miR-27 predicts poor prognosis and promotes tumorigenesis in human multiple myeloma.
hsa-mir-27a	non-small cell lung cancer	down	Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-27a	osteosarcoma	up	MicroRNA-27a Promotes Proliferation, Migration and Invasion by Targeting MAP2K4 in Human Osteosarcoma Cells.
hsa-mir-27a	osteosarcoma	up	Diagnostic and prognostic potentials of microRNA-27a in osteosarcoma.
hsa-mir-27a	osteosarcoma	up	MicroRNA-27a functions as an oncogene in human osteosarcoma by targeting CCNG1.
hsa-mir-27a	osteosarcoma	up	Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.
hsa-mir-27a	ovarian cancer	up	Oncogenic MicroRNA-27a is a Target for Genistein in Ovarian Cancer Cells.
hsa-mir-27a	ovarian cancer	up	MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.
hsa-mir-27a	ovarian cancer	up	MiR-27a promotes EMT in ovarian cancer through active Wnt/??-catenin signalling by targeting FOXO1.
hsa-mir-27a	ovarian cancer	up	Integrated microarray meta-analysis identifies miRNA-27a as an oncogene in ovarian cancer by inhibiting FOXO1.
hsa-mir-27a	pancreatic cancer	up	Genistein Inhibits Cell Growth and Invasion Through Regulation of MiR-27a in Pancreatic Cancer Cells.
hsa-mir-27a	pancreatic ductal adenocarcinoma	up	MiRNAs are Unlikely to be Involved in Retinoid Receptor Gene Regulation in Pancreatic Cancer Cells.
hsa-mir-27a	prostate cancer	down	Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression.
hsa-mir-27a	renal cell carcinoma	down	MicroRNA-27a functions as a tumor suppressor in renal cell carcinoma by targeting epidermal growth factor receptor.
hsa-mir-27a	renal cell carcinoma	up	miR-27a promotes cell proliferation and metastasis in renal cell carcinoma.
hsa-mir-27a	small cell lung cancer	down	miR-27a regulates the self renewal of the H446 small cell lung cancer cell line in vitro.
hsa-mir-27a	squamous carcinoma	up	Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-27a*	head and neck squamous cell carcinoma	down	Coordinated Targeting of the EGFR Signaling Axis by MicroRNA-27a*
hsa-mir-27a-3p	colorectal cancer	up	miR-27a-3p targeting RXR? promotes colorectal cancer progression by activating Wnt/?-catenin pathway.
hsa-mir-27a-3p	esophageal squamous cell carcinoma	up	MiR-27a-3p promotes esophageal cancer cell proliferation via F-box and WD repeat domain-containing 7 (FBXW7) suppression.
hsa-mir-27a-3p	gastric cancer	up	MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2.
hsa-mir-27a-3p	glioma	up	miR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1.
hsa-mir-27a-3p	hepatocellular carcinoma	down	MicroRNA-27a-3p inhibits cell viability and migration through down-regulating DUSP16 in hepatocellular carcinoma.
hsa-mir-27a-3p	hepatocellular carcinoma	down	miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
hsa-mir-27a-3p	nasopharyngeal carcinoma	up	Dysregulated miR-27a-3p promotes nasopharyngeal carcinoma cell proliferation and migration by targeting Mapk10.
hsa-mir-27a-3p	oral squamous cell carcinoma	down	MicroRNA-27a-3p regulates epithelial to mesenchymal transition via targeting YAP1 in oral squamous cell carcinoma cells.
hsa-mir-27b	acute myeloid leukemia	down	MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1.
hsa-mir-27b	breast cancer	up	miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study.
hsa-mir-27b	cervical cancer	up	MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.
hsa-mir-27b	cervical cancer	up	miR-27b is upregulated in cervical carcinogenesis and promotes cell growth and invasion by regulating CDH11 and epithelial-mesenchymal transition.
hsa-mir-27b	cervical carcinoma	up	Elevation of miR-27b by HPV16 E7 inhibits PPAR? expression and promotes proliferation and invasion in cervical carcinoma cells.
hsa-mir-27b	colorectal cancer	down	MiR-27b directly targets Rab3D to inhibit the malignant phenotype in colorectal cancer.
hsa-mir-27b	gastric cancer	down	MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.
hsa-mir-27b	gastric cancer	up	miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition.
hsa-mir-27b	gastric cancer	down	miR-27b inhibits gastric cancer metastasis by targeting NR2F2.
hsa-mir-27b	glioma	up	Expression and function of miR-27b in human glioma.
hsa-mir-27b	glioma	up	MicroRNA-27b inhibits Spry2 expression and promotes cell invasion in glioma U251 cells.
hsa-mir-27b	hepatocellular carcinoma	down	Clinicopathological significance of miR-27b targeting Golgi protein 73 in patients with hepatocellular carcinoma.
hsa-mir-27b	hepatocellular carcinoma	up	MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
hsa-mir-27b	multiple myeloma	up	Increased expression of miR-27 predicts poor prognosis and promotes tumorigenesis in human multiple myeloma.
hsa-mir-27b	non-small cell lung cancer	down	MicroRNA-27b suppresses growth and invasion of NSCLC cells by targeting Sp1.
hsa-mir-27b	non-small cell lung cancer	down	Overexpression of MicroRNA-27b Inhibits Proliferation, Migration, and Invasion via Suppression of MET Expression.
hsa-mir-27b	oral squamous cell carcinoma	down	MicroRNA-27b inhibits cell proliferation in oral squamous cell carcinoma by targeting FZD7 and Wnt signaling pathway.
hsa-mir-27b	oral squamous cell carcinoma	down	The tumor-suppressive microRNA-23b/27b cluster regulates the MET oncogene in oral squamous cell carcinoma.
hsa-mir-27b	oral squamous cell carcinoma	up	Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-27b	ovarian cancer	up	MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.
hsa-mir-27b	ovarian cancer	down	MicroRNA-27b functions as a new inhibitor of ovarian cancer-mediated vasculogenic mimicry through suppression of VE-cadherin expression.
hsa-mir-27b	pancreatic ductal adenocarcinoma	up	MiRNAs are Unlikely to be Involved in Retinoid Receptor Gene Regulation in Pancreatic Cancer Cells.
hsa-mir-27b-3p	breast cancer	down	miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells.
hsa-mir-27b-3p	breast cancer	down	Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression.
hsa-mir-27b-3p	gastric cancer	down	miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
hsa-mir-27b-3p	multiple myeloma	up	Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.
hsa-mir-27b-5p	oral squamous cell carcinoma	down	MEHP promotes the proliferation of oral cancer cells via down regulation of miR-27b-5p and miR-372-5p.
hsa-mir-28	gastric cancer	up	MicroRNA-28 promotes cell proliferation and invasion in gastric cancer via the PTEN/PI3K/AKT signalling pathway.
hsa-mir-28-3p	colorectal cancer	down	Strand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer Cells.
hsa-mir-28-3p	esophageal cancer	up	Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-28-3p	esophageal squamous cell carcinoma	up	A novel serum microRNA signature to screen esophageal squamous cell carcinoma.
hsa-mir-28-5p	chronic lymphocytic leukemia	down	NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
hsa-mir-28-5p	colorectal cancer	down	Strand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer Cells.
hsa-mir-28-5p	gastric cancer	down	MicroRNA-28-5p inhibits the migration and invasion of gastric cancer cells by suppressing AKT phosphorylation.
hsa-mir-28-5p	glioma	down	MicroRNA-28-5p regulates glioma cell proliferation, invasion and migration by targeting SphK1.
hsa-mir-28-5p	hepatocellular carcinoma	down	miR-28-5p-IL-34-Macrophage Feedback Loop Modulates Hepatocellular Carcinoma Metastasis.
hsa-mir-28-5p	ovarian cancer	up	miR-28-5p promotes the development and progression of ovarian cancer through inhibition of N4BP1.
hsa-mir-28-5p	renal cell carcinoma	down	A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma.
hsa-mir-28-5p	renal cell carcinoma	down	miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.
hsa-mir-2861	basal cell carcinoma	down	Expression of microRNAs in basal cell carcinoma.
hsa-mir-2861	cervical cancer	down	miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6.
hsa-mir-2861	papillary thyroid carcinoma	up	lncRNA DGCR5 acts as a tumor suppressor in papillary thyroid carcinoma via sequestering miR-2861.
hsa-mir-296	cervical cancer	down	MicroRNA-296 targets specificity protein 1 to suppress cell proliferation and invasion in cervical cancer.
hsa-mir-296	colorectal cancer	down	miR-296 inhibits the metastasis and epithelial-mesenchymal transition of colorectal cancer by targeting S100A4.
hsa-mir-296	colorectal cancer	down	MicroRNA-296 inhibits colorectal cancer cell growth and enhances apoptosis by targeting ARRB1-mediated AKT activation.
hsa-mir-296	hepatocellular carcinoma	down	miR-296 inhibits proliferation and induces apoptosis by targeting FGFR1 in human hepatocellular carcinoma.
hsa-mir-296-3p	non-small cell lung cancer	down	MiR-296-3p may affect the proliferation and migration of non-small cell lung cancer cells via regulating RABL3.
hsa-mir-296-5p	breast cancer	down	Epigenetic silencing of miR-296 and miR-512 ensures hTERT dependent apoptosis protection and telomere maintenance in basal-type breast cancer cells.
hsa-mir-296-5p	esophageal squamous cell carcinoma	down	MiR-296-5p inhibits cell invasion and migration of esophageal squamous cell carcinoma by downregulating STAT3 signaling.
hsa-mir-296-5p	esophageal squamous cell carcinoma	up	A novel serum microRNA signature to screen esophageal squamous cell carcinoma.
hsa-mir-296-5p	gastric cancer	up	MicroRNA-296-5p increases proliferation in gastric cancer through repression of Caudal-related homeobox 1.
hsa-mir-296-5p	gastric cancer	up	Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer.
hsa-mir-296-5p	glioblastoma	down	Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells.
hsa-mir-296-5p	papillary thyroid carcinoma	down	MiR-296-5p suppresses papillary thyroid carcinoma cell growth via targeting PLK1.
hsa-mir-297	lung adenocarcinoma	up	miR-297 acts as an oncogene by targeting GPC5 in lung adenocarcinoma.
hsa-mir-297	oral squamous cell carcinoma	down	Long intergenic non-coding RNA 668 regulates VEGFA signaling through inhibition of miR-297 in oral squamous cell carcinoma.
hsa-mir-298	hepatocellular carcinoma	down	MicroRNA-298 represses hepatocellular carcinoma progression by inhibiting CTNND1-mediated Wnt/?-catenin signaling.
hsa-mir-299	glioblastoma	up	Up-regulated microRNA-299 corrected with poor prognosis of glioblastoma multiforme patients by targeting ELL2.
hsa-mir-299-3p	colon carcinoma	down	MicroRNA-299-3p suppresses proliferation and invasion by targeting VEGFA in human colon carcinoma.
hsa-mir-299-3p	hepatocellular carcinoma	down	MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma.
hsa-mir-299-3p	thyroid cancer	down	MiR-299-3p functions as a tumor suppressor in thyroid cancer by regulating SHOC2.
hsa-mir-299-5p	hepatocellular carcinoma	up	Knockdown of miR-299-5p inhibits the progression of hepatocellular carcinoma by targeting SIAH1.
hsa-mir-29a	acute myeloid leukemia	up	microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia.
hsa-mir-29a	acute myeloid leukemia	down	MicroRNA29a regulates the expression of the nuclear oncogene Ski.
hsa-mir-29a	breast cancer	up	Next-generation sequencing of microRNAs for breast cancer detection.
hsa-mir-29a	breast cancer	up	microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer.
hsa-mir-29a	breast cancer	down	MicroRNA-29a inhibits cell migration and invasion by targeting Roundabout 1 in breast cancer cells.
hsa-mir-29a	breast cancer	up	Mir-29a promotes cell proliferation and EMT in breast cancer by targeting ten eleven translocation 1.
hsa-mir-29a	cervical cancer	down	MiR-29a inhibits cell proliferation and migration by targeting the CDC42/PAK1 signaling pathway in cervical cancer.
hsa-mir-29a	cervical squamous cell carcinoma	down	Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma.
hsa-mir-29a	cholangiocarcinoma	up	Increased Expression of miR-29a and Its Prognostic Significance in Patients with Cholangiocarcinoma.
hsa-mir-29a	colon cancer	down	miRNA-29a inhibits colon cancer growth by regulation of the PTEN/Akt/GSK3? and Wnt/?-catenin signaling pathways.
hsa-mir-29a	colorectal cancer	up	microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers.
hsa-mir-29a	colorectal cancer	up	MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4.
hsa-mir-29a	colorectal cancer	up	Evaluation of microRNAs-29a, 92a and 145 in colorectal carcinoma as candidate diagnostic markers: An Egyptian pilot study.
hsa-mir-29a	ependymoma	up	Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-29a	gastric cancer	down	Application values of miR-194 and miR-29 in the diagnosis and prognosis of gastric cancer.
hsa-mir-29a	gastric cancer	down	Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines.
hsa-mir-29a	gastric cancer	down	MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer.
hsa-mir-29a	gastric cancer	down	miR-29a suppresses growth and invasion of gastric cancer cells in vitro by targeting VEGF-A.
hsa-mir-29a	gastric cancer	down	MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability.
hsa-mir-29a	gastric cancer	down	MicroRNA-29a inhibits cell migration and invasion via targeting Roundabout homolog 1 in gastric cancer cells.
hsa-mir-29a	gastric cancer	down	Cell-derived microvesicles mediate the delivery of miR-29a/c to suppress angiogenesis in gastric carcinoma.
hsa-mir-29a	glioblastoma	up	MicroRNA-29a activates a multi-component growth and invasion program in glioblastoma.
hsa-mir-29a	glioma	down	MiR-29a Inhibits Glioma Tumorigenesis through a Negative Feedback Loop of TRAF4/Akt Signaling.
hsa-mir-29a	head and neck squamous cell carcinoma	down	Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.
hsa-mir-29a	hepatocellular carcinoma	down	Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma.
hsa-mir-29a	hepatocellular carcinoma	down	microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma.
hsa-mir-29a	hepatocellular carcinoma	down	Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.
hsa-mir-29a	hepatocellular carcinoma	down	Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.
hsa-mir-29a	hepatocellular carcinoma	down	MiR-29a suppresses cell proliferation by targeting SIRT1 in hepatocellular carcinoma.
hsa-mir-29a	hepatocellular carcinoma	down	miR-29a suppresses growth and migration of hepatocellular carcinoma by regulating CLDN1.
hsa-mir-29a	hepatocellular carcinoma	down	Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
hsa-mir-29a	lung cancer	down	Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis.
hsa-mir-29a	lung cancer	down	MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer.
hsa-mir-29a	mantle cell lymphoma	down	microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-29a	mesenchymal cancer	down	miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR.
hsa-mir-29a	monocytic leukemia	down	Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia.
hsa-mir-29a	nasopharyngeal cancer	down	MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway.
hsa-mir-29a	nasopharyngeal carcinoma	down	microRNA-29a functions as a tumor suppressor in nasopharyngeal carcinoma 5-8F cells through targeting VEGF.
hsa-mir-29a	neuroblastoma	down	Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis.
hsa-mir-29a	non-small cell lung cancer	down	Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.
hsa-mir-29a	non-small cell lung cancer	down	MicroRNA-29a functions as a potential tumor suppressor through directly targeting CDC42 in non-small cell lung cancer.
hsa-mir-29a	oral squamous cell carcinoma	down	MicroRNA-29a upregulates MMP2 in oral squamous cell carcinoma to promote cancer invasion and anti-apoptosis.
hsa-mir-29a	osteosarcoma	up	miR-29 promotes osteosarcoma cell proliferation and migration by targeting PTEN.
hsa-mir-29a	pancreatic cancer	up	MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin.
hsa-mir-29a	pancreatic cancer	down	Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential.
hsa-mir-29a	papillary thyroid carcinoma	down	miR-29a inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting DPP4.
hsa-mir-29a	papillary thyroid carcinoma	down	miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.
hsa-mir-29a	retinoblastoma	down	miR-29a inhibits human retinoblastoma progression by targeting STAT3.
hsa-mir-29a-3p	colorectal cancer	down	Downregulation of RPS15A by miR-29a-3p attenuates cell proliferation in colorectal carcinoma.
hsa-mir-29a-3p	gastric cancer	down	Reduced miR-29a-3p expression is linked to the cell proliferation and cell migration in gastric cancer.
hsa-mir-29a-3p	hepatocellular carcinoma	down	XPD suppresses cell proliferation and migration via miR-29a-3p-Mdm2/PDGF-B axis in HCC.
hsa-mir-29a-3p	hepatocellular carcinoma	down	miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma.
hsa-mir-29a-3p	oral squamous cell carcinoma	up	Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p.
hsa-mir-29a-5p	endometrial cancer	down	MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
hsa-mir-29b	acute myeloid leukemia	down	The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation.
hsa-mir-29b	acute myeloid leukemia	down	Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia.
hsa-mir-29b	cholangiocarcinoma	down	[Overpression of miR-29b suppresses the proliferation and induces apoptosis of cholangiocarcinoma cells].
hsa-mir-29b	chronic lymphocytic leukemia	down	Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
hsa-mir-29b	colorectal cancer	down	miR-29b suppresses tumor growth and metastasis in colorectal cancer via downregulating Tiam1 expression and inhibiting epithelial-mesenchymal transition.
hsa-mir-29b	colorectal cancer	down	[Expression of microRNA-29b in colorectal cancer and its relationship with clinicopathological features].
hsa-mir-29b	endometrial cancer	down	MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
hsa-mir-29b	esophageal squamous cell carcinoma	down	miR-29b inhibits the progression of esophageal squamous cell carcinoma by targeting MMP-2.
hsa-mir-29b	gastric cancer	down	MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability.
hsa-mir-29b	gastric cancer	down25428377	MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability.
hsa-mir-29b	gastric cancer	down	Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer.
hsa-mir-29b	gastric cancer	down	Methylation-induced downregulation and tumor suppressive role of microRNA-29b in gastric cancer through targeting LASP1.
hsa-mir-29b	gastric cancer	down	RUNX3-mediated up-regulation of miR-29b suppresses the proliferation and migration of gastric cancer cells by targeting KDM2A.
hsa-mir-29b	glioblastoma	down	miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma.
hsa-mir-29b	glioblastoma	down	miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2.
hsa-mir-29b	glioblastoma	down	Genome-wide analysis of YB-1-RNA interactions reveals a novel role of YB-1 in miRNA processing in glioblastoma multiforme.
hsa-mir-29b	glioma	down	MiR-29b inhibits the growth of glioma via MYCN dependent way.
hsa-mir-29b	lung adenocarcinoma	down	MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma.
hsa-mir-29b	lung cancer	down	ARHGEF19 interacts with BRAF to activate MAPK signaling during the tumorigenesis of non-small cell lung cancer.
hsa-mir-29b	mantle cell lymphoma	down	microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-29b	monocytic leukemia	down	Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia.
hsa-mir-29b	non-small cell lung cancer	down	Preclinical rationale for combining an EGFR antibody with cisplatin/gemcitabine for the treatment of NSCLC.
hsa-mir-29b	non-small cell lung cancer	down	Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.
hsa-mir-29b	non-small cell lung cancer	down	MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN.
hsa-mir-29b	oral squamous cell carcinoma	up	Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
hsa-mir-29b	osteosarcoma	down	MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.
hsa-mir-29b	osteosarcoma	down	Tissue expression levels of miR-29b and miR-422a in children, adolescents, and young adults' age groups and their association with prediction of poor prognosis in human osteosarcoma.
hsa-mir-29b	ovarian cancer	down	MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3.
hsa-mir-29b	pancreatic cancer	down	MiR-29b suppresses proliferation and mobility by targeting SOX12 and DNMT3b in pancreatic cancer.
hsa-mir-29b	prostate cancer	down	miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling.
hsa-mir-29b-1	breast cancer	up	microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer.
hsa-mir-29b-1	gastric cancer	down	Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines.
hsa-mir-29b-1	gastric cancer	down	Application values of miR-194 and miR-29 in the diagnosis and prognosis of gastric cancer.
hsa-mir-29b-1	head and neck squamous cell carcinoma	down	Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.
hsa-mir-29b-1	hepatocellular carcinoma	down	Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma.
hsa-mir-29b-1	hepatocellular carcinoma	down	Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.
hsa-mir-29b-1	hepatocellular carcinoma	down	Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.
hsa-mir-29b-1	hepatocellular carcinoma	down	Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
hsa-mir-29b-1	mesenchymal cancer	down	miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR.
hsa-mir-29b-1	nasopharyngeal cancer	down	MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway.
hsa-mir-29b-1	osteosarcoma	up	miR-29 promotes osteosarcoma cell proliferation and migration by targeting PTEN.
hsa-mir-29b-1	pancreatic cancer	down	Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential.
hsa-mir-29b-1-5p	mesenchymal cancer	down	miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR.
hsa-mir-29b-2	breast cancer	up	microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer.
hsa-mir-29b-2	gastric cancer	down	Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines.
hsa-mir-29b-2	gastric cancer	down	Application values of miR-194 and miR-29 in the diagnosis and prognosis of gastric cancer.
hsa-mir-29b-2	head and neck squamous cell carcinoma	down	Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.
hsa-mir-29b-2	hepatocellular carcinoma	down	Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma.
hsa-mir-29b-2	hepatocellular carcinoma	down	Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.
hsa-mir-29b-2	hepatocellular carcinoma	down	Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.
hsa-mir-29b-2	hepatocellular carcinoma	down	Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
hsa-mir-29b-2	mesenchymal cancer	down	miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR.
hsa-mir-29b-2	nasopharyngeal cancer	down	MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway.
hsa-mir-29b-2	osteosarcoma	up	miR-29 promotes osteosarcoma cell proliferation and migration by targeting PTEN.
hsa-mir-29b-2	pancreatic cancer	down	Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential.
hsa-mir-29c	acute myeloid leukemia	down	Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine.
hsa-mir-29c	basal cell carcinoma	down	Expression of microRNAs in basal cell carcinoma.
hsa-mir-29c	bladder cancer	down	Down-regulation of miR-29c in human bladder cancer and the inhibition of proliferation in T24 cell via PI3K-AKT pathway.
hsa-mir-29c	breast cancer	up	microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer.
hsa-mir-29c	breast cancer	down	miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.
hsa-mir-29c	breast cancer	down	LINC00511 knockdown enhances paclitaxel cytotoxicity in breast cancer via regulating miR-29c/CDK6 axis.
hsa-mir-29c	esophageal squamous cell carcinoma	down	miR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression.
hsa-mir-29c	esophageal squamous cell carcinoma	down	Predictive Value of Serum miR-10b, miR-29c, and miR-205 as Promising Biomarkers in Esophageal Squamous Cell Carcinoma Screening.
hsa-mir-29c	gastric cancer	down	Application values of miR-194 and miR-29 in the diagnosis and prognosis of gastric cancer.
hsa-mir-29c	gastric cancer	down	microRNA-29c inhibits cell proliferation by targeting NASP in human gastric cancer.
hsa-mir-29c	gastric cancer	down	Cell-derived microvesicles mediate the delivery of miR-29a/c to suppress angiogenesis in gastric carcinoma.
hsa-mir-29c	gastric cancer	down	Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines.
hsa-mir-29c	gastric cancer	down	The tumor suppressor microRNA-29c is downregulated and restored by celecoxib in human gastric cancer cells.
hsa-mir-29c	gastric cancer	down	MiR-29c is downregulated in gastric carcinomas and regulates cell proliferation by targeting RCC2.
hsa-mir-29c	gastric cancer	down	[Relationship between the expression level of miR-29c and biological behavior of gastric cancer].
hsa-mir-29c	gastric cancer	down	MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1.
hsa-mir-29c	gastric cancer	down	MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability.
hsa-mir-29c	gastric cancer	down	Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer.
hsa-mir-29c	glioma	down	MiR-29c inhibits glioma cell proliferation, migration, invasion and angiogenesis.
hsa-mir-29c	head and neck squamous cell carcinoma	down	Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.
hsa-mir-29c	hepatocellular carcinoma	down	Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma.
hsa-mir-29c	hepatocellular carcinoma	down	PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells.
hsa-mir-29c	hepatocellular carcinoma	down	MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma.
hsa-mir-29c	hepatocellular carcinoma	down	Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.
hsa-mir-29c	hepatocellular carcinoma	down	Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.
hsa-mir-29c	hepatocellular carcinoma	down	A suppressive role of ionizing radiation-responsive miR-29c in the development of liver carcinoma via targeting WIP1.
hsa-mir-29c	hepatocellular carcinoma	down	Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
hsa-mir-29c	hepatocellular carcinoma	down	Low miR-29c expression is a prognostic marker in hepatocellular carcinoma.
hsa-mir-29c	lung adenocarcinoma	down	MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma.
hsa-mir-29c	lung cancer	down	miRNA-29c Suppresses Lung Cancer Cell Adhesion to Extracellular Matrix and Metastasis by Targeting Integrin ?1 and Matrix Metalloproteinase2 (MMP2).
hsa-mir-29c	malignant melanoma	up	MicroRNA-29c induces G1 arrest of melanoma by targeting CDK6.
hsa-mir-29c	mantle cell lymphoma	down	microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-29c	mesenchymal cancer	down	miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR.
hsa-mir-29c	nasopharyngeal cancer	down	Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma.
hsa-mir-29c	nasopharyngeal cancer	down	MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway.
hsa-mir-29c	nasopharyngeal carcinoma	down	Downregulation of lncRNA X Inactive Specific Transcript (XIST) Suppresses Cell Proliferation and Enhances Radiosensitivity by Upregulating mir-29c in Nasopharyngeal Carcinoma Cells.
hsa-mir-29c	nasopharyngeal carcinoma	down	MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma.
hsa-mir-29c	non-small cell lung cancer	up	Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.
hsa-mir-29c	non-small cell lung cancer	down	Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.
hsa-mir-29c	non-small cell lung cancer	up	Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer.
hsa-mir-29c	non-small cell lung cancer	up	Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
hsa-mir-29c	non-small cell lung cancer	down	MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway.
hsa-mir-29c	non-small cell lung cancer	down	MicroRNA-29c inhibits proliferation and promotes apoptosis in non-small cell lung cancer cells by targeting VEGFA.
hsa-mir-29c	osteosarcoma	down	BMP-2 and miR-29c in osteosarcoma tissues on proliferation and invasion of osteosarcoma cells.
hsa-mir-29c	osteosarcoma	up	miR-29 promotes osteosarcoma cell proliferation and migration by targeting PTEN.
hsa-mir-29c	pancreatic cancer	down	Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential.
hsa-mir-29c	pancreatic cancer	down	miR-29c suppresses pancreatic cancer liver metastasis in an orthotopic implantation model in nude mice and affects survival in pancreatic cancer patients.
hsa-mir-29c	prostate cancer	down	Up-regulated miR-29c inhibits cell proliferation and glycolysis by inhibiting SLC2A3 expression in prostate cancer.
hsa-mir-29c*	basal cell carcinoma	down	Expression of microRNAs in basal cell carcinoma.
hsa-mir-29c-3p	colon cancer	down	p53 target miR-29c-3p suppresses colon cancer cell invasion and migration through inhibition of PHLDB2.
hsa-mir-29c-3p	colorectal cancer	down	hsa-miR-29c-3p regulates biological function of colorectal cancer by targeting SPARC.
hsa-mir-29c-3p	hepatocellular carcinoma	down	miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma.
hsa-mir-29c-5p	gallbladder carcinoma	down	MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway.
hsa-mir-300	breast cancer	down	miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
hsa-mir-300	glioblastoma	down	MicroRNA-300 inhibited glioblastoma progression through ROCK1.
hsa-mir-300	head and neck squamous cell carcinoma	down	miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
hsa-mir-300	hepatocellular carcinoma	down	miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
hsa-mir-300	laryngeal squamous cell carcinoma	down	MiR-300 suppresses laryngeal squamous cell carcinoma proliferation and metastasis by targeting ROS1.
hsa-mir-300	laryngeal squamous cell carcinoma	up	Reduced miR-300 expression predicts poor prognosis in patients with laryngeal squamous cell carcinoma.
hsa-mir-300	non-small cell lung cancer	down	MicroRNA-300 targets hypoxia inducible factor-3 alpha to inhibit tumorigenesis of human non-small cell lung cancer.
hsa-mir-300	oral squamous cell carcinoma	down	MicroRNA-300 suppresses metastasis of oral squamous cell carcinoma by inhibiting epithelial-to-mesenchymal transition.
hsa-mir-300	osteosarcoma	up	Up-Regulation of MiR-300 Promotes Proliferation and Invasion of Osteosarcoma by Targeting BRD7.
hsa-mir-300	osteosarcoma	up	Upregulation of miR-300 and downregulation of miR-125b act as potential predictor biomarkers in progression, metastasis, and poor prognosis of osteosarcoma.
hsa-mir-300	pancreatic cancer	down	MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/?-catenin signaling pathway by targeting CUL4B in pancreatic cancer ce
hsa-mir-301a	colorectal cancer	up	Serum overexpression of miR-301a and miR-23a in patients with colorectal cancer.
hsa-mir-301a	colorectal cancer	up	MicroRNA-301a promotes migration and invasion by targeting TGFBR2 in human colorectal cancer.
hsa-mir-301a	colorectal cancer	up	MiR-301a promotes colorectal cancer cell growth and invasion by directly targeting SOCS6.
hsa-mir-301a	endometrial cancer	down	Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.
hsa-mir-301a	gastric cancer	up	Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer.
hsa-mir-301a	gastric cancer	up	Abnormal expression of miR-301a in gastric cancer associated with progression and poor prognosis.
hsa-mir-301a	gastric cancer	up	Onco-miR-130 promotes cell proliferation and migration by targeting TGF?R2 in gastric cancer.
hsa-mir-301a	glioma	up	Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
hsa-mir-301a	hepatocellular carcinoma	up	miR-301a Is a Candidate Oncogene that Targets the Homeobox Gene Gax in Human Hepatocellular Carcinoma.
hsa-mir-301a	multiple myeloma	up	miR-301a promotes cell proliferation by directly targeting TIMP2 in multiple myeloma.
hsa-mir-301a	non-small cell lung cancer	up	Increased expression of microRNA-301a in nonsmall-cell lung cancer and its clinical significance.
hsa-mir-301a	non-small cell lung cancer	down	MiR-130 exerts tumor suppressive function on the tumorigenesis of human non-small cell lung cancer by targeting PTEN.
hsa-mir-301a	pancreatic adenocarcinoma	up	miR-301a as an NF-?B activator in pancreatic cancer cells.
hsa-mir-301a	pancreatic cancer	up	miR-301a promotes pancreatic cancer cell proliferation by directly inhibiting Bim expression.
hsa-mir-301a	prostate cancer	up	Hypoxia induced upregulation of miR-301a/b contributes to increased cell autophagy and viability of prostate cancer cells by targeting NDRG2.
hsa-mir-301a	prostate cancer	up	MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.
hsa-mir-301a	prostate cancer	up	Hyperglycaemia-induced miR-301a promotes cell proliferation by repressing p21 and Smad4 in prostate cancer.
hsa-mir-301a-3p	breast cancer	up	MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ER? Positive Breast Cancer.
hsa-mir-301a-3p	colorectal cancer	up	Overexpression of miR-301a-3p promotes colorectal cancer cell proliferation and metastasis by targeting deleted in liver cancer-1 and runt-related transcription factor 3.
hsa-mir-301a-3p	hepatocellular carcinoma	up	MicroRNA-301a-3p suppressed the progression of hepatocellular carcinoma via targeting VGLL4.
hsa-mir-301a-3p	laryngeal squamous cell carcinoma	up	Hsa-miR-301a-3p Acts as an Oncogene in Laryngeal Squamous Cell Carcinoma via Target Regulation of Smad4.
hsa-mir-301a-3p	pancreatic cancer	up	MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.
hsa-mir-301b	endometrial cancer	down	Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.
hsa-mir-301b	gastric cancer	up	Onco-miR-130 promotes cell proliferation and migration by targeting TGF?R2 in gastric cancer.
hsa-mir-301b	glioma	up	MicroRNA-301b promotes the proliferation and invasion of glioma cells through enhancing activation of Wnt/?-catenin signaling via targeting Glypican-5.
hsa-mir-301b	lung cancer	up	Hypoxia-induced microRNA-301b regulates apoptosis by targeting Bim in lung cancer.
hsa-mir-301b	non-small cell lung cancer	down	MiR-130 exerts tumor suppressive function on the tumorigenesis of human non-small cell lung cancer by targeting PTEN.
hsa-mir-301b	pancreatic carcinoma	up	MicroRNA-301b promotes cell invasiveness through targeting TP63 in pancreatic carcinoma cells.
hsa-mir-301b	prostate cancer	up	Hypoxia induced upregulation of miR-301a/b contributes to increased cell autophagy and viability of prostate cancer cells by targeting NDRG2.
hsa-mir-301b-3p	hepatocellular carcinoma	up	MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
hsa-mir-301b-3p	prostate cancer	up	Hypoxia induced microRNA-301b-3p overexpression promotes proliferation, migration and invasion of prostate cancer cells by targeting LRP1B.
hsa-mir-302a	cervical cancer	down	MicroRNA-302 inhibits cell migration and invasion in cervical cancer by targeting DCUN1D1.
hsa-mir-302a	chronic myelogenous leukemia	down	miR-302 cluster inhibits angiogenesis and growth of K562 leukemia cells by targeting VEGFA.
hsa-mir-302a	colon cancer	down	MicroRNA-302a functions as a putative tumor suppressor in colon cancer by targeting Akt.
hsa-mir-302a	hepatocellular carcinoma	down	miR-302a inhibits human HepG2 and SMMC-7721 cells proliferation and promotes apoptosis by targeting MAP3K2 and PBX3.
hsa-mir-302a	osteosarcoma	down	MicroRNA-302a inhibits osteosarcoma cell migration and invasion by directly targeting IGF-1R.
hsa-mir-302a	prostate cancer	down	MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer.
hsa-mir-302a-3p	hepatocellular carcinoma	down	MicroRNA-302a-3p suppresses hepatocellular carcinoma progression by inhibiting proliferation and invasion.
hsa-mir-302a-5p	non-small cell lung cancer	down	MiR-302a-5p suppresses cell proliferation and invasion in non-small cell lung carcinoma by targeting ITGA6.
hsa-mir-302b	bladder cancer	down	MiR-302b regulates cell functions and acts as a potential biomarker to predict recurrence in bladder cancer.
hsa-mir-302b	cervical cancer	down	MicroRNA-302 inhibits cell migration and invasion in cervical cancer by targeting DCUN1D1.
hsa-mir-302b	chronic myelogenous leukemia	down	miR-302 cluster inhibits angiogenesis and growth of K562 leukemia cells by targeting VEGFA.
hsa-mir-302b	esophageal cancer	down	miR-302b inhibits cancer-related inflammation by targeting ERBB4, IRF2 and CXCR4 in esophageal cancer.
hsa-mir-302b	esophageal squamous cell carcinoma	down	miR-302b is a potential molecular marker of esophageal squamous cell carcinoma and functions as a tumor suppressor by targeting ErbB4.
hsa-mir-302b	gastric adenocarcinoma	down	Down-regulation of miR-302b, an ESC-specific microRNA, in Gastric Adenocarcinoma.
hsa-mir-302b	gastric cancer	down	miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ ?-catenin/EMT signaling cascade in gastric cancer.
hsa-mir-302b	gastric cancer	down	miR-302b regulates cell cycles by targeting CDK2 via ERK signaling pathway in gastric cancer.
hsa-mir-302b	glioblastoma	down	The microRNA-302b-inhibited insulin-like growth factor-binding protein 2 signaling pathway induces glioma cell apoptosis by targeting nuclear factor IA.
hsa-mir-302b	hepatocellular carcinoma	down	MicroRNA-302b suppresses cell proliferation by targeting EGFR in human hepatocellular carcinoma SMMC-7721 cells.
hsa-mir-302b	hepatocellular carcinoma	down	miRNA-302b Suppresses Human Hepatocellular Carcinoma by Targeting AKT2.
hsa-mir-302b	hepatocellular carcinoma	down	miR-302b suppresses cell invasion and metastasis by directly targeting AKT2 in human hepatocellular carcinoma cells.
hsa-mir-302b	lung cancer	down	Exosomes-Derived MiR-302b Suppresses Lung Cancer Cell Proliferation and Migration via TGF?RII Inhibition.
hsa-mir-302b	osteosarcoma	down	MiR-302b Suppresses Osteosarcoma Cell Migration and Invasion by Targeting Runx2.
hsa-mir-302b-3p	esophageal cancer	down	MicroRNA 302b-3p/302c-3p/302d-3p inhibits epithelial-mesenchymal transition and promotes apoptosis in human endometrial carcinoma cells.
hsa-mir-302b-3p	gastric cancer	down	MicroRNA-302b-3p Suppresses Cell Proliferation Through AKT Pathway by Targeting IGF-1R in Human Gastric Cancer.
hsa-mir-302b-3p	non-small cell lung cancer	down	Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
hsa-mir-302c	cervical cancer	down	MicroRNA-302 inhibits cell migration and invasion in cervical cancer by targeting DCUN1D1.
hsa-mir-302c	chronic myelogenous leukemia	down	miR-302 cluster inhibits angiogenesis and growth of K562 leukemia cells by targeting VEGFA.
hsa-mir-302c	hepatocellular carcinoma	down	MiR-302c inhibits tumor growth of hepatocellular carcinoma by suppressing the endothelial-mesenchymal transition of endothelial cells.
hsa-mir-302c-3p	esophageal cancer	down	MicroRNA 302b-3p/302c-3p/302d-3p inhibits epithelial-mesenchymal transition and promotes apoptosis in human endometrial carcinoma cells.
hsa-mir-302c-3p	hepatocellular carcinoma	down	The tumor suppressive miR-302c-3p inhibits migration and invasion of hepatocellular carcinoma cells by targeting TRAF4.
hsa-mir-302c-3p	renal cell carcinoma	down	microRNA-302c-3p inhibits renal cell carcinoma cell proliferation by targeting Grb2-associated binding 2 (Gab2).
hsa-mir-302d	cervical cancer	down	MicroRNA-302 inhibits cell migration and invasion in cervical cancer by targeting DCUN1D1.
hsa-mir-302d	chronic myelogenous leukemia	down	miR-302 cluster inhibits angiogenesis and growth of K562 leukemia cells by targeting VEGFA.
hsa-mir-302d	glioblastoma	down	Tumor suppressors microRNA-302d and microRNA-16 inhibit human glioblastoma multiforme by targeting NF-?B and FGF2.
hsa-mir-302d-3p	esophageal cancer	down	MicroRNA 302b-3p/302c-3p/302d-3p inhibits epithelial-mesenchymal transition and promotes apoptosis in human endometrial carcinoma cells.
hsa-mir-302f	cervical cancer	down	MicroRNA-302 inhibits cell migration and invasion in cervical cancer by targeting DCUN1D1.
hsa-mir-302f	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-3064	ovarian cancer	down	MicroRNA-532 and microRNA-3064 inhibit cell proliferation and invasion by acting as direct regulators of human telomerase reverse transcriptase in ovarian cancer.
hsa-mir-30a	breast cancer	down	MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.
hsa-mir-30a	breast cancer	down	Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer.
hsa-mir-30a	breast cancer	down	MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin.
hsa-mir-30a	breast cancer	down	miR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2.
hsa-mir-30a	breast cancer	down	MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.
hsa-mir-30a	cervical cancer	down	Downregulation of miR-30a is associated with proliferation and invasion via targeting MEF2D in cervical cancer.
hsa-mir-30a	chondrosarcoma	down	Association of SOX4 regulated by tumor suppressor miR-30a with poor prognosis in low-grade chondrosarcoma.
hsa-mir-30a	colorectal cancer	down	MicroRNA-30a-5p (miR-30a) regulates cell motility and EMT by directly targeting oncogenic TM4SF1 in colorectal cancer.
hsa-mir-30a	colorectal cancer	down	MicroRNA-30a attenuates mutant KRAS-driven colorectal tumorigenesis via direct suppression of ME1.
hsa-mir-30a	colorectal cancer	down	MicroRNA-30a Inhibits Colorectal Cancer Metastasis Through Down-Regulation of Type I Insulin-Like Growth Factor Receptor.
hsa-mir-30a	colorectal carcinoma	down	miR-30a suppresses cell migration and invasion through downregulation of PIK3CD in colorectal carcinoma.
hsa-mir-30a	gastric cancer	up	miR-30 functions as an oncomiR in gastric cancer cells through regulation of P53-mediated mitochondrial apoptotic pathway.
hsa-mir-30a	glioma	down	miR-30a inhibits glioma progression and stem cell?like properties by repression of Wnt5a.
hsa-mir-30a	hepatocellular carcinoma	down	MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma.
hsa-mir-30a	hepatocellular carcinoma	down	MicroRNA-30a suppresses tumor progression by blocking Ras/Raf/MEK/ERK signaling pathway in hepatocellular carcinoma.
hsa-mir-30a	hepatocellular carcinoma	down	Effects of microRNA-30a on migration, invasion and prognosis of hepatocellular carcinoma.
hsa-mir-30a	lung adenocarcinoma	down	Overexpression of miR-30a in lung adenocarcinoma A549 cell line inhibits migration and invasion via targeting EYA2.
hsa-mir-30a	lung cancer	down	miR-30a suppresses lung cancer progression by targeting SIRT1.
hsa-mir-30a	non-small cell lung cancer	down	MiR-30 suppresses lung cancer cell 95D epithelial mesenchymal transition and invasion through targeted regulating Snail.
hsa-mir-30a	non-small cell lung cancer	down	MicroRNA-30a suppresses non-small-cell lung cancer by targeting Myb-related protein B.
hsa-mir-30a	non-small cell lung cancer	down	MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer.
hsa-mir-30a	non-small cell lung cancer	down	MiR-30a suppresses non-small cell lung cancer progression through AKT signaling pathway by targeting IGF1R.
hsa-mir-30a	non-small cell lung cancer	down	Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer.
hsa-mir-30a	osteosarcoma	down	miR-30a suppresses osteosarcoma proliferation and metastasis by downregulating MEF2D expression.
hsa-mir-30a	ovarian carcinoma	down	miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma.
hsa-mir-30a	pancreatic cancer	down	MiR-30a regulates cancer cell response to chemotherapy through SNAI1/IRS1/AKT pathway.
hsa-mir-30a	papillary thyroid carcinoma	down	Long noncoding RNA CNALPTC1 promotes cell proliferation and migration of papillary thyroid cancer via sponging miR-30 family.
hsa-mir-30a	papillary thyroid carcinoma	down	MicroRNA-30a suppresses papillary thyroid cancer cell proliferation, migration and invasion by directly targeting E2F7.
hsa-mir-30a	prostate cancer	down	miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.
hsa-mir-30a	renal cell carcinoma	down	MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib.
hsa-mir-30a	renal cell carcinoma	down	MicroRNA-30a suppresses the proliferation, migration and invasion of human renal cell carcinoma cells by directly targeting ADAM9.
hsa-mir-30a-3p	colorectal cancer	down	Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.
hsa-mir-30a-3p	hepatocellular carcinoma	down	MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma.
hsa-mir-30a-5p	breast cancer	down	miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect.
hsa-mir-30a-5p	colon cancer	down	MiR-30a-5p Suppresses Tumor Metastasis of Human Colorectal Cancer by Targeting ITGB3.
hsa-mir-30a-5p	colon carcinoma	down	MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL.
hsa-mir-30a-5p	colorectal cancer	down	Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer.
hsa-mir-30a-5p	colorectal cancer	down	MiR-30a-5p Suppresses Tumor Metastasis of Human Colorectal Cancer by Targeting ITGB3.
hsa-mir-30a-5p	esophageal squamous cell carcinoma	up	Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
hsa-mir-30a-5p	gastric cancer	down	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-30a-5p	gastric cancer	down	MicroRNA-30a-5p inhibits the proliferation and invasion of gastric cancer cells by targeting insulin-like growth factor 1 receptor.
hsa-mir-30a-5p	glioma	up	Analysis of hsa-miR-30a-5p Expression in Human Gliomas.
hsa-mir-30a-5p	glioma	up	MiR-30a-5p is induced by Wnt/?-catenin pathway and promotes glioma cell invasion by repressing NCAM.
hsa-mir-30a-5p	glioma	up	A positive feedback loop of miR-30a-5p-WWP1-NF-?B in the regulation of glioma development.
hsa-mir-30a-5p	head and neck squamous cell carcinoma	up	Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
hsa-mir-30a-5p	hepatocellular carcinoma	down	MicroRNA-30a-5p suppresses proliferation, invasion and tumor growth of hepatocellular cancer cells via targeting FOXA1.
hsa-mir-30a-5p	hepatocellular carcinoma	down	Clinicopathological role of miR-30a-5p in hepatocellular carcinoma tissues and prediction of its function with bioinformatics analysis.
hsa-mir-30a-5p	liver cancer	down	Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
hsa-mir-30a-5p	malignant melanoma	down	The role of microRNA-30a and downstream snail1 on the growth and metastasis of melanoma tumor.
hsa-mir-30a-5p	non-small cell lung cancer	down	p53/miR-30a-5p/ SOX4 feedback loop mediates cellular proliferation, apoptosis, and migration of non-small-cell lung cancer.
hsa-mir-30a-5p	non-small cell lung cancer	down	miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study.
hsa-mir-30a-5p	non-small cell lung cancer	down	CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer.
hsa-mir-30a-5p	osteosarcoma	down	MiR-30a-5p inhibits osteosarcoma cell proliferation and migration by targeting FOXD1.
hsa-mir-30a-5p	ovarian cancer	down	Mechanism of Low Expression of miR-30a-5p on Epithelial-Mesenchymal Transition and Metastasis in Ovarian Cancer.
hsa-mir-30b	colorectal cancer	down	MiR-30b regulates migration and invasion of human colorectal cancer via SIX1.
hsa-mir-30b	esophageal cancer	down	Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-30b	esophageal cancer	down	miR-30b inhibits cancer cell growth, migration, and invasion by targeting homeobox A1 in esophageal cancer.
hsa-mir-30b	gastric cancer	up	miR-30 functions as an oncomiR in gastric cancer cells through regulation of P53-mediated mitochondrial apoptotic pathway.
hsa-mir-30b	gastric cancer	down	miR-30b, Down-Regulated in Gastric Cancer, Promotes Apoptosis and Suppresses Tumor Growth by Targeting Plasminogen Activator Inhibitor-1.
hsa-mir-30b	gastric cancer	down	MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer.
hsa-mir-30b	glioblastoma	up	Oncogenic Role of MicroRNA-30b-5p in Glioblastoma Through Targeting Proline-Rich Transmembrane Protein 2.
hsa-mir-30b	hepatocellular carcinoma	down	MicroRNA-30b Suppresses Epithelial-Mesenchymal Transition and Metastasis of Hepatoma Cells.
hsa-mir-30b	medulloblastoma	up	Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma.
hsa-mir-30b	non-small cell lung cancer	down	MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18.
hsa-mir-30b	non-small cell lung cancer	up	Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
hsa-mir-30b	non-small cell lung cancer	down	MicroRNA-30b inhibits non-small cell lung cancer cell growth by targeting the epidermal growth factor receptor.
hsa-mir-30b	non-small cell lung cancer	down	microRNA-30b inhibits cell invasion and migration through targeting collagen triple helix repeat containing 1 in non-small cell lung cancer.
hsa-mir-30b	papillary thyroid carcinoma	down	Long noncoding RNA CNALPTC1 promotes cell proliferation and migration of papillary thyroid cancer via sponging miR-30 family.
hsa-mir-30b	prostate cancer	down	miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.
hsa-mir-30b-3p	glioma	up	Down-regulated microRNA-30b-3p inhibits proliferation, invasion and migration of glioma cells via inactivation of the AKT signaling pathway by up-regulating RECK.
hsa-mir-30b-5p	glioma	down	MiR-30b-5p modulates glioma cell proliferation by direct targeting MTDH.
hsa-mir-30b-5p	pancreatic ductal adenocarcinoma	up	Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-30c	acute myeloid leukemia	down	Transcription factor C/EBP?-induced microRNA-30c inactivates Notch1 during granulopoiesis and is downregulated in acute myeloid leukemia.
hsa-mir-30c	breast cancer	down	Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer.
hsa-mir-30c	colorectal cancer	down	MiR-30c exerts tumor suppressive functions in colorectal carcinoma by directly targeting BCL9.
hsa-mir-30c	endometrial cancer	down	microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1.
hsa-mir-30c	endometrial cancer	down	Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancer.
hsa-mir-30c	esophageal squamous cell carcinoma	down	MicroRNA-30c functions as a tumor suppressor via targeting SNAI1 in esophageal squamous cell carcinoma.
hsa-mir-30c	gastric cancer	down	Hypoxia decreases macrophage glycolysis and M1 percentage by targeting microRNA-30c and mTOR in human gastric cancer.
hsa-mir-30c	glioblastoma	down	MiR-30c impedes glioblastoma cell proliferation and migration by targeting SOX9.
hsa-mir-30c	non-small cell lung cancer	down	Low expression of microRNA-30c promotes invasion by inducing epithelial mesenchymal transition in non-small cell lung cancer.
hsa-mir-30c	non-small cell lung cancer	down	MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18.
hsa-mir-30c	papillary thyroid carcinoma	down	Long noncoding RNA CNALPTC1 promotes cell proliferation and migration of papillary thyroid cancer via sponging miR-30 family.
hsa-mir-30c	prostate cancer	down	Low expression of microRNA-30c promotes prostate cancer cells invasion involved in downregulation of KRAS protein.
hsa-mir-30c	renal cell carcinoma	down	Hypoxia-induced downregulation of miR-30c promotes epithelial-mesenchymal transition in human renal cell carcinoma.
hsa-mir-30c-1	gastric cancer	up	miR-30 functions as an oncomiR in gastric cancer cells through regulation of P53-mediated mitochondrial apoptotic pathway.
hsa-mir-30c-1	prostate cancer	down	miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.
hsa-mir-30c-2	gastric cancer	up	miR-30 functions as an oncomiR in gastric cancer cells through regulation of P53-mediated mitochondrial apoptotic pathway.
hsa-mir-30c-2	prostate cancer	down	miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.
hsa-mir-30d	colon cancer	down	Mir-30d suppresses cell proliferation of colon cancer cells by inhibiting cell autophagy and promoting cell apoptosis.
hsa-mir-30d	colorectal cancer	down	miRNA-30d serves a critical function in colorectal cancer initiation, progression and invasion via directly targeting the GNA13 gene.
hsa-mir-30d	gastric cancer	up	miR-30 functions as an oncomiR in gastric cancer cells through regulation of P53-mediated mitochondrial apoptotic pathway.
hsa-mir-30d	hepatocellular carcinoma	up	MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma.
hsa-mir-30d	lung cancer	up	Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients.
hsa-mir-30d	medulloblastoma	up	Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma.
hsa-mir-30d	non-small cell lung cancer	down	Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
hsa-mir-30d	non-small cell lung cancer	down	Non-small cell lung cancer: miR-30d suppresses tumor invasion and migration by directly targeting NFIB.
hsa-mir-30d	papillary thyroid carcinoma	down	Long noncoding RNA CNALPTC1 promotes cell proliferation and migration of papillary thyroid cancer via sponging miR-30 family.
hsa-mir-30d	prostate cancer	down	miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.
hsa-mir-30d	prostate cancer	down	Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1.
hsa-mir-30d	prostate cancer	up	MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
hsa-mir-30d	renal cell carcinoma	down	Proliferation inhibition and the underlying molecular mechanisms of microRNA-30d in renal carcinoma cells.
hsa-mir-30d-5p	non-small cell lung cancer	down	MicroRNA-30d-5p inhibits tumour cell proliferation and motility by directly targeting CCNE2 in non-small cell lung cancer.
hsa-mir-30d-5p	non-small cell lung cancer	down	Expression Signature and Role of miR-30d-5p in Non-Small Cell Lung Cancer: a Comprehensive Study Based on in Silico Analysis of Public Databases and in Vitro Experiments.
hsa-mir-30e	breast cancer	down	MiR-30e inhibits tumor growth and chemoresistance via targeting IRS1 in Breast Cancer.
hsa-mir-30e	breast cancer	down	Abnormal miRNA-30e Expression is Associated with Breast Cancer Progression.
hsa-mir-30e	cervical carcinoma	down	MicroRNA-30e Functions as a Tumor Suppressor in Cervical Carcinoma Cells through Targeting GALNT7.
hsa-mir-30e	cholangiocarcinoma	down	Extracellular vesicle-encapsulated miR-30e suppresses cholangiocarcinoma cell invasion and migration via inhibiting epithelial-mesenchymal transition.
hsa-mir-30e	chronic myelogenous leukemia	down	MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL protein.
hsa-mir-30e	gastric cancer	up	miR-30 functions as an oncomiR in gastric cancer cells through regulation of P53-mediated mitochondrial apoptotic pathway.
hsa-mir-30e	glioma	up	Ionizing radiation-inducible miR-30e promotes glioma cell invasion through EGFR stabilization by directly targeting CBL-B.
hsa-mir-30e	hepatocellular carcinoma	down	MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway.
hsa-mir-30e	hepatocellular carcinoma	down	Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma.
hsa-mir-30e	liver cancer	down	MiR-30e suppresses proliferation of hepatoma cells via targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) mRNA.
hsa-mir-30e	lung carcinoma	down	MicroRNA-30e reduces cell growth and enhances drug sensitivity to gefitinib in lung carcinoma.
hsa-mir-30e	non-small cell lung cancer	down	MicroRNA-30e inhibits proliferation and invasion of non-small cell lung cancer via targeting SOX9.
hsa-mir-30e	papillary thyroid carcinoma	down	Long noncoding RNA CNALPTC1 promotes cell proliferation and migration of papillary thyroid cancer via sponging miR-30 family.
hsa-mir-30e	prostate cancer	down	miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.
hsa-mir-30e*	glioma	up	MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-?B/I?B? negative feedback loop.
hsa-mir-30e*	prostate cancer	up	miR-30e* is overexpressed in prostate cancer and promotes NF-?B-mediated proliferation and tumor growth.
hsa-mir-30e-3p	renal clear cell carcinoma	down	MicroRNA-30e-3p inhibits cell invasion and migration in clear cell renal cell carcinoma by targeting Snail1.
hsa-mir-30e-5p	bladder cancer	down	miR-30e-5p suppresses cell proliferation and migration in bladder cancer through regulating metadherin.
hsa-mir-30e-5p	colorectal cancer	down	P53-induced miR-30e-5p inhibits colorectal cancer invasion and metastasis by targeting ITGA6 and ITGB1.
hsa-mir-30e-5p	lung adenocarcinoma	up	MicroRNA-30e-5p promotes cell growth by targeting PTPN13 and indicates poor survival and recurrence in lung adenocarcinoma.
hsa-mir-30e-5p	non-small cell lung cancer	down	MicroRNA-30e-5p suppresses non-small cell lung cancer tumorigenesis by regulating USP22-mediated Sirt1/JAK/STAT3 signaling.
hsa-mir-30e-5p	non-small cell lung cancer	down	Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
hsa-mir-31	breast cancer	down	Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis.
hsa-mir-31	breast cancer	down	miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer.
hsa-mir-31	cervical cancer	up	MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.
hsa-mir-31	cervical cancer	up	miR-31 functions as an oncogene in cervical cancer.
hsa-mir-31	cervical cancer	up	miR-31 Functions as an Oncomir Which Promotes Epithelial-Mesenchymal Transition via Regulating BAP1 in Cervical Cancer.
hsa-mir-31	chordoma	down	MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.
hsa-mir-31	chronic myelogenous leukemia	down	Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.
hsa-mir-31	colon cancer	up	The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer.
hsa-mir-31	colorectal cancer	up	Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer.
hsa-mir-31	colorectal cancer	up	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-31	colorectal cancer	up	MicroRNA signatures: novel biomarker for colorectal cancer?
hsa-mir-31	colorectal cancer	up	Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer.
hsa-mir-31	colorectal cancer	up	Elevated microRNA-31 expression regulates colorectal cancer progression by repressing its target gene SATB2.
hsa-mir-31	colorectal cancer	up	Identification of microRNA-135b in Stool as a Potential Noninvasive Biomarker for Colorectal Cancer and Adenoma.
hsa-mir-31	colorectal cancer	up	SATB1 and 2 in colorectal cancer.
hsa-mir-31	colorectal cancer	up	The potential role of microRNA-31 expression in early colorectal cancer.
hsa-mir-31	esophageal cancer	up	Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-31	esophageal squamous cell carcinoma	up	The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma.
hsa-mir-31	gastric cancer	down	Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance.
hsa-mir-31	gastric cancer	down	Tumor suppressor microRNA-31 inhibits gastric carcinogenesis by targeting Smad4 and SGPP2.
hsa-mir-31	gastric cancer	down	MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells.
hsa-mir-31	gastric cancer	down	MicroRNA-31 triggers G2/M cell cycle arrest, enhances the chemosensitivity and inhibits migration and invasion of human gastric cancer cells by downregulating the expression of zeste homolo
hsa-mir-31	gastric cancer	down	MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
hsa-mir-31	gastric cancer	down	Upregulation of microRNA-31 targeting integrin ?5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells.
hsa-mir-31	gastric cancer	down	Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2.
hsa-mir-31	gastric cancer	down	MicroRNA-31 Function as a Suppressor Was Regulated by Epigenetic Mechanisms in Gastric Cancer.
hsa-mir-31	glioblastoma	down	Human miR-31 targets radixin and inhibits migration and invasion of glioma cells.
hsa-mir-31	glioblastoma	down	Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
hsa-mir-31	glioblastoma	down	MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors.
hsa-mir-31	head and neck squamous cell carcinoma	up	Co-targeting of multiple microRNAs on factor-inhibiting hypoxia-inducible factor (FIH) gene for the pathogenesis of head and neck carcinomas.
hsa-mir-31	hepatocellular carcinoma	up	Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-31	intrahepatic cholangiocarcinoma	up	miR-31 promotes oncogenesis in intrahepatic cholangiocarcinoma cells via the direct suppression of RASA1.
hsa-mir-31	laryngeal squamous cell carcinoma	down	Long non-coding RNA LOC554202 promotes laryngeal squamous cell carcinoma progression through regulating miR-31.
hsa-mir-31	liver cancer	down	MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer.
hsa-mir-31	lung adenocarcinoma	up	MicroRNA-31 Predicts the Presence of Lymph Node Metastases and Survival in Patients with Lung Adenocarcinoma.
hsa-mir-31	lung adenocarcinoma	down	MicroRNA-31 inhibits lung adenocarcinoma stem-like cells via down-regulation of MET-PI3K-Akt signaling pathway.
hsa-mir-31	lung adenocarcinoma	up	MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer.
hsa-mir-31	lung cancer	up	BAP1 suppresses lung cancer progression and is inhibited by miR-31.
hsa-mir-31	lung carcinoma	down	MiR-31 Functions as a Tumor Suppressor in Lung Adenocarcinoma Mainly by Targeting HuR.
hsa-mir-31	malignant melanoma	down	The miR-31-SOX10 axis regulates tumor growth and chemotherapy resistance of melanoma via PI3K/AKT pathway.
hsa-mir-31	malignant melanoma	down	Regulation of cancer aggressive features in melanoma cells by microRNAs.
hsa-mir-31	malignant melanoma	down	Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma.
hsa-mir-31	medulloblastoma	down	MicroRNA-31 suppresses medulloblastoma cell growth by inhibiting DNA replication through minichromosome maintenance 2.
hsa-mir-31	non-small cell lung cancer	up	Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application.
hsa-mir-31	oral carcinoma	up	Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma.
hsa-mir-31	oral carcinoma	up	Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma.
hsa-mir-31	oral squamous cell carcinoma	up	miR-31 is up-regulated in oral premalignant epithelium and contributes to the immortalization of normal oral keratinocytes.
hsa-mir-31	oral squamous cell carcinoma	up	EGF up-regulates miR-31 through the C/EBP? signal cascade in oral carcinoma.
hsa-mir-31	osteosarcoma	down	MicroRNA-31 inhibits osteosarcoma cell proliferation, migration and invasion by targeting PIK3C2A.
hsa-mir-31	pancreatic ductal adenocarcinoma	up	Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-31	papillary thyroid carcinoma	down	MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways.
hsa-mir-31	papillary thyroid carcinoma	up	Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.
hsa-mir-31	prostate cancer	down	Class I HDAC inhibitor mocetinostat induces apoptosis by activation of miR-31 expression and suppression of E2F6.
hsa-mir-31	prostate cancer	down	Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells.
hsa-mir-31	prostate cancer	up	Screening Biomarkers of Prostate Cancer by Integrating microRNA and mRNA Microarrays.
hsa-mir-31	prostate cancer	down	Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31.
hsa-mir-31	rectal cancer	up	Expression of miR-31 in rectal cancer patients and its effect on proliferation ability of rectal cancer cells SW837.
hsa-mir-31-3p	medullary thyroid carcinoma	down	Two GEO MicroRNA Expression Profile Based High-Throughput Screen to Identify MicroRNA-31-3p Regulating Growth of Medullary Thyroid Carcinoma Cell by Targeting RASA2.
hsa-mir-31-5p	colorectal cancer	up	MiR-31-5p promotes the cell growth, migration and invasion of colorectal cancer cells by targeting NUMB.
hsa-mir-31-5p	hepatocellular carcinoma	down	Increased expression of microRNA-31-5p inhibits cell proliferation, migration, and invasion via regulating Sp1 transcription factor in HepG2 hepatocellular carcinoma cell line.
hsa-mir-31-5p	renal cell carcinoma	down	MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1).
hsa-mir-3117	hepatocellular carcinoma	up	miR-3117 regulates hepatocellular carcinoma cell proliferation by targeting PHLPPL.
hsa-mir-3120-5p	colon cancer	up	miR-3120-5p promotes colon cancer stem cell stemness and invasiveness through targeting Axin2.
hsa-mir-3127	hepatocellular carcinoma	up	MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation.
hsa-mir-3129	gastric cancer	up	microRNA-3129 promotes cell proliferation in gastric cancer cell line SGC7901 via positive regulation of pRb.
hsa-mir-3131	hepatocellular carcinoma	up	An Indel Polymorphism within pre-miR3131 Confers Risk for Hepatocellular Carcinoma.
hsa-mir-3136-3p	breast cancer	up	Identification of chemoresistance-associated miRNAs in breast cancer.
hsa-mir-3163	retinoblastoma	down	Silencing of ABCG2 by MicroRNA-3163 Inhibits Multidrug Resistance in Retinoblastoma Cancer Stem Cells.
hsa-mir-3174	gastric cancer	down	miR-3174 Contributes to Apoptosis and Autophagic Cell Death Defects in Gastric Cancer Cells by Targeting ARHGAP10.
hsa-mir-3174	rectal cancer	up	MiR-3174 functions as an oncogene in rectal cancer by targeting PCBD2.
hsa-mir-3175	glioma	up	HOXB1 Is a Tumor Suppressor Gene Regulated by miR-3175 in Glioma.
hsa-mir-3183	colorectal cancer	down	miR-496, miR-1185, miR-654, miR-3183 and miR-495 are downregulated in colorectal cancer cells and have putative roles in the mTOR pathway.
hsa-mir-3188	breast cancer	up	MiR-3188 Regulates Cell Proliferation, Apoptosis, and Migration in Breast Cancer By Targeting TUSC5 and Regulating the p38 MAPK Signaling Pathway.
hsa-mir-3188	non-small cell lung cancer	down	MiR-3188 Inhibits Non-small Cell Lung Cancer Cell Proliferation Through FOXO1-Mediated mTOR-p-PI3K/AKT-c-JUN Signaling Pathway.
hsa-mir-3189-3p	astrocytoma	down	Anti-Tumoral Effects of miR-3189-3p in Glioblastoma.
hsa-mir-3189-3p	glioblastoma	down	Anti-Tumoral Effects of miR-3189-3p in Glioblastoma.
hsa-mir-3191	colorectal cancer	up	MicroRNA-3191 promotes migration and invasion by downregulating TGFBR2 in colorectal cancer.
hsa-mir-3196	basal cell carcinoma	down	Expression of microRNAs in basal cell carcinoma.
hsa-mir-32	acute myeloid leukemia	up	MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis.
hsa-mir-32	breast cancer	up	MicroRNA-32 promotes cell proliferation, migration and suppresses apoptosis in breast cancer cells by targeting FBXW7.
hsa-mir-32	colorectal cancer	up	The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer.
hsa-mir-32	colorectal cancer	up	Analysis of promoter methylation and epigenetic regulation of miR-32 in colorectal cancer cells.
hsa-mir-32	colorectal cancer	up	MicroRNA 32 promotes cell proliferation, migration, and suppresses apoptosis in colon cancer cells by targeting OTU domain containing 3.
hsa-mir-32	colorectal cancer	up	MiR-32 promotes tumorigenesis of colorectal cancer by targeting BMP5.
hsa-mir-32	esophageal squamous cell carcinoma	up	miR-32 promotes esophageal squamous cell carcinoma metastasis by targeting CXXC5.
hsa-mir-32	gastric cancer	up	MiR-32 promotes gastric carcinoma tumorigenesis by targeting Kruppel-like factor 4.
hsa-mir-32	glioma	down	MiR-32 Inhibits Proliferation and Metastasis by Targeting EZH2 in Glioma.
hsa-mir-32	hepatocellular carcinoma	up	MicroRNA-32 Regulates Development and Progression of Hepatocellular Carcinoma by Targeting ADAMTS9 and Affects Its Prognosis.
hsa-mir-32	hepatocellular carcinoma	up	MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN.
hsa-mir-32	hepatocellular carcinoma	up	Upregulation of microRNA-32 is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma.
hsa-mir-32	liver cancer	up	Downregulation of SRC Kinase Signaling Inhibitor 1 (SRCIN1) Expression By MicroRNA-32 Promotes Proliferation and Epithelial-Mesenchymal Transition in Human Liver Cancer Cells.
hsa-mir-32	lung cancer	down	Inhibition of miR-32 activity promoted EMT induced by PM2.5 exposure through the modulation of the Smad1-mediated signaling pathways in lung cancer cells.
hsa-mir-32	nasopharyngeal carcinoma	up	Isoliquiritigenin suppresses the proliferation and induced apoptosis via miR-32/LATS2/Wnt in nasopharyngeal carcinoma.
hsa-mir-32	non-small cell lung cancer	down	Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
hsa-mir-32	non-small cell lung cancer	down	Tanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer.
hsa-mir-32	non-small cell lung cancer	down	miR-32 functions as a tumor suppressor and directly targets SOX9 in human non-small cell lung cancer.
hsa-mir-32	non-small cell lung cancer	down	miR-32 functions as a tumor suppressor and directly targets SOX9 in human non-small cell lung cancer [Retraction].
hsa-mir-32	oral squamous cell carcinoma	down	MiR-32 functions as a tumor suppressor and directly targets EZH2 in human oral squamous cell carcinoma.
hsa-mir-32	osteosarcoma	down	MicroRNA-32 inhibits osteosarcoma cell proliferation and invasion by targeting Sox9.
hsa-mir-32	uveal melanoma	down	MicroRNA-32 functions as a tumor suppressor and directly targets EZH2 in uveal melanoma.
hsa-mir-32	uveal melanoma	down	RETRACTION of articles with plagiarism in common with other publications.
hsa-mir-320	breast cancer	down	MicroRNA-320 inhibits cell proliferation and invasion in breast cancer cells by targeting SOX4.
hsa-mir-320	cervical cancer	down	Down-regulation of miR-320 associated with cancer progression and cell apoptosis via targeting Mcl-1 in cervical cancer.
hsa-mir-320	cervical cancer	down	MicroRNA-320 suppresses cervical cancer cell viability, migration and invasion via directly targeting FOXM1.
hsa-mir-320	chronic myelogenous leukemia	down	microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-mir-320	colon cancer	down	miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1.
hsa-mir-320	colorectal cancer	down	MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.
hsa-mir-320	gastric cancer	down	MicroRNA-320 inhibits invasion and induces apoptosis by targeting CRKL and inhibiting ERK and AKT signaling in gastric cancer cells.
hsa-mir-320	glioblastoma	down	miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.
hsa-mir-320	glioma	down	MicroRNA-320 inhibits cell proliferation in glioma by targeting E2F1.
hsa-mir-320	non-small cell lung cancer	down	MicroRNA-320 was downregulated in non-small cell lung cancer and inhibited cell proliferation, migration and invasion by targeting fatty acid synthase.
hsa-mir-320	osteosarcoma	down	MicroRNA-320 inhibits osteosarcoma cells proliferation by directly targeting fatty acid synthase.
hsa-mir-320	ovarian cancer	down	miR-320 inhibited ovarian cancer oncogenicity via targeting TWIST1 expression.
hsa-mir-320	retinoblastoma	down	MicroRNA-320 inhibits cell proliferation, migration and invasion in retinoblastoma by targeting specificity protein 1.
hsa-mir-3200-5p	osteosarcoma	up	MicroRNA-3200-5p Promotes Osteosarcoma Cell Invasion via Suppression of BRMS1.
hsa-mir-320a	breast cancer	down	Rab14 Suppression Mediated by MiR-320a Inhibits Cell Proliferation, Migration and Invasion in Breast Cancer.
hsa-mir-320a	breast cancer	down	MicroRNA-320a inhibits breast cancer metastasis by targeting metadherin.
hsa-mir-320a	colon cancer	down	MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting ?-catenin.
hsa-mir-320a	colorectal cancer	down	microRNA-320a inhibits tumor invasion by targeting neuropilin?1 and is associated with liver metastasis in colorectal cancer.
hsa-mir-320a	colorectal cancer	down	miR-320a suppresses colorectal cancer progression by targeting Rac1.
hsa-mir-320a	colorectal cancer	down	[Corrigendum] microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer.
hsa-mir-320a	colorectal cancer	down	Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
hsa-mir-320a	gastric cancer	down	miR-320a serves as a negative regulator in the progression of gastric cancer by targeting RAB14.
hsa-mir-320a	gastric cancer	down	MiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis.
hsa-mir-320a	glioblastoma	down	MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R.
hsa-mir-320a	glioma	down	miR-320a functions as a suppressor for gliomas by targeting SND1 and ?-catenin, and predicts the prognosis of patients.
hsa-mir-320a	glioma	down	miRNA-320a inhibits glioma cell invasion and migration by directly targeting aquaporin 4.
hsa-mir-320a	hepatocellular carcinoma	down	miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinoma.
hsa-mir-320a	leiomyosarcoma	up	Differentiating soft tissue leiomyosarcoma and undifferentiated pleomorphic sarcoma: A miRNA analysis.
hsa-mir-320a	nasopharyngeal carcinoma	down	MicroRNA-320a inhibits cell proliferation, migration and invasion by targeting BMI-1 in nasopharyngeal carcinoma.
hsa-mir-320a	non-small cell lung cancer	down	Decreased expression of microRNA-320a promotes proliferation and invasion of non-small cell lung cancer cells by increasing VDAC1 expression.
hsa-mir-320a	non-small cell lung cancer	down	MicroRNA-320a is downregulated in non-small cell lung cancer and suppresses tumor cell growth and invasion by directly targeting insulin-like growth factor 1 receptor.
hsa-mir-320a	osteosarcoma	up	Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
hsa-mir-320a	pancreatic cancer	up	MicroRNA-320a promotes 5-FU resistance in human pancreatic cancer cells.
hsa-mir-320a-3p	non-small cell lung cancer	down	MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway.
hsa-mir-320b	colorectal cancer	up	MicroRNA-320b promotes colorectal cancer proliferation and invasion by competing with its homologous microRNA-320a.
hsa-mir-320c	bladder cancer	down	MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6.
hsa-mir-320c	glioma	down	Down-regulation of miRNA-320c promotes tumor growth and metastasis and predicts poor prognosis in human glioma.
hsa-mir-320d	glioma	down	Downregulation of MicroRNA-320d predicts poor overall survival and promotes the growth and invasive abilities in glioma.
hsa-mir-323	prostate cancer	down	MiR-323 Inhibits Prostate Cancer Vascularization Through Adiponectin Receptor.
hsa-mir-323	prostate cancer	up	microRNA-323 upregulation promotes prostate cancer growth and docetaxel resistance by repressing p73.
hsa-mir-323-3p	pancreatic ductal adenocarcinoma	down	MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
hsa-mir-323-5p	oral squamous cell carcinoma	down	Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-323a-3p	glioblastoma	down	Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients.
hsa-mir-323a-3p	osteosarcoma	down	MiR-323a-3p suppressed the glycolysis of osteosarcoma via targeting LDHA.
hsa-mir-324-3p	gastric cancer	up	miR-324-3p promotes gastric cancer development by activating Smad4-mediated Wnt/beta-catenin signaling pathway.
hsa-mir-324-3p	hepatocellular carcinoma	up	MiR-324-3p promotes tumor growth through targeting DACT1 and activation of Wnt/?-catenin pathway in hepatocellular carcinoma.
hsa-mir-324-3p	nasopharyngeal carcinoma	down	The expression of microRNA-324-3p as a tumor suppressor in nasopharyngeal carcinoma and its clinical significance.
hsa-mir-324-3p	nasopharyngeal carcinoma	down	MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B.
hsa-mir-324-3p	nasopharyngeal carcinoma	down	[The expression and significance of miRNA-324-3p and WNT2B in nasopharyngeal carcinoma].
hsa-mir-324-3p	nasopharyngeal carcinoma	down	miR-324-3p suppresses migration and invasion by targeting WNT2B in nasopharyngeal carcinoma.
hsa-mir-324-5p	colorectal cancer	down	Up-regulation of miR-324-5p inhibits proliferation and invasion of colorectal cancer cells by targeting ELAVL1.
hsa-mir-324-5p	gastric cancer	down	MiR-324-5p reduces viability and induces apoptosis in gastric cancer cells through modulating TSPAN8.
hsa-mir-324-5p	hepatocellular carcinoma	down	MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1.
hsa-mir-324-5p	ovarian cancer	down	Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
hsa-mir-325	bladder cancer	down	MicroRNA-325 Is a Potential Biomarker and Tumor Regulator in Human Bladder Cancer.
hsa-mir-325	hepatocellular carcinoma	down	The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1.
hsa-mir-326	acute myeloid leukemia	down	LncRNA KCNQ1OT1 controls cell proliferation, differentiation and apoptosis by sponging miR-326 to regulate c-Myc expression in acute myeloid leukemia.
hsa-mir-326	breast cancer	down	MicroRNA-326 Functions as a Tumor Suppressor in Breast Cancer by Targeting ErbB/PI3K Signaling Pathway.
hsa-mir-326	breast cancer	down	Functional analyses of microRNA-326 in breast cancer development.
hsa-mir-326	cervical cancer	down	LncRNA-HOTAIR Activates Tumor Cell Proliferation and Migration by Suppressing MiR-326 in Cervical Cancer.
hsa-mir-326	chronic myelogenous leukemia	down	Targeting of the signal transducer Smo links microRNA-326 to the oncogenic Hedgehog pathway in CD34(+) CML stem/progenitor cells.
hsa-mir-326	colorectal cancer	up	MicroRNA-326 functions as a tumor suppressor in colorectal cancer by targeting the nin one binding protein.
hsa-mir-326	esophageal squamous cell carcinoma	down	MicroRNA-326 inhibits cell proliferation and invasion in esophageal squamous cell carcinoma through targeting LIM and SH3 protein 1.
hsa-mir-326	gastric cancer	down	Down-regulation of miR-326 is associated with poor prognosis and promotes growth and metastasis by targeting FSCN1 in gastric cancer.
hsa-mir-326	gastric cancer	down	MiR-326 inhibits gastric cancer cell growth through down regulating NOB1.
hsa-mir-326	glioblastoma	down	Expression and clinical significance of microRNA-326 in human glioma miR-326 expression in glioma.
hsa-mir-326	glioma	down	The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors.
hsa-mir-326	glioma	down	MicroRNA-326 functions as a tumor suppressor in glioma by targeting the Nin one binding protein (NOB1).
hsa-mir-326	glioma	down	Targeting the SMO oncogene by miR-326 inhibits glioma biological behaviors and stemness.
hsa-mir-326	glioma	down	Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326.
hsa-mir-326	hepatocellular carcinoma	down	Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1.
hsa-mir-326	hepatocellular carcinoma	down	MicroRNA-326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1.
hsa-mir-326	lung cancer	down	MiR-326 regulates cell proliferation and migration in lung cancer by targeting phox2a and is regulated by HOTAIR.
hsa-mir-326	malignant melanoma	down	MicroRNA-326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways.
hsa-mir-326	osteosarcoma	down	MiR-326 is a diagnostic biomarker and regulates cell survival and apoptosis by targeting Bcl-2 in osteosarcoma.
hsa-mir-328	acute myeloid leukemia	down	Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.
hsa-mir-328	cervical cancer	down	microRNA-328 inhibits cervical cancer cell proliferation and tumorigenesis by targeting TCF7L2.
hsa-mir-328	colon cancer	down	miR-328 mediates a metabolic shift in colon cancer cells by targeting SLC2A1/GLUT1.
hsa-mir-328	colorectal cancer	down	MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer.
hsa-mir-328	esophageal cancer	down	MiR-328 suppresses the survival of esophageal cancer cells by targeting PLCE1.
hsa-mir-328	gastric cancer	down	Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation.
hsa-mir-328	glioma	up	MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.
hsa-mir-328	glioma	down	microRNA-328 is a favorable prognostic marker in human glioma via suppressing invasive and proliferative phenotypes of malignant cells.
hsa-mir-328	hepatocellular carcinoma	up	Downregulated miR-328 suppressed cell invasion and growth in hepatocellular carcinoma via targeting PTEN.
hsa-mir-328	nasopharyngeal carcinoma	down	MicroRNA-328 inhibits migration and epithelial-mesenchymal transition by targeting CD44 in nasopharyngeal carcinoma cells.
hsa-mir-328	non-small cell lung cancer	up	Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC.
hsa-mir-328-3p	non-small cell lung cancer	down	Up- regulation of miR-328-3p sensitizes non-small cell lung cancer to radiotherapy.
hsa-mir-328-3p	osteosarcoma	down	Elevated expression of microRNA-328-3p suppresses aggressive malignant behaviors via targeting matrix metalloprotease 16 in osteosarcoma.
hsa-mir-328-3p	ovarian cancer	up	Inhibition of miR-328-3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian Cancer.
hsa-mir-328-5p	breast cancer	down	miR-328-5p inhibits MDA-MB-231 breast cancer cell proliferation by targeting RAGE.
hsa-mir-329	breast cancer	down	Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer.
hsa-mir-329	breast cancer	down	Expression patterns of microRNA-329 and its clinical performance in diagnosis and prognosis of breast cancer.
hsa-mir-329	cholangiocarcinoma	down	microRNA-329 suppresses epithelial-to-mesenchymal transition and lymph node metastasis in bile duct cancer by inhibiting laminin subunit beta 3.
hsa-mir-329	colorectal cancer	down	miR-329 regulates the sensitivity of 5-FU in chemotherapy of colorectal cancer by targeting E2F1.
hsa-mir-329	gastric cancer	down	MicroRNA-329 inhibits cell proliferation and tumor growth while facilitates apoptosis via negative regulation of KDM1A in gastric cancer.
hsa-mir-329	gastric cancer	down	By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth.
hsa-mir-329	hepatocellular carcinoma	down	Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.
hsa-mir-329	non-small cell lung cancer	down	Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
hsa-mir-329	oral squamous cell carcinoma	down	Downregulated miR-329 and miR-410 promote the proliferation and invasion of oral squamous cell carcinoma by targeting Wnt-7b.
hsa-mir-329	osteosarcoma	down	MiR-329 suppresses osteosarcoma development by downregulating Rab10.
hsa-mir-329	pancreatic cancer	down	mir-329 restricts tumor growth by targeting grb2 in pancreatic cancer.
hsa-mir-329	papillary thyroid carcinoma	down	miR-329 inhibits papillary thyroid cancer progression via direct targeting WNT1.
hsa-mir-329-3p	cervical cancer	down	LncRNA TP73-AS1 is a novel regulator in cervical cancer via miR-329-3p/ARF1 axis.
hsa-mir-329-3p	cervical cancer	down	Down-regulation of miR-329-3p is associated with worse prognosis in patients with cervical cancer.
hsa-mir-330	colorectal cancer	down	MicroRNA-330 inhibited cell proliferation and enhanced chemosensitivity to 5-fluorouracil in colorectal cancer by directly targeting thymidylate synthase.
hsa-mir-330	colorectal cancer	down	miR-330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancer.
hsa-mir-330	glioblastoma	down	Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
hsa-mir-330	osteosarcoma	down	MicroRNA-330-3p Expression Indicates Good Prognosis and Suppresses Cell Proliferation by Targeting Bmi-1 in Osteosarcoma.
hsa-mir-330	prostate cancer	down	MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.
hsa-mir-330	prostate cancer	down	microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells.
hsa-mir-330-3p	breast cancer	up	Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.
hsa-mir-330-3p	breast cancer	up	Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis.
hsa-mir-330-3p	esophageal squamous cell carcinoma	up	MicroRNA-330-3p functions as an oncogene in human esophageal cancer by targeting programmed cell death 4.
hsa-mir-330-3p	gastric cancer	down	MiR-330-3p inhibits gastric cancer progression through targeting MSI1.
hsa-mir-330-3p	liver cancer	down	miR-330-3p suppresses liver cancer cell migration by targeting MAP2K1.
hsa-mir-330-3p	lung cancer	up	miR-330-3p promotes lung cancer cells invasion, migration, and metastasis by directly targeting hSOD2b.
hsa-mir-330-3p	non-small cell lung cancer	up	Circ_0078767 suppresses non-small-cell lung cancer by protecting RASSF1A expression via sponging miR-330-3p.
hsa-mir-330-3p	non-small cell lung cancer	up	MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
hsa-mir-330-3p	non-small cell lung cancer	up	The Key microRNAs Regulated the Development of Non-small Cell Lung Cancer by Targeting TGF-?-induced epithelial-mesenchymal Transition.
hsa-mir-330-3p	non-small cell lung cancer	up	miR-330-3p controls cell proliferation by targeting early growth response 2 in non-small-cell lung cancer.
hsa-mir-330-5p	glioblastoma	down	miR-330-5p suppresses glioblastoma cell proliferation and invasiveness through targeting ITGA5.
hsa-mir-330-5p	non-small cell lung cancer	down	Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer.
hsa-mir-330-5p	ovarian cancer	down	LncRNA EWSAT1 promotes ovarian cancer progression through targeting miR-330-5p expression.
hsa-mir-331	acute myeloid leukemia	up	Expression of microRNA-331 can be used as a predictor for response to therapy and survival in acute myeloid leukemia patients.
hsa-mir-331	malignant melanoma	down	MicroRNA-331 inhibits proliferation and invasion of melanoma cells by targeting astrocyte-elevated gene-1.
hsa-mir-331-3p	cervical cancer	down	LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p.
hsa-mir-331-3p	cervical cancer	down	MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2.
hsa-mir-331-3p	colorectal cancer	down	miR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer.
hsa-mir-331-3p	gastric cancer	down	miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer.
hsa-mir-331-3p	glioblastoma	down	miR-331-3p regulates expression of neuropilin-2 in glioblastoma.
hsa-mir-331-3p	hepatocellular carcinoma	up	Hsa-miR-331-3p inhibits VHL expression by directly targeting its mRNA 3'-UTR in HCC cell lines.
hsa-mir-331-3p	hepatocellular carcinoma	up	Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
hsa-mir-331-3p	non-small cell lung cancer	down	MicroRNA-331-3p inhibits epithelial-mesenchymal transition by targeting ErbB2 and VAV2 through the Rac1/PAK1/?-catenin axis in non-small-cell lung cancer.
hsa-mir-331-3p	pancreatic cancer	up	miR-331-3p Functions as an Oncogene by Targeting ST7L in Pancreatic Cancer.
hsa-mir-331-3p	prostate cancer	down	miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer.
hsa-mir-331-3p	prostate cancer	down	Regulation of Expression of Deoxyhypusine Hydroxylase (DOHH), the Enzyme That Catalyzes the Activation of eIF5A, by miR-331-3p and miR-642-5p in Prostate Cancer Cells.
hsa-mir-335	adrenal cortical carcinoma	down	miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer.
hsa-mir-335	astrocytoma	up	Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells.
hsa-mir-335	bladder cancer	down	MiR-335 suppresses cell proliferation and migration by upregulating CRKL in bladder cancer.
hsa-mir-335	bladder cancer	down	MicroRNA-335 is downregulated in bladder cancer and inhibits cell growth, migration and invasion via targeting ROCK1.
hsa-mir-335	breast cancer	down	MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer.
hsa-mir-335	breast cancer	down	Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-335	breast cancer	down	MiR-335 inhibits migration of breast cancer cells through targeting oncoprotein c-Met.
hsa-mir-335	breast cancer	down	MicroRNA-335 suppresses the proliferation, migration, and invasion of breast cancer cells by targeting EphA4.
hsa-mir-335	cervical cancer	down	MicroRNA-335 represents an independent prognostic marker in cervical cancer.
hsa-mir-335	chondrosarcoma	down	Analysis of microRNAs expressions in chondrosarcoma.
hsa-mir-335	colorectal cancer	down	microRNA-335 inhibits colorectal cancer HCT116 cells growth and epithelial-mesenchymal transition (EMT) process by targeting Twist1.
hsa-mir-335	colorectal cancer	up	Overexpression of miR-335 confers cell proliferation and tumour growth to colorectal carcinoma cells.
hsa-mir-335	esophageal squamous cell carcinoma	down	Up-regulation of miR-335 predicts a favorable prognosis in esophageal squamous cell carcinoma.
hsa-mir-335	gastric cancer	down	The clinical significance of miR-335, miR-124, miR-218 and miR-484 downregulation in gastric cancer.
hsa-mir-335	glioma	up	Tumor microRNA-335 expression is associated with poor prognosis in human glioma.
hsa-mir-335	hepatocellular carcinoma	down	Epigenetic silencing of miR-335 and its host gene MEST in hepatocellular carcinoma.
hsa-mir-335	hepatocellular carcinoma	down	MiR-335 acts as a potential tumor suppressor miRNA via downregulating ROCK1 expression in hepatocellular carcinoma.
hsa-mir-335	meningioma	up	miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas.
hsa-mir-335	mesenchymal cancer	down	MicroRNA Expression Profiles in Kaposi's Sarcoma.
hsa-mir-335	neuroblastoma	down	MiRNA-335 Suppresses Neuroblastoma Cell Invasiveness By Direct Targeting of Multiple Genes from the non-Canonical TGF-? Signalling Pathway.
hsa-mir-335	non-small cell lung cancer	down	Effect of miR-335 upregulation on the apoptosis and invasion of lung cancer cell A549 and H1299.
hsa-mir-335	non-small cell lung cancer	down	miR-335 inhibited cell proliferation of lung cancer cells by target Tra2?.
hsa-mir-335	osteosarcoma	down	MicroRNA-335 and its target Rock1 synergistically influence tumor progression and prognosis in osteosarcoma.
hsa-mir-335	osteosarcoma	down	MiR-335 functions as a tumor suppressor and regulates survivin expression in osteosarcoma.
hsa-mir-335	osteosarcoma	down	miR-335 negatively regulates osteosarcoma stem cell-like properties by targeting POU5F1.
hsa-mir-335	osteosarcoma	down	miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells.
hsa-mir-335	ovarian cancer	down	miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w.
hsa-mir-335	ovarian cancer	down	Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.
hsa-mir-335	pancreatic cancer	down	miR-335 functions as a tumor suppressor in pancreatic cancer by targeting OCT4.
hsa-mir-335	papillary thyroid carcinoma	down	MicroRNA-335 is downregulated in papillary thyroid cancer and suppresses cancer cell growth, migration and invasion by directly targeting ZEB2.
hsa-mir-335	primary gallbladder carcinoma	down	Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma.
hsa-mir-335	prostate cancer	down	MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase.
hsa-mir-335	renal clear cell carcinoma	down	miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
hsa-mir-335-5p	colorectal cancer	down	MiR-335-5p Inhibits Cell Proliferation, Migration and Invasion in Colorectal Cancer through Downregulating LDHB.
hsa-mir-335-5p	gastric cancer	down	The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
hsa-mir-335-5p	gastric cancer	down	Downregulation of miR-335-5p by Long Noncoding RNA ZEB1-AS1 in Gastric Cancer Promotes Tumor Proliferation and Invasion.
hsa-mir-335-5p	gastric cancer	down	MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer.
hsa-mir-335-5p	thyroid cancer	down	miR-335-5p targeting ICAM-1 inhibits invasion and metastasis of thyroid cancer cells.
hsa-mir-337	cervical cancer	down	MicroRNA-337 inhibits cell proliferation and invasion of cervical cancer through directly targeting specificity protein 1.
hsa-mir-337	cutaneous t-cell lymphoma	down	miR-337 suppresses cutaneous T-cell lymphoma via the STAT3 pathway.
hsa-mir-337	non-small cell lung cancer	down	Hsa-miR-337 inhibits non-small cell lung cancer cell invasion and migration by targeting TCF7.
hsa-mir-337	non-small cell lung cancer	up	Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
hsa-mir-337	pancreatic ductal adenocarcinoma	down	miR-337 regulates the proliferation and invasion in pancreatic ductal adenocarcinoma by targeting HOXB7.
hsa-mir-337-3p	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-337-3p	gastric cancer	down	miRNA-337-3p inhibits gastric cancer progression through repressing myeloid zinc finger 1-facilitated expression of matrix metalloproteinase 14.
hsa-mir-337-3p	hepatocellular carcinoma	down	miR-337-3p suppresses the proliferation and invasion of hepatocellular carcinoma cells through targeting JAK2.
hsa-mir-337-3p	neuroblastoma	down	miRNA-337-3p suppresses neuroblastoma progression by repressing the transcription of matrix metalloproteinase 14.
hsa-mir-338	cervical cancer	down	miR-338 modulates proliferation and autophagy by PI3K/AKT/mTOR signaling pathway in cervical cancer.
hsa-mir-338	gastric cancer	down	MicroRNA-338 Inhibits Growth, Invasion and Metastasis of Gastric Cancer by Targeting NRP1 Expression.
hsa-mir-338	gastric cancer	down	MicroRNA-338 inhibits proliferation, migration, and invasion of gastric cancer cells by the Wnt/?-catenin signaling pathway.
hsa-mir-338	glioma	down	MiR-338 suppresses cell proliferation and invasion by targeting CTBP2 in glioma.
hsa-mir-338	nasopharyngeal carcinoma	down	MicroRNA-338 inhibits migration and proliferation by targeting hypoxia-induced factor 1? in nasopharyngeal carcinoma.
hsa-mir-338	oral squamous cell carcinoma	down	miR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1.
hsa-mir-338-3p	cervical cancer	down	MiRNA-338-3p regulates cervical cancer cells proliferation by targeting MACC1 through MAPK signaling pathway.
hsa-mir-338-3p	cervical cancer	down	LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p.
hsa-mir-338-3p	colorectal cancer	down	Relationship between miRNA-338-3p expression and progression and prognosis of human colorectal carcinoma.
hsa-mir-338-3p	colorectal cancer	down	miR-338-3p regulates the proliferation, apoptosis and migration of SW480 cells by targeting MACC1.
hsa-mir-338-3p	colorectal carcinoma	down	MicroRNA-338-3p Inhibits Colorectal Carcinoma Cell Invasion and Migration by Targeting Smoothened.
hsa-mir-338-3p	gastric cancer	down	Epigenetic silencing of miR-338-3p contributes to tumorigenicity in gastric cancer by targeting SSX2IP.
hsa-mir-338-3p	gastric cancer	down	miR-338-3p Suppresses Gastric Cancer Progression through a PTEN-AKT Axis by Targeting P-REX2a.
hsa-mir-338-3p	gastric cancer	down	MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling.
hsa-mir-338-3p	gastric cancer	down	Hypermethylation of miR-338-3p and Impact of its Suppression on Cell Metastasis Through N-Cadherin Accumulation at the Cell -Cell Junction and Degradation of MMP in Gastric Cancer.
hsa-mir-338-3p	gastric cancer	down	miR-338-3p functions as a tumor suppressor in gastric cancer by targeting PTP1B.
hsa-mir-338-3p	gastric cancer	down	miR-338-3p inhibits the proliferation and migration of gastric cancer cells by targeting ADAM17.
hsa-mir-338-3p	glioma	down	Mir-338-3p Inhibits Malignant Biological Behaviors of Glioma Cells by Targeting MACC1 Gene.
hsa-mir-338-3p	hepatocellular carcinoma	down	miR-338-3p Is Down-Regulated by Hepatitis B Virus X and Inhibits Cell Proliferation by Targeting the 3'-UTR Region of CyclinD1.
hsa-mir-338-3p	hepatocellular carcinoma	down	MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1?.
hsa-mir-338-3p	hepatocellular carcinoma	down	MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4).
hsa-mir-338-3p	hepatocellular carcinoma	down	miR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells.
hsa-mir-338-3p	hepatocellular carcinoma	down	miR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells.
hsa-mir-338-3p	hepatocellular carcinoma	down	Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma.
hsa-mir-338-3p	liver cancer	down	miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened.
hsa-mir-338-3p	malignant melanoma	down	MicroRNA-338-3p suppresses cell proliferation, migration and invasion in human malignant melanoma by targeting MACC1.
hsa-mir-338-3p	neuroblastoma	down	miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a.
hsa-mir-338-3p	non-small cell lung cancer	down	microRNA-338-3p functions as a tumor suppressor in human non?small?cell lung carcinoma and targets Ras-related protein 14.
hsa-mir-338-3p	non-small cell lung cancer	down	miR-338-3p suppresses epithelial-mesenchymal transition and metastasis in human nonsmall cell lung cancer.
hsa-mir-338-3p	non-small cell lung cancer	down	MiR-338-3p inhibits the growth and invasion of non-small cell lung cancer cells by targeting IRS2.
hsa-mir-338-3p	non-small cell lung cancer	down	The regulation of Neuropilin 1 expression by miR-338-3p promotes non-small cell lung cancer via changes in EGFR signaling.
hsa-mir-338-3p	osteosarcoma	down	microRNA-338-3p inhibits proliferation, migration, invasion, and EMT in osteosarcoma cells by targeting activator of 90 kDa heat shock protein ATPase homolog 1.
hsa-mir-338-3p	osteosarcoma	down	MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
hsa-mir-338-3p	prostate cancer	down	miR-338-3p targets RAB23 and suppresses tumorigenicity of prostate cancer cells.
hsa-mir-338-3p	prostate carcinoma	down	microRNA-205 and microRNA-338-3p Reduces Cell Apoptosis in Prostate Carcinoma Tissue and LNCaP Prostate Carcinoma Cells by Directly Targeting the B-Cell Lymphoma 2 (Bcl-2) Gene.
hsa-mir-338-3p	renal cell carcinoma	down	MicroRNA-338-3p targets SOX4 and inhibits cell proliferation and invasion of renal cell carcinoma.
hsa-mir-338-3p	thyroid cancer	down	MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.
hsa-mir-338-5p	colorectal cancer	up	MiR-338-5p promotes metastasis of colorectal cancer by inhibition of phosphatidylinositol 3-kinase, catalytic subunit type 3-mediated autophagy pathway.
hsa-mir-338-5p	esophageal squamous cell carcinoma	down	miR-338-5p inhibits cell proliferation, colony formation, migration and cisplatin resistance in esophageal squamous cancer cells by targeting FERMT2.
hsa-mir-338-5p	glioblastoma	down	MiR-338-5p suppresses proliferation, migration, invasion, and promote apoptosis of glioblastoma cells by directly targeting EFEMP1.
hsa-mir-338-5p	glioma	down	MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1.
hsa-mir-338-5p	glioma	up	MiR-338-5p Promotes Glioma Cell Invasion by Regulating TSHZ3 and MMP2.
hsa-mir-338-5p	malignant melanoma	up	MiR-338-5p promotes the growth and metastasis of malignant melanoma cells via targeting CD82.
hsa-mir-338-5p	retinoblastoma	up	Serum miR-338-5p has potential for use as a tumor marker for retinoblastoma.
hsa-mir-339	gastric cancer	down	MicroRNA-339, an epigenetic modulating target is involved in human gastric carcinogenesis through targeting NOVA1.
hsa-mir-339	hepatocellular carcinoma	down	MicroRNA-339 inhibits human hepatocellular carcinoma proliferation and invasion via targeting ZNF689.
hsa-mir-339	non-small cell lung cancer	up	Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC.
hsa-mir-339-3p	acute myeloid leukemia	down	Micro-RNA Profiling of Exosomes from Marrow-Derived Mesenchymal Stromal Cells in Patients with Acute Myeloid Leukemia: Implications in Leukemogenesis.
hsa-mir-339-3p	colorectal cancer	down	miR-339-3p inhibits proliferation and metastasis of colorectal cancer.
hsa-mir-339-3p	malignant melanoma	down	miR-339-3p Is a Tumor Suppressor in Melanoma.
hsa-mir-339-5p	breast cancer	down	MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis.
hsa-mir-339-5p	hepatocellular carcinoma	down	Effects of miR-339-5p on invasion and prognosis of hepatocellular carcinoma.
hsa-mir-339-5p	lung adenocarcinoma	down	miR-339-5p inhibits lung adenocarcinoma invasion and migration by directly targeting BCL6.
hsa-mir-339-5p	ovarian cancer	down	miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6.
hsa-mir-339-5p	papillary thyroid carcinoma	up	microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.
hsa-mir-33a	breast cancer	down	MiR-33a Decreases High-Density Lipoprotein-Induced Radiation Sensitivity in Breast Cancer.
hsa-mir-33a	breast cancer	down	MiR-33a suppresses breast cancer cell proliferation and metastasis by targeting ADAM9 and ROS1.
hsa-mir-33a	cervical cancer	up	[MicroRNA-33a regulates the invasion of cervical cancer cells via targeting Twist1].
hsa-mir-33a	colorectal cancer	down	MicroRNA-33a and let-7e inhibit human colorectal cancer progression by targeting ST8SIA1.
hsa-mir-33a	glioma	up	miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways.
hsa-mir-33a	hepatocellular carcinoma	down	Aflatoxin B1 Negatively Regulates Wnt/?-Catenin Signaling Pathway through Activating miR-33a.
hsa-mir-33a	hepatocellular carcinoma	down	MicroRNA-33a downregulation is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma.
hsa-mir-33a	hepatocellular carcinoma	up	MicroRNA-33a promotes cell proliferation and inhibits apoptosis by targeting PPAR? in human hepatocellular carcinoma.
hsa-mir-33a	lung cancer	down	MicroRNA-33a inhibits lung cancer cell proliferation and invasion by regulating the expression of ?-catenin.
hsa-mir-33a	lung cancer	down	MircoRNA-33a inhibits epithelial-to-mesenchymal transition and metastasis and could be a prognostic marker in non-small cell lung cancer.
hsa-mir-33a	lung cancer	down	miR-33a inhibits cell proliferation and invasion by targeting CAND1 in lung cancer.
hsa-mir-33a	malignant melanoma	down	miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1?.
hsa-mir-33a	malignant melanoma	down	miR-33a is downregulated in melanoma cells and modulates cell proliferation by targeting PCTAIRE1.
hsa-mir-33a	non-small cell lung cancer	down	miR-33a inhibits cell proliferation and invasion by targeting CAND1 in lung cancer.
hsa-mir-33a	pancreatic cancer	down	miR-33a suppresses the nuclear translocation of ?-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells.
hsa-mir-33a	prostate cancer	down	miR-33a is a tumor suppressor microRNA that is decreased in prostate cancer.
hsa-mir-33a	renal cell carcinoma	down	miR-33a inhibits cell growth in renal cancer by downregulation of MDM4 expression.
hsa-mir-33a-3p	hepatocellular carcinoma	down	MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinoma.
hsa-mir-33a-5p	colorectal cancer	down	MicroRNA-33a-5p suppresses colorectal cancer cell growth by inhibiting MTHFD2.
hsa-mir-33a-5p	esophageal squamous cell carcinoma	down	MicroRNA-33a-5p suppresses esophageal squamous cell carcinoma progression via regulation of lncRNA DANCR and ZEB1.
hsa-mir-33a-5p	glioma	down	Long non-coding RNA DANCR facilitates glioma malignancy by sponging miR-33a-5p.
hsa-mir-33a-5p	hepatocellular carcinoma	down	Downregulation of miR-33a-5p in Hepatocellular Carcinoma: A Possible Mechanism for Chemotherapy Resistance.
hsa-mir-33a-5p	lung cancer	down	A two-miRNA signature (miR-33a-5p and miR-128-3p) in whole blood as potential biomarker for early diagnosis of lung cancer.
hsa-mir-33a-5p	osteosarcoma	down	MicroRNA-33a-5p suppresses growth of osteosarcoma cells and is downregulated in human osteosarcoma.
hsa-mir-33b	breast cancer	down	MicroRNA-33b Inhibits Breast Cancer Metastasis by Targeting HMGA2, SALL4 and Twist1.
hsa-mir-33b	colorectal cancer	down	MicroRNA-33b inhibits tumor cell growth and is associated with prognosis in colorectal cancer patients.
hsa-mir-33b	esophageal squamous cell carcinoma	down	[The expression and significance of miR-33b and HMGA2 in esophageal squamous cell carcinoma].
hsa-mir-33b	gastric cancer	down	Curcumin inhibits cell growth and induces cell apoptosis through upregulation of miR-33b in gastric cancer.
hsa-mir-33b	hepatocellular carcinoma	down	[MicroRNA-33b inhibits cell proliferation in hepatocellular carcinoma via targeting SALL4].
hsa-mir-33b	lung adenocarcinoma	down	MicroRNA-33b inhibits lung adenocarcinoma cell growth, invasion, and epithelial-mesenchymal transition by suppressing Wnt/?-catenin/ZEB1 signaling.
hsa-mir-33b	malignant melanoma	down	MicroRNA-33b inhibits cell proliferation and glycolysis by targeting hypoxia-inducible factor-1? in malignant melanoma.
hsa-mir-33b	non-small cell lung cancer	down	Downregulation of miR-33b promotes non-small cell lung cancer cell growth through reprogramming glucose metabolism miR-33b regulates non-small cell lung cancer cell growth.
hsa-mir-33b	osteosarcoma	down	MiR-33b inhibits osteosarcoma cell proliferation through suppression of glycolysis by targeting Lactate Dehydrogenase A (LDHA).
hsa-mir-33b	osteosarcoma	down	MicroRNA-33b suppresses migration and invasion by targeting c-Myc in osteosarcoma cells.
hsa-mir-33b	osteosarcoma	down	MicroRNA-33b inhibits the proliferation and migration of osteosarcoma cells via targeting hypoxia-inducible factor-1?.
hsa-mir-340	acute myeloid leukemia	down	Low expression of microRNA-340 confers adverse clinical outcome in patients with acute myeloid leukemia.
hsa-mir-340	breast cancer	down	miR-340 and ZEB1 negative feedback loop regulates TGF-?- mediated breast cancer progression.
hsa-mir-340	breast cancer	down	miR-340 suppresses cell migration and invasion by targeting MYO10 in breast cancer.
hsa-mir-340	breast cancer	down	MicroRNA-340 inhibits invasion and metastasis by downregulating ROCK1 in breast cancer cells.
hsa-mir-340	cervical cancer	down	MiR-340 suppresses the metastasis by targeting EphA3 in cervical cancer.
hsa-mir-340	colorectal cancer	down	miR-340 suppresses tumor growth and enhances chemosensitivity of colorectal cancer by targeting RLIP76.
hsa-mir-340	endometrial cancer	down	MicroRNA-340 Inhibits Tumor Cell Proliferation and Induces Apoptosis in Endometrial Carcinoma Cell Line RL 95-2.
hsa-mir-340	esophageal squamous cell carcinoma	down	MicroRNA-340 Inhibits Esophageal Cancer Cell Growth and Invasion by Targeting Phosphoserine Aminotransferase 1.
hsa-mir-340	gastric cancer	up	Effect of miR-340 on gastric cancer cell proliferation and apoptosis.
hsa-mir-340	gastric cancer	up	MiR-340 affects gastric cancer cell proliferation, cycle, and apoptosis through regulating SOCS3/JAK-STAT signaling pathway.
hsa-mir-340	gastric cancer	down	miR-340 Inhibits Proliferation and Induces Apoptosis in Gastric Cancer Cell Line SGC-7901, Possibly via the AKT Pathway.
hsa-mir-340	gastric cancer	down	Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
hsa-mir-340	gastric cancer	down	[Role of miRNA-340 in modulating gastric cancer cell proliferation and bioinformatic analysis].
hsa-mir-340	glioblastoma	up	miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.
hsa-mir-340	glioblastoma	down	miR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2.
hsa-mir-340	glioblastoma	down	miR-340 suppresses glioblastoma multiforme.
hsa-mir-340	hepatocellular carcinoma	down	Effects of miR-340 on hepatocellular carcinoma by targeting the DcR3 gene.
hsa-mir-340	hepatocellular carcinoma	down	MicroRNA-340 inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting JAK1.
hsa-mir-340	hepatocellular carcinoma	down	Hepatitis B virus promotes cancer cell migration by downregulating miR-340-5p expression to induce STAT3 overexpression.
hsa-mir-340	non-small cell lung cancer	down	miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer.
hsa-mir-340	non-small cell lung cancer	down	Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
hsa-mir-340	oral cancer	down	MicroRNA-340 Mediates Metabolic Shift in Oral Squamous Cell Carcinoma by Targeting Glucose Transporter-1.
hsa-mir-340	osteosarcoma	down	MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1.
hsa-mir-340	osteosarcoma	down	Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway.
hsa-mir-340	ovarian cancer	down	microRNA-340 induces apoptosis by downregulation of BAG3 in ovarian cancer SKOV3 cells.
hsa-mir-340	pancreatic cancer	down	MicroRNA-340 suppresses pancreatic cancer growth by targeting BICD2.
hsa-mir-340	prostate cancer	down	microRNA-340 Suppresses Tumorigenic Potential of Prostate Cancer Cells by Targeting High-Mobility Group Nucleosome-Binding Domain 5.
hsa-mir-340	prostate cancer	down	MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
hsa-mir-340	squamous carcinoma	down	MicroRNA-340 inhibits squamous cell carcinoma cell proliferation, migration and invasion by downregulating RhoA.
hsa-mir-340*	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-340-5p	acute myeloid leukemia	down	High expression of long intergenic non-coding RNA LINC00662 contributes to malignant growth of acute myeloid leukemia cells by upregulating ROCK1 via sponging microRNA-340-5p.
hsa-mir-340-5p	colorectal cancer	down	MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3.
hsa-mir-340-5p	gastric cancer	down	LncRNA CASC11 promoted gastric cancer cell proliferation, migration and invasion in vitro by regulating cell cycle pathway.
hsa-mir-340-5p	glioblastoma	down	An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme.
hsa-mir-340-5p	glioblastoma	down	miR-340-5p Suppresses Aggressiveness in Glioblastoma Multiforme by Targeting Bcl-w and Sox2.
hsa-mir-340-5p	multiple myeloma	down	Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.
hsa-mir-340-5p	non-small cell lung cancer	down	MicroRNA-340-5p suppresses non-small cell lung cancer cell growth and metastasis by targeting ZNF503.
hsa-mir-340-5p	osteosarcoma	down	MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt/?-catenin signaling pathway via targeting the STAT3 gene.
hsa-mir-340-5p	thyroid cancer	up	Up-regulation of miR-340-5p promotes progression of thyroid cancer by inhibiting BMP4.
hsa-mir-342	acute myeloid leukemia	down	Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia.
hsa-mir-342	acute promyelocytic leukemia	down	A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes.
hsa-mir-342	colorectal cancer	down	MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1.
hsa-mir-342	colorectal cancer	down	FOXM1 and FOXQ1 are promising prognostic biomarkers and novel targets of tumor suppressive miR-342 in human colorectal cancer.
hsa-mir-342	glioblastoma	down	Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.
hsa-mir-342	hepatocellular carcinoma	down	MiR-342 regulates cell proliferation and apoptosis in hepatocellular carcinoma through Wnt/?-catenin signaling pathway.
hsa-mir-342	malignant melanoma	down	MicroRNA-342 prohibits proliferation and invasion of melanoma cells by directly targeting Zinc-finger E-box binding homeobox 1.
hsa-mir-342	nasopharyngeal carcinoma	down	MicroRNA-342 inhibits cell proliferation and invasion in nasopharyngeal carcinoma by directly targeting ZEB1.
hsa-mir-342-3p	cervical cancer	down	miR-342-3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer.
hsa-mir-342-3p	hepatocellular carcinoma	down	Down-regulation of miR-342-3p in hepatocellular carcinoma tissues and its prognostic significance.
hsa-mir-342-3p	hepatocellular carcinoma	down	miR-342-3p suppresses hepatocellular carcinoma proliferation through inhibition of IGF-1R-mediated Warburg effect.
hsa-mir-342-3p	nasopharyngeal carcinoma	down	microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
hsa-mir-342-3p	non-small cell lung cancer	down	miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells.
hsa-mir-342-3p	non-small cell lung cancer	down	miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer.
hsa-mir-342-3p	oral squamous cell carcinoma	down	MicroRNA-342-3p functions as a tumor suppressor by targeting LIM and SH3 protein 1 in oral squamous cell carcinoma.
hsa-mir-342-3p	osteosarcoma	down	MicroRNA-342-3p Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma Cells By Targeting Astrocyte-Elevated Gene-1 (AEG-1).
hsa-mir-342-5p	colon cancer	down	microRNA-342-5p and miR-608 inhibit colon cancer tumorigenesis by targeting NAA10.
hsa-mir-345	colorectal cancer	down	MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
hsa-mir-345	gastric cancer	down	MicroRNA-345 inhibits metastasis and epithelial-mesenchymal transition of gastric cancer by targeting FOXQ1.
hsa-mir-345	hepatocellular carcinoma	down	MicroRNA-345 inhibits hepatocellular carcinoma metastasis by inhibiting YAP1.
hsa-mir-345	hepatocellular carcinoma	down	miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
hsa-mir-345	non-small cell lung cancer	down	MicroRNA-345 suppresses cell invasion and migration in non-small cell lung cancer by directly targeting YAP1.
hsa-mir-345	non-small cell lung cancer	down	Prognostic significance of tissue miR-345 downregulation in non-small cell lung cancer.
hsa-mir-345	oral squamous cell carcinoma	up	Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia.
hsa-mir-345	prostate cancer	down	MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer.
hsa-mir-345-5p	pancreatic cancer	down	MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8.
hsa-mir-345-5p	pancreatic ductal adenocarcinoma	down	MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8.
hsa-mir-346	breast cancer	up	MiR-346 promotes the biological function of breast cancer cells by targeting SRCIN1 and reduces chemosensitivity to docetaxel.
hsa-mir-346	breast cancer	up	When figures and data contradict text: MiR346 is apparently reduced in breast cancer tissue, contrary to claims by a paper's author.
hsa-mir-346	follicular thyroid carcinoma	up	A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.
hsa-mir-346	hepatocellular carcinoma	up	LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis.
hsa-mir-346	hepatocellular carcinoma	up	miR-346 Promotes HCC Progression by Suppressing Breast Cancer Metastasis Suppressor 1 Expression.
hsa-mir-346	hepatocellular carcinoma	down	MiR-346 suppresses cell proliferation through SMYD3 dependent approach in hepatocellular carcinoma.
hsa-mir-346	liver cancer	up	miRNA-346 promotes proliferation, migration and invasion in liver cancer.
hsa-mir-346	nasopharyngeal carcinoma	up	miR-346 promotes migration and invasion of nasopharyngeal carcinoma cells via targeting BRMS1.
hsa-mir-346	ovarian cancer	up	MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.
hsa-mir-346	papillary thyroid carcinoma	up	A three plasma microRNA signature for papillary thyroid carcinoma diagnosis in Chinese patients.
hsa-mir-34a	acute myeloid leukemia	down	Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.
hsa-mir-34a	acute myeloid leukemia	down	MiR-34a Promotes Apoptosis and Inhibits Autophagy by Targeting HMGB1 in Acute Myeloid Leukemia Cells.
hsa-mir-34a	b-cell lymphoma	down	The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells.
hsa-mir-34a	basal cell carcinoma	down	Expression of miR-34a in basal cell carcinoma patients and its relationship with prognosis.
hsa-mir-34a	bladder cancer	down	MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44.
hsa-mir-34a	brain cancer	down	MicroRNA-target cross-talks: Key players in glioblastoma multiforme.
hsa-mir-34a	breast cancer	down	Circulating miR-34a levels are reduced in colorectal cancer.
hsa-mir-34a	breast cancer	down	MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.
hsa-mir-34a	breast cancer	down	Targeted Expression of miR-34a Using the T-VISA System Suppresses Breast Cancer Cell Growth and Invasion.
hsa-mir-34a	breast cancer	down	MicroRNA-34a Suppresses Cell Proliferation by Targeting LMTK3 in Human Breast Cancer MCF-7 Cell Line.
hsa-mir-34a	breast cancer	down	MicroRNA-34a suppresses the breast cancer stem cell-like characteristics by downregulating Notch1 pathway.
hsa-mir-34a	breast cancer	down	MicroRNA-34a suppresses breast cancer cell proliferation and invasion by targeting Notch1.
hsa-mir-34a	breast cancer	down	The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer.
hsa-mir-34a	breast cancer	down	Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
hsa-mir-34a	breast cancer	down	MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/?-Catenin Signaling Pathway.
hsa-mir-34a	breast cancer	down	miR-34a expression in human breast cancer is associated with drug resistance.
hsa-mir-34a	cervical cancer	down	MicroRNA-34a-Upregulated Retinoic Acid-Inducible Gene-I Promotes Apoptosis and Delays Cell Cycle Transition in Cervical Cancer Cells.
hsa-mir-34a	cervical cancer	down	HPV E6/p53 mediated down-regulation of miR-34a inhibits Warburg effect through targeting LDHA in cervical cancer.
hsa-mir-34a	cervical carcinoma	down	MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.
hsa-mir-34a	cholangiocarcinoma	down	microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway.
hsa-mir-34a	cholangiocarcinoma	up	miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth.
hsa-mir-34a	chordoma	down	MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET.
hsa-mir-34a	choriocarcinoma	down	MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.
hsa-mir-34a	choriocarcinoma	down	MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.
hsa-mir-34a	clear cell renal cell cancer	up	The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels.
hsa-mir-34a	colon cancer	down	MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
hsa-mir-34a	colon cancer	down	Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF.
hsa-mir-34a	colon cancer	down	MiR-34a inhibits colon cancer proliferation and metastasis by inhibiting platelet-derived growth factor receptor ?.
hsa-mir-34a	colorectal cancer	down	Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer.
hsa-mir-34a	colorectal cancer	down	Circulating miR-34a levels are reduced in colorectal cancer.
hsa-mir-34a	colorectal cancer	down	Dysregulation of MicroRNA-34a Expression in Colorectal Cancer Inhibits the Phosphorylation of FAK Via VEGF.
hsa-mir-34a	colorectal cancer	down	Novel evidence for curcumin and boswellic acid induced chemoprevention through regulation of miR-34a and miR-27a in colorectal cancer.
hsa-mir-34a	colorectal cancer	down	MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer.
hsa-mir-34a	colorectal cancer	down	S-adenosylmethionine and methylthioadenosine inhibit cancer metastasis by targeting microRNA 34a/b-methionine adenosyltransferase 2A/2B axis.
hsa-mir-34a	colorectal cancer	down	MicroRNA-34a suppresses colorectal cancer metastasis by regulating Notch signaling.
hsa-mir-34a	colorectal cancer	down	TGF-? secreted by tumor-associated macrophages promotes proliferation and invasion of colorectal cancer via miR-34a-VEGF axis.
hsa-mir-34a	endometrial cancer	down	Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma.
hsa-mir-34a	endometrial cancer	down	The Significance of miR-34a Expression in Endometrial Carcinogenesis: Correlation With Expression of p16 and Ki-67 Proteins in Endometrial Cancers.
hsa-mir-34a	endometrial cancer	down	MicroRNA-34a inhibits cells proliferation and invasion by downregulating Notch1 in endometrial cancer.
hsa-mir-34a	esophageal cancer	down	miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation.
hsa-mir-34a	esophageal cancer	down	miR-34a inhibits the in vitro cell proliferation and migration in human esophageal cancer.
hsa-mir-34a	esophageal squamous cell carcinoma	down	miR-34a inhibits the migration and invasion of esophageal squamous cell carcinoma by targeting Yin Yang-1.
hsa-mir-34a	esophageal squamous cell carcinoma	down	Tumor suppressor microRNA-34a inhibits cell migration and invasion by targeting MMP-2/MMP-9/FNDC3B in esophageal squamous cell carcinoma.
hsa-mir-34a	esophageal squamous cell carcinoma	down	MicroRNA-34a suppresses invasion and metastatic in esophageal squamous cell carcinoma by regulating CD44.
hsa-mir-34a	esophageal squamous cell carcinoma	down	miR-34a inhibits esophageal squamous cell carcinoma progression via regulation of FOXM1.
hsa-mir-34a	extrahepatic cholangiocarcinoma	down	microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway.
hsa-mir-34a	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-34a	gastric cancer	down	Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells.
hsa-mir-34a	gastric cancer	down	Evaluation of MicroRNA Expression Pattern of Gastric Adenocarcinoma Associated with Socioeconomic, Environmental and Lifestyle Factors in Northwestern Hungary.
hsa-mir-34a	gastric cancer	down	microRNA-34a Inhibits the Growth, Invasion and Metastasis of Gastric Cancer by Targeting PDGFR and MET Expression.
hsa-mir-34a	gastric cancer	down	MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in gastric cancer.
hsa-mir-34a	gastric cancer	down	Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a.
hsa-mir-34a	gastric cancer	down	The prognostic value of miR-34a expression in completely resected gastric cancer: tumor recurrence and overall survival.
hsa-mir-34a	gastric cancer	down	A meta-analysis of the effect of microRNA-34a on the progression and prognosis of gastric cancer.
hsa-mir-34a	gastric cancer	down	MicroRNA-34a inhibits tumor invasion and metastasis in gastric cancer by targeting Tgif2.
hsa-mir-34a	gastric cancer	down	Prognostic Significance of MiR-34a Expression in Patients with Gastric Cancer after Radical Gastrectomy.
hsa-mir-34a	gastric cancer	down	MicroRNA-34a regulates proliferation and apoptosis of gastric cancer cells by targeting silent information regulator 1.
hsa-mir-34a	glioblastoma	down	MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.
hsa-mir-34a	glioblastoma	down	MicroRNA-34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme.
hsa-mir-34a	glioblastoma	down	miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme.
hsa-mir-34a	glioma	down	MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.
hsa-mir-34a	glioma	down	microRNA-34a is tumor suppressive in brain tumors and glioma stem cells.
hsa-mir-34a	glioma	down	MicroRNA-34a induces apoptosis in the human glioma cell line, A172, through enhanced ROS production and NOX2 expression.
hsa-mir-34a	glioma	down	miR-34a attenuates glioma cells progression and chemoresistance via targeting PD-L1.
hsa-mir-34a	head and neck squamous cell carcinoma	down	Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis.
hsa-mir-34a	hepatoblastoma	down	Exosomal miR-34s panel as potential novel diagnostic and prognostic biomarker in patients with hepatoblastoma.
hsa-mir-34a	hepatocellular carcinoma	down	Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma.
hsa-mir-34a	hepatocellular carcinoma	up	miR-34a: Multiple Opposing Targets and One Destiny in Hepatocellular Carcinoma.
hsa-mir-34a	hepatocellular carcinoma	down	0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop.
hsa-mir-34a	hepatocellular carcinoma	down	MicroRNA-34a inhibit hepatocellular carcinoma progression by repressing hexokinase-1.
hsa-mir-34a	hepatocellular carcinoma	down	Expression Analysis of Serum microRNA-34a and microRNA-183 in Hepatocellular Carcinoma
hsa-mir-34a	hepatocellular carcinoma	down	miR-34a Inhibits Cell Proliferation by Targeting SATB2 in Hepatocellular Carcinoma.
hsa-mir-34a	hepatocellular carcinoma	down	Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma.
hsa-mir-34a	hepatocellular carcinoma	down	miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
hsa-mir-34a	hepatocellular carcinoma	down	Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model.
hsa-mir-34a	hepatocellular carcinoma	down	Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET.
hsa-mir-34a	hepatocellular carcinoma	down	MicroRNA-34a Targets Bcl-2 and Sensitizes Human Hepatocellular Carcinoma Cells to Sorafenib Treatment.
hsa-mir-34a	hepatocellular carcinoma	down	Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer.
hsa-mir-34a	laryngeal cancer	up	MicroRNA profile in site-specific head and neck squamous cell cancer.
hsa-mir-34a	laryngeal carcinoma	down	Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
hsa-mir-34a	liver cancer	down	MicroRNA-34a inhibits metastasis in liver cancer cells.
hsa-mir-34a	lung cancer	down	Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.
hsa-mir-34a	malignant melanoma	down	MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
hsa-mir-34a	malignant melanoma	down	Regulation of cancer aggressive features in melanoma cells by microRNAs.
hsa-mir-34a	malignant melanoma	down	Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene.
hsa-mir-34a	malignant melanoma	down	Identification of FLOT2 as a novel target for microRNA-34a in melanoma.
hsa-mir-34a	medullary thyroid carcinoma	up	Evaluation of miRNAs expression in medullary thyroid carcinoma tissue samples: miR-34a and miR-144 as promising overexpressed markers in MTC.
hsa-mir-34a	neuroblastoma	down	miR-34a inhibits progression of neuroblastoma by targeting autophagy-related gene 5.
hsa-mir-34a	neuroblastoma	down	MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
hsa-mir-34a	neuroblastoma	down	A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene.
hsa-mir-34a	non-small cell lung cancer	up	Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer.
hsa-mir-34a	non-small cell lung cancer	down	Restoration of p53/miR-34a regulatory axis decreases survival advantage and ensures Bax-dependent apoptosis of non-small cell lung carcinoma cells.
hsa-mir-34a	non-small cell lung cancer	down	The microRNA miR-34a Inhibits Non-Small Cell Lung Cancer (NSCLC) Growth and the CD44hi Stem-Like NSCLC Cells.
hsa-mir-34a	non-small cell lung cancer	down	MiR-34a modulates ionizing radiation-induced senescence in lung cancer cells.
hsa-mir-34a	non-small cell lung cancer	down	MicroRNA-34a/EGFR axis plays pivotal roles in lung tumorigenesis.
hsa-mir-34a	oral cancer	down	MiR-34a inhibits oral cancer progression partially by repression of interleukin-6-receptor.
hsa-mir-34a	oral squamous cell carcinoma	down	Down Regulation of miR-34a and miR-143 May Indirectly Inhibit p53 in Oral Squamous Cell Carcinoma: a Pilot Study.
hsa-mir-34a	oropharyngeal cancer	up	MicroRNA profile in site-specific head and neck squamous cell cancer.
hsa-mir-34a	osteosarcoma	down	The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/?III-Tubulin Axis.
hsa-mir-34a	osteosarcoma	down	MiR-34a and miR-203 Inhibit Survivin Expression to Control Cell Proliferation and Survival in Human Osteosarcoma Cells.
hsa-mir-34a	osteosarcoma	down	miR-34a is downregulated in human osteosarcoma stem-like cells and promotes invasion, tumorigenic ability and self-renewal capacity.
hsa-mir-34a	osteosarcoma	down	MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo.
hsa-mir-34a	osteosarcoma	down	MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether à go-go 1 expression.
hsa-mir-34a	osteosarcoma	down	Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.
hsa-mir-34a	osteosarcoma	down	MicroRNA-34a inhibits tumor invasion and metastasis in osteosarcoma partly by effecting C-IAP2 and Bcl-2.
hsa-mir-34a	osteosarcoma	down	MicroRNA-34a promotes cell cycle arrest and apoptosis and suppresses cell adhesion by targeting DUSP1 in osteosarcoma.
hsa-mir-34a	ovarian cancer	down	MiRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1.
hsa-mir-34a	ovarian cancer	down	Frequent downregulation of miR-34 family in human ovarian cancers.
hsa-mir-34a	ovarian cancer	down	MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL.
hsa-mir-34a	ovarian cancer	down	MicroRNA-34 suppresses proliferation of human ovarian cancer cells by triggering autophagy and apoptosis and inhibits cell invasion by targeting Notch 1.
hsa-mir-34a	pancreatic adenocarcinoma	down	Simultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreatic adenocarcinoma.
hsa-mir-34a	pancreatic cancer	down	miR-34 increases in vitro PANC-1 cell sensitivity to gemcitabine via targeting Slug/PUMA.
hsa-mir-34a	pancreatic cancer	down	miR-34a inhibits pancreatic cancer progression through Snail1-mediated epithelial-mesenchymal transition and the Notch signaling pathway.
hsa-mir-34a	pancreatic cancer	down	MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.
hsa-mir-34a	pancreatic cancer	down	Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells.
hsa-mir-34a	pancreatic ductal adenocarcinoma	up	MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.
hsa-mir-34a	pancreatic ductal adenocarcinoma	down	The Clinical Significance of miR-34a in Pancreatic Ductal Carcinoma and Associated Molecular and Cellular Mechanisms.
hsa-mir-34a	pancreatic ductal adenocarcinoma	down	EZH2 coupled with HOTAIR to silence MicroRNA-34a by the induction of heterochromatin formation in human pancreatic ductal adenocarcinoma.
hsa-mir-34a	papillary thyroid carcinoma	up	MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
hsa-mir-34a	prostate cancer	down	The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
hsa-mir-34a	prostate cancer	down	MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells.
hsa-mir-34a	prostate cancer	down	LEF1 Targeting EMT in Prostate Cancer Invasion is Regulated by miR-34a.
hsa-mir-34a	prostate cancer	down	Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
hsa-mir-34a	prostate cancer	down	Modulation of miR-34a in curcumin-induced antiproliferation of prostate cancer cells.
hsa-mir-34a	prostate cancer	down	Methylation-induced silencing of miR-34a enhances chemoresistance by directly upregulating ATG4B-induced autophagy through AMPK/mTOR pathway in prostate cancer.
hsa-mir-34a	prostate cancer	down	miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.
hsa-mir-34a	prostate cancer	down	miR-34a inhibits cell proliferation in prostate cancer by downregulation of SIRT1 expression.
hsa-mir-34a	prostate cancer	down	Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
hsa-mir-34a	rectal cancer	up	The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer.
hsa-mir-34a	renal cell carcinoma	down	MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma.
hsa-mir-34a	renal cell carcinoma	down	Tumor suppressor microRNA-34a inhibits cell proliferation by targeting Notch1 in renal cell carcinoma.
hsa-mir-34a	renal cell carcinoma	down	MicroRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cell.
hsa-mir-34a	retinoblastoma	down	Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
hsa-mir-34a	retinoblastoma	down	Shikonin-mediated up-regulation of miR-34a and miR-202 inhibits retinoblastoma proliferation.
hsa-mir-34a	squamous carcinoma	up	Unique MicroRNA Expression Profiles in Cervical Cancer.
hsa-mir-34a	thyroid cancer	down	LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling.
hsa-mir-34a	uveal melanoma	down	MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
hsa-mir-34a-5p	colorectal cancer	down	miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
hsa-mir-34a-5p	glioma	down	MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2.
hsa-mir-34a-5p	hepatocellular carcinoma	down	MicroRNA-34a-5p enhances sensitivity to chemotherapy by targeting AXL in hepatocellular carcinoma MHCC-97L cells.
hsa-mir-34a-5p	nasopharyngeal carcinoma	down	The Long Noncoding RNA NEAT1 Targets miR-34a-5p and Drives Nasopharyngeal Carcinoma Progression via Wnt/?-Catenin Signaling.
hsa-mir-34a-5p	papillary thyroid carcinoma	up	A three plasma microRNA signature for papillary thyroid carcinoma diagnosis in Chinese patients.
hsa-mir-34b	breast cancer	down	MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.
hsa-mir-34b	breast cancer	down	The Regulation and Function of miR-21-FOXO3a-miR-34b/c Signaling in Breast Cancer.
hsa-mir-34b	chronic lymphocytic leukemia	down	Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
hsa-mir-34b	endometrial serous adenocarcinoma	down	MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma.
hsa-mir-34b	gastric cancer	down	Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer.
hsa-mir-34b	hepatoblastoma	down	Exosomal miR-34s panel as potential novel diagnostic and prognostic biomarker in patients with hepatoblastoma.
hsa-mir-34b	hepatocellular carcinoma	down	Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer.
hsa-mir-34b	lung cancer	down	Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.
hsa-mir-34b	nasopharyngeal carcinoma	down	miR-34b inhibits nasopharyngeal carcinoma cell proliferation by targeting ubiquitin-specific peptidase 22.
hsa-mir-34b	nasopharyngeal carcinoma	down	MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A.
hsa-mir-34b	non-small cell lung cancer	down	MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met.
hsa-mir-34b	osteosarcoma	down	Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.
hsa-mir-34b	ovarian cancer	down	Frequent downregulation of miR-34 family in human ovarian cancers.
hsa-mir-34b	ovarian cancer	down	MicroRNA-34 suppresses proliferation of human ovarian cancer cells by triggering autophagy and apoptosis and inhibits cell invasion by targeting Notch 1.
hsa-mir-34b	ovarian carcinoma	down	MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
hsa-mir-34b	pancreatic cancer	down	MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.
hsa-mir-34b	pancreatic cancer	down	MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3.
hsa-mir-34b	pancreatic cancer	down	miR-34 increases in vitro PANC-1 cell sensitivity to gemcitabine via targeting Slug/PUMA.
hsa-mir-34b	papillary thyroid carcinoma	down	MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.
hsa-mir-34b	papillary thyroid carcinoma	up	Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.
hsa-mir-34b	prostate cancer	down	miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.
hsa-mir-34b	uveal melanoma	down	MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets.
hsa-mir-34b-3p	prostate cancer	down	Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians.
hsa-mir-34b-5p	malignant melanoma	up	MiR-34b-5p Suppresses Melanoma Differentiation-Associated Gene 5 (MDA5) Signaling Pathway to Promote Avian Leukosis Virus Subgroup J (ALV-J)-Infected Cells Proliferaction and ALV-J Replication.
hsa-mir-34c	breast cancer	down	MicroRNA-34c Suppresses Breast Cancer Migration and Invasion by Targeting GIT1.
hsa-mir-34c	breast cancer	down	MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.
hsa-mir-34c	breast cancer	down	Expression of miR-34c induces G2/M cell cycle arrest in breast cancer cells.
hsa-mir-34c	breast cancer	down	The Regulation and Function of miR-21-FOXO3a-miR-34b/c Signaling in Breast Cancer.
hsa-mir-34c	chronic lymphocytic leukemia	down	Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
hsa-mir-34c	colon cancer	down	Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF.
hsa-mir-34c	colorectal cancer	down	Interrupted E2F1-miR-34c-SCF negative feedback loop by hyper-methylation promotes colorectal cancer cell proliferation.
hsa-mir-34c	endometrial cancer	down	MiR-34c oligonucleotide enhances chemosensitivity of Ishikawa cell to cisplatin by inducing apoptosis.
hsa-mir-34c	endometrial cancer	down	miR-34c plays a role of tumor suppressor in HEC?1-B cells by targeting E2F3 protein.
hsa-mir-34c	gastric cancer	down	Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.
hsa-mir-34c	hepatoblastoma	down	Exosomal miR-34s panel as potential novel diagnostic and prognostic biomarker in patients with hepatoblastoma.
hsa-mir-34c	lung cancer	down	Uncovering growth-suppressive MicroRNAs in lung cancer.
hsa-mir-34c	lung cancer	down	Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.
hsa-mir-34c	malignant melanoma	down	Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene.
hsa-mir-34c	medulloblastoma	up	Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-34c	nasopharyngeal carcinoma	down	MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.
hsa-mir-34c	nasopharyngeal carcinoma	down	MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A.
hsa-mir-34c	non-small cell lung cancer	down	MiR-34c acts as a tumor suppressor in non-small cell lung cancer by inducing endoplasmic reticulum stress through targeting HMGB1.
hsa-mir-34c	osteosarcoma	down	MiR-34c inhibits osteosarcoma metastasis and chemoresistance.
hsa-mir-34c	osteosarcoma	down	Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.
hsa-mir-34c	ovarian cancer	down	Frequent downregulation of miR-34 family in human ovarian cancers.
hsa-mir-34c	ovarian cancer	down	MicroRNA-34 suppresses proliferation of human ovarian cancer cells by triggering autophagy and apoptosis and inhibits cell invasion by targeting Notch 1.
hsa-mir-34c	ovarian carcinoma	down	MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
hsa-mir-34c	pancreatic cancer	down	MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.
hsa-mir-34c	pancreatic cancer	down	miR-34 increases in vitro PANC-1 cell sensitivity to gemcitabine via targeting Slug/PUMA.
hsa-mir-34c	prostate cancer	down	miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
hsa-mir-34c	uveal melanoma	down	MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets.
hsa-mir-34c-3p	glioma	down	Differential effects of miR-34c-3p and miR-34c-5p on the proliferation, apoptosis and invasion of glioma cells.
hsa-mir-34c-3p	hepatocellular carcinoma	up	MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
hsa-mir-34c-3p	hepatocellular carcinoma	down	miR-34c-3p inhibits cell proliferation, migration and invasion of hepatocellular carcinoma by targeting MARCKS.
hsa-mir-34c-3p	nasopharyngeal carcinoma	up	Tumor-educated platelet miR-34c-3p and miR-18a-5p as potential liquid biopsy biomarkers for nasopharyngeal carcinoma diagnosis.
hsa-mir-34c-3p	non-small cell lung cancer	down	MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
hsa-mir-34c-3p	non-small cell lung cancer	down	Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells.
hsa-mir-34c-5p	colorectal cancer	down	SATB2 targeted by methylated miR-34c-5p suppresses proliferation and metastasis attenuating the epithelial-mesenchymal transition in colorectal cancer.
hsa-mir-34c-5p	glioma	down	Differential effects of miR-34c-3p and miR-34c-5p on the proliferation, apoptosis and invasion of glioma cells.
hsa-mir-3607	lung adenocarcinoma	up	Upregulation of miR-3607 promotes lung adenocarcinoma proliferation by suppressing APC expression.
hsa-mir-3607-3p	non-small cell lung cancer	down	miR-3607-3p suppresses non-small cell lung cancer (NSCLC) by targeting TGFBR1 and CCNE2.
hsa-mir-361	osteosarcoma	down	MiR-361 inhibits osteosarcoma cell lines invasion and proliferation by targeting FKBP14.
hsa-mir-361-3p	non-small cell lung cancer	down	MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
hsa-mir-361-3p	non-small cell lung cancer	down	Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors.
hsa-mir-361-3p	retinoblastoma	down	MicroRNA-361-3p regulates retinoblastoma cell proliferation and stemness by targeting hedgehog signaling.
hsa-mir-361-5p	breast cancer	down	Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/ PI3K/Akt pathway.
hsa-mir-361-5p	breast cancer	down	MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1.
hsa-mir-361-5p	colorectal cancer	down	MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1.
hsa-mir-361-5p	gastric cancer	down	MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1.
hsa-mir-361-5p	gastric cancer	down	MiR-361-5p inhibits the mobility of gastric cancer cells through suppressing epithelial-mesenchymal transition via the Wnt/?-catenin pathway.
hsa-mir-361-5p	glioma	down	miR-361-5p inhibits glioma migration and invasion by targeting SND1.
hsa-mir-361-5p	glioma	down	MicroRNA-361-5p inhibits epithelial-to-mesenchymal transition of glioma cells through targeting Twist1.
hsa-mir-361-5p	hepatocellular carcinoma	down	MicroRNA-361-5p Inhibits Cancer Cell Growth by Targeting CXCR6 in Hepatocellular Carcinoma.
hsa-mir-361-5p	lung cancer	down	miR-361-5p suppresses lung cancer cell lines progression by targeting FOXM1.
hsa-mir-361-5p	non-small cell lung cancer	down	Downregulation of miR-361-5p associates with aggressive clinicopathological features and unfavorable prognosis in non-small cell lung cancer.
hsa-mir-361-5p	papillary thyroid carcinoma	down	MicroRNA-361-5p inhibits papillary thyroid carcinoma progression by targeting ROCK1.
hsa-mir-361-5p	retinoblastoma	down	MiR-361-5p inhibits cell proliferation and induces cell apoptosis in retinoblastoma by negatively regulating CLDN8.
hsa-mir-3613	papillary thyroid carcinoma	up	Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.
hsa-mir-3619-5p	bladder cancer	down	MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting ?-catenin and CDK2 and activating p21.
hsa-mir-3619-5p	prostate cancer	down	miR-3619-5p inhibits prostate cancer cell growth by activating CDKN1A expression.
hsa-mir-362	cervical cancer	down	MicroRNA-362 is downregulated in cervical cancer and inhibits cell proliferation, migration and invasion by directly targeting SIX1.
hsa-mir-362	colorectal cancer	down	MicroRNA-362 Inhibits Cell Proliferation and Invasion by Directly Targeting SIX1 in Colorectal Cancer.
hsa-mir-362	lung cancer	up	Aberrant Expression of miR-362 Promotes Lung Cancer Metastasis through Downregulation of Sema3A.
hsa-mir-362	non-small cell lung cancer	up	Aberrant Expression of miR-362 Promotes Lung Cancer Metastasis through Downregulation of Sema3A.
hsa-mir-362	renal cell carcinoma	up	A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma.
hsa-mir-362-3p	breast cancer	down	Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer.
hsa-mir-362-3p	cervical adenocarcinoma	down	MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma.
hsa-mir-362-3p	gastric cancer	up	Anti-miR-362-3p Inhibits Migration and Invasion of Human Gastric Cancer Cells by Its Target CD82.
hsa-mir-362-3p	gastric cancer	up	Erratum to: Anti-miR-362-3p Inhibits Migration and Invasion of Human Gastric Cancer Cells by Its Target CD82.
hsa-mir-362-3p	glioma	down	MicroRNA-362-3p Targets PAX3 to Inhibit the Development of Glioma through Mediating Wnt/?-Catenin Pathway.
hsa-mir-362-3p	hepatocellular carcinoma	up	Upregulation of miR-362-3p modulates proliferation and anchorage-independent growth by directly targeting Tob2 in hepatocellular carcinoma.
hsa-mir-362-3p	renal cell carcinoma	down	miR-362-3p targets nemo-like kinase and functions as a tumor suppressor in renal cancer cells.
hsa-mir-362-5p	hepatocellular carcinoma	up	MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma.
hsa-mir-362-5p	neuroblastoma	down	miR-362-5p inhibits proliferation and migration of neuroblastoma cells by targeting phosphatidylinositol 3-kinase-C2?.
hsa-mir-363	gastric cancer	up	miR-363 promotes proliferation and chemo-resistance of human gastric cancer via targeting of FBW7 ubiquitin ligase expression.
hsa-mir-363	head and neck cancer	down	MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancer.
hsa-mir-363	head and neck squamous cell carcinoma	down	Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin.
hsa-mir-363	hepatocellular carcinoma	down	Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1.
hsa-mir-363	hepatocellular carcinoma	down	Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma progression and metastasis through miR-363/CDK6 axis.
hsa-mir-363	hepatocellular carcinoma	down	miR-363 inhibits the growth, migration and invasion of hepatocellular carcinoma cells by regulating E2F3.
hsa-mir-363	osteosarcoma	down	microRNA-363 plays a tumor suppressive role in osteosarcoma by directly targeting MAP2K4.
hsa-mir-363	ovarian cancer	down	MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1.
hsa-mir-363-3p	acute myeloid leukemia	up	MicroRNA expression profiling in adrenal myelolipoma.
hsa-mir-363-3p	colorectal cancer	down	MiR-363-3p suppresses tumor growth and metastasis of colorectal cancer via targeting SphK2.
hsa-mir-363-3p	colorectal cancer	down	MiR-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting Sox4.
hsa-mir-363-3p	gastric cancer	down	Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.
hsa-mir-363-3p	hepatocellular carcinoma	down	MicroRNA-363-3p is downregulated in hepatocellular carcinoma and inhibits tumorigenesis by directly targeting specificity protein 1.
hsa-mir-363-3p	lung adenocarcinoma	down	miR-363-3p inhibits migration, invasion, and epithelial-mesenchymal transition by targeting NEDD9 and SOX4 in non-small-cell lung cancer.
hsa-mir-363-3p	lung adenocarcinoma	down	miR-363-3p inhibits tumor growth by targeting PCNA in lung adenocarcinoma.
hsa-mir-363-3p	osteosarcoma	down	MiR-363-3p inhibits osteosarcoma cell proliferation and invasion via targeting SOX4.
hsa-mir-363-3p	papillary thyroid carcinoma	down	MicroRNA-363-3p inhibits papillary thyroid carcinoma progression by targeting PIK3CA.
hsa-mir-363-3p	papillary thyroid carcinoma	down	MicroRNA-363-3p suppresses anoikis resistance in human papillary thyroid carcinoma via targeting integrin alpha 6.
hsa-mir-3646	breast cancer	up	miR-3646 promotes cell proliferation, migration, and invasion via regulating G2/M transition in human breast cancer cells.
hsa-mir-365	breast cancer	down	Overexpression of microRNA-365 inhibits breast cancer cell growth and chemo-resistance through GALNT4.
hsa-mir-365	breast cancer	down	A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer.
hsa-mir-365	cholangiocarcinoma	down	MiR-365 suppresses cholangiocarcinoma cell proliferation and induces apoptosis by targeting E2F2.
hsa-mir-365	colon cancer	down	microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2.
hsa-mir-365	esophageal cancer	down	MicroRNA-365 suppresses cell growth and invasion in esophageal squamous cell carcinoma by modulating phosphoserine aminotransferase 1.
hsa-mir-365	esophageal squamous cell carcinoma	down	MicroRNA-365 suppresses cell growth and invasion in esophageal squamous cell carcinoma by modulating phosphoserine aminotransferase 1.
hsa-mir-365	glioblastoma	down	MicroRNA-365 suppressed cell proliferation and migration via targeting PAX6 in glioblastoma.
hsa-mir-365	hepatocellular carcinoma	down	Prognostic significance and anti-proliferation effect of microRNA-365 in hepatocellular carcinoma.
hsa-mir-365	hepatocellular carcinoma	down	miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma.
hsa-mir-365	hepatocellular carcinoma	down	miR-365 induces hepatocellular carcinoma cell apoptosis through targeting Bcl-2.
hsa-mir-365	hepatocellular carcinoma	down	miR-365 Regulates Liver Cancer Stem Cells via RAC1 pathway.
hsa-mir-365	lung cancer	down	MicroRNA-365 regulates NKX2-1, a key mediator of lung cancer.
hsa-mir-365	malignant melanoma	down	MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.
hsa-mir-365	malignant melanoma	down	MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).
hsa-mir-365	malignant melanoma	down	MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.
hsa-mir-365	non-small cell lung cancer	down	Associations of deregulation of mir-365 and its target mRNA TTF-1 and survival in patients with NSCLC.
hsa-mir-365	non-small cell lung cancer	down	Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
hsa-mir-365	non-small cell lung cancer	down	Altered expression of microRNA-365 is related to the occurrence and development of non-small-cell lung cancer by inhibiting TRIM25 expression.
hsa-mir-365	oral squamous cell carcinoma	down	Long non-coding RNA NEAT1 promotes migration and invasion of oral squamous cell carcinoma cells by sponging microRNA-365.
hsa-mir-365	osteosarcoma	down	miR-365 functions as a tumor suppressor by directly targeting CYR61 in osteosarcoma.
hsa-mir-365	ovarian cancer	down	MicroRNA-365 inhibits ovarian cancer progression by targeting Wnt5a.
hsa-mir-3650	hepatocellular carcinoma	down	Tumor-suppressive miR-3650 inhibits tumor metastasis by directly targeting NFASC in hepatocellular carcinoma.
hsa-mir-3653	colon cancer	down	MiR-3653 inhibits the metastasis and epithelial-mesenchymal transition of colon cancer by targeting Zeb2.
hsa-mir-3658	bladder cancer	up	Hsa-miR-3658 Promotes Cell Proliferation, Migration and Invasion by Effecting LASS2 in Bladder Cancer.
hsa-mir-3658	bladder cancer	up	Upregulation of miR-3658 in bladder cancer and tumor progression.
hsa-mir-365a-3p	laryngeal squamous cell carcinoma	up	MicroRNA-365a-3p promotes tumor growth and metastasis in laryngeal squamous cell carcinoma.
hsa-mir-365a-3p	lung adenocarcinoma	up	MicroRNA-365 promotes lung carcinogenesis by downregulating the USP33/SLIT2/ROBO1 signalling pathway.
hsa-mir-365b-3p	retinoblastoma	down	MiR-365b-3p, down-regulated in retinoblastoma, regulates cell cycle progression and apoptosis of human retinoblastoma cells by targeting PAX6.
hsa-mir-3662	hepatocellular carcinoma	down	MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1?-mediated Warburg effect.
hsa-mir-3662	lung cancer	up	Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.
hsa-mir-3663-3p	glioma	up	MiR-363-3p modulates cell growth and invasion in glioma by directly targeting pyruvate dehydrogenase B.
hsa-mir-3666	lung cancer	down	MicroRNA-3666 inhibits lung cancer cell proliferation, migration, and invasiveness by targeting BPTF.
hsa-mir-367	gastric cancer	down	The microRNA-367 Inhibits the Invasion and Metastasis of Gastric Cancer by Directly Repressing Rab23.
hsa-mir-367	hepatocellular carcinoma	up	miR-367 promotes proliferation and invasion of hepatocellular carcinoma cells by negatively regulating PTEN.
hsa-mir-367	medulloblastoma	up	miR-367 promotes proliferation and stem-like traits in medulloblastoma cells.
hsa-mir-367	non-small cell lung cancer	up	miR-367 promotes tumor growth by inhibiting FBXW7 in NSCLC.
hsa-mir-367	osteosarcoma	up	MiR-367 negatively regulates apoptosis induced by adriamycin in osteosarcoma cells by targeting KLF4.
hsa-mir-367	pancreatic cancer	up	miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-? signalling pathway.
hsa-mir-367	uveal melanoma	up	miR-367 promotes uveal melanoma cell proliferation and migration by regulating PTEN.
hsa-mir-369-3p	glioblastoma	down	Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients.
hsa-mir-369-3p	thyroid cancer	down	Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer (PTC).
hsa-mir-369-5p	pancreatic ductal adenocarcinoma	up	Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-3691-5p	hepatocellular carcinoma	up	miR-3691-5p promotes hepatocellular carcinoma cell migration and invasion through activating PI3K/Akt signaling by targeting PTEN.
hsa-mir-370	acute myeloid leukemia	up	Integration of SNP and mRNA arrays with microRNA profiling reveals that MiR-370 is upregulated and targets NF1 in acute myeloid leukemia.
hsa-mir-370	bladder cancer	down	Up-regulation of p21(WAF1/CIP1) by miRNAs and its implications in bladder cancer cells.
hsa-mir-370	breast cancer	up	High MicroRNA-370 Expression Correlates with Tumor Progression and Poor Prognosis in Breast Cancer.
hsa-mir-370	breast cancer	up	microRNA-370 Promotes Cell Growth by Targeting WNK2 in Breast Cancer.
hsa-mir-370	colonic adenocarcinoma	down	Hsa-miR-370 inhibited P-selectin-induced cell adhesion in human colon adenocarcinoma cells.
hsa-mir-370	esophageal squamous cell carcinoma	down	Alpinumisoflavone induces apoptosis in esophageal squamous cell carcinoma by modulating miR-370/PIM1 signaling.
hsa-mir-370	gastric cancer	up	Overexpression of miR-370 and downregulation of its novel target TGF?-RII contribute to the progression of gastric carcinoma.
hsa-mir-370	gastric cancer	up	Upregulation of miR-370 contributes to the progression of gastric carcinoma via suppression of FOXO1.
hsa-mir-370	gastric cancer	down	MicroRNA-370 inhibits the proliferation, invasion and EMT of gastric cancer cells by directly targeting PAQR4.
hsa-mir-370	gastric cancer	down	Upregulation of microRNA-370 promotes cell apoptosis and inhibits proliferation by targeting PTEN in human gastric cancer.
hsa-mir-370	glioma	down	Knockdown of Long Non-Coding RNA KCNQ1OT1 Restrained Glioma Cells' Malignancy by Activating miR-370/CCNE2 Axis.
hsa-mir-370	hepatocellular carcinoma	down	Perturbation of miR-370-LIN28A-NF-?B regulatory circuit contributes to the development of hepatocellular carcinoma.
hsa-mir-370	laryngeal squamous cell carcinoma	down	miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC).
hsa-mir-370	liver cancer	down	MiR-370 promotes cell death of liver cancer cells by Akt/FoxO3a signalling pathway.
hsa-mir-370	malignant melanoma	up	MiR-370 functions as oncogene in melanoma by direct targeting pyruvate dehydrogenase B.
hsa-mir-370	non-small cell lung cancer	down	MicroRNA-370 inhibits the progression of non-small cell lung cancer by downregulating oncogene TRAF4.
hsa-mir-370	oral squamous cell carcinoma	down	miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma.
hsa-mir-370	osteosarcoma	down	DNA Methylation Mediated Down-Regulation of miR-370 Regulates Cell Growth through Activation of the Wnt/?-Catenin Signaling Pathway in Human Osteosarcoma Cells.
hsa-mir-370	osteosarcoma	down	MicroRNA-370 directly targets FOXM1 to inhibit cell growth and metastasis in osteosarcoma cells.
hsa-mir-370	primary cns lymphomas	down	miR-370 Sensitizes TMZ Response Dependent of MGMT Status in Primary Central Nervous System Lymphoma.
hsa-mir-370-3p	glioma	down	MicroRNA-370-3p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting ?-catenin.
hsa-mir-371	esophageal squamous cell carcinoma	up	Upregulation of miR-371-373 cluster, a human embryonic stem cell specific microRNA cluster, in esophageal squamous cell carcinoma.
hsa-mir-371	hepatocellular carcinoma	up	MiR-371 promotes proliferation and metastasis in hepatocellular carcinoma by targeting PTEN.
hsa-mir-371-5p	gastric cancer	up	MicroRNA-371-5p targets SOX2 in gastric cancer.
hsa-mir-371-5p	hepatocellular carcinoma	up	miR-371-5p down-regulates pre mRNA processing factor 4 homolog B (PRPF4B) and facilitates the G1/S transition in human hepatocellular carcinoma cells.
hsa-mir-371-5p	nasopharyngeal carcinoma	down	miR-371-5p suppresses the proliferative and migratory capacity of human nasopharyngeal carcinoma by targeting BCL2.
hsa-mir-372	breast cancer	up	miR-372 promotes breast cancer cell proliferation by directly targeting LATS2.
hsa-mir-372	cervical cancer	down	MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.
hsa-mir-372	colorectal cancer	up	Serum miR-372 is a diagnostic and prognostic biomarker in patients with early colorectal cancer.
hsa-mir-372	endometrial cancer	down	MicroRNA-372 inhibits endometrial carcinoma development by targeting the expression of the Ras homolog gene family member C (RhoC).
hsa-mir-372	epithelial ovarian cancer	up	Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.
hsa-mir-372	esophageal squamous cell carcinoma	up	Upregulation of miR-371-373 cluster, a human embryonic stem cell specific microRNA cluster, in esophageal squamous cell carcinoma.
hsa-mir-372	glioma	up	Correlation of microrna-372 upregulation with poor prognosis in human glioma.
hsa-mir-372	head and neck squamous cell carcinoma	up	miR-372 inhibits p62 in head and neck squamous cell carcinoma in vitro and in vivo.
hsa-mir-372	hepatocellular carcinoma	up	Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma.
hsa-mir-372	hepatocellular carcinoma	down	miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis.
hsa-mir-372	oral squamous cell carcinoma	up	Upregulation of miR-372 and -373 associates with lymph node metastasis and poor prognosis of oral carcinomas.
hsa-mir-372	ovarian carcinoma	down	The role of miR-372 in ovarian carcinoma cell proliferation.
hsa-mir-372	prostate cancer	down	microRNA-372 Suppresses Migration and Invasion by Targeting p65 in Human Prostate Cancer Cells.
hsa-mir-372	renal cell carcinoma	down	miR-372 suppresses tumour proliferation and invasion by targeting IGF2BP1 in renal cell carcinoma.
hsa-mir-372	renal cell carcinoma	down	MicroRNA-372 functions as a tumor suppressor in cell invasion, migration and epithelial-mesenchymal transition by targeting ATAD2 in renal cell carcinoma.
hsa-mir-372-3p	breast carcinoma	up	MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway.
hsa-mir-372-3p	lung squamous cell carcinoma	up	MiR-372-3p promotes cell growth and metastasis by targeting FGF9 in lung squamous cell carcinoma.
hsa-mir-372-3p	osteosarcoma	down	MiR-372-3p inhibits the growth and metastasis of osteosarcoma cells by targeting FXYD6.
hsa-mir-372-5p	oral squamous cell carcinoma	down	MEHP promotes the proliferation of oral cancer cells via down regulation of miR-27b-5p and miR-372-5p.
hsa-mir-373	bladder cancer	down	Enhancing E-cadherin expression via promoter-targeted miR-373 suppresses bladder cancer cells growth and metastasis.
hsa-mir-373	breast cancer	up	Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.
hsa-mir-373	breast cancer	up	The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis.
hsa-mir-373	breast cancer	up	MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1?-TWIST signaling axis in breast cancer.
hsa-mir-373	breast cancer	up	Epigenetic Silencing of ITGA2 by MiR-373 Promotes Cell Migration in Breast Cancer.
hsa-mir-373	cervical carcinoma	up	MicroRNA-373 functions as an oncogene and targets YOD1 gene in cervical cancer.
hsa-mir-373	colon cancer	down	Epigenetic silencing of microRNA-373 plays an important role in regulating cell proliferation in colon cancer.
hsa-mir-373	endometrial cancer	up	MicroRNA-373 promotes the development of endometrial cancer by targeting LATS2 and activating the Wnt/?-Catenin pathway.
hsa-mir-373	epithelial ovarian cancer	up	Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.
hsa-mir-373	esophageal squamous cell carcinoma	up	MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer.
hsa-mir-373	esophageal squamous cell carcinoma	up	Erratum: MicroRNA-373 promotes migration and invasion in human esophageal squamous cell carcinoma by inhibiting TIMP3 expression.
hsa-mir-373	esophageal squamous cell carcinoma	up	MicroRNA-373 promotes migration and invasion in human esophageal squamous cell carcinoma by inhibiting TIMP3 expression.
hsa-mir-373	esophageal squamous cell carcinoma	up	Upregulation of miR-371-373 cluster, a human embryonic stem cell specific microRNA cluster, in esophageal squamous cell carcinoma.
hsa-mir-373	gastric adenocarcinoma	up	MicroRNA-373 is upregulated and targets TNFAIP1 in human gastric cancer, contributing to tumorigenesis.
hsa-mir-373	gastric cancer	down	miR-373 suppresses gastric cancer metastasis by downregulating vimentin.
hsa-mir-373	glioblastoma	down	Long Non-Coding RNA HOXA-AS2 Regulates Malignant Glioma Behaviors and Vasculogenic Mimicry Formation via the MiR-373/EGFR Axis.
hsa-mir-373	glioma	down	Down-expression of miR-373 predicts poor prognosis of glioma and could be a potential therapeutic target.
hsa-mir-373	glioma	down	miR-373 Inhibits Glioma Cell U251 Migration and Invasion by Down-Regulating CD44 and TGFBR2.
hsa-mir-373	hepatocellular carcinoma	up	MicroRNA-373, a new regulator of protein phosphatase?6, functions as an oncogene in hepatocellular carcinoma.
hsa-mir-373	lung cancer	up	Down-regulation of miR-373 increases the radiosensitivity of lung cancer cells by targeting TIMP2.
hsa-mir-373	malignant melanoma	up	MicroRNA-373 promotes cell migration via targeting salt-inducible kinase 1 expression in melanoma.
hsa-mir-373	neuroblastoma	up	miR-373 promotes neuroblastoma cell proliferation, migration, and invasion by targeting SRCIN1.
hsa-mir-373	non-small cell lung cancer	down	Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes.
hsa-mir-373	non-small cell lung cancer	down	MicroRNA-373 Inhibits Cell Proliferation and Invasion via Targeting BRF2 in Human Non-small Cell Lung Cancer A549 Cell Line.
hsa-mir-373	oral squamous cell carcinoma	up	Upregulation of miR-372 and -373 associates with lymph node metastasis and poor prognosis of oral carcinomas.
hsa-mir-373	oral squamous cell carcinoma	up	MiR-373 promotes proliferation and metastasis of oral squamous cell carcinoma by targeting SPOP.
hsa-mir-373	osteosarcoma	up	microRNA-373 promotes growth and cellular invasion in osteosarcoma cells by activation of PI3K/AKT-Rac1-JNK pathway: The potential role in spinal osteosarcoma.
hsa-mir-373	pancreatic cancer	down	Micro RNA-373 is Down-regulated in Pancreatic Cancer and Inhibits Cancer Cell Invasion.
hsa-mir-373-3p	esophageal squamous cell carcinoma	up	MicroRNA-373 promotes the development of esophageal squamous cell carcinoma by targeting LATS2 and OXR1.
hsa-mir-373-3p	lung adenocarcinoma	up	miR-373-3p promotes lung adenocarcinoma cell proliferation via APP.
hsa-mir-373-3p	prostate cancer	down	MicroRNA-373-3p inhibits prostate cancer progression by targeting AKT1.
hsa-mir-374a	bladder cancer	down	MicroRNA-374a Inhibits Aggressive Tumor Biological Behavior in Bladder Carcinoma by Suppressing Wnt/?-Catenin Signaling.
hsa-mir-374a	breast cancer	up	Upregulation of miR-374a promotes tumor metastasis and progression by downregulating LACTB and predicts unfavorable prognosis in breast cancer.
hsa-mir-374a	breast cancer	down	Effects of Differential Distribution of Microvessel Density, Possibly Regulated by miR-374a, on Breast Cancer Prognosis.
hsa-mir-374a	colon cancer	down	microRNA-374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K/AKT pathway.
hsa-mir-374a	esophageal cancer	up	MicroRNA-374a promotes esophageal cancer cell proliferation via Axin2 suppression.
hsa-mir-374a	gastric cancer	up	miR-374a promotes cell proliferation, migration and invasion by targeting SRCIN1 in gastric cancer.
hsa-mir-374a	glioma	up	miR-374a Inhibitor Enhances Etoposide-Induced Cytotoxicity Against Glioma Cells Through Upregulation of FOXO1.
hsa-mir-374a	glioma	down	Downregulation of microRNA-374a predicts poor prognosis in human glioma.
hsa-mir-374a	hepatocellular carcinoma	up	MicroRNA-374a Promotes Hepatocellular Carcinoma Cell Proliferation by Targeting Mitogen-Inducible Gene-6 (MIG-6).
hsa-mir-374a	lung adenocarcinoma	down	MiR-374a suppresses lung adenocarcinoma cell proliferation and invasion by targeting TGFA gene expression.
hsa-mir-374a	pancreatic cancer	up	MicroRNA-374a promotes pancreatic cancer cell proliferation and epithelial to mesenchymal transition by targeting SRCIN1.
hsa-mir-374a-5p	gastric cancer	down	MicroRNA expression profiling provides novel insights into immune-related pathways involved in gastric cancer.
hsa-mir-374a-5p	osteosarcoma	up	Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
hsa-mir-374b	cervical cancer	down	MicroRNA-374b inhibits cervical cancer cell proliferation and induces apoptosis through the p38/ERK signaling pathway by binding to JAM-2.
hsa-mir-374b	cervical cancer	down	MiR-374b reduces cell proliferation and cell invasion of cervical cancer through regulating FOXM1.
hsa-mir-374b	colon cancer	down	MicroRNA-374b reduces the proliferation and invasion of colon cancer cells by regulation of LRH-1/Wnt signaling.
hsa-mir-374b	gastrointestinal stromal tumor	up	MiR-374b Promotes Proliferation and Inhibits Apoptosis of Human GIST Cells by Inhibiting PTEN through Activation of the PI3K/Akt Pathway.
hsa-mir-374b	glioma	down	MicroRNA-374b inhibits migration and invasion of glioma cells by targeting EGFR.
hsa-mir-374b	glioma	up	MiR-374b targets GATA3 to promote progression and development of glioblastoma via regulating SEMA3B.
hsa-mir-374b	liver cancer	down	MicroRNA-374b inhibits liver cancer progression via down regulating programmed cell death-1 expression on cytokine-induced killer cells.
hsa-mir-374b	prostate cancer	down	Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients.
hsa-mir-374b	t-cell lymphoblastic lymphoma	down	MicroRNA-374b suppresses proliferation and promotes apoptosis in T-cell lymphoblastic lymphoma by repressing AKT1 and Wnt-16.
hsa-mir-374b-5p	bladder cancer	down	MiR-454-3p and miR-374b-5p suppress migration and invasion of bladder cancer cells through targetting ZEB2.
hsa-mir-374b-5p	ovarian cancer	down	MiR-374b-5p-FOXP1 feedback loop regulates cell migration, epithelial-mesenchymal transition and chemosensitivity in ovarian cancer.
hsa-mir-374c-5p	cervical cancer	down	MicroRNA-374c-5p regulates the invasion and migration of cervical cancer by acting on the Foxc1/snail pathway.
hsa-mir-375	brain cancer	up	MicroRNA-target cross-talks: Key players in glioblastoma multiforme.
hsa-mir-375	breast cancer	down	miR-375 inhibits cancer stem cell phenotype and tamoxifen resistance by degrading HOXB3 in human ER-positive breast cancer.
hsa-mir-375	breast cancer	down	MicroRNA-375 targets PAX6 and inhibits the viability, migration and invasion of human breast cancer MCF-7 cells.
hsa-mir-375	cervical squamous cell carcinoma	down	miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1.
hsa-mir-375	colon cancer	down	Exosome-Carried microRNA-375 Inhibits Cell Progression and Dissemination via Bcl-2 Blocking in Colon Cancer.
hsa-mir-375	colorectal cancer	down	MicroRNA-375 suppresses human colorectal cancer metastasis by targeting Frizzled 8.
hsa-mir-375	colorectal cancer	down	miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes.
hsa-mir-375	colorectal cancer	down	The expression profiling of serum miR-92a, miR-375, and miR-760 in colorectal cancer: An Egyptian study.
hsa-mir-375	colorectal cancer	down	The inhibitory effect of miR-375 targeting sp1 in colorectal cancer cell proliferation.
hsa-mir-375	colorectal cancer	down	microRNA-375 inhibits colorectal cancer cells proliferation by downregulating JAK2/STAT3 and MAP3K8/ERK signaling pathways.
hsa-mir-375	colorectal cancer	down	Expression levels of microRNA-375 in colorectal carcinoma.
hsa-mir-375	colorectal cancer	down	Identification and functional screening of microRNAs highly deregulated in colorectal cancer.
hsa-mir-375	colorectal cancer	down	MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
hsa-mir-375	colorectal cancer	up	MicroRNA-375 accelerates the invasion and migration of colorectal cancer through targeting RECK.
hsa-mir-375	esophageal adenocarcinoma	down	Circulating miRNA profile in esophageal adenocarcinoma.
hsa-mir-375	esophageal cancer	down	MicroRNA-375 suppresses esophageal cancer cell growth and invasion by repressing metadherin expression.
hsa-mir-375	esophageal cancer	down	Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer.
hsa-mir-375	esophageal cancer	down	The expression of miR-21 and miR-375 predict prognosis of esophageal cancer.
hsa-mir-375	esophageal squamous cell carcinoma	down	Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma.
hsa-mir-375	esophageal squamous cell carcinoma	down	Cell-specific detection of miR-375 downregulation for predicting the prognosis of esophageal squamous cell carcinoma by miRNA in situ hybridization.
hsa-mir-375	esophageal squamous cell carcinoma	down	Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma.
hsa-mir-375	esophageal squamous cell carcinoma	down	Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma.
hsa-mir-375	esophageal squamous cell carcinoma	down	MiR-375 suppresses invasion and metastasis by direct targeting of SHOX2 in esophageal squamous cell carcinoma.
hsa-mir-375	esophageal squamous cell carcinoma	down	Circulating plasma microRNAs in the detection of esophageal squamous cell carcinoma.
hsa-mir-375	esophageal squamous cell carcinoma	down	Study of expression levels and clinical significance of miR-503 and miR-375 in patients with esophageal squamous cell carcinoma.
hsa-mir-375	esophageal squamous cell carcinoma	down	MicroRNA-375 inhibits esophageal squamous cell carcinoma proliferation through direct targeting of SP1.
hsa-mir-375	gastric cancer	down	MicroRNA expression profiling provides novel insights into immune-related pathways involved in gastric cancer.
hsa-mir-375	gastric cancer	down	miRNA and mRNA expression profiles in gastric cancer patients and the relationship with circRNA.
hsa-mir-375	gastric cancer	down	Circ-SERPINE2 promotes the development of gastric carcinoma by sponging miR-375 and modulating YWHAZ.
hsa-mir-375	gastric cancer	down	MicroRNA-375 Functions as a Tumor-Suppressor Gene in Gastric Cancer by Targeting Recepteur d'Origine Nantais.
hsa-mir-375	gastric cancer	down	MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.
hsa-mir-375	gastric cancer	down	MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2.
hsa-mir-375	gastric cancer	down	miR-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expression.
hsa-mir-375	gastric cancer	down	Snail-regulated MiR-375 inhibits migration and invasion of gastric cancer cells by targeting JAK2.
hsa-mir-375	gastric cancer	down	Deregulation of MicroRNA-375 Inhibits Proliferation and Migration in Gastric Cancer in Association With Autophagy-Mediated AKT/mTOR Signaling Pathways.
hsa-mir-375	gastric cancer	down	miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
hsa-mir-375	gastric cancer	down	Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.
hsa-mir-375	glioma	down	Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma.
hsa-mir-375	glioma	down	Knockdown of long non-coding RNA LUCAT1 inhibits cell viability and invasion by regulating miR-375 in glioma.
hsa-mir-375	glioma	down	MicroRNA-375 inhibits glioma cell proliferation and migration by downregulating RWDD3 in vitro.
hsa-mir-375	head and neck squamous cell carcinoma	down	Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas.
hsa-mir-375	head and neck squamous cell carcinoma	down	MicroRNA-375 Suppresses Extracellular Matrix Degradation and Invadopodial Activity in Head and Neck Squamous Cell Carcinoma.
hsa-mir-375	head and neck squamous cell carcinoma	down	miR-375 inhibits IFN-?-induced programmed death 1 ligand 1 surface expression in head and neck squamous cell carcinoma cells by blocking JAK2/STAT1 signaling.
hsa-mir-375	hepatocellular carcinoma	down	The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma.
hsa-mir-375	hepatocellular carcinoma	down	Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma.
hsa-mir-375	hepatocellular carcinoma	down	Low-level expression of microRNA-375 predicts poor prognosis in hepatocellular carcinoma.
hsa-mir-375	hepatocellular carcinoma	down	MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
hsa-mir-375	hepatocellular carcinoma	down	miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions.
hsa-mir-375	kidney cancer	down	MicroRNA-375 inhibits the proliferation, migration and invasion of kidney cancer cells by triggering apoptosis and modulation of PDK1 expression.
hsa-mir-375	laryngeal cancer	down	MicroRNA profile in site-specific head and neck squamous cell cancer.
hsa-mir-375	laryngeal squamous cell carcinoma	down	miR-375 Suppresses IGF1R Expression and Contributes to Inhibition of Cell Progression in Laryngeal Squamous Cell Carcinoma.
hsa-mir-375	laryngeal squamous cell carcinoma	up	miR-148a and miR-375 may serve as predictive biomarkers for early diagnosis of laryngeal carcinoma.
hsa-mir-375	liver cancer	down	Upregulation of miR-375 inhibits human liver cancer cell growth by modulating cell proliferation and apoptosis via targeting ErbB2.
hsa-mir-375	medullary thyroid carcinoma	up	Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients.
hsa-mir-375	multiple myeloma	down	Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma.
hsa-mir-375	nasopharyngeal carcinoma	down	Significance of dysregulated metadherin and microRNA-375 in head and neck cancer.
hsa-mir-375	non-small cell lung cancer	down	Decreased expression of microRNA-375 in nonsmall cell lung cancer and its clinical significance.
hsa-mir-375	non-small cell lung cancer	up	Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.
hsa-mir-375	non-small cell lung cancer	down	Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
hsa-mir-375	oral cancer	down	MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.
hsa-mir-375	oral cancer	down	Anti-Cancer Drugs Reactivate Tumor Suppressor miR-375 Expression in Tongue Cancer Cells.
hsa-mir-375	oral carcinoma	down	Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma.
hsa-mir-375	oral squamous cell carcinoma	down	MicroRNA-375 Inhibits Growth and Enhances Radiosensitivity in Oral Squamous Cell Carcinoma by Targeting Insulin Like Growth Factor 1 Receptor.
hsa-mir-375	oral squamous cell carcinoma	down	MiR-375/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasion.
hsa-mir-375	oropharyngeal cancer	down	MicroRNA profile in site-specific head and neck squamous cell cancer.
hsa-mir-375	osteosarcoma	down	MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
hsa-mir-375	osteosarcoma	down	MicroRNA-375 functions as a tumor suppressor in osteosarcoma by targeting PIK3CA.
hsa-mir-375	pancreatic cancer	down	MicroRNA-375 is downregulated in pancreatic cancer and inhibits cell proliferation in vitro.
hsa-mir-375	pancreatic cancer	down	Expression levels of microRNA-375 in pancreatic cancer.
hsa-mir-375	pancreatic cancer	down	Deregulation of MicroRNA-375 inhibits cancer proliferation migration and chemosensitivity in pancreatic cancer through the association of HOXB3.
hsa-mir-375	pancreatic carcinoma	down	MicroRNA-375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signaling pathway.
hsa-mir-375	pancreatic ductal adenocarcinoma	down	Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma.
hsa-mir-375	pancreatic ductal adenocarcinoma	down	Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-375	papillary thyroid carcinoma	down	Over-expression of microRNA-375 inhibits papillary thyroid carcinoma cell proliferation and induces cell apoptosis by targeting ERBB2.
hsa-mir-375	squamous carcinoma	down	Tumor suppressive microRNA-375 regulates lactate dehydrogenase B in maxillary sinus squamous cell carcinoma.
hsa-mir-376a	breast cancer	down	miR-376a inhibits breast cancer cell progression by targeting neuropilin-1 NR.
hsa-mir-376a	chondrosarcoma	down	Analysis of microRNAs expressions in chondrosarcoma.
hsa-mir-376a	gastric cancer	down	Downregulation of microRNA-376a in Gastric Cancer and Association with Poor Prognosis.
hsa-mir-376a	glioblastoma	down	Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.
hsa-mir-376a	hepatocellular carcinoma	down	miR-376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma.
hsa-mir-376a	malignant melanoma	down	Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor.
hsa-mir-376a	non-small cell lung cancer	down	MiR-376a suppresses the proliferation and invasion of non-small-cell lung cancer by targeting c-Myc.
hsa-mir-376a	ovarian cancer	up	MiR-376a promotion of proliferation and metastases in ovarian cancer: Potential role as a biomarker.
hsa-mir-376a	pancreatic ductal adenocarcinoma	up	Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-376a	renal cell carcinoma	down	MiR-376a functions as tumor suppressor by targeting SGK3 in renal cell carcinoma.
hsa-mir-376b	breast cancer	up	MicroRNA-376b promotes breast cancer metastasis by targeting Hoxd10 directly.
hsa-mir-376c	cervical cancer	down	miR-376c inhibits cervical cancer cell proliferation and invasion by targeting BMI1.
hsa-mir-376c	gastric cancer	up	miR-376c promotes carcinogenesis and serves as a plasma marker for gastric carcinoma.
hsa-mir-376c	malignant melanoma	down	Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor.
hsa-mir-376c	non-small cell lung cancer	down	MicroRNA-376c suppresses non-small-cell lung cancer cell growth and invasion by targeting LRH-1-mediated Wnt signaling pathway.
hsa-mir-376c	osteosarcoma	down	MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.
hsa-mir-376c	osteosarcoma	down	MicroRNA-376c Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting to Transforming Growth Factor-Alpha.
hsa-mir-376c-3p	gastric adenocarcinoma	down	hsa-miR-376c-3p Regulates Gastric Tumor Growth Both In Vitro and In Vivo.
hsa-mir-377	cervical cancer	down	MicroRNA-377 targets zinc finger E-box-binding homeobox 2 to inhibit cell proliferation and invasion of cervical cancer.
hsa-mir-377	gastric cancer	down	MiR-377 suppresses cell proliferation and metastasis in gastric cancer via repressing the expression of VEGFA.
hsa-mir-377	gastric cancer	up	The regulation and function of microRNA-377/RASSF8 signaling axis in gastric cancer.
hsa-mir-377	gastric cancer	up	MicroRNA-377 predicts poor clinical outcome of gastric cancer and induces tumorigenesis by targeting multiple tumor-suppressor genes.
hsa-mir-377	hepatocellular carcinoma	down	MicroRNA-377 Suppresses Cell Proliferation and Invasion by Inhibiting TIAM1 Expression in Hepatocellular Carcinoma.
hsa-mir-377	hepatocellular carcinoma	down	Downregulation of miR-377 contributes to IRX3 deregulation in hepatocellular carcinoma.
hsa-mir-377	non-small cell lung cancer	down	microRNA-377 inhibits non-small-cell lung cancer through targeting AEG-1.
hsa-mir-377	oral squamous cell carcinoma	down	Downregulation of miR-377 Promotes Oral Squamous Cell Carcinoma Growth and Migration by Targeting HDAC9.
hsa-mir-377	pancreatic ductal adenocarcinoma	down	MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
hsa-mir-377	renal clear cell carcinoma	down	miR-377 functions as a tumor suppressor in human clear cell renal cell carcinoma by targeting ETS1.
hsa-mir-377-3p	colorectal cancer	up	miR-377-3p drives malignancy characteristics via upregulating GSK-3? expression and activating NF-?B pathway in hCRC cells.
hsa-mir-377-3p	ovarian cancer	down	MicroRNA-377-3p inhibits growth and invasion through sponging JAG1 in ovarian cancer.
hsa-mir-377-5p	lung cancer	down	miR-377-5p inhibits lung cancer cell proliferation, invasion, and cell cycle progression by targeting AKT1 signaling.
hsa-mir-378	acute myeloid leukemia	up	Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia.
hsa-mir-378	basal cell carcinoma	down	Expression of microRNAs in basal cell carcinoma.
hsa-mir-378	breast cancer	up	Association between mir-24 and mir-378 in formalin-fixed paraffin-embedded tissues of breast cancer.
hsa-mir-378	chronic myelogenous leukemia	up	MiR-378 promoted cell proliferation and inhibited apoptosis by enhanced stem cell properties in chronic myeloid leukemia K562 cells.
hsa-mir-378	colorectal cancer	down	Identification and functional screening of microRNAs highly deregulated in colorectal cancer.
hsa-mir-378	colorectal cancer	down	MicroRNA-378 inhibits cell growth and enhances l-OHP-induced apoptosis in human colorectal cancer.
hsa-mir-378	colorectal cancer	down	[Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer].
hsa-mir-378	gastric cancer	down	[Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer].
hsa-mir-378	gastric cancer	down	MicroRNA profiling of human gastric cancer.
hsa-mir-378	gastric cancer	down	MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer.
hsa-mir-378	glioma	down	Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma.
hsa-mir-378	lung cancer	up	Circular RNA hsa_circ_0007059 restrains proliferation and epithelial-mesenchymal transition in lung cancer cells via inhibiting microRNA-378.
hsa-mir-378	nasopharyngeal carcinoma	down	MicroRNA-378 functions as an onco-miR in nasopharyngeal carcinoma by repressing TOB2 expression.
hsa-mir-378	oral squamous cell carcinoma	up	MicroRNA-378 promotes the malignant progression of oral squamous cell carcinoma by mediating FOXN3.
hsa-mir-378	ovarian cancer	up	Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
hsa-mir-378	ovarian cancer	up	MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer.
hsa-mir-378	prostate cancer	down	MiR-378 suppresses prostate cancer cell growth through downregulation of MAPK1 in vitro and in vivo.
hsa-mir-378	renal cell carcinoma	down	A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma.
hsa-mir-378a-3p	colorectal cancer	down	Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
hsa-mir-378a-3p	pancreatic cancer	down	Preliminary investigation of the function of hsa_circ_0006215 in pancreatic cancer.
hsa-mir-378a-5p	colorectal cancer	down	Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
hsa-mir-378a-5p	colorectal cancer	down	Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
hsa-mir-379	breast cancer	down	miR-379 regulates cyclin B1 expression and is decreased in breast cancer.
hsa-mir-379	cervical cancer	down	MicroRNA-379 Suppresses Cervical Cancer Cell Proliferation and Invasion by Directly Targeting V-crk Avian Sarcoma Virus CT10 Oncogene Homolog-Like (CRKL).
hsa-mir-379	gastric cancer	down	MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
hsa-mir-379	glioma	down	MicroRNA-379 inhibits cell proliferation and invasion in glioma via targeting metadherin and regulating PTEN/AKT pathway.
hsa-mir-379	laryngeal carcinoma	down	MicroRNA-379 inhibits laryngeal carcinoma cell proliferation and invasion through directly targeting TCF-4.
hsa-mir-379	nasopharyngeal carcinoma	down	MicroRNA-379 suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma by targeting tumor protein D52.
hsa-mir-379	osteosarcoma	down	MicroRNA-379 suppresses osteosarcoma progression by targeting PDK1.
hsa-mir-379-5p	hepatocellular carcinoma	down	MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
hsa-mir-381	breast cancer	down	miR-381 suppresses C/EBP?-dependent Cx43 expression in breast cancer cells.
hsa-mir-381	breast cancer	down	Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-381	colon cancer	down	Down-regulation of MicroRNA-381 promotes cell proliferation and invasion in colon cancer through up-regulation of LRH-1.
hsa-mir-381	colon cancer	down	[Expression and proliferative regulation of miR-204 related to mitochondrial transcription factor A in colon cancer].
hsa-mir-381	colorectal cancer	down	MiR-381 functions as a tumor suppressor in colorectal cancer by targeting Twist1.
hsa-mir-381	endometrial cancer	down	MicroRNA-381 inhibits cell proliferation and invasion in endometrial carcinoma by targeting the IGF-1R.
hsa-mir-381	esophageal squamous cell carcinoma	down	MicroRNA-381 enhances radiosensitivity in esophageal squamous cell carcinoma by targeting X-linked inhibitor of apoptosis protein.
hsa-mir-381	gastric cancer	down	MiR-381 inhibits migration and invasion in human gastric carcinoma through downregulatedting SOX4.
hsa-mir-381	gastric cancer	down	MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression.
hsa-mir-381	hepatocellular carcinoma	down	MicroRNA-381 suppresses cell growth and invasion by targeting the liver receptor homolog-1 in hepatocellular carcinoma.
hsa-mir-381	lung adenocarcinoma	down	MicroRNA-381 represses ID1 and is deregulated in lung adenocarcinoma.
hsa-mir-381	non-small cell lung cancer	down	microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-?B signaling.
hsa-mir-381	osteosarcoma	down	MicroRNA-381 suppresses the proliferation of osteosarcoma cells through LRH-1/Wnt/?-catenin signaling pathway.
hsa-mir-381	renal cell carcinoma	down	Inhibition of MicroRNA-381 Promotes Tumor Cell Growth and Chemoresistance in Clear-Cell Renal Cell Carcinoma.
hsa-mir-381-3p	papillary thyroid carcinoma	down	MiR-381-3p inhibits proliferation, migration and invasion by targeting LRP6 in papillary thyroid carcinoma.
hsa-mir-382	colorectal cancer	down	MiR-382 functions as tumor suppressor and chemosensitizer in colorectal cancer.
hsa-mir-382	colorectal cancer	down	MicroRNA-382 inhibits cell growth and migration in colorectal cancer by targeting SP1.
hsa-mir-382	colorectal cancer	down	MiR-382 inhibits cell growth and invasion by targeting NR2F2 in colorectal cancer.
hsa-mir-382	non-small cell lung cancer	down	MicroRNA-382 inhibits cancer cell growth and metastasis in NSCLC via targeting LMO3.
hsa-mir-382	non-small cell lung cancer	down	miR-382 inhibits tumor progression by targeting SETD8 in non-small cell lung cancer.
hsa-mir-382	osteosarcoma	down	miR-382 Inhibits Osteosarcoma Metastasis and Relapse by Targeting Y Box-Binding Protein 1.
hsa-mir-382	osteosarcoma	down	miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma.
hsa-mir-382	ovarian cancer	down	miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer.
hsa-mir-382	prostate cancer	down	MicroRNA-382 inhibits prostate cancer cell proliferation and metastasis through targeting COUP-TFII.
hsa-mir-382-5p	acute myeloid leukemia	up	miR-382-5p modulates the ATRA-induced differentiation of acute promyelocytic leukemia by targeting tumor suppressor PTEN.
hsa-mir-382-5p	esophageal adenocarcinoma	up	Profiling of circulating microRNAs in patients with Barrett's esophagus and esophageal adenocarcinoma.
hsa-mir-382-5p	glioma	down	The role of miR-382-5p in glioma cell proliferation, migration and invasion.
hsa-mir-383	breast cancer	down	MicroRNA-383 Regulates the Apoptosis of Tumor Cells through Targeting Gadd45g.
hsa-mir-383	cholangiocarcinoma	up	miR-383 promotes cholangiocarcinoma cell proliferation, migration, and invasion through targeting IRF1.
hsa-mir-383	colon cancer	down	MicroRNA-383 acts as a tumor suppressor in colorectal cancer by modulating CREPT/RPRD1B expression.
hsa-mir-383	colon cancer	down	Upregulation of microRNA-383 inhibits the proliferation, migration and invasion of colon cancer cells.
hsa-mir-383	colorectal cancer	down	MicroRNA-383 suppresses cell proliferation and invasion in colorectal cancer by directly targeting paired box 6.
hsa-mir-383	gastric cancer	down	miR-383 Inhibited the Cell Cycle Progression of Gastric Cancer Cells via Targeting Cyclin E2.
hsa-mir-383	glioma	down	Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor.
hsa-mir-383	glioma	down	MicroRNA-383 inhibits anchorage-independent growth and induces cell cycle arrest of glioma cells by targeting CCND1.
hsa-mir-383	glioma	down	MicroRNA-383 expression regulates proliferation, migration, invasion, and apoptosis in human glioma cells.
hsa-mir-383	hepatocellular carcinoma	down	miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
hsa-mir-383	lung cancer	down	MicroRNA-383 is a tumor suppressor in human lung cancer by targeting endothelial PAS domain-containing protein 1.
hsa-mir-383	medulloblastoma	down	MiR-383 is Downregulated in Medulloblastoma and Targets Peroxiredoxin 3 (PRDX3).
hsa-mir-383	non-small cell lung cancer	down	MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.
hsa-mir-383	non-small cell lung cancer	down	microRNA-383 regulates cell viability and apoptosis by mediating Wnt/?-catenin signaling pathway in non-small cell lung cancer.
hsa-mir-383	ovarian cancer	down	miR-383 inhibits ovarian cancer cell proliferation, invasion and aerobic glycolysis by targeting LDHA.
hsa-mir-383-5p	gastric cancer	down	MicroRNA-383-5p inhibits the progression of gastric carcinoma via targeting HDAC9 expression.
hsa-mir-383-5p	ovarian cancer	down	Up-regulation of miR-383-5p suppresses proliferation and enhances chemosensitivity in ovarian cancer cells by targeting TRIM27.
hsa-mir-384	breast cancer	down	MicroRNA-384 inhibits the progression of breast cancer by targeting ACVR1.
hsa-mir-384	colorectal cancer	down	MiR-384 inhibits human colorectal cancer metastasis by targeting KRAS and CDC42.
hsa-mir-384	esophageal squamous cell carcinoma	down	MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma through blockade of the LIMK1/cofilin signaling pathway by binding to LIMK1.
hsa-mir-384	gastric cancer	down	miR-384 targets metadherin gene to suppress growth, migration, and invasion of gastric cancer cells.
hsa-mir-384	glioma	down	CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis.
hsa-mir-384	hepatocellular carcinoma	down	LncRNA CRNDE promotes hepatic carcinoma cell proliferation, migration and invasion by suppressing miR-384.
hsa-mir-384	hepatocellular carcinoma	down	Long noncoding RNA NEAT1 promotes cell proliferation, migration, and invasion in hepatocellular carcinoma through interacting with miR-384.
hsa-mir-384	hepatocellular carcinoma	down	MiR-384 regulated IRS1 expression and suppressed cell proliferation of human hepatocellular carcinoma.
hsa-mir-384	hepatocellular carcinoma	down	Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma.
hsa-mir-384	non-small cell lung cancer	down	MicroRNA-384 represses the growth and invasion of non-small-cell lung cancer by targeting astrocyte elevated gene-1/Wnt signaling.
hsa-mir-384	papillary thyroid carcinoma	down	LncRNA CRNDE promotes cell proliferation, invasion and migration by competitively binding miR-384 in papillary thyroid cancer.
hsa-mir-384	renal cell carcinoma	down	MicroRNA-384 Inhibits the Growth and Invasion of Renal Cell Carcinoma Cells by Targeting Astrocyte Elevated Gene 1.
hsa-mir-384	renal cell carcinoma	down	miR-384 suppressed renal cell carcinoma cell proliferation and migration through targeting RAB23.
hsa-mir-3908	glioblastoma	down	AdipoR1-mediated miR-3908 inhibits glioblastoma tumorigenicity through downregulation of STAT2 associated with the AMPK/SIRT1 pathway.
hsa-mir-3910	hepatocellular carcinoma	up	MiR-3910 Promotes the Growth and Migration of Cancer Cells in the Progression of Hepatocellular Carcinoma.
hsa-mir-3928	osteosarcoma	down	Down-Regulation of miR-3928 Promoted Osteosarcoma Growth.
hsa-mir-3934-5p	non-small cell lung cancer	up	Downregulation of miR-3934-5p enhances A549 cell sensitivity to cisplatin by targeting TP53INP1.
hsa-mir-3940-5p	non-small cell lung cancer	down	miR-3940-5p Functions as a Tumor Suppressor in Non-Small Cell Lung Cancer Cells by Targeting Cyclin D1 and Ubiquitin Specific Peptidase-28.
hsa-mir-409-3p	bladder cancer	down	MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met.
hsa-mir-409-3p	breast cancer	down	miR-409-3p suppresses breast cancer cell growth and invasion by targeting Akt1.
hsa-mir-409-3p	cervical carcinoma	down	MicroRNA-409 inhibits the proliferative ability of cervical carcinoma cells by regulating AKT.
hsa-mir-409-3p	colon cancer	down	miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy.
hsa-mir-409-3p	colorectal cancer	down	MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression.
hsa-mir-409-3p	colorectal cancer	down	Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine.
hsa-mir-409-3p	gastric cancer	down	MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers.
hsa-mir-409-3p	gastric cancer	down	MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer.
hsa-mir-409-3p	glioma	down	MicroRNA-409-3p Represses Glioma Cell Invasion and Proliferation by Targeting High-mobility Group Nucleosome Binding Domain 5.
hsa-mir-409-3p	lung adenocarcinoma	down	MicroRNA-409-3p functions as a tumor suppressor in human lung adenocarcinoma by targeting c-Met.
hsa-mir-409-3p	osteosarcoma	down	MiR-409-3p regulates cell proliferation and tumor growth by targeting E74-like factor 2 in osteosarcoma.
hsa-mir-409-3p	osteosarcoma	down	MicroRNA-409-3p inhibits osteosarcoma cell migration and invasion by targeting catenin-?1.
hsa-mir-409-3p	ovarian cancer	down	Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
hsa-mir-409-3p	papillary thyroid carcinoma	down	MicroRNA-409-3p suppresses cell proliferation and cell cycle progression by targeting cyclin D2 in papillary thyroid carcinoma.
hsa-mir-410	acute lymphoblastic leukemia	up	MiR-410 regulates malignant biological behavior of pediatric acute lymphoblastic leukemia through targeting FKBP5 and Akt signaling pathway.
hsa-mir-410	colon cancer	up	Long noncoding RNA CCAT1 functions as a ceRNA to antagonize the effect of miR-410 on the down-regulation of ITPKB in human HCT-116 and HCT-8 cells.
hsa-mir-410	colorectal cancer	up	miR-410 acts as an oncogene in colorectal cancer cells by targeting dickkopf-related protein 1 via the Wnt/?-catenin signaling pathway.
hsa-mir-410	gastric cancer	down	MicroRNA-410 Suppresses Migration and Invasion by Targeting MDM2 in Gastric Cancer.
hsa-mir-410	glioma	down	Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410.
hsa-mir-410	non-small cell lung cancer	up	MicroRNA-410 promotes cell proliferation by targeting BRD7 in non-small cell lung cancer.
hsa-mir-410	oral squamous cell carcinoma	down	Downregulated miR-329 and miR-410 promote the proliferation and invasion of oral squamous cell carcinoma by targeting Wnt-7b.
hsa-mir-410	pancreatic cancer	down	MicroRNA-410 functions as a tumor suppressor by targeting angiotensin II type 1 receptor in pancreatic cancer.
hsa-mir-410-3p	breast cancer	down	miR-410-3p suppresses breast cancer progression by targeting Snail.
hsa-mir-410-3p	prostate cancer	down	miR-410-3p promotes prostate cancer progression via regulating PTEN/AKT/mTOR signaling pathway.
hsa-mir-411	cervical cancer	down	MicroRNA-411 inhibits cervical cancer progression by directly targeting STAT3.
hsa-mir-411	colorectal cancer	down	MicroRNA-411 inhibits malignant biological behaviours of colorectal cancer cells by directly targeting PIK3R3.
hsa-mir-411	gastric cancer	down	MiR-411 inhibits gastric cancer proliferation and migration through targeting SETD6.
hsa-mir-411	lung cancer	up	miR-411 contributes the cell proliferation of lung cancer by targeting FOXO1.
hsa-mir-411	osteosarcoma	up	MicroRNA-411 promoted the osteosarcoma progression by suppressing MTSS1 expression.
hsa-mir-411	ovarian cancer	down	Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
hsa-mir-411	renal cell carcinoma	down	MiR-411 functions as a tumor suppressor in renal cell cancer.
hsa-mir-411-5p	breast cancer	down	miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2.
hsa-mir-421	breast cancer	down	MicroRNA-421 inhibits breast cancer metastasis by targeting metastasis associated 1.
hsa-mir-421	gastric cancer	up	MicroRNA-421 regulated by HIF-1? promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer.
hsa-mir-421	gastric cancer	up	MicroRNA-421 promotes the proliferation and metastasis of gastric cancer cells by targeting claudin-11.
hsa-mir-421	gastric cancer	up	Increased expression of miR-421 in human gastric carcinoma and its clinical association.
hsa-mir-421	gastric cancer	up	MiR-421 regulates apoptosis of BGC-823 gastric cancer cells by targeting caspase-3.
hsa-mir-421	gastric cancer	up	MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer.
hsa-mir-421	glioma	down	MiR-421 inhibits the malignant phenotype in glioma by directly targeting MEF2D.
hsa-mir-421	nasopharyngeal carcinoma	up	miR-421 induces cell proliferation and apoptosis resistance in human nasopharyngeal carcinoma via downregulation of FOXO4.
hsa-mir-421	neuroblastoma	up	Downregulation of tumor suppressor menin by miR-421 promotes proliferation and migration of neuroblastoma.
hsa-mir-421	non-small cell lung cancer	up	Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer.
hsa-mir-421	non-small cell lung cancer	up	MicroRNA-421 promotes proliferation and invasion of non-small cell lung cancer cells through targeting PDCD4.
hsa-mir-421	osteosarcoma	up	miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.
hsa-mir-421	prostate cancer	down	A transcriptional target of androgen receptor, miR-421 regulates proliferation and metabolism of prostate cancer cells.
hsa-mir-422a	colorectal cancer	down	MiR-422a targets MAPKK6 and regulates cell growth and apoptosis in colorectal cancer cells.
hsa-mir-422a	colorectal cancer	down	miR-422a inhibits cell proliferation in colorectal cancer by targeting AKT1 and MAPK1.
hsa-mir-422a	colorectal cancer	down	Identification and functional screening of microRNAs highly deregulated in colorectal cancer.
hsa-mir-422a	colorectal cancer	down	miR-422a is an independent prognostic factor and functions as a potential tumor suppressor in colorectal cancer.
hsa-mir-422a	glioblastoma	down	MiR-422a acts as a tumor suppressor in glioblastoma by targeting PIK3CA.
hsa-mir-422a	glioma	down	miR-422a Inhibits Glioma Proliferation and Invasion by Targeting IGF1 and IGF1R.
hsa-mir-422a	head and neck squamous cell carcinoma	down	MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma.
hsa-mir-422a	hepatocellular carcinoma	down	A double-negative feedback loop between MicroRNA-422a and FOXG1/Q1/E1 regulates hepatocellular carcinoma tumor growth and metastasis.
hsa-mir-422a	non-small cell lung cancer	down	MicroRNA-422a functions as a tumor suppressor in non-small cell lung cancer through SULF2-mediated TGF-?/SMAD signaling pathway.
hsa-mir-422a	osteosarcoma	down	Tissue expression levels of miR-29b and miR-422a in children, adolescents, and young adults' age groups and their association with prediction of poor prognosis in human osteosarcoma.
hsa-mir-422a	osteosarcoma	down	miR-422a inhibits osteosarcoma proliferation by targeting BCL2L2 and KRAS.
hsa-mir-422a	thyroid cancer	down	Iodine Promotes Tumorigenesis of Thyroid Cancer by Suppressing Mir-422a and Up-Regulating MAPK1.
hsa-mir-423	breast cancer	up	Genetic analysis and preliminary function study of miR-423 in breast cancer.
hsa-mir-423	hepatocellular carcinoma	up	MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma.
hsa-mir-423-3p	colorectal cancer	up	MiR-423-3p Enhances Cell Growth Through Inhibition of p21Cip1/Waf1 in Colorectal Cancer.
hsa-mir-423-3p	glioma	up	MicroRNA-423-3p promotes glioma growth by targeting PANX2.
hsa-mir-423-3p	laryngeal carcinoma	up	microRNA-423-3p promotes tumor progression via modulation of AdipoR2 in laryngeal carcinoma.
hsa-mir-423-3p	lung cancer	up	Overexpression of microRNA-423-3p indicates poor prognosis and promotes cell proliferation, migration, and invasion of lung cancer.
hsa-mir-423-5p	colon cancer	down	MicroRNA-423-5p inhibits colon cancer growth by promoting caspase-dependent apoptosis.
hsa-mir-423-5p	colorectal cancer	down	Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
hsa-mir-423-5p	glioma	up	miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
hsa-mir-423-5p	hepatocellular carcinoma	up	Long Non-coding RNA FENDRR Acts as a miR-423-5p Sponge to Suppress the Treg-Mediated Immune Escape of Hepatocellular Carcinoma Cells.
hsa-mir-423-5p	non-small cell lung cancer	up	MiR-423-5p in brain metastasis: potential role in diagnostics and molecular biology.
hsa-mir-423-5p	oral cancer	up	A Three-MicroRNA Signature as a Potential Biomarker for the Early Detection of Oral Cancer.
hsa-mir-423-5p	osteosarcoma	down	miR-423-5p Inhibits Osteosarcoma Proliferation and Invasion Through Directly Targeting STMN1.
hsa-mir-423-5p	ovarian cancer	down	miR-423-5p serves as a diagnostic indicator and inhibits the proliferation and invasion of ovarian cancer.
hsa-mir-424	acute myeloid leukemia	down	MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1.
hsa-mir-424	bladder cancer	down	DNMT1-dependent suppression of microRNA424 regulates tumor progression in human bladder cancer.
hsa-mir-424	cervical cancer	down	Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer.
hsa-mir-424	chronic lymphocytic leukemia	down	miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in chronic lymphocytic leukemia.
hsa-mir-424	chronic myelogenous leukemia	up	Restoration of miR-424 suppresses BCR-ABL activity and sensitizes CML cells to imatinib treatment.
hsa-mir-424	colon cancer	down	MiR-424/503-Mediated Rictor Upregulation Promotes Tumor Progression.
hsa-mir-424	colorectal cancer	up	Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
hsa-mir-424	colorectal cancer	down	miR-424 targets AKT3 and PSAT1 and has a tumor-suppressive role in human colorectal cancer.
hsa-mir-424	endometrial cancer	down	MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7.
hsa-mir-424	endometrial cancer	down	MicroRNA-424 suppresses estradiol-induced cell proliferation via targeting GPER in endometrial cancer cells.
hsa-mir-424	endometrial cancer	down	MicroRNA-424 regulates epithelial-mesenchymal transition of endometrial carcinoma by directly targeting insulin-like growth factor 1 receptor.
hsa-mir-424	esophageal cancer	down	miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation.
hsa-mir-424	esophageal squamous cell carcinoma	up	miR-424 coordinates multilayered regulation of cell cycle progression to promote esophageal squamous cell carcinoma cell proliferation.
hsa-mir-424	glioma	down	MicroRNA-424 inhibits cell migration, invasion and epithelial-mesenchymal transition in human glioma by targeting KIF23 and functions as a novel prognostic predictor.
hsa-mir-424	glioma	down	MiR-424 functions as a tumor suppressor in glioma cells and is down-regulated by DNA methylation.
hsa-mir-424	hepatocellular carcinoma	down	Decreased expression of serum miR-424 correlates with poor prognosis of patients with hepatocellular carcinoma.
hsa-mir-424	hepatocellular carcinoma	down	MicroRNA-424 is down-regulated in hepatocellular carcinoma and suppresses cell migration and invasion through c-Myb.
hsa-mir-424	hepatocellular carcinoma	down	MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma.
hsa-mir-424	non-small cell lung cancer	up	MiR-424 Promotes Non-Small Cell Lung Cancer Progression and Metastasis through Regulating the Tumor Suppressor Gene TNFAIP1.
hsa-mir-424	osteosarcoma	down	Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase.
hsa-mir-424	osteosarcoma	down	The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression.
hsa-mir-424	ovarian cancer	up	MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.
hsa-mir-424-3p	non-small cell lung cancer	down	Loss of MiR-424-3p, not miR-424-5p, confers chemoresistance through targeting YAP1 in non-small cell lung cancer.
hsa-mir-424-5p	esophageal squamous cell carcinoma	down	MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT.
hsa-mir-424-5p	gastric cancer	up	miR-424-5p promotes proliferation of gastric cancer by targeting Smad3 through TGF-? signaling pathway.
hsa-mir-424-5p	hepatocellular carcinoma	down	MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
hsa-mir-424-5p	hepatocellular carcinoma	down	MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression.
hsa-mir-424-5p	intrahepatic cholangiocarcinoma	down	miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5.
hsa-mir-424-5p	liver cancer	down	miR-424-5p Regulates Hepatoma Cell Proliferation and Apoptosis.
hsa-mir-424-5p	ovarian cancer	down	Clinical Impact of microRNAs Associated With Cancer Stem Cells as a Prognostic Factor in Ovarian Carcinoma.
hsa-mir-424-5p	pancreatic cancer	up	MicroRNA-424-5p Suppresses the Expression of SOCS6 in Pancreatic Cancer.
hsa-mir-425	breast cancer	down	Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status.
hsa-mir-425	esophageal squamous cell carcinoma	up	Enhanced Expression of miR-425 Promotes Esophageal Squamous Cell Carcinoma Tumorigenesis by Targeting SMAD2.
hsa-mir-425	gastric cancer	up	NF-kappaB-dependent MicroRNA-425 upregulation promotes gastric cancer cell growth by targeting PTEN upon IL-1? induction.
hsa-mir-425	lung adenocarcinoma	down	MicroRNA-425 promotes the development of lung adenocarcinoma via targeting A disintegrin and metalloproteinases 9 (ADAM9).
hsa-mir-425	malignant melanoma	down	miR-425 inhibits melanoma metastasis through repression of PI3K-Akt pathway by targeting IGF-1.
hsa-mir-425	nasopharyngeal carcinoma	down	MicroRNA-425 is downregulated in nasopharyngeal carcinoma and regulates tumor cell viability and invasion by targeting hepatoma-derived growth factor.
hsa-mir-425-5p	acute myeloid leukemia	down	Micro-RNA Profiling of Exosomes from Marrow-Derived Mesenchymal Stromal Cells in Patients with Acute Myeloid Leukemia: Implications in Leukemogenesis.
hsa-mir-425-5p	cervical cancer	up	MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
hsa-mir-425-5p	cervical cancer	up	Downregulation of microRNA-425-5p suppresses cervical cancer tumorigenesis by targeting AIFM1.
hsa-mir-425-5p	colorectal cancer	up	A panel of microRNA signature in serum for colorectal cancer diagnosis.
hsa-mir-425-5p	gastric cancer	up	MiR-425-5p promotes tumor progression via modulation of CYLD in gastric cancer.
hsa-mir-425-5p	gastric cancer	up	microRNA-425-5p is upregulated in human gastric cancer and contributes to invasion and metastasis in vitro and in vivo.
hsa-mir-425-5p	gastric cancer	up	Clinical value of miR-425-5p detection and its association with cell proliferation and apoptosis of gastric cancer.
hsa-mir-425-5p	osteosarcoma	down	miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt/?-catenin signaling pathway.
hsa-mir-425-5p	renal cell carcinoma	up	Oncogenic miR-425-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
hsa-mir-4260	colorectal cancer	up	Therapeutic Inhibition of miR-4260 Suppresses Colorectal Cancer via Targeting MCC and SMAD4.
hsa-mir-4261	colorectal cancer	up	Therapeutic Suppression of miR-4261 Attenuates Colorectal Cancer by Targeting MCC.
hsa-mir-4262	hepatocellular carcinoma	up	MicroRNA-4262 activates the NF-?B and enhances the proliferation of hepatocellular carcinoma cells.
hsa-mir-4262	non-small cell lung cancer	up	Involvement of miR-4262 in paclitaxel resistance through the regulation of PTEN in non-small cell lung cancer.
hsa-mir-4268	gastric cancer	down	MicroRNA-4268 inhibits cell proliferation via AKT/JNK signalling pathways by targeting Rab6B in human gastric cancer.
hsa-mir-4270	non-small cell lung cancer	up	LINC00472 Acts as a Tumor Suppressor in NSCLC through KLLN-Mediated p53-Signaling Pathway via MicroRNA-149-3p and MicroRNA-4270.
hsa-mir-4282	breast cancer	down	MiR-4282 inhibits proliferation, invasion and metastasis of human breast cancer by targeting Myc.
hsa-mir-4282	colorectal carcinoma	down	MiR-4282 suppresses proliferation and mobility of human colorectal carcinoma cells by targeting semaphorin 3E.
hsa-mir-4286	esophageal carcinoma	up	MicroRNA-4286 promotes esophageal carcinoma development by targeting INPP4A to evoke the JAK2/STAT3 pathway activation.
hsa-mir-4286	non-small cell lung cancer	up	MicroRNA-4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non-small cell lung cancer.
hsa-mir-429	astrocytoma	down	miRNA-429 Inhibits Astrocytoma Proliferation and Invasion by Targeting BMI1.
hsa-mir-429	bladder cancer	up	Hsa-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2B.
hsa-mir-429	bladder cancer	down	Expression of microRNAs in the Urine of Patients With Bladder Cancer.
hsa-mir-429	breast cancer	up	Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.
hsa-mir-429	breast cancer	down	miR-429 inhibits migration and invasion of breast cancer cells in vitro.
hsa-mir-429	cervical cancer	down	miR-429 is involved in regulation of NF-?B activity by targeting IKK? and suppresses oncogenic activity in cervical cancer cells.
hsa-mir-429	colon cancer	down	MicroRNA-429 inhibits the migration and invasion of colon cancer cells by targeting PAK6/cofilin signaling.
hsa-mir-429	colorectal cancer	up	MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2.
hsa-mir-429	colorectal cancer	down	MiR-200 suppresses metastases of colorectal cancer through ZEB1.
hsa-mir-429	colorectal cancer	up	Effect of evodiamine and berberine on miR-429 as an oncogene in human colorectal cancer.
hsa-mir-429	colorectal cancer	up	miR-429 mediates tumor growth and metastasis in colorectal cancer.
hsa-mir-429	colorectal carcinoma	down	miR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma.
hsa-mir-429	gastric cancer	down	miR-429 modulates the expression of c-myc in human gastric carcinoma cells.
hsa-mir-429	gastric cancer	up	Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.
hsa-mir-429	gastric cancer	down	MicroRNA-429 inhibits gastric cancer migration and invasion through the downregulation of specificity protein 1.
hsa-mir-429	gastric cancer	down	MiR-429 Induces Gastric Carcinoma Cell Apoptosis Through Bcl-2.
hsa-mir-429	gastric cancer	down	MiR-429 regulates gastric cancer cell invasiveness through ZEB proteins.
hsa-mir-429	gastric cancer	down	miR-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells.
hsa-mir-429	glioblastoma	down	MiR-429 suppresses glioblastoma multiforme by targeting SOX2.
hsa-mir-429	glioblastoma	down	MiR-429 induces apoptosis of glioblastoma cell through Bcl-2.
hsa-mir-429	glioma	down	miR-429 inhibits glioma invasion through BMK1 suppression.
hsa-mir-429	glioma	up	The Potential Prognostic Value of MicroRNA-429 for Human Gliomas.
hsa-mir-429	hepatocellular carcinoma	down	MiR-429 regulates the metastasis and EMT of HCC cells through targeting RAB23.
hsa-mir-429	hepatocellular carcinoma	down	miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition.
hsa-mir-429	hepatocellular carcinoma	up	MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis.
hsa-mir-429	hepatocellular carcinoma	up	Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4.
hsa-mir-429	hepatocellular carcinoma	down	Upregulated microRNA-429 inhibits the migration of HCC cells by targeting TRAF6 through the NF-?B pathway.
hsa-mir-429	lung adenocarcinoma	down	miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.
hsa-mir-429	lung cancer	up	MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.
hsa-mir-429	malignant melanoma	up	MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion.
hsa-mir-429	malignant melanoma	down	MicroRNA-429 inhibits cancer cell proliferation and migration by targeting the AKT1 in melanoma.
hsa-mir-429	mesenchymal cancer	down	MicroRNA Expression Profiles in Kaposi's Sarcoma.
hsa-mir-429	nasopharyngeal carcinoma	down	miR-429 suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma by downregulation of TLN1.
hsa-mir-429	nephroblastoma	down	MiR-429 regulates the proliferation and apoptosis of nephroblastoma cells through targeting c-myc.
hsa-mir-429	non-small cell lung cancer	down	Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer.
hsa-mir-429	oral cancer	down	Grainyhead-like 2 regulates epithelial plasticity and stemness in oral cancer cells.
hsa-mir-429	oral squamous cell carcinoma	down	MiR-429 inhibits oral squamous cell carcinoma growth by targeting ZEB1.
hsa-mir-429	oral squamous cell carcinoma	down	QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.
hsa-mir-429	osteosarcoma	down	Tumor-Suppressing Effects of miR-429 on Human Osteosarcoma.
hsa-mir-429	osteosarcoma	down	MiR-429 suppresses the progression and metastasis of osteosarcoma by targeting ZEB1.
hsa-mir-429	ovarian cancer	up	The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition.
hsa-mir-429	ovarian cancer	down	A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
hsa-mir-429	ovarian cancer	down	Ectopic over-expression of miR-429 induces mesenchymal-to-epithelial transition (MET) and increased drug sensitivity in metastasizing ovarian cancer cells.
hsa-mir-429	pancreatic ductal adenocarcinoma	down	MiR-429 suppresses neurotrophin-3 to alleviate perineural invasion of pancreatic cancer.
hsa-mir-429	prostate cancer	up	Downregulation of microRNA-429 inhibits cell proliferation by targeting p27Kip1 in human prostate cancer cells.
hsa-mir-429	renal cell carcinoma	down	MicroRNA-429 suppresses cell proliferation, epithelial-mesenchymal transition, and metastasis by direct targeting of BMI1 and E2F3 in renal cell carcinoma.
hsa-mir-4295	anaplastic thyroid carcinoma	up	miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1A.
hsa-mir-4295	bladder cancer	up	MiR-4295 promotes cell growth in bladder cancer by targeting BTG1.
hsa-mir-4295	bladder cancer	up	Erratum: MiR-4295 promotes cell growth in bladder cancer by targeting BTG1.
hsa-mir-4295	gastric cancer	up	Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
hsa-mir-4295	glioma	up	RUNX3 is down-regulated in glioma by Myc-regulated miR-4295.
hsa-mir-4299	non-small cell lung cancer	down	MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway.
hsa-mir-4301	breast cancer	down	A novel report of MiR-4301 induces cell apoptosis by negatively regulating DRD2 expression in human breast cancer cells.
hsa-mir-4301	lung cancer	down	An Inventive Report of Inducing Apoptosis in Non-Small Cell Lung Cancer (NSCLC) Cell Lines by Transfection of MiR-4301.
hsa-mir-4301	nasopharyngeal carcinoma	down	Long Noncoding RNA HOTTIP Promotes Nasopharyngeal Cancer Cell Proliferation, Migration, and Invasion by Inhibiting miR-4301.
hsa-mir-431	colorectal cancer	down	MiR-431 inhibits colorectal cancer cell invasion via repressing CUL4B.
hsa-mir-431	colorectal cancer	down	MiR-431 inhibits colorectal cancer cell invasion via repressing CUL4B.
hsa-mir-431	hepatocellular carcinoma	down	MicroRNA-431 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the ZEB1-mediated epithelial-mensenchymal transition.
hsa-mir-431	lung cancer	down	MiR-431 suppresses proliferation and metastasis of lung cancer via down-regulating DDX5.
hsa-mir-431	malignant melanoma	down	MiR-431 is a prognostic marker and suppresses cell growth, migration and invasion by targeting NOTCH2 in melanoma.
hsa-mir-431	pancreatic cancer	down	MiR-431 inhibits cell proliferation and induces cell apoptosis by targeting CDK14 in pancreatic cancer.
hsa-mir-431	papillary thyroid carcinoma	down	Downregulation of MiR-431 expression associated with lymph node metastasis and promotes cell invasion in papillary thyroid carcinoma.
hsa-mir-431-5p	hepatocellular carcinoma	down	miR-431-5p alters the epithelial-to-mesenchymal transition markers by targeting UROC28 in hepatoma cells.
hsa-mir-4316	papillary thyroid carcinoma	down	DNA copy number gain-mediated lncRNA LINC01061 upregulation predicts poor prognosis and promotes papillary thyroid cancer progression.
hsa-mir-4317	gastric cancer	down	Clinicopathological and prognostic significance of miR-4317 expression in gastric cancer patients.
hsa-mir-4317	gastric cancer	down	miRNA-4317 Suppresses Human Gastric Cancer Cell Proliferation by Targeting ZNF322.
hsa-mir-4317	non-small cell lung cancer	down	miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).
hsa-mir-4319	colorectal cancer	down	MiR-4319 suppresses colorectal cancer progression by targeting ABTB1.
hsa-mir-432	cervical cancer	down	MicroRNA-432 is downregulated in cervical cancer and directly targets FN1 to inhibit cell proliferation and invasion.
hsa-mir-432	lung adenocarcinoma	down	MicroRNA-432 functions as a tumor suppressor gene through targeting E2F3 and AXL in lung adenocarcinoma.
hsa-mir-432	osteosarcoma	down	MicroRNA-432 is downregulated in osteosarcoma and inhibits cell proliferation and invasion by directly targeting metastasis-associated in colon cancer-1.
hsa-mir-432	ovarian cancer	down	Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
hsa-mir-432-3p	esophageal squamous cell carcinoma	up	miR-432 Induces NRF2 Stabilization by Directly Targeting KEAP1.
hsa-mir-432-5p	bladder cancer	up	Down-regulated RBM5 inhibits bladder cancer cell apoptosis by initiating an miR-432-5p/?-catenin feedback loop.
hsa-mir-4326	lung cancer	up	miR-4326 promotes lung cancer cell proliferation through targeting tumor suppressor APC2.
hsa-mir-4328	mucinous cystadenocarcinoma	down	Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.
hsa-mir-433	breast cancer	down	miR-433 inhibits breast cancer cell growth via the MAPK signaling pathway by targeting Rap1a.
hsa-mir-433	breast cancer	down	MicroRNA-433 targets AKT3 and inhibits cell proliferation and viability in breast cancer.
hsa-mir-433	cervical cancer	down	MicroRNA-433 inhibits cervical cancer progression by directly targeting metadherin to regulate the AKT and ?-catenin signalling pathways.
hsa-mir-433	colon cancer	down	MicroRNA-433 Represses Proliferation and Invasion of Colon Cancer Cells by Targeting Homeobox A1.
hsa-mir-433	colorectal cancer	down	A CREB1/miR-433 reciprocal feedback loop modulates proliferation and metastasis in colorectal cancer.
hsa-mir-433	colorectal cancer	down	Reduced miR-433 expression is associated with advanced stages and early relapse of colorectal cancer and restored miR-433 expression suppresses the migration, invasion and proliferation of tumor cells
hsa-mir-433	colorectal cancer	down	miR-433 reduces cell viability and promotes cell apoptosis by regulating MACC1 in colorectal cancer.
hsa-mir-433	gastric cancer	down	Down-regulated miR-9 and miR-433 in human gastric carcinoma.
hsa-mir-433	gastric cancer	down	The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer.
hsa-mir-433	hepatocellular carcinoma	down	MicroRNA-433 inhibits cell proliferation in hepatocellular carcinoma by targeting p21 activated kinase (PAK4).
hsa-mir-433	liver cancer	down	The microRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element binding protein.
hsa-mir-433	non-small cell lung cancer	down	miR-433 suppresses tumor progression via Smad2 in non-small cell lung cancer.
hsa-mir-433	oral squamous cell carcinoma	down	MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK.
hsa-mir-433	oral squamous cell carcinoma	down	miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6.
hsa-mir-433	osteosarcoma	up	MicroRNA-433 regulates apoptosis by targeting PDCD4 in human osteosarcoma cells.
hsa-mir-433	ovarian cancer	down	MicroRNA-433 inhibits migration and invasion of ovarian cancer cells via targeting Notch1.
hsa-mir-433	retinoblastoma	down	MiR-433 inhibits retinoblastoma malignancy by suppressing Notch1 and PAX6 expression.
hsa-mir-433-3p	glioma	down	MiR-433-3p suppresses cell growth and enhances chemosensitivity by targeting CREB in human glioma.
hsa-mir-4417	hepatocellular carcinoma	up	miR-4417 Targets Tripartite Motif-Containing 35 (TRIM35) and Regulates Pyruvate Kinase Muscle 2 (PKM2) Phosphorylation to Promote Proliferation and Suppress Apoptosis in Hepatocellular Carcinoma Cells
hsa-mir-4423	lung cancer	up	MicroRNA 4423 is a primate-specific regulator of airway epithelial cell differentiation and lung carcinogenesis.
hsa-mir-4429	papillary thyroid carcinoma	down	Long noncoding RNA LINC00313 modulates papillary thyroid cancer tumorigenesis via sponging miR-4429.
hsa-mir-4443	osteosarcoma	down	Long non-coding RNA FEZF1-AS1 promotes osteosarcoma progression by regulating miR-4443/NUPR1 axis.
hsa-mir-4443	ovarian cancer	down	Downregulation of miR-4443 and miR-5195-3p in ovarian cancer tissue contributes to metastasis and tumorigenesis.
hsa-mir-4455	gastric cancer	down	Vasodilator-stimulated phosphoprotein (VASP), a novel target of miR-4455, promotes gastric cancer cell proliferation, migration, and invasion, through activating the PI3K/AKT signaling pathway.
hsa-mir-4458	breast cancer	down	miR-4458 inhibits breast cancer cell growth, migration, and invasion by targeting CPSF4.
hsa-mir-4458	colon cancer	down	miR-4458 suppresses glycolysis and lactate production by directly targeting hexokinase2 in colon cancer cells.
hsa-mir-4458	hepatocellular carcinoma	down	Tumor-suppressing effect of miR-4458 on human hepatocellular carcinoma.
hsa-mir-4458	non-small cell lung cancer	down	MicroRNA-4458 suppresses migration and epithelial-mesenchymal transition via targeting HMGA1 in non-small-cell lung cancer cells.
hsa-mir-4465	non-small cell lung cancer	down	MicroRNA-4465 suppresses tumor proliferation and metastasis in non-small cell lung cancer by directly targeting the oncogene EZH2.
hsa-mir-4469	breast cancer	up	CDK3, target of miR-4469, suppresses breast cancer metastasis via inhibiting Wnt/?-catenin pathway.
hsa-mir-448	breast cancer	down	miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
hsa-mir-448	colorectal cancer	down	miR-448 suppresses proliferation and invasion by regulating IGF1R in colorectal cancer cells.
hsa-mir-448	gastric cancer	down	miR-448 suppressed gastric cancer proliferation and invasion by regulating ADAM10.
hsa-mir-448	gastric cancer	up	MiR-448 promotes glycolytic metabolism of gastric cancer by downregulating KDM2B.
hsa-mir-448	glioma	down	Effect of glycolysis inhibition by miR-448 on glioma radiosensitivity.
hsa-mir-448	hepatocellular carcinoma	down	miRNA-448 inhibits cell growth by targeting BCL-2 in hepatocellular carcinoma.
hsa-mir-448	hepatocellular carcinoma	down	Low Expression of miR-448 Induces EMT and Promotes Invasion by Regulating ROCK2 in Hepatocellular Carcinoma.
hsa-mir-448	lung squamous cell carcinoma	down	miR-448 is a novel prognostic factor of lung squamous cell carcinoma and regulates cells growth and metastasis by targeting DCLK1.
hsa-mir-448	non-small cell lung cancer	down	microRNA-448 inhibits the progression of non-small-cell lung cancer through regulating IRS2.
hsa-mir-448	osteosarcoma	down	Overexpression of microRNA-448 inhibits osteosarcoma cell proliferation and invasion through targeting of astrocyte elevated gene-1.
hsa-mir-448	osteosarcoma	down	MicroRNA-448 suppresses osteosarcoma cell proliferation and invasion through targeting EPHA7.
hsa-mir-448	ovarian cancer	down	miR-448 negatively regulates ovarian cancer cell growth and metastasis by targeting CXCL12.
hsa-mir-448	pancreatic ductal adenocarcinoma	down	MicroRNA-448 suppresses metastasis of pancreatic ductal adenocarcinoma through targeting JAK1/STAT3 pathway.
hsa-mir-4484	glioblastoma	down	Impact of somatic copy number alterations on the glioblastoma miRNome: miR-4484 is a genomically deleted tumour suppressor.
hsa-mir-4487	colorectal cancer	down	Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer.
hsa-mir-449	gastric cancer	down	miR-449 inhibits cell proliferation and is down-regulated in gastric cancer.
hsa-mir-4493	glioma	down	Circ-ZNF264 Promotes the Growth of Glioma Cells by Upregulating the Expression of miR-4493 Target Gene Apelin.
hsa-mir-4497	laryngeal squamous cell carcinoma	down	MicroRNA-4497 functions as a tumor suppressor in laryngeal squamous cell carcinoma via negatively modulation the GBX2.
hsa-mir-449a	breast cancer	down	MiR-449a suppresses cell migration and invasion by targeting PLAGL2 in breast cancer.
hsa-mir-449a	breast cancer	up	[Effects of miR-449a on proliferation and migration of human breast cancer cell line MCF-7].
hsa-mir-449a	breast cancer	up	MiR-449a promotes breast cancer progression by targeting CRIP2.
hsa-mir-449a	colorectal cancer	down	miR-449a inhibits colorectal cancer progression by targeting SATB2.
hsa-mir-449a	colorectal cancer	down	miR-449a inhibits colorectal cancer progression by targeting SATB2.
hsa-mir-449a	endometrial cancer	down	Suppressive effect of microRNA-449a on the NDRG1/PTEN/AKT axis regulates endometrial cancer growth and metastasis.
hsa-mir-449a	endometrial cancer	down	MiR-449a functions as a tumor suppressor in endometrial cancer by targeting CDC25A.
hsa-mir-449a	endometrial cancer	down	MicroRNA-449a Inhibits Tumor Metastasis through AKT/ERK1/2 Inactivation by Targeting Steroid Receptor Coactivator (SRC) in Endometrial Cancer.
hsa-mir-449a	gastric adenocarcinoma	down	microRNA-449a functions as a tumor-suppressor in gastric adenocarcinoma by targeting Bcl-2.
hsa-mir-449a	gastric cancer	down	miR-449a Regulates Proliferation and Chemosensitivity to Cisplatin by Targeting Cyclin D1 and BCL2 in SGC7901 Cells.
hsa-mir-449a	gastric cancer	down	miR-449a and CDK6 in gastric carcinoma.
hsa-mir-449a	gastric cancer	down	MicroRNA-449a inhibits proliferation and induces apoptosis by directly repressing E2F3 in gastric cancer.
hsa-mir-449a	glioblastoma	down	MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein.
hsa-mir-449a	hepatocellular carcinoma	down	miR-449a inhibits proliferation and invasion by regulating ADAM10 in hepatocellular carcinoma.
hsa-mir-449a	hepatocellular carcinoma	down	Epigenetically regulated miR-449a enhances hepatitis B virus replication by targeting cAMP-responsive element binding protein 5 and modulating hepatocytes phenotype.
hsa-mir-449a	hepatocellular carcinoma	down	Clinical significance of microRNA-449a in hepatocellular carcinoma with microarray data mining together with initial bioinformatics analysis.
hsa-mir-449a	hepatocellular carcinoma	down	MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway.
hsa-mir-449a	liver cancer	down	miR-449a promotes liver cancer cell apoptosis by down-regulation of Calpain6 and POU2F1.
hsa-mir-449a	lung cancer	down	Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer.
hsa-mir-449a	lung cancer	down	MicroRNA-449a inhibits cell growth in lung cancer and regulates long noncoding RNA nuclear enriched abundant transcript 1.
hsa-mir-449a	lung cancer	down	MiR-449a Suppresses LDHA-Mediated Glycolysis to Enhance the Sensitivity of Non-Small Cell Lung Cancer Cells to Ionizing Radiation.
hsa-mir-449a	nasopharyngeal carcinoma	down	MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A.
hsa-mir-449a	neuroblastoma	down	microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest.
hsa-mir-449a	non-small cell lung cancer	down	MicroRNA-449a Is Downregulated in Non-Small Cell Lung Cancer and Inhibits Migration and Invasion by Targeting c-Met.
hsa-mir-449a	non-small cell lung cancer	down	microRNA-449a Suppresses Non-small Cell Lung Cancer.
hsa-mir-449a	non-small cell lung cancer	down	MiR-449a suppresses tumor growth, migration and invasion in non-small cell lung cancer by targeting HMGB1-mediated NF-?B signaling way.
hsa-mir-449a	non-small cell lung cancer	down	MiR-449a suppresses cell invasion by inhibiting MAP2K1 in non-small cell lung cancer.
hsa-mir-449a	osteosarcoma	down	The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression.
hsa-mir-449a	osteosarcoma	down	miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2.
hsa-mir-449a	ovarian cancer	down	MicroRNA-449a reduces cell survival and enhances cisplatin-induced cytotoxicity via downregulation of NOTCH1 in ovarian cancer cells.
hsa-mir-449a	pancreatic cancer	down	MicroRNA-449a functions as a tumor suppressor in pancreatic cancer by the epigenetic regulation of ATDC expression.
hsa-mir-449a	prostate cancer	down	miR-449a targets HDAC-1 and induces growth arrest in prostate cancer.
hsa-mir-449a	prostate cancer	down	miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.
hsa-mir-449b	lung cancer	down	Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer.
hsa-mir-449b	non-small cell lung cancer	down	Inhibitory Effect of MiR-449b on Cancer Cell Growth and Invasion through LGR4 in Non-Small-Cell Lung Carcinoma.
hsa-mir-449b-3p	nasopharyngeal carcinoma	down	Feedback loop in miR-449b-3p/ADAM17/NF-?B promotes metastasis in nasopharyngeal carcinoma.
hsa-mir-449b-5p	breast cancer	down	MicroRNA-449b-5p suppresses the growth and invasion of breast cancer cells via inhibiting CREPT-mediated Wnt/?-catenin signaling.
hsa-mir-449b-5p	nasopharyngeal carcinoma	down	MicroRNA-449b-5p suppresses cell proliferation, migration and invasion by targeting TPD52 in nasopharyngeal carcinoma.
hsa-mir-449c	gastric cancer	down	miR-449c inhibits migration and invasion of gastric cancer cells by targeting PFKFB3.
hsa-mir-449c	gastric cancer	down	MiR-449c inhibits gastric carcinoma growth.
hsa-mir-4500	glioma	down	microRNA-4500 inhibits human glioma cell progression by targeting IGF2BP1.
hsa-mir-4500	non-small cell lung cancer	down	Down-regulation of miR-4500 promoted non-small cell lung cancer growth.
hsa-mir-4500	papillary thyroid carcinoma	down	MiR-4500 Regulates PLXNC1 and Inhibits Papillary Thyroid Cancer Progression.
hsa-mir-450a	hepatocellular carcinoma	down	microRNA-450a targets DNA methyltransferase 3a in hepatocellular carcinoma.
hsa-mir-450a	oral squamous cell carcinoma	up	TNF-?-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility.
hsa-mir-450b-3p	breast cancer	down	Targeting HER3 with miR-450b-3p suppresses breast cancer cells proliferation.
hsa-mir-450b-3p	hepatocellular carcinoma	down	MicroRNA-450b-3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma.
hsa-mir-450b-5p	colorectal cancer	down	miR-450b-5p Suppresses Stemness and the Development of Chemoresistance by Targeting SOX2 in Colorectal Cancer.
hsa-mir-450b-5p	colorectal cancer	up	miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression.
hsa-mir-451	acute myeloid leukemia	up	c-Myc suppresses miR-451?YWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia.
hsa-mir-451	bladder cancer	down	miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT.
hsa-mir-451	bladder cancer	down	miR-451 suppresses bladder cancer cell migration and invasion via directly targeting c-Myc.
hsa-mir-451	breast cancer	down	Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.
hsa-mir-451	breast cancer	down	Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer.
hsa-mir-451	chronic myelogenous leukemia	down	microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-mir-451	colon cancer	down	The tumour suppressor effects and regulation of cancer stem cells by macrophage migration inhibitory factor targeted miR-451 in colon cancer.
hsa-mir-451	colon cancer	down	miR-451 regulates FoxO3 nuclear accumulation through Ywhaz in human colorectal cancer.
hsa-mir-451	colorectal carcinoma	down	MicroRNA-451 Inhibits Growth of Human Colorectal Carcinoma Cells via Downregulation of Pi3k/Akt Pathway.
hsa-mir-451	esophageal carcinoma	down	Effect of miR-451 on the Biological Behavior of the Esophageal Carcinoma Cell Line EC9706.
hsa-mir-451	gastric cancer	down	MiR-451 as a new tumor marker for gastric cancer.
hsa-mir-451	glioma	down	MiRNA-451 plays a role as tumor suppressor in human glioma cells.
hsa-mir-451	glioma	down	MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma.
hsa-mir-451	glioma	down	miRNA-451 inhibits glioma cell proliferation and invasion through the mTOR/HIF-1?/VEGF signaling pathway by targeting CAB39.
hsa-mir-451	glioma	down	miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1.
hsa-mir-451	head and neck squamous cell carcinoma	down	MicoRNA-451 is a novel tumor suppressor via targeting c-myc in head and neck squamous cell carcinomas.
hsa-mir-451	hepatocellular carcinoma	down	miR-451 Inhibits Cell Proliferation in Human Hepatocellular Carcinoma through Direct Suppression of IKK-?
hsa-mir-451	hepatocellular carcinoma	down	miR-451: Potential role as tumor suppressor of human hepatoma cell growth and invasion.
hsa-mir-451	hepatocellular carcinoma	down	MicroRNA-451 regulates activating transcription factor?2 expression and inhibits liver cancer cell migration.
hsa-mir-451	hepatocellular carcinoma	down	MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
hsa-mir-451	lung adenocarcinoma	down	Acquisition of radioresistance in docetaxel-resistant human lung adenocarcinoma cells is linked with dysregulation of miR-451/c-Myc-survivin/rad-51 signaling.
hsa-mir-451	mucinous cystadenocarcinoma	up	Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.
hsa-mir-451	nasopharyngeal carcinoma	down	MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma.
hsa-mir-451	non-small cell lung cancer	down	MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).
hsa-mir-451	non-small cell lung cancer	down	The expression and function of miRNA-451 in non-small cell lung cancer.
hsa-mir-451	non-small cell lung cancer	down	Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
hsa-mir-451	non-small cell lung cancer	down	LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis.
hsa-mir-451	osteosarcoma	down	Tumor-Suppressing Effects of miR451 in Human Osteosarcoma.
hsa-mir-451	osteosarcoma	down	MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients
hsa-mir-451	osteosarcoma	down	Suppression of liver receptor homolog-1 by microRNA-451 represses the proliferation of osteosarcoma cells.
hsa-mir-451	osteosarcoma	down	miR-451 inhibits cell growth, migration and angiogenesis in human osteosarcoma via down-regulating IL 6R.
hsa-mir-451	pancreatic cancer	up	MiR-451 Promotes Cell Proliferation and Metastasis in Pancreatic Cancer through Targeting CAB39.
hsa-mir-451	papillary thyroid carcinoma	down	MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
hsa-mir-451	renal cell carcinoma	down	microRNA-451 inhibited cell proliferation, migration and invasion through regulation of MIF in renal cell carcinoma.
hsa-mir-4513	breast cancer	up	miR-4513 promotes breast cancer progression through targeting TRIM3.
hsa-mir-4513	gastric cancer	up	miR-4513 promotes gastric cancer cell proliferation and epithelial-mesenchymal transition through targeting KAT6B.
hsa-mir-451a	acute myeloid leukemia	up	MicroRNA expression profiling in adrenal myelolipoma.
hsa-mir-451a	basal cell carcinoma	down	MicroRNA-451a acts as tumor suppressor in cutaneous basal cell carcinoma.
hsa-mir-451a	breast cancer	down	miR-451a Inhibited Cell Proliferation and Enhanced Tamoxifen Sensitive in Breast Cancer via Macrophage Migration Inhibitory Factor.
hsa-mir-451a	chronic myelogenous leukemia	down	Differential expression profiles and functional analysis of plasma miRNAs associated with chronic myeloid leukemia phases.
hsa-mir-451a	colorectal cancer	down	MiR-451a suppressing BAP31 can inhibit proliferation and increase apoptosis through inducing ER stress in colorectal cancer.
hsa-mir-451a	hepatocellular carcinoma	down	MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma.
hsa-mir-451a	hypopharyngeal cancer	down	NF-?B inhibition reverses acidic bile-induced miR-21, miR-155, miR-192, miR-34a, miR-375 and miR-451a deregulations in human hypopharyngeal cells.
hsa-mir-451a	hypopharyngeal squamous cell carcinoma	down	Identification of tumour suppressive microRNA-451a in hypopharyngeal squamous cell carcinoma based on microRNA expression signature.
hsa-mir-451a	non-small cell lung cancer	down	Regulation by Pink1 on the mitochondrial dysfunction in endothelial cells post the hypoxia mimetic agent CoCl2 treatment.
hsa-mir-451a	non-small cell lung cancer	down	MiR-451a suppressed cell migration and invasion in non-small cell lung cancer through targeting ATF2.
hsa-mir-451a	osteosarcoma	down	miR-451a Inhibits the Growth and Invasion of Osteosarcoma via Targeting TRIM66.
hsa-mir-451a	pancreatic cancer	up	An elevated expression of serum exosomal microRNA-191, -?21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker.
hsa-mir-451a	papillary thyroid carcinoma	down	miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.
hsa-mir-452	breast cancer	down	Tumor-suppressive microRNA-452 inhibits migration and invasion of breast cancer cells by directly targeting RAB11A.
hsa-mir-452	breast cancer	down	Downregulation of tumor suppressive microRNAs in vivo in dense breast tissue of postmenopausal women.
hsa-mir-452	colorectal cancer	up	MiR-452 promotes an aggressive colorectal cancer phenotype by regulating a Wnt/?-catenin positive feedback loop.
hsa-mir-452	colorectal cancer	down	Decreased miR-452 expression in human colorectal cancer and its tumor suppressive function.
hsa-mir-452	esophageal cancer	up	Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-452	glioma	down	Downregulation of miR-452 Promotes Stem-Like Traits and Tumorigenicity of Gliomas.
hsa-mir-452	hepatocellular carcinoma	up	MicroRNA-452 promotes tumorigenesis in hepatocellular carcinoma by targeting cyclin-dependent kinase inhibitor 1B.
hsa-mir-452	non-small cell lung cancer	down	Up-Regulation of MiR-452 Inhibits Metastasis of Non-Small Cell Lung Cancer by Regulating BMI1.
hsa-mir-452	osteosarcoma	down	Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma.
hsa-mir-452	prostate cancer	down	Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer.
hsa-mir-452-5p	prostate cancer	down	Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis.
hsa-mir-452-5p	renal cell carcinoma	up	Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals.
hsa-mir-4530	breast carcinoma	up	MicroRNA-4530 promotes angiogenesis by targeting VASH1 in breast carcinoma cells.
hsa-mir-454	esophageal cancer	down	Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-454	gastric cancer	up	Histone deacetylase 3 is associated with gastric cancer cell growth via the miR-454-mediated targeting of CHD5.
hsa-mir-454	gastric cancer	down	MicroRNA-454 inhibits tumor cell proliferation, migration and invasion by downregulating zinc finger E?box?binding homeobox 1 in gastric cancer.
hsa-mir-454	glioblastoma	down	MiR-454 inhibited cell proliferation of human glioblastoma cells by suppressing PDK1 expression.
hsa-mir-454	hepatocellular carcinoma	up	miR-454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinoma.
hsa-mir-454	hepatocellular carcinoma	up	Involvement of miR-454 overexpression in the poor prognosis of hepatocellular carcinoma.
hsa-mir-454	non-small cell lung cancer	up	MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN.
hsa-mir-454	osteosarcoma	down	miR-454 is down-regulated in osteosarcomas and suppresses cell proliferation and invasion by directly targeting c-Met.
hsa-mir-454	prostate cancer	up	Suppression of microRNA-454 impedes the proliferation and invasion of prostate cancer cells by promoting N-myc downstream-regulated gene 2 and inhibiting WNT/?-catenin signaling.
hsa-mir-454	uveal melanoma	up	MicroRNA-454 functions as an oncogene by regulating PTEN in uveal melanoma.
hsa-mir-454-3p	bladder cancer	down	MiR-454-3p and miR-374b-5p suppress migration and invasion of bladder cancer cells through targetting ZEB2.
hsa-mir-454-3p	cervical cancer	up	miR-454-3p promotes proliferation and induces apoptosis in human cervical cancer cells by targeting TRIM3.
hsa-mir-454-3p	cervical cancer	down	MicroRNA-454-3p inhibits cervical cancer cell invasion and migration by targeting c-Met.
hsa-mir-454-3p	colon cancer	up	[Expression of miR-454-3p and its effect on proliferation, invasion and metastasis of colon cancer].
hsa-mir-454-3p	glioma	down	miR-454-3p Is an Exosomal Biomarker and Functions as a Tumor Suppressor in Glioma.
hsa-mir-454-3p	hepatocellular carcinoma	up	High miR-454-3p expression predicts poor prognosis in hepatocellular carcinoma.
hsa-mir-454-3p	non-small cell lung cancer	down	Downregulation of Calbindin 1 by miR-454-3p Suppresses Cell Proliferation in Nonsmall Cell Lung Cancer In Vitro.
hsa-mir-455	breast cancer	down	miR-455 inhibits breast cancer cell proliferation through targeting CDK14.
hsa-mir-455	colon cancer	down	MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase.
hsa-mir-455	colorectal cancer	down	MicroRNA-455 suppresses the oncogenic function of HDAC2 in human colorectal cancer.
hsa-mir-455	colorectal cancer	down	MiR-455 functions as a tumor suppressor through targeting GATA6 in colorectal cancer.
hsa-mir-455	gastric cancer	down	miR-455 inhibits cell proliferation and migration via negative regulation of EGFR in human gastric cancer.
hsa-mir-455	hepatocellular carcinoma	up	MicroRNA-455 regulates migration and invasion of human hepatocellular carcinoma by targeting Runx2.
hsa-mir-455	hepatocellular carcinoma	down	Identifying microRNA panels specifically associated with hepatocellular carcinoma and its different etiologies.
hsa-mir-455	non-small cell lung cancer	down	MicroRNA-455 suppresses non-small cell lung cancer through targeting ZEB1.
hsa-mir-455-3p	basal cell carcinoma	up	Expression of microRNAs in basal cell carcinoma.
hsa-mir-455-3p	breast cancer	down	Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer.
hsa-mir-455-3p	esophageal squamous cell carcinoma	up	MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.
hsa-mir-455-3p	esophageal squamous cell carcinoma	up	Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma.
hsa-mir-455-3p	malignant melanoma	down	MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells.
hsa-mir-455-3p	non-small cell lung cancer	down	miR-455-3p serves as prognostic factor and regulates the proliferation and migration of non-small cell lung cancer through targeting HOXB5.
hsa-mir-455-3p	pancreatic cancer	down	Downregulation of MicroRNA-455-3p Links to Proliferation and Drug Resistance of Pancreatic Cancer Cells via Targeting TAZ.
hsa-mir-455-5p	basal cell carcinoma	up	Expression of microRNAs in basal cell carcinoma.
hsa-mir-455-5p	colon cancer	up	miR-455-5p functions as a potential oncogene by targeting galectin-9 in colon cancer.
hsa-mir-455-5p	colorectal cancer	down	Expression profile and biological function of miR-455-5p in colorectal carcinoma.
hsa-mir-455-5p	esophageal squamous cell carcinoma	down	Inhibitory effect of microRNA-455-5p on biological functions of esophageal squamous cell carcinoma Eca109 cells via Rab31.
hsa-mir-455-5p	gastric cancer	down	MiR-455-5p acts as a novel tumor suppressor in gastric cancer by down-regulating RAB18.
hsa-mir-455-5p	malignant melanoma	up	Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis.
hsa-mir-455-5p	non-small cell lung cancer	up	miR-455-5p promotes cell growth and invasion by targeting SOCO3 in non-small cell lung cancer.
hsa-mir-4649-3p	nasopharyngeal carcinoma	down	MicroRNA-4649-3p inhibits cell proliferation by targeting protein tyrosine phosphatase SHP-1 in nasopharyngeal carcinoma cells.
hsa-mir-466	colorectal cancer	down	MicroRNA-466 (miR-466) functions as a tumor suppressor and prognostic factor in colorectal cancer (CRC).
hsa-mir-466	hepatocellular carcinoma	down	MicroRNA-466 inhibits cancer cell migration and invasion in hepatocellular carcinoma by indirectly mediating the downregulation of ROCK2.
hsa-mir-466	osteosarcoma	down	MicroRNA-466 inhibits osteosarcoma cell proliferation and induces apoptosis by targeting CCND1.
hsa-mir-466	prostate cancer	down	MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
hsa-mir-4723-5p	prostate cancer	down	MicroRNA-4723 Inhibits Prostate Cancer Growth through Inactivation of the Abelson Family of Nonreceptor Protein Tyrosine Kinases.
hsa-mir-4732-5p	breast cancer	up	miR-4732-5p promotes breast cancer progression by targeting TSPAN13.
hsa-mir-4735-3p	non-small cell lung cancer	up	FBXL3 is regulated by miRNA-4735-3p and suppresses cell proliferation and migration in non-small cell lung cancer.
hsa-mir-4775	colorectal cancer	up	miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGF?-mediated epithelial to mesenchymal transition.
hsa-mir-4782-3p	non-small cell lung cancer	down	miR-4782-3p Inhibited Non-Small Cell Lung Cancer growth via USP14.
hsa-mir-4787-5p	pancreatic ductal adenocarcinoma	down	Inhibition of S-Adenosylmethionine-Dependent Methyltransferase Attenuates TGF?1-Induced EMT and Metastasis in Pancreatic Cancer: Putative Roles of miR-663a and miR-4787-5p.
hsa-mir-4792	nasopharyngeal carcinoma	down	miR-4792 inhibits epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma by targeting FOXC1.
hsa-mir-483	breast cancer	down	MiR-483 suppresses cell proliferation and promotes cell apoptosis by targeting SOX3 in breast cancer.
hsa-mir-483	colon cancer	down	Mir-483 inhibits colon cancer cell proliferation and migration by targeting TRAF1.
hsa-mir-483	colorectal cancer	down	Extracellular metabolic energetics can promote cancer progression.
hsa-mir-483	gastric cancer	down	miR-483 is down-regulated in gastric cancer and suppresses cell proliferation, invasion and protein O-GlcNAcylation by targeting OGT.
hsa-mir-483-3p	adrenal cortical carcinoma	up	The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
hsa-mir-483-3p	esophageal squamous cell carcinoma	up	miR-483-3p plays an oncogenic role in esophageal squamous cell carcinoma by targeting tumor suppressor EI24.
hsa-mir-483-3p	hepatocellular carcinoma	up	Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-? stimulated HSCs in transgenic mice.
hsa-mir-483-5p	adrenal cortical carcinoma	up	miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer.
hsa-mir-483-5p	adrenal cortical carcinoma	up	The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
hsa-mir-483-5p	adrenal cortical carcinoma	up	MicroRNA expression profiling in adrenal myelolipoma.
hsa-mir-483-5p	adrenal cortical carcinoma	up	Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors.
hsa-mir-483-5p	adrenal cortical carcinoma	up	MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer.
hsa-mir-483-5p	glioblastoma	down	MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1.
hsa-mir-483-5p	glioma	down	MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1.
hsa-mir-483-5p	hepatocellular carcinoma	up	Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-? stimulated HSCs in transgenic mice.
hsa-mir-483-5p	hepatocellular carcinoma	up	Serum miR-483-5p as a potential biomarker to detect hepatocellular carcinoma.
hsa-mir-483-5p	hepatocellular carcinoma	up	MiR-483-5p promotes IGF-II transcription and is associated with poor prognosis of hepatocellular carcinoma.
hsa-mir-483-5p	oral squamous cell carcinoma	up	Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
hsa-mir-483-5p	prostate cancer	up	miR-483-5p promotes prostate cancer cell proliferation and invasion by targeting RBM5.
hsa-mir-484	cervical cancer	down	miR-484 suppresses proliferation and epithelial-mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells.
hsa-mir-484	colon cancer	down	MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase.
hsa-mir-484	gastric cancer	down	The clinical significance of miR-335, miR-124, miR-218 and miR-484 downregulation in gastric cancer.
hsa-mir-485	colorectal cancer	down	MicroRNA-485 plays tumour-suppressive roles in colorectal cancer by directly targeting GAB2.
hsa-mir-485	hepatocellular carcinoma	down	The long noncoding RNA NEAT1 contributes to hepatocellular carcinoma development by sponging miR-485 and enhancing the expression of the STAT3.
hsa-mir-485	lung adenocarcinoma	down	MiR-485 inhibits metastasis and EMT of lung adenocarcinoma by targeting Flot2.
hsa-mir-485-3p	breast cancer	down	MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1? expression.
hsa-mir-485-3p	glioblastoma	down	Downregulation of miR-485-3p promotes glioblastoma cell proliferation and migration via targeting RNF135.
hsa-mir-485-3p	glioblastoma	down	Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
hsa-mir-485-3p	hepatocellular carcinoma	up	MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.
hsa-mir-485-5p	acute myeloid leukemia	down	MiRNA-485-5p suppresses the proliferation of acute myeloid leukemia via targeting SALL4.
hsa-mir-485-5p	breast cancer	down	MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1? expression.
hsa-mir-485-5p	breast cancer	down	miR-485-5p suppresses breast cancer progression and chemosensitivity by targeting survivin.
hsa-mir-485-5p	colorectal cancer	down	MicroRNA-485-5p reduces O-GlcNAcylation of Bmi-1 and inhibits colorectal cancer proliferation.
hsa-mir-485-5p	colorectal cancer	down	microRNA-485-5p Functions as a Tumor Suppressor in Colorectal Cancer Cells by Targeting CD147.
hsa-mir-485-5p	esophageal cancer	down	MiRNA-485-5p, inhibits esophageal cancer cells proliferation and invasion by down-regulating O-linked N-acetylglucosamine transferase.
hsa-mir-485-5p	gastric cancer	down	miR-485-5p acts as a negative regulator in gastric cancer progression by targeting flotillin-1.
hsa-mir-485-5p	gastric cancer	down	Reduced miR-485-5p expression predicts poor prognosis in patients with gastric cancer.
hsa-mir-485-5p	glioblastoma	down	Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma.
hsa-mir-485-5p	glioma	down	A tumor-suppressive microRNA, miRNA-485-5p, inhibits glioma cell proliferation and invasion by down-regulating TPD52L2.
hsa-mir-485-5p	hepatocellular carcinoma	down	MicroRNA-485-5p suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting stanniocalcin 2.
hsa-mir-485-5p	hepatocellular carcinoma	down	Involvement of miR-485-5p in hepatocellular carcinoma progression targeting EMMPRIN.
hsa-mir-485-5p	malignant melanoma	down	MicroRNA-485-5p represses melanoma cell invasion and proliferation by suppressing Frizzled7.
hsa-mir-485-5p	non-small cell lung cancer	down	MicroRNA-485-5p suppresses growth and metastasis in non-small cell lung cancer cells by targeting IGF2BP2.
hsa-mir-486	acute myeloid leukemia	up	Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics.
hsa-mir-486	colorectal cancer	down	Concentration of circulating miRNA-containing particles in serum enhances miRNA detection and reflects CRC tissue-related deregulations.
hsa-mir-486	esophageal cancer	down	Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-486	glioma	up	miR-486 sustains NF-?B activity by disrupting multiple NF-?B-negative feedback loops.
hsa-mir-486-3p	breast cancer	down	Identification of microRNA expression in sentinel lymph nodes from patients with breast cancer via RNA sequencing for diagnostic accuracy.
hsa-mir-486-3p	oral cancer	down	MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1.
hsa-mir-486-3p	retinoblastoma	down	Computational and in vitro Investigation of miRNA-Gene Regulations in Retinoblastoma Pathogenesis: miRNA Mimics Strategy.
hsa-mir-486-5p	acute myeloid leukemia	up	MicroRNA expression profiling in adrenal myelolipoma.
hsa-mir-486-5p	cervical cancer	up	Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
hsa-mir-486-5p	colorectal cancer	down	DNA-methylation-mediated silencing of miR-486-5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/?-catenin signal pathways.
hsa-mir-486-5p	esophageal squamous cell carcinoma	down	Downregulated miR-486-5p acts as a tumor suppressor in esophageal squamous cell carcinoma.
hsa-mir-486-5p	hepatocellular carcinoma	down	MiR-486-5p negatively regulates oncogenic NEK2 in hepatocellular carcinoma.
hsa-mir-486-5p	hepatocellular carcinoma	down	MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
hsa-mir-486-5p	lung cancer	down	Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer.
hsa-mir-486-5p	non-small cell lung cancer	down	Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer.
hsa-mir-486-5p	non-small cell lung cancer	up	miR-486-5p functions as an oncogene by targeting PTEN in non-small cell lung cancer.
hsa-mir-486-5p	non-small cell lung cancer	down	miR-486-5p inhibits cell proliferation and invasion through repressing GAB2 in non-small cell lung cancer.
hsa-mir-486-5p	non-small cell lung cancer	down	MicroRNA-486-5p improves nonsmall-cell lung cancer chemotherapy sensitivity and inhibits epithelial-mesenchymal transition by targeting twinfilin actin binding protein 1.
hsa-mir-486-5p	non-small cell lung cancer	down	ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status.
hsa-mir-486-5p	non-small cell lung cancer	down	miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study.
hsa-mir-486-5p	papillary thyroid carcinoma	down	miR-486-5p inhibits cell growth of papillary thyroid carcinoma by targeting fibrillin-1.
hsa-mir-486-5p	prostate cancer	down	miR-486-5p suppresses prostate cancer metastasis by targeting Snail and regulating epithelial-mesenchymal transition.
hsa-mir-486-5p	prostate cancer	up	The miR-486-5p plays a causative role in prostate cancer through negative regulation of multiple tumor suppressor pathways.
hsa-mir-487a	esophageal cancer	up	MicroRNA-487a promotes proliferation of esophageal cancer cells by inhibiting p62 expression.
hsa-mir-487a	hepatocellular carcinoma	up	miRNA-487a Promotes Proliferation and Metastasis in Hepatocellular Carcinoma.
hsa-mir-487b	colorectal cancer	down	DNA methylation-regulated and tumor-suppressive roles of miR-487b in colorectal cancer via targeting MYC, SUZ12, and KRAS.
hsa-mir-487b-3p	colonic adenocarcinoma	down	The miR-487b-3p/GRM3/TGF? signaling axis is an important regulator of colon cancer tumorigenesis.
hsa-mir-488	gastric cancer	down	miR-488 acts as a tumor suppressor gene in gastric cancer.
hsa-mir-488	hepatocellular carcinoma	down	MiR-488 suppresses cell proliferation and invasion by targeting ADAM9 and lncRNA HULC in hepatocellular carcinoma.
hsa-mir-488	osteosarcoma	up	Hypoxia-inducible microRNA-488 regulates apoptosis by targeting Bim in osteosarcoma.
hsa-mir-488	osteosarcoma	down	MicroRNA-488 inhibits proliferation, invasion and EMT in osteosarcoma cell lines by targeting aquaporin 3.
hsa-mir-488	ovarian cancer	down	microRNA-488 inhibits chemoresistance of ovarian cancer cells by targeting Six1 and mitochondrial function.
hsa-mir-488	prostate cancer	down	MicroRNA-488 inhibits proliferation and glycolysis in human prostate cancer cells by regulating PFKFB3.
hsa-mir-488	renal cell carcinoma	down	miR-488 inhibits cell growth and metastasis in renal cell carcinoma by targeting HMGN5.
hsa-mir-488-3p	esophageal squamous cell carcinoma	down	MicroRNA-488-3p inhibits proliferation and induces apoptosis by targeting ZBTB2 in esophageal squamous cell carcinoma.
hsa-mir-489	breast cancer	down	Overexpression of miR-489 enhances efficacy of 5-fluorouracil-based treatment in breast cancer stem cells by targeting XIAP.
hsa-mir-489	breast cancer	down	Autophagy, Cell Viability, and Chemoresistance Are Regulated By miR-489 in Breast Cancer.
hsa-mir-489	breast cancer	down	A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth.
hsa-mir-489	cervical cancer	down	miRNA-489 as a biomarker in diagnosis and treatment of cervical cancer.
hsa-mir-489	colorectal cancer	down	MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer.
hsa-mir-489	glioma	down	miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
hsa-mir-489	hepatocellular carcinoma	down	microRNA-489 Plays an Anti-Metastatic Role in Human Hepatocellular Carcinoma by Targeting Matrix Metalloproteinase-7.
hsa-mir-489-3p	osteosarcoma	up	Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway.
hsa-mir-489-5p	breast cancer	down	GSE1 negative regulation by miR-489-5p promotes breast cancer cell proliferation and invasion.
hsa-mir-489-5p	breast cancer	down	Long noncoding RNA Linc00460 promotes breast cancer progression by regulating the miR-489-5p/FGF7/AKT axis.
hsa-mir-490	breast cancer	down	MicroRNA-490 inhibits tumorigenesis and progression in breast cancer.
hsa-mir-490	gastric cancer	down	The long noncoding RNA colon cancer-associated transcript-1/miR-490 axis regulates gastric cancer cell migration by targeting hnRNPA1.
hsa-mir-490-3p	colorectal cancer	down	MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGF?R1.
hsa-mir-490-3p	colorectal cancer	down	Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/?-catenin signaling pathway.
hsa-mir-490-3p	colorectal cancer	down	MiR-490-3p Functions As a Tumor Suppressor by Inhibiting Oncogene VDAC1 Expression in Colorectal Cancer.
hsa-mir-490-3p	gastric cancer	down	Epigenetic Silencing of miR-490-3p Reactivates the Chromatin Remodeler SMARCD1 to Promote Helicobacter pylori-Induced Gastric Carcinogenesis.
hsa-mir-490-3p	gastric cancer	down	MicroRNA-490-3p regulates cell proliferation and apoptosis in gastric cancer via direct targeting of AKT1.
hsa-mir-490-3p	glioma	down	miR-490-3p functions as a tumor suppressor in glioma by inhibiting high-mobility group AT-hook 2 expression.
hsa-mir-490-3p	hepatocellular carcinoma	down	Investigation of miR-490-3p Expression in Hepatocellular Carcinoma Based on Reverse Transcription-Polymerase Chain Reaction (RT-qPCR) and a Meta-Analysis of 749 Cases.
hsa-mir-490-3p	hepatocellular carcinoma	down	MiR-490-3p inhibits autophagy via targeting ATG7 in hepatocellular carcinoma.
hsa-mir-490-3p	hepatocellular carcinoma	up	miR-490-3p Modulates Cell Growth and Epithelial to Mesenchymal Transition of Hepatocellular Carcinoma Cells by Targeting Endoplasmic Reticulum-Golgi Intermediate Compartment Protein 3 (ERGIC3).
hsa-mir-490-3p	lung cancer	up	MicroRNA-490 regulates lung cancer metastasis by targeting poly r(C)-binding protein 1.
hsa-mir-490-3p	osteosarcoma	down	Decreased expression of miR-490-3p in osteosarcoma and its clinical significance.
hsa-mir-490-3p	osteosarcoma	down	MicroRNA-490-3p regulates cell proliferation and apoptosis by targeting HMGA2 in osteosarcoma.
hsa-mir-490-5p	bladder cancer	down	MicroRNA expression signatures of bladder cancer revealed by deep sequencing.
hsa-mir-490-5p	bladder cancer	down	MicroRNA-490-5p inhibits proliferation of bladder cancer by targeting c-Fos.
hsa-mir-490-5p	bladder cancer	down	MicroRNA-490-5p is a novel tumor suppressor targeting c-FOS in human bladder cancer.
hsa-mir-490-5p	hepatocellular carcinoma	down	MiR-490-5p Inhibits Hepatocellular Carcinoma Cell Proliferation, Migration and Invasion by Directly Regulating ROBO1.
hsa-mir-490-5p	hepatocellular carcinoma	down	MiR-490-5p Suppresses Cell Proliferation and Invasion by Targeting BUB1 in Hepatocellular Carcinoma Cells.
hsa-mir-490-5p	renal cell carcinoma	down	miR-490-5p suppresses tumor growth in renal cell carcinoma through targeting PIK3CA.
hsa-mir-491	esophageal cancer	down	Low Expression of miR-491 Promotes Esophageal Cancer Cell Invasion by Targeting TPX2.
hsa-mir-491	hepatocellular carcinoma	down	[miR-491 inhibits the proliferation, invasion and migration of hepatocellular carcinoma cell via down-regulating TPX2 expression].
hsa-mir-491	osteosarcoma	down	miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting ?B-crystallin.
hsa-mir-491-5p	cervical cancer	down	MicroRNA-491-5p suppresses cervical cancer cell growth by targeting hTERT.
hsa-mir-491-5p	colorectal cancer	down	miR-491-5p functions as a tumor suppressor by targeting IGF2 in colorectal cancer.
hsa-mir-491-5p	gastric cancer	down	MiRNA-491-5p inhibits cell proliferation, invasion and migration via targeting JMJD2B and serves as a potential biomarker in gastric cancer.
hsa-mir-491-5p	gastric cancer	down	Downregulation of miR-491-5p promotes gastric cancer metastasis by regulating SNAIL and FGFR4.
hsa-mir-491-5p	nasopharyngeal carcinoma	down	miR-491-5p suppresses cell growth and invasion by targeting Notch3 in nasopharyngeal carcinoma.
hsa-mir-491-5p	non-small cell lung cancer	down	MicroRNAs-491-5p suppresses cell proliferation and invasion by inhibiting IGF2BP1 in non-small cell lung cancer.
hsa-mir-491-5p	osteosarcoma	down	miR-491-5p inhibits osteosarcoma cell proliferation by targeting PKM2.
hsa-mir-491-5p	prostate cancer	down	MiR-491-5p negatively regulates cell proliferation and motility by targeting PDGFRA in prostate cancer.
hsa-mir-492	hepatoblastoma	up	MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma.
hsa-mir-493	bladder cancer	down	Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4.
hsa-mir-493	gastric cancer	up	miR-493 mediated DKK1 down-regulation confers proliferation, invasion and chemo-resistance in gastric cancer cells.
hsa-mir-493	gastric cancer	down	MiR-493 suppresses the proliferation and invasion of gastric cancer cells by targeting RhoC.
hsa-mir-493	hepatocellular carcinoma	down	MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma.
hsa-mir-493	hepatocellular carcinoma	down	MicroRNA-493 suppresses hepatocellular carcinoma tumorigenesis through down-regulation of anthrax toxin receptor 1 (ANTXR1) and R-Spondin 2 (RSPO2).
hsa-mir-493	malignant melanoma	down	Downregulation of miR-493 promoted melanoma proliferation by suppressing IRS4 expression.
hsa-mir-493	pancreatic cancer	down	miR-493 inhibits proliferation and invasion in pancreatic cancer cells and inversely regulated hERG1 expression.
hsa-mir-493	pituitary carcinoma	up	MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas.
hsa-mir-493	prostate cancer	up	miR-493 Promotes Prostate Cancer Cells Proliferation by Targeting PHLPP2 and Activating Akt Signaling Pathway.
hsa-mir-493-3p	prostate cancer	down	Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels.
hsa-mir-493-5p	hepatocellular carcinoma	down	miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.
hsa-mir-493-5p	liver cancer	down	MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2.
hsa-mir-493-5p	prostate cancer	down	c-Met, CREB1 and EGFR are involved in miR-493-5p inhibition of EMT via AKT/GSK-3?/Snail signaling in prostate cancer.
hsa-mir-494	acute myeloid leukemia	down	MicroRNA-494 Activation Suppresses Bone Marrow Stromal Cell-Mediated Drug Resistance in Acute Myeloid Leukemia Cells.
hsa-mir-494	breast cancer	up	Overexpression of mir-183 and mir-494 promotes proliferation and migration in human breast cancer cell lines.
hsa-mir-494	breast cancer	down	MicroRNA-494 inhibits breast cancer progression by directly targeting PAK1.
hsa-mir-494	breast cancer	down	miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/?-catenin signaling pathway.
hsa-mir-494	cervical cancer	up	MicroRNA-494 promotes cervical cancer proliferation through the regulation of PTEN.
hsa-mir-494	cervical cancer	down	miR-494 inhibits cervical cancer cell proliferation through upregulation of SOCS6 expression.
hsa-mir-494	colorectal cancer	up	Prognostic and clinicopathological significance of microRNA-494 overexpression in cancers: a meta-analysis.
hsa-mir-494	colorectal cancer	up	miR?494 is an independent prognostic factor and promotes cell migration and invasion in colorectal cancer by directly targeting PTEN.
hsa-mir-494	colorectal cancer	up	MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
hsa-mir-494	esophageal cancer	down	Long non-coding RNA XIST promotes the development of esophageal cancer by sponging miR-494 to regulate CDK6 expression.
hsa-mir-494	esophageal squamous cell carcinoma	down	Upregulation of miR-494 Inhibits Cell Growth and Invasion and Induces Cell Apoptosis by Targeting Cleft Lip and Palate Transmembrane 1-Like in Esophageal Squamous Cell Carcinoma.
hsa-mir-494	gastric cancer	down	miR-494 acts as an anti-oncogene in gastric carcinoma by targeting c-myc.
hsa-mir-494	gastric cancer	down	MicroRNA 494 increases chemosensitivity to doxorubicin in gastric cancer cells by targeting phosphodiesterases 4D.
hsa-mir-494	gastric cancer	down	miR-494 Sensitizes Gastric Cancer Cells to TRAIL Treatment Through Downregulation of Survivin.
hsa-mir-494	gastrointestinal stromal tumor	down	Survivin is a novel transcription regulator of KIT and is downregulated by miRNA-494 in gastrointestinal stromal tumors.
hsa-mir-494	glioma	up	Ionizing radiation-inducible miR-494 promotes glioma cell invasion through EGFR stabilization by targeting p190B RhoGAP.
hsa-mir-494	hepatocellular carcinoma	up	MiR-494 within an oncogenic MicroRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of MCC.
hsa-mir-494	hepatocellular carcinoma	up	MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors.
hsa-mir-494	hepatocellular carcinoma	up	miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN.
hsa-mir-494	malignant melanoma	up	Blockage of transferred exosome-shuttled miR-494 inhibits melanoma growth and metastasis.
hsa-mir-494	nasopharyngeal carcinoma	down	Upregulation of miR-21 and downregulation of miR-494 may serve as emerging molecular biomarkers for prediagnostic samples of subjects who developed nasopharyngeal carcinoma associates with lymph node
hsa-mir-494	non-small cell lung cancer	up	Expression and clinical evidence of miR-494 and PTEN in non-small cell lung cancer.
hsa-mir-494	non-small cell lung cancer	up	Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer.
hsa-mir-494	non-small cell lung cancer	up	Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
hsa-mir-494	non-small cell lung cancer	up	Prognostic and clinicopathological significance of microRNA-494 overexpression in cancers: a meta-analysis.
hsa-mir-494	oral cancer	down	miR-494 represses HOXA10 expression and inhibits cell proliferation in oral cancer.
hsa-mir-494	ovarian cancer	down	Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
hsa-mir-494	ovarian cancer	down	miR-494 inhibits ovarian cancer cell proliferation and promotes apoptosis by targeting FGFR2.
hsa-mir-494	pancreatic cancer	down	Correlation of miR-494 expression with tumor progression and patient survival in pancreatic cancer.
hsa-mir-494	pancreatic ductal adenocarcinoma	down	Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and ?-catenin signaling in pancreatic ductal adenocarcinoma cells.
hsa-mir-494-3p	hepatocellular carcinoma	up	MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN.
hsa-mir-494-3p	nasopharyngeal carcinoma	up	MicroRNA-494-3p Promotes Cell Growth, Migration, and Invasion of Nasopharyngeal Carcinoma by Targeting Sox7.
hsa-mir-495	bladder cancer	up	microRNA-495 promotes bladder cancer cell growth and invasion by targeting phosphatase and tensin homolog.
hsa-mir-495	breast cancer	down	Demethylation of miR-495 inhibits cell proliferation, migration and promotes apoptosis by targeting STAT-3 in breast cancer.
hsa-mir-495	breast cancer	up	miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1.
hsa-mir-495	breast cancer	down	Downregulated miR-45 Inhibits the G1-S Phase Transition by Targeting Bmi-1 in Breast Cancer.
hsa-mir-495	breast cancer	down	Lnc RNA SNHG20 participated in proliferation, invasion and migration of breast cancer cells via miR-495.
hsa-mir-495	colorectal cancer	down	The MiR-495/Annexin A3/P53 Axis Inhibits the Invasion and EMT of Colorectal Cancer Cells.
hsa-mir-495	colorectal cancer	down	miR-496, miR-1185, miR-654, miR-3183 and miR-495 are downregulated in colorectal cancer cells and have putative roles in the mTOR pathway.
hsa-mir-495	endometrial cancer	down	Role of MicroRNAs in carcinogenesis that potential for biomarker of endometrial cancer.
hsa-mir-495	esophageal squamous cell carcinoma	down	MiR-495 inhibits esophageal squamous cell carcinoma progression by targeting Akt1.
hsa-mir-495	gastric cancer	down	MicroRNA-495 Inhibits Gastric Cancer Cell Migration and Invasion Possibly via Targeting High Mobility Group AT-Hook 2 (HMGA2).
hsa-mir-495	gastric cancer	down	MicroRNA-495 inhibits proliferation, metastasis and promotes apoptosis by targeting Twist1 in gastric cancer cells.
hsa-mir-495	gastric cancer	up	Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells.
hsa-mir-495	glioma	down	MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6.
hsa-mir-495	glioma	down	miR-495 mediates metabolic shift in glioma cells via targeting Glut1.
hsa-mir-495	glioma	down	Hsa-miR-495 acts as a tumor suppressor gene in glioma via the negative regulation of MYB.
hsa-mir-495	hepatocellular carcinoma	up	MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.
hsa-mir-495	hepatocellular carcinoma	down	MicroRNA-495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin-like growth factor receptor-1.
hsa-mir-495	lung cancer	down	The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells.
hsa-mir-495	malignant melanoma	down	miR-495 inhibits proliferation, migration, and invasion and induces apoptosis via inhibiting PBX3 in melanoma cells.
hsa-mir-495	medulloblastoma	down	MiR-495 is a Predictive Biomarker that Downregulates GFI1 Expression in Medulloblastoma.
hsa-mir-495	non-small cell lung cancer	down	miR-199a-5p and miR-495 target GRP78 within UPR pathway of lung cancer.
hsa-mir-495	non-small cell lung cancer	down	MicroRNA-495 inhibits the progression of non-small-cell lung cancer by targeting TCF4 and inactivating Wnt/?-catenin pathway.
hsa-mir-495	oral squamous cell carcinoma	down	MiR-495/IGF-1/AKT Signaling as a Novel Axis Is Involved in the Epithelial-to-Mesenchymal Transition of Oral Squamous Cell Carcinoma.
hsa-mir-495	osteosarcoma	down	Overexpression of microRNA-495 suppresses the proliferation and invasion and induces the apoptosis of osteosarcoma cells by targeting high-mobility group nucleosome-binding domain 5.
hsa-mir-495	renal cell carcinoma	down	MicroRNA-495 suppresses human renal cell carcinoma malignancy by targeting SATB1.
hsa-mir-495-3p	gastric cancer	down	MicroRNA-495-3p functions as a tumour suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis.
hsa-mir-495-3p	malignant melanoma	down	lncRNA NEAT1 facilitates melanoma cell proliferation, migration, and invasion via regulating miR-495-3p and E2F3.
hsa-mir-496	acute myeloid leukemia	down	Role of circRNA-DLEU2 in human acute myeloid leukemia.
hsa-mir-496	colorectal cancer	down	miR-496, miR-1185, miR-654, miR-3183 and miR-495 are downregulated in colorectal cancer cells and have putative roles in the mTOR pathway.
hsa-mir-496	colorectal cancer	up	MiR-496 promotes migration and epithelial-mesenchymal transition by targeting RASSF6 in colorectal cancer.
hsa-mir-496	non-small cell lung cancer	down	miR-496 suppress tumorigenesis via targeting BDNF-mediated PI3K/Akt signaling pathway in non-small cell lung cancer.
hsa-mir-497	adrenal cortical carcinoma	down	The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
hsa-mir-497	breast cancer	down	Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer.
hsa-mir-497	breast cancer	down26338045	microRNA-497 induces cell apoptosis by negatively regulating Bcl-2 protein expression at the posttranscriptional level in human breast cancer.
hsa-mir-497	breast cancer	down	microRNA-497 induces cell apoptosis by negatively regulating Bcl-2 protein expression at the posttranscriptional level in human breast cancer.
hsa-mir-497	breast cancer	down	LncRNA GACAT3 predicts poor prognosis and promotes cell proliferation in breast cancer through regulation of miR-497/CCND2.
hsa-mir-497	breast carcinoma	down	miR-497 suppresses angiogenesis in breast carcinoma by targeting HIF-1?.
hsa-mir-497	breast carcinoma	down	miR-497 inhibits epithelial mesenchymal transition in breast carcinoma by targeting Slug.
hsa-mir-497	cervical cancer	down	MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
hsa-mir-497	colorectal cancer	down	MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer.
hsa-mir-497	colorectal cancer	down	MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis.
hsa-mir-497	colorectal cancer	up	MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis.
hsa-mir-497	colorectal cancer	up	MiR-497 promotes metastasis of colorectal cancer cells through Nrdp1 inhibition.
hsa-mir-497	colorectal cancer	down	MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1.
hsa-mir-497	colorectal cancer	down	miR-497 suppresses epithelial-mesenchymal transition and metastasis in colorectal cancer cells by targeting fos-related antigen-1.
hsa-mir-497	colorectal cancer	down	Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
hsa-mir-497	colorectal cancer	down	MicroRNA-497 inhibits tumor growth through targeting insulin receptor substrate 1 in colorectal cancer.
hsa-mir-497	gastric cancer	down	The putative tumor suppressor microRNA-497 modulates gastric cancer cell proliferation and invasion by repressing eIF4E.
hsa-mir-497	gastric cancer	down	FGFR1 is an independent prognostic factor and can be regulated by miR-497 in gastric cancer progression.
hsa-mir-497	glioma	down	miR-497/Wnt3a/c-jun feedback loop regulates growth and epithelial-to-mesenchymal transition phenotype in glioma cells.
hsa-mir-497	glioma	down	Reduced expression of microRNA-497 is associated with greater angiogenesis and poor prognosis in human gliomas.
hsa-mir-497	glioma	up	Hypoxia-induced miR-497 decreases glioma cell sensitivity to TMZ by inhibiting apoptosis.
hsa-mir-497	hepatocellular carcinoma	down	Checkpoint kinase 1 is negatively regulated by miR-497 in hepatocellular carcinoma.
hsa-mir-497	hepatocellular carcinoma	down	MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1.
hsa-mir-497	hepatocellular carcinoma	down	microRNA-497 inhibits cell proliferation and induces apoptosis by targeting YAP1 in human hepatocellular carcinoma.
hsa-mir-497	kidney cancer	down	Down-regulation of miR-497 is associated with poor prognosis in renal cancer.
hsa-mir-497	multiple myeloma	down	MicroRNA-497 suppresses cell proliferation and induces apoptosis through targeting PBX3 in human multiple myeloma.
hsa-mir-497	multiple myeloma	down	MicroRNA-497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl-2.
hsa-mir-497	nasopharyngeal carcinoma	down	The potent tumor suppressor miR-497 inhibits cancer phenotypes in nasopharyngeal carcinoma by targeting ANLN and HSPA4L.
hsa-mir-497	non-small cell lung cancer	down	Role of miR-497 in VEGF-A-mediated cancer cell growth and invasion in non-small cell lung cancer.
hsa-mir-497	non-small cell lung cancer	down	miR-145 and miR-497 suppress TGF-?-induced epithelial-mesenchymal transition of non-small cell lung cancer by targeting MTDH.
hsa-mir-497	non-small cell lung cancer	down	Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancer.
hsa-mir-497	non-small cell lung cancer	down	MiR-497 Suppresses YAP1 and Inhibits Tumor Growth in Non-Small Cell Lung Cancer.
hsa-mir-497	oral squamous cell carcinoma	up	MiR-497 enhances metastasis of oral squamous cell carcinoma through SMAD7 suppression.
hsa-mir-497	osteosarcoma	down	MicroRNA-497 inhibits cell proliferation, migration, and invasion by targeting AMOT in human osteosarcoma cells.
hsa-mir-497	osteosarcoma	down	MicroRNA-497 suppress osteosarcoma by targeting MAPK/Erk pathway.
hsa-mir-497	osteosarcoma	down	miR-497 as a potential serum biomarker for the diagnosis and prognosis of osteosarcoma.
hsa-mir-497	osteosarcoma	down	Downregulation of microRNA-497 is associated with upregulation of synuclein ? in patients with osteosarcoma.
hsa-mir-497	osteosarcoma	down	MicroRNA-497 suppresses osteosarcoma tumor growth in vitro and in vivo.
hsa-mir-497	osteosarcoma	down	The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma.
hsa-mir-497	ovarian cancer	down	MicroRNA-497 inhibition of ovarian cancer cell migration and invasion through targeting of SMAD specific E3 ubiquitin protein ligase 1.
hsa-mir-497	ovarian cancer	down	MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.
hsa-mir-497	pancreatic cancer	down	Insulin-like growth factor 1 receptor (IGF-1R) as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer.
hsa-mir-497	pancreatic cancer	down	MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis.
hsa-mir-497	papillary thyroid carcinoma	down	miR-497 inhibited proliferation, migration and invasion of thyroid papillary carcinoma cells by negatively regulating YAP1 expression.
hsa-mir-497	prostate cancer	down	MicroRNA-497 Suppresses Proliferation and Induces Apoptosis in Prostate Cancer Cells.
hsa-mir-497	prostate cancer	down	Tumor-suppressive microRNA-497 targets IKK? to regulate NF-?B signaling pathway in human prostate cancer cells.
hsa-mir-497	renal cell carcinoma	down	MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells.
hsa-mir-497	retinoblastoma	down	microRNA-497 overexpression decreases proliferation, migration and invasion of human retinoblastoma cells via targeting vascular endothelial growth factor A.
hsa-mir-497	thyroid cancer	down	MicroRNA-497 inhibits thyroid cancer tumor growth and invasion by suppressing BDNF.
hsa-mir-497-5p	breast cancer	down	HOXC13-AS promotes breast cancer cell growth through regulating miR-497-5p/PTEN axis.
hsa-mir-497-5p	colorectal cancer	down	Up-regulation of microRNA-497-5p inhibits colorectal cancer cell proliferation and invasion via targeting PTPN3.
hsa-mir-497-5p	gastric cancer	down	miR-497-5p inhibits gastric cancer cell proliferation and growth through targeting PDK3.
hsa-mir-497-5p	hepatocellular carcinoma	down	MiR-497-5p inhibits cell proliferation and metastasis in hepatocellular carcinoma by targeting insulin-like growth factor 1.
hsa-mir-497-5p	hepatocellular carcinoma	up	lncRNA XIST regulates proliferation and migration of hepatocellular carcinoma cells by acting as miR-497-5p molecular sponge and targeting PDCD4.
hsa-mir-497-5p	malignant melanoma	down	MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells.
hsa-mir-497-5p	non-small cell lung cancer	down	MicroRNA-497-5p inhibits proliferation and invasion of non-small cell lung cancer by regulating FGF2.
hsa-mir-498	breast cancer	down	MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression.
hsa-mir-498	breast cancer	up	MicroRNA-498 promotes proliferation and migration by targeting the tumor suppressor PTEN in breast cancer cells.
hsa-mir-498	cervical cancer	down	Downregulation of hsa_circ_0007534 restricts the proliferation and invasion of cervical cancer through regulating miR-498/BMI-1 signaling.
hsa-mir-498	colorectal cancer	down	Downregulation of microRNA-498 in colorectal cancers and its cellular effects.
hsa-mir-498	esophageal squamous cell carcinoma	down	MiR-498 in oesophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.
hsa-mir-498	gastric cancer	down	Upregulating microRNA-498 inhibits gastric cancer proliferation invasion and chemoresistance through inverse interaction of Bmi1.
hsa-mir-498	non-small cell lung cancer	down	MicroRNA-498 is downregulated in non-small cell lung cancer and correlates with tumor progression.
hsa-mir-498	non-small cell lung cancer	down	Targeting the HMGA2 oncogene by miR-498 inhibits non-small cell lung cancer biological behaviors.
hsa-mir-498	ovarian cancer	down	1,25-Dihydroxyvitamin D3 Suppresses Telomerase Expression and Human Cancer Growth through MicroRNA-498.
hsa-mir-498	ovarian cancer	down	MiR-498 regulated FOXO3 expression and inhibited the proliferation of human ovarian cancer cells.
hsa-mir-498	ovarian cancer	down	Low miR-498 expression levels are associated with poor prognosis in ovarian cancer.
hsa-mir-498	retinoblastoma	up	miR-498 promotes cell proliferation and inhibits cell apoptosis in retinoblastoma by directly targeting CCPG1.
hsa-mir-499-5p	colorectal cancer	up	MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4.
hsa-mir-499-5p	non-small cell lung cancer	down	Overexpression of miR-499-5p inhibits non-small cell lung cancer proliferation and metastasis by targeting VAV3.
hsa-mir-499a-5p	glioma	down	Knockdown of LncRNA SCAMP1 suppressed malignant biological behaviours of glioma cells via modulating miR-499a-5p/LMX1A/NLRC5 pathway.
hsa-mir-499a-5p	lung adenocarcinoma	up	Exosomal miR-499a-5p promotes cell proliferation, migration and EMT via mTOR signaling pathway in lung adenocarcinoma.
hsa-mir-499a-5p	oral squamous cell carcinoma	down	The association between miR-499a polymorphism and oral squamous cell carcinoma progression.
hsa-mir-499a-5p	osteosarcoma	down	MicroRNA-499a-5p inhibits osteosarcoma cell proliferation and differentiation by targeting protein phosphatase 1D through protein kinase B/glycogen synthase kinase 3? signaling.
hsa-mir-500	gastric cancer	up	MicroRNA-500 sustains nuclear factor-?B activation and induces gastric cancer cell proliferation and resistance to apoptosis.
hsa-mir-500	hepatocellular carcinoma	up	MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.
hsa-mir-500	prostate cancer	up	Inhibition of microRNA-500 has anti-cancer effect through its conditional downstream target of TFPI in human prostate cancer.
hsa-mir-500	prostate cancer	up	miR-500 promotes cell proliferation by directly targetting LRP1B in prostate cancer.
hsa-mir-5003-3p	breast cancer	up	miR-5003-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization and direct targeting of E-cadherin.
hsa-mir-500a	hepatocellular carcinoma	up	Serum miR-483-5p as a potential biomarker to detect hepatocellular carcinoma.
hsa-mir-500a	hepatocellular carcinoma	up	MicroRNA-500a promotes migration and invasion in hepatocellular carcinoma by activating the Wnt/?-catenin signaling pathway.
hsa-mir-500a-3p	hepatocellular carcinoma	up	miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma.
hsa-mir-500a-3p	non-small cell lung cancer	down	MiRNA-500a-3p inhibits cell proliferation and invasion by targeting lymphocyte antigen 6 complex locus K (LY6K) in human non-small cell lung cancer.
hsa-mir-500a-5p	colorectal cancer	down	The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.
hsa-mir-501	cervical cancer	up	miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD.
hsa-mir-501	hepatocellular carcinoma	up	miR-501 acts as an independent prognostic factor that promotes the epithelial-mesenchymal transition through targeting JDP2 in hepatocellular carcinoma.
hsa-mir-501	hepatocellular carcinoma	up	MicroRNA-501 promotes HBV replication by targeting HBXIP.
hsa-mir-501-3p	hepatocellular carcinoma	down	microRNA-501-3p suppresses metastasis and progression of hepatocellular carcinoma through targeting LIN7A.
hsa-mir-501-3p	prostate cancer	down	Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes.
hsa-mir-501-3p	prostate cancer	down	MicroRNA-501-3p restricts prostate cancer growth through regulating cell cycle-related and expression-elevated protein in tumor/cyclin D1 signaling.
hsa-mir-501-5p	gastric cancer	up	Upregulation of miR-501-5p activates the wnt/?-catenin signaling pathway and enhances stem cell-like phenotype in gastric cancer.
hsa-mir-501-5p	hepatocellular carcinoma	up	MiR-501-5p regulates CYLD expression and promotes cell proliferation in human hepatocellular carcinoma.
hsa-mir-501-5p	lung adenocarcinoma	up	[Expression profile of miR-501-5p in lung adenocarcinoma patients from Xuanwei area].
hsa-mir-502	colon cancer	down	Inhibition of autophagy and tumor growth in colon cancer by miR-502.
hsa-mir-502	hepatocellular carcinoma	down	miR-502 inhibits cell proliferation and tumor growth in hepatocellular carcinoma through suppressing phosphoinositide 3-kinase catalytic subunit gamma.
hsa-mir-502-3p	hepatocellular carcinoma	down	MiR-502-3P suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SET.
hsa-mir-502-5p	breast cancer	down	Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
hsa-mir-502-5p	gastric cancer	up	Rs56288038 (C/G) in 3'UTR of IRF-1 Regulated by MiR-502-5p Promotes Gastric Cancer Development.
hsa-mir-503	breast cancer	up	MiR-503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression.
hsa-mir-503	cervical cancer	down	miR-503 expression is downregulated in cervical cancer and suppresses tumor growth by targeting AKT2.
hsa-mir-503	colon cancer	down	MiR-424/503-Mediated Rictor Upregulation Promotes Tumor Progression.
hsa-mir-503	colorectal cancer	down	miR-503 inhibits cell proliferation and induces apoptosis in colorectal cancer cells by targeting E2F3.
hsa-mir-503	colorectal cancer	up	MiR-503 promotes the migration and invasion of colorectal cancer cells by regulating PDCD4.
hsa-mir-503	colorectal cancer	up	miRNA-503 Promotes Tumor Progression and Is Associated with Early Recurrence and Poor Prognosis in Human Colorectal Cancer.
hsa-mir-503	esophageal cancer	up	MicroRNA-503 promotes tumor progression and acts as a novel biomarker for prognosis in oesophageal cancer.
hsa-mir-503	esophageal squamous cell carcinoma	down	Downregulation of miR-503 Promotes ESCC Cell Proliferation, Migration, and Invasion by Targeting Cyclin D1.
hsa-mir-503	esophageal squamous cell carcinoma	up	Study of expression levels and clinical significance of miR-503 and miR-375 in patients with esophageal squamous cell carcinoma.
hsa-mir-503	gastric cancer	down	MiR-503 suppresses cell proliferation and invasion of gastric cancer by targeting HMGA2 and inactivating WNT signaling pathway.
hsa-mir-503	gastric cancer	down	MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2.
hsa-mir-503	gastric cancer	down	microRNA-503 inhibits gastric cancer cell growth and epithelial-to-mesenchymal transition.
hsa-mir-503	glioblastoma	down	MicroRNA-503 acts as a tumor suppressor in glioblastoma for multiple antitumor effects by targeting IGF-1R.
hsa-mir-503	glioblastoma	up	TGF-â1-induced miR-503 controls cell growth and apoptosis by targeting PDCD4 in glioblastoma cells.
hsa-mir-503	glioma	down	miR-503 inhibits cell proliferation and invasion in glioma by targeting L1CAM.
hsa-mir-503	hepatocellular carcinoma	down	MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor.
hsa-mir-503	hepatocellular carcinoma	down	MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma.
hsa-mir-503	hepatocellular carcinoma	down	miR-503 suppresses metastasis of hepatocellular carcinoma cell by targeting PRMT1.
hsa-mir-503	laryngeal carcinoma	down	MiR-503 enhances the radiosensitivity of laryngeal carcinoma cells via the inhibition of WEE1.
hsa-mir-503	lung cancer	down	CircRNA circ-BANP-mediated miR-503/LARP1 signaling contributes to lung cancer progression.
hsa-mir-503	non-small cell lung cancer	down	Epigenetic silencing of MicroRNA-503 regulates FANCA expression in non-small cell lung cancer cell.
hsa-mir-503	non-small cell lung cancer	down	Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.
hsa-mir-503	oral squamous cell carcinoma	down	Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-503	osteosarcoma	down	MicroRNA-503 acts as a tumor suppressor in osteosarcoma by targeting L1CAM.
hsa-mir-503	osteosarcoma	down	Downregulation of miR-133b/miR-503 acts as efficient prognostic and diagnostic factors in patients with osteosarcoma and these predictor biomarkers are correlated with overall survival.
hsa-mir-503	osteosarcoma	down	miR-503 is down-regulated in osteosarcoma and suppressed MG63 proliferation and invasion by targeting VEGFA/Rictor.
hsa-mir-503	osteosarcoma	down	MicroRNA-503 represses epithelial-mesenchymal transition and inhibits metastasis of osteosarcoma by targeting c-myb.
hsa-mir-503	osteosarcoma	down	MicroRNA-503 suppresses cell proliferation and invasion in osteosarcoma via targeting insulin-like growth factor 1 receptor.
hsa-mir-503	ovarian cancer	up	MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.
hsa-mir-503	prostate cancer	down	miR-503 suppresses tumor cell proliferation and metastasis by directly targeting RNF31 in prostate cancer.
hsa-mir-503	prostate cancer	down	microRNA-503 suppresses the migration, proliferation and colony formation of prostate cancer cells by targeting tumor protein D52 like 2.
hsa-mir-503	prostate cancer	down	GATA3-driven expression of miR-503 inhibits prostate cancer progression by repressing ZNF217 expression.
hsa-mir-503	retinoblastoma	up	MicroRNA-503 serves an oncogenic role in retinoblastoma progression by directly targeting PTPN12.
hsa-mir-503-3p	breast cancer	up	miR-503-3p promotes epithelial-mesenchymal transition in breast cancer by directly targeting SMAD2 and E-cadherin.
hsa-mir-503-3p	lung cancer	down	miR-503-3p induces apoptosis of lung cancer cells by regulating p21 and CDK4 expression.
hsa-mir-504	glioblastoma	down	Serum expression level of miR-504 can differentiate between glioblastoma multiforme and solitary brain metastasis of non-small cell lung carcinoma.
hsa-mir-504	glioblastoma	down	miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-?-catenin pathway.
hsa-mir-504	hypopharyngeal squamous cell carcinoma	down	microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma.
hsa-mir-504	hypopharyngeal squamous cell carcinoma	down	Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.
hsa-mir-504	osteosarcoma	up	MicroRNA-504 modulates osteosarcoma cell chemoresistance to cisplatin by targeting p53.
hsa-mir-504	osteosarcoma	up	miR-504 promotes tumour growth and metastasis in human osteosarcoma by targeting TP53INP1.
hsa-mir-504-3p	acute myeloid leukemia	down	Upregulation of miR-504-3p is associated with favorable prognosis of acute myeloid leukemia and may serve as a tumor suppressor by targeting MTHFD2.
hsa-mir-505	breast cancer	down	Downregulation of miR-505 promotes cell proliferation, migration and invasion, and predicts poor prognosis in breast cancer.
hsa-mir-505	endometrial cancer	down	MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-?.
hsa-mir-505	gastric cancer	down	MicroRNA-505 suppresses gastric cancer cell proliferation and invasion by directly targeting Polo-like kinase-1.
hsa-mir-505	glioblastoma	down	Combination with TMZ and miR-505 inhibits the development of glioblastoma by regulating the WNT7B/Wnt/?-catenin signaling pathway.
hsa-mir-505	hepatocellular carcinoma	down	MiR-505 suppressed the growth of hepatocellular carcinoma cells via targeting IGF-1R.
hsa-mir-505	hepatocellular carcinoma	down	MicroRNA-505 suppresses proliferation and invasion in hepatoma cells by directly targeting high-mobility group box 1.
hsa-mir-505	hepatocellular carcinoma	down	Identifying microRNA panels specifically associated with hepatocellular carcinoma and its different etiologies.
hsa-mir-505	hepatocellular carcinoma	down	miR-505 enhances doxorubicin-induced cytotoxicity in hepatocellular carcinoma through repressing the Akt pathway by directly targeting HMGB1.
hsa-mir-505	mesenchymal cancer	down	MicroRNA-505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion.
hsa-mir-505	osteosarcoma	down	MicroRNA-505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion.
hsa-mir-505	renal cell carcinoma	down	microRNA-505 negatively regulates HMGB1 to suppress cell proliferation in renal cell carcinoma.
hsa-mir-505-5p	cervical cancer	down	MicroRNA-505-5p functions as a tumor suppressor by targeting cyclin-dependent kinase 5 in cervical cancer.
hsa-mir-506	bladder cancer	down	MiR-506 inhibits cell proliferation, invasion, migration and epithelial-to-mesenchymal transition through targeting RWDD4 in human bladder cancer.
hsa-mir-506	breast cancer	down	Up-regulation of miR-506 inhibits cell growth and disrupt the cell cycle by targeting YAP in breast cancer cells.
hsa-mir-506	cervical cancer	down	Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.
hsa-mir-506	cervical cancer	down	miR-506 suppresses cervical cancer cell proliferation both in vitro and in vivo.
hsa-mir-506	colon cancer	down	MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2.
hsa-mir-506	colon cancer	up	Expression levels of miR-205 and miR-506 in colon cancer tissues and their relationships with clinicopathological features.
hsa-mir-506	colorectal cancer	down	miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1.
hsa-mir-506	colorectal cancer	down	MiR-506 Suppresses Colorectal Cancer Development by Inhibiting Orphan Nuclear Receptor NR4A1 Expression.
hsa-mir-506	colorectal cancer	down	miR-506 inhibits cell proliferation and invasion by targeting TET family in colorectal cancer.
hsa-mir-506	esophageal cancer	down	MicroRNA-506 inhibits esophageal cancer cell proliferation via targeting CREB1.
hsa-mir-506	gastric cancer	down	miR-506 Inhibits Epithelial-to-Mesenchymal Transition and Angiogenesis in Gastric Cancer.
hsa-mir-506	gastric cancer	down	MicroRNA-506 inhibits gastric cancer proliferation and invasion by directly targeting Yap1.
hsa-mir-506	gastric cancer	down	Reactivation of microRNA-506 inhibits gastric carcinoma cell metastasis through ZEB2.
hsa-mir-506	glioblastoma	down	miR-506 inhibits the proliferation and invasion by targeting IGF2BP1 in glioblastoma.
hsa-mir-506	glioma	down	miR-506 functions as a tumor suppressor in glioma by targeting STAT3.
hsa-mir-506	hepatocellular carcinoma	down	microRNA-506 regulates proliferation, migration and invasion in hepatocellular carcinoma by targeting F-spondin 1 (SPON1).
hsa-mir-506	hepatocellular carcinoma	down	MiR-506 suppresses cell proliferation and tumor growth by targeting Rho-associated protein kinase 1 in hepatocellular carcinoma.
hsa-mir-506	hepatocellular carcinoma	down	MiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3'UTR.
hsa-mir-506	liver cancer	down	MiR-506 suppresses liver cancer angiogenesis through targeting sphingosine kinase 1 (SPHK1) mRNA.
hsa-mir-506	lung cancer	down	Multipronged activity of combinatorial miR-143 and miR-506 inhibits Lung Cancer cell cycle progression and angiogenesis in vitro.
hsa-mir-506	nasopharyngeal carcinoma	down	MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/?-catenin signaling pathway by down-regulating LHX2.
hsa-mir-506	nasopharyngeal carcinoma	down	MiR-506 suppresses tumor proliferation and invasion by targeting FOXQ1 in nasopharyngeal carcinoma.
hsa-mir-506	neuroblastoma	down	miR-506 suppresses neuroblastoma metastasis by targeting ROCK1.
hsa-mir-506	oral squamous cell carcinoma	down	MicroRNA-506 suppresses growth and metastasis of oral squamous cell carcinoma via targeting GATA6.
hsa-mir-506	osteosarcoma	down	Overexpression of miR-506 suppresses proliferation and promotes apoptosis of osteosarcoma cells by targeting astrocyte elevated gene-1.
hsa-mir-506	pancreatic cancer	down	Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-?B signaling.
hsa-mir-506	pancreatic ductal adenocarcinoma	up	MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression.
hsa-mir-506	papillary thyroid carcinoma	down	MiR-506 suppresses papillary thyroid carcinoma cell proliferation and metastasis via targeting IL17RD.
hsa-mir-506	renal clear cell carcinoma	down	MiR-506 is down-regulated in clear cell renal cell carcinoma and inhibits cell growth and metastasis via targeting FLOT1.
hsa-mir-506	renal clear cell carcinoma	down	Correction: MiR-506 Is Down-Regulated in Clear Cell Renal Cell Carcinoma and Inhibits Cell Growth and Metastasis via Targeting FLOT1.
hsa-mir-506-3p	osteosarcoma	down	MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression.
hsa-mir-506-3p	retinoblastoma	down	MiR-506-3p inhibits cell proliferation, induces cell cycle arrest and apoptosis in retinoblastoma by directly targeting NEK6.
hsa-mir-508	renal clear cell carcinoma	down	MicroRNA-508 is downregulated in clear cell renal cell carcinoma and targets ZEB1 to suppress cell proliferation and invasion.
hsa-mir-508-3p	gastric cancer	down	miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-?B signaling in gastric carcinogenesis.
hsa-mir-508-3p	kidney cancer	down	Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma.
hsa-mir-508-5p	gastric cancer	down	MicroRNA-508-5p suppresses metastasis in human gastric cancer by targeting S-phase kinase?associated protein 2.
hsa-mir-508-5p	glioma	down	MiR-508-5p is a prognostic marker and inhibits cell proliferation and migration in glioma.
hsa-mir-508-5p	hepatocellular carcinoma	down	miR-508-5p acts as an anti-oncogene by targeting MESDC1 in hepatocellular carcinoma.
hsa-mir-509-3p	gastric cancer	down	MicroRNA-509-3p inhibits cancer cell proliferation and migration via upregulation of XIAP in gastric cancer cells.
hsa-mir-509-3p	glioma	down	MicroRNA-509-3p inhibits cell proliferation and invasion via downregulation of X-linked inhibitor of apoptosis in glioma.
hsa-mir-509-3p	kidney cancer	down	Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma.
hsa-mir-509-3p	ovarian cancer	down	miR-509-3p promotes cisplatin-induced apoptosis in ovarian cancer cells through the regulation of anti-apoptotic genes.
hsa-mir-509-3p	ovarian cancer	down	MicroRNA-509-3p increases the sensitivity of epithelial ovarian cancer cells to cisplatin-induced apoptosis.
hsa-mir-509-3p	renal cell carcinoma	down	MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
hsa-mir-509-5p	non-small cell lung cancer	down	The Tumor Suppressive Role of MiRNA-509-5p by Targeting FOXM1 in Non-Small Cell Lung Cancer.
hsa-mir-509-5p	non-small cell lung cancer	down	MiR-509-5p suppresses the proliferation, migration, and invasion of non-small cell lung cancer by targeting YWHAG.
hsa-mir-509-5p	pancreatic cancer	down	miR-509-5p inhibits cellular proliferation and migration via targeting MDM2 in pancreatic cancer cells.
hsa-mir-509-5p	papillary thyroid carcinoma	up	MiR-509-5p improves the proliferative and invasive abilities of papillary thyroid carcinoma cells by inhibiting SFRP1.
hsa-mir-509-5p	prostate cancer	down	Inhibition of invasion and migration of prostate cancer cells by miRNA-509-5p via targeting MDM2.
hsa-mir-509-5p	renal cell carcinoma	down	Tumor suppressive miR-509-5p contributes to cell migration, proliferation and antiapoptosis in renal cell carcinoma.
hsa-mir-5095	non-small cell lung cancer	down	Long noncoding RNA LINC01296 induces non-small cell lung cancer growth and progression through sponging miR-5095.
hsa-mir-510	breast cancer	up	MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer.
hsa-mir-510	non-small cell lung cancer	up	MicroRNA-510 Plays Oncogenic Roles in Non-Small Cell Lung Cancer by Directly Targeting SRC Kinase Signaling Inhibitor 1.
hsa-mir-510-5p	renal cell carcinoma	down	Downregulated microRNA-510-5p acts as a tumor suppressor in renal cell carcinoma.
hsa-mir-510-5p	thyroid cancer	up	microRNA-510-5p promotes thyroid cancer cell proliferation, migration, and invasion through suppressing SNHG15.
hsa-mir-5100	lung cancer	up	MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6.
hsa-mir-5100	lung cancer	up	miR-5100 promotes tumor growth in lung cancer by targeting Rab6.
hsa-mir-511	colorectal cancer	down	MicroRNA-511 inhibits cellular proliferation and invasion in colorectal cancer by directly targeting hepatoma-derived growth factor.
hsa-mir-511	hepatocellular carcinoma	down	circZFR promotes cell proliferation and migration by regulating miR-511/AKT1 axis in hepatocellular carcinoma.
hsa-mir-511	lung adenocarcinoma	down	miR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2.
hsa-mir-511-5p	colorectal cancer	down	MiR-511-5p functions as a tumor suppressor and a predictive of prognosis in colorectal cancer by directly targeting GPR116.
hsa-mir-512-3p	non-small cell lung cancer	down	Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer.
hsa-mir-512-5p	breast cancer	down	Epigenetic silencing of miR-296 and miR-512 ensures hTERT dependent apoptosis protection and telomere maintenance in basal-type breast cancer cells.
hsa-mir-512-5p	non-small cell lung cancer	down	miR-512-5p induces apoptosis and inhibits glycolysis by targeting p21 in non-small cell lung cancer cells.
hsa-mir-513	esophageal cancer	down	miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation.
hsa-mir-513a-5p	osteosarcoma	down	miR-513a-5p regulates radiosensitivity of osteosarcoma by targeting human apurinic/apyrimidinic endonuclease.
hsa-mir-513a-5p	osteosarcoma	down	miR-513a-5p regulates radiosensitivity of osteosarcoma by targeting human apurinic/apyrimidinic endonuclease.
hsa-mir-513b	gastric cancer	down	Upregulation of miR-513b inhibits cell proliferation, migration, and promotes apoptosis by targeting high mobility group-box 3 protein in gastric cancer.
hsa-mir-513c	neuroblastoma	down	MiR-513c suppresses neuroblastoma cell migration, invasion, and proliferation through direct targeting glutaminase (GLS).
hsa-mir-514	ovarian cancer	down	MiR-514 attenuates proliferation and increases chemoresistance by targeting ATP binding cassette subfamily in ovarian cancer.
hsa-mir-514a-3p	renal cell carcinoma	down	miR-514a-3p functions as a tumor suppressor in renal cell carcinoma.
hsa-mir-514a-3p	renal clear cell carcinoma	down	MiR-514a-3p inhibits cell proliferation and epithelial-mesenchymal transition by targeting EGFR in clear cell renal cell carcinoma.
hsa-mir-514b-3p	colorectal cancer	down	The distinct role of strand-specific miR-514b-3p and miR-514b-5p in colorectal cancer metastasis.
hsa-mir-515-5p	prostate cancer	down	MiR-515-5p acts as a tumor suppressor via targeting TRIP13 in prostate cancer.
hsa-mir-516a-3p	breast cancer	down	miR-516a-3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway.
hsa-mir-516a-5p	non-small cell lung cancer	down	MiR-516a-5p inhibits the proliferation of non-small cell lung cancer by targeting HIST3H2A.
hsa-mir-516b	esophageal squamous cell carcinoma	down	miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma.
hsa-mir-516b	non-small cell lung cancer	down	Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer.
hsa-mir-517a	breast cancer	down	Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines.
hsa-mir-517a	colorectal cancer	up	miR-517a is an independent prognostic marker and contributes to cell migration and invasion in human colorectal cancer.
hsa-mir-517a	glioma	up	miR-517a is up-regulated in glioma and promotes glioma tumorigenesis in vitro and in vivo.
hsa-mir-517a	hepatocellular carcinoma	up	miR-517a promotes Warburg effect in HCC by directly targeting FBP1.
hsa-mir-517c	glioblastoma	down	MIR517C inhibits autophagy and the epithelial-to-mesenchymal (-like) transition phenotype in human glioblastoma through KPNA2-dependent disruption of TP53 nuclear translocation.
hsa-mir-518a-3p	colorectal cancer	down	Downregulation of miR-518a-3p activates the NIK-dependent NF-?B pathway in colorectal cancer.
hsa-mir-518b	esophageal squamous cell carcinoma	down	miR-518b is down-regulated, and involved in cell proliferation and invasion by targeting Rap1b in esophageal squamous cell carcinoma.
hsa-mir-5195-3p	non-small cell lung cancer	down	MicroRNA-5195-3p plays a suppressive role in cell proliferation, migration and invasion by targeting MYO6 in human non-small cell lung cancer.
hsa-mir-5195-3p	osteosarcoma	down	miR-5195-3p Suppresses Cell Proliferation and Induces Apoptosis by Directly Targeting NEDD9 in Osteosarcoma.
hsa-mir-5195-3p	ovarian cancer	down	Downregulation of miR-4443 and miR-5195-3p in ovarian cancer tissue contributes to metastasis and tumorigenesis.
hsa-mir-519a	glioblastoma	down	miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
hsa-mir-519a	glioblastoma	down	MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway.
hsa-mir-519a	glioma	down	MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway.
hsa-mir-519a	hepatocellular carcinoma	up	MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma.
hsa-mir-519a	ovarian cancer	down	MicroRNA-519a inhibits the proliferation and promotes the apoptosis of ovarian cancer cells through targeting signal transducer and activator of transcription 3.
hsa-mir-519b-3p	colorectal cancer	down	MiR-519b-3p Inhibits the Proliferation and Invasion in Colorectal Cancer via Modulating the uMtCK/Wnt Signaling Pathway.
hsa-mir-519c-3p	hepatocellular carcinoma	up	MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3.
hsa-mir-519d	breast cancer	down	MiR-519d suppresses breast cancer tumorigenesis and metastasis via targeting MMP3.
hsa-mir-519d	breast cancer	down	miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression.
hsa-mir-519d	gastric cancer	down	MIR-519d suppresses the gastric cancer epithelial-mesenchymal transition via Twist1 and inhibits Wnt/?-catenin signaling pathway.
hsa-mir-519d	hepatocellular carcinoma	down	MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703.
hsa-mir-519d	hepatocellular carcinoma	up	In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.
hsa-mir-519d	lung adenocarcinoma	down	Overexpression of miR-519d in lung adenocarcinoma inhibits cell proliferation and invasion via the association of eIF4H.
hsa-mir-519d	malignant melanoma	up	MicroRNA-519d promotes melanoma progression by downregulating EphA4.
hsa-mir-519d	oral squamous cell carcinoma	down	Dysregulation of MiR-519d Affects Oral Squamous Cell Carcinoma Invasion and Metastasis by Targeting MMP3.
hsa-mir-519d	osteosarcoma	down	CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d.
hsa-mir-519d	ovarian cancer	down	MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP.
hsa-mir-519d	prostate cancer	down	MiR-519d inhibits prostate cancer cell proliferation, cycle and invasion via targeting NRBP1.
hsa-mir-519d-3p	breast cancer	down	MiR-519d-3p suppresses breast cancer cell growth and motility via targeting LIM domain kinase 1.
hsa-mir-519d-3p	cervical cancer	down	MicroRNA-519d-3p Inhibits Proliferation and Promotes Apoptosis by Targeting HIF-2? in Cervical Cancer Under Hypoxic Conditions.
hsa-mir-519d-3p	colorectal cancer	down	MicroRNA-519d-3p inhibits cell proliferation and migration by targeting TROAP in colorectal cancer.
hsa-mir-519d-3p	gastric cancer	down	miR-519d-3p Inhibits Cell Proliferation and Invasion of Gastric Cancer by Downregulating B-Cell Lymphoma 6.
hsa-mir-520a	hepatocellular carcinoma	down	MicroRNA-218 and microRNA-520a inhibit cell proliferation by downregulating E2F2 in hepatocellular carcinoma.
hsa-mir-520a-3p	breast cancer	down	Suppressing role of miR-520a-3p in breast cancer through CCND1 and CD44.
hsa-mir-520a-3p	non-small cell lung cancer	down	microRNA-520a-3p inhibits proliferation and cancer stem cell phenotype by targeting HOXD8 in non-small cell lung cancer.
hsa-mir-520a-3p	non-small cell lung cancer	down	The microRNA-520a-3p inhibits proliferation, apoptosis and metastasis by targeting MAP3K2 in non-small cell lung cancer.
hsa-mir-520a-3p	small cell lung cancer	down	microRNA-520a-3p inhibits proliferation and cancer stem cell phenotype by targeting HOXD8 in non-small cell lung cancer.
hsa-mir-520b	breast cancer	down	Identification of chemoresistance-associated miRNAs in breast cancer.
hsa-mir-520b	colorectal cancer	down	MicroRNA-520b Functions as a Tumor Suppressor in Colorectal Cancer by Inhibiting DCUN1D1.
hsa-mir-520b	glioma	down	MiR-520b inhibits the development of glioma by directly targeting MBD2.
hsa-mir-520b	hepatocellular carcinoma	down	MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA.
hsa-mir-520b	lung cancer	down	MiR-520b restrains cell growth by targeting HDAC4 in lung cancer.
hsa-mir-520b	non-small cell lung cancer	up	MiR-520b promotes the progression of non-small cell lung cancer through activating Hedgehog pathway.
hsa-mir-520b	non-small cell lung cancer	down	Role of miR-520b in non-small cell lung cancer.
hsa-mir-520b	ovarian cancer	up	Upregulation of miR-520b promotes ovarian cancer growth.
hsa-mir-520c	breast cancer	up	The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis.
hsa-mir-520c	glioma	down	MicroRNA-520c inhibits glioma cell migration and invasion by the suppression of transforming growth factor-? receptor type 2.
hsa-mir-520c-3p	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-520c-3p	hepatocellular carcinoma	down	MicroRNA-520c-3p inhibits hepatocellular carcinoma cell proliferation and invasion through induction of cell apoptosis by targeting glypican-3.
hsa-mir-520c-3p	hepatocellular carcinoma	down	HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
hsa-mir-520c-3p	papillary thyroid carcinoma	down	Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
hsa-mir-520d-3p	breast cancer	down	MiR-520d-3p antitumor activity in human breast cancer via post-transcriptional regulation of spindle and kinetochore associated 2 expression.
hsa-mir-520d-3p	gastric cancer	down	MicroRNA 520d-3p inhibits gastric cancer cell proliferation, migration, and invasion by downregulating EphA2 expression.
hsa-mir-520d-3p	hepatocellular carcinoma	down	Deregulation of miR-520d-3p promotes hepatocellular carcinoma development via lncRNA MIAT regulation and EPHA2 signaling activation.
hsa-mir-520d-3p	osteosarcoma	down	MicroRNA-520d-3p inhibits osteosarcoma progression by degradation of Akt1.
hsa-mir-520d-5p	colorectal cancer	down	SP1-mediated microRNA-520d-5p suppresses tumor growth and metastasis in colorectal cancer by targeting CTHRC1.
hsa-mir-520d-5p	glioma	down	MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1.
hsa-mir-520e	breast cancer	up	miR-520e regulates cell proliferation, apoptosis and migration in breast cancer.
hsa-mir-520e	glioma	down	MicroRNA-520e restricts the proliferation and invasion of glioma cells through the downregulation of Wnt/?-catenin signaling by targeting fibroblast growth factor 19.
hsa-mir-520f	gastric cancer	down	MicroRNA-520f suppresses growth of gastric carcinoma cells by target ATPase family AAA domain-containing protein 2 (ATAD2).
hsa-mir-520f	hepatocellular carcinoma	up	MiR-520f promotes cell aggressiveness by regulating fibroblast growth factor 16 in hepatocellular carcinoma.
hsa-mir-520f	lung cancer	down	MiR-520f acts as a biomarker for the diagnosis of lung cancer.
hsa-mir-520g	breast cancer	up	Study on the relationship between miR-520g and the development of breast cancer.
hsa-mir-520g	hepatocellular carcinoma	up	MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7.
hsa-mir-522	endometrial cancer	up	miR-522 facilitates the prosperities of endometrial carcinoma cells by directly binding to monoamine oxidase B.
hsa-mir-522	hepatocellular carcinoma	up	miR-522 contributes to cell proliferation of hepatocellular carcinoma by targeting DKK1 and SFRP2.
hsa-mir-522	hepatocellular carcinoma	up	Upregulation of miR-522 is associated with poor outcome of hepatocellular carcinoma.
hsa-mir-522-3p	colorectal cancer	up	miR-522-3p Promotes Tumorigenesis in Human Colorectal Cancer via Targeting Bloom Syndrome Protein.
hsa-mir-524	glioma	down	MicroRNA-524 inhibits the progress of glioma via the direct targeting of NCF2.
hsa-mir-524	osteosarcoma	up	MicroRNA-524 promotes cell proliferation by down-regulating PTEN expression in osteosarcoma.
hsa-mir-524	thyroid cancer	down	MiR-524 inhibits cell proliferation and induces cell apoptosis in thyroid cancer via targeting SPAG9.
hsa-mir-524-5p	gastric cancer	down	Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9.
hsa-mir-524-5p	gastric cancer	down	MicroRNA-524-5p suppresses the growth and invasive abilities of gastric cancer cells.
hsa-mir-525-3p	liver cancer	up	MiR-525-3p Enhances the Migration and Invasion of Liver Cancer Cells by Downregulating ZNF395.
hsa-mir-525-5p	laryngeal cancer	up	New miRNA expression abnormalities in laryngeal squamous cell carcinoma.
hsa-mir-526b	breast cancer	up	COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation.
hsa-mir-526b	breast cancer	up	miR526b and miR655 Induce Oxidative Stress in Breast Cancer.
hsa-mir-526b	cervical cancer	down	By downregulating PBX3, miR-526b suppresses the epithelial-mesenchymal transition process in cervical cancer cells.
hsa-mir-526b	gastric cancer	down	Circ_SPECC1 enhances the inhibition of miR-526b on downstream KDM4A/YAP1 pathway to regulate the growth and invasion of gastric cancer cells.
hsa-mir-526b	hepatocellular carcinoma	down	microRNA-526b servers as a prognostic factor and exhibits tumor suppressive property by targeting Sirtuin 7 in hepatocellular carcinoma.
hsa-mir-526b	non-small cell lung cancer	down	By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer.
hsa-mir-526b-3p	colon cancer	down	miR-526b-3p functions as a tumor suppressor in colon cancer by regulating HIF-1?.
hsa-mir-526b-3p	glioma	down	miR-526b-3p serves as a prognostic factor and regulates the proliferation, invasion, and migration of glioma through targeting WEE1.
hsa-mir-527	glioma	up	Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-532	colorectal cancer	down	microRNA-532 suppresses the PI3K/Akt signaling pathway to inhibit colorectal cancer progression by directly targeting IGF-1R.
hsa-mir-532	gastric cancer	up	miR-532 promoted gastric cancer migration and invasion by targeting NKD1.
hsa-mir-532	ovarian cancer	down	MicroRNA-532 and microRNA-3064 inhibit cell proliferation and invasion by acting as direct regulators of human telomerase reverse transcriptase in ovarian cancer.
hsa-mir-532-3p	hepatocellular carcinoma	up	miR-532-3p promotes hepatocellular carcinoma progression by targeting PTPRT.
hsa-mir-532-3p	ovarian cancer	down	Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.
hsa-mir-532-5p	bladder cancer	down	Downregulation of microRNA-532-5p promotes the proliferation and invasion of bladder cancer cells through promotion of HMGB3/Wnt/?-catenin signaling.
hsa-mir-532-5p	colorectal cancer	up	Oncogenic role of microRNA-532-5p in human colorectal cancer via targeting of the 5'UTR of RUNX3.
hsa-mir-532-5p	gastric cancer	down	LINC01410-miR-532-NCF2-NF-kB feedback loop promotes gastric cancer angiogenesis and metastasis.
hsa-mir-532-5p	kidney cancer	down	MiR-532-5p suppresses renal cancer cell proliferation by disrupting the ETS1-mediated positive feedback loop with the KRAS-NAP1L1/P-ERK axis.
hsa-mir-532-5p	malignant melanoma	up	Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
hsa-mir-532-5p	ovarian carcinoma	down	MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features.
hsa-mir-532-5p	retinoblastoma	down	Computational and in vitro Investigation of miRNA-Gene Regulations in Retinoblastoma Pathogenesis: miRNA Mimics Strategy.
hsa-mir-539	breast cancer	down	miR-539 acts as a tumor suppressor by targeting epidermal growth factor receptor in breast cancer.
hsa-mir-539	colorectal cancer	down	MicroRNA-539 inhibits colorectal cancer progression by directly targeting SOX4.
hsa-mir-539	colorectal cancer	down	miR-539 inhibits human colorectal cancer progression by targeting RUNX2.
hsa-mir-539	gastric cancer	down	Downregulation miR-539 is associated with poor prognosis of gastric cancer patients and aggressive progression of gastric cancer cells.
hsa-mir-539	glioma	down	MicroRNA-539 inhibits glioma cell proliferation and invasion by targeting DIXDC1.
hsa-mir-539	hepatocellular carcinoma	down	microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
hsa-mir-539	hepatocellular carcinoma	down	miR-539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion.
hsa-mir-539	hepatocellular carcinoma	down	Down-regulation of MAP2K1 by miR-539 inhibits hepatocarcinoma progression.
hsa-mir-539	nasopharyngeal carcinoma	down	miR-539 induces cell cycle arrest in nasopharyngeal carcinoma by targeting cyclin-dependent kinase 4.
hsa-mir-539	osteosarcoma	down	MicroRNA-539 suppresses osteosarcoma cell invasion and migration in vitro and targeting Matrix metallopeptidase-8.
hsa-mir-539	pancreatic cancer	down	MiR-539 functions as a tumor suppressor in pancreatic cancer by targeting TWIST1.
hsa-mir-539	papillary thyroid carcinoma	down	microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor ?1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
hsa-mir-539	prostate cancer	down	miR-539 inhibits prostate cancer progression by directly targeting SPAG5.
hsa-mir-539	thyroid cancer	down	MiR-539 inhibits thyroid cancer cell migration and invasion by directly targeting CARMA1.
hsa-mir-539-5p	glioma	down	Long Non-coding RNA LINC00339 Stimulates Glioma Vasculogenic Mimicry Formation by Regulating the miR-539-5p/TWIST1/MMPs Axis.
hsa-mir-541	pancreatic ductal adenocarcinoma	up	Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
hsa-mir-541-3p	non-small cell lung cancer	down	MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer.
hsa-mir-542-3p	astrocytoma	down	MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma.
hsa-mir-542-3p	bladder cancer	down	MicroRNA-542-3p suppresses cellular proliferation of bladder cancer cells through post-transcriptionally regulating survivin.
hsa-mir-542-3p	colorectal cancer	down	miR-542-3p inhibits the growth and invasion of colorectal cancer cells through targeted regulation of cortactin.
hsa-mir-542-3p	colorectal cancer	down	miR-542-3p inhibits colorectal cancer cell proliferation, migration and invasion by targeting OTUB1.
hsa-mir-542-3p	gastric cancer	down	MicroRNA-542-3p suppresses cell growth of gastric cancer cells via targeting oncogene astrocyte-elevated gene-1.
hsa-mir-542-3p	glioblastoma	down	MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma.
hsa-mir-542-3p	hepatocellular carcinoma	down	MicroRNA-542-3p inhibits the growth of hepatocellular carcinoma cells by targeting FZD7/Wnt signaling pathway.
hsa-mir-542-3p	hepatocellular carcinoma	down	MicroRNA-542-3p functions as a tumor suppressor via directly targeting survivin in hepatocellular carcinoma.
hsa-mir-542-3p	hepatocellular carcinoma	down	Downregulation of miR-542-3p promotes cancer metastasis through activating TGF-?/Smad signaling in hepatocellular carcinoma.
hsa-mir-542-3p	malignant melanoma	down	miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine/threonine protein kinase, PIM1, in melanoma.
hsa-mir-542-3p	non-small cell lung cancer	down	MiR-542-3p exerts tumor suppressive functions in non-small cell lung cancer cells by upregulating FTSJ2.
hsa-mir-542-3p	oral squamous cell carcinoma	up	[Expression and correlation of survivin and hsa-miR-542-3p in patients with oral squamous cell carcinoma].
hsa-mir-542-3p	oral squamous cell carcinoma	down	MicroRNA-542-3p inhibits oral squamous cell carcinoma progression by inhibiting ILK/TGF-?1/Smad2/3 signaling.
hsa-mir-542-3p	osteosarcoma	up	Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
hsa-mir-542-3p	osteosarcoma	down	MicroR-542-3p can mediate ILK and further inhibit cell proliferation, migration and invasion in osteosarcoma cells.
hsa-mir-542-5p	basal cell carcinoma	up	Expression of microRNAs in basal cell carcinoma.
hsa-mir-542-5p	non-small cell lung cancer	down	The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model.
hsa-mir-542-5p	osteosarcoma	up	MiR-542-5p is a negative prognostic factor and promotes osteosarcoma tumorigenesis by targeting HUWE1.
hsa-mir-543	colorectal cancer	down	MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
hsa-mir-543	colorectal cancer	up	miR-543 promotes colorectal cancer proliferation and metastasis by targeting KLF4.
hsa-mir-543	endometrial cancer	down	MicroRNA-543 suppresses endometrial cancer oncogenicity via targeting FAK and TWIST1 expression.
hsa-mir-543	gastric cancer	up	miR-543 promotes gastric cancer cell proliferation by targeting SIRT1.
hsa-mir-543	gastric cancer	up	miRNA-543 promotes cell migration and invasion by targeting SPOP in gastric cancer.
hsa-mir-543	glioma	down	miR-543 functions as a tumor suppressor in glioma in vitro and in vivo.
hsa-mir-543	liver cancer	down	MicroRNA-543 suppresses liver cancer growth and induces apoptosis via the JAK2/STAT3 signaling pathway.
hsa-mir-543	osteosarcoma	up	MiRNA-543 promotes osteosarcoma cell proliferation and glycolysis by partially suppressing PRMT9 and stabilizing HIF-1? protein.
hsa-mir-543	prostate cancer	up	MiR-543 Promotes Proliferation and Epithelial-Mesenchymal Transition in Prostate Cancer via Targeting RKIP.
hsa-mir-543	prostate cancer	down	MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase.
hsa-mir-543	renal cell carcinoma	up	MiR-543 promotes cell proliferation and metastasis of renal cell carcinoma by targeting Dickkopf 1 through the Wnt/?-catenin signaling pathway.
hsa-mir-544	breast cancer	down	MicroRNA-544 down-regulates both Bcl6 and Stat3 to inhibit tumor growth of human triple negative breast cancer.
hsa-mir-544	cervical cancer	down	Transcription factor KLF4 regulates microRNA-544 that targets YWHAZ in cervical cancer.
hsa-mir-544	colorectal cancer	up	MicroRNA-544 promotes colorectal cancer progression by targeting forkhead box O1.
hsa-mir-544	gastric cancer	up	Oncogenic miR-544 is an Important Molecular Target in Gastric Cancer.
hsa-mir-544	glioma	down	MicroRNA-544 inhibits glioma proliferation, invasion and migration but induces cell apoptosis by targeting PARK7.
hsa-mir-544	liver cancer	up	MiR-544 promotes immune escape through downregulation of NCR1/NKp46 via targeting RUNX3 in liver cancer.
hsa-mir-544a	breast cancer	up	miR-544a Promotes Breast Cancer Cell Migration and Invasion Reducing Cadherin 1 Expression.
hsa-mir-544a	lung cancer	up	TINCR suppresses proliferation and invasion through regulating miR-544a/FBXW7 axis in lung cancer.
hsa-mir-544a	lung cancer	down	LEF1-AS1 contributes to proliferation and invasion through regulating miR-544a/ FOXP1 axis in lung cancer.
hsa-mir-545	gastric cancer	down	MiRNA-545 negatively regulates the oncogenic activity of EMS1 in gastric cancer.
hsa-mir-545	hepatocellular carcinoma	up	Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma.
hsa-mir-545	lung cancer	down	MicroRNA-545 Suppresses Cell Proliferation by Targeting Cyclin D1 and CDK4 in Lung Cancer Cells.
hsa-mir-548a-5p	hepatocellular carcinoma	up	MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
hsa-mir-548b	glioma	down	miR-548b inhibits the proliferation and invasion of malignant gliomas by targeting metastasis tumor-associated protein-2.
hsa-mir-548b-3p	hepatocellular carcinoma	down	miR-548b-3p Regulates Proliferation, Apoptosis, and Mitochondrial Function by Targeting CIP2A in Hepatocellular Carcinoma.
hsa-mir-548c	ovarian cancer	down	MiR-548c impairs migration and invasion of endometrial and ovarian cancer cells via downregulation of Twist.
hsa-mir-548c-3p	glioma	down	MicroRNA-548c-3p inhibits T98G glioma cell proliferation and migration by downregulating c-Myb.
hsa-mir-548c-3p	papillary thyroid carcinoma	down	MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1?-mediated VEGF signaling pathway.
hsa-mir-548c-5p	colorectal cancer	down	miR-548c-5p inhibits colorectal cancer cell proliferation by targeting PGK1.
hsa-mir-548d-3p	oral squamous cell carcinoma	up	LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma.
hsa-mir-548d-3p	osteosarcoma	down	miR-548d-3p inhibits osteosarcoma by downregulating KRAS.
hsa-mir-548k	esophageal squamous cell carcinoma	up	Up-regulated miR-548k promotes esophageal squamous cell carcinoma progression via targeting long noncoding RNA-LET.
hsa-mir-548p	hepatocellular carcinoma	down	MicroRNA-548p suppresses hepatitis B virus X protein associated hepatocellular carcinoma by downregulating oncoprotein HBXIP.
hsa-mir-550a-3p	non-small cell lung cancer	up	MiR-550a-3p promotes non-small cell lung cancer cell proliferation and metastasis through down-regulating TIMP2.
hsa-mir-551a	colorectal cancer	down	Extracellular metabolic energetics can promote cancer progression.
hsa-mir-551a	ovarian cancer	down	Demethoxycurcumin inhibited human epithelia ovarian cancer cells' growth via up-regulating miR-551a.
hsa-mir-551b	colorectal cancer	down	Decreased expression of miR-551b predicts poor prognosis and promotes tumorigenesis by targeting PTP4A3 in human colorectal cancer.
hsa-mir-551b	gastric cancer	down	miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting ERBB4 expression.
hsa-mir-551b-3p	gastric cancer	down	Serum miR-551b-3p is a potential diagnostic biomarker for gastric cancer.
hsa-mir-551b-3p	gastric cancer	down	Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.
hsa-mir-551b-3p	ovarian cancer	up	Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer.
hsa-mir-552	colorectal cancer	up	MicroRNA-552 promotes tumor cell proliferation and migration by directly targeting DACH1 via the Wnt/?-catenin signaling pathway in colorectal cancer.
hsa-mir-552	colorectal cancer	up	Increased expression of miR-552 acts as a potential predictor biomarker for poor prognosis of colorectal cancer.
hsa-mir-552	colorectal cancer	up	miR-552-5p facilitates osteosarcoma cell proliferation and metastasis by targeting WIF1.
hsa-mir-552	hepatocellular carcinoma	up	MicroRNA-552 promotes hepatocellular carcinoma progression by downregulating WIF1.
hsa-mir-552	hepatocellular carcinoma	up	MiR-552 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells by inhibiting AJAP1 expression.
hsa-mir-552	osteosarcoma	up	MicroRNA-552 promotes migration and invasion of osteosarcoma through targeting TIMP2.
hsa-mir-552-5p	osteosarcoma	up	miR-552-5p facilitates osteosarcoma cell proliferation and metastasis by targeting WIF1.
hsa-mir-556-3p	bladder cancer	up	miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.
hsa-mir-556-3p	esophageal cancer	up	MicroRNA-556-3p promotes the progression of esophageal cancer via targeting DAB2IP.
hsa-mir-558	gastric cancer	up	miRNA-558 promotes gastric cancer progression through attenuating Smad4-mediated repression of heparanase expression.
hsa-mir-558	neuroblastoma	up	microRNA-558 facilitates the expression of hypoxia-inducible factor 2 alpha through binding to 5'-untranslated region in neuroblastoma.
hsa-mir-5582-3p	glioma	down	Hsa-miR-5582-3P regulatory effect on TGF? signaling through targeting of TGF?-R1, TGF?-R2, SMAD3, and SMAD4 transcripts.
hsa-mir-5590-3p	gastric cancer	down	miR-5590-3p inhibited tumor growth in gastric cancer by targeting DDX5/AKT/m-TOR pathway.
hsa-mir-561	gastric cancer	down	MicroRNA-561 inhibits gastric cancercell proliferation and invasion by downregulating c-Myc expression.
hsa-mir-562	glioblastoma	down	MicroRNA-562 negatively regulated c-MET/AKT pathway in the growth of glioblastoma cells.
hsa-mir-564	chronic myelogenous leukemia	down	Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.
hsa-mir-564	gastric cancer	down	miR-564 is downregulated in gastric carcinoma and targets E2F3.
hsa-mir-564	glioblastoma	down	MicroRNA-564 is downregulated in glioblastoma and inhibited proliferation and invasion of glioblastoma cells by targeting TGF-?1.
hsa-mir-564	hepatocellular carcinoma	down	miR-564 inhibits hepatocellular carcinoma cell proliferation and invasion by targeting the GRB2-ERK1/2-AKT axis.
hsa-mir-564	lung cancer	down	MiR-564 functions as a tumor suppressor in human lung cancer by targeting ZIC3.
hsa-mir-564	osteosarcoma	down	MiR-564 is down-regulated in osteosarcoma and inhibits the proliferation of osteosarcoma cells via targeting Akt.
hsa-mir-566	glioma	up	MicroRNA-566 activates EGFR signaling and its inhibition sensitizes glioblastoma cells to nimotuzumab.
hsa-mir-566	renal cell carcinoma	up	miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma.
hsa-mir-567	breast cancer	down	MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration.
hsa-mir-567	osteosarcoma	down	MicroRNA-567 inhibits cell proliferation, migration and invasion by targeting FGF5 in osteosarcoma.
hsa-mir-5691	papillary thyroid carcinoma	up	Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.
hsa-mir-5692a	hepatocellular carcinoma	up	MiR-5692a promotes proliferation and inhibits apoptosis by targeting HOXD8 in hepatocellular carcinoma.
hsa-mir-5692a	hepatocellular carcinoma	up	MiR-5692a promotes the invasion and metastasis of hepatocellular carcinoma via MMP9.
hsa-mir-570	chronic myelogenous leukemia	down	MiR-570 inhibits cell proliferation and glucose metabolism by targeting IRS1 and IRS2 in human chronic myelogenous leukemia.
hsa-mir-570	hepatocellular carcinoma	up	MiR-570 inhibited the cell proliferation and invasion through directly targeting B7-H1 in hepatocellular carcinoma.
hsa-mir-570	lung cancer	up	MicroRNA-570 promotes lung carcinoma proliferation through targeting tumor suppressor KLF9.
hsa-mir-5703	ovarian cancer	up	Clinical Impact of microRNAs Associated With Cancer Stem Cells as a Prognostic Factor in Ovarian Carcinoma.
hsa-mir-572	basal cell carcinoma	down	Expression of microRNAs in basal cell carcinoma.
hsa-mir-572	nasopharyngeal carcinoma	down	Interaction between miR-572 and PPP2R2C, and their effects on the proliferation, migration, and invasion of nasopharyngeal carcinoma (NPC) cells.
hsa-mir-572	ovarian cancer	up	Upregulation of MiR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression.
hsa-mir-572	renal cell carcinoma	up	A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma.
hsa-mir-573	hepatocellular carcinoma	up	The miR-573/apoM/Bcl2A1-dependent signal transduction pathway is essential for hepatocyte apoptosis and hepatocarcinogenesis.
hsa-mir-573	malignant melanoma	down	miR-573 regulates melanoma progression by targeting the melanoma cell adhesion molecule.
hsa-mir-573	prostate cancer	down	miR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition.
hsa-mir-574	chronic myelogenous leukemia	down	microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.
hsa-mir-574-3p	breast cancer	down	Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines.
hsa-mir-574-3p	chronic myelogenous leukemia	down	Overexpression of miR-574-3p suppresses proliferation and induces apoptosis of chronic myeloid leukemia cells via targeting IL6/JAK/STAT3 pathway.
hsa-mir-574-3p	esophageal cancer	down	Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-574-3p	gastric cancer	down	MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells.
hsa-mir-574-3p	hepatocellular carcinoma	up	Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.
hsa-mir-574-3p	osteosarcoma	down	miR-574-3p acts as a tumor promoter in osteosarcoma by targeting SMAD4 signaling pathway.
hsa-mir-574-5p	colorectal cancer	down	Hsa-miR-574-5p negatively regulates MACC-1 expression to suppress colorectal cancer liver metastasis.
hsa-mir-574-5p	colorectal cancer	up	Long noncoding RNA LINC00052 inhibits colorectal cancer metastasis by sponging microRNA-574-5p to modulate CALCOCO1 expression.
hsa-mir-575	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-575	hepatocellular carcinoma	up	Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.
hsa-mir-576-3p	bladder cancer	down	MicroRNA-576-3p Inhibits Proliferation in Bladder Cancer Cells by Targeting Cyclin D1.
hsa-mir-576-3p	bladder cancer	down	MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer.
hsa-mir-576-5p	glioblastoma	up	miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.
hsa-mir-577	colorectal cancer	down	microRNA-577 suppresses tumor growth and enhances chemosensitivity in colorectal cancer.
hsa-mir-577	gastric cancer	up	miR-577 Regulates TGF-? Induced Cancer Progression through a SDPR-Modulated Positive-Feedback Loop with ERK-NF-?B in Gastric Cancer.
hsa-mir-577	gastric cancer	down	MicroRNA-577 inhibits gastric cancer growth by targeting E2F transcription factor 3.
hsa-mir-577	glioblastoma	down	miR-577 inhibits glioblastoma tumor growth via the Wnt signaling pathway.
hsa-mir-577	hepatocellular carcinoma	down	Inhibition effect of miR-577 on hepatocellular carcinoma cell growth via targeting ?-catenin.
hsa-mir-577	non-small cell lung cancer	down	miR-577 suppresses cell proliferation and epithelial-mesenchymal transition by regulating the WNT2B mediated Wnt/?-catenin pathway in non-small cell lung cancer.
hsa-mir-577	papillary thyroid carcinoma	down	MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2.
hsa-mir-582	colorectal cancer	up	MicroRNA-582 promotes tumorigenesis by targeting phosphatase and tensin homologue in colorectal cancer.
hsa-mir-582-3p	prostate cancer	down	miR-582-3p and miR-582-5p Suppress Prostate Cancer Metastasis to Bone by Repressing TGF-? Signaling.
hsa-mir-582-5p	colorectal cancer	down	Upregulation of miR-582-5p inhibits cell proliferation, cell cycle progression and invasion by targeting Rab27a in human colorectal carcinoma.
hsa-mir-582-5p	colorectal cancer	up	miR-582-5P induces colorectal cancer cell proliferation by targeting adenomatous polyposis coli.
hsa-mir-582-5p	gastric cancer	down	MicroRNA-582-5p suppressed gastric cancer cell proliferation via targeting AKT3.
hsa-mir-582-5p	hepatocellular carcinoma	down	miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3.
hsa-mir-582-5p	non-small cell lung cancer	down	miR-582-5p is a potential prognostic marker in human non-small cell lung cancer and functions as a tumor suppressor by targeting MAP3K2.
hsa-mir-582-5p	non-small cell lung cancer	down	MicroRNA-582-5p suppresses non-small cell lung cancer cells growth and invasion via downregulating NOTCH1.
hsa-mir-582-5p	prostate cancer	down	miR-582-3p and miR-582-5p Suppress Prostate Cancer Metastasis to Bone by Repressing TGF-? Signaling.
hsa-mir-584	anaplastic thyroid carcinoma	up	TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells.
hsa-mir-584	esophageal squamous cell carcinoma	up	A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.
hsa-mir-584	glioma	down	MicroRNA-584 functions as a tumor suppressor and targets PTTG1IP in glioma.
hsa-mir-584	glioma	up	Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-584	non-small cell lung cancer	down	MicroRNA-584 inhibits cell proliferation and invasion in non-small cell lung cancer by directly targeting MTDH.
hsa-mir-584-3p	colorectal cancer	down	A novel lncRNA LOC101927746 accelerates progression of colorectal cancer via inhibiting miR-584-3p and activating SSRP1.
hsa-mir-584-3p	gastric cancer	down	miRNA-584-3p inhibits gastric cancer progression by repressing Yin Yang 1- facilitated MMP-14 expression.
hsa-mir-585	gastric cancer	down	MicroRNA-585 suppresses tumor proliferation and migration in gastric cancer by directly targeting MAPK1.
hsa-mir-585	non-small cell lung cancer	down	MicroRNA-585 acts as a tumor suppressor in non-small-cell lung cancer by targeting hSMG-1.
hsa-mir-586	osteosarcoma	up	Downregulation of microRNA-586 Inhibits Proliferation, Invasion and Metastasis and Promotes Apoptosis in Human Osteosarcoma U2-OS Cell Line.
hsa-mir-588	breast cancer	down	MicroRNA-588 is downregulated and may have prognostic and functional roles in human breast cancer.
hsa-mir-588	gastric cancer	down	MicroRNA-588 regulates invasion, migration and epithelial-mesenchymal transition via targeting EIF5A2 pathway in gastric cancer.
hsa-mir-588	lung squamous cell carcinoma	down	MicroRNA-588 suppresses tumor cell migration and invasion by targeting GRN in lung squamous cell carcinoma.
hsa-mir-588	prostate cancer	up	MicroRNA-588 is upregulated in human prostate cancer with prognostic and functional implications.
hsa-mir-589	gastric cancer	up	miR-589 promotes gastric cancer aggressiveness by a LIFR-PI3K/AKT-c-Jun regulatory feedback loop.
hsa-mir-589	non-small cell lung cancer	down	Hypermethylation of miRNA-589 promoter leads to upregulation of HDAC5 which promotes malignancy in non-small cell lung cancer.
hsa-mir-589-5p	endometrial cancer	down	Targeting Thyroid Receptor Interacting Protein 6 by MicroRNA-589-5p Inhibits Cell Proliferation, Migration, and Invasion in Endometrial Carcinoma.
hsa-mir-589-5p	hepatocellular carcinoma	up	Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling.
hsa-mir-589-5p	hepatocellular carcinoma	down	miR-589-5p inhibits MAP3K8 and suppresses CD90(+) cancer stem cells in hepatocellular carcinoma.
hsa-mir-590	non-small cell lung cancer	down	microRNA-590 suppresses the tumorigenesis and invasiveness of non-small cell lung cancer cells by targeting ADAM9.
hsa-mir-590-3p	breast cancer	down	MiR-590-3p Inhibits Proliferation and Promotes Apoptosis by Targeting Activating Transcription Factor 3 in Human Breast Cancer Cells.
hsa-mir-590-3p	colon cancer	up	Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR S
hsa-mir-590-3p	colon cancer	up	MiR-590-3p promotes proliferation and metastasis of colorectal cancer via Hippo pathway.
hsa-mir-590-3p	colon cancer	up	[Expression and proliferative regulation of miR-204 related to mitochondrial transcription factor A in colon cancer].
hsa-mir-590-3p	colon cancer	up	miR-590-3p promotes colon cancer cell proliferation via Wnt/?-catenin signaling pathway by inhibiting WIF1 and DKK1.
hsa-mir-590-3p	glioblastoma	up	MicroRNA-590-3p enhances the radioresistance in glioblastoma cells by targeting LRIG1.
hsa-mir-590-3p	glioblastoma	down	miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2.
hsa-mir-590-3p	glioma	down	Inhibition of the aberrant A1CF-FAM224A-miR-590-3p-ZNF143 positive feedback loop attenuated malignant biological behaviors of glioma cells.
hsa-mir-590-3p	hepatocellular carcinoma	down	Identifying key regulating miRNAs in hepatocellular carcinomas by an omics' method.
hsa-mir-590-3p	hepatocellular carcinoma	down	MiR-590-3p suppresses hepatocellular carcinoma growth by targeting TEAD1.
hsa-mir-590-3p	osteosarcoma	down	miR-590-3p is a novel microRNA which suppresses osteosarcoma progression by targeting SOX9.
hsa-mir-590-3p	ovarian cancer	up	miR-590-3p Targets Cyclin G2 and FOXO3 to Promote Ovarian Cancer Cell Proliferation, Invasion, and Spheroid Formation.
hsa-mir-590-3p	ovarian cancer	up	miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2-Versican Pathway.
hsa-mir-590-3p	prostate cancer	up	MicroRNA-590-3p promotes cell proliferation and invasion by targeting inositol polyphosphate 4-phosphatase type II in human prostate cancer cells.
hsa-mir-590-5p	breast cancer	down	MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-?-catenin si
hsa-mir-590-5p	breast cancer	down	MicroRNA miR-590-5p inhibits breast cancer cell stemness and metastasis by targeting SOX2.
hsa-mir-590-5p	cervical cancer	up	MicroRNA-590 Promotes Cervical Cancer Cell Growth and Invasion by Targeting CHL1.
hsa-mir-590-5p	colorectal cancer	up	Hypoxia-induced microRNA-590-5p promotes colorectal cancer progression by modulating matrix metalloproteinase activity.
hsa-mir-590-5p	colorectal cancer	down	MiR-590-5p inhibits colorectal cancer angiogenesis and metastasis by regulating nuclear factor 90/vascular endothelial growth factor A axis.
hsa-mir-590-5p	gastric cancer	up	miR-590-5p regulates gastric cancer cell growth and chemosensitivity through RECK and the AKT/ERK pathway.
hsa-mir-590-5p	hepatocellular carcinoma	up	MicroRNA-590-5p regulates proliferation and invasion in human hepatocellular carcinoma cells by targeting TGF-? RII.
hsa-mir-590-5p	hepatocellular carcinoma	down	MiR-590-5P Inhibits Growth of HepG2 Cells via Decrease of S100A10 Expression and Inhibition of the Wnt Pathway.
hsa-mir-590-5p	liver cancer	up	miR-590-5p promotes liver cancer growth and chemotherapy resistance through directly targeting FOXO1.
hsa-mir-590-5p	malignant melanoma	down	[miR-590-5p inhibits A375 cell invasion and migration in malignant melanoma by directly inhibiting YAP1 expression].
hsa-mir-590-5p	non-small cell lung cancer	down	MicroRNA-590-5p suppresses the proliferation and invasion of non-small cell lung cancer by regulating GAB1.
hsa-mir-591	breast cancer	down	MiR-591 functions as tumor suppressor in breast cancer by targeting TCF4 and inhibits Hippo-YAP/TAZ signaling pathway.
hsa-mir-591	hepatocellular carcinoma	down	MicroRNA-591 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Lowering Drug Resistance through Inhibition of Far-Upstream Element-Binding Protein 2-Mediated Phosphoinositide 3-Kinase/Akt
hsa-mir-592	acute myeloid leukemia	down	MiR-592 functions as a tumor suppressor in acute myeloid leukemia by targeting ROCK1 and predicts patients' prognosis.
hsa-mir-592	breast cancer	down	Suppressive role of miR-592 in breast cancer by repressing TGF-?2.
hsa-mir-592	colorectal cancer	up	An oncogenic role of miR-592 in tumorigenesis of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A).
hsa-mir-592	colorectal cancer	up	Up-regulation of miR-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer.
hsa-mir-592	gastric cancer	up	MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
hsa-mir-592	glioma	down	MiR-592 suppresses the development of glioma by regulating Rho-associated protein kinase.
hsa-mir-592	glioma	down	MiR-592 functions as a tumor suppressor in glioma by targeting IGFBP2.
hsa-mir-592	hepatocellular carcinoma	down	MicroRNA-592 targets IGF-1R to suppress cellular proliferation, migration and invasion in hepatocellular carcinoma.
hsa-mir-592	hepatocellular carcinoma	down	MicroRNA-592 targets DEK oncogene and suppresses cell growth in the hepatocellular carcinoma cell line HepG2.
hsa-mir-592	hepatocellular carcinoma	down	miR-592/WSB1/HIF-1? axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth.
hsa-mir-592	non-small cell lung cancer	down	miR-592 functions as a tumor suppressor in human non-small cell lung cancer by targeting SOX9.
hsa-mir-593	colon cancer	down	[miR-593 inhibits proliferation of colon cancer cells in vitro by down-regulating PLK1].
hsa-mir-593-5p	gastric cancer	down	Regulation of cell proliferation and metastasis by microRNA-593-5p in human gastric cancer.
hsa-mir-595	glioblastoma	up	MiR-595 targeting regulation of SOX7 expression promoted cell proliferation of human glioblastoma.
hsa-mir-595	ovarian cancer	down	MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1.
hsa-mir-596	gastric cancer	down	MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation.
hsa-mir-597	breast cancer	down	miR-597 inhibits breast cancer cell proliferation, migration and invasion through FOSL2.
hsa-mir-597	nasopharyngeal carcinoma	up	MiR-597 Targeting 14-3-3? Enhances Cellular Invasion and EMT in Nasopharyngeal Carcinoma Cells.
hsa-mir-597-5p	colon cancer	down	MicroRNA (miR)-597-5p Inhibits Colon Cancer Cell Migration and Invasion by Targeting FOS-Like Antigen 2 (FOSL2).
hsa-mir-598	colorectal cancer	down	miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT.
hsa-mir-598	gastric cancer	down	miR-598 acts as a tumor suppressor in human gastric cancer by targeting IGF-1R.
hsa-mir-598	glioblastoma	down	MicroRNA-598 Inhibits Cell Proliferation and Invasion of Glioblastoma by Directly Targeting Metastasis Associated in Colon Cancer-1 (MACC1).
hsa-mir-598	non-small cell lung cancer	down	MiR-598 Suppresses Invasion and Migration by Negative Regulation of Derlin-1 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
hsa-mir-598	osteosarcoma	down	MiR-598: A tumor suppressor with biomarker significance in osteosarcoma.
hsa-mir-598	ovarian cancer	down	The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI.
hsa-mir-599	breast cancer	down	Hsa-miR-599 suppresses the migration and invasion by targeting BRD4 in breast cancer.
hsa-mir-599	gastric cancer	down	MicroRNA-599 inhibits metastasis and epithelial-mesenchymal transition via targeting EIF5A2 in gastric cancer.
hsa-mir-599	glioma	down	miR-599 inhibits proliferation and invasion of glioma by targeting periostin.
hsa-mir-599	glioma	down	MiR-599 as a potential biomarker for prognosis of glioma.
hsa-mir-599	glioma	down	MicroRNA-599 suppresses glioma progression by targeting RAB27B.
hsa-mir-599	hepatocellular carcinoma	down	Identification a novel tumor-suppressive hsa-miR-599 regulates cells proliferation, migration and invasion by targeting oncogenic MYC in hepatocellular carcinoma.
hsa-mir-600	acute myeloid leukemia	down	A regulatory circuitry between miR-193a/miR-600 and WT1 enhances leukemogenesis in acute myeloid leukemia.
hsa-mir-600	colorectal cancer	down	LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
hsa-mir-600	lung cancer	down	miR-600 inhibits lung cancer via downregulating the expression of METTL3.
hsa-mir-600	non-small cell lung cancer	down	miR-600 inhibits lung cancer via downregulating the expression of METTL3.
hsa-mir-601	breast cancer	down	miR-601 is a prognostic marker and suppresses cell growth and invasion by targeting PTP4A1 in breast cancer.
hsa-mir-601	esophageal squamous cell carcinoma	down	MiR-601 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma (ESCC) by targeting HDAC6.
hsa-mir-601	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-603	glioma	up	miR-603 promotes glioma cell growth via Wnt/?-catenin pathway by inhibiting WIF1 and CTNNBIP1.
hsa-mir-603	osteosarcoma	up	MicroRNA-603 functions as an oncogene by suppressing BRCC2 protein translation in osteosarcoma.
hsa-mir-603	ovarian cancer	down	miR-603 targeted hexokinase-2 to inhibit the malignancy of ovarian cancer cells.
hsa-mir-605	glioblastoma	down	microRNA-605 directly targets SOX9 to alleviate the aggressive phenotypes of glioblastoma multiforme cell lines by deactivating the PI3K/Akt pathway.
hsa-mir-605	malignant melanoma	down	MicroRNA-605 functions as a tumor suppressor by targeting INPP4B in melanoma.
hsa-mir-605	non-small cell lung cancer	up	microRNA-605 promotes cell proliferation, migration and invasion in non-small cell lung cancer by directly targeting LATS2.
hsa-mir-605-3p	glioma	down	LncRNA BLACAT1 regulates VASP expression via binding to miR-605-3p and promotes giloma development.
hsa-mir-608	chordoma	down	MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET.
hsa-mir-608	colon cancer	down	microRNA-342-5p and miR-608 inhibit colon cancer tumorigenesis by targeting NAA10.
hsa-mir-608	glioblastoma	down	Serum expression level of miR-504 can differentiate between glioblastoma multiforme and solitary brain metastasis of non-small cell lung carcinoma.
hsa-mir-608	hepatocellular carcinoma	down	microRNA-608 inhibits human hepatocellular carcinoma cell proliferation via targeting the BET family protein BRD4.
hsa-mir-608	prostate cancer	down	Nonconserved miR-608 suppresses prostate cancer progression through RAC2/PAK4/LIMK1 and BCL2L1/caspase-3 pathways by targeting the 3'-UTRs of RAC2/BCL2L1 and the coding region of PAK4.
hsa-mir-610	colorectal cancer	down	MiR-610 inhibits cell proliferation and invasion in colorectal cancer by repressing hepatoma-derived growth factor.
hsa-mir-610	glioma	down	MicroRNA-610 is downregulated in glioma cells, and inhibits proliferation and motility by directly targeting MDM2.
hsa-mir-610	hepatocellular carcinoma	down	Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/?-catenin signaling in human hepatocellular carcinoma.
hsa-mir-610	lung cancer	down	[miR-610 suppresses lung cancer cell proliferation and invasion by targeting GJA3].
hsa-mir-610	malignant melanoma	down	MicroRNA-610 inhibits tumor growth of melanoma by targeting LRP6.
hsa-mir-610	oral squamous cell carcinoma	down	MiR-610 functions as a tumor suppressor in oral squamous cell carcinoma by directly targeting AGK.
hsa-mir-610	osteosarcoma	down	MicroRNA-610 suppresses osteosarcoma oncogenicity via targeting TWIST1 expression.
hsa-mir-612	hepatocellular carcinoma	down	miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma.
hsa-mir-612	malignant melanoma	down	Overexpression of microRNA-612 Restrains the Growth, Invasion, and Tumorigenesis of Melanoma Cells by Targeting Espin.
hsa-mir-613	bladder cancer	down	miR-613 inhibits bladder cancer proliferation and migration through targeting SphK1.
hsa-mir-613	breast cancer	down	miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer.
hsa-mir-613	breast cancer	down	miR-613 inhibits proliferation and invasion of breast cancer cell via VEGFA.
hsa-mir-613	cervical cancer	up	MiR-613 promotes cell proliferation and invasion in cervical cancer via targeting PTPN9.
hsa-mir-613	colon cancer	up	MicroRNA-613 promotes colon cancer cell proliferation, invasion and migration by targeting ATOH1.
hsa-mir-613	colorectal cancer	down	MicroRNA-613 targets FMNL2 and suppresses progression of colorectal cancer.
hsa-mir-613	esophageal squamous cell carcinoma	down	MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
hsa-mir-613	gastric cancer	down	MicroRNA-613 inhibits the progression of gastric cancer by targeting CDK9.
hsa-mir-613	gastric cancer	down	miR-613 inhibits gastric cancer progression through repressing brain derived neurotrophic factor.
hsa-mir-613	gastric cancer	down	MicroRNA-613 induces the sensitivity of gastric cancer cells to cisplatin through targeting SOX9 expression.
hsa-mir-613	gastric cancer	down	miR-613 inhibits Warburg effect in gastric cancer by targeting PFKFB2.
hsa-mir-613	glioma	down	MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14.
hsa-mir-613	glioma	down	Role of miR-613 as a tumor suppressor in glioma cells by targeting SOX9.
hsa-mir-613	hepatocellular carcinoma	down	MiR-613 functions as tumor suppressor in hepatocellular carcinoma by targeting YWHAZ.
hsa-mir-613	hepatocellular carcinoma	down	miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway.
hsa-mir-613	hepatocellular carcinoma	down	miR-613 inhibits the growth and invasiveness of human hepatocellular carcinoma via targeting DCLK1.
hsa-mir-613	laryngeal squamous cell carcinoma	down	MiR-613 suppressed the laryngeal squamous cell carcinoma progression through regulating PDK1.
hsa-mir-613	nasopharyngeal carcinoma	down	microRNA-613 exerts anti-angiogenic effect on nasopharyngeal carcinoma cells through inactivating the AKT signaling pathway by down-regulating FN1.
hsa-mir-613	osteosarcoma	down	CXCR4-mediated osteosarcoma growth and pulmonary metastasis is suppressed by MicroRNA-613.
hsa-mir-613	ovarian cancer	down	MicroRNA-613 inhibited ovarian cancer cell proliferation and invasion by regulating KRAS.
hsa-mir-613	pancreatic cancer	down	LncRNA HOTAIR acts a competing endogenous RNA to control the expression of notch3 via sponging miR-613 in pancreatic cancer.
hsa-mir-613	papillary thyroid carcinoma	down	Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
hsa-mir-613	papillary thyroid carcinoma	down	MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2.
hsa-mir-613	prostate cancer	down	MicroRNA-613 represses prostate cancer cell proliferation and invasion through targeting Frizzled7.
hsa-mir-613	retinoblastoma	down	MiR-613 suppresses retinoblastoma cell proliferation, invasion, and tumor formation by targeting E2F5.
hsa-mir-614	lung cancer	down	[MiR-614 Inhibited Lung Cancer Cell Invasion and Proliferation via Targeting PSA].
hsa-mir-614	ovarian cancer	up	Upregulation of miR-614 promotes proliferation and inhibits apoptosis in ovarian cancer by suppressing PPP2R2A expression.
hsa-mir-615	glioblastoma	down	MiR-615 inhibits cell proliferation, migration and invasion by targeting EGFR in human glioblastoma.
hsa-mir-615	prostate cancer	down	MiR-615 inhibits prostate cancer cell proliferation and invasion by directly targeting Cyclin D2.
hsa-mir-615-3p	gastric cancer	up	miR-615-3p promotes proliferation and migration and inhibits apoptosis through its potential target CELF2 in gastric cancer.
hsa-mir-615-3p	non-small cell lung cancer	down	Long non-coding RNA HOTTIP promotes hypoxia-induced glycolysis through targeting miR-615-3p/HMGB3 axis in non-small cell lung cancer cells.
hsa-mir-615-3p	non-small cell lung cancer	down	Identification of microRNA-615-3p as a novel tumor suppressor in non-small cell lung cancer.
hsa-mir-615-5p	hepatocellular carcinoma	up	miR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2 (SHMT2) in hepatocellular carcinoma.
hsa-mir-615-5p	hepatocellular carcinoma	down	KDM4B-mediated epigenetic silencing of miRNA-615-5p augments RAB24 to facilitate malignancy of hepatoma cells.
hsa-mir-615-5p	pancreatic cancer	down	MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2.
hsa-mir-615-5p	pancreatic ductal adenocarcinoma	down	miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma.
hsa-mir-615-5p	pancreatic ductal adenocarcinoma	down	Correction: MiRNA-615-5p Functions as a Tumor Suppressor in Pancreatic Ductal Adenocarcinoma by Targeting AKT2.
hsa-mir-616	glioma	up	MiR-616 promotes proliferation and inhibits apoptosis in glioma cells by suppressing expression of SOX7 via the Wnt signaling pathway.
hsa-mir-616	non-small cell lung cancer	up	MicroRNA-616 promotes the growth and metastasis of non-small cell lung cancer by targeting SOX7.
hsa-mir-616*	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-616-3p	gastric cancer	up	MiR-616-3p promotes angiogenesis and EMT in gastric cancer via the PTEN/AKT/mTOR pathway.
hsa-mir-618	gastric cancer	down	miR-618 Suppresses Metastasis in Gastric Cancer by Downregulating the Expression of TGF-?2.
hsa-mir-618	prostate cancer	down	miR-618 Inhibits Prostate Cancer Migration and Invasion by Targeting FOXP2.
hsa-mir-620	hepatocellular carcinoma	up	Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR-620.
hsa-mir-621	bladder cancer	down	MicroRNA-621 inhibits cell proliferation and metastasis in bladder cancer by suppressing Wnt/?-catenin signaling.
hsa-mir-621	hepatocellular carcinoma	down	MicroRNA-621 Acts as a Tumor Radiosensitizer by Directly Targeting SETDB1 in Hepatocellular Carcinoma.
hsa-mir-621	hepatocellular carcinoma	down	Downregulated miR-621 promotes cell proliferation via targeting CAPRIN1 in hepatocellular carcinoma.
hsa-mir-622	colorectal cancer	up	Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.
hsa-mir-622	colorectal cancer	up	Decrease of miR-622 expression suppresses migration and invasion by targeting regulation of DYRK2 in colorectal cancer cells.
hsa-mir-622	colorectal cancer	down	miR-622 inhibits angiogenesis by suppressing the CXCR4-VEGFA axis in colorectal cancer.
hsa-mir-622	esophageal squamous cell carcinoma	down	MiR-622 functions as a tumor suppressor and directly targets E2F1 in human esophageal squamous cell carcinoma.
hsa-mir-622	gastric cancer	down	Down-regulation of miR-622 in gastric cancer promotes cellular invasion and tumor metastasis by targeting ING1 gene.
hsa-mir-622	glioblastoma	down	Upregulated miRNA-622 inhibited cell proliferation, motility, and invasion via repressing Kirsten rat sarcoma in glioblastoma.
hsa-mir-622	glioma	down	miR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells.
hsa-mir-622	hepatocellular carcinoma	down	microRNA-622 acts as a tumor suppressor in hepatocellular carcinoma.
hsa-mir-622	papillary thyroid carcinoma	down	miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma.
hsa-mir-623	hepatocellular carcinoma	down	Overexpression of miR-623 suppresses progression of hepatocellular carcinoma via regulating the PI3K/Akt signaling pathway by targeting XRCC5.
hsa-mir-623	lung adenocarcinoma	down	Correction to: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma.
hsa-mir-623	lung adenocarcinoma	down	Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma.
hsa-mir-623	lung adenocarcinoma	down	Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma.
hsa-mir-625	breast cancer	down	miR-625 suppresses cell proliferation and migration by targeting HMGA1 in breast cancer.
hsa-mir-625	colorectal cancer	down	Decreased expression of microRNA-625 is associated with tumor metastasis and poor prognosis in patients with colorectal cancer.
hsa-mir-625	gastric cancer	down	Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK.
hsa-mir-625	gastric cancer	down	miR-625 reverses multidrug resistance in gastric cancer cells by directly targeting ALDH1A1.
hsa-mir-625	glioma	down	MicroRNA-625 inhibits the proliferation and increases the chemosensitivity of glioma by directly targeting AKT2.
hsa-mir-625	hepatocellular carcinoma	down	miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma.
hsa-mir-625	hepatocellular carcinoma	down	miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma.
hsa-mir-625	laryngeal squamous cell carcinoma	down	MicroRNA-625 inhibits cell invasion and epithelial-mesenchymal transition by targeting SOX4 in laryngeal squamous cell carcinoma.
hsa-mir-625	malignant melanoma	down	microRNA-625 inhibits tumorigenicity by suppressing proliferation, migration and invasion in malignant melanoma.
hsa-mir-625*	non-small cell lung cancer	down	Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors.
hsa-mir-625-3p	colorectal cancer	down	Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding.
hsa-mir-625-3p	colorectal carcinoma	up	MiR-625-3p promotes cell migration and invasion via inhibition of SCAI in colorectal carcinoma cells.
hsa-mir-625-3p	oral squamous cell carcinoma	up	MicroRNA-625-3p promotes cell migration of oral squamous cell carcinoma by regulating SCAI expression.
hsa-mir-625-3p	thyroid cancer	up	Icariin inhibits cell proliferation, migration and invasion by down-regulation of microRNA-625-3p in thyroid cancer cells.
hsa-mir-626	glioblastoma	up	miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.
hsa-mir-627	colonic adenocarcinoma	down	MicroRNA-627 Mediates the Epigenetic Mechanisms of Vitamin D to Suppress Proliferation of Human Colorectal Cancer Cells and Growth of Xenograft Tumors in Mice.
hsa-mir-627	gastric cancer	up	A three-miRNA signature as promising non-invasive diagnostic marker for gastric cancer.
hsa-mir-627-3p	osteosarcoma	down	miR-627-3p inhibits osteosarcoma cell proliferation and metastasis by targeting PTN.
hsa-mir-627-5p	glioma	down	NR2C2-uORF targeting UCA1-miR-627-5p-NR2C2 feedback loop to regulate the malignant behaviors of glioma cells.
hsa-mir-628	acute myeloid leukemia	down	microRNA-628 inhibits the proliferation of acute myeloid leukemia cells by directly targeting IGF-1R.
hsa-mir-628	prostate cancer	down	miR-628 reduces prostate cancer proliferation and invasion via the FGFR2 signaling pathway.
hsa-mir-628-5p	glioma	down	MicroRNA-628-5p inhibits cell proliferation in glioma by targeting DDX59.
hsa-mir-628-5p	prostate cancer	down	Circulatory miR-628-5p is downregulated in prostate cancer patients.
hsa-mir-629	gastric cancer	up	A three-miRNA signature as promising non-invasive diagnostic marker for gastric cancer.
hsa-mir-629	ovarian cancer	up	Knockdown of miR-629 Inhibits Ovarian Cancer Malignant Behaviors by Targeting Testis-Specific Y-Like Protein 5.
hsa-mir-629	pancreatic cancer	up	MiR-629 promotes human pancreatic cancer progression by targeting FOXO3.
hsa-mir-629-5p	hepatocellular carcinoma	up	miR-629-5p promotes growth and metastasis of hepatocellular carcinoma by activating ?-catenin.
hsa-mir-630	breast cancer	down	MiR-630 suppresses breast cancer progression by targeting metadherin.
hsa-mir-630	breast cancer	down	MicroRNA-630 inhibits breast cancer progression by directly targeting BMI1.
hsa-mir-630	colorectal cancer	up	MicroRNA-630 is a prognostic marker for patients with colorectal cancer.
hsa-mir-630	esophageal squamous cell carcinoma	down	MiR-630 inhibits invasion and metastasis in esophageal squamous cell carcinoma.
hsa-mir-630	gastric cancer	down	MicroRNA-630 Suppresses Epithelial-to-Mesenchymal Transition by Regulating FoxM1 in Gastric Cancer Cells.
hsa-mir-630	gastric cancer	down	miR-630 inhibits epithelial-to-mesenchymal transition (EMT) by regulating Wnt/betacatenin pathway in gastric cancer cells.
hsa-mir-630	glioma	down	Inhibition of miR-630 enhances the cell resistance to radiation by directly targeting CDC14A in human glioma.
hsa-mir-630	hepatocellular carcinoma	up	miR-630 Overexpression in Hepatocellular Carcinoma Tissues is Positively Correlated with alpha-Fetoprotein.
hsa-mir-630	hepatocellular carcinoma	down	MicroRNA-630 suppresses tumor metastasis through the TGF-?- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma.
hsa-mir-630	kidney cancer	up	miR-630 functions as a tumor oncogene in renal cell carcinoma.
hsa-mir-630	lung cancer	down	MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells.
hsa-mir-630	non-small cell lung cancer	down	miR-630 targets LMO3 to regulate cell growth and metastasis in lung cancer.
hsa-mir-630	ovarian cancer	up	Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
hsa-mir-630	pancreatic cancer	down	Upregulation of miR-150* and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R.
hsa-mir-630	papillary thyroid carcinoma	down	MiR-630 inhibits papillary thyroid carcinoma cell growth, metastasis, and epithelial-mesenchymal transition by suppressing JAK2/STAT3 signaling pathway.
hsa-mir-630	renal clear cell carcinoma	up	Up-regulation of miR-630 in clear cell renal cell carcinoma is associated with lower overall survival.
hsa-mir-632	gastric cancer	up	miR-632 promotes gastric cancer progression by accelerating angiogenesis in a TFF1-dependent manner.
hsa-mir-632	laryngeal cancer	up	MiR-632 promotes laryngeal carcinoma cell proliferation, migration and invasion through negative regulation of GSK3?.
hsa-mir-632	oral squamous cell carcinoma	down	Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-634	cervical cancer	down	MiR-634 decreases cell proliferation and induces apoptosis by targeting mTOR signaling pathway in cervical cancer cells.
hsa-mir-634	glioma	down	MiR-634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf-ERK signaling pathway.
hsa-mir-634	hepatocellular carcinoma	down	miR-634 exhibits anti-tumor activities toward hepatocellular carcinoma via Rab1A and DHX33.
hsa-mir-634	hepatocellular carcinoma	down	miR-634 exhibits anti-tumor activities toward hepatocellular carcinoma via Rab1A and DHX33.
hsa-mir-634	pancreatic cancer	down	MicroRNA-634 functions as a tumor suppressor in pancreatic cancer via directly targeting heat shock-related 70-kDa protein 2.
hsa-mir-635	non-small cell lung cancer	down	The microRNA-635 suppresses tumorigenesis in non-small cell lung cancer.
hsa-mir-637	hepatocellular carcinoma	up	MiR-637 inhibits proliferation and invasion of hepatoma cells by targeted degradation of AKT1.
hsa-mir-637	hepatocellular carcinoma	down	Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling.
hsa-mir-637	malignant melanoma	down	MiR-637 suppresses melanoma progression through directly targeting P-REX2a and inhibiting PTEN/AKT signaling pathway.
hsa-mir-637	pancreatic ductal adenocarcinoma	down	Primate-specific miRNA-637 inhibited tumorigenesis in human pancreatic ductal adenocarcinoma cells by suppressing Akt1 expression.
hsa-mir-638	basal cell carcinoma	down	Expression of microRNAs in basal cell carcinoma.
hsa-mir-638	breast cancer	down	Downregulation of miR-638 promotes progression of breast cancer and is associated with prognosis of breast cancer patients.
hsa-mir-638	breast cancer	down	miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.
hsa-mir-638	breast cancer	down	miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple negative breast cancer.
hsa-mir-638	cervical cancer	down	MiR-638 inhibits cervical cancer metastasis through Wnt/?-catenin signaling pathway and correlates with prognosis of cervical cancer patients.
hsa-mir-638	colorectal cancer	down	MicroRNA-638 inhibits cell proliferation, invasion and regulates cell cycle by targeting tetraspanin 1 in human colorectal carcinoma.
hsa-mir-638	esophageal squamous cell carcinoma	up	MiRNA-638 promotes autophagy and malignant phenotypes of cancer cells via directly suppressing DACT3.
hsa-mir-638	gastric cancer	down	MicroRNA profiling of human gastric cancer.
hsa-mir-638	gastric cancer	down	miR-638 Suppresses Cell Proliferation in Gastric Cancer by Targeting Sp2.
hsa-mir-638	gastric cancer	down	MicroRNA-638 inhibits cell proliferation by targeting phospholipase D1 in human gastric carcinoma.
hsa-mir-638	gastric cancer	down	MiR-638 acts as a tumor suppressor gene in gastric cancer.
hsa-mir-638	gastric cancer	down	MeCP2, a target of miR-638, facilitates gastric cancer cell proliferation through activation of the MEK1/2-ERK1/2 signaling pathway by upregulating GIT1.
hsa-mir-638	hepatocellular carcinoma	down	Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF.
hsa-mir-638	hepatocellular carcinoma	down	Loss of miR-638 promotes invasion and epithelial-mesenchymal transition by targeting SOX2 in hepatocellular carcinoma.
hsa-mir-638	malignant melanoma	up	miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy.
hsa-mir-638	osteosarcoma	down	MicroRNA-638 inhibits cell proliferation by targeting suppress PIM1 expression in human osteosarcoma.
hsa-mir-638	osteosarcoma	down	MicroRNA-638 expression change in osteosarcoma patients via PLD1 and VEGF expression.
hsa-mir-639	bladder cancer	up	Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?
hsa-mir-639	thyroid cancer	up	MiR-639 promoted cell proliferation and cell cycle in human thyroid cancer by suppressing CDKN1A expression.
hsa-mir-641	cervical cancer	down	miRNA-641 inhibits the proliferation, migration, and invasion and induces apoptosis of cervical cancer cells by directly targeting ZEB1.
hsa-mir-641	lung cancer	down	MiR-641 Functions as a Tumor Suppressor by Targeting MDM2 in Human Lung Cancer.
hsa-mir-642a-5p	prostate cancer	down	Regulation of Expression of Deoxyhypusine Hydroxylase (DOHH), the Enzyme That Catalyzes the Activation of eIF5A, by miR-331-3p and miR-642-5p in Prostate Cancer Cells.
hsa-mir-644a	esophageal squamous cell carcinoma	down	Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem-cell-like Phenotype via Dysregulation of PITX2.
hsa-mir-644a	gastric cancer	down	miR-644a inhibits cellular proliferation and invasion via suppression of CtBP1 in gastric cancer cells.
hsa-mir-644a	hepatocellular carcinoma	down	MicroRNA-644a promotes apoptosis of hepatocellular carcinoma cells by downregulating the expression of heat shock factor 1.
hsa-mir-645	breast cancer	up	Downregulation of microRNA-645 suppresses breast cancer cell metastasis via targeting DCDC2.
hsa-mir-645	colorectal cancer	up	MicroRNA-645 is an oncogenic regulator in colon cancer.
hsa-mir-645	osteosarcoma	up	MicroRNA-645 promotes metastasis of osteosarcoma via targeting tumor suppressor NM23 nucleoside diphosphate kinase 2.
hsa-mir-645	renal clear cell carcinoma	up	MicroRNA-645 promotes cell metastasis and proliferation of renal clear cell carcinoma by targeting GK5.
hsa-mir-646	colorectal cancer	down	Low-level miR-646 in colorectal cancer inhibits cell proliferation and migration by targeting NOB1 expression.
hsa-mir-646	esophageal cancer	down	Long noncoding RNA HOTAIR mediates the estrogen-induced metastasis of endometrial cancer cells via the miR-646/NPM1 axis.
hsa-mir-646	gastric cancer	down	MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer.
hsa-mir-646	oral squamous cell carcinoma	down	Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-646	osteosarcoma	down	miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 (FGF2).
hsa-mir-646	osteosarcoma	down	Downregulation of microRNA-217 and microRNA-646 acts as potential predictor biomarkers in progression, metastasis, and unfavorable prognosis of human osteosarcoma.
hsa-mir-646	renal cell carcinoma	down	Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1).
hsa-mir-647	gastric cancer	down	MicroRNA-647 Targets SRF-MYH9 Axis to Suppress Invasion and Metastasis of Gastric Cancer.
hsa-mir-647	gastric cancer	down	Role of miR-647 in human gastric cancer suppression.
hsa-mir-647	non-small cell lung cancer	down	MicroRNA-647 promotes the therapeutic effectiveness of argon-helium cryoablation and inhibits cell proliferation through targeting TRAF2 via the NF-?B signaling pathway in non-small cell lung cancer.
hsa-mir-650	acute myeloid leukemia	down	miRNA-650 exerts anti-leukemia activity by inhibiting cell proliferation through Gfi1 targeting.
hsa-mir-650	chronic lymphocytic leukemia	up	NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
hsa-mir-650	colorectal cancer	up	MicroRNA-650 targets inhibitor of growth 4 to promote colorectal cancer progression via mitogen activated protein kinase signaling.
hsa-mir-650	gastric cancer	up	MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity.
hsa-mir-650	glioma	up	MicroRNA-650 expression in glioma is associated with prognosis of patients.
hsa-mir-650	hepatocellular carcinoma	up	Upregulation of miR-650 is correlated with down-regulation of ING4 and progression of hepatocellular carcinoma.
hsa-mir-650	oral cancer	up	MiR-650 regulates the proliferation, migration and invasion of human oral cancer by targeting growth factor independent 1 (Gfi1).
hsa-mir-652	endometrial cancer	up	miR-652 Promotes Tumor Proliferation and Metastasis by Targeting RORA in Endometrial Cancer.
hsa-mir-652	gastric cancer	up	A three-miRNA signature as promising non-invasive diagnostic marker for gastric cancer.
hsa-mir-652	glioblastoma	down	MicroRNA-652 suppresses malignant phenotypes in glioblastoma multiforme via FOXK1-mediated AKT/mTOR signaling pathway.
hsa-mir-652	prostate cancer	up	MicroRNA-652 induces NED in LNCaP and EMT in PC3 prostate cancer cells.
hsa-mir-652-3p	breast cancer	down	Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR.
hsa-mir-652-3p	non-small cell lung cancer	up	MiR-652-3p is upregulated in non-small cell lung cancer and promotes proliferation and metastasis by directly targeting Lgl1.
hsa-mir-653	breast cancer	down	Silencing of hsa_circ_0004771 inhibits proliferation and induces apoptosis in breast cancer through activation of miR-653 by targeting ZEB2 signaling pathway.
hsa-mir-654	colorectal cancer	down	miR-496, miR-1185, miR-654, miR-3183 and miR-495 are downregulated in colorectal cancer cells and have putative roles in the mTOR pathway.
hsa-mir-654-5p	gastric cancer	down	A positive feedback loop consisting of C12orf59/NF-?B/CDH11 promotes gastric cancer invasion and metastasis.
hsa-mir-654-5p	ovarian cancer	down	MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways.
hsa-mir-655	breast cancer	up	miR526b and miR655 Induce Oxidative Stress in Breast Cancer.
hsa-mir-655	esophageal squamous cell carcinoma	down	Analysis of the correlation between the expression of miR-655 and esophageal cancer prognosis.
hsa-mir-655	esophageal squamous cell carcinoma	down	Low levels of tumour suppressor miR-655 in plasma contribute to lymphatic progression and poor outcomes in oesophageal squamous cell carcinoma.
hsa-mir-655	esophageal squamous cell carcinoma	down	Mir-655 up-regulation suppresses cell invasion by targeting pituitary tumor-transforming gene-1 in esophageal squamous cell carcinoma.
hsa-mir-655	ovarian cancer	down	Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
hsa-mir-655	retinoblastoma	down	MicroRNA-655 attenuates the malignant biological behaviours of retinoblastoma cells by directly targeting PAX6 and suppressing the ERK and p38 MAPK signalling pathways.
hsa-mir-655-3p	hepatocellular carcinoma	down	MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and ?-catenin pathway in Hepatocellular Carcinoma.
hsa-mir-655-3p	non-small cell lung cancer	down	miR-655-3p inhibits cell migration and invasion by targeting pituitary tumor-transforming 1 in non-small cell lung cancer.
hsa-mir-656	glioma	down	miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
hsa-mir-657	hepatocellular carcinoma	up	MiR-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through NF-?B pathways.
hsa-mir-660	gastric cancer	down	RNA N6-methyladenosine modification participates in miR-660/E2F3 axis-mediated inhibition of cell proliferation in gastric cancer.
hsa-mir-660	lung cancer	down	Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models.
hsa-mir-660	lung cancer	down	Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
hsa-mir-660-5p	breast cancer	up	Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.
hsa-mir-660-5p	non-small cell lung cancer	up	Exosomal miR-660-5p promotes tumor growth and metastasis in non-small cell lung cancer.
hsa-mir-661	glioma	down	MiR-661 inhibits glioma cell proliferation, migration and invasion by targeting hTERT.
hsa-mir-661	non-small cell lung cancer	up	MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer.
hsa-mir-661	non-small cell lung cancer	up	MicroRNA-661 promotes non-small cell lung cancer progression by directly targeting RUNX3.
hsa-mir-661	non-small cell lung cancer	up	Clinical impact of serum miR-661 in diagnosis and prognosis of non-small cell lung cancer.
hsa-mir-661	ovarian cancer	up	MiR-661 contributed to cell proliferation of human ovarian cancer cells by repressing INPP5J expression.
hsa-mir-661	pancreatic ductal adenocarcinoma	up	MicroRNA-661 expression is upregulated in pancreatic ductal adenocarcinoma and promotes cell proliferation.
hsa-mir-663	gastric cancer	down	Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells.
hsa-mir-663	glioblastoma	down	miR-663 suppresses oncogenic function of CXCR4 in glioblastoma.
hsa-mir-663	glioblastoma	down	MicroRNA-663 inhibits the proliferation, migration and invasion of glioblastoma cells via targeting TGF-?1.
hsa-mir-663	hepatocellular carcinoma	up	miR-663 overexpression induced by endoplasmic reticulum stress modulates hepatocellular carcinoma cell apoptosis via transforming growth factor beta 1.
hsa-mir-663	lung cancer	up	MicroRNA-663 targets TGFB1 and regulates lung cancer proliferation.
hsa-mir-663	nasopharyngeal carcinoma	up	MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma.
hsa-mir-663	nasopharyngeal carcinoma	up	miR-663 promotes NPC cell proliferation by directly targeting CDKN2A.
hsa-mir-663	ovarian cancer	up	MicroRNA-663 facilitates the growth, migration and invasion of ovarian cancer cell by inhibiting TUSC2.
hsa-mir-663	papillary thyroid carcinoma	down	MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma.
hsa-mir-663a	hepatocellular carcinoma	down	miR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2.
hsa-mir-663a	hepatocellular carcinoma	down	miR-663a inhibits tumor growth and invasion by regulating TGF-?1 in hepatocellular carcinoma.
hsa-mir-663a	non-small cell lung cancer	down	MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD.
hsa-mir-663a	pancreatic ductal adenocarcinoma	down	Inhibition of S-Adenosylmethionine-Dependent Methyltransferase Attenuates TGF?1-Induced EMT and Metastasis in Pancreatic Cancer: Putative Roles of miR-663a and miR-4787-5p.
hsa-mir-663a	renal cell carcinoma	up	Oncogenic miR-663a is associated with cellular function and poor prognosis in renal cell carcinoma.
hsa-mir-663b	nasopharyngeal carcinoma	up	MicroRNA-663b promotes cell proliferation and epithelial mesenchymal transition by directly targeting SMAD7 in nasopharyngeal carcinoma.
hsa-mir-663b	nasopharyngeal carcinoma	up	miR-663b promotes tumor cell proliferation, migration and invasion in nasopharyngeal carcinoma through targeting TUSC2.
hsa-mir-663b	osteosarcoma	up	Blockade of miR-663b inhibits cell proliferation and induces apoptosis in osteosarcoma via regulating TP73 expression.
hsa-mir-663b	pancreatic cancer	down	Epigenetic inhibition of miR-663b by long non-coding RNA HOTAIR promotes pancreatic cancer cell proliferation via up-regulation of insulin-like growth factor 2.
hsa-mir-664	cervical cancer	down	MicroRNA-664 suppresses the growth of cervical cancer cells via targeting c-Kit.
hsa-mir-664	cervical cancer	down	Up-regulation of microRNA-664 inhibits cell growth and increases cisplatin sensitivity in cervical cancer.
hsa-mir-664	cervical cancer	down	Down-regulation of miR-664 in cervical cancer is associated with lower overall survival.
hsa-mir-664	hepatocellular carcinoma	up	Overexpression of miR-664 is associated with poor overall survival and accelerates cell proliferation, migration and invasion in hepatocellular carcinoma.
hsa-mir-664	hepatocellular carcinoma	up	MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.
hsa-mir-664	osteosarcoma	up	Mir-664 promotes osteosarcoma cells proliferation via downregulating of FOXO4.
hsa-mir-664a-3p	gastric cancer	up	miR-664a-3p functions as an oncogene by targeting Hippo pathway in the development of gastric cancer.
hsa-mir-665	breast cancer	up	miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer.
hsa-mir-665	hepatocellular carcinoma	up	miR-665 promotes hepatocellular carcinoma cell migration, invasion, and proliferation by decreasing Hippo signaling through targeting PTPRB.
hsa-mir-665	neuroblastoma	down	miR-665 targets c-MYC and HDAC8 to inhibit murine neuroblastoma cell growth.
hsa-mir-665	osteosarcoma	down	MicroRNA-665 suppressed the invasion and metastasis of osteosarcoma by directly inhibiting RAB23.
hsa-mir-665	retinoblastoma	down	MicroRNA-665 inhibits the oncogenicity of retinoblastoma by directly targeting high-mobility group box 1 and inactivating the Wnt/?-catenin pathway.
hsa-mir-668	oral squamous cell carcinoma	down	Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-671	prostate cancer	up	miR-671 promotes prostate cancer cell proliferation by targeting tumor suppressor SOX6.
hsa-mir-671-5p	breast cancer	down	miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
hsa-mir-671-5p	gastric cancer	down	miR-671-5p inhibits gastric cancer cell proliferation and promotes cell apoptosis by targeting URGCP.
hsa-mir-671-5p	invasive ductal carcinoma	down	miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
hsa-mir-671-5p	osteosarcoma	down	miR-671-5p Inhibits Tumor Proliferation by Blocking Cell Cycle in Osteosarcoma.
hsa-mir-6716-5p	colorectal cancer	up	miR-6716-5p promotes metastasis of colorectal cancer through downregulating NAT10 expression.
hsa-mir-675	breast cancer	up	Over-expression of miR-675 in formalin-fixed paraffin-embedded (FFPE) tissues of breast cancer patients.
hsa-mir-675	colon cancer	up	Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer.
hsa-mir-675	gastric cancer	up	MiR-675 is frequently overexpressed in gastric cancer and enhances cell proliferation and invasion via targeting a potent anti-tumor gene PITX1.
hsa-mir-675	gastric cancer	up	Long Noncoding RNA H19/miR-675 Axis Promotes Gastric Cancer via FADD/Caspase 8/Caspase 3 Signaling Pathway.
hsa-mir-675	glioma	up	Long Non-Coding RNA H19 Promotes Glioma Cell Invasion by Deriving miR-675.
hsa-mir-675	head and neck squamous cell carcinoma	up	Overexpression of lncRNA H19/miR-675 promotes tumorigenesis in head and neck squamous cell carcinoma.
hsa-mir-675	hepatocellular carcinoma	down	Downregulation of LncRNAH19 and MiR-675 promotes migration and invasion of human hepatocellular carcinoma cells through AKT/GSK-3?/Cdc25A signaling pathway.
hsa-mir-675	hepatocellular carcinoma	up	MiR-675 Promotes the Growth of Hepatocellular Carcinoma Cells Through the Cdc25A Pathway.
hsa-mir-675	neuroblastoma	up	Angelica sinensis polysaccharide inhibits proliferation, migration, and invasion by downregulating microRNA-675 in human neuroblastoma cell line SH-SY5Y.
hsa-mir-675	pancreatic ductal adenocarcinoma	down	Long noncoding RNA H19 derived miR-675 regulates cell proliferation by down-regulating E2F-1 in human pancreatic ductal adenocarcinoma.
hsa-mir-675	retinoblastoma	up	microRNA-675 promotes glioma cell proliferation and motility by negatively regulating retinoblastoma 1.
hsa-mir-675-5p	colon cancer	up	MiR-675-5p supports hypoxia induced epithelial to mesenchymal transition in colon cancer cells.
hsa-mir-675-5p	gastric cancer	up	Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients.
hsa-mir-675-5p	non-small cell lung cancer	up	Upregulation of miR-675-5p induced by lncRNA H19 was associated with tumor progression and development by targeting tumor suppressor p53 in non-small cell lung cancer.
hsa-mir-675-5p	non-small cell lung cancer	up	Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
hsa-mir-6775-3p	esophageal squamous cell carcinoma	down	Tumor suppressive miR-6775-3p inhibits ESCC progression through forming a positive feedback loop with p53 via MAGE-A family proteins.
hsa-mir-6778-5p	colorectal cancer	up	CircRNA CBL.11 suppresses cell proliferation by sponging miR-6778-5p in colorectal cancer.
hsa-mir-6868-5p	colorectal cancer	down	Dysregulation of miR-6868-5p/FOXM1 circuit contributes to colorectal cancer angiogenesis.
hsa-mir-6883-5p	colorectal cancer	down	miR-6883 Family miRNAs Target CDK4/6 to Induce G1 Phase Cell-Cycle Arrest in Colon Cancer Cells.
hsa-mir-7	breast cancer	down	Identification of direct target genes of miR-7, miR-9, miR-96, and miR-182 in the human breast cancer cell lines MCF-7 and MDA-MB-231.
hsa-mir-7	breast cancer	down	MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression.
hsa-mir-7	breast cancer	down	Inhibition of breast cancer growth via miR-7 suppressing ALDH1A3 activity concomitant with decreasing breast cancer stem cell subpopulation.
hsa-mir-7	cervical cancer	down	MicroRNA-7 inhibits metastasis and invasion through targeting focal adhesion kinase in cervical cancer.
hsa-mir-7	cervical cancer	down	Identification of microRNAs (miR-203/miR-7) as potential markers for the early detection of lymph node metastases in patients with cervical cancer.
hsa-mir-7	colorectal cancer	down	miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2.
hsa-mir-7	colorectal cancer	up	MicroRNA-7 Is Associated with Malignant Potential and Poor Prognosis in Human Colorectal Cancer.
hsa-mir-7	colorectal cancer	down	MicroRNA-7 inhibits colorectal cancer cell proliferation, migration and invasion via TYRO3 and phosphoinositide 3-kinase/protein B kinase/mammalian target of rapamycin pathway suppression.
hsa-mir-7	colorectal cancer	down	TRIP6, as a target of miR-7, regulates the proliferation and metastasis of colorectal cancer cells.
hsa-mir-7	epithelial ovarian cancer	down	Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.
hsa-mir-7	gastric cancer	down	MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor.
hsa-mir-7	gastric cancer	down	Effects of Yangzheng Sanjie Decoction-containing serum mediated by microRNA-7 on cell proliferation and apoptosis in gastric cancer.
hsa-mir-7	glioblastoma	down	microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma.
hsa-mir-7	glioblastoma	down	Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
hsa-mir-7	glioblastoma	down	miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways.
hsa-mir-7	glioma	down	MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism.
hsa-mir-7	glioma	down	MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas.
hsa-mir-7	hepatocellular carcinoma	down	miR-7 inhibits tumor growth and metastasis by targeting the PI3K/AKT pathway in hepatocellular carcinoma.
hsa-mir-7	hepatocellular carcinoma	down	Downregulation of miR-7 upregulates Cullin 5 (CUL5) to facilitate G1/S transition in human hepatocellular carcinoma cells.
hsa-mir-7	hepatocellular carcinoma	down	MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells.
hsa-mir-7	hepatocellular carcinoma	up	Suppression of miR-7 biogenesis by NF90-NF45 controls cell proliferation in hepatocellular carcinoma.
hsa-mir-7	hepatocellular carcinoma	down	The Circular RNA Cdr1as Act as an Oncogene in Hepatocellular Carcinoma through Targeting miR-7 Expression.
hsa-mir-7	laryngeal squamous cell carcinoma	up	CDR1as is overexpressed in laryngeal squamous cell carcinoma to promote the tumour's progression via miR-7 signals.
hsa-mir-7	lung cancer	up	EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
hsa-mir-7	lung cancer	down	Promoter mutation of tumor suppressor microRNA-7 is associated with poor prognosis of lung cancer.
hsa-mir-7	non-small cell lung cancer	down	MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
hsa-mir-7	non-small cell lung cancer	down	MicroRNA-7 inhibits the malignant phenotypes of non?small cell lung cancer in vitro by targeting Pax6.
hsa-mir-7	osteosarcoma	down	Upregulation of microRNA-7 contributes to inhibition of the growth and metastasis of osteosarcoma cells through the inhibition of IGF1R.
hsa-mir-7	pancreatic cancer	up	Curcumin inhibits cell growth and invasion through up-regulation of miR-7 in pancreatic cancer cells.
hsa-mir-7	pancreatic cancer	down	miR-7 Suppresses Tumor Progression by Directly Targeting MAP3K9 in Pancreatic Cancer.
hsa-mir-7	pancreatic carcinoma	down	MicroRNA-7 functions as a tumor-suppressor gene by regulating ILF2 in pancreatic carcinoma.
hsa-mir-7	prostate cancer	down	MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway.
hsa-mir-7	renal cell carcinoma	up	Identification of miR-7 as an oncogene in renal cell carcinoma.
hsa-mir-7-5p	colorectal cancer	down	Long Non-coding RNA Zinc Finger Antisense 1 (ZFAS1) Regulates Proliferation, Migration, Invasion, and Apoptosis by Targeting MiR-7-5p in Colorectal Cancer.
hsa-mir-7-5p	colorectal cancer	down	miR-7-5p regulates the proliferation and migration of colorectal cancer cells by negatively regulating the expression of Krüppel-like factor 4.
hsa-mir-7-5p	glioblastoma	down	miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.
hsa-mir-7-5p	glioblastoma	down	MiR-7-5p is frequently downregulated in glioblastoma microvasculature and inhibits vascular endothelial cell proliferation by targeting RAF1.
hsa-mir-7-5p	glioblastoma	down	Glycolytic inhibitor 2-Deoxy-d-Glucose activates migration and invasion in glioblastoma cells through modulation of the miR-7-5p/TFF3 signaling pathway.
hsa-mir-7-5p	glioblastoma	down	miR-7-5p inhibits cell migration and invasion in glioblastoma through targeting SATB1.
hsa-mir-7-5p	glioma	down	Circ-U2AF1 promotes human glioma via derepressing neuro-oncological ventral antigen 2 by sponging hsa-miR-7-5p.
hsa-mir-7-5p	malignant melanoma	down	miRNA-7-5p inhibits melanoma cell migration and invasion.
hsa-mir-7-5p	malignant melanoma	down	microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-?B.
hsa-mir-7-5p	pancreatic ductal adenocarcinoma	down	MiR-7-5p functions as a tumor suppressor by targeting SOX18 in pancreatic ductal adenocarcinoma.
hsa-mir-708	bladder cancer	up	Relevance function of microRNA-708 in the pathogenesis of cancer.
hsa-mir-708	colorectal cancer	up	Relevance function of microRNA-708 in the pathogenesis of cancer.
hsa-mir-708	gastric cancer	down	Relevance function of microRNA-708 in the pathogenesis of cancer.
hsa-mir-708	gastric cancer	down	Tumor suppressive microRNA-708 targets Notch1 to suppress cell proliferation and invasion in gastric cancer.
hsa-mir-708	hepatocellular carcinoma	down	Relevance function of microRNA-708 in the pathogenesis of cancer.
hsa-mir-708	hepatocellular carcinoma	down	miRNA-708 functions as a tumour suppressor in hepatocellular carcinoma by targeting SMAD3.
hsa-mir-708	hepatocellular carcinoma	down	MicroRNA-708 is downregulated in hepatocellular carcinoma and suppresses tumor invasion and migration.
hsa-mir-708	lung cancer	up	Relevance function of microRNA-708 in the pathogenesis of cancer.
hsa-mir-708	prostate cancer	down	Relevance function of microRNA-708 in the pathogenesis of cancer.
hsa-mir-708	renal cell carcinoma	down	Inhibition of c-FLIPL expression by miRNA-708 increases the sensitivity of renal cancer cells to anti-cancer drugs.
hsa-mir-708-3p	breast cancer	down	MicroRNA-708-3p mediates metastasis and chemoresistance through inhibition of epithelial-to-mesenchymal transition in breast cancer.
hsa-mir-708-5p	non-small cell lung cancer	down	Downregulation of DNMT3A by miR-708-5p inhibits lung cancer stem cell-like phenotypes through repressing Wnt/?-catenin signaling.
hsa-mir-708-5p	osteosarcoma	down	MicroRNA-708-5p affects proliferation and invasion of osteosarcoma cells by targeting URGCP.
hsa-mir-708-5p	pancreatic ductal adenocarcinoma	up	MiR-708-5p inhibits the progression of pancreatic ductal adenocarcinoma by targeting Sirt3.
hsa-mir-718	esophageal squamous cell carcinoma	down	Predictive value of plasma miRNA-718 for esophageal squamous cell carcinoma.
hsa-mir-718	gastric cancer	up	High miR-718 Suppresses Phosphatase and Tensin Homolog (PTEN) Expression and Correlates to Unfavorable Prognosis in Gastric Cancer.
hsa-mir-720	acute myeloid leukemia	down	[DNA methylation-mediated epigenetic silencing of miR-720 contributes to leukemogenesis in acute myeloid leukemia].
hsa-mir-720	breast cancer	down	miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.
hsa-mir-720	cervical cancer	up	MicroRNA-720 promotes in vitro cell migration by targeting Rab35 expression in cervical cancer cells.
hsa-mir-720	colorectal cancer	up	Evaluation of miR-720 prognostic significance in patients with colorectal cancer.
hsa-mir-720	renal cell carcinoma	up	MicroRNA-720 regulates E-cadherin-?E-catenin complex and promotes renal cell carcinoma.
hsa-mir-744	colorectal cancer	down	MicroRNA-744 inhibits cellular proliferation and invasion of colorectal cancer by directly targeting oncogene Notch1.
hsa-mir-744	gastric cancer	up	MicroRNA-744 promotes cell apoptosis via targeting B cell lymphoma-2 in gastric cancer cell line SGC-7901.
hsa-mir-744	glioblastoma	down	microRNA-744 is downregulated in glioblastoma and inhibits the aggressive behaviors by directly targeting NOB1.
hsa-mir-744	glioblastoma	down	Intronic miR-744 Inhibits Glioblastoma Migration by Functionally Antagonizing Its Host Gene MAP2K4.
hsa-mir-744	nasopharyngeal carcinoma	up	MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5.
hsa-mir-744	nasopharyngeal carcinoma	up	Up-regulation of serum miR-744 predicts poor prognosis in patients with nasopharyngeal carcinoma.
hsa-mir-744	pancreatic cancer	up	MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/?-catenin pathway.
hsa-mir-744	prostate cancer	up	Oncogenic miR-744 promotes prostate cancer growth through direct targeting of LKB1.
hsa-mir-744	prostate cancer	up	MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/?-catenin signaling.
hsa-mir-7515	lung cancer	down	The Novel miR-7515 Decreases the Proliferation and Migration of Human Lung Cancer Cells by Targeting c-Met.
hsa-mir-758	cervical cancer	down	Regulatory roles of miRNA-758 and matrix extracellular phosphoglycoprotein in cervical cancer.
hsa-mir-758	cervical cancer	down	MicroRNA-758 inhibits cervical cancer cell proliferation and metastasis by targeting HMGB3 through the WNT/?-catenin signaling pathway.
hsa-mir-758	non-small cell lung cancer	down	Overexpression of miR-758 inhibited proliferation, migration, invasion, and promoted apoptosis of non-small cell lung cancer cells by negatively regulating HMGB.
hsa-mir-758-3p	bladder cancer	down	miR-758-3p suppresses human bladder cancer cell proliferation, migration and invasion by targeting NOTCH2.
hsa-mir-758-3p	papillary thyroid carcinoma	down	MiR-758-3p regulates papillary thyroid cancer cell proliferation and migration by targeting TAB1.
hsa-mir-758-5p	glioblastoma	down	Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
hsa-mir-760	colorectal cancer	down	MiR-760 suppresses human colorectal cancer growth by targeting BATF3/AP-1/cyclinD1 signaling.
hsa-mir-760	colorectal cancer	down	The expression profiling of serum miR-92a, miR-375, and miR-760 in colorectal cancer: An Egyptian study.
hsa-mir-760	glioma	down	Long non-coding RNA LOC730100 enhances proliferation and invasion of glioma cells through competitively sponging miR-760 from FOXA1 mRNA.
hsa-mir-760	hepatocellular carcinoma	down	MicroRNA-760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1-PTEN/Akt Signaling Pathway.
hsa-mir-760	non-small cell lung cancer	down	Correction to: MiR-760 suppresses non-small cell lung cancer proliferation and metastasis by targeting ROS1.
hsa-mir-760	non-small cell lung cancer	down	MiR-760 suppresses non-small cell lung cancer proliferation and metastasis by targeting ROS1.
hsa-mir-760	non-small cell lung cancer	down	MiR-760 enhances TRAIL sensitivity in non-small cell lung cancer via targeting the protein FOXA1.
hsa-mir-760	ovarian cancer	up	MiR-760 overexpression promotes proliferation in ovarian cancer by downregulation of PHLPP2 expression.
hsa-mir-761	breast cancer	up	microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
hsa-mir-761	colorectal cancer	down	MicroRNA-761 promotes the sensitivity of colorectal cancer cells to 5-Fluorouracil through targeting FOXM1.
hsa-mir-761	colorectal cancer	down	MicroRNA-761 is downregulated in colorectal cancer and regulates tumor progression by targeting Rab3D.
hsa-mir-761	colorectal cancer	down	MiR-761 inhibits colorectal cancer cell proliferation and invasion through targeting HDAC1.
hsa-mir-761	gastric cancer	up	microRNA-761 regulates glycogen synthase kinase 3? expression and promotes the proliferation and cell cycle of human gastric cancer cells.
hsa-mir-761	hepatocellular carcinoma	up	MicroRNA-761 is upregulated in hepatocellular carcinoma and regulates tumorigenesis by targeting Mitofusin-2.
hsa-mir-761	non-small cell lung cancer	up	MiR-761 Promotes Progression and Metastasis of Non-Small Cell Lung Cancer by Targeting ING4 and TIMP2.
hsa-mir-761	ovarian carcinoma	down	miR-761 inhibits tumor progression by targeting MSI1 in ovarian carcinoma.
hsa-mir-762	breast cancer	up	microRNA-762 promotes breast cancer cell proliferation and invasion by targeting IRF7 expression.
hsa-mir-765	esophageal squamous cell carcinoma	up	Up-regulation of miR-765 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
hsa-mir-765	hepatocellular carcinoma	up	Mir-765 promotes cell proliferation by downregulating INPP4B expression in human hepatocellular carcinoma.
hsa-mir-765	osteosarcoma	down	MicroRNA-765 Enhances the Anti-Angiogenic Effect of CDDP via APE1 in Osteosarcoma.
hsa-mir-765	osteosarcoma	down	LncRNA Linc00511 promotes osteosarcoma cell proliferation and migration through sponging miR-765.
hsa-mir-765	prostate cancer	down	Hsa-miRNA-765 as a Key Mediator for Inhibiting Growth, Migration and Invasion in Fulvestrant-Treated Prostate Cancer.
hsa-mir-766	colon cancer	down	miRNA-766 induces apoptosis of human colon cancer cells through the p53/Bax signaling pathway by MDM4.
hsa-mir-766	colorectal cancer	up	MicroRNA-766 targeting regulation of SOX6 expression promoted cell proliferation of human colorectal cancer.
hsa-mir-766	hepatocellular carcinoma	up	MicroRNA-766 promotes cancer progression by targeting NR3C2 in hepatocellular carcinoma.
hsa-mir-766-3p	hepatocellular carcinoma	down	MicroRNA-766-3p Inhibits Tumour Progression by Targeting Wnt3a in Hepatocellular Carcinoma.
hsa-mir-766-3p	renal cell carcinoma	down	DNA-methylation-mediated repression of miR-766-3p promotes cell proliferation via targeting SF2 expression in renal cell carcinoma.
hsa-mir-767	malignant melanoma	up	MiR-767 promoted cell proliferation in human melanoma by suppressing CYLD expression.
hsa-mir-767-3p	lung adenocarcinoma	down	miR-767-3p inhibits growth and migration of lung adenocarcinoma cells by regulating CLDN18.
hsa-mir-769	colorectal cancer	down	microRNA-769 is downregulated in colorectal cancer and inhibits cancer progression by directly targeting cyclin-dependent kinase 1.
hsa-mir-769	colorectal cancer	down	MiR-769 Inhibits Colorectal Cancer Cell Proliferation and Invasion by Targeting HEY1.
hsa-mir-769	malignant melanoma	up	MiR-769 promoted cell proliferation in human melanoma by suppressing GSK3B expression.
hsa-mir-769-5p	non-small cell lung cancer	down	miR-769-5p suppressed cell proliferation, migration and invasion by targeting TGFBR1 in non-small cell lung carcinoma.
hsa-mir-770	glioma	down	MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma.
hsa-mir-770	glioma	down	Overexpression of miR-770 indicates a favorable prognosis and suppresses tumorigenesis by modulating PI3K-AKT pathway in glioma.
hsa-mir-770	hepatocellular carcinoma	up	Wnt/?-catenin signaling inhibits FBXW7 expression by upregulation of microRNA-770 in hepatocellular carcinoma.
hsa-mir-770	non-small cell lung cancer	down	Evaluating the diagnostic and prognostic value of serum miR-770 in non-small cell lung cancer.
hsa-mir-770	non-small cell lung cancer	down	MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/?-catenin pathway in non-small cell lung cancer.
hsa-mir-7702	colorectal cancer	down	Species-specific function of microRNA-7702 in human colorectal cancer cells via targeting TADA1.
hsa-mir-802	breast cancer	down	MicroRNA-802 suppresses breast cancer proliferation through downregulation of FoxM1.
hsa-mir-802	cervical cancer	down	microRNA-802 inhibits cell proliferation and induces apoptosis in human cervical cancer by targeting serine/arginine-rich splicing factor 9.
hsa-mir-802	gastric cancer	down	Upregulation of miR-802 suppresses gastric cancer oncogenicity via targeting RAB23 expression.
hsa-mir-802	osteosarcoma	up	MicroRNA-802 promotes osteosarcoma cell proliferation by targeting p27.
hsa-mir-802	prostate cancer	down	microRNA-802 inhibits epithelial-mesenchymal transition through targeting flotillin-2 in human prostate cancer.
hsa-mir-873	breast cancer	down	MiR-873 regulates ER? transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells.
hsa-mir-873	colorectal cancer	down	MicroRNA-873 inhibits colorectal cancer metastasis by targeting ELK1 and STRN4.
hsa-mir-873	esophageal cancer	down	MicroRNA-873 acts as a tumor suppressor in esophageal cancer by inhibiting differentiated embryonic chondrocyte expressed gene 2.
hsa-mir-873	glioblastoma	down	MiRNA-873 Inhibits Glioblastoma Tumorigenesis and Metastasis by Suppressing the Expression of IGF2BP1.
hsa-mir-873	hepatocellular carcinoma	up	The miR-873/NDFIP1 axis promotes hepatocellular carcinoma growth and metastasis through the AKT/mTOR-mediated Warburg effect.
hsa-mir-873	hepatocellular carcinoma	up	MicroRNA-873 Promotes Cell Proliferation, Migration, and Invasion by Directly Targeting TSLC1 in Hepatocellular Carcinoma.
hsa-mir-873	pancreatic ductal adenocarcinoma	down	The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers.
hsa-mir-873-5p	colon cancer	down	miR-873-5p inhibits the progression of colon cancer via repression of tumor suppressor candidate 3/AKT signaling.
hsa-mir-873-5p	colorectal cancer	down	MiR-873-5p inhibits cell migration, invasion and epithelial-mesenchymal transition in colorectal cancer via targeting ZEB1.
hsa-mir-873-5p	colorectal cancer	down	MiR-873-5p suppresses cell proliferation and epithelial-mesenchymal transition via directly targeting Jumonji domain-containing protein 8 through the NF-?B pathway in colorectal cancer.
hsa-mir-873-5p	gastric cancer	down	MiR-873-5P controls gastric cancer progression by targeting hedgehog-GLI signaling.
hsa-mir-874	breast cancer	down	MicroRNA-874 inhibits cell proliferation and induces apoptosis in human breast cancer by targeting CDK9.
hsa-mir-874	colorectal cancer	down	MiR-874 inhibits cell growth and induces apoptosis by targeting STAT3 in human colorectal cancer cells.
hsa-mir-874	colorectal cancer	down	MicroRNA-874 inhibits growth, induces apoptosis and reverses chemoresistance in colorectal cancer by targeting X-linked inhibitor of apoptosis protein.
hsa-mir-874	colorectal cancer	down	Decreased expression of miR-874 and its tumor suppressive function in human colorectal cancer.
hsa-mir-874	gastric cancer	down	Correction: miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer.
hsa-mir-874	gastric cancer	down	miR-874 Inhibits cell proliferation, migration and invasion through targeting aquaporin-3 in gastric cancer.
hsa-mir-874	gastric cancer	down	miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer.
hsa-mir-874	head and neck squamous cell carcinoma	down	Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.
hsa-mir-874	hepatocellular carcinoma	down	microRNA-874 suppresses tumor proliferation and metastasis in hepatocellular carcinoma by targeting the DOR/EGFR/ERK pathway.
hsa-mir-874	hepatocellular carcinoma	down	MiR-874 inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting SOX12.
hsa-mir-874	osteosarcoma	down	MicroRNA-874 inhibits cell proliferation and invasion by targeting cyclin-dependent kinase 9 in osteosarcoma.
hsa-mir-874	osteosarcoma	down	Decreased expression of tumor suppressive miR-874 and its clinical significance in human osteosarcoma.
hsa-mir-874	rhabdomyosarcoma	down	MicroRNA-874 functions as a tumor suppressor in rhabdomyosarcoma by directly targeting GEFT.
hsa-mir-874-3p	hepatocellular carcinoma	down	miR-874-3p is down-regulated in hepatocellular carcinoma and negatively regulates PIN1 expression.
hsa-mir-874-3p	nasopharyngeal carcinoma	down	MiR-874-3p suppresses cell proliferation and invasion by targeting ADAM19 in nasopharyngeal carcinoma.
hsa-mir-875	non-small cell lung cancer	up	MiR-875 can regulate the proliferation and apoptosis of non-small cell lung cancer cells via targeting SOCS2.
hsa-mir-875-5p	hepatocellular carcinoma	down	MicroRNA-876-5p inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by targeting BCL6 corepressor like 1.
hsa-mir-876	breast cancer	down	MicroRNA-876 is sponged by long noncoding RNA LINC00707 and directly targets metadherin to inhibit breast cancer malignancy.
hsa-mir-876-3p	gastric cancer	down	MiR-876-3p regulates cisplatin resistance and stem cell-like properties of gastric cancer cells by targeting TMED3.
hsa-mir-876-3p	pancreatic adenocarcinoma	down	MicroRNA-876-3p functions as a tumor suppressor gene and correlates with cell metastasis in pancreatic adenocarcinoma via targeting JAG2.
hsa-mir-876-5p	breast cancer	down	miR-876-5p suppresses breast cancer progression through targeting TFAP2A.
hsa-mir-876-5p	gastric cancer	down	MiR-876-5p regulates gastric cancer cell proliferation, apoptosis and migration through targeting WNT5A and MITF.
hsa-mir-876-5p	head and neck squamous cell carcinoma	down	MiR-876-5p modulates head and neck squamous cell carcinoma metastasis and invasion by targeting vimentin.
hsa-mir-876-5p	osteosarcoma	down	MicroRNA-876-5p inhibits cell proliferation, migration and invasion by targeting c-Met in osteosarcoma.
hsa-mir-877	hepatocellular carcinoma	down	Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1.
hsa-mir-877	non-small cell lung cancer	down	MicroRNA-877 inhibits cell proliferation and invasion in non-small cell lung cancer by directly targeting IGF-1R.
hsa-mir-877	oral squamous cell carcinoma	down	Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
hsa-mir-877-5p	hepatocellular carcinoma	down	Comment on: MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma.
hsa-mir-877-5p	hepatocellular carcinoma	down	MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma.
hsa-mir-885-5p	hepatocellular carcinoma	down	miR-885-5p suppresses hepatocellular carcinoma metastasis and inhibits Wnt/?-catenin signaling pathway.
hsa-mir-885-5p	hepatocellular carcinoma	up	Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.
hsa-mir-885-5p	laryngeal cancer	down	New miRNA expression abnormalities in laryngeal squamous cell carcinoma.
hsa-mir-885-5p	neuroblastoma	down	MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival.
hsa-mir-885-5p	osteosarcoma	down	miR-885-5p suppresses osteosarcoma proliferation, migration and invasion through regulation of ?-catenin.
hsa-mir-885-5p	osteosarcoma	up	MicroRNA-885-5p promotes osteosarcoma proliferation and migration by downregulation of cell division cycle protein 73 homolog expression.
hsa-mir-885-5p	renal clear cell carcinoma	up	microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.
hsa-mir-886-3p	small cell lung cancer	down	MicroRNA-886-3P functions as a tumor suppressor in small cell lung cancer.
hsa-mir-886-3p	thyroid cancer	down	MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer.
hsa-mir-886-5p	cervical carcinoma	down	MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells.
hsa-mir-887-5p	endometrial cancer	up	Changes in the Expression of Serum MiR-887-5p in Patients With Endometrial Cancer.
hsa-mir-888	colorectal cancer	up	miR-888 functions as an oncogene and predicts poor prognosis in colorectal cancer.
hsa-mir-888	hepatocellular carcinoma	up	MiR-888 promotes cell migration and invasion of hepatocellular carcinoma by targeting SMAD4.
hsa-mir-888-5p	hepatocellular carcinoma	up	Up-regulation of miR-888-5p in hepatocellular carcinoma cell lines and its effect on malignant characteristics of cells.
hsa-mir-889	cervical cancer	down	MicroRNA-889-3p targets FGFR2 to inhibit cervical cancer cell viability and invasion.
hsa-mir-889	colorectal cancer	up	MicroRNA-889 promotes cell proliferation in colorectal cancer by targeting DAB2IP.
hsa-mir-889	non-small cell lung cancer	up	MiR-889 promotes cell growth in human non-small cell lung cancer by regulating KLF9.
hsa-mir-889-3p	osteosarcoma	up	Hsa-miR-889-3p promotes the proliferation of osteosarcoma through inhibiting myeloid cell nuclear differentiation antigen expression.
hsa-mir-892a	colorectal cancer	up	miR-892a regulated PPP2R2A expression and promoted cell proliferation of human colorectal cancer cells.
hsa-mir-892a	hepatocellular carcinoma	up	MiR-892a Promotes Hepatocellular Carcinoma Cells Proliferation and Invasion Through Targeting CD226.
hsa-mir-892b	breast cancer	down	miR-892b Silencing Activates NF-?B and Promotes Aggressiveness in Breast Cancer.
hsa-mir-9	acute lymphoblastic leukemia	down	MicroRNA-9 suppresses cancer proliferation and cell cycle progression in acute lymphoblastic leukemia with inverse association of neuropilin-1.
hsa-mir-9	acute myeloid leukemia	down	MiR-9 functions as a tumor suppressor in acute myeloid leukemia by targeting CX chemokine receptor 4.
hsa-mir-9	bladder cancer	up	miR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer.
hsa-mir-9	breast cancer	down	Her-2 expression regulated by downregulation of miR-9 and which affects chemotherapeutic effect in breast cancer.
hsa-mir-9	breast cancer	down	Identification of direct target genes of miR-7, miR-9, miR-96, and miR-182 in the human breast cancer cell lines MCF-7 and MDA-MB-231.
hsa-mir-9	breast cancer	up	MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1.
hsa-mir-9	cervical adenocarcinoma	down	Down-regulation of microRNA-9 leads to activation of IL-6/Jak/STAT3 pathway through directly targeting IL-6 in HeLa cell.
hsa-mir-9	cervical cancer	up	MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer.
hsa-mir-9	cervical cancer	up	Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection.
hsa-mir-9	colorectal cancer	down	MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer.
hsa-mir-9	colorectal cancer	down	Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.
hsa-mir-9	esophageal squamous cell carcinoma	up	Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer.
hsa-mir-9	esophageal squamous cell carcinoma	up	MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma.
hsa-mir-9	esophageal squamous cell carcinoma	up	Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
hsa-mir-9	gastric adenocarcinoma	down	Analyses of methylation status of CpG islands in promoters of miR-9 genes family in human gastric adenocarcinoma.
hsa-mir-9	gastric adenocarcinoma	down	Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma.
hsa-mir-9	gastric cancer	down	Down-regulated miR-9 and miR-433 in human gastric carcinoma.
hsa-mir-9	gastric cancer	down	Aberrant hypermethylation of miR-9 genes in gastric cancer.
hsa-mir-9	gastric cancer	down	Development of a novel microRNA promoter microarray for ChIP-on-chip assay to identify epigenetically regulated microRNAs.
hsa-mir-9	gastric cancer	down	microRNA-9 Suppresses the Proliferation, Invasion and Metastasis of Gastric Cancer Cells through Targeting Cyclin D1 and Ets1.
hsa-mir-9	gastric cancer	down	Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
hsa-mir-9	glioblastoma	down	MiR-9 Promotes Apoptosis Via Suppressing SMC1A Expression in GBM Cell Lines.
hsa-mir-9	glioma	up	Identification of microRNAs associated with glioma diagnosis and prognosis.
hsa-mir-9	glioma	up	MiR-9 promotes tumorigenesis and angiogenesis and is activated by MYC and OCT4 in human glioma.
hsa-mir-9	glioma	up	[MiR-9 regulates the expression of CBX7 in human glioma].
hsa-mir-9	glioma	up	The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells.
hsa-mir-9	glioma	up	Increased expression of microRNA-9 predicts an unfavorable prognosis in human glioma.
hsa-mir-9	head and neck squamous cell carcinoma	down	MicroRNA-9 inhibits growth and invasion of head and neck cancer cells and is a predictive biomarker of response to plerixafor, an inhibitor of its target CXCR4.
hsa-mir-9	hepatocellular carcinoma	up	Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
hsa-mir-9	hepatocellular carcinoma	down	Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
hsa-mir-9	hepatocellular carcinoma	up	LincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through miR-9/E-cadherin cascade signaling pathway molecular mechanism.
hsa-mir-9	hepatocellular carcinoma	down	Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-?B in hepatocellular carcinoma.
hsa-mir-9	hepatocellular carcinoma	up	MicroRNA-9 is a ponderable index for the prognosis of human hepatocellular carcinoma.
hsa-mir-9	laryngeal squamous cell carcinoma	up	MicroRNA-9 as a novel prognostic biomarker in human laryngeal squamous cell carcinoma.
hsa-mir-9	malignant melanoma	down	MicroRNA-9 up-regulates E-cadherin through inhibition of NF-?B1-Snail1 pathway in melanoma.
hsa-mir-9	malignant melanoma	down	MicroRNA-9 inhibits the proliferation and migration of malignant melanoma cells via targeting sirituin 1.
hsa-mir-9	malignant melanoma	down	MicroRNA-9 suppresses the growth, migration, and invasion of malignant melanoma cells via targeting NRP1.
hsa-mir-9	medulloblastoma	down	Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-9	multiple myeloma	up	MiR-9 promotes multiple myeloma progression by regulating TRIM56/NF-?B pathway.
hsa-mir-9	nasopharyngeal carcinoma	down	miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma.
hsa-mir-9	nasopharyngeal carcinoma	down	Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma.
hsa-mir-9	non-small cell lung cancer	up	Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer.
hsa-mir-9	non-small cell lung cancer	up	Oncogenic miR-9 is a target of erlotinib in NSCLCs.
hsa-mir-9	non-small cell lung cancer	up	TGF-?1-induced epithelial-mesenchymal transition in lung cancer cells involves upregulation of miR-9 and downregulation of its target, E-cadherin.
hsa-mir-9	non-small cell lung cancer	up	MiR-9 is involved in TGF-?1-induced lung cancer cell invasion and adhesion by targeting SOX7.
hsa-mir-9	oral squamous cell carcinoma	down	MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/?-catenin signaling pathway.
hsa-mir-9	oral squamous cell carcinoma	down	Association of Decreased Expression of Serum miR-9 with Poor Prognosis of Oral Squamous Cell Carcinoma Patients.
hsa-mir-9	osteosarcoma	up	Serum miR-9 as a prognostic biomarker in patients with osteosarcoma.
hsa-mir-9	osteosarcoma	up	miR-9 Modulates Osteosarcoma Cell Growth by Targeting the GCIP Tumor Suppressor.
hsa-mir-9	ovarian cancer	down	MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.
hsa-mir-9	ovarian cancer	up	MicroRNA-9 promotes tumorigenesis and mediates sensitivity to cisplatin in primary epithelial ovarian cancer cells.
hsa-mir-9	ovarian cancer	up	Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer.
hsa-mir-9	pancreatic ductal adenocarcinoma	up	MiRNAs are Unlikely to be Involved in Retinoid Receptor Gene Regulation in Pancreatic Cancer Cells.
hsa-mir-9	uveal melanoma	down	MicroRNA-9 suppresses uveal melanoma cell migration and invasion through the NF-?B1 pathway.
hsa-mir-9-3p	gastric cancer	down	Transcriptome profiling reveals miR-9-3p as a novel tumor suppressor in gastric cancer.
hsa-mir-9-3p	hepatocellular carcinoma	down	Exosomal miR-9-3p suppresses HBGF-5 expression and is a functional biomarker in hepatocellular carcinoma.
hsa-mir-9-3p	hepatocellular carcinoma	down	LncRNA SAMMSON negatively regulates miR-9-3p in hepatocellular carcinoma cells and has prognostic values.
hsa-mir-9-3p	medullary thyroid carcinoma	up	Upregulated miR-9-3p promotes cell growth and inhibits apoptosis in medullary thyroid carcinoma by targeting BLCAP.
hsa-mir-9-3p	nasopharyngeal carcinoma	down	Elevation of MiR-9-3p suppresses the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via down-regulating FN1, ITGB1 and ITGAV.
hsa-mir-9-3p	papillary thyroid carcinoma	up	Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.
hsa-mir-9-5p	colorectal cancer	down	MiR-9-5p suppresses cell metastasis and epithelial-mesenchymal transition through targeting FOXP2 and predicts prognosis of colorectal carcinoma.
hsa-mir-9-5p	non-small cell lung cancer	up	MiR-9-5p promotes cell growth and metastasis in non-small cell lung cancer through the repression of TGFBR2.
hsa-mir-9-5p	pancreatic cancer	down	miR-9-5p inhibits pancreatic cancer cell proliferation, invasion and glutamine metabolism by targeting GOT1.
hsa-mir-9-5p	prostate cancer	up	Inhibition of miR-9-5p suppresses prostate cancer progress by targeting StarD13.
hsa-mir-92	bladder cancer	up	MicroRNA-92 promotes invasion and chemoresistance by targeting GSK3? and activating Wnt signaling in bladder cancer cells.
hsa-mir-92	colorectal cancer	up	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-92	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-92	gastric cancer	up	MicroRNA-92 promotes gastric cancer cell proliferation and invasion through targeting FXR.
hsa-mir-92	gastric cancer	down	MiR-92 suppresses proliferation and induces apoptosis by targeting EP4/Notch1 axis in gastric cancer.
hsa-mir-92	medulloblastoma	up	The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
hsa-mir-92	neuroblastoma	up	MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.
hsa-mir-92	pancreatic cancer	up	MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.
hsa-mir-922	hepatocellular carcinoma	up	miR-922 regulates CYLD expression and promotes the cell proliferation of human hepatocellular carcinoma.
hsa-mir-92a	acute myeloid leukemia	down	miR-92a inhibits proliferation and induces apoptosis by regulating Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) expression in acute myeloid leukemia.
hsa-mir-92a	acute myeloid leukemia	down	Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia.
hsa-mir-92a	acute promyelocytic leukemia	up	Inhibition of MicroRNA miR-92a Inhibits Cell Proliferation in Human Acute Promyelocytic Leukemia.
hsa-mir-92a	b-cell lymphoma	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-92a	breast cancer	down	Downregulation of miR-92a is associated with aggressive breast cancer features and increased tumour macrophage infiltration.
hsa-mir-92a	breast cancer	down	Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer.
hsa-mir-92a	breast cancer	down	MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.
hsa-mir-92a	breast carcinoma	up	MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
hsa-mir-92a	cervical cancer	up	miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7.
hsa-mir-92a	cervical cancer	up	Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer.
hsa-mir-92a	cervical cancer	up	MicroRNA-92a Promotes Cell Proliferation in Cervical Cancer via Inhibiting p21 Expression and Promoting Cell Cycle Progression.
hsa-mir-92a	cervical cancer	up	MicroRNA-92a promotes cell viability and invasion in cervical cancer via directly targeting Dickkopf-related protein 3.
hsa-mir-92a	cholangiocarcinoma	up	miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
hsa-mir-92a	chronic myelogenous leukemia	up	miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.
hsa-mir-92a	colorectal cancer	up	MicroRNA-92a Promotes Colorectal Cancer Cell Growth and Migration by Inhibiting KLF4.
hsa-mir-92a	colorectal cancer	up	MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-92a	colorectal cancer	up	MicroRNA signatures: novel biomarker for colorectal cancer?
hsa-mir-92a	colorectal cancer	up	Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps.
hsa-mir-92a	colorectal cancer	up	Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.
hsa-mir-92a	colorectal cancer	up	MicroRNA-92a Functions as an Oncogene in Colorectal Cancer by Targeting PTEN.
hsa-mir-92a	colorectal cancer	up	The expression profiling of serum miR-92a, miR-375, and miR-760 in colorectal cancer: An Egyptian study.
hsa-mir-92a	colorectal cancer	up	MiR-92a promotes stem cell-like properties by activating Wnt/?-catenin signaling in colorectal cancer.
hsa-mir-92a	colorectal cancer	up	MicroRNA-92a Promotes Colorectal Cancer Cell Growth and Migration by Inhibiting KLF4.
hsa-mir-92a	colorectal cancer	down	Concentration of circulating miRNA-containing particles in serum enhances miRNA detection and reflects CRC tissue-related deregulations.
hsa-mir-92a	endometrial cancer	up	In vitro and in vivo activity of miR-92a-Locked Nucleic Acid (LNA)-Inhibitor against endometrial cancer.
hsa-mir-92a	esophageal squamous cell carcinoma	up	microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin.
hsa-mir-92a	esophageal squamous cell carcinoma	up	TNF-? is a novel target of miR-19a.
hsa-mir-92a	glioma	up	MiRNA-92a promotes cell proliferation and invasion through binding to KLF4 in glioma.
hsa-mir-92a	hepatocellular carcinoma	up	Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development.
hsa-mir-92a	hepatocellular carcinoma	up	MiR-17-92 cluster promotes hepatocarcinogenesis.
hsa-mir-92a	hepatocellular carcinoma	up	MicroRNA-92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7.
hsa-mir-92a	hepatocellular carcinoma	up	miR-92a promotes hepatocellular carcinoma cells proliferation and invasion by FOXA2 targeting.
hsa-mir-92a	lung cancer	up	A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
hsa-mir-92a	lung cancer	up	Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
hsa-mir-92a	lung cancer	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-92a	malignant melanoma	up	Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
hsa-mir-92a	mantle cell lymphoma	up	The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
hsa-mir-92a	nasopharyngeal carcinoma	up	MicroRNA-92a promotes metastasis of nasopharyngeal carcinoma by targeting the PTEN/AKT pathway.
hsa-mir-92a	non-small cell lung cancer	up	MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN.
hsa-mir-92a	non-small cell lung cancer	up	MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
hsa-mir-92a	oral squamous cell carcinoma	up	MiR-92a regulates oral squamous cell carcinoma (OSCC) cell growth by targeting FOXP1 expression.
hsa-mir-92a	osteosarcoma	up	Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
hsa-mir-92a	osteosarcoma	up	The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.
hsa-mir-92a	ovarian cancer	up	Supernatant versus exosomal urinary microRNAs. Two fractions with different outcomes in gynaecological cancers.
hsa-mir-92a-3p	breast cancer	up	Bioinformatics-based interaction analysis of miR-92a-3p and key genes in tamoxifen-resistant breast cancer cells.
hsa-mir-92a-3p	colorectal cancer	up	CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
hsa-mir-92a-3p	glioma	up	The long non-coding RNA SNHG14 inhibits cell proliferation and invasion and promotes apoptosis by sponging miR-92a-3p in glioma.
hsa-mir-92a-3p	glioma	up	miR-92a-3p Exerts Various Effects in Glioma and Glioma Stem-Like Cells Specifically Targeting CDH1/?-Catenin and Notch-1/Akt Signaling Pathways.
hsa-mir-92b	cholangiocarcinoma	up	The role of miR-92b in cholangiocarcinoma patients.
hsa-mir-92b	glioblastoma	up	The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas.
hsa-mir-92b	glioma	up	MiR-92b inhibitor promoted glioma cell apoptosis via targeting DKK3 and blocking the Wnt/beta-catenin signaling pathway.
hsa-mir-92b	hepatocellular carcinoma	up	MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST.
hsa-mir-92b	nasopharyngeal cancer	down	MicroRNA-92b inhibits epithelial-mesenchymal transition-induced migration and invasion by targeting Smad3 in nasopharyngeal cancer.
hsa-mir-92b	non-small cell lung cancer	up	MiR-92b regulates the cell growth, cisplatin chemosensitivity of A549 non small cell lung cancer cell line and target PTEN.
hsa-mir-92b	non-small cell lung cancer	up	Inhibition of miR-92b suppresses nonsmall cell lung cancer cells growth and motility by targeting RECK.
hsa-mir-92b	non-small cell lung cancer	down	Regulation of Twist in the metastasis of non-small cell lung cancer by miR-92b.
hsa-mir-92b	oral squamous cell carcinoma	up	MicroRNA-92b promotes tumor growth and activation of NF-?B signaling via regulation of NLK in oral squamous cell carcinoma.
hsa-mir-92b	osteosarcoma	up	miR-92b promotes tumor proliferation, migration, and invasion by targeting RECK in osteosarcoma.
hsa-mir-92b	osteosarcoma	up	MicroRNA-92b promotes cell proliferation and invasion in osteosarcoma by directly targeting Dickkopf-related protein 3.
hsa-mir-92b-3p	colorectal carcinoma	up	miR-92b-3p Promotes Colorectal Carcinoma Cell Proliferation, Invasion, and Migration by Inhibiting FBXW7 In Vitro and In Vivo.
hsa-mir-92b-3p	gastric cancer	up	Downregulation of microRNA-92b-3p suppresses proliferation, migration, and invasion of gastric cancer SGC-7901 cells by targeting Homeobox D10.
hsa-mir-93	basal cell carcinoma	up	Expression of microRNAs in basal cell carcinoma.
hsa-mir-93	bladder cancer	up	MicroRNA-93 promotes bladder cancer proliferation and invasion by targeting PEDF.
hsa-mir-93	breast cancer	up	Molecular mechanism and role of microRNA-93 in human cancers: A study based on bioinformatics analysis, meta-analysis, and quantitative polymerase chain reaction validation.
hsa-mir-93	colon cancer	down	Clinical significance of microRNA-93 downregulation in human colon cancer.
hsa-mir-93	colorectal cancer	up	Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-93	colorectal carcinoma	down	MicroRNA-93 suppress colorectal cancer development via Wnt/?-catenin pathway downregulating.
hsa-mir-93	endometrial cancer	up	TSA Suppresses miR-106b-93-25 Cluster Expression through Downregulation of MYC and Inhibits Proliferation and Induces Apoptosis in Human EMC.
hsa-mir-93	endometrial cancer	up	Molecular mechanism and role of microRNA-93 in human cancers: A study based on bioinformatics analysis, meta-analysis, and quantitative polymerase chain reaction validation.
hsa-mir-93	endometrial cancer	up	MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells.
hsa-mir-93	esophageal cancer	up	Molecular mechanism and role of microRNA-93 in human cancers: A study based on bioinformatics analysis, meta-analysis, and quantitative polymerase chain reaction validation.
hsa-mir-93	esophageal squamous cell carcinoma	up	Micro ribonucleic acid-93 promotes proliferation and migration of esophageal squamous cell carcinoma by targeting disabled 2.
hsa-mir-93	gastric cancer	up	Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer
hsa-mir-93	gastric cancer	up	MicroRNA-93 promotes proliferation and metastasis of gastric cancer via targeting TIMP2.
hsa-mir-93	gastric cancer	up	Tumor Expression of miR-10b, miR-21, miR-143 and miR-145 Is Related to Clinicopathological Features of Gastric Cancer in a Central European Population.
hsa-mir-93	glioma	down	Evaluation Expression of Microrna-93 and Integrin ?8 in Different Types of Glioma Tumors
hsa-mir-93	glioma	up	MiRNA-93 functions as an oncogene in glioma by directly targeting RBL2.
hsa-mir-93	glioma	up	[Overexpressed microRNA-93 inhibits the proliferation and promotes apoptosis of A172 glioma cells].
hsa-mir-93	glioma	up	miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway.
hsa-mir-93	glioma	up	MicroRNA-93 promotes the malignant phenotypes of human glioma cells and induces their chemoresistance to temozolomide.
hsa-mir-93	head and neck squamous cell carcinoma	up	Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas.
hsa-mir-93	head and neck squamous cell carcinoma	up	Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
hsa-mir-93	hepatocellular carcinoma	up	Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.
hsa-mir-93	hepatocellular carcinoma	up	The miR-93 promotes proliferation by directly targeting PDCD4 in hepatocellular carcinoma.
hsa-mir-93	hepatocellular carcinoma	up	Exosomal miR-93 promotes proliferation and invasion in hepatocellular carcinoma by directly inhibiting TIMP2/TP53INP1/CDKN1A.
hsa-mir-93	hepatocellular carcinoma	up	Molecular mechanism and role of microRNA-93 in human cancers: A study based on bioinformatics analysis, meta-analysis, and quantitative polymerase chain reaction validation.
hsa-mir-93	hepatocellular carcinoma	up	miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
hsa-mir-93	hepatocellular carcinoma	up	miR-93 enhances hepatocellular carcinoma invasion and metastasis by EMT via targeting PDCD4.
hsa-mir-93	laryngeal cancer	up	Molecular mechanism and role of microRNA-93 in human cancers: A study based on bioinformatics analysis, meta-analysis, and quantitative polymerase chain reaction validation.
hsa-mir-93	laryngeal squamous cell carcinoma	up	MicroRNA-93 regulates cyclin G2 expression and plays an oncogenic role in laryngeal squamous cell carcinoma.
hsa-mir-93	lung cancer	up	miR-93 promotes TGF-?-induced epithelial-to-mesenchymal transition through downregulation of NEDD4L in lung cancer cells.
hsa-mir-93	lung cancer	up	Molecular mechanism and role of microRNA-93 in human cancers: A study based on bioinformatics analysis, meta-analysis, and quantitative polymerase chain reaction validation.
hsa-mir-93	nasopharyngeal cancer	up	Molecular mechanism and role of microRNA-93 in human cancers: A study based on bioinformatics analysis, meta-analysis, and quantitative polymerase chain reaction validation.
hsa-mir-93	nasopharyngeal carcinoma	up	MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2.
hsa-mir-93	nasopharyngeal carcinoma	up	miR-93 enhances cell proliferation by directly targeting CDKN1A in nasopharyngeal carcinoma.
hsa-mir-93	non-small cell lung cancer	up	Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer.
hsa-mir-93	osteosarcoma	up	microRNA-93 promotes cell proliferation via targeting of PTEN in Osteosarcoma cells.
hsa-mir-93	osteosarcoma	up	MicroRNA-93 promotes cell proliferation by directly targeting P21 in osteosarcoma cells.
hsa-mir-93	osteosarcoma	up	[Effects of miR-93 on proliferation and apoptosis of osteosarcoma cells].
hsa-mir-93	ovarian carcinoma	down	RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
hsa-mir-93	prostate cancer	up	Molecular mechanism and role of microRNA-93 in human cancers: A study based on bioinformatics analysis, meta-analysis, and quantitative polymerase chain reaction validation.
hsa-mir-93-5p	breast cancer	up	MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
hsa-mir-93-5p	cervical cancer	up	MiR-93-5p promotes cervical cancer progression by targeting THBS2/MMPS signal pathway.
hsa-mir-93-5p	esophageal cancer	up	MicroRNA-93-5p/IFNAR1 axis accelerates metastasis of endometrial carcinoma by activating the STAT3 pathway.
hsa-mir-93-5p	gastric cancer	up	miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway.
hsa-mir-93-5p	gastric cancer	up	MiR-93-5p promotes gastric cancer-cell progression via inactivation of the Hippo signaling pathway.
hsa-mir-93-5p	hepatocellular carcinoma	up	MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis.
hsa-mir-93-5p	hepatocellular carcinoma	up	Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
hsa-mir-93-5p	hepatocellular carcinoma	up	MiR-93-5p Promotes Cell Proliferation through Down-Regulating PPARGC1A in Hepatocellular Carcinoma Cells by Bioinformatics Analysis and Experimental Verification.
hsa-mir-93-5p	non-small cell lung cancer	up	MiR-93-5p up-regulation is involved in non-small cell lung cancer cells proliferation and migration and poor prognosis.
hsa-mir-93-5p	ovarian cancer	up	MicroRNA profiling of plasma exosomes from patients with ovarian cancer using high-throughput sequencing.
hsa-mir-934	bladder cancer	up	Inhibition of UBE2N-dependent CDK6 protein degradation by miR-934 promotes human bladder cancer cell growth.
hsa-mir-934	ovarian cancer	up	Oncogene miR-934 promotes ovarian cancer cell proliferation and inhibits cell apoptosis through targeting BRMS1L.
hsa-mir-935	gastric cancer	down	miR-935 suppresses gastric signet ring cell carcinoma tumorigenesis by targeting Notch1 expression.
hsa-mir-935	gastric cancer	up	miR-935 promotes gastric cancer cell proliferation by targeting SOX7.
hsa-mir-935	liver cancer	up	MiR-935 promotes liver cancer cell proliferation and migration by targeting SOX7.
hsa-mir-935	non-small cell lung cancer	down	microRNA-935 is reduced in non-small-cell lung cancer tissue, is linked poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.
hsa-mir-936	glioma	down	MicroRNA-936 induces cell cycle arrest and inhibits glioma cell proliferation by targeting CKS1.
hsa-mir-936	non-small cell lung cancer	down	Overexpression of microRNA-936 suppresses non-small cell lung cancer cell proliferation and invasion via targeting E2F2.
hsa-mir-937	breast cancer	up	miR-937 regulates the proliferation and apoptosis via targeting APAF1 in breast cancer.
hsa-mir-937	gastric cancer	down	MicroRNA-937 inhibits cell proliferation and metastasis in gastric cancer cells by downregulating FOXL2.
hsa-mir-937	lung cancer	up	miR-937 contributes to the lung cancer cell proliferation by targeting INPP4B.
hsa-mir-938	colorectal cancer	up	miR-938 promotes colorectal cancer cell proliferation via targeting tumor suppressor PHLPP2.
hsa-mir-939-3p	lung cancer	up	Overexpression of miR-939-3p predicts poor prognosis and promotes progression in lung cancer.
hsa-mir-940	bladder cancer	up	MicroRNA-940 Targets INPP4A or GSK3? and Activates the Wnt/?-Catenin Pathway to Regulate the Malignant Behavior of Bladder Cancer Cells.
hsa-mir-940	colorectal cancer	down	MicroRNA-940 restricts the expression of metastasis-associated gene MACC1 and enhances the antitumor effect of Anlotinib on colorectal cancer.
hsa-mir-940	esophageal cancer	up	miR-940 potentially promotes proliferation and metastasis of endometrial carcinoma through regulation of MRVI1.
hsa-mir-940	gastric cancer	up	MicroRNA-940 promotes tumor cell invasion and metastasis by downregulating ZNF24 in gastric cancer.
hsa-mir-940	gastric cancer	down	Plasma miR-940 may serve as a novel biomarker for gastric cancer.
hsa-mir-940	glioblastoma	down	Long noncoding RNA lncHERG promotes cell proliferation, migration and invasion in glioblastoma.
hsa-mir-940	glioma	down	MicroRNA-940 inhibits glioma progression by blocking mitochondrial folate metabolism through targeting of MTHFD2.
hsa-mir-940	hepatocellular carcinoma	down	MiR-940 inhibits hepatocellular carcinoma growth and correlates with prognosis of hepatocellular carcinoma patients.
hsa-mir-940	hepatocellular carcinoma	down	miR-940 Suppresses Tumor Cell Invasion and Migration via Regulation of CXCR2 in Hepatocellular Carcinoma.
hsa-mir-940	non-small cell lung cancer	down	MiR-940 inhibits TGF-?-induced epithelial-mesenchymal transition and cell invasion by targeting Snail in non-small cell lung cancer.
hsa-mir-940	pancreatic carcinoma	up	Over-expression of microRNA-940 promotes cell proliferation by targeting GSK3? and sFRP1 in human pancreatic carcinoma.
hsa-mir-940	prostate cancer	down	MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1.
hsa-mir-941	hepatocellular carcinoma	down	DNA Methylation-mediated Repression of miR-941 Enhances Lysine (K)-specific Demethylase 6B Expression in Hepatoma Cells.
hsa-mir-942	colorectal cancer	up	Hsa-miR-942 fingerprint in colorectal cancer through Wnt signaling pathway.
hsa-mir-942	esophageal squamous cell carcinoma	up	miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/?-catenin signalling pathway.
hsa-mir-944	breast cancer	up	MiR-944 functions as a novel oncogene and regulates the chemoresistance in breast cancer.
hsa-mir-944	cervical cancer	up	Novel functions and targets of miR-944 in human cervical cancer cells.
hsa-mir-944	cervical cancer	up	Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer.
hsa-mir-944	colon cancer	down	miR-944 inhibits cell migration and invasion by targeting MACC1 in colorectal cancer.
hsa-mir-944	colorectal cancer	down	Primate-specific miR-944 activates p53-dependent tumor suppression in human colorectal cancers.
hsa-mir-944	colorectal cancer	down	Ectopic expression of miR-944 impairs colorectal cancer cell proliferation and invasion by targeting GATA binding protein 6.
hsa-mir-944	endometrial cancer	up	miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.
hsa-mir-944	hepatocellular carcinoma	down	microRNA-944 inhibits the malignancy of hepatocellular carcinoma by directly targeting IGF-1R and deactivating the PI3K/Akt signaling pathway.
hsa-mir-944	lung adenocarcinoma	down	miR-944 inhibits lung adenocarcinoma tumorigenesis by targeting STAT1 interaction.
hsa-mir-944	lung cancer	up	Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.
hsa-mir-944	non-small cell lung cancer	down	MicroRNA-944 Affects Cell Growth by Targeting EPHA7 in Non-Small Cell Lung Cancer.
hsa-mir-95	colorectal cancer	up	MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma.
hsa-mir-95	colorectal carcinoma	up	MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma.
hsa-mir-95	gastric cancer	up	microRNA-95 knockdown inhibits epithelial-mesenchymal transition and cancer stem cell phenotype in gastric cancer cells through MAPK pathway by upregulating DUSP5.
hsa-mir-95	gastric cancer	up	miRNA and mRNA expression profiles in gastric cancer patients and the relationship with circRNA.
hsa-mir-95	gastric cancer	down	Downregulation of miR-95 in gastric cancer promotes EMT via regulation of Slug, thereby promoting migration and invasion.
hsa-mir-95	non-small cell lung cancer	up	MiR-95 induces proliferation and chemo- or radioresistance through directly targeting sorting nexin1 (SNX1) in non-small cell lung cancer.
hsa-mir-95-3p	hepatocellular carcinoma	up	Up-regulation of miR-95-3p in hepatocellular carcinoma promotes tumorigenesis by targeting p21 expression.
hsa-mir-95-3p	osteosarcoma	down	Upregulation of miR?95-3p inhibits growth of osteosarcoma by targeting HDGF.
hsa-mir-95-3p	osteosarcoma	up	Downregulation of microRNA-95-3p suppresses cell growth of osteosarcoma via CDKN1A/p21 expression.
hsa-mir-9500	lung cancer	down	The novel miR-9500 regulates the proliferation and migration of human lung cancer cells by targeting Akt1.
hsa-mir-96	bladder cancer	up	MicroRNA expression signatures of bladder cancer revealed by deep sequencing.
hsa-mir-96	bladder cancer	up	Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.
hsa-mir-96	bladder cancer	up	Upregulation of microRNA-96 and its oncogenic functions by targeting CDKN1A in bladder cancer.
hsa-mir-96	breast cancer	up	Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a.
hsa-mir-96	breast cancer	up	miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer.
hsa-mir-96	breast cancer	up	miR-96 promotes breast cancer metastasis by suppressing MTSS1.
hsa-mir-96	breast cancer	up	High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer.
hsa-mir-96	breast cancer	up	miR-96 promotes cell proliferation, migration and invasion by targeting PTPN9 in breast cancer.
hsa-mir-96	chronic myelogenous leukemia	up	Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.
hsa-mir-96	colorectal cancer	up	Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer.
hsa-mir-96	colorectal cancer	up	MicroRNA-96 promotes the proliferation of colorectal cancer cells and targets tumor protein p53 inducible nuclear protein 1, forkhead box protein O1 (FOXO1) and FOXO3a.
hsa-mir-96	colorectal cancer	up	High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis.
hsa-mir-96	colorectal cancer	up	MicroRNA-96 Promotes Tumor Invasion in Colorectal Cancer via RECK.
hsa-mir-96	esophageal cancer	up	MiR-96 promotes proliferation and chemo- or radioresistance by down-regulating RECK in esophageal cancer.
hsa-mir-96	glioma	up	The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas.
hsa-mir-96	glioma	up	miR-96/HBP1/Wnt/?-catenin regulatory circuitry promotes glioma growth.
hsa-mir-96	glioma	up	MicroRNA-96 Regulates Apoptosis by Targeting PDCD4 in Human Glioma Cells.
hsa-mir-96	hepatocellular carcinoma	up	Inhibition of miR-96 expression reduces cell proliferation and clonogenicity of HepG2 hepatoma cells.
hsa-mir-96	hepatocellular carcinoma	up	OncomiR miR-96 and miR-182 promote cell proliferation and invasion through targeting ephrinA5 in hepatocellular carcinoma.
hsa-mir-96	hepatocellular carcinoma	up	Wnt/?-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion.
hsa-mir-96	lung adenocarcinoma	up	Identification and characterization of miR-96, a potential biomarker of NSCLC, through bioinformatic analysis.
hsa-mir-96	lung cancer	up	Circulating exosomal microRNA-96 promotes cell proliferation, migration and drug resistance by targeting LMO7.
hsa-mir-96	nasopharyngeal carcinoma	down	MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma.
hsa-mir-96	non-small cell lung cancer	up	miR-96 promotes invasion and metastasis by targeting GPC3 in non-small cell lung cancer cells.
hsa-mir-96	non-small cell lung cancer	up	Identification and characterization of miR-96, a potential biomarker of NSCLC, through bioinformatic analysis.
hsa-mir-96	non-small cell lung cancer	down	Expression of microRNA-96 and its potential functions by targeting FOXO3 in non-small cell lung cancer.
hsa-mir-96	non-small cell lung cancer	up	miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9.
hsa-mir-96	osteosarcoma	down	microRNA-96 acts as a tumor suppressor gene in human osteosarcoma via target regulation of EZRIN.
hsa-mir-96	ovarian cancer	up	The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimul
hsa-mir-96	ovarian cancer	up	Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
hsa-mir-96	pancreatic cancer	down	miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer.
hsa-mir-96	prostate cancer	up	miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells.
hsa-mir-96	prostate cancer	up	miR-96 promotes cell proliferation and clonogenicity by down-regulating of FOXO1 in prostate cancer cells.
hsa-mir-96	prostate cancer	up	Transforming growth factor-? promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway.
hsa-mir-96	renal cell carcinoma	down	miR-96 suppresses renal cell carcinoma invasion via downregulation of Ezrin expression.
hsa-mir-96-5p	breast cancer	up	Identification of microRNA expression in sentinel lymph nodes from patients with breast cancer via RNA sequencing for diagnostic accuracy.
hsa-mir-96-5p	colorectal cancer	down	MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients.
hsa-mir-96-5p	head and neck squamous cell carcinoma	up	miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells.
hsa-mir-96-5p	hepatocellular carcinoma	up	Oncogenic miR-96-5p inhibits apoptosis by targeting the caspase-9 gene in hepatocellular carcinoma.
hsa-mir-98	bladder cancer	up	MicroRNA-98 promotes drug resistance and regulates mitochondrial dynamics by targeting LASS2 in bladder cancer cells.
hsa-mir-98	breast cancer	down	microRNA-98 inhibits the proliferation, invasion, migration and promotes apoptosis of breast cancer cells by binding to HMGA2.
hsa-mir-98	breast cancer	down	Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.
hsa-mir-98	breast cancer	down	Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-mir-98	bronchioloalveolar carcinoma	down	let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
hsa-mir-98	colon cancer	down	let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
hsa-mir-98	colon cancer	down	MicroRNA-98 Suppress Warburg Effect by Targeting HK2 in Colon Cancer Cells.
hsa-mir-98	colon cancer	down	[Periostin regulated by let-7/miR-98 family mediates the apoptosis and epithelial-mesenchymal transition of colon cancer].
hsa-mir-98	esophageal squamous cell carcinoma	down	Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.
hsa-mir-98	esophageal squamous cell carcinoma	down	MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma.
hsa-mir-98	esophageal squamous cell carcinoma	down	Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
hsa-mir-98	gastric cancer	up	MicroRNA profiling of human gastric cancer.
hsa-mir-98	gastric cancer	down	Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.
hsa-mir-98	glioma	down	MiR-98 Promotes Apoptosis of Glioma Cells via Suppressing IKBKE/NF-?B Pathway.
hsa-mir-98	glioma	down	Overexpression of RKIP inhibits cell invasion in glioma cell lines through upregulation of miR-98.
hsa-mir-98	glioma	down	Overexpression of miR-98 inhibits cell invasion in glioma cell lines via downregulation of IKK?.
hsa-mir-98	glioma	down	Methylation-induced downregulation and tumor-suppressive role of microRNA-98 in glioma through targeting Sal-like protein 4.
hsa-mir-98	hepatocellular carcinoma	down	MicroRNA-98 suppresses cell proliferation, migration and invasion by targeting collagen triple helix repeat containing 1 in hepatocellular carcinoma.
hsa-mir-98	hepatocellular carcinoma	down	miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/?-catenin signaling pathway.
hsa-mir-98	hepatocellular carcinoma	down	MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
hsa-mir-98	hepatocellular carcinoma	down	MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-mir-98	hepatocellular carcinoma	down	MiR-98 suppresses the effects of tumor-associated macrophages on promoting migration and invasion of hepatocellular carcinoma cells by regulating IL-10.
hsa-mir-98	lung cancer	down	Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
hsa-mir-98	lung cancer	down	Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
hsa-mir-98	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
hsa-mir-98	malignant melanoma	down	miR-98 suppresses melanoma metastasis through a negative feedback loop with its target gene IL-6.
hsa-mir-98	nasopharyngeal carcinoma	down	MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
hsa-mir-98	nasopharyngeal carcinoma	down	The effects of microRNA-98 inhibits cell proliferation and invasion by targeting STAT3 in nasopharyngeal carcinoma.
hsa-mir-98	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
hsa-mir-98	non-small cell lung cancer	down	MiR-98 inhibits cell proliferation and invasion of non-small cell carcinoma lung cancer by targeting PAK1.
hsa-mir-98	non-small cell lung cancer	down	MicroRNA-98 plays a suppressive role in non-small cell lung cancer through inhibition of SALL4 protein expression.
hsa-mir-98	non-small cell lung cancer	down	Low serum miR-98 as an unfavorable prognostic biomarker in patients with non-small cell lung cancer.
hsa-mir-98	oral squamous cell carcinoma	down	miR-98 suppresses tumor cell growth and metastasis by targeting IGF1R in oral squamous cell carcinoma.
hsa-mir-98	ovarian cancer	down	EZH2-specific microRNA-98 inhibits human ovarian cancer stem cell proliferation via regulating the pRb-E2F pathway.
hsa-mir-98	ovarian carcinoma	down	MiRNA-98 inhibits ovarian carcinoma cell proliferation, migration and invasion via targeting SALL4.
hsa-mir-98	pancreatic ductal adenocarcinoma	down	let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.
hsa-mir-98	papillary thyroid carcinoma	down	Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.
hsa-mir-98	squamous carcinoma	down	MiR-98 inhibits malignant progression via targeting MTDH in squamous cell carcinoma of the head and neck.
hsa-mir-98-5p	hepatocellular carcinoma	down	MicroRNA-98-5p inhibits cell proliferation and induces cell apoptosis in hepatocellular carcinoma via targeting IGF2BP1.
hsa-mir-98-5p	non-small cell lung cancer	down	MicroRNA-98-5p inhibits proliferation and metastasis in non-small cell lung cancer by targeting TGFBR1.
hsa-mir-98-5p	non-small cell lung cancer	down	NEAT1/has-mir-98-5p/MAPK6 axis is involved in non-small-cell lung cancer (NSCLC) development.
hsa-mir-98-5p	osteosarcoma	down	LncRNA SNHG16 sponges miR-98-5p to regulate cellular processes in osteosarcoma.
hsa-mir-98-5p	pancreatic ductal adenocarcinoma	down	Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
hsa-mir-99a	acute myeloid leukemia	up	Prognostic significance of microRNA-99a in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
hsa-mir-99a	bladder cancer	down	Evaluation of MicroRNA-99a and MicroRNA-205 Expression Levels in Bladder Cancer.
hsa-mir-99a	bladder cancer	down	microRNA-99a inhibiting cell proliferation, migration and invasion by targeting fibroblast growth factor receptor 3 in bladder cancer.
hsa-mir-99a	bladder cancer	down	microRNA-99a acts as a tumor suppressor and is down-regulated in bladder cancer.
hsa-mir-99a	breast cancer	down	MiR-99a antitumor activity in human breast cancer cells through targeting of mTOR expression.
hsa-mir-99a	breast cancer	down	MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells.
hsa-mir-99a	breast cancer	down	MiR-99a suppress proliferation, migration and invasion through regulating insulin-like growth factor 1 receptor in breast cancer.
hsa-mir-99a	breast cancer	down	Low levels of serum miR-99a is a predictor of poor prognosis in breast cancer.
hsa-mir-99a	cervical cancer	down	miR-99a and -99b inhibit cervical cancer cell proliferation and invasion by targeting mTOR signaling pathway.
hsa-mir-99a	cervical carcinoma	down	miR-99 inhibits cervical carcinoma cell proliferation by targeting TRIB2.
hsa-mir-99a	endometrial cancer	down	A dual PI3K/AKT/mTOR signaling inhibitor miR-99a suppresses endometrial carcinoma.
hsa-mir-99a	esophageal squamous cell carcinoma	down	MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma.
hsa-mir-99a	esophageal squamous cell carcinoma	down	MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
hsa-mir-99a	gastric cancer	up	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-99a	glioma	down	Roles of microRNA-99 family in human glioma.
hsa-mir-99a	hepatocellular carcinoma	down	MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.
hsa-mir-99a	hepatocellular carcinoma	down	Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.
hsa-mir-99a	hepatocellular carcinoma	down	PLGA-based dual targeted nanoparticles enhance miRNA transfection efficiency in hepatic carcinoma.
hsa-mir-99a	liver cancer	down	miRNA-99a inhibits cell invasion and migration in liver cancer by directly targeting HOXA1.
hsa-mir-99a	lung adenocarcinoma	down	Clinic significance of microRNA-99a expression in human lung adenocarcinoma.
hsa-mir-99a	lung adenocarcinoma	down	miR-99a regulates ROS-mediated invasion and migration of lung adenocarcinoma cells by targeting NOX4.
hsa-mir-99a	mesenchymal cancer	down	MicroRNA Expression Profiles in Kaposi's Sarcoma.
hsa-mir-99a	nasopharyngeal carcinoma	down	MiR-99a suppresses cell invasion and metastasis in nasopharyngeal carcinoma through targeting HOXA1.
hsa-mir-99a	nasopharyngeal carcinoma	down	MiR-99a inhibits cell proliferation of nasopharyngeal carcinoma by targeting mTOR and serves as a prognostic factor.
hsa-mir-99a	non-small cell lung cancer	down	miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
hsa-mir-99a	non-small cell lung cancer	down	microRNA-99a is downregulated and promotes proliferation, migration and invasion in non-small cell lung cancer A549 and H1299 cells.
hsa-mir-99a	oral squamous cell carcinoma	down	Diagnostic and prognostic value of serum miR-99a expression in oral squamous cell carcinoma.
hsa-mir-99a	osteosarcoma	down	Tumor-suppressive miR-99a inhibits cell proliferation via targeting of TNFAIP8 in osteosarcoma cells.
hsa-mir-99a	ovarian cancer	down	MiR-99a suppressed cell proliferation and invasion by directly targeting HOXA1 through regulation of the AKT/mTOR signaling pathway and EMT in ovarian cancer.
hsa-mir-99a	pancreatic cancer	up	Antagonism of microRNA-99a promotes cell invasion and down-regulates E-cadherin expression in pancreatic cancer cells by regulating mammalian target of rapamycin.
hsa-mir-99a	prostate cancer	down	Expression of microRNA-99a-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 Cases.
hsa-mir-99a	renal cell carcinoma	down	WITHDRAWN: MicroRNA-99a Suppresses Proliferation, Migration, Invasion and Induces G1-phase Cell Cycle Arrest via Targeting Insulin-like Growth Factor 1 Receptor Pathway in Renal Cell Carcinoma 786-0 a
hsa-mir-99a-5p	bladder cancer	down	MiR-99a-5p inhibits bladder cancer cell proliferation by directly targeting mammalian target of rapamycin and predicts patient survival.
hsa-mir-99a-5p	breast cancer	down	MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
hsa-mir-99b	cervical cancer	down	MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
hsa-mir-99b	cervical cancer	down	miR-99a and -99b inhibit cervical cancer cell proliferation and invasion by targeting mTOR signaling pathway.
hsa-mir-99b	cervical carcinoma	down	miR-99 inhibits cervical carcinoma cell proliferation by targeting TRIB2.
hsa-mir-99b	esophageal cancer	up	Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-99b	esophageal squamous cell carcinoma	up	ZEB1 induced miR-99b/let-7e/miR-125a cluster promotes invasion and metastasis in esophageal squamous cell carcinoma.
hsa-mir-99b	glioma	down	Roles of microRNA-99 family in human glioma.
hsa-mir-99b	hepatocellular carcinoma	up	miR-99b promotes metastasis of hepatocellular carcinoma through inhibition of claudin 11 expression and may serve as a prognostic marker.
hsa-mir-99b	hepatocellular carcinoma	up	The role of miR-99b in mediating hepatocellular carcinoma invasion and migration.
hsa-mir-99b	lung cancer	down	microRNA-99b acts as a tumor suppressor in non-small cell lung cancer by directly targeting fibroblast growth factor receptor 3.
hsa-mir-99b-3p	hepatocellular carcinoma	up	miR-99b-3p promotes hepatocellular carcinoma metastasis and proliferation by targeting protocadherin 19.
hsa-mir-99b-3p	oral squamous cell carcinoma	down	miRNA-99b-3p functions as a potential tumor suppressor by targeting glycogen synthase kinase-3? in oral squamous cell carcinoma Tca-8113 cells.
hsa-mir-99b-5p	non-small cell lung cancer	down	miRNA-99b-5p targets FZD8 to inhibit non-small cell lung cancer proliferation, migration and invasion.
hsa-mir-99b-5p	ovarian cancer	down	MicroRNA profiling of plasma exosomes from patients with ovarian cancer using high-throughput sequencing.
mir-17	b-cell lymphoma	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-17	breast carcinoma	up	MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
mir-17	chronic myelogenous leukemia	up	miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.
mir-17	colorectal cancer	up	MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
mir-17	esophageal squamous cell carcinoma	up	TNF-? is a novel target of miR-19a.
mir-17	hepatocellular carcinoma	up	MiR-17-92 cluster promotes hepatocarcinogenesis.
mir-17	lung cancer	up	A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
mir-17	lung cancer	up	Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
mir-17	lung cancer	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-17	mantle cell lymphoma	up	The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
mir-17	osteosarcoma	up	Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
mir-17	osteosarcoma	up	The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.
mir-18a	b-cell lymphoma	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-18a	breast carcinoma	up	MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
mir-18a	chronic myelogenous leukemia	up	miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.
mir-18a	colorectal cancer	up	MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
mir-18a	esophageal squamous cell carcinoma	up	TNF-? is a novel target of miR-19a.
mir-18a	hepatocellular carcinoma	up	MiR-17-92 cluster promotes hepatocarcinogenesis.
mir-18a	lung cancer	up	A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
mir-18a	lung cancer	up	Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
mir-18a	lung cancer	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-18a	mantle cell lymphoma	up	The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
mir-18a	osteosarcoma	up	Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
mir-18a	osteosarcoma	up	The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.
mir-19a	b-cell lymphoma	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-19a	breast carcinoma	up	MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
mir-19a	chronic myelogenous leukemia	up	miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.
mir-19a	colorectal cancer	up	MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
mir-19a	esophageal squamous cell carcinoma	up	TNF-? is a novel target of miR-19a.
mir-19a	hepatocellular carcinoma	up	MiR-17-92 cluster promotes hepatocarcinogenesis.
mir-19a	lung cancer	up	A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
mir-19a	lung cancer	up	Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
mir-19a	lung cancer	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-19a	mantle cell lymphoma	up	The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
mir-19a	osteosarcoma	up	Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
mir-19a	osteosarcoma	up	The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.
mir-19b	b-cell lymphoma	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-19b	breast carcinoma	up	MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
mir-19b	chronic myelogenous leukemia	up	miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.
mir-19b	colorectal cancer	up	MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
mir-19b	esophageal squamous cell carcinoma	up	TNF-? is a novel target of miR-19a.
mir-19b	hepatocellular carcinoma	up	MiR-17-92 cluster promotes hepatocarcinogenesis.
mir-19b	lung cancer	up	A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
mir-19b	lung cancer	up	Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
mir-19b	lung cancer	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-19b	mantle cell lymphoma	up	The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
mir-19b	osteosarcoma	up	Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
mir-19b	osteosarcoma	up	The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.
mir-20a	b-cell lymphoma	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-20a	breast carcinoma	up	MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
mir-20a	chronic myelogenous leukemia	up	miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.
mir-20a	colorectal cancer	up	MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
mir-20a	esophageal squamous cell carcinoma	up	TNF-? is a novel target of miR-19a.
mir-20a	hepatocellular carcinoma	up	MiR-17-92 cluster promotes hepatocarcinogenesis.
mir-20a	lung cancer	up	A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
mir-20a	lung cancer	up	Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
mir-20a	lung cancer	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-20a	mantle cell lymphoma	up	The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
mir-20a	osteosarcoma	up	Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
mir-20a	osteosarcoma	up	The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.
mir-92a	b-cell lymphoma	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-92a	breast carcinoma	up	MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
mir-92a	chronic myelogenous leukemia	up	miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.
mir-92a	colorectal cancer	up	MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
mir-92a	esophageal squamous cell carcinoma	up	TNF-? is a novel target of miR-19a.
mir-92a	hepatocellular carcinoma	up	MiR-17-92 cluster promotes hepatocarcinogenesis.
mir-92a	lung cancer	up	A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
mir-92a	lung cancer	up	Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
mir-92a	lung cancer	up	MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
mir-92a	mantle cell lymphoma	up	The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
mir-92a	osteosarcoma	up	Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
mir-92a	osteosarcoma	up	The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.
mmu-mir-290-3p	breast cancer	down	Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b.
mmu-mir-290-5p	breast cancer	down	Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b.